country,term,count
AL,ACUTE MYOCARDIAL INFARCTION,2
DZ,DEATH,2
DZ,HAEMATURIA,2
DZ,CARDIAC VENTRICULAR DISORDER,1
DZ,CEREBRAL HAEMATOMA,1
DZ,CHOLESTASIS,1
DZ,CONVULSION,1
DZ,GINGIVAL BLEEDING,1
DZ,HAEMATEMESIS,1
DZ,MENINGORRHAGIA,1
DZ,OVERDOSE,1
DZ,TREATMENT FAILURE,1
DZ,VENTRICULAR FIBRILLATION,1
DZ,VOMITING,1
AR,HYPERTENSION,7
AR,FATIGUE,6
AR,BLOOD PRESSURE INCREASED,5
AR,PNEUMONIA,5
AR,ACUTE MYOCARDIAL INFARCTION,4
AR,DRUG INEFFECTIVE,4
AR,DYSPNOEA,4
AR,INFARCTION,4
AR,INFECTION,4
AR,RENAL FAILURE,4
AR,ANAEMIA,3
AR,ARTERIAL OCCLUSIVE DISEASE,3
AR,ASTHENIA,3
AR,BLOOD PRESSURE FLUCTUATION,3
AR,CARDIAC ARREST,3
AR,COUGH,3
AR,DIABETES MELLITUS,3
AR,DRUG-INDUCED LIVER INJURY,3
AR,HEADACHE,3
AR,MYOCARDIAL INFARCTION,3
AR,NEUTROPENIA,3
AR,PAIN,3
AR,PAIN IN EXTREMITY,3
AR,PARKINSON^S DISEASE,3
AR,URINARY TRACT INFECTION,3
AR,WEIGHT DECREASED,3
AR,ABDOMINAL PAIN UPPER,2
AR,ANGINA PECTORIS,2
AR,BLOOD PRESSURE ABNORMAL,2
AR,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
AR,BRONCHIECTASIS,2
AR,CARDIAC FAILURE,2
AR,CORONARY ARTERY DISEASE,2
AR,CORONARY ARTERY OCCLUSION,2
AR,DEPRESSION,2
AR,DIABETIC FOOT,2
AR,DRUG ADMINISTRATION ERROR,2
AR,DYSPEPSIA,2
AR,HAEMATOMA,2
AR,HAEMATURIA,2
AR,HEPATIC STEATOSIS,2
AR,HEPATOMEGALY,2
AR,HIATUS HERNIA,2
AR,HYPOTENSION,2
AR,INJECTION SITE PAIN,2
AR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
AR,LOSS OF CONSCIOUSNESS,2
AR,NAUSEA,2
AR,PERIPHERAL SWELLING,2
AR,PRODUCT USE IN UNAPPROVED INDICATION,2
AR,PULMONARY FIBROSIS,2
AR,PYREXIA,2
AR,SUDDEN DEATH,2
AR,SYNCOPE,2
AR,VOMITING,2
AR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
AR,ABASIA,1
AR,ABNORMAL FAECES,1
AR,ACCIDENTAL OVERDOSE,1
AR,ACUTE CORONARY SYNDROME,1
AR,ACUTE KIDNEY INJURY,1
AR,AGEUSIA,1
AR,ANAL ABSCESS,1
AR,ANGINA UNSTABLE,1
AR,ANGIOEDEMA,1
AR,AORTIC ANEURYSM,1
AR,AORTIC DILATATION,1
AR,APNOEA,1
AR,ARRHYTHMIA,1
AR,ARTERIAL DISORDER,1
AR,ARTERIAL STENOSIS,1
AR,ARTHRALGIA,1
AR,ASCITES,1
AR,ASPIRATION,1
AR,ASTHMA,1
AR,ATRIOVENTRICULAR BLOCK,1
AR,BACK PAIN,1
AR,BACTERAEMIA,1
AR,BALANITIS CANDIDA,1
AR,BILE DUCT STENOSIS,1
AR,BLOOD CHOLESTEROL INCREASED,1
AR,BLOOD GLUCOSE INCREASED,1
AR,BLOOD PRESSURE DECREASED,1
AR,BLOOD PRESSURE SYSTOLIC INCREASED,1
AR,BLOOD SODIUM DECREASED,1
AR,BRADYCARDIA,1
AR,BRONCHITIS,1
AR,BRONCHOSPASM,1
AR,BRUXISM,1
AR,CARDIAC DISORDER,1
AR,CARDIO-RESPIRATORY ARREST,1
AR,CEREBROVASCULAR ACCIDENT,1
AR,CHEST DISCOMFORT,1
AR,CHOKING,1
AR,CHRONIC KIDNEY DISEASE,1
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AR,COLON NEOPLASM,1
AR,CONGENITAL CYSTIC KIDNEY DISEASE,1
AR,CONTUSION,1
AR,DEVICE RELATED INFECTION,1
AR,DIABETES MELLITUS INADEQUATE CONTROL,1
AR,DIABETIC COMPLICATION,1
AR,DISEASE PROGRESSION,1
AR,DRUG INTOLERANCE,1
AR,DRY GANGRENE,1
AR,DYSPNOEA PAROXYSMAL NOCTURNAL,1
AR,ECZEMA,1
AR,EXERCISE TOLERANCE DECREASED,1
AR,FALL,1
AR,FEAR,1
AR,FLATULENCE,1
AR,FOOD INTOLERANCE,1
AR,GAIT DISTURBANCE,1
AR,GALLBLADDER ADENOMA,1
AR,GALLBLADDER POLYP,1
AR,GANGRENE,1
AR,GASTRIC DISORDER,1
AR,GASTRIC HAEMORRHAGE,1
AR,GASTRITIS,1
AR,GASTRITIS EROSIVE,1
AR,GENITAL HAEMORRHAGE,1
AR,GINGIVAL BLEEDING,1
AR,HAEMORRHAGE,1
AR,HAEMORRHAGIC ANAEMIA,1
AR,HAND DEFORMITY,1
AR,HEPATIC NECROSIS,1
AR,HEPATITIS,1
AR,HEPATITIS ACUTE,1
AR,HEPATOTOXICITY,1
AR,HERNIAL EVENTRATION,1
AR,HIP FRACTURE,1
AR,HOT FLUSH,1
AR,HYPERSENSITIVITY,1
AR,HYPERTENSIVE CRISIS,1
AR,HYPERTENSIVE EMERGENCY,1
AR,HYPOGLYCAEMIA,1
AR,HYPOKINESIA,1
AR,HYPOTHYROIDISM,1
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AR,INCORRECT DOSE ADMINISTERED,1
AR,INCORRECT PRODUCT STORAGE,1
AR,INFLUENZA LIKE ILLNESS,1
AR,INGUINAL HERNIA,1
AR,INJECTION SITE BRUISING,1
AR,INJECTION SITE HAEMATOMA,1
AR,INJECTION SITE INFLAMMATION,1
AR,ISCHAEMIC STROKE,1
AR,JOINT SWELLING,1
AR,LARYNGOSPASM,1
AR,LEFT VENTRICULAR DYSFUNCTION,1
AR,LETHARGY,1
AR,LIVER DISORDER,1
AR,LUNG DISORDER,1
AR,LUNG NEOPLASM MALIGNANT,1
AR,MALAISE,1
AR,MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
AR,MITRAL VALVE INCOMPETENCE,1
AR,MONOPLEGIA,1
AR,MOVEMENT DISORDER,1
AR,MUSCLE SPASMS,1
AR,NASOPHARYNGITIS,1
AR,NECK PAIN,1
AR,NECROTISING FASCIITIS,1
AR,NERVOUSNESS,1
AR,OCULAR HYPERAEMIA,1
AR,OEDEMA PERIPHERAL,1
AR,OROPHARYNGEAL DISCOMFORT,1
AR,OSTEOARTHRITIS,1
AR,PAINFUL RESPIRATION,1
AR,PANCYTOPENIA,1
AR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AR,PERIPHERAL VASCULAR DISORDER,1
AR,PERIPHERAL VENOUS DISEASE,1
AR,PERITONEAL EFFLUENT ABNORMAL,1
AR,PERITONEAL HAEMORRHAGE,1
AR,PLEURAL EFFUSION,1
AR,PROSTATE CANCER,1
AR,PROSTATITIS,1
AR,PRURITUS,1
AR,PRURITUS GENERALISED,1
AR,PSORIATIC ARTHROPATHY,1
AR,PULMONARY OEDEMA,1
AR,RENAL CANCER,1
AR,RENAL DISORDER,1
AR,RENAL FAILURE CHRONIC,1
AR,RESPIRATION ABNORMAL,1
AR,SCLERODERMA,1
AR,SEPSIS,1
AR,SINUS TACHYCARDIA,1
AR,SKIN DISCOLOURATION,1
AR,SKIN INFECTION,1
AR,SKIN ULCER,1
AR,SOFT TISSUE INFECTION,1
AR,STENOSIS,1
AR,STRESS,1
AR,STRESS ECHOCARDIOGRAM ABNORMAL,1
AR,SYNOVIAL RUPTURE,1
AR,TACHYCARDIA,1
AR,TESTICULAR PAIN,1
AR,THROMBOCYTOPENIA,1
AR,TOXICITY TO VARIOUS AGENTS,1
AR,TUMOUR HAEMORRHAGE,1
AR,TYPE 1 DIABETES MELLITUS,1
AR,URINARY INCONTINENCE,1
AR,VAGINAL HAEMORRHAGE,1
AR,WEIGHT INCREASED,1
AR,WHEEZING,1
AR,WHITE BLOOD CELL COUNT DECREASED,1
AU,DRUG-INDUCED LIVER INJURY,34
AU,DYSPNOEA,26
AU,FALL,24
AU,CHEST PAIN,23
AU,ACUTE MYOCARDIAL INFARCTION,22
AU,HYPOTENSION,19
AU,MYOCARDIAL INFARCTION,19
AU,MALAISE,18
AU,DEATH,16
AU,NAUSEA,16
AU,ABDOMINAL PAIN,14
AU,DIARRHOEA,14
AU,FATIGUE,14
AU,PNEUMONIA,14
AU,VOMITING,14
AU,ANGIOEDEMA,13
AU,CARDIAC ARREST,13
AU,DIZZINESS,13
AU,HAEMORRHAGE,13
AU,HYPERTENSION,12
AU,ANGINA PECTORIS,11
AU,DRUG INEFFECTIVE,11
AU,HAEMOGLOBIN DECREASED,11
AU,LOSS OF CONSCIOUSNESS,11
AU,PAIN,11
AU,DYSPHAGIA,10
AU,HAEMATOMA,10
AU,TRANSIENT ISCHAEMIC ATTACK,10
AU,ACUTE KIDNEY INJURY,9
AU,ATRIAL FIBRILLATION,9
AU,CELLULITIS,9
AU,CONTUSION,9
AU,RENAL FAILURE ACUTE,9
AU,RENAL HAEMORRHAGE,9
AU,CARDIAC FAILURE,8
AU,CEREBROVASCULAR ACCIDENT,8
AU,CONDITION AGGRAVATED,8
AU,CONFUSIONAL STATE,8
AU,GASTROOESOPHAGEAL REFLUX DISEASE,8
AU,HEADACHE,8
AU,HYPOGLYCAEMIA,8
AU,MYOCARDIAL ISCHAEMIA,8
AU,MYOPATHY,8
AU,OVERDOSE,8
AU,SYNCOPE,8
AU,VASCULAR PSEUDOANEURYSM,8
AU,ANAEMIA,7
AU,ARTHRALGIA,7
AU,BRADYCARDIA,7
AU,HEPATOTOXICITY,7
AU,LETHARGY,7
AU,TACHYCARDIA,7
AU,ASTHENIA,6
AU,BLOOD PRESSURE INCREASED,6
AU,CHEST DISCOMFORT,6
AU,COMA SCALE ABNORMAL,6
AU,COUGH,6
AU,CYSTOID MACULAR OEDEMA,6
AU,FEELING ABNORMAL,6
AU,GASTROINTESTINAL HAEMORRHAGE,6
AU,HYPONATRAEMIA,6
AU,INFLUENZA,6
AU,LEFT VENTRICULAR DYSFUNCTION,6
AU,MUSCULAR WEAKNESS,6
AU,PAIN IN EXTREMITY,6
AU,PALPITATIONS,6
AU,PLATELET COUNT DECREASED,6
AU,PYREXIA,6
AU,RASH,6
AU,RENAL IMPAIRMENT,6
AU,RETINAL HAEMORRHAGE,6
AU,SEPSIS,6
AU,THROMBOCYTOPENIA,6
AU,BALANCE DISORDER,5
AU,BLOOD GLUCOSE INCREASED,5
AU,COLONIC PSEUDO-OBSTRUCTION,5
AU,CORONARY ARTERY DISEASE,5
AU,GENERAL PHYSICAL HEALTH DETERIORATION,5
AU,HAEMORRHAGE INTRACRANIAL,5
AU,HYPOVOLAEMIC SHOCK,5
AU,JOINT SWELLING,5
AU,LIVER FUNCTION TEST ABNORMAL,5
AU,LOWER RESPIRATORY TRACT INFECTION,5
AU,NEUTROPHIL COUNT INCREASED,5
AU,PULMONARY EMBOLISM,5
AU,RETINAL ARTERY OCCLUSION,5
AU,RETINAL EXUDATES,5
AU,SOMNOLENCE,5
AU,TROPONIN INCREASED,5
AU,VISION BLURRED,5
AU,ABDOMINAL DISTENSION,4
AU,ABDOMINAL TENDERNESS,4
AU,ACUTE CORONARY SYNDROME,4
AU,BACK PAIN,4
AU,BLOOD CREATININE INCREASED,4
AU,BLOOD IRON DECREASED,4
AU,CARDIAC DISORDER,4
AU,CHILLS,4
AU,CIRCULATORY COLLAPSE,4
AU,CONVULSION,4
AU,DECREASED APPETITE,4
AU,DEHYDRATION,4
AU,DRUG HYPERSENSITIVITY,4
AU,EPISTAXIS,4
AU,EYE PAIN,4
AU,GLOMERULAR FILTRATION RATE DECREASED,4
AU,HAEMATURIA,4
AU,HALLUCINATION,4
AU,HIP FRACTURE,4
AU,HOT FLUSH,4
AU,HYPERHIDROSIS,4
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
AU,INFECTIVE EXACERBATION OF BRONCHIECTASIS,4
AU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,4
AU,LACERATION,4
AU,LOCALISED INFECTION,4
AU,MEMORY IMPAIRMENT,4
AU,MULTI-ORGAN FAILURE,4
AU,NEUTROPENIA,4
AU,OEDEMA PERIPHERAL,4
AU,OSTEOPOROSIS,4
AU,PARAESTHESIA,4
AU,PLEURAL EFFUSION,4
AU,PRURITUS,4
AU,PULMONARY OEDEMA,4
AU,RENAL FAILURE,4
AU,RESPIRATORY FAILURE,4
AU,SKIN CANCER,4
AU,URINARY TRACT INFECTION,4
AU,URTICARIA,4
AU,WEIGHT INCREASED,4
AU,WHITE BLOOD CELL COUNT INCREASED,4
AU,ABDOMINAL DISCOMFORT,3
AU,ABDOMINAL PAIN UPPER,3
AU,ANAPHYLACTIC REACTION,3
AU,ANXIETY,3
AU,AORTIC STENOSIS,3
AU,APHASIA,3
AU,BASAL CELL CARCINOMA,3
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
AU,BLOOD POTASSIUM INCREASED,3
AU,BLOOD PRESSURE SYSTOLIC INCREASED,3
AU,BLOOD UREA INCREASED,3
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
AU,COGNITIVE DISORDER,3
AU,DEAFNESS,3
AU,DIVERTICULITIS,3
AU,DRUG ADMINISTRATION ERROR,3
AU,EJECTION FRACTION DECREASED,3
AU,FEMUR FRACTURE,3
AU,GAIT DISTURBANCE,3
AU,GASTROINTESTINAL SOUNDS ABNORMAL,3
AU,GLAUCOMA,3
AU,HAEMATOCRIT DECREASED,3
AU,HEART RATE INCREASED,3
AU,HYPERCHOLESTEROLAEMIA,3
AU,HYPOAESTHESIA,3
AU,HYPOKALAEMIA,3
AU,HYPOPHAGIA,3
AU,INFECTION,3
AU,LIMB INJURY,3
AU,MALIGNANT NEOPLASM PROGRESSION,3
AU,MELAENA,3
AU,MONOCYTE COUNT INCREASED,3
AU,MYOCLONUS,3
AU,MYOSITIS,3
AU,OCULAR ICTERUS,3
AU,ORTHOSTATIC HYPOTENSION,3
AU,PALLOR,3
AU,PANCYTOPENIA,3
AU,PERICARDIAL EFFUSION,3
AU,PULMONARY HAEMORRHAGE,3
AU,RASH MACULO-PAPULAR,3
AU,RASH PRURITIC,3
AU,RHABDOMYOLYSIS,3
AU,SCHIZOPHRENIA,3
AU,SKIN ULCER,3
AU,STENT PLACEMENT,3
AU,SUBDURAL HAEMATOMA,3
AU,SUICIDAL IDEATION,3
AU,SWELLING,3
AU,VENTRICULAR HYPOKINESIA,3
AU,VISUAL ACUITY REDUCED,3
AU,WEIGHT DECREASED,3
AU,YELLOW SKIN,3
AU,ABDOMINAL PAIN LOWER,2
AU,ACCIDENTAL EXPOSURE TO PRODUCT,2
AU,ACIDOSIS,2
AU,ADRENAL GLAND CANCER,2
AU,AGEUSIA,2
AU,APLASIA PURE RED CELL,2
AU,ARTHRITIS,2
AU,ASCITES,2
AU,ASTHMA,2
AU,ATRIAL FLUTTER,2
AU,AUTONOMIC NEUROPATHY,2
AU,BACTERAEMIA,2
AU,BACTERIAL INFECTION,2
AU,BLOOD BICARBONATE INCREASED,2
AU,BLOOD CALCIUM DECREASED,2
AU,BLOOD CALCIUM INCREASED,2
AU,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,2
AU,BLOOD PARATHYROID HORMONE INCREASED,2
AU,BODY TEMPERATURE INCREASED,2
AU,BREAST CANCER,2
AU,C-REACTIVE PROTEIN INCREASED,2
AU,CALCIUM IONISED INCREASED,2
AU,CARDIAC FAILURE CONGESTIVE,2
AU,CARDIOVASCULAR DISORDER,2
AU,CATARACT,2
AU,CEREBRAL HAEMORRHAGE,2
AU,CEREBRAL INFARCTION,2
AU,CEREBRAL ISCHAEMIA,2
AU,CHRONIC KIDNEY DISEASE,2
AU,CLAVICLE FRACTURE,2
AU,CLONUS,2
AU,COLD SWEAT,2
AU,COMPARTMENT SYNDROME,2
AU,CONSTIPATION,2
AU,CORONARY ARTERY STENOSIS,2
AU,CYSTITIS,2
AU,CYTOMEGALOVIRUS GASTRITIS,2
AU,DEAFNESS BILATERAL,2
AU,DELIRIUM,2
AU,DEPRESSION,2
AU,DISEASE PROGRESSION,2
AU,DISORIENTATION,2
AU,DIVERTICULUM,2
AU,DRY EYE,2
AU,DRY MOUTH,2
AU,DYSPHONIA,2
AU,DYSPNOEA EXERTIONAL,2
AU,DYSURIA,2
AU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
AU,ENTERITIS,2
AU,FOOD INTERACTION,2
AU,FUNCTIONAL GASTROINTESTINAL DISORDER,2
AU,GASTRIC DILATATION,2
AU,GASTRIC HAEMORRHAGE,2
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
AU,GOUT,2
AU,HAEMOPTYSIS,2
AU,HAEMORRHAGIC STROKE,2
AU,HAEMORRHOIDAL HAEMORRHAGE,2
AU,HEMIPLEGIA,2
AU,HEPATITIS C,2
AU,HERNIA,2
AU,HYPERSENSITIVITY,2
AU,HYPERTONIA,2
AU,HYPOCALCAEMIA,2
AU,HYPOXIA,2
AU,IRON DEFICIENCY,2
AU,ISCHAEMIC STROKE,2
AU,JAUNDICE,2
AU,KNEE ARTHROPLASTY,2
AU,LEUKOCYTOSIS,2
AU,LEUKOPENIA,2
AU,LOW DENSITY LIPOPROTEIN INCREASED,2
AU,LYMPHOCYTE COUNT INCREASED,2
AU,MUCOSAL INFLAMMATION,2
AU,MUSCLE RIGIDITY,2
AU,MUSCLE SPASMS,2
AU,MUSCULOSKELETAL PAIN,2
AU,MUSCULOSKELETAL STIFFNESS,2
AU,MYALGIA,2
AU,MYOCARDITIS,2
AU,MYOGLOBINURIA,2
AU,NECK PAIN,2
AU,NEPHROPATHY,2
AU,NERVE COMPRESSION,2
AU,NEUROPATHY PERIPHERAL,2
AU,NOCTURIA,2
AU,OEDEMA,2
AU,ORAL PAIN,2
AU,ORTHOPNOEA,2
AU,OSTEOARTHRITIS,2
AU,OSTEOMYELITIS,2
AU,OSTEONECROSIS OF JAW,2
AU,OSTEOPOROTIC FRACTURE,2
AU,OXYGEN SATURATION DECREASED,2
AU,PAIN IN JAW,2
AU,POLLAKIURIA,2
AU,PRESYNCOPE,2
AU,PRODUCT QUALITY ISSUE,2
AU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
AU,PSYCHOTIC DISORDER,2
AU,RASH MACULAR,2
AU,RECTAL HAEMORRHAGE,2
AU,RED BLOOD CELL COUNT DECREASED,2
AU,RED CELL DISTRIBUTION WIDTH INCREASED,2
AU,RENAL HAEMATOMA,2
AU,RENAL PAIN,2
AU,RESPIRATORY ARREST,2
AU,RESPIRATORY DISTRESS,2
AU,RETROPERITONEAL HAEMORRHAGE,2
AU,RHEUMATOID ARTHRITIS,2
AU,RIB FRACTURE,2
AU,SEDATION,2
AU,SEROTONIN SYNDROME,2
AU,SKIN DISCOLOURATION,2
AU,SKIN LESION,2
AU,SKIN MASS,2
AU,SLEEP APNOEA SYNDROME,2
AU,SPUTUM DISCOLOURED,2
AU,SQUAMOUS CELL CARCINOMA,2
AU,STAPHYLOCOCCAL INFECTION,2
AU,SWOLLEN TONGUE,2
AU,SYSTOLIC DYSFUNCTION,2
AU,TEMPERATURE INTOLERANCE,2
AU,THERAPY CESSATION,2
AU,THIRST,2
AU,THROMBOSIS,2
AU,TOOTH EXTRACTION,2
AU,TRANSFERRIN SATURATION DECREASED,2
AU,TUBULOINTERSTITIAL NEPHRITIS,2
AU,UNRESPONSIVE TO STIMULI,2
AU,URINARY INCONTINENCE,2
AU,VASCULITIS,2
AU,VASODILATATION,2
AU,VENTRICULAR FIBRILLATION,2
AU,VENTRICULAR TACHYCARDIA,2
AU,VITREOUS HAEMORRHAGE,2
AU,WHITE BLOOD CELL COUNT DECREASED,2
AU,ABASIA,1
AU,ABNORMAL BEHAVIOUR,1
AU,ABNORMAL SENSATION IN EYE,1
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,1
AU,ACUTE MYELOID LEUKAEMIA,1
AU,ACUTE PULMONARY OEDEMA,1
AU,ACUTE RESPIRATORY DISTRESS SYNDROME,1
AU,ACUTE RESPIRATORY FAILURE,1
AU,ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD,1
AU,ADVERSE DRUG REACTION,1
AU,ADVERSE EVENT,1
AU,AFFECT LABILITY,1
AU,AGGRESSION,1
AU,AGITATION,1
AU,ALOPECIA,1
AU,ALTERED STATE OF CONSCIOUSNESS,1
AU,AMAUROSIS FUGAX,1
AU,ANGER,1
AU,ANGIODYSPLASIA,1
AU,ANGIOMYOLIPOMA,1
AU,ANGIOPLASTY,1
AU,ANION GAP INCREASED,1
AU,ANOSMIA,1
AU,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,1
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,1
AU,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
AU,AORTIC DILATATION,1
AU,AORTIC DISSECTION,1
AU,AORTIC VALVE INCOMPETENCE,1
AU,APPARENT DEATH,1
AU,APPENDICITIS,1
AU,ARTERIAL OCCLUSIVE DISEASE,1
AU,ARTERIAL THROMBOSIS,1
AU,ARTERIOGRAM CORONARY ABNORMAL,1
AU,ARTERIOSCLEROSIS,1
AU,ARTHRITIS BACTERIAL,1
AU,ARTHROPATHY,1
AU,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
AU,ASTHENOPIA,1
AU,ATELECTASIS,1
AU,ATRIOVENTRICULAR BLOCK COMPLETE,1
AU,AUTOIMMUNE COLITIS,1
AU,BACK DISORDER,1
AU,BACTERIAL PROSTATITIS,1
AU,BACTERIAL SEPSIS,1
AU,BALANOPOSTHITIS,1
AU,BENIGN PROSTATIC HYPERPLASIA,1
AU,BILE DUCT OBSTRUCTION,1
AU,BILIRUBIN CONJUGATED INCREASED,1
AU,BIOPSY LYMPH GLAND,1
AU,BIPOLAR DISORDER,1
AU,BLEPHARITIS,1
AU,BLINDNESS TRANSIENT,1
AU,BLISTER,1
AU,BLOOD ALBUMIN DECREASED,1
AU,BLOOD ALKALINE PHOSPHATASE DECREASED,1
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
AU,BLOOD BILIRUBIN INCREASED,1
AU,BLOOD CHLORIDE DECREASED,1
AU,BLOOD CHLORIDE INCREASED,1
AU,BLOOD CHOLESTEROL INCREASED,1
AU,BLOOD GLUCOSE ABNORMAL,1
AU,BLOOD KETONE BODY,1
AU,BLOOD LACTIC ACID,1
AU,BLOOD LACTIC ACID INCREASED,1
AU,BLOOD MAGNESIUM DECREASED,1
AU,BLOOD MAGNESIUM INCREASED,1
AU,BLOOD PH DECREASED,1
AU,BLOOD PHOSPHORUS INCREASED,1
AU,BLOOD PRESSURE ABNORMAL,1
AU,BLOOD TESTOSTERONE INCREASED,1
AU,BLOOD TRIGLYCERIDES INCREASED,1
AU,BLOOD UREA NITROGEN/CREATININE RATIO INCREASED,1
AU,BLOOD URIC ACID INCREASED,1
AU,BLOOD URINE PRESENT,1
AU,BONE CANCER METASTATIC,1
AU,BONE PAIN,1
AU,BOWEL MOVEMENT IRREGULARITY,1
AU,BREAST TENDERNESS,1
AU,BRONCHIECTASIS,1
AU,BRONCHITIS,1
AU,CANCER SURGERY,1
AU,CARDIAC COMPLICATION ASSOCIATED WITH DEVICE,1
AU,CARDIAC FLUTTER,1
AU,CARDIAC MURMUR,1
AU,CARDIOGENIC SHOCK,1
AU,CARDIOMYOPATHY,1
AU,CARDIOPULMONARY FAILURE,1
AU,CARDIOVERSION,1
AU,CAROTID ARTERY STENOSIS,1
AU,CATARACT OPERATION,1
AU,CATHETER MANAGEMENT,1
AU,CATHETER SITE HAEMORRHAGE,1
AU,CEREBELLAR INFARCTION,1
AU,CHOKING,1
AU,CHOLECYSTECTOMY,1
AU,CHOLECYSTITIS,1
AU,CHOLECYSTITIS INFECTIVE,1
AU,CHOLELITHIASIS,1
AU,CLAUSTROPHOBIA,1
AU,COLITIS,1
AU,COLONIC OBSTRUCTION,1
AU,COLONOSCOPY,1
AU,COLOSTOMY,1
AU,CONCOMITANT DISEASE AGGRAVATED,1
AU,CONCOMITANT DISEASE PROGRESSION,1
AU,CONJUNCTIVAL HAEMORRHAGE,1
AU,CONTRAINDICATED PRODUCT ADMINISTERED,1
AU,CORNEAL DEPOSITS,1
AU,CORONARY ANGIOPLASTY,1
AU,CORONARY ARTERIAL STENT INSERTION,1
AU,CORONARY ARTERY DILATATION,1
AU,CORONARY ARTERY DISSECTION,1
AU,CORONARY ARTERY OCCLUSION,1
AU,COSTOVERTEBRAL ANGLE TENDERNESS,1
AU,CREATININE RENAL CLEARANCE ABNORMAL,1
AU,CYST,1
AU,CYTOMEGALOVIRUS OESOPHAGITIS,1
AU,DEEP VEIN THROMBOSIS,1
AU,DEMENTIA ALZHEIMER^S TYPE,1
AU,DEMYELINATION,1
AU,DENTAL CARIES,1
AU,DEVICE DIFFICULT TO USE,1
AU,DEVICE OCCLUSION,1
AU,DIABETES MELLITUS INADEQUATE CONTROL,1
AU,DIASTOLIC DYSFUNCTION,1
AU,DIFFUSE LARGE B-CELL LYMPHOMA,1
AU,DISSEMINATED INTRAVASCULAR COAGULATION,1
AU,DRUG DISPENSING ERROR,1
AU,DRUG INTOLERANCE,1
AU,DRUG LEVEL INCREASED,1
AU,DRUG WITHDRAWAL MAINTENANCE THERAPY,1
AU,DYSGEUSIA,1
AU,EAR INFECTION,1
AU,ECG SIGNS OF MYOCARDIAL ISCHAEMIA,1
AU,ELECTROCARDIOGRAM ABNORMAL,1
AU,ELECTROCARDIOGRAM QT PROLONGED,1
AU,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
AU,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
AU,ELECTROCARDIOGRAM T WAVE INVERSION,1
AU,EMBOLISM,1
AU,EMPHYSEMA,1
AU,ENCEPHALITIS,1
AU,ENCOPRESIS,1
AU,ENDOSCOPY UPPER GASTROINTESTINAL TRACT,1
AU,ENTERITIS INFECTIOUS,1
AU,ENTEROCOLITIS,1
AU,EOSINOPHILIA,1
AU,EPIGLOTTITIS,1
AU,ERYTHEMA,1
AU,ESCHERICHIA BACTERAEMIA,1
AU,ESCHERICHIA INFECTION,1
AU,ESCHERICHIA SEPSIS,1
AU,ESCHERICHIA URINARY TRACT INFECTION,1
AU,EYE DISORDER,1
AU,FACE OEDEMA,1
AU,FACIAL PAIN,1
AU,FACIAL PARALYSIS,1
AU,FAECAL INCONTINENCE,1
AU,FAECES DISCOLOURED,1
AU,FEELING HOT,1
AU,FEELING JITTERY,1
AU,FEMORAL NECK FRACTURE,1
AU,FLANK PAIN,1
AU,FLATULENCE,1
AU,FLUID OVERLOAD,1
AU,FLUSHING,1
AU,FOOD ALLERGY,1
AU,FOOT FRACTURE,1
AU,FOREIGN BODY,1
AU,FUNGAL INFECTION,1
AU,GALLBLADDER OBSTRUCTION,1
AU,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
AU,GANGRENE,1
AU,GASTRIC DISORDER,1
AU,GASTRIC ULCER,1
AU,GASTRITIS,1
AU,GASTROENTERITIS,1
AU,GASTROINTESTINAL DISORDER,1
AU,GRIEF REACTION,1
AU,HAEMATEMESIS,1
AU,HAEMATOCHEZIA,1
AU,HAEMODYNAMIC INSTABILITY,1
AU,HAEMOGLOBIN INCREASED,1
AU,HAEMOLYSIS,1
AU,HAEMORRHAGIC INFARCTION,1
AU,HALLUCINATION_ AUDITORY,1
AU,HEAD DISCOMFORT,1
AU,HEART RATE DECREASED,1
AU,HEART RATE IRREGULAR,1
AU,HEMIANOPIA HOMONYMOUS,1
AU,HEPATIC CIRRHOSIS,1
AU,HEPATIC CYST,1
AU,HEPATIC ENZYME INCREASED,1
AU,HEPATIC FAILURE,1
AU,HEPATIC STEATOSIS,1
AU,HEPATITIS,1
AU,HEPATOMEGALY,1
AU,HERPES ZOSTER,1
AU,HIGH FREQUENCY ABLATION,1
AU,HOMELESS,1
AU,HOSPITALISATION,1
AU,HYPERCALCAEMIA,1
AU,HYPERNATRAEMIA,1
AU,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
AU,HYPERPARATHYROIDISM PRIMARY,1
AU,HYPHAEMA,1
AU,HYPOKINESIA,1
AU,HYPOMAGNESAEMIA,1
AU,HYPOPHOSPHATAEMIA,1
AU,HYPOPITUITARISM,1
AU,HYPOTHYROIDISM,1
AU,HYPOVOLAEMIA,1
AU,IDIOPATHIC PULMONARY FIBROSIS,1
AU,IMPAIRED DRIVING ABILITY,1
AU,IMPAIRED HEALING,1
AU,IMPAIRED SELF-CARE,1
AU,IMPLANT SITE DISCHARGE,1
AU,INCONTINENCE,1
AU,INCORRECT DOSE ADMINISTERED,1
AU,INFECTIOUS PLEURAL EFFUSION,1
AU,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
AU,INFERIOR VENA CAVA DILATATION,1
AU,INGROWN HAIR,1
AU,INJECTION SITE BRUISING,1
AU,INJECTION SITE INFECTION,1
AU,INJECTION SITE PAIN,1
AU,INJURY,1
AU,INSOMNIA,1
AU,INTERSTITIAL LUNG DISEASE,1
AU,INTERVERTEBRAL DISC DEGENERATION,1
AU,INTESTINAL PERFORATION,1
AU,INTRAOCULAR PRESSURE INCREASED,1
AU,INTRAVENTRICULAR HAEMORRHAGE,1
AU,IRON DEFICIENCY ANAEMIA,1
AU,ISCHAEMIC CARDIOMYOPATHY,1
AU,JAUNDICE CHOLESTATIC,1
AU,JOINT INJURY,1
AU,JOINT RANGE OF MOTION DECREASED,1
AU,JOINT STIFFNESS,1
AU,KIDNEY INFECTION,1
AU,KNEE OPERATION,1
AU,LACTIC ACIDOSIS,1
AU,LARGE INTESTINAL OBSTRUCTION,1
AU,LARGE INTESTINE POLYP,1
AU,LEFT ATRIAL DILATATION,1
AU,LEFT VENTRICULAR FAILURE,1
AU,LEFT VENTRICULAR HYPERTROPHY,1
AU,LIMB DISCOMFORT,1
AU,LOCAL SWELLING,1
AU,LOWER GASTROINTESTINAL HAEMORRHAGE,1
AU,LOWER LIMB FRACTURE,1
AU,LUNG INFECTION,1
AU,LYMPHADENOPATHY,1
AU,LYMPHADENOPATHY MEDIASTINAL,1
AU,LYMPHOCYTE COUNT DECREASED,1
AU,LYMPHOCYTIC HYPOPHYSITIS,1
AU,MACULAR DEGENERATION,1
AU,MACULAR OEDEMA,1
AU,MAGNESIUM DEFICIENCY,1
AU,MEAN CELL VOLUME INCREASED,1
AU,MELANOSIS COLI,1
AU,MESENTERIC ARTERY EMBOLISM,1
AU,METASTASES TO BONE MARROW,1
AU,METASTASES TO CENTRAL NERVOUS SYSTEM,1
AU,METASTASES TO EYE,1
AU,METASTASES TO GASTROINTESTINAL TRACT,1
AU,METASTASES TO LIVER,1
AU,METASTATIC NEOPLASM,1
AU,METASTATIC RENAL CELL CARCINOMA,1
AU,MIGRAINE,1
AU,MITRAL VALVE INCOMPETENCE,1
AU,MOBILITY DECREASED,1
AU,MOTION SICKNESS,1
AU,MUCOSAL ULCERATION,1
AU,MUCOUS STOOLS,1
AU,MUSCULOSKELETAL CHEST PAIN,1
AU,MYDRIASIS,1
AU,MYELOCYTE COUNT INCREASED,1
AU,MYELODYSPLASTIC SYNDROME,1
AU,NAIL GROWTH ABNORMAL,1
AU,NASOPHARYNGITIS,1
AU,NECROTISING MYOSITIS,1
AU,NEOPLASM,1
AU,NEOPLASM PROGRESSION,1
AU,NERVE INJURY,1
AU,NEUTROPHIL COUNT DECREASED,1
AU,NIPPLE PAIN,1
AU,OCULAR HYPERAEMIA,1
AU,OCULAR MYASTHENIA,1
AU,OLIGURIA,1
AU,OPPORTUNISTIC INFECTION,1
AU,ORBITAL OEDEMA,1
AU,OROPHARYNGEAL PAIN,1
AU,PANCREATIC CYST,1
AU,PANCREATITIS,1
AU,PARACENTESIS,1
AU,PARAESTHESIA ORAL,1
AU,PARASITIC GASTROENTERITIS,1
AU,PARKINSONISM,1
AU,PENILE BLISTER,1
AU,PEPTIC ULCER,1
AU,PEPTIC ULCER HAEMORRHAGE,1
AU,PERICARDITIS,1
AU,PERIORBITAL OEDEMA,1
AU,PERIPHERAL SWELLING,1
AU,PERIPHERAL VASCULAR DISORDER,1
AU,PERITONEAL HAEMORRHAGE,1
AU,PERITONITIS,1
AU,PERITONITIS BACTERIAL,1
AU,PHARYNGEAL OEDEMA,1
AU,PHOTOPHOBIA,1
AU,PHOTOSENSITIVITY REACTION,1
AU,PLATELET DYSFUNCTION,1
AU,PNEUMONIA CRYPTOCOCCAL,1
AU,PNEUMONITIS,1
AU,POISONING DELIBERATE,1
AU,POLYMORPHIC LIGHT ERUPTION,1
AU,POST PROCEDURAL HAEMATOMA,1
AU,POTENTIATING DRUG INTERACTION,1
AU,PRESBYOPIA,1
AU,PROCEDURAL COMPLICATION,1
AU,PROCEDURAL HAEMORRHAGE,1
AU,PRODUCT SUBSTITUTION ISSUE,1
AU,PRODUCT TASTE ABNORMAL,1
AU,PRODUCTIVE COUGH,1
AU,PROSTATE CANCER,1
AU,PROTEIN TOTAL DECREASED,1
AU,PROTEINURIA,1
AU,PRURIGO,1
AU,PSORIATIC ARTHROPATHY,1
AU,PUBIS FRACTURE,1
AU,PULMONARY ARTERIAL HYPERTENSION,1
AU,PULMONARY ARTERIAL WEDGE PRESSURE INCREASED,1
AU,PULMONARY CONGESTION,1
AU,PULMONARY HYPERTENSION,1
AU,PULMONARY MASS,1
AU,PULSELESS ELECTRICAL ACTIVITY,1
AU,PUPIL FIXED,1
AU,QUADRIPLEGIA,1
AU,RASH ERYTHEMATOUS,1
AU,RECTAL CANCER,1
AU,RECTAL PROLAPSE,1
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
AU,REFUSAL OF EXAMINATION,1
AU,RENAL ATROPHY,1
AU,RENAL INJURY,1
AU,RENAL SURGERY,1
AU,RESPIRATORY DISORDER,1
AU,RESPIRATORY RATE INCREASED,1
AU,RESTLESS LEGS SYNDROME,1
AU,RETCHING,1
AU,RETINAL ARTERY EMBOLISM,1
AU,RETINAL DISORDER,1
AU,RIGHT ATRIAL DILATATION,1
AU,SCIATICA,1
AU,SCOLIOSIS,1
AU,SCROTAL ABSCESS,1
AU,SEASONAL ALLERGY,1
AU,SENSORY LOSS,1
AU,SERUM FERRITIN DECREASED,1
AU,SHORT-BOWEL SYNDROME,1
AU,SINUS ARREST,1
AU,SINUS TACHYCARDIA,1
AU,SKIN GRAFT INFECTION,1
AU,SKIN NEOPLASM EXCISION,1
AU,SKIN PAPILLOMA,1
AU,SLEEP DISORDER,1
AU,SMALL INTESTINAL HAEMORRHAGE,1
AU,SMALL INTESTINAL OBSTRUCTION,1
AU,SPINAL COLUMN STENOSIS,1
AU,SPLENIC CYST,1
AU,SPLENOMEGALY,1
AU,SPONTANEOUS HAEMORRHAGE,1
AU,SPUTUM INCREASED,1
AU,SQUAMOUS CELL CARCINOMA OF SKIN,1
AU,STEVENS-JOHNSON SYNDROME,1
AU,STOMA SITE DISCHARGE,1
AU,STOMA SITE ERYTHEMA,1
AU,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,1
AU,SYNOVITIS,1
AU,TACHYPNOEA,1
AU,TENDONITIS,1
AU,THINKING ABNORMAL,1
AU,THORACIC VERTEBRAL FRACTURE,1
AU,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
AU,THYROID CANCER,1
AU,TOOTH DISORDER,1
AU,TOOTH INFECTION,1
AU,TORSADE DE POINTES,1
AU,TOXIC NODULAR GOITRE,1
AU,TOXICITY TO VARIOUS AGENTS,1
AU,TRANSFERRIN SATURATION INCREASED,1
AU,TRANSFUSION,1
AU,TRAUMATIC HAEMATOMA,1
AU,TREATMENT NONCOMPLIANCE,1
AU,TROPONIN I INCREASED,1
AU,TROPONIN T INCREASED,1
AU,ULCER,1
AU,ULCER HAEMORRHAGE,1
AU,UNDERDOSE,1
AU,UPPER LIMB FRACTURE,1
AU,URINARY RETENTION,1
AU,URINE FLOW DECREASED,1
AU,URINE OUTPUT DECREASED,1
AU,VAGINAL OPERATION,1
AU,VASCULAR CALCIFICATION,1
AU,VASCULAR OCCLUSION,1
AU,VASCULAR STENT THROMBOSIS,1
AU,VASCULITIC RASH,1
AU,VENTRICULAR EXTRASYSTOLES,1
AU,VICTIM OF ABUSE,1
AU,VIITH NERVE PARALYSIS,1
AU,VIRAL MYOCARDITIS,1
AU,VISUAL IMPAIRMENT,1
AU,VITAMIN B12 DEFICIENCY,1
AU,VITAMIN D ABNORMAL,1
AU,VITAMIN D DECREASED,1
AU,VITAMIN D DEFICIENCY,1
AU,VITREOUS FLOATERS,1
AU,WEIGHT ABNORMAL,1
AU,WHEEZING,1
AU,WOUND DEHISCENCE,1
AU,WOUND DRAINAGE,1
AU,WRIST FRACTURE,1
AU,WRONG DRUG ADMINISTERED,1
AT,NAUSEA,10
AT,SYNCOPE,9
AT,DYSGEUSIA,8
AT,FALL,8
AT,ACUTE MYOCARDIAL INFARCTION,7
AT,ANAEMIA,7
AT,DRY MOUTH,7
AT,MYALGIA,6
AT,ASTHENIA,5
AT,ATROPHIC VULVOVAGINITIS,5
AT,CEREBRAL ATROPHY,5
AT,HAEMORRHAGE,5
AT,VAGINAL DISCHARGE,5
AT,BACTERIAL VAGINOSIS,4
AT,CARDIAC FAILURE,4
AT,CAROTID ARTERY THROMBOSIS,4
AT,CEREBRAL MICROANGIOPATHY,4
AT,DEATH,4
AT,FATIGUE,4
AT,GENERAL PHYSICAL HEALTH DETERIORATION,4
AT,HYPERTENSION,4
AT,OSTEITIS,4
AT,PNEUMONIA,4
AT,ANGINA PECTORIS,3
AT,ARTHRALGIA,3
AT,CEREBROVASCULAR ACCIDENT,3
AT,CORONARY ARTERY DISEASE,3
AT,DIZZINESS,3
AT,DYSPNOEA,3
AT,EPISTAXIS,3
AT,HEADACHE,3
AT,PARAESTHESIA,3
AT,SECOND PRIMARY MALIGNANCY,3
AT,SOMNOLENCE,3
AT,TACHYCARDIA,3
AT,THROMBOCYTOPENIA,3
AT,VASCULAR STENT THROMBOSIS,3
AT,APLASTIC ANAEMIA,2
AT,ATRIAL FIBRILLATION,2
AT,BACK PAIN,2
AT,BLOOD CREATININE INCREASED,2
AT,BLOOD GLUCOSE INCREASED,2
AT,BLOOD LACTATE DEHYDROGENASE INCREASED,2
AT,BLOOD PRESSURE DECREASED,2
AT,BLOOD URINE PRESENT,2
AT,CEREBRAL HAEMORRHAGE,2
AT,CIRCULATORY COLLAPSE,2
AT,CORONARY ARTERY STENOSIS,2
AT,COUGH,2
AT,DRUG INEFFECTIVE,2
AT,DYSPNOEA EXERTIONAL,2
AT,HAEMATOMA,2
AT,HAEMORRHAGE INTRACRANIAL,2
AT,HAEMORRHAGE SUBCUTANEOUS,2
AT,HYPERHIDROSIS,2
AT,HYPONATRAEMIA,2
AT,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
AT,INFECTION,2
AT,INTESTINAL HAEMORRHAGE,2
AT,LEFT VENTRICULAR HYPERTROPHY,2
AT,LUNG NEOPLASM MALIGNANT,2
AT,MALAISE,2
AT,MITRAL VALVE INCOMPETENCE,2
AT,MUSCLE RIGIDITY,2
AT,MUSCULAR WEAKNESS,2
AT,MYOCARDIAL INFARCTION,2
AT,MYOCARDIAL ISCHAEMIA,2
AT,OBESITY,2
AT,OEDEMA PERIPHERAL,2
AT,OSTEONECROSIS OF JAW,2
AT,PAIN,2
AT,PAIN IN EXTREMITY,2
AT,PALLOR,2
AT,PARKINSONISM,2
AT,PERIPHERAL SWELLING,2
AT,PLATELET ANISOCYTOSIS,2
AT,PLATELET COUNT DECREASED,2
AT,PLATELET COUNT INCREASED,2
AT,PROCEDURAL HAEMORRHAGE,2
AT,PROSTATE CANCER RECURRENT,2
AT,PYREXIA,2
AT,RALES,2
AT,RASH,2
AT,RENAL FAILURE,2
AT,RESTLESSNESS,2
AT,SKIN EXFOLIATION,2
AT,SLEEP DISORDER,2
AT,SPLENOMEGALY,2
AT,SWOLLEN TONGUE,2
AT,TRANSFERRIN DECREASED,2
AT,TRANSIENT ISCHAEMIC ATTACK,2
AT,TYPE 2 DIABETES MELLITUS,2
AT,URINARY TRACT INFECTION,2
AT,WHITE BLOOD CELL COUNT INCREASED,2
AT,ABDOMINAL PAIN UPPER,1
AT,ABSCESS ORAL,1
AT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
AT,ACUTE ABDOMEN,1
AT,ACUTE MYELOID LEUKAEMIA,1
AT,AGEUSIA,1
AT,AMAUROSIS,1
AT,AMNESIA,1
AT,ANGIOEDEMA,1
AT,ANGIOPLASTY,1
AT,AORTIC ANEURYSM,1
AT,AORTIC STENOSIS,1
AT,AORTIC VALVE CALCIFICATION,1
AT,AORTIC VALVE INCOMPETENCE,1
AT,APHASIA,1
AT,ARRHYTHMIA,1
AT,ARTERIAL HAEMORRHAGE,1
AT,ARTERIAL THERAPEUTIC PROCEDURE,1
AT,ARTERIOSCLEROSIS,1
AT,ARTERIOSCLEROSIS CORONARY ARTERY,1
AT,ASCITES,1
AT,ASPHYXIA,1
AT,ATRIAL TACHYCARDIA,1
AT,ATRIOVENTRICULAR BLOCK COMPLETE,1
AT,BASAL CELL CARCINOMA,1
AT,BEDRIDDEN,1
AT,BENIGN PROSTATIC HYPERPLASIA,1
AT,BLEPHARITIS,1
AT,BLINDNESS,1
AT,BLINDNESS UNILATERAL,1
AT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
AT,BLOOD GLUCOSE FLUCTUATION,1
AT,BLOOD PRESSURE FLUCTUATION,1
AT,BLOOD URIC ACID INCREASED,1
AT,BLUE TOE SYNDROME,1
AT,BONE MARROW DISORDER,1
AT,BRADYCARDIA,1
AT,BRAIN INJURY,1
AT,BRAIN STEM INFARCTION,1
AT,BUNDLE BRANCH BLOCK RIGHT,1
AT,C-REACTIVE PROTEIN INCREASED,1
AT,CARDIAC ANEURYSM,1
AT,CARDIAC ARREST,1
AT,CARDIOGENIC SHOCK,1
AT,CARDIOVASCULAR DISORDER,1
AT,CAROTID ARTERY STENOSIS,1
AT,CATARACT,1
AT,CELLULITIS,1
AT,CENTRAL NERVOUS SYSTEM LESION,1
AT,CHEST DISCOMFORT,1
AT,CHRONIC SINUSITIS,1
AT,CONCUSSION,1
AT,CONDITION AGGRAVATED,1
AT,CONFUSIONAL STATE,1
AT,CORONARY ARTERY INSUFFICIENCY,1
AT,CORONARY ARTERY OCCLUSION,1
AT,DEAFNESS,1
AT,DECREASED APPETITE,1
AT,DECUBITUS ULCER,1
AT,DEMENTIA,1
AT,DEPRESSION,1
AT,DIABETIC FOOT INFECTION,1
AT,DIARRHOEA,1
AT,DIFFUSE LARGE B-CELL LYMPHOMA,1
AT,DIPLEGIA,1
AT,DRUG ADMINISTRATION ERROR,1
AT,DRUG DOSE OMISSION,1
AT,DRY SKIN,1
AT,DUODENITIS,1
AT,DYSARTHRIA,1
AT,DYSPEPSIA,1
AT,EMBOLISM ARTERIAL,1
AT,ERYSIPELAS,1
AT,ERYTHEMA MULTIFORME,1
AT,EXPOSED BONE IN JAW,1
AT,FACIAL BONES FRACTURE,1
AT,FEAR,1
AT,FEELING ABNORMAL,1
AT,FUNGAL SEPSIS,1
AT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
AT,GASTRIC DISORDER,1
AT,GASTRITIS EROSIVE,1
AT,GASTROINTESTINAL DISORDER,1
AT,GASTROOESOPHAGEAL REFLUX DISEASE,1
AT,GENITAL HERPES,1
AT,GLOMERULAR FILTRATION RATE DECREASED,1
AT,HAEMATEMESIS,1
AT,HAEMATOCRIT INCREASED,1
AT,HAEMATURIA,1
AT,HAEMODYNAMIC INSTABILITY,1
AT,HAEMOLYSIS,1
AT,HEART RATE INCREASED,1
AT,HEART VALVE STENOSIS,1
AT,HEPATITIS,1
AT,HEPATOMEGALY,1
AT,HERPES ZOSTER,1
AT,HYPERCHOLESTEROLAEMIA,1
AT,HYPERHOMOCYSTEINAEMIA,1
AT,HYPERKALAEMIA,1
AT,HYPERLIPIDAEMIA,1
AT,HYPERTROPHY,1
AT,HYPOAESTHESIA,1
AT,HYPOTENSION,1
AT,HYPOXIA,1
AT,IMPAIRED HEALING,1
AT,INFARCTION,1
AT,INFERIOR VENA CAVA DILATATION,1
AT,INFLAMMATION,1
AT,INFLUENZA LIKE ILLNESS,1
AT,INSOMNIA,1
AT,INTERMITTENT CLAUDICATION,1
AT,INTERVERTEBRAL DISC PROTRUSION,1
AT,IRIDOCYCLITIS,1
AT,ISCHAEMIA,1
AT,JOINT INJURY,1
AT,JOINT SWELLING,1
AT,KETOACIDOSIS,1
AT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
AT,LARGE INTESTINE POLYP,1
AT,LEFT VENTRICULAR FAILURE,1
AT,LEG AMPUTATION,1
AT,LEUKOCYTOSIS,1
AT,LIP SWELLING,1
AT,LIVER DISORDER,1
AT,LOCAL SWELLING,1
AT,LUMBAR VERTEBRAL FRACTURE,1
AT,LUNG CANCER METASTATIC,1
AT,MALLORY-WEISS SYNDROME,1
AT,METASTASIS,1
AT,MUSCLE SPASMS,1
AT,MYELOFIBROSIS,1
AT,NAIL DISORDER,1
AT,NEOPLASM MALIGNANT,1
AT,NEUROGENIC BLADDER,1
AT,NIGHTMARE,1
AT,OPTIC ATROPHY,1
AT,OPTIC NEURITIS,1
AT,ORAL MUCOSAL ERYTHEMA,1
AT,OROPHARYNGEAL PAIN,1
AT,OSTEOARTHRITIS,1
AT,OSTEOLYSIS,1
AT,OSTEOMYELITIS,1
AT,OSTEONECROSIS,1
AT,PALPITATIONS,1
AT,PANCREATIC CARCINOMA,1
AT,PANCREATITIS,1
AT,PARAPLEGIA,1
AT,PARKINSON^S DISEASE,1
AT,PERIODONTITIS,1
AT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AT,PERIPHERAL ARTERY ANEURYSM,1
AT,PERIPHERAL VASCULAR DISORDER,1
AT,PERITONITIS,1
AT,PHARYNGEAL HAEMORRHAGE,1
AT,PHLEBITIS,1
AT,PHOTOSENSITIVITY REACTION,1
AT,PNEUMONITIS,1
AT,POLLAKIURIA,1
AT,POLYNEUROPATHY,1
AT,POST HERPETIC NEURALGIA,1
AT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
AT,POSTOPERATIVE WOUND INFECTION,1
AT,PRODUCT QUALITY ISSUE,1
AT,PROTHROMBIN TIME PROLONGED,1
AT,PRURITUS,1
AT,PULMONARY ARTERY DILATATION,1
AT,PULMONARY CONGESTION,1
AT,PULMONARY EMBOLISM,1
AT,PULMONARY OEDEMA,1
AT,PULMONARY VALVE INCOMPETENCE,1
AT,PULMONARY VASCULAR DISORDER,1
AT,RASH PAPULAR,1
AT,REACTIVE PSYCHOSIS,1
AT,RENAL FAILURE ACUTE,1
AT,RENAL FAILURE CHRONIC,1
AT,RESPIRATORY DISTRESS,1
AT,RETROPERITONEAL HAEMATOMA,1
AT,RHABDOMYOLYSIS,1
AT,RIGHT VENTRICULAR DILATATION,1
AT,ROTATOR CUFF SYNDROME,1
AT,SCAR,1
AT,SCOLIOSIS,1
AT,SENSORY LOSS,1
AT,SEPSIS,1
AT,SEROTONIN SYNDROME,1
AT,SKIN BURNING SENSATION,1
AT,SKIN DISORDER,1
AT,SKIN HAEMORRHAGE,1
AT,SKIN REACTION,1
AT,SLEEP APNOEA SYNDROME,1
AT,SPEECH DISORDER,1
AT,SPINAL OSTEOARTHRITIS,1
AT,SPLEEN DISORDER,1
AT,SQUAMOUS CELL CARCINOMA,1
AT,STRESS,1
AT,SUICIDE ATTEMPT,1
AT,SYSTOLIC DYSFUNCTION,1
AT,TENDON RUPTURE,1
AT,THERAPEUTIC RESPONSE DECREASED,1
AT,TINNITUS,1
AT,TOE AMPUTATION,1
AT,TOOTH IMPACTED,1
AT,TRANSAMINASES INCREASED,1
AT,TRICUSPID VALVE INCOMPETENCE,1
AT,TUBULOINTERSTITIAL NEPHRITIS,1
AT,TUMOUR FLARE,1
AT,VASCULAR PROCEDURE COMPLICATION,1
AT,VENOUS RECANALISATION,1
AT,VERTIGO,1
AT,VISION BLURRED,1
AT,WOUND,1
BS,GINGIVAL BLEEDING,1
BS,NEPHROLITHIASIS,1
BH,PRODUCT QUALITY ISSUE,4
BH,DRUG INEFFECTIVE,3
BH,THROMBOSIS IN DEVICE,3
BH,CORONARY ARTERY RESTENOSIS,1
BD,CARDIAC TAMPONADE,5
BD,PLEURAL EFFUSION,4
BD,ACUTE PULMONARY OEDEMA,3
BD,PERICARDIAL EFFUSION,3
BD,ASTHENIA,2
BD,DRUG RESISTANCE,2
BD,HAEMOTHORAX,2
BD,PERICARDIAL HAEMORRHAGE,2
BD,CARDIAC FAILURE,1
BD,CEREBROVASCULAR ACCIDENT,1
BD,DISORIENTATION,1
BD,ELECTROLYTE IMBALANCE,1
BD,GENERAL PHYSICAL HEALTH DETERIORATION,1
BD,HYPERTENSION,1
BD,HYPOPHAGIA,1
BD,HYPOTENSION,1
BD,JUGULAR VEIN DISTENSION,1
BD,LOGORRHOEA,1
BD,PERICARDIAL RUB,1
BD,POLLAKIURIA,1
BD,TACHYCARDIA,1
BB,CEREBROVASCULAR ACCIDENT,1
BB,DRY SKIN,1
BB,PARAPSORIASIS,1
BB,RASH ERYTHEMATOUS,1
BB,RASH PAPULAR,1
BY,NEPHROPATHY,14
BY,BRADYCARDIA,2
BY,CARDIAC TAMPONADE,1
BY,CEREBRAL HAEMORRHAGE,1
BY,DEATH,1
BY,HYPOTENSION,1
BY,LOSS OF CONSCIOUSNESS,1
BY,THERAPY NON-RESPONDER,1
BE,DYSPNOEA,11
BE,GENERAL PHYSICAL HEALTH DETERIORATION,9
BE,ACUTE KIDNEY INJURY,8
BE,ASTHENIA,7
BE,DEATH,6
BE,DECREASED APPETITE,6
BE,FALL,6
BE,FATIGUE,6
BE,MYOCARDIAL INFARCTION,6
BE,ANAEMIA,5
BE,CARDIAC FAILURE,5
BE,DIARRHOEA,5
BE,HAEMORRHAGE,5
BE,PYREXIA,5
BE,ARTHRALGIA,4
BE,DRUG INEFFECTIVE,4
BE,OEDEMA PERIPHERAL,4
BE,PNEUMONIA,4
BE,PRURITUS,4
BE,RENAL FAILURE,4
BE,RESPIRATORY FAILURE,4
BE,SINUS BRADYCARDIA,4
BE,WEIGHT DECREASED,4
BE,ABDOMINAL PAIN UPPER,3
BE,ACUTE CORONARY SYNDROME,3
BE,BACK PAIN,3
BE,CEREBROVASCULAR ACCIDENT,3
BE,CONSTIPATION,3
BE,DEHYDRATION,3
BE,ECZEMA,3
BE,EPISTAXIS,3
BE,GAIT DISTURBANCE,3
BE,GASTROINTESTINAL HAEMORRHAGE,3
BE,HAEMATOMA,3
BE,HAEMOGLOBIN DECREASED,3
BE,HYPOTENSION,3
BE,INTERSTITIAL LUNG DISEASE,3
BE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
BE,LOSS OF CONSCIOUSNESS,3
BE,LOWER GASTROINTESTINAL HAEMORRHAGE,3
BE,MELAENA,3
BE,PANCREATITIS,3
BE,PLATELET COUNT DECREASED,3
BE,PNEUMONIA ASPIRATION,3
BE,PRURITUS GENERALISED,3
BE,RENAL FAILURE ACUTE,3
BE,ABDOMINAL DISTENSION,2
BE,ABDOMINAL PAIN,2
BE,ACUTE MYOCARDIAL INFARCTION,2
BE,ARRHYTHMIA,2
BE,ATRIAL FIBRILLATION,2
BE,BLOOD CREATININE INCREASED,2
BE,CARDIAC ARREST,2
BE,CARDIAC MURMUR,2
BE,CHEST PAIN,2
BE,COGNITIVE DISORDER,2
BE,COLITIS,2
BE,COLON CANCER,2
BE,CONTUSION,2
BE,DEEP VEIN THROMBOSIS,2
BE,DRUG ADMINISTRATION ERROR,2
BE,DRUG INTOLERANCE,2
BE,DRUG-INDUCED LIVER INJURY,2
BE,DYSPHAGIA,2
BE,EYE PAIN,2
BE,FAECALOMA,2
BE,GASTRIC HAEMORRHAGE,2
BE,GASTROINTESTINAL DISORDER,2
BE,GASTROINTESTINAL INFECTION,2
BE,HEADACHE,2
BE,INFARCTION,2
BE,INSOMNIA,2
BE,IRON DEFICIENCY ANAEMIA,2
BE,LYMPHADENOPATHY,2
BE,MITRAL VALVE INCOMPETENCE,2
BE,MUSCULOSKELETAL PAIN,2
BE,MYOCARDIAL ISCHAEMIA,2
BE,NAUSEA,2
BE,NEUTROPENIA,2
BE,OVERDOSE,2
BE,PAIN IN EXTREMITY,2
BE,PALPITATIONS,2
BE,PARAESTHESIA,2
BE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
BE,PLATELET AGGREGATION INCREASED,2
BE,RASH,2
BE,RHINORRHOEA,2
BE,SEASONAL ALLERGY,2
BE,SUDDEN DEATH,2
BE,THROAT TIGHTNESS,2
BE,THROMBOCYTOPENIA,2
BE,TRANSIENT ISCHAEMIC ATTACK,2
BE,TRICUSPID VALVE INCOMPETENCE,2
BE,VERTIGO,2
BE,ABDOMINAL ABSCESS,1
BE,ABNORMAL FAECES,1
BE,ACHLORHYDRIA,1
BE,ACQUIRED HAEMOPHILIA,1
BE,ACUTE MYELOID LEUKAEMIA,1
BE,ACUTE PULMONARY OEDEMA,1
BE,ADENOCARCINOMA PANCREAS,1
BE,AGRANULOCYTOSIS,1
BE,ALOPECIA,1
BE,ANAL HAEMORRHAGE,1
BE,ANGIOEDEMA,1
BE,APHAGIA,1
BE,APHASIA,1
BE,ARTERIAL STENT INSERTION,1
BE,ARTERIAL THROMBOSIS,1
BE,ARTERIOSCLEROSIS CORONARY ARTERY,1
BE,ASTHMA,1
BE,ATRIAL FLUTTER,1
BE,ATRIOVENTRICULAR BLOCK COMPLETE,1
BE,ATYPICAL FIBROXANTHOMA,1
BE,ATYPICAL PNEUMONIA,1
BE,AUDITORY DISORDER,1
BE,BLOOD GLUCOSE ABNORMAL,1
BE,BLOOD POTASSIUM ABNORMAL,1
BE,BLOOD URINE PRESENT,1
BE,BONE MARROW FAILURE,1
BE,BUNDLE BRANCH BLOCK RIGHT,1
BE,CARDIAC DEATH,1
BE,CARDIAC DISORDER,1
BE,CARDIAC FIBRILLATION,1
BE,CARDIOVASCULAR DISORDER,1
BE,CAROTID ARTERY STENOSIS,1
BE,CATARACT,1
BE,CHEST DISCOMFORT,1
BE,CHEST X-RAY ABNORMAL,1
BE,CHILLS,1
BE,CHOLELITHIASIS,1
BE,CHROMATURIA,1
BE,COLITIS ULCERATIVE,1
BE,COMA,1
BE,CONCOMITANT DISEASE AGGRAVATED,1
BE,CONDITION AGGRAVATED,1
BE,CONFUSIONAL STATE,1
BE,CONTRAINDICATED PRODUCT ADMINISTERED,1
BE,CONTRAST MEDIA ALLERGY,1
BE,CORNEAL OPACITY,1
BE,CORONARY ARTERY RESTENOSIS,1
BE,COUGH,1
BE,CREPITATIONS,1
BE,DECUBITUS ULCER,1
BE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
BE,DEPRESSED MOOD,1
BE,DEPRESSION,1
BE,DEVICE DISLOCATION,1
BE,DEVICE OCCLUSION,1
BE,DIABETES MELLITUS,1
BE,DILATATION VENTRICULAR,1
BE,DIVERTICULUM,1
BE,DIZZINESS,1
BE,DRY MOUTH,1
BE,DUODENAL ULCER,1
BE,DYSKINESIA,1
BE,DYSPEPSIA,1
BE,EMBOLISM,1
BE,EMOTIONAL DISORDER,1
BE,EMPHYSEMA,1
BE,ENTERITIS,1
BE,ENTEROBACTER SEPSIS,1
BE,ERYTHEMA,1
BE,ERYTHEMA OF EYELID,1
BE,EXPOSED BONE IN JAW,1
BE,EYE ALLERGY,1
BE,EYE HAEMORRHAGE,1
BE,EYE IRRITATION,1
BE,EYE OEDEMA,1
BE,EYE PARAESTHESIA,1
BE,EYELID IRRITATION,1
BE,EYELID OEDEMA,1
BE,EYELID PAIN,1
BE,FACTOR VIII DEFICIENCY,1
BE,FEELING DRUNK,1
BE,FEMORAL NECK FRACTURE,1
BE,FIBROSIS,1
BE,FLOPPY IRIS SYNDROME,1
BE,FREEZING PHENOMENON,1
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
BE,GASTRIC HAEMANGIOMA,1
BE,GASTROINTESTINAL TRACT ADENOMA,1
BE,GASTROINTESTINAL ULCER HAEMORRHAGE,1
BE,GENERAL PHYSICAL CONDITION ABNORMAL,1
BE,HAEMATEMESIS,1
BE,HAEMATOCHEZIA,1
BE,HAEMODYNAMIC INSTABILITY,1
BE,HAEMORRHOIDAL HAEMORRHAGE,1
BE,HAEMOTHORAX,1
BE,HALLUCINATION_ VISUAL,1
BE,HELICOBACTER INFECTION,1
BE,HEPATIC FAILURE,1
BE,HEPATOTOXICITY,1
BE,HOT FLUSH,1
BE,HYPERBILIRUBINAEMIA,1
BE,HYPERCAPNIA,1
BE,HYPERGLYCAEMIA,1
BE,HYPERKALAEMIA,1
BE,HYPERLACTACIDAEMIA,1
BE,HYPERSENSITIVITY VASCULITIS,1
BE,HYPERTENSION,1
BE,HYPOAESTHESIA,1
BE,HYPOALBUMINAEMIA,1
BE,HYPOCHROMIC ANAEMIA,1
BE,HYPOGLYCAEMIA,1
BE,HYPOGLYCAEMIC COMA,1
BE,HYPOKALAEMIA,1
BE,HYPOMAGNESAEMIA,1
BE,HYPONATRAEMIA,1
BE,HYPOTRICHOSIS,1
BE,HYPOVENTILATION,1
BE,HYPOVOLAEMIC SHOCK,1
BE,HYPOXIA,1
BE,IGA NEPHROPATHY,1
BE,IMPAIRED GASTRIC EMPTYING,1
BE,INFLUENZA LIKE ILLNESS,1
BE,INTESTINAL HAEMORRHAGE,1
BE,INTESTINAL MASS,1
BE,INVESTIGATION,1
BE,IRIS DISORDER,1
BE,ISCHAEMIC STROKE,1
BE,JAUNDICE,1
BE,JOINT SWELLING,1
BE,KNEE OPERATION,1
BE,LEUKOCYTOSIS,1
BE,LIMB OPERATION,1
BE,LUNG ADENOCARCINOMA METASTATIC,1
BE,LUNG NEOPLASM MALIGNANT,1
BE,LUNG SQUAMOUS CELL CARCINOMA STAGE III,1
BE,LYMPHOPENIA,1
BE,MICROCYTIC ANAEMIA,1
BE,MIOSIS,1
BE,MOBILITY DECREASED,1
BE,MUCOUS STOOLS,1
BE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
BE,MUSCLE HAEMORRHAGE,1
BE,MUSCLE SPASMS,1
BE,MUSCULAR WEAKNESS,1
BE,MYALGIA,1
BE,MYASTHENIA GRAVIS,1
BE,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
BE,NASOPHARYNGITIS,1
BE,NERVOUSNESS,1
BE,OCULAR HYPERAEMIA,1
BE,ODYNOPHAGIA,1
BE,OESOPHAGITIS HAEMORRHAGIC,1
BE,ON AND OFF PHENOMENON,1
BE,ORTHOSTATIC TREMOR,1
BE,OSTEONECROSIS OF JAW,1
BE,PACKED RED BLOOD CELL TRANSFUSION,1
BE,PAIN,1
BE,PAIN IN JAW,1
BE,PALLIATIVE CARE,1
BE,PALLOR,1
BE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BE,PANCREATIC CARCINOMA,1
BE,PANCREATITIS ACUTE,1
BE,PANCYTOPENIA,1
BE,PCO2 DECREASED,1
BE,PERICARDIAL HAEMORRHAGE,1
BE,PERIORBITAL OEDEMA,1
BE,PERIPHERAL ARTERY THROMBOSIS,1
BE,PERIPHERAL EMBOLISM,1
BE,PERIPHERAL SWELLING,1
BE,PHRENIC NERVE PARALYSIS,1
BE,PLASMA CELL MYELOMA,1
BE,PLATELET TRANSFUSION,1
BE,PNEUMONIA HAEMOPHILUS,1
BE,POSTURE ABNORMAL,1
BE,PRESCRIBED UNDERDOSE,1
BE,PRODUCT USE ISSUE,1
BE,PROSTATIC DISORDER,1
BE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
BE,PSEUDOMONAS TEST POSITIVE,1
BE,PULMONARY ALVEOLAR HAEMORRHAGE,1
BE,PULMONARY HAEMORRHAGE,1
BE,PULMONARY INFARCTION,1
BE,PULMONARY MASS,1
BE,QUADRIPARESIS,1
BE,RECURRENT CANCER,1
BE,RENAL ABSCESS,1
BE,RESPIRATORY DISORDER,1
BE,RESPIRATORY TRACT INFECTION,1
BE,RETINAL HAEMORRHAGE,1
BE,RETINOPATHY HAEMORRHAGIC,1
BE,RETROPERITONEAL HAEMORRHAGE,1
BE,SCAN MYOCARDIAL PERFUSION ABNORMAL,1
BE,SECONDARY SEQUESTRUM,1
BE,SEPSIS,1
BE,SEPTIC ENCEPHALOPATHY,1
BE,SEPTIC SHOCK,1
BE,SHOCK,1
BE,SINUS ARREST,1
BE,SINUS TACHYCARDIA,1
BE,SKIN DISCOLOURATION,1
BE,SKIN DISORDER,1
BE,SKIN HYPERTROPHY,1
BE,SKIN REACTION,1
BE,SMALL INTESTINAL OBSTRUCTION,1
BE,STAPHYLOCOCCAL INFECTION,1
BE,STAPHYLOCOCCAL SEPSIS,1
BE,STENT PLACEMENT,1
BE,SUBCUTANEOUS HAEMATOMA,1
BE,SUBDURAL HAEMATOMA,1
BE,SUBRETINAL FIBROSIS,1
BE,SUPRAVENTRICULAR EXTRASYSTOLES,1
BE,SUPRAVENTRICULAR TACHYCARDIA,1
BE,SYNCOPE,1
BE,TACHYCARDIA,1
BE,TENDERNESS,1
BE,THROAT CANCER,1
BE,THROMBOSIS IN DEVICE,1
BE,TONGUE OEDEMA,1
BE,TORTICOLLIS,1
BE,TOXIC ENCEPHALOPATHY,1
BE,TOXICITY TO VARIOUS AGENTS,1
BE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
BE,UROGENITAL HAEMORRHAGE,1
BE,VAGINAL HAEMORRHAGE,1
BE,VASCULAR MALFORMATION,1
BE,VASCULAR OPERATION,1
BE,VENTRICULAR FIBRILLATION,1
BE,VESTIBULAR NEURONITIS,1
BE,VISUAL IMPAIRMENT,1
BE,VITREOUS HAEMATOMA,1
BE,WHITE BLOOD CELL COUNT DECREASED,1
BA,ARRHYTHMIA SUPRAVENTRICULAR,1
BA,ASPHYXIA,1
BA,ATRIAL FIBRILLATION,1
BA,ATRIAL THROMBOSIS,1
BA,CEREBRAL INFARCTION,1
BA,CEREBRAL ISCHAEMIA,1
BA,CHEST DISCOMFORT,1
BA,FACIAL PARESIS,1
BA,GAIT SPASTIC,1
BA,HEADACHE,1
BA,HEMIANAESTHESIA,1
BA,HEMIPARESIS,1
BA,HYPERTENSIVE CARDIOMYOPATHY,1
BA,MITRAL VALVE INCOMPETENCE,1
BA,PALPITATIONS,1
BA,PARAESTHESIA,1
BA,PERIPHERAL SWELLING,1
BA,REFLEXES ABNORMAL,1
BA,ROMBERG TEST POSITIVE,1
BW,FALL,1
BW,SUBDURAL HAEMATOMA,1
BR,INFARCTION,94
BR,CEREBROVASCULAR ACCIDENT,77
BR,MYOCARDIAL INFARCTION,73
BR,WEIGHT DECREASED,73
BR,MALAISE,70
BR,DRUG INEFFECTIVE,69
BR,DYSPNOEA,63
BR,CARDIAC DISORDER,62
BR,PAIN,58
BR,FATIGUE,54
BR,PAIN IN EXTREMITY,54
BR,CORONARY ARTERY OCCLUSION,53
BR,FALL,45
BR,GAIT DISTURBANCE,43
BR,CHEST PAIN,40
BR,HYPERTENSION,40
BR,ARTERIAL OCCLUSIVE DISEASE,39
BR,BLOOD GLUCOSE INCREASED,39
BR,BLOOD PRESSURE INCREASED,39
BR,DIABETES MELLITUS,36
BR,PNEUMONIA,36
BR,ARTHRALGIA,35
BR,NAUSEA,35
BR,ASTHENIA,34
BR,DECREASED APPETITE,32
BR,URINARY TRACT INFECTION,32
BR,ANAEMIA,31
BR,DIARRHOEA,31
BR,DEPRESSION,30
BR,BLOOD CHOLESTEROL INCREASED,29
BR,DIZZINESS,29
BR,HEADACHE,29
BR,VENOUS OCCLUSION,29
BR,MEMORY IMPAIRMENT,27
BR,ACUTE MYOCARDIAL INFARCTION,26
BR,CATARACT,25
BR,HYPERGLYCAEMIA,25
BR,HYPERSENSITIVITY,25
BR,PYREXIA,25
BR,FEELING ABNORMAL,24
BR,INTENTIONAL PRODUCT MISUSE,22
BR,ANXIETY,21
BR,ARRHYTHMIA,21
BR,BACK PAIN,21
BR,HAEMORRHAGE,21
BR,VISION BLURRED,21
BR,VOMITING,21
BR,COUGH,20
BR,VISUAL IMPAIRMENT,20
BR,INFLUENZA,19
BR,TREMOR,19
BR,ABDOMINAL PAIN UPPER,17
BR,ANGINA PECTORIS,17
BR,BLOOD PRESSURE DECREASED,17
BR,INJECTION SITE PAIN,17
BR,INSOMNIA,17
BR,ISCHAEMIC STROKE,17
BR,PRODUCT USE ISSUE,17
BR,SOMNOLENCE,17
BR,ABDOMINAL PAIN,16
BR,DRUG DOSE OMISSION,16
BR,PERIPHERAL SWELLING,16
BR,CONSTIPATION,15
BR,HYPOTENSION,15
BR,ISCHAEMIA,15
BR,PRURITUS,14
BR,RENAL DISORDER,14
BR,SYNCOPE,14
BR,WEIGHT INCREASED,14
BR,DYSPHAGIA,13
BR,GASTRITIS,13
BR,HYPOGLYCAEMIA,13
BR,PULMONARY OEDEMA,13
BR,RENAL FAILURE,13
BR,GLAUCOMA,12
BR,HAEMATOCHEZIA,12
BR,HYPOAESTHESIA,12
BR,MYALGIA,12
BR,TACHYCARDIA,12
BR,THROMBOSIS,12
BR,WOUND,12
BR,ABASIA,11
BR,ASTHMA,11
BR,CARDIAC ARREST,11
BR,DEATH,11
BR,HALLUCINATION,11
BR,LEUKOPENIA,11
BR,MUSCULAR WEAKNESS,11
BR,OSTEOARTHRITIS,11
BR,SPEECH DISORDER,11
BR,STRESS,11
BR,VASCULAR STENT THROMBOSIS,11
BR,VISUAL ACUITY REDUCED,11
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,11
BR,ANGIOPATHY,10
BR,BLOOD PRESSURE FLUCTUATION,10
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,10
BR,CORONARY ARTERY DISEASE,10
BR,DEVICE OCCLUSION,10
BR,DYSPHONIA,10
BR,FEMUR FRACTURE,10
BR,INFECTION,10
BR,INTESTINAL HAEMORRHAGE,10
BR,SWELLING,10
BR,ABDOMINAL DISCOMFORT,9
BR,AORTIC ANEURYSM,9
BR,BALANCE DISORDER,9
BR,CARDIAC FAILURE,9
BR,CAROTID ARTERY OCCLUSION,9
BR,COMA,9
BR,DISEASE PROGRESSION,9
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,9
BR,LIVER DISORDER,9
BR,NERVOUSNESS,9
BR,PARAESTHESIA,9
BR,SKIN DISCOLOURATION,9
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,9
BR,AGGRESSION,8
BR,ANGINA UNSTABLE,8
BR,ANGIOPLASTY,8
BR,CARDIO-RESPIRATORY ARREST,8
BR,CHILLS,8
BR,CONDITION AGGRAVATED,8
BR,DIABETES MELLITUS INADEQUATE CONTROL,8
BR,DRUG ADMINISTRATION ERROR,8
BR,INJECTION SITE ERYTHEMA,8
BR,MUSCLE SPASMS,8
BR,PRURITUS GENERALISED,8
BR,ALOPECIA,7
BR,ARTERIOSCLEROSIS,7
BR,ARTHRITIS,7
BR,ARTHROPATHY,7
BR,BEDRIDDEN,7
BR,BLOOD CREATININE INCREASED,7
BR,BLOOD GLUCOSE DECREASED,7
BR,BLOOD TRIGLYCERIDES INCREASED,7
BR,BRONCHITIS,7
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,7
BR,CONFUSIONAL STATE,7
BR,DEMENTIA ALZHEIMER^S TYPE,7
BR,DYSPEPSIA,7
BR,DYSSTASIA,7
BR,EATING DISORDER,7
BR,GASTROOESOPHAGEAL REFLUX DISEASE,7
BR,HAEMORRHAGIC STROKE,7
BR,HEART RATE DECREASED,7
BR,HERNIA,7
BR,INCORRECT DOSE ADMINISTERED,7
BR,LOCAL SWELLING,7
BR,LOSS OF CONSCIOUSNESS,7
BR,LUNG DISORDER,7
BR,MOVEMENT DISORDER,7
BR,OEDEMA PERIPHERAL,7
BR,SEPSIS,7
BR,UNEVALUABLE EVENT,7
BR,VEIN DISORDER,7
BR,AMNESIA,6
BR,ANEURYSM,6
BR,ARTERIOSCLEROSIS CORONARY ARTERY,6
BR,BLINDNESS UNILATERAL,6
BR,BLISTER,6
BR,BLOOD GLUCOSE FLUCTUATION,6
BR,BURNING SENSATION,6
BR,CARDIOVASCULAR DISORDER,6
BR,EMPHYSEMA,6
BR,EYE DISORDER,6
BR,EYE HAEMORRHAGE,6
BR,FEELING HOT,6
BR,FLATULENCE,6
BR,GASTRIC HAEMORRHAGE,6
BR,GASTROINTESTINAL HAEMORRHAGE,6
BR,HAEMATURIA,6
BR,HEAD INJURY,6
BR,HEART RATE IRREGULAR,6
BR,HEMIPLEGIA,6
BR,HERPES ZOSTER,6
BR,JOINT SWELLING,6
BR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,6
BR,LIMB INJURY,6
BR,LOCALISED INFECTION,6
BR,MOBILITY DECREASED,6
BR,NASOPHARYNGITIS,6
BR,NECK PAIN,6
BR,NEOPLASM MALIGNANT,6
BR,PARKINSON^S DISEASE,6
BR,PROSTATE CANCER,6
BR,RENAL IMPAIRMENT,6
BR,SPINAL DISORDER,6
BR,THYROID DISORDER,6
BR,WHEEZING,6
BR,ABDOMINAL DISTENSION,5
BR,ADVERSE EVENT,5
BR,AGITATION,5
BR,APPARENT DEATH,5
BR,ARTERIAL DISORDER,5
BR,BLOOD POTASSIUM DECREASED,5
BR,BLOOD PRESSURE ABNORMAL,5
BR,BONE DISORDER,5
BR,BONE MARROW TOXICITY,5
BR,CARDIOMEGALY,5
BR,CATHETERISATION CARDIAC,5
BR,COLON CANCER,5
BR,CORONARY ARTERY RESTENOSIS,5
BR,CRYING,5
BR,DRUG HYPERSENSITIVITY,5
BR,EPISTAXIS,5
BR,EYE PAIN,5
BR,FAECES DISCOLOURED,5
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,5
BR,HAEMATOMA,5
BR,HEPATITIS,5
BR,IMMUNODEFICIENCY,5
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,5
BR,INJECTION SITE BRUISING,5
BR,INJECTION SITE HAEMORRHAGE,5
BR,LIMB DISCOMFORT,5
BR,MUSCULOSKELETAL STIFFNESS,5
BR,NERVOUS SYSTEM DISORDER,5
BR,NEUROPATHY PERIPHERAL,5
BR,OSTEOPOROSIS,5
BR,PRODUCT QUALITY ISSUE,5
BR,RESPIRATORY DISORDER,5
BR,RHEUMATOID ARTHRITIS,5
BR,SEIZURE,5
BR,SINUSITIS,5
BR,SKIN EXFOLIATION,5
BR,SPINAL PAIN,5
BR,SWELLING FACE,5
BR,THROAT IRRITATION,5
BR,ANKYLOSING SPONDYLITIS,4
BR,ASTHMATIC CRISIS,4
BR,ATYPICAL PNEUMONIA,4
BR,BLINDNESS,4
BR,BLOOD CHOLESTEROL ABNORMAL,4
BR,BLOOD GLUCOSE ABNORMAL,4
BR,BLOOD SODIUM DECREASED,4
BR,BODY HEIGHT DECREASED,4
BR,CARDIAC FAILURE CONGESTIVE,4
BR,CARDIOGENIC SHOCK,4
BR,CAROTID ARTERY STENOSIS,4
BR,CHOLELITHIASIS,4
BR,CONVULSION,4
BR,DEMENTIA,4
BR,DEPRESSED MOOD,4
BR,DIARRHOEA HAEMORRHAGIC,4
BR,DISORIENTATION,4
BR,DIVERTICULITIS,4
BR,DRUG INTOLERANCE,4
BR,DRUG PRESCRIBING ERROR,4
BR,EMOTIONAL DISORDER,4
BR,ERYTHEMA,4
BR,GASTRIC ULCER,4
BR,GASTROINTESTINAL DISORDER,4
BR,GLUCOSE TOLERANCE IMPAIRED,4
BR,HEAD DISCOMFORT,4
BR,HEART RATE INCREASED,4
BR,HYPOKINESIA,4
BR,IMPAIRED HEALING,4
BR,INJECTION SITE HAEMATOMA,4
BR,INTERVERTEBRAL DISC PROTRUSION,4
BR,IRRITABILITY,4
BR,LUNG INFECTION,4
BR,MEDICATION ERROR,4
BR,MULTI-ORGAN FAILURE,4
BR,MUSCULOSKELETAL DISORDER,4
BR,ORAL CANDIDIASIS,4
BR,PLATELET COUNT DECREASED,4
BR,PLEURAL EFFUSION,4
BR,PRODUCTIVE COUGH,4
BR,PULMONARY FIBROSIS,4
BR,RENAL FAILURE CHRONIC,4
BR,RIB FRACTURE,4
BR,SEPTIC SHOCK,4
BR,SINUS BRADYCARDIA,4
BR,SLUGGISHNESS,4
BR,SMALL INTESTINAL HAEMORRHAGE,4
BR,THROMBOSIS IN DEVICE,4
BR,TRANSIENT ISCHAEMIC ATTACK,4
BR,VENOUS THROMBOSIS,4
BR,YELLOW SKIN,4
BR,ABDOMINAL HERNIA,3
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,3
BR,ACUTE PULMONARY OEDEMA,3
BR,ACUTE RESPIRATORY FAILURE,3
BR,AORTIC DISORDER,3
BR,ARTHROPOD BITE,3
BR,ATRIAL FIBRILLATION,3
BR,BACTERIAL INFECTION,3
BR,BLOOD URINE PRESENT,3
BR,BREAST CANCER,3
BR,BRONCHOPNEUMONIA,3
BR,BUNDLE BRANCH BLOCK LEFT,3
BR,CARDIOMYOPATHY,3
BR,CATHETER PLACEMENT,3
BR,CEREBRAL INFARCTION,3
BR,CEREBRAL ISCHAEMIA,3
BR,CHEST DISCOMFORT,3
BR,CHROMATURIA,3
BR,CHRONIC KIDNEY DISEASE,3
BR,COLD SWEAT,3
BR,CONCOMITANT DISEASE AGGRAVATED,3
BR,CONTRAINDICATED PRODUCT ADMINISTERED,3
BR,CORONARY ARTERY STENOSIS,3
BR,CYANOSIS,3
BR,CYST,3
BR,DEAFNESS,3
BR,DEHYDRATION,3
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,3
BR,DIABETIC METABOLIC DECOMPENSATION,3
BR,DISCOMFORT,3
BR,DISTURBANCE IN ATTENTION,3
BR,DIVERTICULUM,3
BR,DRUG DEPENDENCE,3
BR,DRUG-INDUCED LIVER INJURY,3
BR,DRY EYE,3
BR,DRY MOUTH,3
BR,DYSENTERY,3
BR,DYSURIA,3
BR,EAR INFECTION,3
BR,ERECTILE DYSFUNCTION,3
BR,ERYSIPELAS,3
BR,EXPIRED PRODUCT ADMINISTERED,3
BR,EYE IRRITATION,3
BR,EYE PRURITUS,3
BR,FEELING COLD,3
BR,FLUID RETENTION,3
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,3
BR,GASTRITIS EROSIVE,3
BR,GASTROINTESTINAL CARCINOMA,3
BR,GASTROINTESTINAL INJURY,3
BR,GENERAL PHYSICAL HEALTH DETERIORATION,3
BR,HAEMATEMESIS,3
BR,HAEMOGLOBIN DECREASED,3
BR,HEARING IMPAIRED,3
BR,HYPERHIDROSIS,3
BR,HYPERTENSIVE CRISIS,3
BR,HYPOACUSIS,3
BR,HYPOPHAGIA,3
BR,INFLAMMATION,3
BR,INJECTION SITE INDURATION,3
BR,INJECTION SITE NODULE,3
BR,INJECTION SITE PRURITUS,3
BR,INJECTION SITE SWELLING,3
BR,INJURY,3
BR,INTESTINAL ISCHAEMIA,3
BR,LABYRINTHITIS,3
BR,LUNG NEOPLASM MALIGNANT,3
BR,MUSCULOSKELETAL CHEST PAIN,3
BR,NOSOCOMIAL INFECTION,3
BR,OEDEMA,3
BR,OROPHARYNGEAL PAIN,3
BR,OXYGEN SATURATION DECREASED,3
BR,PANCREATITIS,3
BR,POLYURIA,3
BR,PRESYNCOPE,3
BR,PSORIASIS,3
BR,RECTAL HAEMORRHAGE,3
BR,RENAL INJURY,3
BR,RESPIRATORY TRACT INFECTION,3
BR,RETCHING,3
BR,RETINAL VASCULAR THROMBOSIS,3
BR,ROAD TRAFFIC ACCIDENT,3
BR,SCIATICA,3
BR,SECRETION DISCHARGE,3
BR,SENSORY LOSS,3
BR,SKIN INJURY,3
BR,STAPHYLOCOCCAL INFECTION,3
BR,STENT PLACEMENT,3
BR,SUDDEN DEATH,3
BR,SUFFOCATION FEELING,3
BR,THROAT TIGHTNESS,3
BR,THROMBOCYTOPENIA,3
BR,TOOTH ABSCESS,3
BR,TOOTH SOCKET HAEMORRHAGE,3
BR,ULCER,3
BR,UPPER LIMB FRACTURE,3
BR,URINARY RETENTION,3
BR,URTICARIA,3
BR,VERTIGO,3
BR,VIRAL INFECTION,3
BR,WOUND HAEMORRHAGE,3
BR,WOUND INFECTION,3
BR,ABNORMAL FAECES,2
BR,ACUTE RESPIRATORY DISTRESS SYNDROME,2
BR,AGEUSIA,2
BR,ANAL HAEMORRHAGE,2
BR,AORTIC OCCLUSION,2
BR,APNOEA,2
BR,APPLICATION SITE HYPERSENSITIVITY,2
BR,ASPHYXIA,2
BR,ASPIRATION,2
BR,BLOOD CHOLESTEROL DECREASED,2
BR,BLOOD IMMUNOGLOBULIN E INCREASED,2
BR,BLOOD POTASSIUM INCREASED,2
BR,BLOOD UREA ABNORMAL,2
BR,BLOOD URIC ACID INCREASED,2
BR,BONE PAIN,2
BR,BRADYCARDIA,2
BR,BRAIN HYPOXIA,2
BR,BREAST MASS,2
BR,CARDIAC OPERATION,2
BR,CARDIAC VENTRICULAR THROMBOSIS,2
BR,CAROTID ARTERY DISEASE,2
BR,CHOKING,2
BR,CHOKING SENSATION,2
BR,CHOLECYSTITIS ACUTE,2
BR,CHONDROPATHY,2
BR,COMPLICATION ASSOCIATED WITH DEVICE,2
BR,CONTUSION,2
BR,COORDINATION ABNORMAL,2
BR,CORONARY ARTERY INSUFFICIENCY,2
BR,CORONARY BYPASS THROMBOSIS,2
BR,CROHN^S DISEASE,2
BR,DECREASED IMMUNE RESPONSIVENESS,2
BR,DEEP VEIN THROMBOSIS,2
BR,DERMATITIS ALLERGIC,2
BR,DEVICE MALFUNCTION,2
BR,DIABETIC NEUROPATHY,2
BR,DISEASE RECURRENCE,2
BR,DRUG DISPENSING ERROR,2
BR,DRUG EFFECT INCREASED,2
BR,DRY SKIN,2
BR,DYSGEUSIA,2
BR,DYSKINESIA,2
BR,DYSPNOEA EXERTIONAL,2
BR,ERUCTATION,2
BR,EXOSTOSIS,2
BR,EXTRA DOSE ADMINISTERED,2
BR,EYE MOVEMENT DISORDER,2
BR,FAT TISSUE INCREASED,2
BR,FEAR,2
BR,FEBRILE NEUTROPENIA,2
BR,FEEDING DISORDER,2
BR,FIBROMYALGIA,2
BR,FISTULA,2
BR,FUMBLING,2
BR,GAIT INABILITY,2
BR,GASTRIC DISORDER,2
BR,GASTROENTERITIS,2
BR,GASTROINTESTINAL INFLAMMATION,2
BR,GASTROINTESTINAL NEOPLASM,2
BR,GASTROINTESTINAL TRACT ADENOMA,2
BR,GINGIVAL BLEEDING,2
BR,GOUT,2
BR,GROIN PAIN,2
BR,HAEMATOCRIT DECREASED,2
BR,HAEMOPTYSIS,2
BR,HAND DEFORMITY,2
BR,HAND FRACTURE,2
BR,HEART RATE ABNORMAL,2
BR,HELICOBACTER GASTRITIS,2
BR,HEMIPARESIS,2
BR,HEPATIC FAILURE,2
BR,HEPATIC PAIN,2
BR,HEPATIC STEATOSIS,2
BR,HERPES VIRUS INFECTION,2
BR,HIGH DENSITY LIPOPROTEIN DECREASED,2
BR,HIP FRACTURE,2
BR,HYPERAEMIA,2
BR,HYPERCHOLESTEROLAEMIA,2
BR,HYPERKERATOSIS,2
BR,HYPERSOMNIA,2
BR,HYPOAESTHESIA ORAL,2
BR,HYPOMAGNESAEMIA,2
BR,HYPOTHERMIA,2
BR,HYPOTHYROIDISM,2
BR,ILL-DEFINED DISORDER,2
BR,IMPATIENCE,2
BR,INFUSION RELATED REACTION,2
BR,INJECTION SITE DISCOLOURATION,2
BR,INJECTION SITE MASS,2
BR,INTENTIONAL PRODUCT USE ISSUE,2
BR,INTERNAL HAEMORRHAGE,2
BR,INTESTINAL POLYP,2
BR,INTRAOCULAR PRESSURE INCREASED,2
BR,ISCHAEMIC CARDIOMYOPATHY,2
BR,JOINT EFFUSION,2
BR,LACRIMATION INCREASED,2
BR,LETHARGY,2
BR,LIP DISCOLOURATION,2
BR,LOW DENSITY LIPOPROTEIN DECREASED,2
BR,LOW DENSITY LIPOPROTEIN INCREASED,2
BR,LYMPHADENOPATHY,2
BR,LYMPHOMA,2
BR,MALIGNANT NEOPLASM PROGRESSION,2
BR,MELAENA,2
BR,MENISCUS INJURY,2
BR,MICTURITION URGENCY,2
BR,MIGRAINE,2
BR,MOOD ALTERED,2
BR,MOTOR DYSFUNCTION,2
BR,MOUTH HAEMORRHAGE,2
BR,MOUTH INJURY,2
BR,MULTIPLE ALLERGIES,2
BR,MULTIPLE SCLEROSIS RELAPSE,2
BR,MUSCLE RIGIDITY,2
BR,MUSCLE STRAIN,2
BR,MUSCULOSKELETAL PAIN,2
BR,MYOCARDIAL ISCHAEMIA,2
BR,NEPHROCALCINOSIS,2
BR,NEPHROLITHIASIS,2
BR,NO ADVERSE EVENT,2
BR,OBESITY,2
BR,OBSTRUCTIVE AIRWAYS DISORDER,2
BR,ORAL PAIN,2
BR,ORAL PUSTULE,2
BR,OVERDOSE,2
BR,PALLOR,2
BR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
BR,PALPITATIONS,2
BR,PANIC REACTION,2
BR,PARALYSIS,2
BR,PELVIC FRACTURE,2
BR,PERICARDIAL EFFUSION,2
BR,PERIPHERAL VASCULAR DISORDER,2
BR,PHARYNGEAL INFLAMMATION,2
BR,PHARYNGEAL OEDEMA,2
BR,PNEUMONIA ASPIRATION,2
BR,POLYDIPSIA,2
BR,POLYP,2
BR,POOR PERIPHERAL CIRCULATION,2
BR,PROCEDURAL SITE REACTION,2
BR,PRODUCT PREPARATION ERROR,2
BR,PRODUCT STORAGE ERROR,2
BR,PROSTATOMEGALY,2
BR,PSYCHOTIC DISORDER,2
BR,PULMONARY CONGESTION,2
BR,PULMONARY HYPERTENSION,2
BR,PULPITIS DENTAL,2
BR,RASH,2
BR,RESPIRATORY FAILURE,2
BR,RETINAL DETACHMENT,2
BR,RHEUMATIC DISORDER,2
BR,RHINITIS,2
BR,SEDATION,2
BR,SENSORY DISTURBANCE,2
BR,SHOCK,2
BR,SKIN DISORDER,2
BR,SKIN LESION,2
BR,SKIN MASS,2
BR,SKIN PAPILLOMA,2
BR,SPINAL FRACTURE,2
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,2
BR,THERAPEUTIC RESPONSE DECREASED,2
BR,THERAPY CESSATION,2
BR,THIRST,2
BR,TONGUE DISORDER,2
BR,TOOTH LOSS,2
BR,TRANSAMINASES INCREASED,2
BR,TYPE 2 DIABETES MELLITUS,2
BR,UNDERDOSE,2
BR,URINARY INCONTINENCE,2
BR,VARICOSE VEIN,2
BR,VENTRICULAR HYPOKINESIA,2
BR,VIITH NERVE PARALYSIS,2
BR,VITAMIN D DECREASED,2
BR,WHEELCHAIR USER,2
BR,WHITE BLOOD CELL COUNT DECREASED,2
BR,ABDOMINAL RIGIDITY,1
BR,ABNORMAL BEHAVIOUR,1
BR,ABNORMAL DREAMS,1
BR,ABSCESS,1
BR,ACCIDENT,1
BR,ACCIDENT AT HOME,1
BR,ACCIDENTAL OVERDOSE,1
BR,ACQUIRED HAEMOPHILIA,1
BR,ACUTE CORONARY SYNDROME,1
BR,ACUTE KIDNEY INJURY,1
BR,ADENOCARCINOMA,1
BR,ADENOCARCINOMA GASTRIC,1
BR,ADENOMA BENIGN,1
BR,ADJUSTMENT DISORDER,1
BR,ADVERSE DRUG REACTION,1
BR,AFFECTIVE DISORDER,1
BR,ALLERGY TO ARTHROPOD STING,1
BR,ANAPHYLACTIC REACTION,1
BR,ANKLE FRACTURE,1
BR,ANOSMIA,1
BR,AORTIC CALCIFICATION,1
BR,AORTIC DISSECTION RUPTURE,1
BR,AORTIC INJURY,1
BR,AORTIC VALVE STENOSIS,1
BR,APALLIC SYNDROME,1
BR,APHAGIA,1
BR,APHASIA,1
BR,APHONIA,1
BR,APHTHOUS ULCER,1
BR,APPENDICECTOMY,1
BR,APPENDICITIS,1
BR,APPETITE DISORDER,1
BR,APPLICATION SITE BURN,1
BR,APPLICATION SITE RASH,1
BR,ARRHYTHMIA SUPRAVENTRICULAR,1
BR,ARTERIAL STENOSIS,1
BR,ASCITES,1
BR,ASPIRATION BRONCHIAL,1
BR,ATAXIA,1
BR,ATELECTASIS,1
BR,AUDITORY DISORDER,1
BR,AUTOIMMUNE HEPATITIS,1
BR,BACK DISORDER,1
BR,BACK INJURY,1
BR,BENIGN PROSTATIC HYPERPLASIA,1
BR,BILE DUCT STONE,1
BR,BIPOLAR DISORDER,1
BR,BLADDER CANCER,1
BR,BLADDER PAIN,1
BR,BLINDNESS TRANSIENT,1
BR,BLISTER INFECTED,1
BR,BLOOD ALBUMIN INCREASED,1
BR,BLOOD BLISTER,1
BR,BLOOD CALCIUM INCREASED,1
BR,BLOOD CREATININE ABNORMAL,1
BR,BLOOD DISORDER,1
BR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
BR,BLOOD PRESSURE SYSTOLIC INCREASED,1
BR,BLOOD TEST ABNORMAL,1
BR,BLOOD THYROID STIMULATING HORMONE DECREASED,1
BR,BLOOD TRIGLYCERIDES ABNORMAL,1
BR,BLOOD UREA DECREASED,1
BR,BLOOD UREA INCREASED,1
BR,BLOOD URINE,1
BR,BONE DECALCIFICATION,1
BR,BREAST ABSCESS,1
BR,BREAST CANCER RECURRENT,1
BR,BREATH ODOUR,1
BR,BREATH SOUNDS ABNORMAL,1
BR,BRONCHIAL DISORDER,1
BR,BRONCHIAL SECRETION RETENTION,1
BR,BRONCHITIS CHRONIC,1
BR,BRONCHOSPASM,1
BR,BURNING FEET SYNDROME,1
BR,C-REACTIVE PROTEIN DECREASED,1
BR,C-REACTIVE PROTEIN INCREASED,1
BR,CARDIAC ANEURYSM,1
BR,CARDIAC FAILURE ACUTE,1
BR,CARDIAC FIBRILLATION,1
BR,CARDIOTHORACIC RATIO INCREASED,1
BR,CARDIOVERSION,1
BR,CAROTID ARTERIOSCLEROSIS,1
BR,CAROTID ARTERY CALCIFICATION,1
BR,CARTILAGE ATROPHY,1
BR,CARTILAGE INJURY,1
BR,CATARRH,1
BR,CEREBRAL ARTERY EMBOLISM,1
BR,CEREBRAL ARTERY OCCLUSION,1
BR,CEREBRAL ATROPHY,1
BR,CEREBRAL THROMBOSIS,1
BR,CERVICOBRACHIAL SYNDROME,1
BR,CHEST EXPANSION DECREASED,1
BR,CHEST X-RAY ABNORMAL,1
BR,CHIKUNGUNYA VIRUS INFECTION,1
BR,CHOLECYSTITIS,1
BR,CHRONIC GASTRITIS,1
BR,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
BR,CIRCULATORY COLLAPSE,1
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
BR,COAGULOPATHY,1
BR,COCCYDYNIA,1
BR,COLITIS,1
BR,COLITIS ISCHAEMIC,1
BR,COMMUNICATION DISORDER,1
BR,COMPUTERISED TOMOGRAM HEAD ABNORMAL,1
BR,CONGENITAL HEART VALVE DISORDER,1
BR,CONJUNCTIVITIS,1
BR,CORNEAL ENDOTHELIAL CELL LOSS,1
BR,CORNEAL OPACITY,1
BR,CORNEAL SCAR,1
BR,CORONARY ARTERY DISSECTION,1
BR,CORONARY REVASCULARISATION,1
BR,CORONARY VASCULAR GRAFT OCCLUSION,1
BR,CRANIOCEREBRAL INJURY,1
BR,CRYSTAL URINE,1
BR,CUSHING^S SYNDROME,1
BR,CYSTITIS,1
BR,DEAFNESS UNILATERAL,1
BR,DECREASED VIBRATORY SENSE,1
BR,DEFORMITY,1
BR,DELIRIUM,1
BR,DEMENTIA WITH LEWY BODIES,1
BR,DENGUE FEVER,1
BR,DEPRESSION SUICIDAL,1
BR,DERMATOMYOSITIS,1
BR,DEVICE ISSUE,1
BR,DEVICE MATERIAL OPACIFICATION,1
BR,DIABETIC KETOACIDOSIS,1
BR,DIABETIC RETINOPATHY,1
BR,DIAPHRAGMATIC DISORDER,1
BR,DIET REFUSAL,1
BR,DIPLOPIA,1
BR,DISORGANISED SPEECH,1
BR,DROOLING,1
BR,DRUG ABUSE,1
BR,DRUG EFFECT DECREASED,1
BR,DRUG EFFECT INCOMPLETE,1
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
BR,DRUG RESISTANCE,1
BR,DRY THROAT,1
BR,DUODENAL ULCER,1
BR,DUODENECTOMY,1
BR,DUODENITIS,1
BR,DYSARTHRIA,1
BR,DYSBACTERIOSIS,1
BR,DYSCHEZIA,1
BR,DYSLIPIDAEMIA,1
BR,DYSPLASIA,1
BR,EAR DISCOMFORT,1
BR,EAR DISORDER,1
BR,EAR HAEMORRHAGE,1
BR,EAR INJURY,1
BR,EAR PAIN,1
BR,ECZEMA NUMMULAR,1
BR,ELECTRIC SHOCK,1
BR,ELECTROCARDIOGRAM CHANGE,1
BR,ELECTROCARDIOGRAM Q WAVE ABNORMAL,1
BR,EMBOLISM,1
BR,EMBOLISM VENOUS,1
BR,EMOTIONAL DISTRESS,1
BR,ENCEPHALITIS,1
BR,ENDOCARDITIS,1
BR,ENDOTRACHEAL INTUBATION,1
BR,ENTERITIS,1
BR,EROSIVE OESOPHAGITIS,1
BR,ESCHERICHIA INFECTION,1
BR,ESCHERICHIA TEST POSITIVE,1
BR,EXPIRED DRUG ADMINISTERED,1
BR,EXTREMITY NECROSIS,1
BR,EYE INFECTION,1
BR,EYELID MARGIN CRUSTING,1
BR,EYELID OEDEMA,1
BR,EYELID PTOSIS,1
BR,FAECALOMA,1
BR,FAECES SOFT,1
BR,FEAR OF DEATH,1
BR,FEELING DRUNK,1
BR,FEELING OF DESPAIR,1
BR,FINGER DEFORMITY,1
BR,FLUID INTAKE REDUCED,1
BR,FOOD INTOLERANCE,1
BR,FOOT FRACTURE,1
BR,FOREIGN BODY SENSATION IN EYES,1
BR,FORMICATION,1
BR,FRACTURE,1
BR,FRACTURE MALUNION,1
BR,FRACTURED COCCYX,1
BR,GANGRENE,1
BR,GASTRIC CANCER,1
BR,GASTRIC INFECTION,1
BR,GASTRODUODENAL ULCER,1
BR,GASTROINTESTINAL INFECTION,1
BR,GASTROINTESTINAL MOTILITY DISORDER,1
BR,GASTROINTESTINAL OBSTRUCTION,1
BR,GASTROINTESTINAL OEDEMA,1
BR,GASTROINTESTINAL PAIN,1
BR,GASTROINTESTINAL PERFORATION,1
BR,GASTROINTESTINAL TOXICITY,1
BR,GENERALISED ERYTHEMA,1
BR,GENERALISED TONIC-CLONIC SEIZURE,1
BR,GINGIVAL BLISTER,1
BR,GLIOBLASTOMA MULTIFORME,1
BR,GLOMERULONEPHRITIS MEMBRANOUS,1
BR,GLUCOSE URINE PRESENT,1
BR,H1N1 INFLUENZA,1
BR,HAEMATOLOGICAL MALIGNANCY,1
BR,HAEMODIALYSIS,1
BR,HAEMODYNAMIC INSTABILITY,1
BR,HAEMOLYSIS,1
BR,HAEMOPHILUS INFECTION,1
BR,HAEMORRHAGE URINARY TRACT,1
BR,HAEMORRHOIDS,1
BR,HAIR COLOUR CHANGES,1
BR,HALLUCINATION_ VISUAL,1
BR,HEART DISEASE CONGENITAL,1
BR,HEART VALVE REPLACEMENT,1
BR,HEPATIC ENCEPHALOPATHY,1
BR,HEPATIC NEOPLASM,1
BR,HIATUS HERNIA,1
BR,HORDEOLUM,1
BR,HOSPITALISATION,1
BR,HUNGER,1
BR,HYPERCOAGULATION,1
BR,HYPERTHYROIDISM,1
BR,HYPERURICAEMIA,1
BR,HYPOCALCAEMIA,1
BR,HYPOGLYCAEMIC SEIZURE,1
BR,HYPOPERFUSION,1
BR,HYPOTONIA,1
BR,HYPOXIA,1
BR,HYSTERECTOMY,1
BR,IMMUNE SYSTEM DISORDER,1
BR,IMMUNOSUPPRESSION,1
BR,IMPAIRED SELF-CARE,1
BR,INCARCERATED INGUINAL HERNIA,1
BR,INCISION SITE ABSCESS,1
BR,INCORRECT DRUG ADMINISTRATION RATE,1
BR,INCORRECT DRUG DOSAGE FORM ADMINISTERED,1
BR,INCORRECT PRODUCT STORAGE,1
BR,INCORRECT STORAGE OF DRUG,1
BR,INCREASED APPETITE,1
BR,INCREASED UPPER AIRWAY SECRETION,1
BR,INGROWN HAIR,1
BR,INGUINAL HERNIA,1
BR,INJECTION SITE HYPERSENSITIVITY,1
BR,INJECTION SITE INJURY,1
BR,INJECTION SITE OEDEMA,1
BR,INJECTION SITE RASH,1
BR,INJECTION SITE WARMTH,1
BR,INSULIN RESISTANCE,1
BR,INTENTIONAL DRUG MISUSE,1
BR,INTESTINAL INFARCTION,1
BR,INTESTINAL OBSTRUCTION,1
BR,INTESTINAL OPERATION,1
BR,INTRACRANIAL ANEURYSM,1
BR,INTRACRANIAL PRESSURE INCREASED,1
BR,INVASIVE DUCTAL BREAST CARCINOMA,1
BR,IRON DEFICIENCY ANAEMIA,1
BR,JAUNDICE,1
BR,JAW DISORDER,1
BR,JOINT DISLOCATION,1
BR,JOINT INJURY,1
BR,KAPOSI^S SARCOMA,1
BR,KERATITIS,1
BR,LABORATORY TEST ABNORMAL,1
BR,LACTOSE INTOLERANCE,1
BR,LARGE INTESTINE POLYP,1
BR,LARYNGEAL OEDEMA,1
BR,LEARNING DISABILITY,1
BR,LEFT ATRIAL ENLARGEMENT,1
BR,LEFT VENTRICULAR DYSFUNCTION,1
BR,LEFT VENTRICULAR FAILURE,1
BR,LEG AMPUTATION,1
BR,LEUKAEMIA,1
BR,LEUKOCYTOSIS,1
BR,LIBIDO DECREASED,1
BR,LIGAMENT SPRAIN,1
BR,LIMB OPERATION,1
BR,LIP DISORDER,1
BR,LIP EXFOLIATION,1
BR,LIPODYSTROPHY ACQUIRED,1
BR,LOOSE TOOTH,1
BR,LOSS OF LIBIDO,1
BR,LOWER LIMB FRACTURE,1
BR,LUMBAR VERTEBRAL FRACTURE,1
BR,LUNG ABSCESS,1
BR,LUNG ADENOCARCINOMA,1
BR,LUNG HYPERINFLATION,1
BR,LUNG INFILTRATION,1
BR,LUNG NEOPLASM,1
BR,LUNG PERFORATION,1
BR,LYMPH NODE PAIN,1
BR,LYMPHADENITIS,1
BR,MACULAR DEGENERATION,1
BR,MACULE,1
BR,MACULOPATHY,1
BR,MALIGNANT MELANOMA,1
BR,MASS,1
BR,MASTICATION DISORDER,1
BR,MEDIASTINAL DISORDER,1
BR,MEDIASTINITIS,1
BR,MEDIASTINUM NEOPLASM,1
BR,MEDICAL DEVICE IMPLANTATION,1
BR,MEDICAL DEVICE SITE DISCHARGE,1
BR,MEDICAL DIET,1
BR,MENIERE^S DISEASE,1
BR,METABOLIC SYNDROME,1
BR,METASTASES TO BONE,1
BR,METASTASES TO LIVER,1
BR,MIOSIS,1
BR,MITRAL VALVE INCOMPETENCE,1
BR,MONOPLEGIA,1
BR,MUCOSAL INFLAMMATION,1
BR,MULTIMORBIDITY,1
BR,MULTIPLE INJURIES,1
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
BR,MULTIPLE SCLEROSIS,1
BR,MUSCLE ATROPHY,1
BR,MUSCLE DISORDER,1
BR,MUSCLE FATIGUE,1
BR,MUSCLE TIGHTNESS,1
BR,MUSCULOSKELETAL DISCOMFORT,1
BR,MYOCARDIAL NECROSIS,1
BR,MYOCARDIAL NECROSIS MARKER INCREASED,1
BR,MYOPATHY,1
BR,NECROSIS,1
BR,NEOPLASM,1
BR,NEOPLASM RECURRENCE,1
BR,NEPHROTIC SYNDROME,1
BR,NERVE DEGENERATION,1
BR,NERVE ROOT INJURY LUMBAR,1
BR,NEURALGIA,1
BR,NEUTROPENIA,1
BR,NIGHT SWEATS,1
BR,NYSTAGMUS,1
BR,OCULAR HYPERAEMIA,1
BR,OESOPHAGEAL CANDIDIASIS,1
BR,OESOPHAGEAL INJURY,1
BR,OESOPHAGEAL ULCER,1
BR,OESOPHAGITIS,1
BR,ONYCHOCLASIS,1
BR,OPTIC ATROPHY,1
BR,ORAL INFECTION,1
BR,OROPHARYNGEAL BLISTERING,1
BR,OSTEOMYELITIS BACTERIAL,1
BR,OSTEOPENIA,1
BR,OXYGEN CONSUMPTION DECREASED,1
BR,OXYGEN SATURATION ABNORMAL,1
BR,OXYGEN SUPPLEMENTATION,1
BR,PAIN IN JAW,1
BR,PANCREATIC CARCINOMA,1
BR,PANCREATIC ENZYMES INCREASED,1
BR,PANCREATITIS ACUTE,1
BR,PANIC DISORDER,1
BR,PAPULE,1
BR,PARKINSONISM,1
BR,PATIENT-DEVICE INCOMPATIBILITY,1
BR,PELVIC PAIN,1
BR,PENILE PROSTHESIS INSERTION,1
BR,PEPTIC ULCER,1
BR,PERFORATED ULCER,1
BR,PERFORMANCE STATUS DECREASED,1
BR,PERICARDITIS,1
BR,PERIPHERAL ARTERY ANEURYSM,1
BR,PERIPHERAL ARTERY STENT INSERTION,1
BR,PERIPHERAL ARTERY THROMBOSIS,1
BR,PERIPHERAL EMBOLISM,1
BR,PERIPHERAL ISCHAEMIA,1
BR,PERIPHERAL NERVE INJURY,1
BR,PERITONITIS,1
BR,PEYRONIE^S DISEASE,1
BR,PHARYNGITIS,1
BR,PHLEBITIS,1
BR,PHLEBOTOMY,1
BR,PHOTOPHOBIA,1
BR,PIGMENTATION DISORDER,1
BR,PLASMA CELL MYELOMA,1
BR,PLATELET AGGREGATION ABNORMAL,1
BR,PLATELET DISORDER,1
BR,PLATELET MORPHOLOGY ABNORMAL,1
BR,PNEUMONIA BACTERIAL,1
BR,PNEUMOTHORAX,1
BR,POISONING,1
BR,POLLAKIURIA,1
BR,POLYGLANDULAR DISORDER,1
BR,POOR QUALITY DRUG ADMINISTERED,1
BR,POST PROCEDURAL COMPLICATION,1
BR,POST PROCEDURAL HAEMORRHAGE,1
BR,POST PROCEDURAL PERSISTENT DRAIN FLUID,1
BR,PRE-EXISTING CONDITION IMPROVED,1
BR,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,1
BR,PROCEDURAL COMPLICATION,1
BR,PRODUCT AVAILABILITY ISSUE,1
BR,PRODUCT DIFFICULT TO SWALLOW,1
BR,PRODUCT DROPPER ISSUE,1
BR,PRODUCT TASTE ABNORMAL,1
BR,PRODUCT USE IN UNAPPROVED INDICATION,1
BR,PROSTATITIS,1
BR,PROTEINURIA,1
BR,PSEUDOMEMBRANOUS COLITIS,1
BR,PSYCHIATRIC SYMPTOM,1
BR,PULMONARY ARTERY THROMBOSIS,1
BR,PULMONARY BULLA,1
BR,PULMONARY EMBOLISM,1
BR,PULMONARY HAEMORRHAGE,1
BR,PULSE PRESSURE DECREASED,1
BR,PULSELESS ELECTRICAL ACTIVITY,1
BR,PUNCTURE SITE HAEMORRHAGE,1
BR,PURPURA,1
BR,PURULENCE,1
BR,PURULENT DISCHARGE,1
BR,PYELONEPHRITIS,1
BR,RADIATION SKIN INJURY,1
BR,RASH ERYTHEMATOUS,1
BR,RASH MACULAR,1
BR,RASH MACULO-PAPULAR,1
BR,RASH PRURITIC,1
BR,REACTION TO DRUG EXCIPIENTS,1
BR,RECTAL POLYP,1
BR,RECTAL TENESMUS,1
BR,RENAL ARTERY OCCLUSION,1
BR,RENAL FAILURE ACUTE,1
BR,RENAL ISCHAEMIA,1
BR,RENAL PAIN,1
BR,REPETITIVE SPEECH,1
BR,RESPIRATORY ARREST,1
BR,RESPIRATORY DISTRESS,1
BR,RESPIRATORY RATE INCREASED,1
BR,RETINOPATHY,1
BR,RHINALGIA,1
BR,RHINORRHOEA,1
BR,RIGHT-TO-LEFT CARDIAC SHUNT,1
BR,SCAR,1
BR,SCOLIOSIS,1
BR,SCROTAL DISORDER,1
BR,SCROTAL PAIN,1
BR,SCROTAL SWELLING,1
BR,SEASONAL ALLERGY,1
BR,SENILE DEMENTIA,1
BR,SILENT MYOCARDIAL INFARCTION,1
BG,CHEST PAIN,4
BG,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
BG,ELECTROCARDIOGRAM T WAVE INVERSION,3
BG,GASTROINTESTINAL HAEMORRHAGE,3
BG,VASCULAR STENT THROMBOSIS,3
BG,ACUTE CORONARY SYNDROME,2
BG,ACUTE MYOCARDIAL INFARCTION,2
BG,ANGINA PECTORIS,2
BG,ATRIAL FIBRILLATION,2
BG,CARDIAC ARREST,2
BG,CARDIOVASCULAR SYMPTOM,2
BG,FATIGUE,2
BG,HEMIPLEGIA,2
BG,ISCHAEMIC STROKE,2
BG,PAIN IN EXTREMITY,2
BG,TROPONIN INCREASED,2
BG,TYPE 2 DIABETES MELLITUS,2
BG,ABASIA,1
BG,ABDOMINAL WALL HAEMATOMA,1
BG,ANAEMIA,1
BG,ANGINA UNSTABLE,1
BG,APHASIA,1
BG,ARTHRALGIA,1
BG,BACK PAIN,1
BG,BLADDER DIVERTICULUM,1
BG,CARDIAC FAILURE,1
BG,CARDIAC FAILURE CONGESTIVE,1
BG,CEREBROVASCULAR ACCIDENT,1
BG,CHEMICAL POISONING,1
BG,CHOLECYSTITIS ACUTE,1
BG,CHRONIC GASTRITIS,1
BG,CORONARY ARTERY STENOSIS,1
BG,DELIRIUM,1
BG,DRUG ADMINISTRATION ERROR,1
BG,DRUG INEFFECTIVE,1
BG,DRUG INTOLERANCE,1
BG,DUODENAL ULCER HAEMORRHAGE,1
BG,DYSPNOEA,1
BG,DYSSTASIA,1
BG,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
BG,EXPOSURE DURING PREGNANCY,1
BG,GASTRIC HAEMORRHAGE,1
BG,GASTRITIS EROSIVE,1
BG,GASTROOESOPHAGEAL REFLUX DISEASE,1
BG,GENERAL PHYSICAL CONDITION ABNORMAL,1
BG,GENERAL PHYSICAL HEALTH DETERIORATION,1
BG,GINGIVAL BLEEDING,1
BG,HAEMATEMESIS,1
BG,HAEMATURIA,1
BG,HAEMORRHAGE INTRACRANIAL,1
BG,HAEMORRHAGIC ANAEMIA,1
BG,HEMIPARESIS,1
BG,HEPATIC FAILURE,1
BG,HYPOTENSION,1
BG,INFECTIOUS PLEURAL EFFUSION,1
BG,INSOMNIA,1
BG,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
BG,LUNG ABSCESS,1
BG,MEDICATION ERROR,1
BG,METABOLIC DISORDER,1
BG,METASTASES TO BONE,1
BG,MONOPARESIS,1
BG,MYOCARDIAL ISCHAEMIA,1
BG,NECK PAIN,1
BG,NOCTURIA,1
BG,OEDEMA PERIPHERAL,1
BG,PAIN,1
BG,PARESIS,1
BG,PELVIC PAIN,1
BG,POST PROCEDURAL HAEMORRHAGE,1
BG,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
BG,PULMONARY CONGESTION,1
BG,RENAL FAILURE,1
BG,RESPIRATORY FAILURE,1
BG,SHOCK HAEMORRHAGIC,1
BG,SPINAL PAIN,1
BG,SUBCUTANEOUS HAEMATOMA,1
BG,TACHYCARDIA,1
BG,TENDON PAIN,1
BG,TRANSIENT ISCHAEMIC ATTACK,1
BG,URINARY TRACT INFECTION ENTEROCOCCAL,1
BG,VASCULAR PSEUDOANEURYSM,1
BG,VIROLOGIC FAILURE,1
BG,WEIGHT DECREASED,1
CA,FATIGUE,145
CA,FALL,121
CA,DYSPNOEA,113
CA,MYOCARDIAL INFARCTION,112
CA,ASTHENIA,107
CA,DIZZINESS,106
CA,DRUG INEFFECTIVE,90
CA,NAUSEA,82
CA,DIARRHOEA,79
CA,ARTHRALGIA,75
CA,HEADACHE,75
CA,BLOOD PRESSURE INCREASED,72
CA,WEIGHT DECREASED,72
CA,PNEUMONIA,71
CA,MALAISE,66
CA,COUGH,63
CA,DEATH,63
CA,PAIN,62
CA,CHEST PAIN,57
CA,CEREBROVASCULAR ACCIDENT,55
CA,VOMITING,55
CA,DECREASED APPETITE,51
CA,PAIN IN EXTREMITY,51
CA,PYREXIA,47
CA,OEDEMA PERIPHERAL,46
CA,GAIT DISTURBANCE,45
CA,HYPOTENSION,45
CA,BACK PAIN,43
CA,HAEMOGLOBIN DECREASED,43
CA,ABDOMINAL PAIN,38
CA,BALANCE DISORDER,38
CA,PERIPHERAL SWELLING,38
CA,WEIGHT INCREASED,38
CA,NASOPHARYNGITIS,36
CA,HYPOAESTHESIA,34
CA,PRURITUS,34
CA,ABDOMINAL PAIN UPPER,33
CA,MYALGIA,33
CA,RASH,33
CA,URINARY TRACT INFECTION,32
CA,CONDITION AGGRAVATED,31
CA,DYSPEPSIA,31
CA,HYPERTENSION,31
CA,ABDOMINAL DISCOMFORT,30
CA,ANGINA PECTORIS,30
CA,CONSTIPATION,30
CA,ANAEMIA,29
CA,ACUTE MYOCARDIAL INFARCTION,27
CA,CHEST DISCOMFORT,27
CA,CONFUSIONAL STATE,27
CA,GENERAL PHYSICAL HEALTH DETERIORATION,27
CA,INFLUENZA,27
CA,JOINT SWELLING,27
CA,OXYGEN SATURATION DECREASED,27
CA,CARDIAC DISORDER,26
CA,GASTROINTESTINAL HAEMORRHAGE,26
CA,MUSCLE SPASMS,26
CA,BLOOD PRESSURE SYSTOLIC INCREASED,25
CA,DEPRESSION,24
CA,PULMONARY OEDEMA,24
CA,TRANSIENT ISCHAEMIC ATTACK,24
CA,HEART RATE DECREASED,23
CA,HEART RATE INCREASED,23
CA,PRODUCTIVE COUGH,23
CA,RHEUMATOID ARTHRITIS,23
CA,CARDIAC FAILURE CONGESTIVE,22
CA,DRY MOUTH,22
CA,LUNG INFECTION,22
CA,MULTIPLE FRACTURES,22
CA,BLOOD CREATININE INCREASED,21
CA,BRADYCARDIA,21
CA,CONTUSION,21
CA,FEELING ABNORMAL,21
CA,HAEMORRHAGE,21
CA,HYPERHIDROSIS,21
CA,INSOMNIA,21
CA,MUSCULAR WEAKNESS,21
CA,PARAESTHESIA,21
CA,ACUTE CORONARY SYNDROME,20
CA,BLOOD PRESSURE DECREASED,20
CA,BRONCHITIS,20
CA,CORONARY ARTERY DISEASE,20
CA,HALLUCINATION_ AUDITORY,20
CA,PARANOIA,20
CA,PRODUCT SUBSTITUTION ISSUE,20
CA,PSYCHOTIC DISORDER,20
CA,VISION BLURRED,20
CA,WHEEZING,20
CA,DYSPNOEA EXERTIONAL,19
CA,LOWER RESPIRATORY TRACT INFECTION,19
CA,MOBILITY DECREASED,19
CA,ATRIAL FIBRILLATION,18
CA,INFUSION RELATED REACTION,18
CA,RENAL FAILURE,18
CA,SEPSIS,18
CA,SOMNOLENCE,18
CA,DEHYDRATION,17
CA,EPISTAXIS,17
CA,FLATULENCE,17
CA,INFECTION,17
CA,OSTEOARTHRITIS,17
CA,STENT PLACEMENT,17
CA,SYNCOPE,17
CA,ACUTE KIDNEY INJURY,16
CA,ARTHRITIS,16
CA,BLOOD PRESSURE DIASTOLIC DECREASED,16
CA,BLOOD PRESSURE FLUCTUATION,16
CA,CARDIAC ARREST,16
CA,CATARACT,16
CA,CHILLS,16
CA,LOSS OF CONSCIOUSNESS,16
CA,MUSCULOSKELETAL PAIN,16
CA,PLATELET COUNT DECREASED,16
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,15
CA,MUSCULOSKELETAL STIFFNESS,15
CA,PLEURAL EFFUSION,15
CA,SINUSITIS,15
CA,THROMBOSIS,15
CA,ABDOMINAL DISTENSION,14
CA,ANXIETY,14
CA,BODY TEMPERATURE DECREASED,14
CA,CEREBRAL HAEMORRHAGE,14
CA,DYSPHAGIA,14
CA,HERPES ZOSTER,14
CA,HYPERSENSITIVITY,14
CA,ORTHOSTATIC HYPOTENSION,14
CA,ALOPECIA,13
CA,ARTHROPATHY,13
CA,ASTHMA,13
CA,BLOOD GLUCOSE INCREASED,13
CA,CELLULITIS,13
CA,CROHN^S DISEASE,13
CA,DRUG HYPERSENSITIVITY,13
CA,ERYTHEMA,13
CA,GASTROINTESTINAL DISORDER,13
CA,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,13
CA,LETHARGY,13
CA,OROPHARYNGEAL PAIN,13
CA,PALPITATIONS,13
CA,RENAL IMPAIRMENT,13
CA,RHINORRHOEA,13
CA,SLEEP DISORDER,13
CA,ABASIA,12
CA,APHASIA,12
CA,CARDIAC FAILURE,12
CA,ELECTROCARDIOGRAM QT PROLONGED,12
CA,MEMORY IMPAIRMENT,12
CA,SEIZURE,12
CA,WHITE BLOOD CELL COUNT DECREASED,12
CA,ARRHYTHMIA,11
CA,CORONARY ARTERY OCCLUSION,11
CA,DIABETES MELLITUS,11
CA,DIVERTICULITIS,11
CA,DYSARTHRIA,11
CA,HAEMOPTYSIS,11
CA,HEAD INJURY,11
CA,HYPERGLYCAEMIA,11
CA,IMPAIRED HEALING,11
CA,INCORRECT DOSE ADMINISTERED,11
CA,PULMONARY EMBOLISM,11
CA,TINNITUS,11
CA,TREMOR,11
CA,VERTIGO,11
CA,CYSTITIS,10
CA,DEMENTIA,10
CA,FEELING HOT,10
CA,HAEMATOCHEZIA,10
CA,HAEMATURIA,10
CA,HEMIPARESIS,10
CA,HOT FLUSH,10
CA,HYPERTONIC BLADDER,10
CA,ISCHAEMIC STROKE,10
CA,MELAENA,10
CA,NASAL CONGESTION,10
CA,PRODUCT USE ISSUE,10
CA,PULMONARY FUNCTION TEST DECREASED,10
CA,RESPIRATORY DISORDER,10
CA,THROAT IRRITATION,10
CA,ANGINA UNSTABLE,9
CA,BLISTER,9
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,9
CA,COGNITIVE DISORDER,9
CA,CONVULSION,9
CA,DISEASE PROGRESSION,9
CA,DRUG ADMINISTRATION ERROR,9
CA,DRUG DOSE OMISSION,9
CA,DYSGEUSIA,9
CA,DYSSTASIA,9
CA,DYSURIA,9
CA,FLUID RETENTION,9
CA,LOCALISED INFECTION,9
CA,MIGRAINE,9
CA,NECK PAIN,9
CA,NEUTROPHIL COUNT DECREASED,9
CA,RENAL FAILURE ACUTE,9
CA,SKIN ULCER,9
CA,SPUTUM DISCOLOURED,9
CA,UPPER GASTROINTESTINAL HAEMORRHAGE,9
CA,URINARY RETENTION,9
CA,WOUND,9
CA,ASCITES,8
CA,BONE PAIN,8
CA,FREQUENT BOWEL MOVEMENTS,8
CA,GASTROOESOPHAGEAL REFLUX DISEASE,8
CA,HAEMATEMESIS,8
CA,HAEMORRHAGIC STROKE,8
CA,HEART RATE IRREGULAR,8
CA,HEPATIC ENZYME INCREASED,8
CA,HIP FRACTURE,8
CA,HOSPITALISATION,8
CA,HYPOGLYCAEMIA,8
CA,INJECTION SITE PAIN,8
CA,LUNG DISORDER,8
CA,NEPHROLITHIASIS,8
CA,PELVIC FRACTURE,8
CA,POLLAKIURIA,8
CA,SINUS BRADYCARDIA,8
CA,SWELLING,8
CA,URINARY INCONTINENCE,8
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,8
CA,BLOOD POTASSIUM DECREASED,7
CA,CHROMATURIA,7
CA,CLOSTRIDIUM DIFFICILE INFECTION,7
CA,COLITIS ULCERATIVE,7
CA,DEAFNESS BILATERAL,7
CA,DELIRIUM,7
CA,DIABETIC KETOACIDOSIS,7
CA,DRUG INTOLERANCE,7
CA,DRY SKIN,7
CA,EYE HAEMORRHAGE,7
CA,HEPATIC CIRRHOSIS,7
CA,HYPOKALAEMIA,7
CA,HYPOPHAGIA,7
CA,ILL-DEFINED DISORDER,7
CA,INCREASED TENDENCY TO BRUISE,7
CA,INTESTINAL OBSTRUCTION,7
CA,LACERATION,7
CA,LOCAL SWELLING,7
CA,NEOPLASM,7
CA,NEOPLASM MALIGNANT,7
CA,POST PROCEDURAL COMPLICATION,7
CA,PULMONARY MASS,7
CA,RASH PRURITIC,7
CA,RED BLOOD CELL COUNT DECREASED,7
CA,RESPIRATORY TRACT CONGESTION,7
CA,RHABDOMYOLYSIS,7
CA,SKIN EXFOLIATION,7
CA,SKIN LESION,7
CA,SPEECH DISORDER,7
CA,SWOLLEN TONGUE,7
CA,VISUAL IMPAIRMENT,7
CA,ARTERIOSCLEROSIS,6
CA,ATRIOVENTRICULAR BLOCK,6
CA,BASAL CELL CARCINOMA,6
CA,BLOOD POTASSIUM INCREASED,6
CA,CARDIOMEGALY,6
CA,CHOLESTATIC LIVER INJURY,6
CA,CORONARY ARTERIAL STENT INSERTION,6
CA,DIABETES MELLITUS INADEQUATE CONTROL,6
CA,DYSPHONIA,6
CA,FLUID OVERLOAD,6
CA,GASTROENTERITIS,6
CA,GENERALISED TONIC-CLONIC SEIZURE,6
CA,HAEMATOMA,6
CA,HAEMORRHAGE INTRACRANIAL,6
CA,HALLUCINATION,6
CA,HEAD DISCOMFORT,6
CA,HEPATIC NEOPLASM,6
CA,LARYNGITIS,6
CA,LIMB INJURY,6
CA,MALIGNANT NEOPLASM PROGRESSION,6
CA,METASTASES TO LIVER,6
CA,MUSCULOSKELETAL DISORDER,6
CA,MYOCARDIAL ISCHAEMIA,6
CA,NEUROPATHY PERIPHERAL,6
CA,ORAL HERPES,6
CA,OSTEOMYELITIS,6
CA,PALLOR,6
CA,POOR VENOUS ACCESS,6
CA,PRESYNCOPE,6
CA,PULMONARY HAEMORRHAGE,6
CA,RASH ERYTHEMATOUS,6
CA,RASH GENERALISED,6
CA,RENAL DISORDER,6
CA,RESPIRATORY TRACT INFECTION,6
CA,SKIN CANCER,6
CA,SKIN DISORDER,6
CA,SPLENOMEGALY,6
CA,SUBDURAL HAEMATOMA,6
CA,SUICIDAL IDEATION,6
CA,SWELLING FACE,6
CA,THERAPY NON-RESPONDER,6
CA,UPPER RESPIRATORY TRACT INFECTION,6
CA,URTICARIA,6
CA,VENTRICULAR FIBRILLATION,6
CA,VIRAL INFECTION,6
CA,WHITE BLOOD CELL COUNT INCREASED,6
CA,ABSCESS,5
CA,ALANINE AMINOTRANSFERASE INCREASED,5
CA,AMNESIA,5
CA,ASPARTATE AMINOTRANSFERASE INCREASED,5
CA,ATAXIA,5
CA,BLOOD PRESSURE ABNORMAL,5
CA,BLOOD SODIUM DECREASED,5
CA,BLOOD UREA INCREASED,5
CA,BLOOD URINE PRESENT,5
CA,BRAIN HERNIATION,5
CA,BREATH SOUNDS ABNORMAL,5
CA,CARDIAC VALVE DISEASE,5
CA,CHOLELITHIASIS,5
CA,CYST,5
CA,DEVICE OCCLUSION,5
CA,DRUG EFFECT DECREASED,5
CA,EAR INFECTION,5
CA,EATING DISORDER,5
CA,EJECTION FRACTION DECREASED,5
CA,EYE INFECTION,5
CA,FUNGAL INFECTION,5
CA,GASTROINTESTINAL MOTILITY DISORDER,5
CA,GENERALISED OEDEMA,5
CA,GLAUCOMA,5
CA,HERNIA,5
CA,HYPERCHOLESTEROLAEMIA,5
CA,HYPOTHYROIDISM,5
CA,IMPAIRED WORK ABILITY,5
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
CA,INFLUENZA LIKE ILLNESS,5
CA,INJECTION SITE ERYTHEMA,5
CA,INJECTION SITE EXTRAVASATION,5
CA,INJECTION SITE REACTION,5
CA,INJECTION SITE SWELLING,5
CA,IRRITABILITY,5
CA,JAUNDICE,5
CA,LOWER GASTROINTESTINAL HAEMORRHAGE,5
CA,LOWER LIMB FRACTURE,5
CA,LUNG NEOPLASM MALIGNANT,5
CA,MASS,5
CA,MILIARIA,5
CA,MUSCLE TIGHTNESS,5
CA,NEUROLEPTIC MALIGNANT SYNDROME,5
CA,PANCYTOPENIA,5
CA,PNEUMONIA ASPIRATION,5
CA,POOR QUALITY SLEEP,5
CA,POSTOPERATIVE WOUND INFECTION,5
CA,RASH PAPULAR,5
CA,RECTAL HAEMORRHAGE,5
CA,RESPIRATORY DISTRESS,5
CA,RESPIRATORY FAILURE,5
CA,RESPIRATORY RATE INCREASED,5
CA,RIB FRACTURE,5
CA,ROAD TRAFFIC ACCIDENT,5
CA,SCIATICA,5
CA,SECOND PRIMARY MALIGNANCY,5
CA,SHOCK,5
CA,SKIN DISCOLOURATION,5
CA,SPINAL COLUMN STENOSIS,5
CA,STRESS,5
CA,TORSADE DE POINTES,5
CA,TOXICITY TO VARIOUS AGENTS,5
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
CA,ABDOMINAL PAIN LOWER,4
CA,ABNORMAL FAECES,4
CA,ACUTE PULMONARY OEDEMA,4
CA,AGEUSIA,4
CA,AGITATION,4
CA,ANGIOEDEMA,4
CA,ANKLE FRACTURE,4
CA,ANTICHOLINERGIC SYNDROME,4
CA,ARTERIAL OCCLUSIVE DISEASE,4
CA,BACK INJURY,4
CA,BACTERIAL INFECTION,4
CA,BLINDNESS,4
CA,BLOOD IRON DECREASED,4
CA,BODY TEMPERATURE INCREASED,4
CA,BONE CANCER,4
CA,BRAIN OEDEMA,4
CA,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,4
CA,CARDIAC OPERATION,4
CA,CARDIOGENIC SHOCK,4
CA,CAROTID ARTERY OCCLUSION,4
CA,CAROTID ARTERY STENOSIS,4
CA,CONTRAINDICATED PRODUCT ADMINISTERED,4
CA,CREATININE RENAL CLEARANCE DECREASED,4
CA,DEEP VEIN THROMBOSIS,4
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,4
CA,DEPRESSED MOOD,4
CA,DISEASE RECURRENCE,4
CA,DISTURBANCE IN ATTENTION,4
CA,DRUG WITHDRAWAL SYNDROME,4
CA,DRY EYE,4
CA,EAR DISCOMFORT,4
CA,EYE DISORDER,4
CA,EYE PAIN,4
CA,FAECES DISCOLOURED,4
CA,FEELING COLD,4
CA,FISTULA,4
CA,FULL BLOOD COUNT DECREASED,4
CA,GASTRIC DISORDER,4
CA,GASTROINTESTINAL ULCER,4
CA,GLOSSODYNIA,4
CA,GOUT,4
CA,HAND DEFORMITY,4
CA,HIATUS HERNIA,4
CA,HYPERSOMNIA,4
CA,HYPOKINESIA,4
CA,HYPOMAGNESAEMIA,4
CA,INCREASED APPETITE,4
CA,INFARCTION,4
CA,INFLAMMATION,4
CA,INFUSION SITE ERYTHEMA,4
CA,INJECTION SITE BRUISING,4
CA,INJECTION SITE MASS,4
CA,INJECTION SITE PRURITUS,4
CA,ISCHAEMIC CEREBRAL INFARCTION,4
CA,JOINT RANGE OF MOTION DECREASED,4
CA,KIDNEY INFECTION,4
CA,KNEE ARTHROPLASTY,4
CA,LACRIMATION INCREASED,4
CA,LOSS OF CONTROL OF LEGS,4
CA,LYMPHADENOPATHY,4
CA,MELANOCYTIC NAEVUS,4
CA,MOUTH ULCERATION,4
CA,MUSCLE RUPTURE,4
CA,MYOPATHY,4
CA,NERVE COMPRESSION,4
CA,NEUTROPENIA,4
CA,NIGHT SWEATS,4
CA,NIGHTMARE,4
CA,OBSTRUCTIVE AIRWAYS DISORDER,4
CA,OEDEMA,4
CA,OESOPHAGITIS,4
CA,OSTEONECROSIS OF JAW,4
CA,OTOTOXICITY,4
CA,OVERDOSE,4
CA,PANCREATITIS,4
CA,PANIC ATTACK,4
CA,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
CA,POLYP,4
CA,POTENTIATING DRUG INTERACTION,4
CA,PSORIASIS,4
CA,PULMONARY FUNCTION TEST ABNORMAL,4
CA,PULMONARY THROMBOSIS,4
CA,QUALITY OF LIFE DECREASED,4
CA,RECTAL ADENOCARCINOMA,4
CA,RESTLESSNESS,4
CA,SCOLIOSIS,4
CA,SEROTONIN SYNDROME,4
CA,SINUS CONGESTION,4
CA,SINUS TACHYCARDIA,4
CA,SUICIDE ATTEMPT,4
CA,SYNOVITIS,4
CA,TACHYCARDIA,4
CA,TOOTH ABSCESS,4
CA,TOOTHACHE,4
CA,TRAUMATIC HAEMATOMA,4
CA,WOUND SECRETION,4
CA,ABNORMAL BEHAVIOUR,3
CA,ACCIDENTAL OVERDOSE,3
CA,ACNE,3
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,3
CA,ADVERSE EVENT,3
CA,AGNOSIA,3
CA,ANAL HAEMORRHAGE,3
CA,ANGIOPATHY,3
CA,ANGIOPLASTY,3
CA,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,3
CA,AORTIC ARTERIOSCLEROSIS,3
CA,APHONIA,3
CA,APNOEA,3
CA,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,3
CA,BLOOD CHOLESTEROL INCREASED,3
CA,BLOOD GLUCOSE ABNORMAL,3
CA,BLOOD MAGNESIUM DECREASED,3
CA,BONE DISORDER,3
CA,BURNING SENSATION,3
CA,C-REACTIVE PROTEIN INCREASED,3
CA,CARDIOVASCULAR DISORDER,3
CA,CATARACT OPERATION,3
CA,CATHETER SITE INFECTION,3
CA,CATHETERISATION CARDIAC,3
CA,CIRCULATORY COLLAPSE,3
CA,COMPLICATION ASSOCIATED WITH DEVICE,3
CA,CONCOMITANT DISEASE AGGRAVATED,3
CA,CORONARY ARTERY BYPASS,3
CA,DEVICE RELATED INFECTION,3
CA,DIARRHOEA HAEMORRHAGIC,3
CA,DIPLOPIA,3
CA,DISCOMFORT,3
CA,DISORIENTATION,3
CA,DRUG LEVEL DECREASED,3
CA,EAR PAIN,3
CA,EMOTIONAL DISORDER,3
CA,EPILEPSY,3
CA,ERECTILE DYSFUNCTION,3
CA,EXOSTOSIS,3
CA,FACIAL PARALYSIS,3
CA,FIBROMYALGIA,3
CA,GALLBLADDER DISORDER,3
CA,GASTRIC ULCER,3
CA,GASTRITIS EROSIVE,3
CA,GASTROENTERITIS VIRAL,3
CA,GASTROINTESTINAL INFECTION,3
CA,GINGIVAL BLEEDING,3
CA,GLUCOSE TOLERANCE IMPAIRED,3
CA,GROIN PAIN,3
CA,HAEMATOCRIT DECREASED,3
CA,HAEMORRHAGE URINARY TRACT,3
CA,HAEMORRHAGIC DIATHESIS,3
CA,HEART INJURY,3
CA,HEPARIN-INDUCED THROMBOCYTOPENIA,3
CA,HEPATITIS ACUTE,3
CA,HYPERKALAEMIA,3
CA,HYSTERECTOMY,3
CA,INTENTIONAL PRODUCT MISUSE,3
CA,INTERNATIONAL NORMALISED RATIO INCREASED,3
CA,INTERVERTEBRAL DISC PROTRUSION,3
CA,INTESTINAL STENOSIS,3
CA,JOINT INJURY,3
CA,LARGE INTESTINAL OBSTRUCTION,3
CA,LEFT VENTRICULAR DYSFUNCTION,3
CA,LIVER DISORDER,3
CA,MACULAR DEGENERATION,3
CA,MENTAL DISORDER,3
CA,METASTASES TO LUNG,3
CA,MICTURITION URGENCY,3
CA,MIDDLE INSOMNIA,3
CA,MITRAL VALVE INCOMPETENCE,3
CA,MUSCULOSKELETAL CHEST PAIN,3
CA,NAIL DISCOLOURATION,3
CA,NEOPLASM PROGRESSION,3
CA,NERVOUSNESS,3
CA,NEURALGIA,3
CA,NON-HODGKIN^S LYMPHOMA,3
CA,OESOPHAGEAL CARCINOMA,3
CA,ORAL CANDIDIASIS,3
CA,ORAL PAIN,3
CA,PAIN IN JAW,3
CA,PANCREATIC NEOPLASM,3
CA,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,3
CA,PERSONALITY CHANGE,3
CA,PHARYNGEAL OEDEMA,3
CA,PHLEBITIS,3
CA,PNEUMONITIS,3
CA,POLYURIA,3
CA,POST PROCEDURAL HAEMORRHAGE,3
CA,POST PROCEDURAL INFECTION,3
CA,PROSTATE CANCER,3
CA,PROSTATE CANCER METASTATIC,3
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
CA,PRURITUS GENERALISED,3
CA,PSORIATIC ARTHROPATHY,3
CA,PULMONARY CONGESTION,3
CA,PULSELESS ELECTRICAL ACTIVITY,3
CA,PURULENT DISCHARGE,3
CA,RALES,3
CA,RETCHING,3
CA,SEASONAL ALLERGY,3
CA,SKIN FRAGILITY,3
CA,SKIN HAEMORRHAGE,3
CA,SLEEP APNOEA SYNDROME,3
CA,SQUAMOUS CELL CARCINOMA,3
CA,TEMPERATURE INTOLERANCE,3
CA,TEMPORAL ARTERITIS,3
CA,TENDERNESS,3
CA,TENDON RUPTURE,3
CA,THROAT TIGHTNESS,3
CA,THROMBOCYTOPENIA,3
CA,THROMBOSIS IN DEVICE,3
CA,TOOTH DISORDER,3
CA,TOOTH FRACTURE,3
CA,TOOTH INFECTION,3
CA,TROPONIN INCREASED,3
CA,TYPE 2 DIABETES MELLITUS,3
CA,ULCER,3
CA,UNDERDOSE,3
CA,UNRESPONSIVE TO STIMULI,3
CA,UPPER LIMB FRACTURE,3
CA,URINARY BLADDER HAEMORRHAGE,3
CA,URINE OUTPUT DECREASED,3
CA,UROSEPSIS,3
CA,VENTRICULAR TACHYCARDIA,3
CA,VIITH NERVE INJURY,3
CA,VISUAL ACUITY REDUCED,3
CA,WAIST CIRCUMFERENCE INCREASED,3
CA,WALKING DISABILITY,3
CA,WEIGHT FLUCTUATION,3
CA,ACIDOSIS,2
CA,ACTINIC KERATOSIS,2
CA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
CA,ANEURYSM,2
CA,ANTICONVULSANT DRUG LEVEL INCREASED,2
CA,AORTIC ANEURYSM,2
CA,APLASTIC ANAEMIA,2
CA,APPETITE DISORDER,2
CA,ARTERIAL RUPTURE,2
CA,BLADDER TRANSITIONAL CELL CARCINOMA,2
CA,BLINDNESS UNILATERAL,2
CA,BLOOD ALBUMIN DECREASED,2
CA,BLOOD BILIRUBIN INCREASED,2
CA,BLOOD COUNT ABNORMAL,2
CA,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,2
CA,BLOOD CULTURE POSITIVE,2
CA,BLOOD ELECTROLYTES DECREASED,2
CA,BLOOD GLUCOSE DECREASED,2
CA,BLOOD PRESSURE SYSTOLIC ABNORMAL,2
CA,BLOOD TEST ABNORMAL,2
CA,BRAIN NEOPLASM,2
CA,BRAIN NEOPLASM MALIGNANT,2
CA,BREAST PAIN,2
CA,BREAST TENDERNESS,2
CA,BREAST ULCERATION,2
CA,BURSITIS,2
CA,C-REACTIVE PROTEIN ABNORMAL,2
CA,CARDIAC MURMUR,2
CA,CARDIAC PACEMAKER INSERTION,2
CA,CATHETER SITE PAIN,2
CA,CEREBELLAR HAEMORRHAGE,2
CA,CHOKING SENSATION,2
CA,CHOLECYSTECTOMY,2
CA,CLOSTRIDIAL INFECTION,2
CA,CLOSTRIDIUM DIFFICILE COLITIS,2
CA,COLITIS,2
CA,COLITIS MICROSCOPIC,2
CA,COLON CANCER,2
CA,COLORECTAL ADENOCARCINOMA,2
CA,COMPARTMENT SYNDROME,2
CA,CONCUSSION,2
CA,CORONARY ARTERY EMBOLISM,2
CA,CORONARY ARTERY THROMBOSIS,2
CA,CREPITATIONS,2
CA,CYANOSIS,2
CA,DEAFNESS,2
CA,DECREASED ACTIVITY,2
CA,DELAYED SLEEP PHASE,2
CA,DERMATITIS,2
CA,DEVICE FAILURE,2
CA,DILATATION ATRIAL,2
CA,DIVERTICULUM INTESTINAL HAEMORRHAGIC,2
CA,DRUG EFFECT INCOMPLETE,2
CA,DRUG LEVEL INCREASED,2
CA,DYSPNOEA AT REST,2
CA,EMPHYSEMA,2
CA,EOSINOPHIL COUNT INCREASED,2
CA,EPIDURAL HAEMORRHAGE,2
CA,EPIGASTRIC DISCOMFORT,2
CA,ERUCTATION,2
CA,EYE IRRITATION,2
CA,EYE OEDEMA,2
CA,EYE PRURITUS,2
CA,FAECAL CALPROTECTIN INCREASED,2
CA,FAILURE TO THRIVE,2
CA,FEBRILE NEUTROPENIA,2
CA,FEEDING DISORDER,2
CA,FEMUR FRACTURE,2
CA,FLUSHING,2
CA,FOLLICULITIS,2
CA,FOOT DEFORMITY,2
CA,FORCED VITAL CAPACITY DECREASED,2
CA,FRACTURE,2
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CA,GASTRIC CANCER,2
CA,GASTRIC NEOPLASM,2
CA,GASTRIC POLYPS,2
CA,GASTRITIS,2
CA,GASTROINTESTINAL ANGIODYSPLASIA,2
CA,GASTROINTESTINAL CARCINOMA,2
CA,GASTROINTESTINAL PAIN,2
CA,GLIOBLASTOMA,2
CA,GRAND MAL CONVULSION,2
CA,GRANULOMATOSIS WITH POLYANGIITIS,2
CA,HAEMOGLOBIN ABNORMAL,2
CA,HAEMOGLOBIN INCREASED,2
CA,HAEMORRHOIDS,2
CA,HAND FRACTURE,2
CA,HEART VALVE INCOMPETENCE,2
CA,HEART VALVE STENOSIS,2
CA,HEMIPLEGIA,2
CA,HEPATIC CANCER,2
CA,HEPATIC STEATOSIS,2
CA,HYPERLIPIDAEMIA,2
CA,HYPOACUSIS,2
CA,HYPOAESTHESIA ORAL,2
CA,HYPOCALCAEMIA,2
CA,HYPONATRAEMIA,2
CA,HYPOPNOEA,2
CA,HYPOVENTILATION,2
CA,IDIOPATHIC PULMONARY FIBROSIS,2
CA,IMPLANTABLE DEFIBRILLATOR INSERTION,2
CA,INCOHERENT,2
CA,INCREASED BRONCHIAL SECRETION,2
CA,INCREASED VISCOSITY OF BRONCHIAL SECRETION,2
CA,INFESTATION,2
CA,INFREQUENT BOWEL MOVEMENTS,2
CA,INFUSION SITE DISCHARGE,2
CA,INJURY,2
CA,INNER EAR DISORDER,2
CA,INTERSTITIAL LUNG DISEASE,2
CA,INTESTINAL PERFORATION,2
CA,INTESTINAL POLYP,2
CA,INTRAVENTRICULAR HAEMORRHAGE,2
CA,INVASIVE DUCTAL BREAST CARCINOMA,2
CA,IRITIS,2
CA,IRRITABLE BOWEL SYNDROME,2
CA,ISCHAEMIC CARDIOMYOPATHY,2
CA,JOINT DISLOCATION,2
CA,JOINT STIFFNESS,2
CA,KERATOACANTHOMA,2
CA,LACTIC ACIDOSIS,2
CA,LARYNGEAL CANCER,2
CA,LATERAL MEDULLARY SYNDROME,2
CA,LEG AMPUTATION,2
CA,LEUKOENCEPHALOPATHY,2
CA,LIMB DISCOMFORT,2
CA,LIMB MASS,2
CA,LIVER FUNCTION TEST INCREASED,2
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
CA,MADAROSIS,2
CA,MALIGNANT MELANOMA,2
CA,MALIGNANT MELANOMA IN SITU,2
CA,MENINGIOMA BENIGN,2
CA,MENINGITIS,2
CA,MICTURITION DISORDER,2
CA,MONOCYTE COUNT INCREASED,2
CA,MOUTH HAEMORRHAGE,2
CA,MOVEMENT DISORDER,2
CA,MULTIPLE INJURIES,2
CA,MULTIPLE SCLEROSIS,2
CA,MYOCLONUS,2
CA,MYOSITIS,2
CA,NASAL DISCOMFORT,2
CA,NEGATIVE THOUGHTS,2
CA,NERVE ROOT COMPRESSION,2
CA,NEUTROPHILIA,2
CA,NODULE,2
CA,OCULAR HYPERAEMIA,2
CA,OESOPHAGEAL PAIN,2
CA,ORAL DISCOMFORT,2
CA,ORAL DISORDER,2
CA,OXYGEN CONSUMPTION INCREASED,2
CA,PAINFUL RESPIRATION,2
CA,PALLIATIVE CARE,2
CA,PANCREATIC CARCINOMA,2
CA,PARAESTHESIA ORAL,2
CA,PERICARDITIS,2
CA,PERIPHERAL COLDNESS,2
CA,PERIPHERAL ISCHAEMIA,2
CA,PERIPHERAL VASCULAR DISORDER,2
CA,PERITONITIS,2
CA,PHARYNGITIS,2
CA,PHOTOSENSITIVITY REACTION,2
CA,PLASMA CELL MYELOMA,2
CA,PLATELET COUNT ABNORMAL,2
CA,PLATELET COUNT INCREASED,2
CA,POLYPECTOMY,2
CA,POST PROCEDURAL HAEMATOMA,2
CA,PRESCRIBED UNDERDOSE,2
CA,PRINZMETAL ANGINA,2
CA,PROCEDURAL PAIN,2
CA,PRODUCT QUALITY ISSUE,2
CA,PRODUCT USE IN UNAPPROVED INDICATION,2
CA,PROSTATIC DISORDER,2
CA,PSEUDOMONAS INFECTION,2
CA,PULMONARY FIBROSIS,2
CA,PULMONARY PAIN,2
CA,PYELONEPHRITIS,2
CA,QRS AXIS ABNORMAL,2
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,2
CA,RED CELL DISTRIBUTION WIDTH INCREASED,2
CA,RENAL CYST,2
CA,RESPIRATORY ALKALOSIS,2
CA,RESPIRATORY TRACT INFECTION FUNGAL,2
CA,SCAB,2
CA,SCAR,2
CA,SEBORRHOEIC KERATOSIS,2
CA,SINUS DISORDER,2
CA,SKIN ABRASION,2
CA,SKIN PLAQUE,2
CA,SNEEZING,2
CA,SPINAL CORD COMPRESSION,2
CA,SPINAL CORD INFARCTION,2
CA,SPINAL DISORDER,2
CA,SPUTUM ABNORMAL,2
CA,SPUTUM INCREASED,2
CA,SPUTUM RETENTION,2
CA,SQUAMOUS CELL CARCINOMA OF PHARYNX,2
CA,STAPHYLOCOCCAL INFECTION,2
CA,STAPHYLOCOCCAL SKIN INFECTION,2
CA,STAPHYLOCOCCUS TEST POSITIVE,2
CA,STOMATITIS,2
CA,SUDDEN ONSET OF SLEEP,2
CA,SUNBURN,2
CA,SYNOVIAL CYST,2
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,2
CA,THERAPEUTIC RESPONSE DECREASED,2
CA,THERMAL BURN,2
CA,THINKING ABNORMAL,2
CA,THIRST,2
CA,THYROID DISORDER,2
CA,TINEA PEDIS,2
CA,TOXIC EPIDERMAL NECROLYSIS,2
CA,TRACHEOSTOMY MALFUNCTION,2
CA,TRANSFUSION,2
CA,TREATMENT NONCOMPLIANCE,2
CA,TRICUSPID VALVE INCOMPETENCE,2
CA,TUBERCULOSIS,2
CA,UNEVALUABLE EVENT,2
CA,URINARY BLADDER SUSPENSION,2
CA,VASCULAR OCCLUSION,2
CA,VASCULAR STENT THROMBOSIS,2
CA,VEIN DISORDER,2
CA,VERTEBRAL ARTERY OCCLUSION,2
CA,VOLVULUS,2
CA,WOUND INFECTION,2
CA,WRIST FRACTURE,2
CA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
CA,ABDOMINAL ADHESIONS,1
CA,ABDOMINAL INFECTION,1
CA,ACCIDENT,1
CA,ACETABULUM FRACTURE,1
CA,ACUTE HEPATIC FAILURE,1
CA,ACUTE RESPIRATORY FAILURE,1
CA,ADHESION,1
CA,ADVERSE DRUG REACTION,1
CA,AGGRESSION,1
CA,AGRANULOCYTOSIS,1
CA,ALBUMIN URINE PRESENT,1
CA,ALCOHOLIC,1
CA,ALLERGIC COUGH,1
CA,ALTERED STATE OF CONSCIOUSNESS,1
CA,ALVEOLITIS,1
CA,AMAUROSIS FUGAX,1
CA,AMYOTROPHIC LATERAL SCLEROSIS,1
CA,ANAL ABSCESS,1
CA,ANAL CANCER,1
CA,ANAL FISSURE,1
CA,ANAL FISTULA,1
CA,ANAL INCONTINENCE,1
CA,ANAPHYLACTIC REACTION,1
CA,ANGER,1
CA,ANKLE DEFORMITY,1
CA,ANKYLOSING SPONDYLITIS,1
CA,ANORECTAL DISCOMFORT,1
CA,ANTI A ANTIBODY,1
CA,ANTI-ERYTHROCYTE ANTIBODY POSITIVE,1
CA,ANTIMICROBIAL SUSCEPTIBILITY TEST SENSITIVE,1
CA,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,1
CA,AORTIC STENOSIS,1
CA,APHTHOUS ULCER,1
CA,APPENDICECTOMY,1
CA,ARTHRITIS INFECTIVE,1
CA,ARTHROPOD BITE,1
CA,ATAXIA TELANGIECTASIA,1
CA,ATELECTASIS,1
CA,ATRIAL FLUTTER,1
CA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
CA,ATTENTION-SEEKING BEHAVIOUR,1
CA,AZOTAEMIA,1
CA,BACK DISORDER,1
CA,BACTERAEMIA,1
CA,BACTERIAL TEST POSITIVE,1
CA,BACTERIURIA,1
CA,BANKRUPTCY,1
CA,BARIUM SWALLOW ABNORMAL,1
CA,BASOPHIL COUNT DECREASED,1
CA,BASOPHIL COUNT INCREASED,1
CA,BENIGN NEOPLASM,1
CA,BENIGN NEOPLASM OF BLADDER,1
CA,BENIGN SALIVARY GLAND NEOPLASM,1
CA,BILE DUCT STONE,1
CA,BILIRUBIN CONJUGATED INCREASED,1
CA,BLADDER CANCER,1
CA,BLADDER DISORDER,1
CA,BLADDER NEOPLASM,1
CA,BLINDNESS TRANSIENT,1
CA,BLOOD ALBUMIN INCREASED,1
CA,BLOOD ANTIDIURETIC HORMONE INCREASED,1
CA,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
CA,BLOOD CALCIUM DECREASED,1
CA,BLOOD CALCIUM INCREASED,1
CA,BLOOD CHLORIDE INCREASED,1
CA,BLOOD CHOLESTEROL,1
CA,BLOOD CREATINE INCREASED,1
CA,BLOOD CREATININE ABNORMAL,1
CA,BLOOD DISORDER,1
CA,BLOOD IMMUNOGLOBULIN E INCREASED,1
CA,BLOOD IRON INCREASED,1
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CA,BLOOD PRESSURE DIASTOLIC INCREASED,1
CA,BLOOD PRESSURE SYSTOLIC DECREASED,1
CA,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
CA,BLOOD UREA,1
CA,BLOOD URIC ACID INCREASED,1
CA,BONE DENSITY DECREASED,1
CA,BONE LOSS,1
CA,BRADYARRHYTHMIA,1
CA,BRAIN DEATH,1
CA,BRAIN INJURY,1
CA,BRAIN MIDLINE SHIFT,1
CA,BREAST CANCER FEMALE,1
CA,BREAST CANCER RECURRENT,1
CA,BREAST DISCHARGE,1
CA,BREAST MASS,1
CA,BRONCHIAL IRRITATION,1
CA,BRONCHIECTASIS,1
CA,BRONCHITIS VIRAL,1
CA,BUNDLE BRANCH BLOCK LEFT,1
CA,CALCINOSIS,1
CA,CANCER IN REMISSION,1
CA,CANCER SURGERY,1
CA,CARBON MONOXIDE POISONING,1
CA,CARCINOID TUMOUR,1
CA,CARDIAC ANEURYSM,1
CA,CARDIAC ASTHMA,1
CA,CARDIAC DISCOMFORT,1
CA,CARDIAC ENZYMES INCREASED,1
CA,CARDIAC FLUTTER,1
CA,CARDIAC SEPTAL HYPERTROPHY,1
CA,CARDIAC TAMPONADE,1
CA,CARDIO-RESPIRATORY ARREST,1
CA,CAROTID ARTERY DISEASE,1
CA,CAROTID BRUIT,1
CA,CARPAL TUNNEL SYNDROME,1
CA,CATHETER SITE HAEMATOMA,1
CA,CENTRAL NERVOUS SYSTEM LESION,1
CA,CEREBELLAR INFARCTION,1
CA,CEREBRAL ISCHAEMIA,1
CA,CEREBRAL REVASCULARISATION,1
CA,CEREBROVASCULAR DISORDER,1
CA,CHEMOTHERAPY,1
CA,CHEST X-RAY ABNORMAL,1
CA,CHOLANGIOCARCINOMA,1
CA,CHOLESTASIS,1
CA,CHONDRITIS,1
CA,CHRONIC FATIGUE SYNDROME,1
CA,CHRONIC KIDNEY DISEASE,1
CA,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
CA,CLAUSTROPHOBIA,1
CA,CLOSTRIDIUM TEST POSITIVE,1
CA,CLUBBING,1
CA,CLUSTER HEADACHE,1
CA,COAGULOPATHY,1
CA,COLD SWEAT,1
CA,COLITIS ISCHAEMIC,1
CA,COLON CANCER METASTATIC,1
CA,COLON NEOPLASM,1
CA,COLONIC ABSCESS,1
CA,COLONOSCOPY,1
CA,COLOUR BLINDNESS,1
CA,COMA,1
CA,COMA SCALE ABNORMAL,1
CA,COMPLETED SUICIDE,1
CA,COMPULSIVE SHOPPING,1
CA,CONCOMITANT DISEASE PROGRESSION,1
CA,CONJUNCTIVAL HAEMORRHAGE,1
CA,CONSCIOUSNESS FLUCTUATING,1
CA,CORNEAL DEPOSITS,1
CA,CORONARY ANGIOPLASTY,1
CA,CORONARY ARTERY DISSECTION,1
CA,CORONARY ARTERY STENOSIS,1
CA,CRANIOCEREBRAL INJURY,1
CA,CROUP INFECTIOUS,1
CA,CRYING,1
CA,CRYOGLOBULINAEMIA,1
CA,CYTOMEGALOVIRUS VIRAEMIA,1
CA,DECREASED IMMUNE RESPONSIVENESS,1
CA,DECUBITUS ULCER,1
CA,DEFORMITY,1
CA,DEMENTIA ALZHEIMER^S TYPE,1
CA,DENTAL IMPLANTATION,1
CA,DENTURE WEARER,1
CA,DEPRESSION SUICIDAL,1
CA,DERMATITIS ATOPIC,1
CA,DERMATITIS CONTACT,1
CA,DERMATOSIS,1
CA,DEVICE BREAKAGE,1
CA,DEVICE KINK,1
CA,DEVICE LEAKAGE,1
CA,DEVICE MALFUNCTION,1
CA,DIABETIC FOOT,1
CA,DIABETIC GASTROPARESIS,1
CA,DIALYSIS,1
CA,DIALYSIS RELATED COMPLICATION,1
CA,DIFFUSE LARGE B-CELL LYMPHOMA,1
CA,DISABILITY,1
CA,DIVERTICULUM INTESTINAL,1
CA,DIVORCED,1
CA,DIZZINESS POSTURAL,1
CA,DROOLING,1
CA,DRUG CROSS-REACTIVITY,1
CA,DRUG DEPENDENCE,1
CA,DRUG DISPENSING ERROR,1
CA,DRUG EFFECT INCREASED,1
CA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CA,DRUG WITHDRAWAL CONVULSIONS,1
CA,DRUG-DISEASE INTERACTION,1
CA,DRY THROAT,1
CA,DUODENAL PERFORATION,1
CA,DUODENAL ULCER,1
KY,ABDOMINAL DISCOMFORT,1
KY,DIZZINESS,1
KY,DRUG ABUSE,1
KY,TREATMENT NONCOMPLIANCE,1
CL,ACUTE MYOCARDIAL INFARCTION,1
CL,ANAEMIA,1
CL,ANGINA PECTORIS,1
CL,ARRHYTHMIA,1
CL,ARTERIAL THERAPEUTIC PROCEDURE,1
CL,ATRIOVENTRICULAR BLOCK,1
CL,ATRIOVENTRICULAR SEPTAL DEFECT,1
CL,BLOOD ZINC DECREASED,1
CL,BRONCHITIS,1
CL,CARDIAC DISORDER,1
CL,CARDIO-RESPIRATORY ARREST,1
CL,CEREBROVASCULAR ACCIDENT,1
CL,CHEST PAIN,1
CL,CONJUNCTIVAL HAEMORRHAGE,1
CL,CONJUNCTIVITIS,1
CL,CONSTIPATION,1
CL,CORONARY ARTERY DISEASE,1
CL,DEAFNESS UNILATERAL,1
CL,DECREASED APPETITE,1
CL,DEMENTIA ALZHEIMER^S TYPE,1
CL,DIARRHOEA,1
CL,DIZZINESS,1
CL,DRUG INEFFECTIVE,1
CL,DRUG INTOLERANCE,1
CL,EYE IRRITATION,1
CL,EYE PRURITUS,1
CL,EYE SWELLING,1
CL,FRACTURE,1
CL,GASTRITIS,1
CL,HAEMORRHAGIC STROKE,1
CL,HYPOGEUSIA,1
CL,IMMOBILE,1
CL,INTERNAL HAEMORRHAGE,1
CL,LIMB INJURY,1
CL,MELAENA,1
CL,MULTI-ORGAN FAILURE,1
CL,MUSCLE TONE DISORDER,1
CL,MYOCARDIAL INFARCTION,1
CL,PARAESTHESIA,1
CL,PERIPHERAL ISCHAEMIA,1
CL,PERIPHERAL VASCULAR DISORDER,1
CL,PNEUMONIA,1
CL,POST PROCEDURAL HAEMORRHAGE,1
CL,POSTOPERATIVE WOUND INFECTION,1
CL,PULMONARY FIBROSIS,1
CL,PYREXIA,1
CL,RENAL FAILURE ACUTE,1
CL,SENILE DEMENTIA,1
CL,SEPSIS,1
CL,SINUS BRADYCARDIA,1
CL,SLEEP-RELATED EATING DISORDER,1
CL,TINNITUS,1
CL,TRANSIENT GLOBAL AMNESIA,1
CL,UPPER RESPIRATORY TRACT INFECTION,1
CL,URINARY TRACT INFECTION,1
CL,VASCULAR PSEUDOANEURYSM,1
CL,VISUAL ACUITY REDUCED,1
CL,WEIGHT DECREASED,1
CL,WEIGHT INCREASED,1
CN,VASCULAR STENT THROMBOSIS,45
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,30
CN,CHEST DISCOMFORT,29
CN,PLATELET AGGREGATION INCREASED,28
CN,DIZZINESS,27
CN,GASTROINTESTINAL HAEMORRHAGE,27
CN,DYSPNOEA,26
CN,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,26
CN,DRUG INEFFECTIVE,25
CN,ASTHENIA,23
CN,CHEST PAIN,23
CN,DRUG RESISTANCE,23
CN,PRODUCT COUNTERFEIT,22
CN,VOMITING,21
CN,NAUSEA,20
CN,COMA,18
CN,ANGINA PECTORIS,17
CN,PALPITATIONS,17
CN,THROMBOCYTOPENIA,17
CN,CEREBRAL HAEMORRHAGE,16
CN,CEREBRAL INFARCTION,16
CN,MYOCARDIAL INFARCTION,15
CN,PRURITUS,15
CN,DRUG ADMINISTRATION ERROR,14
CN,GASTRIC ULCER,14
CN,PLATELET COUNT DECREASED,14
CN,VENTRICULAR FIBRILLATION,13
CN,LACTIC ACIDOSIS,12
CN,LIVER INJURY,12
CN,RASH,12
CN,RENAL IMPAIRMENT,12
CN,SUSPECTED COUNTERFEIT PRODUCT,12
CN,THROMBOSIS,12
CN,CARDIAC FAILURE,11
CN,DEATH,11
CN,HAEMOGLOBIN DECREASED,11
CN,HYPERHIDROSIS,11
CN,MUSCULAR WEAKNESS,11
CN,ASPARTATE AMINOTRANSFERASE INCREASED,10
CN,CORONARY ARTERY STENOSIS,10
CN,PYREXIA,10
CN,RHABDOMYOLYSIS,10
CN,SHOCK HAEMORRHAGIC,10
CN,ABDOMINAL DISTENSION,9
CN,ALANINE AMINOTRANSFERASE INCREASED,9
CN,BLOOD CREATINE PHOSPHOKINASE INCREASED,9
CN,COAGULOPATHY,9
CN,HAEMATEMESIS,9
CN,HEADACHE,9
CN,HEPATIC FUNCTION ABNORMAL,9
CN,NERVOUS SYSTEM DISORDER,9
CN,ANGINA UNSTABLE,8
CN,CORONARY ARTERY DISEASE,8
CN,MELAENA,8
CN,MYALGIA,8
CN,SUDDEN CARDIAC DEATH,8
CN,SYNCOPE,8
CN,ABDOMINAL DISCOMFORT,7
CN,ABDOMINAL PAIN UPPER,7
CN,ACUTE MYOCARDIAL INFARCTION,7
CN,BACK PAIN,7
CN,BLOOD PRESSURE DECREASED,7
CN,CARDIAC DISORDER,7
CN,CEREBRAL HAEMATOMA,7
CN,DERMATITIS EXFOLIATIVE,7
CN,DRUG HYPERSENSITIVITY,7
CN,FAECES DISCOLOURED,7
CN,GASTRIC HAEMORRHAGE,7
CN,HAEMATOCHEZIA,7
CN,HAEMORRHAGE,7
CN,KOUNIS SYNDROME,7
CN,MYOSITIS,7
CN,PAIN IN EXTREMITY,7
CN,RESPIRATORY FAILURE,7
CN,TRANSIENT ISCHAEMIC ATTACK,7
CN,ARTERIOSCLEROSIS CORONARY ARTERY,6
CN,BLOOD CREATININE INCREASED,6
CN,BLOOD GLUCOSE INCREASED,6
CN,CONDITION AGGRAVATED,6
CN,CORONARY ARTERY OCCLUSION,6
CN,COUGH,6
CN,DECREASED APPETITE,6
CN,DIARRHOEA,6
CN,EMBOLISM,6
CN,EPISTAXIS,6
CN,GAIT DISTURBANCE,6
CN,GINGIVAL BLEEDING,6
CN,HEMIPARESIS,6
CN,INJECTION SITE HAEMATOMA,6
CN,LOSS OF CONSCIOUSNESS,6
CN,MYOPATHY,6
CN,TRANSAMINASES INCREASED,6
CN,ARTERIAL THROMBOSIS,5
CN,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,5
CN,BRAIN STEM HAEMORRHAGE,5
CN,CORONARY ARTERY RESTENOSIS,5
CN,DISEASE RECURRENCE,5
CN,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,5
CN,HAEMORRHAGE INTRACRANIAL,5
CN,OCCULT BLOOD POSITIVE,5
CN,PAIN,5
CN,PRODUCTIVE COUGH,5
CN,PRURITUS GENERALISED,5
CN,SPINAL EPIDURAL HAEMATOMA,5
CN,THERAPEUTIC RESPONSE DECREASED,5
CN,THROMBOSIS IN DEVICE,5
CN,WHEEZING,5
CN,ABASIA,4
CN,ALTERED STATE OF CONSCIOUSNESS,4
CN,AMAUROSIS,4
CN,ANEURYSM RUPTURED,4
CN,ARTHRALGIA,4
CN,ASTHMA,4
CN,ATRIAL FIBRILLATION,4
CN,BLOOD BILIRUBIN INCREASED,4
CN,BLOOD LACTATE DEHYDROGENASE INCREASED,4
CN,BLOOD PRESSURE INCREASED,4
CN,BLOOD UREA INCREASED,4
CN,BRAIN HERNIATION,4
CN,CARDIOMYOPATHY,4
CN,DISCOMFORT,4
CN,ECCHYMOSIS,4
CN,ERYTHEMA,4
CN,FALL,4
CN,FATIGUE,4
CN,HAEMORRHAGIC TRANSFORMATION STROKE,4
CN,HYPOTENSION,4
CN,INTENTIONAL PRODUCT MISUSE,4
CN,INTRAVENTRICULAR HAEMORRHAGE,4
CN,LETHARGY,4
CN,LEUKOPENIA,4
CN,MEMORY IMPAIRMENT,4
CN,MYOCARDIAL RUPTURE,4
CN,OEDEMA PERIPHERAL,4
CN,RASH ERYTHEMATOUS,4
CN,REGURGITATION,4
CN,VASCULAR PSEUDOANEURYSM,4
CN,VASCULAR STENT STENOSIS,4
CN,ABDOMINAL PAIN,3
CN,ACUTE CORONARY SYNDROME,3
CN,ANAPHYLACTIC SHOCK,3
CN,AORTIC VALVE INCOMPETENCE,3
CN,APHASIA,3
CN,APLASIA PURE RED CELL,3
CN,ATRIOVENTRICULAR BLOCK,3
CN,ATRIOVENTRICULAR BLOCK COMPLETE,3
CN,BILIRUBIN CONJUGATED INCREASED,3
CN,BLOOD LACTIC ACID INCREASED,3
CN,BLOOD URIC ACID INCREASED,3
CN,CARDIAC ARREST,3
CN,CHILLS,3
CN,CHRONIC GASTRITIS,3
CN,CIRCULATORY COLLAPSE,3
CN,CONFUSIONAL STATE,3
CN,CORONARY ARTERY THROMBOSIS,3
CN,DEEP VEIN THROMBOSIS,3
CN,DEHYDRATION,3
CN,DEPRESSED LEVEL OF CONSCIOUSNESS,3
CN,DIABETES MELLITUS,3
CN,DRUG ERUPTION,3
CN,DRUG-INDUCED LIVER INJURY,3
CN,DUODENAL ULCER,3
CN,DYSPHORIA,3
CN,ERUCTATION,3
CN,FIBRIN D DIMER INCREASED,3
CN,GASTROENTERITIS EOSINOPHILIC,3
CN,HAEMATURIA,3
CN,HAEMOPTYSIS,3
CN,HAEMORRHAGIC ANAEMIA,3
CN,HALLUCINATION,3
CN,HEART RATE INCREASED,3
CN,HEMIPLEGIA,3
CN,HENOCH-SCHONLEIN PURPURA,3
CN,LEFT VENTRICULAR FAILURE,3
CN,LUNG INFECTION,3
CN,MYOCARDIAL ISCHAEMIA,3
CN,OEDEMA,3
CN,PALLOR,3
CN,PERICARDIAL HAEMORRHAGE,3
CN,PERIPHERAL ARTERY OCCLUSION,3
CN,PETECHIAE,3
CN,PRODUCT USE IN UNAPPROVED INDICATION,3
CN,PURPURA,3
CN,RASH MACULO-PAPULAR,3
CN,RENAL FAILURE ACUTE,3
CN,SHOCK,3
CN,SOMNAMBULISM,3
CN,TYPE 2 DIABETES MELLITUS,3
CN,VASCULAR OPERATION,3
CN,VASCULAR STENT OCCLUSION,3
CN,VENTRICULAR TACHYCARDIA,3
CN,WEIGHT DECREASED,3
CN,WHITE BLOOD CELL COUNT DECREASED,3
CN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
CN,ACUTE LEFT VENTRICULAR FAILURE,2
CN,ANAEMIA,2
CN,AORTIC ARTERIOSCLEROSIS,2
CN,ARTERIAL OCCLUSIVE DISEASE,2
CN,ASPHYXIA,2
CN,BASAL GANGLIA INFARCTION,2
CN,BODY TEMPERATURE INCREASED,2
CN,BUNDLE BRANCH BLOCK RIGHT,2
CN,CARDIAC FAILURE ACUTE,2
CN,CARDIAC VALVE DISEASE,2
CN,CEREBELLAR INFARCTION,2
CN,CEREBRAL ATROPHY,2
CN,CEREBROVASCULAR DISORDER,2
CN,COAGULATION TIME PROLONGED,2
CN,CONJUNCTIVAL HAEMORRHAGE,2
CN,CYANOSIS,2
CN,DEGENERATIVE AORTIC VALVE DISEASE,2
CN,DELIRIUM,2
CN,DEPRESSED MOOD,2
CN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
CN,DRUG LEVEL INCREASED,2
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CN,DYSPHONIA,2
CN,ECZEMA,2
CN,ELECTROCARDIOGRAM ABNORMAL,2
CN,ELECTROLYTE IMBALANCE,2
CN,ERYTHROPENIA,2
CN,EYE SWELLING,2
CN,EYELID OEDEMA,2
CN,FEELING COLD,2
CN,FLATULENCE,2
CN,GASTRIC ULCER HAEMORRHAGE,2
CN,GASTRITIS,2
CN,GASTRITIS EROSIVE,2
CN,GLOMERULONEPHRITIS,2
CN,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
CN,GOUT,2
CN,GRANULOCYTOPENIA,2
CN,HAEMATOCRIT INCREASED,2
CN,HAEMATOMA,2
CN,HAEMOGLOBIN INCREASED,2
CN,HAEMORRHAGE SUBCUTANEOUS,2
CN,HEPATIC ENZYME INCREASED,2
CN,HEPATOCELLULAR INJURY,2
CN,HYPERKALAEMIA,2
CN,HYPERLIPIDAEMIA,2
CN,HYPERSENSITIVITY,2
CN,HYPOAESTHESIA,2
CN,HYPOGLYCAEMIA,2
CN,HYPOGLYCAEMIC COMA,2
CN,HYPOKALAEMIA,2
CN,INFARCTION,2
CN,INSOMNIA,2
CN,INTERNATIONAL NORMALISED RATIO INCREASED,2
CN,INTRACRANIAL PRESSURE INCREASED,2
CN,ISCHAEMIC CARDIOMYOPATHY,2
CN,LACUNAR INFARCTION,2
CN,LEFT ATRIAL DILATATION,2
CN,LEFT VENTRICULAR HYPERTROPHY,2
CN,LIVER DISORDER,2
CN,MEDICATION RESIDUE PRESENT,2
CN,MUSCLE ATROPHY,2
CN,MUSCLE RIGIDITY,2
CN,PAPULE,2
CN,PARALYSIS,2
CN,PARAPLEGIA,2
CN,PERICARDIAL EFFUSION,2
CN,PERIPHERAL COLDNESS,2
CN,PERIPHERAL VENOUS DISEASE,2
CN,PLEURAL EFFUSION,2
CN,POOR PERIPHERAL CIRCULATION,2
CN,PRESCRIBED OVERDOSE,2
CN,PRODUCT PHYSICAL ISSUE,2
CN,PRODUCT USE ISSUE,2
CN,PROTHROMBIN TIME PROLONGED,2
CN,PULMONARY ALVEOLAR HAEMORRHAGE,2
CN,QUADRIPLEGIA,2
CN,RASH GENERALISED,2
CN,RASH PAPULAR,2
CN,RED BLOOD CELL COUNT DECREASED,2
CN,RED BLOOD CELL COUNT INCREASED,2
CN,RENAL FAILURE,2
CN,SENSORY LOSS,2
CN,SINUS BRADYCARDIA,2
CN,SPEECH DISORDER,2
CN,SPINAL CORD COMPRESSION,2
CN,SUDDEN HEARING LOSS,2
CN,TINNITUS,2
CN,TREATMENT NONCOMPLIANCE,2
CN,URINARY RETENTION,2
CN,URTICARIA,2
CN,VASCULAR OCCLUSION,2
CN,VENTRICULAR ARRHYTHMIA,2
CN,VERTIGO,2
CN,VISION BLURRED,2
CN,ABDOMINAL INFECTION,1
CN,ABNORMAL BEHAVIOUR,1
CN,ABORTION,1
CN,ACINETOBACTER INFECTION,1
CN,ACUTE HEPATIC FAILURE,1
CN,ACUTE PULMONARY OEDEMA,1
CN,ADRENERGIC SYNDROME,1
CN,AFFECT LABILITY,1
CN,AGITATION,1
CN,AGRANULOCYTOSIS,1
CN,ALBUMINURIA,1
CN,ALOPECIA,1
CN,ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED,1
CN,ANGIOPATHY,1
CN,ANGLE CLOSURE GLAUCOMA,1
CN,ANION GAP INCREASED,1
CN,ANURIA,1
CN,ANXIETY,1
CN,AORTIC CALCIFICATION,1
CN,AORTIC DILATATION,1
CN,APHTHOUS ULCER,1
CN,ARRHYTHMIA,1
CN,ARTERIAL INSUFFICIENCY,1
CN,ARTERIAL STENOSIS,1
CN,ARTERIOSPASM CORONARY,1
CN,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
CN,BASE EXCESS NEGATIVE,1
CN,BLOOD ALBUMIN INCREASED,1
CN,BLOOD BICARBONATE DECREASED,1
CN,BLOOD CHOLESTEROL DECREASED,1
CN,BLOOD FIBRINOGEN INCREASED,1
CN,BLOOD GLUCOSE FLUCTUATION,1
CN,BLOOD IMMUNOGLOBULIN E INCREASED,1
CN,BLOOD PH DECREASED,1
CN,BLOOD PRESSURE ABNORMAL,1
CN,BLOOD PRESSURE DIASTOLIC DECREASED,1
CN,BLOOD PRESSURE FLUCTUATION,1
CN,BLOOD PRESSURE SYSTOLIC INCREASED,1
CN,BLOOD URINE,1
CN,BONE PAIN,1
CN,BREATH SOUNDS ABNORMAL,1
CN,BRONCHITIS,1
CN,BRONCHITIS CHRONIC,1
CN,C-REACTIVE PROTEIN INCREASED,1
CN,CALCULUS URETHRAL,1
CN,CARBON DIOXIDE INCREASED,1
CN,CARDIAC ANEURYSM,1
CN,CARDIAC FAILURE CONGESTIVE,1
CN,CARDIAC FLUTTER,1
CN,CARDIAC MYXOMA,1
CN,CARDIAC TAMPONADE,1
CN,CARDIO-RESPIRATORY ARREST,1
CN,CARDIOVASCULAR DISORDER,1
CN,CAROTID ARTERY STENT INSERTION,1
CN,CEREBELLAR ATROPHY,1
CN,CEREBRAL ARTERIOSCLEROSIS,1
CN,CEREBRAL ARTERY EMBOLISM,1
CN,CEREBRAL ARTERY OCCLUSION,1
CN,CEREBRAL DISORDER,1
CN,CEREBRAL ISCHAEMIA,1
CN,CEREBRAL MICROHAEMORRHAGE,1
CN,CEREBRAL VASOCONSTRICTION,1
CN,CEREBROVASCULAR ACCIDENT,1
CN,CEREBROVASCULAR INSUFFICIENCY,1
CN,CEREBROVASCULAR STENOSIS,1
CN,CHOLECYSTITIS ACUTE,1
CN,CHROMATURIA,1
CN,CHRONIC KIDNEY DISEASE,1
CN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CN,COAGULATION TEST ABNORMAL,1
CN,COLD SWEAT,1
CN,COLON NEOPLASM,1
CN,COMPUTERISED TOMOGRAM ABNORMAL,1
CN,CONCOMITANT DISEASE PROGRESSION,1
CN,CONJUNCTIVAL HYPERAEMIA,1
CN,CONTRAINDICATED PRODUCT ADMINISTERED,1
CN,CONVULSION,1
CN,CORONARY NO-REFLOW PHENOMENON,1
CN,COUNTERFEIT DRUG ADMINISTERED,1
CN,CRYSTALLURIA,1
CN,DECREASED ACTIVITY,1
CN,DEGENERATIVE MITRAL VALVE DISEASE,1
CN,DELAYED ISCHAEMIC NEUROLOGICAL DEFICIT,1
CN,DELUSION,1
CN,DERMATITIS,1
CN,DERMATITIS ATOPIC,1
CN,DERMATITIS EXFOLIATIVE GENERALISED,1
CN,DEVICE OCCLUSION,1
CN,DILATATION VENTRICULAR,1
CN,DISORIENTATION,1
CN,DIZZINESS POSTURAL,1
CN,DRUG PRESCRIBING ERROR,1
CN,DRY SKIN,1
CN,DUODENAL ULCER HAEMORRHAGE,1
CN,DYSBACTERIOSIS,1
CN,DYSPEPSIA,1
CN,DYSSTASIA,1
CN,DYSURIA,1
CN,EAR SWELLING,1
CN,EJECTION FRACTION DECREASED,1
CN,EMBOLISM ARTERIAL,1
CN,ENCEPHALOPATHY,1
CN,EOSINOPHILIA,1
CN,EPILEPSY,1
CN,EYE DISORDER,1
CN,EYE HAEMORRHAGE,1
CN,EYE MOVEMENT DISORDER,1
CN,EYE PAIN,1
CN,FACE OEDEMA,1
CN,FACIAL BONES FRACTURE,1
CN,FACIAL PARALYSIS,1
CN,FEELING ABNORMAL,1
CN,FEELING HOT,1
CN,FLUSHING,1
CN,FREQUENT BOWEL MOVEMENTS,1
CN,GASTRIC MUCOSAL LESION,1
CN,GASTRIC PERFORATION,1
CN,GASTROINTESTINAL DISORDER,1
CN,GASTROINTESTINAL MUCOSAL DISORDER,1
CN,GASTROINTESTINAL VASCULAR MALFORMATION,1
CN,GASTROOESOPHAGEAL REFLUX DISEASE,1
CN,GENERAL PHYSICAL HEALTH DETERIORATION,1
CN,GLASSY EYES,1
CN,GLOMERULAR FILTRATION RATE DECREASED,1
CN,HAEMOGLOBIN ABNORMAL,1
CN,HAEMOLYTIC ANAEMIA,1
CN,HAIR COLOUR CHANGES,1
CN,HALO VISION,1
CN,HEAD DISCOMFORT,1
CN,HEART RATE DECREASED,1
CN,HEART RATE IRREGULAR,1
CN,HELICOBACTER INFECTION,1
CN,HEPATIC NEOPLASM,1
CN,HEPATIC STEATOSIS,1
CN,HEPATITIS B CORE ANTIBODY POSITIVE,1
CN,HEPATOMEGALY,1
CN,HEPATOTOXICITY,1
CN,HERPES ZOSTER,1
CN,HICCUPS,1
CN,HIGH DENSITY LIPOPROTEIN INCREASED,1
CN,HOSPITALISATION,1
CN,HYPERCOAGULATION,1
CN,HYPERGLYCAEMIA,1
CN,HYPERPYREXIA,1
CN,HYPERTENSION,1
CN,HYPERURICAEMIA,1
CN,HYPOCHLORAEMIA,1
CN,HYPONATRAEMIA,1
CN,HYPOPROTEINAEMIA,1
CN,IGA NEPHROPATHY,1
CN,ILIAC ARTERY OCCLUSION,1
CN,ILLOGICAL THINKING,1
CN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CN,INCISION SITE PAIN,1
CN,INFLAMMATION,1
CN,INFUSION RELATED REACTION,1
CN,INJECTION SITE HAEMORRHAGE,1
CN,INJECTION SITE RASH,1
CN,INSULIN AUTOIMMUNE SYNDROME,1
CN,INTENTIONAL DRUG MISUSE,1
CN,INTENTIONAL PRODUCT USE ISSUE,1
CN,INTERSTITIAL LUNG DISEASE,1
CN,INTESTINAL HAEMORRHAGE,1
CN,INTRAPERICARDIAL THROMBOSIS,1
CN,ISCHAEMIA,1
CN,JAUNDICE,1
CN,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
CN,LANGUAGE DISORDER,1
CN,LARGE INTESTINAL STENOSIS,1
CN,LEFT VENTRICULAR DYSFUNCTION,1
CN,LIBIDO DECREASED,1
CN,LIMB DISCOMFORT,1
CN,LIVER FUNCTION TEST ABNORMAL,1
CN,LOCAL SWELLING,1
CN,LOCALISED INFECTION,1
CN,LOW DENSITY LIPOPROTEIN DECREASED,1
CN,LOWER GASTROINTESTINAL HAEMORRHAGE,1
CN,LYMPHOCYTE COUNT DECREASED,1
CN,MALAISE,1
CN,MANIA,1
CN,MATERNAL EXPOSURE DURING PREGNANCY,1
CN,METASTASES TO LUNG,1
CN,MITRAL VALVE INCOMPETENCE,1
CN,MONOPLEGIA,1
CN,MOUTH ULCERATION,1
CN,MOVEMENT DISORDER,1
CN,MULTI-ORGAN FAILURE,1
CN,MUSCLE ENZYME INCREASED,1
CN,MUSCLE INJURY,1
CN,MUSCLE OEDEMA,1
CN,MUSCULOSKELETAL PAIN,1
CN,MYOCARDIAL HAEMORRHAGE,1
CN,MYOCARDIAL NECROSIS MARKER INCREASED,1
CN,MYOPATHY TOXIC,1
CN,NASAL OBSTRUCTION,1
CN,NASOPHARYNGITIS,1
CN,NECK PAIN,1
CN,NEPHRITIC SYNDROME,1
CN,NEPHRITIS,1
CN,NEPHROTIC SYNDROME,1
CN,NEUROLOGICAL SYMPTOM,1
CN,NEUTROPENIA,1
CN,NEUTROPHIL COUNT INCREASED,1
CN,NIGHT SWEATS,1
CN,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CN,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
CN,OCULAR DISCOMFORT,1
CN,OCULAR HYPERAEMIA,1
CN,OLIGURIA,1
CN,ORAL MUCOSAL ERUPTION,1
CN,ORTHOPNOEA,1
CN,OVERDOSE,1
CN,OXYGEN SATURATION ABNORMAL,1
CN,PANCYTOPENIA,1
CN,PARAESTHESIA,1
CN,PCO2 INCREASED,1
CN,PEPTIC ULCER,1
CN,PEPTIC ULCER HAEMORRHAGE,1
CN,PERCUTANEOUS CORONARY INTERVENTION,1
CN,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CN,PERIPHERAL ARTERY THROMBOSIS,1
CN,PERIPHERAL ISCHAEMIA,1
CN,PHARYNGEAL HAEMORRHAGE,1
CN,PITUITARY HAEMORRHAGE,1
CN,PITUITARY TUMOUR BENIGN,1
CN,PLEURISY,1
CN,PO2 DECREASED,1
CN,POLLAKIURIA,1
CN,POOR QUALITY SLEEP,1
CN,PRESYNCOPE,1
CN,PRODUCT QUALITY ISSUE,1
CN,PRODUCT TASTE ABNORMAL,1
CN,PROTEIN TOTAL ABNORMAL,1
CN,PSORIASIS,1
CN,PSYCHIATRIC DECOMPENSATION,1
CN,PULMONARY CONGESTION,1
CN,PULMONARY HILAR ENLARGEMENT,1
CN,PULMONARY HYPERTENSION,1
CN,PULMONARY VALVE INCOMPETENCE,1
CN,PULSE ABNORMAL,1
CN,PYELONEPHRITIS ACUTE,1
CN,RALES,1
CN,RASH MACULAR,1
CN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
CN,REFLEXES ABNORMAL,1
CN,RENAL CYST,1
CN,RENAL FAILURE CHRONIC,1
CN,RENAL INJURY,1
CN,RENAL TUBULAR NECROSIS,1
CN,RESPIRATORY ARREST,1
CN,RESPIRATORY DISTRESS,1
CN,RETICULOCYTE COUNT DECREASED,1
CN,RETROPERITONEAL HAEMATOMA,1
CN,RHONCHI,1
CN,RHYTHM IDIOVENTRICULAR,1
CN,RIB FRACTURE,1
CN,SALIVARY HYPERSECRETION,1
CN,SARCOIDOSIS,1
CN,SEIZURE,1
CN,SELF-MEDICATION,1
CN,SENILE DEMENTIA,1
CN,SENSE OF OPPRESSION,1
CN,SICK SINUS SYNDROME,1
CN,SINUS TACHYCARDIA,1
CN,SINUSITIS,1
CN,SKIN EXFOLIATION,1
CN,SKIN HAEMORRHAGE,1
CN,SKIN PLAQUE,1
CN,SLEEP DISORDER,1
CN,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
CN,SPINAL OSTEOARTHRITIS,1
CN,SPLENOMEGALY,1
CN,STENT PLACEMENT,1
CN,STOMATITIS,1
CN,STRESS ULCER,1
CN,SUBARACHNOID HAEMORRHAGE,1
CN,SUBDURAL HAEMATOMA,1
CN,SUDDEN DEATH,1
CN,SUICIDAL IDEATION,1
CN,SURGERY,1
CN,SWELLING,1
CN,SWELLING FACE,1
CN,TACHYPNOEA,1
CN,TACITURNITY,1
CN,TEMPERATURE INTOLERANCE,1
CN,THERAPEUTIC RESPONSE UNEXPECTED,1
CN,THROMBOCYTOPENIC PURPURA,1
CN,THROMBOTIC CEREBRAL INFARCTION,1
CN,THYROID NEOPLASM,1
CN,TIC,1
CN,TROPONIN T INCREASED,1
CN,TRYPTASE INCREASED,1
CN,TUMOUR HAEMORRHAGE,1
CN,UNRESPONSIVE TO STIMULI,1
CN,UPPER RESPIRATORY TRACT INFECTION,1
CN,URINARY INCONTINENCE,1
CN,VERBIGERATION,1
CN,VIITH NERVE PARALYSIS,1
CN,VISUAL IMPAIRMENT,1
CN,VOLUME BLOOD DECREASED,1
CN,WHITE BLOOD CELL COUNT INCREASED,1
CN,WHITE MATTER LESION,1
CN,WRONG DRUG ADMINISTERED,1
CO,ACUTE MYOCARDIAL INFARCTION,24
CO,CARDIO-RESPIRATORY ARREST,18
CO,DYSPNOEA,16
CO,DEATH,14
CO,CARDIAC FAILURE,12
CO,FATIGUE,9
CO,PYREXIA,9
CO,DIZZINESS,8
CO,HEADACHE,8
CO,INFARCTION,8
CO,MYOCARDIAL INFARCTION,8
CO,CHEST PAIN,7
CO,GENERAL PHYSICAL HEALTH DETERIORATION,7
CO,INFLUENZA,7
CO,MALAISE,7
CO,PAIN,7
CO,PULMONARY OEDEMA,7
CO,RENAL FAILURE,7
CO,URINARY TRACT INFECTION,7
CO,VOMITING,7
CO,ABDOMINAL PAIN,6
CO,DRUG INEFFECTIVE,6
CO,FALL,6
CO,HYPOTENSION,6
CO,PNEUMONIA,6
CO,WEIGHT DECREASED,6
CO,BACK PAIN,5
CO,CARDIAC ARREST,5
CO,CARDIAC DISORDER,5
CO,CEREBROVASCULAR ACCIDENT,5
CO,COUGH,5
CO,DECREASED APPETITE,5
CO,DEPRESSED MOOD,5
CO,FEELING ABNORMAL,5
CO,HYPERGLYCAEMIA,5
CO,PAIN IN EXTREMITY,5
CO,RESPIRATORY ARREST,5
CO,VERTIGO,5
CO,ANGINA PECTORIS,4
CO,ASPHYXIA,4
CO,ASTHENIA,4
CO,ATRIAL FIBRILLATION,4
CO,BLOOD GLUCOSE INCREASED,4
CO,CHOLELITHIASIS,4
CO,GAIT DISTURBANCE,4
CO,GASTROINTESTINAL HAEMORRHAGE,4
CO,HYPERTENSION,4
CO,INFECTION,4
CO,NAUSEA,4
CO,SOMNOLENCE,4
CO,ABDOMINAL DISTENSION,3
CO,ABDOMINAL PAIN UPPER,3
CO,ACUTE CORONARY SYNDROME,3
CO,ANAEMIA,3
CO,ARTHRALGIA,3
CO,CARDIOGENIC SHOCK,3
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
CO,CORONARY ARTERY DISEASE,3
CO,DIARRHOEA,3
CO,HYPERHIDROSIS,3
CO,HYPOAESTHESIA,3
CO,INTRACRANIAL ANEURYSM,3
CO,LOSS OF CONSCIOUSNESS,3
CO,LUNG DISORDER,3
CO,MALIGNANT NEOPLASM PROGRESSION,3
CO,PLATELET COUNT DECREASED,3
CO,SEIZURE,3
CO,SINUS ARRHYTHMIA,3
CO,SWELLING,3
CO,THROMBOSIS,3
CO,VISION BLURRED,3
CO,AGITATION,2
CO,ANXIETY,2
CO,ASTHMATIC CRISIS,2
CO,ATRIAL TACHYCARDIA,2
CO,ATRIOVENTRICULAR BLOCK COMPLETE,2
CO,BALANCE DISORDER,2
CO,BLINDNESS,2
CO,BLOOD CREATININE INCREASED,2
CO,BLOOD PRESSURE INCREASED,2
CO,BLOOD URINE PRESENT,2
CO,BONE PAIN,2
CO,CELLULITIS,2
CO,CEREBRAL HAEMORRHAGE,2
CO,CHEST DISCOMFORT,2
CO,CHOLECYSTITIS,2
CO,CONDITION AGGRAVATED,2
CO,CONTRAINDICATED PRODUCT ADMINISTERED,2
CO,CONTUSION,2
CO,DECREASED IMMUNE RESPONSIVENESS,2
CO,DIVERTICULITIS,2
CO,DRUG INTOLERANCE,2
CO,DYSPHAGIA,2
CO,GASTRIC HAEMORRHAGE,2
CO,GASTRIC ULCER,2
CO,GOITRE,2
CO,HAEMATEMESIS,2
CO,HAEMOGLOBIN DECREASED,2
CO,HAEMOPTYSIS,2
CO,HAEMORRHAGIC STROKE,2
CO,HEART RATE INCREASED,2
CO,HEPATOMEGALY,2
CO,HYPERTENSIVE CRISIS,2
CO,HYPOAESTHESIA ORAL,2
CO,HYPOXIA,2
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
CO,INTESTINAL OBSTRUCTION,2
CO,LIVER DISORDER,2
CO,LUNG INFECTION,2
CO,MELAENA,2
CO,MOBILITY DECREASED,2
CO,MOUTH HAEMORRHAGE,2
CO,PALLOR,2
CO,PAPILLARY THYROID CANCER,2
CO,PERIPHERAL SWELLING,2
CO,PERITONITIS BACTERIAL,2
CO,PRODUCT USE ISSUE,2
CO,PROSTATOMEGALY,2
CO,PULMONARY HYPERTENSION,2
CO,RENAL DISORDER,2
CO,RESPIRATORY DISORDER,2
CO,SLEEP APNOEA SYNDROME,2
CO,SUPRAVENTRICULAR EXTRASYSTOLES,2
CO,THROAT IRRITATION,2
CO,TRANSAMINASES INCREASED,2
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CO,ABDOMINAL INFECTION,1
CO,ABDOMINAL SEPSIS,1
CO,ABSCESS,1
CO,ACCIDENT,1
CO,ACUTE KIDNEY INJURY,1
CO,ADVERSE EVENT,1
CO,AGGRESSION,1
CO,ALANINE AMINOTRANSFERASE INCREASED,1
CO,ALOPECIA,1
CO,AMNESIA,1
CO,AMPUTATION,1
CO,ANGINA UNSTABLE,1
CO,ANGIOPATHY,1
CO,ANKLE FRACTURE,1
CO,AORTIC ANEURYSM,1
CO,APATHY,1
CO,APHASIA,1
CO,ARRHYTHMIA,1
CO,ARTERIAL OCCLUSIVE DISEASE,1
CO,ARTERIOSCLEROSIS,1
CO,ARTHRITIS,1
CO,ARTHROPATHY,1
CO,ASCITES,1
CO,ASPARTATE AMINOTRANSFERASE INCREASED,1
CO,BILE DUCT STONE,1
CO,BLINDNESS UNILATERAL,1
CO,BLISTER,1
CO,BLOOD POTASSIUM DECREASED,1
CO,BLOOD PRESSURE DECREASED,1
CO,BONE MARROW OEDEMA,1
CO,BRADYCARDIA,1
CO,BROMHIDROSIS,1
CO,BRONCHITIS,1
CO,BRONCHITIS BACTERIAL,1
CO,BURN OF INTERNAL ORGANS,1
CO,BURNING SENSATION,1
CO,CANDIDA INFECTION,1
CO,CARDIAC FUNCTION DISTURBANCE POSTOPERATIVE,1
CO,CARDIAC FUNCTION TEST ABNORMAL,1
CO,CATARACT,1
CO,CATHETERISATION CARDIAC,1
CO,CELLULITIS ORBITAL,1
CO,CEREBRAL HAEMATOMA,1
CO,CEREBRAL ISCHAEMIA,1
CO,CERVICAL DYSPLASIA,1
CO,CHILLS,1
CO,CHOKING SENSATION,1
CO,CHONDROPATHY,1
CO,CONCOMITANT DISEASE AGGRAVATED,1
CO,CONCOMITANT DISEASE PROGRESSION,1
CO,CONSTIPATION,1
CO,CONVULSION,1
CO,CORONARY ARTERY INSUFFICIENCY,1
CO,CORONARY ARTERY OCCLUSION,1
CO,CYTOGENETIC ANALYSIS ABNORMAL,1
CO,DEAFNESS,1
CO,DEAFNESS UNILATERAL,1
CO,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CO,DEPRESSION,1
CO,DIABETES MELLITUS,1
CO,DIABETIC COMPLICATION,1
CO,DIABETIC FOOT,1
CO,DISCOMFORT,1
CO,DISEASE PROGRESSION,1
CO,DRUG PRESCRIBING ERROR,1
CO,DRUG TOLERANCE,1
CO,DRY THROAT,1
CO,DYSLALIA,1
CO,DYSLIPIDAEMIA,1
CO,DYSPEPSIA,1
CO,DYSPHONIA,1
CO,DYSURIA,1
CO,ECHOCARDIOGRAM ABNORMAL,1
CO,ECZEMA,1
CO,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
CO,ELECTROLYTE IMBALANCE,1
CO,EMBOLISM,1
CO,ENCEPHALOPATHY,1
CO,ERYSIPELAS,1
CO,ERYTHEMA,1
CO,ESCHERICHIA INFECTION,1
CO,EYE INFECTION,1
CO,FACE OEDEMA,1
CO,FEELING DRUNK,1
CO,FEELING HOT,1
CO,FLUID RETENTION,1
CO,FOREIGN BODY IN RESPIRATORY TRACT,1
CO,GALLBLADDER DISORDER,1
CO,GASTRITIS,1
CO,GASTROINTESTINAL INFECTION,1
CO,GASTROINTESTINAL INFLAMMATION,1
CO,GASTROINTESTINAL ISCHAEMIA,1
CO,GINGIVAL BLEEDING,1
CO,GLAUCOMA,1
CO,GROIN PAIN,1
CO,HAEMATOMA,1
CO,HAEMORRHAGE URINARY TRACT,1
CO,HALLUCINATION,1
CO,HEAD INJURY,1
CO,HEMIPLEGIA,1
CO,HERNIA,1
CO,HERPES DERMATITIS,1
CO,HIP FRACTURE,1
CO,HYPERCALCAEMIA,1
CO,HYPERKALAEMIA,1
CO,HYPERSOMNIA,1
CO,HYPERTENSIVE CARDIOMYOPATHY,1
CO,HYPERTENSIVE HEART DISEASE,1
CO,HYPERTENSIVE NEPHROPATHY,1
CO,HYPOGLYCAEMIA,1
CO,HYPOKALAEMIA,1
CO,HYPOKINESIA,1
CO,HYPONATRAEMIA,1
CO,HYPOPHAGIA,1
CO,HYPOTHYROIDISM,1
CO,HYPOVOLAEMIC SHOCK,1
CO,IDIOSYNCRATIC DRUG REACTION,1
CO,IMMUNOSUPPRESSION,1
CO,IMPAIRED HEALING,1
CO,INAPPROPRIATE PRESCRIBING,1
CO,INFLAMMATION,1
CO,INTRAOCULAR PRESSURE TEST ABNORMAL,1
CO,INVESTIGATION ABNORMAL,1
CO,IRRITABLE BOWEL SYNDROME,1
CO,ISCHAEMIA,1
CO,KYPHOSIS,1
CO,LACRIMAL HAEMORRHAGE,1
CO,LEFT VENTRICULAR HYPERTROPHY,1
CO,LEUKOPENIA,1
CO,LIMB INJURY,1
CO,LIVER FUNCTION TEST ABNORMAL,1
CO,LOCALISED OEDEMA,1
CO,LOWER LIMB FRACTURE,1
CO,LUNG NEOPLASM MALIGNANT,1
CO,LYMPHADENOPATHY,1
CO,MEMORY IMPAIRMENT,1
CO,METABOLIC SYNDROME,1
CO,METASTASES TO LUNG,1
CO,METASTASIS,1
CO,METASTATIC RENAL CELL CARCINOMA,1
CO,MUSCLE DISORDER,1
CO,MUSCLE SPASMS,1
CO,NECROSIS,1
CO,NEOPLASM,1
CO,NERVOUS SYSTEM DISORDER,1
CO,NERVOUSNESS,1
CO,OBESITY,1
CO,ODYNOPHAGIA,1
CO,OEDEMA PERIPHERAL,1
CO,OROPHARYNGEAL PAIN,1
CO,OVARIAN CANCER,1
CO,OXYGEN CONSUMPTION INCREASED,1
CO,OXYGEN SATURATION DECREASED,1
CO,PAINFUL RESPIRATION,1
CO,PALPITATIONS,1
CO,PANCREATIC CARCINOMA,1
CO,PANCREATITIS,1
CO,PATHOLOGICAL FRACTURE,1
CO,PELVIC MASS,1
CO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CO,PERIPHERAL COLDNESS,1
CO,PERIPHERAL ISCHAEMIA,1
CO,PERITONITIS VIRAL,1
CO,PETECHIAE,1
CO,PLATELET COUNT INCREASED,1
CO,PNEUMONIA BACTERIAL,1
CO,POLYMYALGIA RHEUMATICA,1
CO,POSTOPERATIVE WOUND INFECTION,1
CO,PRODUCT SUPPLY ISSUE,1
CO,PRODUCTIVE COUGH,1
CO,PROSOPAGNOSIA,1
CO,PSORIASIS,1
CO,PSORIATIC ARTHROPATHY,1
CO,PSYCHIATRIC SYMPTOM,1
CO,PULMONARY PAIN,1
CO,RENAL CELL CARCINOMA,1
CO,RENAL IMPAIRMENT,1
CO,REPERFUSION ARRHYTHMIA,1
CO,RESPIRATORY DISTRESS,1
CO,RESPIRATORY TRACT INFECTION,1
CO,RETINAL HAEMORRHAGE,1
CO,RHINORRHOEA,1
CO,ROAD TRAFFIC ACCIDENT,1
CO,SALIVARY HYPERSECRETION,1
CO,SARCOPENIA,1
CO,SCAR,1
CO,SCLERODERMA,1
CO,SEPSIS,1
CO,SERUM FERRITIN INCREASED,1
CO,SKIN ULCER,1
CO,SOFT TISSUE INJURY,1
CO,SPINAL COLUMN STENOSIS,1
CO,SPINAL PAIN,1
CO,SPLENOMEGALY,1
CO,STEVENS-JOHNSON SYNDROME,1
CO,SUBCUTANEOUS ABSCESS,1
CO,SWELLING FACE,1
CO,SYNCOPE,1
CO,TACHYCARDIA,1
CO,TENOSYNOVITIS,1
CO,THERAPY CESSATION,1
CO,THERAPY NON-RESPONDER,1
CO,THORACIC VERTEBRAL FRACTURE,1
CO,TOXIC SKIN ERUPTION,1
CO,TOXICITY TO VARIOUS AGENTS,1
CO,TREATMENT NONCOMPLIANCE,1
CO,TREMOR,1
CO,TRIGEMINAL NERVE DISORDER,1
CO,TUMOUR MARKER INCREASED,1
CO,TYPE 2 DIABETES MELLITUS,1
CO,ULCER,1
CO,URAEMIC ENCEPHALOPATHY,1
CO,URINE ODOUR ABNORMAL,1
CO,VAGINAL HAEMORRHAGE,1
CO,VASCULAR STENT OCCLUSION,1
CO,VENOUS OCCLUSION,1
CO,VENTRICULAR EXTRASYSTOLES,1
CO,VIRAL INFECTION,1
CO,VITREOUS HAEMORRHAGE,1
CO,VULVOVAGINAL CANDIDIASIS,1
CO,WOUND SECRETION,1
CO,YELLOW SKIN,1
CR,HYPOAESTHESIA,2
CR,PERIPHERAL ISCHAEMIA,2
CR,ABDOMINAL PAIN,1
CR,ARRHYTHMIA,1
CR,BLOOD PRESSURE DECREASED,1
CR,BLOOD PRESSURE INCREASED,1
CR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CR,CORONARY ARTERY INSUFFICIENCY,1
CR,DERMATITIS EXFOLIATIVE,1
CR,DIARRHOEA,1
CR,DIZZINESS,1
CR,FALL,1
CR,FEELING ABNORMAL,1
CR,HAEMATOMA,1
CR,HAEMATURIA,1
CR,HEMIPARESIS,1
CR,HEMIPLEGIA,1
CR,HIP FRACTURE,1
CR,HYPOACUSIS,1
CR,ISCHAEMIC STROKE,1
CR,KIDNEY INFECTION,1
CR,LIPASE INCREASED,1
CR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CR,OBSTRUCTIVE AIRWAYS DISORDER,1
CR,ORAL FUNGAL INFECTION,1
CR,ORAL MUCOSAL ERYTHEMA,1
CR,PANCREATIC DUCT OBSTRUCTION,1
CR,PANCREATIC PSEUDOCYST,1
CR,PANCREATITIS,1
CR,PARAESTHESIA,1
CR,PELVIC FRACTURE,1
CR,POST PROCEDURAL HAEMORRHAGE,1
CR,PRODUCT AVAILABILITY ISSUE,1
CR,RASH VESICULAR,1
CR,STOMATITIS,1
CR,TINNITUS,1
CR,VOMITING,1
HR,RHABDOMYOLYSIS,11
HR,ANAEMIA,7
HR,HAEMATOMA,7
HR,FOOT FRACTURE,6
HR,JOINT DISLOCATION,6
HR,OEDEMA PERIPHERAL,6
HR,DYSPNOEA,4
HR,TOXICITY TO VARIOUS AGENTS,4
HR,CEREBRAL ISCHAEMIA,3
HR,COLONIC PSEUDO-OBSTRUCTION,3
HR,HYPERTROPHIC CARDIOMYOPATHY,3
HR,MITRAL VALVE INCOMPETENCE,3
HR,MYOCARDIAL INFARCTION,3
HR,PLEURAL EFFUSION,3
HR,SUPRAVENTRICULAR EXTRASYSTOLES,3
HR,TRICUSPID VALVE INCOMPETENCE,3
HR,ACUTE MYOCARDIAL INFARCTION,2
HR,ANGINA PECTORIS,2
HR,DRUG INEFFECTIVE,2
HR,HEMIPLEGIA,2
HR,INTESTINAL PSEUDO-OBSTRUCTION,2
HR,ISCHAEMIC STROKE,2
HR,VASCULAR STENT THROMBOSIS,2
HR,ABDOMINAL DISTENSION,1
HR,ARTERIOSCLEROSIS CORONARY ARTERY,1
HR,ATRIAL FIBRILLATION,1
HR,BLOOD CALCIUM INCREASED,1
HR,BLOOD CREATININE INCREASED,1
HR,BLOOD IRON DECREASED,1
HR,BLOOD URIC ACID INCREASED,1
HR,BRONCHOSPASM,1
HR,CARDIAC FAILURE,1
HR,CAROTID ARTERY OCCLUSION,1
HR,CEREBROVASCULAR ACCIDENT,1
HR,CONSTIPATION,1
HR,CORONARY ARTERY DISEASE,1
HR,CORONARY ARTERY STENOSIS,1
HR,DECREASED APPETITE,1
HR,DIARRHOEA,1
HR,DRUG ADMINISTRATION ERROR,1
HR,DRUG RESISTANCE,1
HR,ERYTHEMA,1
HR,EXERCISE TOLERANCE DECREASED,1
HR,FACE OEDEMA,1
HR,GASTRITIS,1
HR,GASTROINTESTINAL SOUNDS ABNORMAL,1
HR,GLOMERULAR FILTRATION RATE DECREASED,1
HR,HAEMARTHROSIS,1
HR,HAEMATURIA,1
HR,HAEMOGLOBIN DECREASED,1
HR,HYPERHIDROSIS,1
HR,HYPERSENSITIVITY,1
HR,ILEUS PARALYTIC,1
HR,INTESTINAL DILATATION,1
HR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
HR,LOCALISED OEDEMA,1
HR,MEAN CELL VOLUME DECREASED,1
HR,NAUSEA,1
HR,NEGATIVE THOUGHTS,1
HR,OVERDOSE,1
HR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
HR,PERIPHERAL ARTERY ANGIOPLASTY,1
HR,PRODUCT USE IN UNAPPROVED INDICATION,1
HR,PYELONEPHRITIS,1
HR,RED BLOOD CELL COUNT DECREASED,1
HR,RENAL HAEMATOMA,1
HR,RETROPERITONEAL HAEMATOMA,1
HR,RETROPERITONEAL HAEMORRHAGE,1
HR,SPLENIC RUPTURE,1
HR,SYNCOPE,1
HR,UNDERDOSE,1
CU,THROMBOSIS IN DEVICE,1
CY,MYOCARDIAL INFARCTION,2
CY,CARDIAC ARREST,1
CY,CARDIAC FAILURE CHRONIC,1
CY,DIZZINESS,1
CY,DRUG PRESCRIBING ERROR,1
CY,DYSPNOEA,1
CY,HEAD INJURY,1
CY,MYOCARDIAL ISCHAEMIA,1
CY,NAUSEA,1
CY,ROAD TRAFFIC ACCIDENT,1
CY,SUBDURAL HAEMATOMA,1
CY,URINE OUTPUT DECREASED,1
CY,VENTRICULAR TACHYCARDIA,1
CY,VIRAL INFECTION,1
CZ,ASTHENIA,5
CZ,CARDIAC ARREST,5
CZ,EPISTAXIS,5
CZ,PARAESTHESIA,5
CZ,ACUTE MYOCARDIAL INFARCTION,4
CZ,ANAEMIA,4
CZ,CIRCULATORY COLLAPSE,4
CZ,DYSPNOEA,4
CZ,RENAL FAILURE,4
CZ,ABDOMINAL PAIN,3
CZ,ANAPHYLACTIC SHOCK,3
CZ,OXYGEN SATURATION DECREASED,3
CZ,PYREXIA,3
CZ,RESPIRATORY ARREST,3
CZ,ACUTE KIDNEY INJURY,2
CZ,ANGINA PECTORIS,2
CZ,ANGIOEDEMA,2
CZ,CARDIAC FAILURE,2
CZ,CHILLS,2
CZ,FALL,2
CZ,FATIGUE,2
CZ,HYPERTENSION,2
CZ,HYPONATRAEMIA,2
CZ,INTESTINAL HAEMORRHAGE,2
CZ,LEUKOCYTOSIS,2
CZ,LOSS OF CONSCIOUSNESS,2
CZ,MYELODYSPLASTIC SYNDROME,2
CZ,MYOCARDIAL INFARCTION,2
CZ,OSTEOPOROSIS,2
CZ,PALPITATIONS,2
CZ,PANCYTOPENIA,2
CZ,PNEUMONIA,2
CZ,PULMONARY EMBOLISM,2
CZ,PULMONARY OEDEMA,2
CZ,RASH,2
CZ,SUDDEN DEATH,2
CZ,SYNCOPE,2
CZ,THROMBOSIS,2
CZ,ABDOMINAL DISCOMFORT,1
CZ,ABDOMINAL PAIN UPPER,1
CZ,ACUTE CORONARY SYNDROME,1
CZ,ACUTE INTERSTITIAL PNEUMONITIS,1
CZ,ALCOHOL POISONING,1
CZ,ANGINA UNSTABLE,1
CZ,ARTERIAL OCCLUSIVE DISEASE,1
CZ,ARTERIAL THROMBOSIS,1
CZ,ASPARTATE AMINOTRANSFERASE INCREASED,1
CZ,ATRIAL FIBRILLATION,1
CZ,ATRIAL FLUTTER,1
CZ,ATRIOVENTRICULAR BLOCK,1
CZ,BLOOD POTASSIUM DECREASED,1
CZ,BONE MARROW FAILURE,1
CZ,BONE PAIN,1
CZ,BREAST CANCER,1
CZ,BUNDLE BRANCH BLOCK RIGHT,1
CZ,CARDIAC FAILURE CONGESTIVE,1
CZ,CARDIOVASCULAR DISORDER,1
CZ,CELLULITIS,1
CZ,CEREBROVASCULAR ACCIDENT,1
CZ,CHEST DISCOMFORT,1
CZ,CHOLELITHIASIS,1
CZ,CHRONIC GASTRITIS,1
CZ,CHRONIC KIDNEY DISEASE,1
CZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CZ,CLOSTRIDIUM DIFFICILE COLITIS,1
CZ,COAGULOPATHY,1
CZ,COLITIS ULCERATIVE,1
CZ,CONDITION AGGRAVATED,1
CZ,CONSTIPATION,1
CZ,CONTRAINDICATED PRODUCT ADMINISTERED,1
CZ,CORONARY ARTERY DISEASE,1
CZ,CYSTITIS,1
CZ,DERMATITIS ALLERGIC,1
CZ,DIABETES MELLITUS,1
CZ,DIARRHOEA,1
CZ,DIARRHOEA HAEMORRHAGIC,1
CZ,DUODENITIS,1
CZ,DYSPEPSIA,1
CZ,DYSPNOEA EXERTIONAL,1
CZ,ENDOCARDITIS,1
CZ,EPIGLOTTIC OEDEMA,1
CZ,ERYTHEMA,1
CZ,ERYTHROPENIA,1
CZ,ESCHERICHIA URINARY TRACT INFECTION,1
CZ,FRONTOTEMPORAL DEMENTIA,1
CZ,GAIT DISTURBANCE,1
CZ,GASTRIC HAEMORRHAGE,1
CZ,GASTRIC ULCER,1
CZ,GASTROENTERITIS SALMONELLA,1
CZ,GASTROINTESTINAL HAEMORRHAGE,1
CZ,GASTROOESOPHAGEAL REFLUX DISEASE,1
CZ,GINGIVAL BLEEDING,1
CZ,HAEMATURIA,1
CZ,HAEMORRHAGE,1
CZ,HEADACHE,1
CZ,HEART RATE IRREGULAR,1
CZ,HELPLESSNESS,1
CZ,HERPES ZOSTER CUTANEOUS DISSEMINATED,1
CZ,HYPERBILIRUBINAEMIA,1
CZ,HYPERGLYCAEMIA,1
CZ,HYPERURICAEMIA,1
CZ,HYPOACUSIS,1
CZ,HYPOAESTHESIA,1
CZ,HYPOKALAEMIA,1
CZ,HYPOTENSION,1
CZ,ILEUS,1
CZ,ILEUS PARALYTIC,1
CZ,INTERMITTENT CLAUDICATION,1
CZ,INTERSTITIAL LUNG DISEASE,1
CZ,LARYNGEAL OEDEMA,1
CZ,LEUKOPENIA,1
CZ,LIP SWELLING,1
CZ,LUNG NEOPLASM MALIGNANT,1
CZ,MASS,1
CZ,MEGACOLON,1
CZ,MELAENA,1
CZ,MENINGITIS,1
CZ,MESENTERIC HAEMORRHAGE,1
CZ,METABOLIC ACIDOSIS,1
CZ,MUSCLE SPASMS,1
CZ,MUSCULAR WEAKNESS,1
CZ,MYALGIA,1
CZ,NEPHROPATHY,1
CZ,NEPHROPATHY TOXIC,1
CZ,NORMOCYTIC ANAEMIA,1
CZ,OEDEMA,1
CZ,OEDEMA PERIPHERAL,1
CZ,OLIGURIA,1
CZ,ORGANIC BRAIN SYNDROME,1
CZ,OSTEOARTHRITIS,1
CZ,OSTEONECROSIS OF JAW,1
CZ,OTITIS MEDIA ACUTE,1
CZ,PAIN,1
CZ,PAIN IN EXTREMITY,1
CZ,PALLOR,1
CZ,PARAESTHESIA ORAL,1
CZ,PERIPHERAL COLDNESS,1
CZ,POLYNEUROPATHY ALCOHOLIC,1
CZ,PRESYNCOPE,1
CZ,PROCEDURAL COMPLICATION,1
CZ,PRODUCT USE ISSUE,1
CZ,PRURITUS,1
CZ,RASH GENERALISED,1
CZ,RESPIRATORY FAILURE,1
CZ,SEPSIS,1
CZ,SINUSITIS,1
CZ,SKULL FRACTURE,1
CZ,SPEECH DISORDER,1
CZ,SPLENOMEGALY,1
CZ,SPONTANEOUS HAEMATOMA,1
CZ,SQUAMOUS CELL CARCINOMA OF LUNG,1
CZ,STOMATITIS,1
CZ,STRESS,1
CZ,STRESS CARDIOMYOPATHY,1
CZ,SUBARACHNOID HAEMORRHAGE,1
CZ,SWOLLEN TONGUE,1
CZ,SYSTOLIC HYPERTENSION,1
CZ,TACHYCARDIA,1
CZ,TONGUE OEDEMA,1
CZ,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
CZ,TREATMENT FAILURE,1
CZ,UROSEPSIS,1
CZ,VENTRICULAR FIBRILLATION,1
CZ,VENTRICULAR TACHYCARDIA,1
CZ,VOMITING,1
CZ,WEIGHT INCREASED,1
DK,DYSPNOEA,16
DK,NEUROPATHY PERIPHERAL,16
DK,DIZZINESS,15
DK,ANAEMIA,14
DK,NAUSEA,14
DK,VOMITING,14
DK,DRUG CLEARANCE DECREASED,11
DK,MYALGIA,10
DK,SENSORY DISTURBANCE,10
DK,CARDIAC ARREST,9
DK,RENAL FAILURE,9
DK,SEPSIS,9
DK,TOXICITY TO VARIOUS AGENTS,9
DK,ANGINA PECTORIS,8
DK,HAEMORRHAGIC DIATHESIS,8
DK,HYPONATRAEMIA,8
DK,RENAL IMPAIRMENT,8
DK,CEREBRAL HAEMORRHAGE,7
DK,CHEST PAIN,7
DK,HAEMATURIA,7
DK,HYPOTENSION,7
DK,MALAISE,7
DK,NEUROTOXICITY,7
DK,PARAESTHESIA,7
DK,RASH,7
DK,ACUTE KIDNEY INJURY,6
DK,CEREBRAL INFARCTION,6
DK,DIARRHOEA,6
DK,FATIGUE,6
DK,INCREASED TENDENCY TO BRUISE,6
DK,PRODUCT SUBSTITUTION ISSUE,6
DK,PSEUDOMEMBRANOUS COLITIS,6
DK,PULMONARY FIBROSIS,6
DK,PYREXIA,6
DK,ACUTE MYOCARDIAL INFARCTION,5
DK,ADENOCARCINOMA OF COLON,5
DK,CHOLELITHIASIS,5
DK,CONSTIPATION,5
DK,CORONARY ARTERY DISSECTION,5
DK,FALL,5
DK,GASTRIC HAEMORRHAGE,5
DK,GENERALISED TONIC-CLONIC SEIZURE,5
DK,HAEMATEMESIS,5
DK,HAEMATOMA,5
DK,HEADACHE,5
DK,HYPOGLYCAEMIA,5
DK,LUNG INFECTION,5
DK,PANCREATITIS,5
DK,POST PROCEDURAL HAEMORRHAGE,5
DK,SLEEP DISORDER,5
DK,BLOOD BILIRUBIN INCREASED,4
DK,CONFUSIONAL STATE,4
DK,DRUG INEFFECTIVE,4
DK,EJECTION FRACTION DECREASED,4
DK,GAIT DISTURBANCE,4
DK,HAEMOGLOBIN DECREASED,4
DK,LIVER DISORDER,4
DK,LOSS OF CONSCIOUSNESS,4
DK,OSTEONECROSIS OF JAW,4
DK,PALPITATIONS,4
DK,PNEUMONIA,4
DK,RENAL CYST,4
DK,RHABDOMYOLYSIS,4
DK,SYNCOPE,4
DK,VENTRICULAR FIBRILLATION,4
DK,ABDOMINAL PAIN,3
DK,ANXIETY,3
DK,BACK PAIN,3
DK,BLISTER,3
DK,BRAIN HERNIATION,3
DK,CARDIAC FAILURE,3
DK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
DK,CLOSTRIDIUM DIFFICILE INFECTION,3
DK,COUGH,3
DK,DECREASED APPETITE,3
DK,DEPRESSED MOOD,3
DK,DEPRESSION,3
DK,DIALYSIS,3
DK,DYSBACTERIOSIS,3
DK,EPIGASTRIC DISCOMFORT,3
DK,EXERCISE TOLERANCE DECREASED,3
DK,FUNGAL SKIN INFECTION,3
DK,GASTRIC ULCER,3
DK,GASTROOESOPHAGEAL REFLUX DISEASE,3
DK,GENERAL PHYSICAL HEALTH DETERIORATION,3
DK,HEPATIC ENZYME INCREASED,3
DK,HERPES ZOSTER,3
DK,ILEOSTOMY,3
DK,INCORRECT DOSE ADMINISTERED,3
DK,INFECTION,3
DK,INTERNATIONAL NORMALISED RATIO DECREASED,3
DK,INTRACRANIAL PRESSURE INCREASED,3
DK,LARGE INTESTINAL HAEMORRHAGE,3
DK,LUNG DISORDER,3
DK,MEMORY IMPAIRMENT,3
DK,MONOPLEGIA,3
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
DK,MUSCLE SPASMS,3
DK,MUSCULAR WEAKNESS,3
DK,OEDEMA PERIPHERAL,3
DK,PSYCHOTIC DISORDER,3
DK,RECTAL HAEMORRHAGE,3
DK,RESTLESSNESS,3
DK,SPEECH DISORDER,3
DK,SUICIDE ATTEMPT,3
DK,TACHYCARDIA,3
DK,TRACHEOSTOMY,3
DK,TUMOUR LYSIS SYNDROME,3
DK,WEIGHT DECREASED,3
DK,ABDOMINAL DISCOMFORT,2
DK,AGGRESSION,2
DK,ALTERED STATE OF CONSCIOUSNESS,2
DK,ARRHYTHMIA,2
DK,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
DK,BALANCE DISORDER,2
DK,BLINDNESS UNILATERAL,2
DK,BLOOD PRESSURE INCREASED,2
DK,BRAIN OEDEMA,2
DK,BUNDLE BRANCH BLOCK RIGHT,2
DK,C-REACTIVE PROTEIN INCREASED,2
DK,CEREBRAL THROMBOSIS,2
DK,CLOSTRIDIUM DIFFICILE SEPSIS,2
DK,COGNITIVE DISORDER,2
DK,CONJUNCTIVAL HAEMORRHAGE,2
DK,DEHYDRATION,2
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,2
DK,DIPLEGIA,2
DK,DISCOMFORT,2
DK,DRY SKIN,2
DK,ELECTROCARDIOGRAM QT PROLONGED,2
DK,ERYTHEMA,2
DK,FACIAL PARESIS,2
DK,FAECAL INCONTINENCE,2
DK,GALLBLADDER ENLARGEMENT,2
DK,HAEMODIALYSIS,2
DK,HAEMORRHAGE,2
DK,HYPERKALAEMIA,2
DK,HYPERSENSITIVITY,2
DK,HYPOAESTHESIA,2
DK,HYPOKALAEMIA,2
DK,JOINT RANGE OF MOTION DECREASED,2
DK,JOINT SWELLING,2
DK,LEUKOCYTOSIS,2
DK,LOWER LIMB FRACTURE,2
DK,MEDICATION ERROR,2
DK,MOBILITY DECREASED,2
DK,NEPHROGENIC SYSTEMIC FIBROSIS,2
DK,PAIN,2
DK,PAIN IN EXTREMITY,2
DK,PULMONARY HYPERTENSION,2
DK,RASH PRURITIC,2
DK,RESPIRATORY DEPRESSION,2
DK,SEPTIC SHOCK,2
DK,SEQUESTRECTOMY,2
DK,SKIN HAEMORRHAGE,2
DK,SKIN HYPERTROPHY,2
DK,SKIN INDURATION,2
DK,SPINAL HAEMATOMA,2
DK,THROMBOCYTOPENIA,2
DK,THROMBOSIS,2
DK,TRANSIENT ISCHAEMIC ATTACK,2
DK,URINARY INCONTINENCE,2
DK,ABDOMINAL DISTENSION,1
DK,ABDOMINAL PAIN UPPER,1
DK,ABSCESS LIMB,1
DK,ACTIVITIES OF DAILY LIVING IMPAIRED,1
DK,AGITATION,1
DK,ALANINE AMINOTRANSFERASE INCREASED,1
DK,ALOPECIA,1
DK,AMNESIA,1
DK,APHASIA,1
DK,ARTHRALGIA,1
DK,ASCITES,1
DK,ASPARTATE AMINOTRANSFERASE INCREASED,1
DK,ASTHENIA,1
DK,ATRIAL FIBRILLATION,1
DK,AUTOIMMUNE PANCREATITIS,1
DK,BACTERAEMIA,1
DK,BACTERIAL TEST POSITIVE,1
DK,BARRETT^S OESOPHAGUS,1
DK,BASAL GANGLIA HAEMORRHAGE,1
DK,BENIGN LUNG NEOPLASM,1
DK,BLOOD ALKALINE PHOSPHATASE INCREASED,1
DK,BLOOD CREATININE INCREASED,1
DK,BLOOD LACTIC ACID INCREASED,1
DK,BLOOD PRESSURE DECREASED,1
DK,BLOOD SODIUM DECREASED,1
DK,BLOOD URINE PRESENT,1
DK,BONE PAIN,1
DK,BRADYCARDIA,1
DK,BREAST DISCOLOURATION,1
DK,BUNDLE BRANCH BLOCK LEFT,1
DK,CEREBRAL DISORDER,1
DK,CEREBRAL ISCHAEMIA,1
DK,CHEST DISCOMFORT,1
DK,CHILLS,1
DK,CHOLECYSTECTOMY,1
DK,CHOLESTASIS,1
DK,CHROMATURIA,1
DK,CLOSTRIDIUM DIFFICILE COLITIS,1
DK,COAGULOPATHY,1
DK,COLITIS,1
DK,CONCUSSION,1
DK,CONFABULATION,1
DK,CORONARY ARTERY DISEASE,1
DK,CORONARY ARTERY OCCLUSION,1
DK,CRYING,1
DK,DEATH,1
DK,DELIRIUM,1
DK,DELUSION,1
DK,DENTURE WEARER,1
DK,DERMATITIS,1
DK,DIABETIC KETOACIDOSIS,1
DK,DIFFUSE LARGE B-CELL LYMPHOMA,1
DK,DISABILITY,1
DK,DISEASE PROGRESSION,1
DK,DRUG HYPERSENSITIVITY,1
DK,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
DK,DRUG WITHDRAWAL SYNDROME,1
DK,DYSARTHRIA,1
DK,DYSPEPSIA,1
DK,DYSSTASIA,1
DK,ECZEMA,1
DK,EMPHYSEMA,1
DK,ENDOTRACHEAL INTUBATION,1
DK,EOSINOPHILIA,1
DK,EPILEPSY,1
DK,EPISTAXIS,1
DK,EXTRADURAL HAEMATOMA,1
DK,FEELING OF DESPAIR,1
DK,FINGER AMPUTATION,1
DK,FLUID OVERLOAD,1
DK,FLUSHING,1
DK,GALLBLADDER POLYP,1
DK,GASTRITIS,1
DK,GASTROINTESTINAL DISORDER,1
DK,GASTROINTESTINAL HAEMORRHAGE,1
DK,GLOMERULAR FILTRATION RATE DECREASED,1
DK,GYNAECOMASTIA,1
DK,HAEMORRHAGE SUBCUTANEOUS,1
DK,HALLUCINATION,1
DK,HEART RATE DECREASED,1
DK,HELICOBACTER INFECTION,1
DK,HEMIANOPIA,1
DK,HEMIPARESIS,1
DK,HEMIPLEGIA,1
DK,HEPATIC CONGESTION,1
DK,HIATUS HERNIA,1
DK,HYDROCEPHALUS,1
DK,HYPERHIDROSIS,1
DK,HYPOACUSIS,1
DK,HYPOGLYCAEMIC ENCEPHALOPATHY,1
DK,ILEUS,1
DK,IMPAIRED HEALING,1
DK,IMPAIRED SELF-CARE,1
DK,INJECTION SITE ABSCESS,1
DK,INJECTION SITE ERYTHEMA,1
DK,INJECTION SITE PAIN,1
DK,INTENTIONAL OVERDOSE,1
DK,INTERNATIONAL NORMALISED RATIO INCREASED,1
DK,INTERSTITIAL LUNG DISEASE,1
DK,JAUNDICE,1
DK,JOINT STIFFNESS,1
DK,KETOACIDOSIS,1
DK,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
DK,LARGE INTESTINE PERFORATION,1
DK,LARYNX IRRITATION,1
DK,LETHARGY,1
DK,LIGAMENT SPRAIN,1
DK,LIP OEDEMA,1
DK,LIVER FUNCTION TEST ABNORMAL,1
DK,LOSS OF LIBIDO,1
DK,LUMBAR VERTEBRAL FRACTURE,1
DK,MELAENA,1
DK,METASTASES TO PERITONEUM,1
DK,MONOPARESIS,1
DK,MOTOR DYSFUNCTION,1
DK,MUSCLE CONTRACTURE,1
DK,MUSCLE HAEMORRHAGE,1
DK,MUSCLE NECROSIS,1
DK,MUSCLE TIGHTNESS,1
DK,MUSCULOSKELETAL STIFFNESS,1
DK,NEPHRITIS,1
DK,NERVOUS SYSTEM DISORDER,1
DK,NEUROLOGIC NEGLECT SYNDROME,1
DK,NEUTROPHIL COUNT DECREASED,1
DK,NIGHT SWEATS,1
DK,NON-CARDIAC CHEST PAIN,1
DK,OBSESSIVE THOUGHTS,1
DK,OBSESSIVE-COMPULSIVE PERSONALITY DISORDER,1
DK,ODYNOPHAGIA,1
DK,OESOPHAGEAL CARCINOMA,1
DK,OSTEOARTHRITIS,1
DK,OSTEOMYELITIS,1
DK,OVERDOSE,1
DK,OXYGEN SUPPLEMENTATION,1
DK,PAIN IN JAW,1
DK,PARKINSON^S DISEASE,1
DK,PARTIAL SEIZURES,1
DK,PATHOLOGICAL FRACTURE,1
DK,PEAU D^ORANGE,1
DK,PERITONITIS,1
DK,PLATELET COUNT DECREASED,1
DK,PLATELET COUNT INCREASED,1
DK,PNEUMOCYSTIS JIROVECI PNEUMONIA,1
DK,PNEUMONIA ASPIRATION,1
DK,POST PROCEDURAL COMPLICATION,1
DK,POSTICTAL STATE,1
DK,PRESYNCOPE,1
DK,PROCEDURAL HYPOTENSION,1
DK,PRODUCT USE IN UNAPPROVED INDICATION,1
DK,PRURITUS,1
DK,PRURITUS GENERALISED,1
DK,PSYCHOMOTOR SKILLS IMPAIRED,1
DK,PULMONARY CONGESTION,1
DK,PULMONARY EMBOLISM,1
DK,PULMONARY OEDEMA,1
DK,PUPILLARY REFLEX IMPAIRED,1
DK,QUALITY OF LIFE DECREASED,1
DK,RASH GENERALISED,1
DK,RASH MACULO-PAPULAR,1
DK,RENAL DISORDER,1
DK,RENAL FAILURE ACUTE,1
DK,RESPIRATION ABNORMAL,1
DK,RETINAL ARTERY EMBOLISM,1
DK,RETINAL ARTERY OCCLUSION,1
DK,SENSATION OF HEAVINESS,1
DK,SKIN BURNING SENSATION,1
DK,SKIN DISCOLOURATION,1
DK,SKIN TIGHTNESS,1
DK,SKIN ULCER,1
DK,SKIN WOUND,1
DK,SNEEZING,1
DK,SPIDER VEIN,1
DK,SQUAMOUS CELL CARCINOMA OF SKIN,1
DK,STAPHYLOCOCCAL INFECTION,1
DK,SUBARACHNOID HAEMORRHAGE,1
DK,SUICIDAL IDEATION,1
DK,SURGERY,1
DK,TENDON DISORDER,1
DK,THROMBOCYTOSIS,1
DK,THROMBOSIS IN DEVICE,1
DK,TOE AMPUTATION,1
DK,ULCER,1
DK,URINARY RETENTION,1
DK,URINARY TRACT INFECTION,1
DK,UROSEPSIS,1
DK,URTICARIA,1
DK,VASCULAR PSEUDOANEURYSM,1
DK,VENTRICULAR ARRHYTHMIA,1
DK,VISION BLURRED,1
DK,VISUAL IMPAIRMENT,1
DK,WITHDRAWAL SYNDROME,1
DK,WOUND,1
DO,ACUTE CORONARY SYNDROME,1
DO,ACUTE KIDNEY INJURY,1
DO,ANAEMIA,1
DO,ARTHRALGIA,1
DO,ASTHENIA,1
DO,BACK PAIN,1
DO,CATARACT,1
DO,DEAFNESS UNILATERAL,1
DO,DIZZINESS,1
DO,DUODENAL ULCER,1
DO,FEMUR FRACTURE,1
DO,GAIT DISTURBANCE,1
DO,GASTROINTESTINAL HAEMORRHAGE,1
DO,HYPERGLYCAEMIA,1
DO,LARYNGEAL OEDEMA,1
DO,PAIN IN EXTREMITY,1
DO,PETECHIAE,1
DO,PRODUCT USE IN UNAPPROVED INDICATION,1
DO,PRURITUS,1
DO,VERTIGO,1
DO,VISUAL ACUITY REDUCED,1
EC,CEREBROVASCULAR ACCIDENT,2
EC,DRUG INEFFECTIVE,2
EC,HYPERTENSIVE CRISIS,2
EC,ACUTE MYOCARDIAL INFARCTION,1
EC,ANGIOEDEMA,1
EC,APHONIA,1
EC,CARDIAC FAILURE,1
EC,CHEST PAIN,1
EC,COAGULATION TIME PROLONGED,1
EC,CONTRAINDICATED PRODUCT ADMINISTERED,1
EC,DECREASED IMMUNE RESPONSIVENESS,1
EC,DEMENTIA,1
EC,DISEASE PROGRESSION,1
EC,DISORIENTATION,1
EC,DIZZINESS,1
EC,DYSPHONIA,1
EC,DYSPNOEA,1
EC,ERYTHEMA,1
EC,GASTROINTESTINAL HAEMORRHAGE,1
EC,GENERAL PHYSICAL HEALTH DETERIORATION,1
EC,HAEMORRHAGE INTRACRANIAL,1
EC,HEPATIC FAILURE,1
EC,HYPONATRAEMIA,1
EC,ISCHAEMIA,1
EC,LARYNGEAL CANCER,1
EC,MEMORY IMPAIRMENT,1
EC,NERVOUS SYSTEM DISORDER,1
EC,OEDEMA PERIPHERAL,1
EC,PARAESTHESIA,1
EC,PERIPHERAL COLDNESS,1
EC,PNEUMONIA,1
EC,RENAL FAILURE,1
EC,SENSORY DISTURBANCE,1
EC,THROMBOSIS,1
EC,URINE SODIUM ABNORMAL,1
EC,VIRAL PHARYNGITIS,1
EC,VISION BLURRED,1
EC,WHITE BLOOD CELL DISORDER,1
EG,DYSPNOEA,4
EG,CHEST PAIN,2
EG,DEATH,2
EG,FATIGUE,2
EG,HAEMOGLOBIN DECREASED,2
EG,HYPERTENSION,2
EG,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
EG,ANAEMIA,1
EG,ANAPHYLACTIC SHOCK,1
EG,ANGINA PECTORIS,1
EG,ARTERIAL THROMBOSIS,1
EG,ARTHRALGIA,1
EG,ASTHENIA,1
EG,BLOOD PRESSURE INCREASED,1
EG,CARDIAC ARREST,1
EG,CARDIAC FAILURE,1
EG,CARDIAC OPERATION,1
EG,CARDIOGENIC SHOCK,1
EG,CHEST DISCOMFORT,1
EG,CORONARY ARTERY INSUFFICIENCY,1
EG,CORONARY ARTERY STENOSIS,1
EG,DIZZINESS,1
EG,DRUG EFFECT INCOMPLETE,1
EG,FEELING ABNORMAL,1
EG,FEELING HOT,1
EG,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
EG,HAEMARTHROSIS,1
EG,HEART RATE IRREGULAR,1
EG,HYPERGLYCAEMIA,1
EG,HYPOGLYCAEMIC COMA,1
EG,HYPOTENSION,1
EG,INFLUENZA,1
EG,INJECTION SITE INDURATION,1
EG,INJECTION SITE SWELLING,1
EG,JOINT SWELLING,1
EG,MYOCARDIAL INFARCTION,1
EG,MYOCARDIAL ISCHAEMIA,1
EG,OEDEMA PERIPHERAL,1
EG,ORTHOPNOEA,1
EG,OVERDOSE,1
EG,PALLOR,1
EG,PALPITATIONS,1
EG,PERCUTANEOUS CORONARY INTERVENTION,1
EG,PULMONARY OEDEMA,1
EG,PULSE WAVEFORM ABNORMAL,1
EG,SURGICAL FAILURE,1
EG,TENDERNESS,1
EG,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
EE,DEVICE OCCLUSION,2
EE,URINARY BLADDER HAEMORRHAGE,2
EE,AGITATION,1
EE,CHILLS,1
EE,CONTRAST MEDIA ALLERGY,1
EE,CYANOSIS,1
EE,GASTROINTESTINAL HAEMORRHAGE,1
EE,GASTROINTESTINAL MUCOSAL DISORDER,1
EE,GASTROINTESTINAL ULCER,1
EE,HYPERTENSIVE CRISIS,1
EE,PROSTATIC HAEMORRHAGE,1
EE,PRURITUS GENERALISED,1
EE,PYREXIA,1
EE,RASH ERYTHEMATOUS,1
EE,TREMOR,1
SZ,MYOCARDIAL ISCHAEMIA,1
SZ,RASH MACULO-PAPULAR,1
SZ,RENAL FAILURE ACUTE,1
SZ,RESPIRATORY FAILURE,1
FI,FALL,8
FI,MUSCULAR WEAKNESS,6
FI,CONTUSION,5
FI,DIZZINESS,5
FI,PNEUMONIA,5
FI,RASH,5
FI,DIARRHOEA,4
FI,DRUG INEFFECTIVE,4
FI,DYSPNOEA,4
FI,FATIGUE,4
FI,GAIT DISTURBANCE,4
FI,HYPERKALAEMIA,4
FI,LOSS OF CONSCIOUSNESS,4
FI,MUSCLE SPASMS,4
FI,BACK PAIN,3
FI,CEREBRAL INFARCTION,3
FI,CHEST PAIN,3
FI,ELECTROCARDIOGRAM ABNORMAL,3
FI,EPILEPSY,3
FI,HAEMOGLOBIN DECREASED,3
FI,HYPOAESTHESIA,3
FI,HYPOGLYCAEMIA,3
FI,LACTIC ACIDOSIS,3
FI,MYOCARDIAL INFARCTION,3
FI,ORAL PAIN,3
FI,OXYGEN SATURATION DECREASED,3
FI,PAIN,3
FI,RHABDOMYOLYSIS,3
FI,WOUND,3
FI,ACUTE KIDNEY INJURY,2
FI,ANAEMIA,2
FI,ANGINA PECTORIS,2
FI,ANGIOPLASTY,2
FI,ASTHENIA,2
FI,BALANCE DISORDER,2
FI,CEREBRAL HAEMORRHAGE,2
FI,CONFUSIONAL STATE,2
FI,COUGH,2
FI,DYSARTHRIA,2
FI,DYSSTASIA,2
FI,HAEMORRHAGIC ANAEMIA,2
FI,HEART RATE ABNORMAL,2
FI,HYPOKALAEMIA,2
FI,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
FI,INFECTION,2
FI,INTERNATIONAL NORMALISED RATIO INCREASED,2
FI,MALAISE,2
FI,MEDICATION ERROR,2
FI,MUSCLE DISORDER,2
FI,MYALGIA,2
FI,MYOCARDIAL ISCHAEMIA,2
FI,OROPHARYNGEAL PAIN,2
FI,RETINAL DETACHMENT,2
FI,SLEEP DISORDER,2
FI,SWELLING FACE,2
FI,SYNCOPE,2
FI,TRANSIENT ISCHAEMIC ATTACK,2
FI,VERTIGO,2
FI,VOMITING,2
FI,ACIDOSIS,1
FI,ACUTE MYOCARDIAL INFARCTION,1
FI,ADVERSE EVENT,1
FI,AGEUSIA,1
FI,ALANINE AMINOTRANSFERASE INCREASED,1
FI,AMENORRHOEA,1
FI,AMNESIA,1
FI,ANAPHYLACTIC REACTION,1
FI,ANOSMIA,1
FI,ANXIETY,1
FI,AORTIC STENOSIS,1
FI,AORTIC VALVE PROLAPSE,1
FI,APHASIA,1
FI,APHONIA,1
FI,ARTHRALGIA,1
FI,ARTHRITIS INFECTIVE,1
FI,ATRIAL FIBRILLATION,1
FI,BEZOAR,1
FI,BLINDNESS CORTICAL,1
FI,BLOOD ALKALINE PHOSPHATASE INCREASED,1
FI,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
FI,BLOOD PRESSURE INCREASED,1
FI,BRADYCARDIA,1
FI,BRONCHOALVEOLAR LAVAGE,1
FI,C-REACTIVE PROTEIN INCREASED,1
FI,CARDIAC TAMPONADE,1
FI,CAROTID ENDARTERECTOMY,1
FI,CEREBRAL ARTERY THROMBOSIS,1
FI,CEREBRAL HYGROMA,1
FI,CEREBRAL ISCHAEMIA,1
FI,CEREBROVASCULAR ACCIDENT,1
FI,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
FI,CONCOMITANT DISEASE AGGRAVATED,1
FI,CONSTIPATION,1
FI,CORONARY ARTERIAL STENT INSERTION,1
FI,CORONARY ARTERY THROMBOSIS,1
FI,DECREASED APPETITE,1
FI,DECREASED IMMUNE RESPONSIVENESS,1
FI,DEEP VEIN THROMBOSIS,1
FI,DEHYDRATION,1
FI,DENTAL RESTORATION FAILURE,1
FI,DEPRESSED LEVEL OF CONSCIOUSNESS,1
FI,DEVICE OCCLUSION,1
FI,DIARRHOEA HAEMORRHAGIC,1
FI,DIPLOPIA,1
FI,DISCOMFORT,1
FI,DISORIENTATION,1
FI,DRUG ERUPTION,1
FI,DRUG SPECIFIC ANTIBODY PRESENT,1
FI,DYSPEPSIA,1
FI,DYSPHONIA,1
FI,ECZEMA,1
FI,EPISTAXIS,1
FI,ERYTHEMA,1
FI,ERYTHEMA NODOSUM,1
FI,EYE PAIN,1
FI,EYE SWELLING,1
FI,EYELID OEDEMA,1
FI,FACE OEDEMA,1
FI,FEELING COLD,1
FI,FEMORAL NECK FRACTURE,1
FI,FOREIGN BODY ASPIRATION,1
FI,FUMBLING,1
FI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FI,GASTRIC DISORDER,1
FI,GASTRIC ULCER HAEMORRHAGE,1
FI,GASTROENTERITIS VIRAL,1
FI,GAZE PALSY,1
FI,GENERAL PHYSICAL HEALTH DETERIORATION,1
FI,GLOSSODYNIA,1
FI,HAEMATOCRIT DECREASED,1
FI,HAEMORRHAGE INTRACRANIAL,1
FI,HAEMOTHORAX,1
FI,HEAD DISCOMFORT,1
FI,HEART RATE IRREGULAR,1
FI,HEMIPLEGIA,1
FI,HYPERKERATOSIS,1
FI,HYPOMENORRHOEA,1
FI,HYPONATRAEMIA,1
FI,HYPOTENSION,1
FI,IMMUNE SYSTEM DISORDER,1
FI,INCOHERENT,1
FI,INCORRECT DRUG ADMINISTRATION DURATION,1
FI,INFLUENZA,1
FI,INJECTION SITE ERYTHEMA,1
FI,INTERNATIONAL NORMALISED RATIO DECREASED,1
FI,INTERSTITIAL LUNG DISEASE,1
FI,JOINT EFFUSION,1
FI,JOINT STIFFNESS,1
FI,JOINT SWELLING,1
FI,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
FI,LARYNGEAL OEDEMA,1
FI,LIGAMENT SPRAIN,1
FI,LOOSE TOOTH,1
FI,LYMPHADENOPATHY MEDIASTINAL,1
FI,MELAENA,1
FI,MIGRAINE,1
FI,MONONEUROPATHY MULTIPLEX,1
FI,MOUTH SWELLING,1
FI,MOVEMENT DISORDER,1
FI,NAUSEA,1
FI,NEOPLASM MALIGNANT,1
FI,NEUROPATHY PERIPHERAL,1
FI,OCULAR HYPERAEMIA,1
FI,OLIGOMENORRHOEA,1
FI,OSTEONECROSIS,1
FI,OSTEONECROSIS OF JAW,1
FI,PAIN IN EXTREMITY,1
FI,PANCYTOPENIA,1
FI,PARAESTHESIA,1
FI,PARKINSONISM,1
FI,PELVIC FRACTURE,1
FI,PLATELET COUNT DECREASED,1
FI,PRURITUS,1
FI,PRURITUS GENERALISED,1
FI,PSORIASIS,1
FI,PULMONARY EMBOLISM,1
FI,PULMONARY HAEMORRHAGE,1
FI,PULMONARY VASCULITIS,1
FI,PURPURA,1
FI,PYREXIA,1
FI,RED BLOOD CELL COUNT DECREASED,1
FI,RENAL FAILURE,1
FI,RENAL IMPAIRMENT,1
FI,RESPIRATORY DISORDER,1
FI,SARCOIDOSIS,1
FI,SKIN DISCOLOURATION,1
FI,SKIN ULCER,1
FI,SPEECH DISORDER,1
FI,SPINAL OSTEOARTHRITIS,1
FI,STAPHYLOCOCCAL SEPSIS,1
FI,TENDON PAIN,1
FI,THERAPEUTIC RESPONSE CHANGED,1
FI,THROMBOCYTOPENIA,1
FI,THROMBOSIS,1
FI,THROMBOTIC STROKE,1
FI,THYROID DISORDER,1
FI,TOOTH LOSS,1
FI,TREMOR,1
FI,TYPE IV HYPERSENSITIVITY REACTION,1
FI,ULCER,1
FI,VISION BLURRED,1
FI,VISUAL IMPAIRMENT,1
FI,WEIGHT DECREASED,1
FI,WHITE BLOOD CELL COUNT INCREASED,1
FR,ANAEMIA,221
FR,ACUTE KIDNEY INJURY,171
FR,FALL,170
FR,THROMBOCYTOPENIA,117
FR,RENAL FAILURE,109
FR,HYPONATRAEMIA,104
FR,CONFUSIONAL STATE,100
FR,MALAISE,98
FR,HYPOTENSION,95
FR,DIARRHOEA,90
FR,ASTHENIA,87
FR,CARDIAC FAILURE,84
FR,PYREXIA,83
FR,MELAENA,78
FR,CHEST PAIN,76
FR,NEUTROPENIA,75
FR,SOMNOLENCE,75
FR,VOMITING,73
FR,EOSINOPHILIA,72
FR,DYSPNOEA,71
FR,HAEMATOMA,70
FR,GENERAL PHYSICAL HEALTH DETERIORATION,66
FR,RENAL FAILURE ACUTE,66
FR,DRUG INEFFECTIVE,65
FR,HYPERKALAEMIA,65
FR,INTERNATIONAL NORMALISED RATIO INCREASED,62
FR,PRURITUS,62
FR,ABDOMINAL PAIN,60
FR,COMA,59
FR,CHOLESTASIS,58
FR,ACUTE CORONARY SYNDROME,56
FR,PANCYTOPENIA,52
FR,WEIGHT DECREASED,52
FR,BRADYCARDIA,51
FR,NAUSEA,51
FR,SUBDURAL HAEMATOMA,51
FR,GASTROINTESTINAL HAEMORRHAGE,49
FR,DEHYDRATION,48
FR,HEADACHE,47
FR,HEPATOCELLULAR INJURY,46
FR,ANGIOEDEMA,45
FR,CONDITION AGGRAVATED,45
FR,DECREASED APPETITE,45
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,44
FR,HYPOKALAEMIA,44
FR,RASH MACULO-PAPULAR,43
FR,DEATH,42
FR,LUNG DISORDER,42
FR,OVERDOSE,42
FR,RECTAL HAEMORRHAGE,42
FR,ATRIAL FIBRILLATION,40
FR,DISORIENTATION,40
FR,LACTIC ACIDOSIS,40
FR,TOXIC SKIN ERUPTION,40
FR,INTERSTITIAL LUNG DISEASE,39
FR,OEDEMA PERIPHERAL,38
FR,RHABDOMYOLYSIS,38
FR,BLOOD CREATININE INCREASED,36
FR,EPISTAXIS,36
FR,RASH,36
FR,AGRANULOCYTOSIS,35
FR,ERYTHEMA,35
FR,GAIT DISTURBANCE,35
FR,MYOCARDIAL INFARCTION,35
FR,PAIN IN EXTREMITY,35
FR,PNEUMONIA,34
FR,CEREBRAL HAEMATOMA,33
FR,HYPERTHERMIA,33
FR,CARDIO-RESPIRATORY ARREST,32
FR,HAEMATURIA,32
FR,LOSS OF CONSCIOUSNESS,32
FR,FATIGUE,31
FR,SYNCOPE,31
FR,TREMOR,31
FR,CEREBROVASCULAR ACCIDENT,30
FR,DIZZINESS,30
FR,HAEMOGLOBIN DECREASED,29
FR,COGNITIVE DISORDER,28
FR,DIABETES MELLITUS,28
FR,HAEMATEMESIS,28
FR,HEAD INJURY,28
FR,HYPOGLYCAEMIA,28
FR,ISCHAEMIC STROKE,28
FR,SEPSIS,28
FR,CARDIOGENIC SHOCK,27
FR,ECZEMA,27
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,27
FR,RESPIRATORY DISTRESS,27
FR,VERTIGO,27
FR,CATARACT,26
FR,DEPRESSION,26
FR,HAEMORRHAGE,26
FR,HYPERTENSION,26
FR,METABOLIC ACIDOSIS,26
FR,ORTHOSTATIC HYPOTENSION,26
FR,PANCREATITIS ACUTE,26
FR,PARAESTHESIA,26
FR,ARTERIOGRAM CORONARY,25
FR,CARDIAC ARREST,25
FR,INFLAMMATION,25
FR,PAIN,25
FR,PULMONARY EMBOLISM,25
FR,SHOCK,25
FR,ACUTE PULMONARY OEDEMA,24
FR,LEUKOPENIA,24
FR,MYALGIA,24
FR,SEPTIC SHOCK,24
FR,ALTERED STATE OF CONSCIOUSNESS,23
FR,ANGINA PECTORIS,23
FR,CHILLS,23
FR,DYSPHAGIA,23
FR,PLEURAL EFFUSION,23
FR,DERMATITIS EXFOLIATIVE,22
FR,SHOCK HAEMORRHAGIC,22
FR,URINARY RETENTION,22
FR,ABNORMAL BEHAVIOUR,21
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,21
FR,SUBARACHNOID HAEMORRHAGE,21
FR,ABDOMINAL PAIN UPPER,20
FR,APHASIA,20
FR,ARTHRALGIA,20
FR,CEREBRAL HAEMORRHAGE,20
FR,COUGH,20
FR,DIABETES MELLITUS INADEQUATE CONTROL,20
FR,PNEUMONIA ASPIRATION,20
FR,TOXICITY TO VARIOUS AGENTS,20
FR,TRANSAMINASES INCREASED,20
FR,URINARY TRACT INFECTION,20
FR,BRONCHITIS,19
FR,CONSTIPATION,19
FR,DRUG RESISTANCE,19
FR,HERNIA,19
FR,HYPERAMMONAEMIA,19
FR,PANCREATITIS,19
FR,TACHYCARDIA,19
FR,AGITATION,18
FR,BACK PAIN,18
FR,LUNG INFECTION,18
FR,PEMPHIGOID,18
FR,RENAL TUBULAR NECROSIS,18
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,17
FR,ACUTE RESPIRATORY FAILURE,17
FR,BALANCE DISORDER,17
FR,DISTURBANCE IN ATTENTION,17
FR,HAEMOPTYSIS,17
FR,HEPATITIS,17
FR,HYPOCALCAEMIA,17
FR,HYPOTHERMIA,17
FR,MUSCULAR WEAKNESS,17
FR,URTICARIA,17
FR,HAEMORRHAGIC ANAEMIA,16
FR,MUSCLE SPASMS,16
FR,NEOPLASM MALIGNANT,16
FR,ARRHYTHMIA,15
FR,C-REACTIVE PROTEIN INCREASED,15
FR,DYSPNOEA EXERTIONAL,15
FR,FEBRILE BONE MARROW APLASIA,15
FR,JAUNDICE,15
FR,LEFT VENTRICULAR FAILURE,15
FR,PULMONARY OEDEMA,15
FR,SEIZURE,15
FR,SINUS BRADYCARDIA,15
FR,TUBULOINTERSTITIAL NEPHRITIS,15
FR,ASPARTATE AMINOTRANSFERASE INCREASED,14
FR,DYSARTHRIA,14
FR,DYSKINESIA,14
FR,DYSPHONIA,14
FR,HALLUCINATION,14
FR,HYPERHIDROSIS,14
FR,INFECTION,14
FR,RENAL IMPAIRMENT,14
FR,RENAL TUBULAR DISORDER,14
FR,SUDDEN DEATH,14
FR,VENTRICULAR FIBRILLATION,14
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,13
FR,ALANINE AMINOTRANSFERASE INCREASED,13
FR,ELECTROCARDIOGRAM QT PROLONGED,13
FR,ENCEPHALOPATHY,13
FR,HOSPITALISATION,13
FR,HYPOMAGNESAEMIA,13
FR,MULTI-ORGAN FAILURE,13
FR,MUSCLE HAEMORRHAGE,13
FR,NEOPLASM,13
FR,OEDEMA,13
FR,PERIPHERAL ISCHAEMIA,13
FR,PULMONARY FIBROSIS,13
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,12
FR,CHEST DISCOMFORT,12
FR,COLITIS,12
FR,GASTROINTESTINAL DISORDER,12
FR,HYPOGLYCAEMIC UNCONSCIOUSNESS,12
FR,LYMPHOPENIA,12
FR,PURPURA,12
FR,RESPIRATORY DISORDER,12
FR,WEIGHT INCREASED,12
FR,ARTERIOSCLEROSIS,11
FR,CELL DEATH,11
FR,CEREBELLAR SYNDROME,11
FR,CEREBRAL INFARCTION,11
FR,CIRCULATORY COLLAPSE,11
FR,CORONARY ARTERY DISEASE,11
FR,DIFFUSE LARGE B-CELL LYMPHOMA,11
FR,HAEMODYNAMIC INSTABILITY,11
FR,HEMIPLEGIA,11
FR,HYPOVOLAEMIC SHOCK,11
FR,INGUINAL HERNIA,11
FR,INSOMNIA,11
FR,LIPASE INCREASED,11
FR,MEMORY IMPAIRMENT,11
FR,NEPHROTIC SYNDROME,11
FR,PRESYNCOPE,11
FR,RASH ERYTHEMATOUS,11
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,11
FR,ABDOMINAL WALL HAEMATOMA,10
FR,ADVERSE EVENT,10
FR,BURNING SENSATION,10
FR,DEEP VEIN THROMBOSIS,10
FR,EPILEPSY,10
FR,HEMIPARESIS,10
FR,HYPOGAMMAGLOBULINAEMIA,10
FR,HYPOXIA,10
FR,MOTOR DYSFUNCTION,10
FR,MYOCLONUS,10
FR,OXYGEN SATURATION DECREASED,10
FR,PYELONEPHRITIS,10
FR,SCIATICA,10
FR,THROMBOSIS,10
FR,ADENOCARCINOMA OF COLON,9
FR,ANAPHYLACTIC SHOCK,9
FR,ANXIETY,9
FR,BLISTER,9
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,9
FR,BLOOD PRESSURE DECREASED,9
FR,BONE PAIN,9
FR,COMA SCALE ABNORMAL,9
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,9
FR,DYSPNOEA AT REST,9
FR,ECCHYMOSIS,9
FR,FRACTURE,9
FR,HAEMARTHROSIS,9
FR,HAEMORRHAGIC STROKE,9
FR,HEPATIC FAILURE,9
FR,HEPATITIS FULMINANT,9
FR,HOT FLUSH,9
FR,HYPERSENSITIVITY,9
FR,LEUKOCYTOSIS,9
FR,MALIGNANT NEOPLASM PROGRESSION,9
FR,NORMOCHROMIC NORMOCYTIC ANAEMIA,9
FR,OESOPHAGITIS,9
FR,PULMONARY ARTERIAL HYPERTENSION,9
FR,RENAL FAILURE CHRONIC,9
FR,SKIN ULCER,9
FR,VASCULAR STENT THROMBOSIS,9
FR,ACIDOSIS,8
FR,ATRIOVENTRICULAR BLOCK,8
FR,BRONCHOSPASM,8
FR,CONVULSION,8
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,8
FR,DROP ATTACKS,8
FR,DRUG LEVEL INCREASED,8
FR,DRUG-INDUCED LIVER INJURY,8
FR,FACE OEDEMA,8
FR,GASTRIC ULCER,8
FR,HYPERTENSIVE CRISIS,8
FR,HYPERTHYROIDISM,8
FR,HYPOGLYCAEMIC COMA,8
FR,IMMUNE THROMBOCYTOPENIC PURPURA,8
FR,INCORRECT DOSE ADMINISTERED,8
FR,IRON DEFICIENCY ANAEMIA,8
FR,MALNUTRITION,8
FR,PARTIAL SEIZURES,8
FR,PERICARDITIS,8
FR,PERIORBITAL HAEMATOMA,8
FR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,8
FR,PLEURISY,8
FR,POLYNEUROPATHY,8
FR,POST PROCEDURAL HAEMORRHAGE,8
FR,PULMONARY VENO-OCCLUSIVE DISEASE,8
FR,RASH GENERALISED,8
FR,RESPIRATORY FAILURE,8
FR,RETROPERITONEAL HAEMATOMA,8
FR,SKIN NECROSIS,8
FR,SLEEP APNOEA SYNDROME,8
FR,STAPHYLOCOCCAL INFECTION,8
FR,STATUS EPILEPTICUS,8
FR,VASCULAR PURPURA,8
FR,VISION BLURRED,8
FR,ABDOMINAL DISTENSION,7
FR,BLADDER CANCER,7
FR,BLOOD BILIRUBIN INCREASED,7
FR,BONE MARROW FAILURE,7
FR,BUNDLE BRANCH BLOCK LEFT,7
FR,CARDIAC TAMPONADE,7
FR,CELLULITIS,7
FR,CHOLANGITIS,7
FR,CHRONIC KIDNEY DISEASE,7
FR,COLITIS ISCHAEMIC,7
FR,CONTRAINDICATED PRODUCT ADMINISTERED,7
FR,DERMATITIS BULLOUS,7
FR,DERMATITIS PSORIASIFORM,7
FR,DIPLOPIA,7
FR,EJECTION FRACTION DECREASED,7
FR,ERYSIPELAS,7
FR,FEBRILE NEUTROPENIA,7
FR,HALLUCINATION_ VISUAL,7
FR,HEPATITIS CHOLESTATIC,7
FR,HYPERGLYCAEMIA,7
FR,HYPOPROTHROMBINAEMIA,7
FR,INFLUENZA,7
FR,ISCHAEMIA,7
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,7
FR,OESOPHAGITIS ULCERATIVE,7
FR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,7
FR,PALPITATIONS,7
FR,PERIPHERAL ARTERY STENOSIS,7
FR,PLATELET COUNT DECREASED,7
FR,PRODUCT USE ISSUE,7
FR,PRURITUS GENERALISED,7
FR,PSORIASIS,7
FR,PSYCHOMOTOR SKILLS IMPAIRED,7
FR,PULMONARY ALVEOLAR HAEMORRHAGE,7
FR,RASH MORBILLIFORM,7
FR,SECOND PRIMARY MALIGNANCY,7
FR,SKIN EXFOLIATION,7
FR,STENT PLACEMENT,7
FR,STEVENS-JOHNSON SYNDROME,7
FR,TONIC CLONIC MOVEMENTS,7
FR,TRANSIENT ISCHAEMIC ATTACK,7
FR,VASCULAR PSEUDOANEURYSM,7
FR,VITREOUS HAEMORRHAGE,7
FR,ACCIDENTAL OVERDOSE,6
FR,ANURIA,6
FR,ARTERITIS,6
FR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,6
FR,BLOOD CULTURE POSITIVE,6
FR,CARDIAC DISORDER,6
FR,CARDIAC FAILURE ACUTE,6
FR,COAGULATION FACTOR V LEVEL DECREASED,6
FR,CORONARY ARTERY STENOSIS,6
FR,CORONARY ARTERY THROMBOSIS,6
FR,CRANIOCEREBRAL INJURY,6
FR,CYANOSIS,6
FR,DELIRIUM,6
FR,DIABETIC KETOACIDOSIS,6
FR,DRY MOUTH,6
FR,DRY SKIN,6
FR,DUODENAL ULCER,6
FR,EXTRADURAL HAEMATOMA,6
FR,EXTREMITY NECROSIS,6
FR,FACIAL PARALYSIS,6
FR,GASTROENTERITIS,6
FR,GENE MUTATION,6
FR,GENERALISED OEDEMA,6
FR,HERNIAL EVENTRATION,6
FR,HYPERLACTACIDAEMIA,6
FR,HYPERSENSITIVITY VASCULITIS,6
FR,HYPOAESTHESIA,6
FR,ILEUS PARALYTIC,6
FR,INTENTIONAL OVERDOSE,6
FR,INTERMITTENT CLAUDICATION,6
FR,INTRA-ABDOMINAL HAEMORRHAGE,6
FR,MITRAL VALVE INCOMPETENCE,6
FR,MUSCULOSKELETAL PAIN,6
FR,MYOCARDIAL ISCHAEMIA,6
FR,OSTEONECROSIS,6
FR,PETECHIAE,6
FR,PHOTOSENSITIVITY REACTION,6
FR,PROTEINURIA,6
FR,RALES,6
FR,SINUS ARRHYTHMIA,6
FR,SUICIDE ATTEMPT,6
FR,TACHYPNOEA,6
FR,TENDON RUPTURE,6
FR,THROMBOSIS IN DEVICE,6
FR,TINNITUS,6
FR,VENTRICULAR EXTRASYSTOLES,6
FR,WHITE BLOOD CELL COUNT INCREASED,6
FR,WOUND,6
FR,ABSCESS,5
FR,ACUTE PRERENAL FAILURE,5
FR,AGGRESSION,5
FR,ANAEMIA MACROCYTIC,5
FR,AORTIC VALVE STENOSIS,5
FR,ATRIAL THROMBOSIS,5
FR,BACTERAEMIA,5
FR,BICYTOPENIA,5
FR,BLOOD PRESSURE INCREASED,5
FR,BUNDLE BRANCH BLOCK RIGHT,5
FR,CACHEXIA,5
FR,CLONUS,5
FR,COLITIS MICROSCOPIC,5
FR,COLITIS ULCERATIVE,5
FR,COLONOSCOPY,5
FR,DERMATOMYOSITIS,5
FR,DIABETIC METABOLIC DECOMPENSATION,5
FR,DISEASE PROGRESSION,5
FR,DRUG ERUPTION,5
FR,DRUG PRESCRIBING ERROR,5
FR,ENTERITIS,5
FR,EOSINOPHIL COUNT INCREASED,5
FR,EXTRAPYRAMIDAL DISORDER,5
FR,FEMUR FRACTURE,5
FR,GASTRITIS,5
FR,GASTROINTESTINAL STOMA COMPLICATION,5
FR,GASTROOESOPHAGEAL REFLUX DISEASE,5
FR,GENERALISED TONIC-CLONIC SEIZURE,5
FR,GOUT,5
FR,HAEMOLYTIC ANAEMIA,5
FR,HEPATIC STEATOSIS,5
FR,HEPATITIS ACUTE,5
FR,HEPATOCELLULAR CARCINOMA,5
FR,HYPOTONIA,5
FR,INTERVERTEBRAL DISC PROTRUSION,5
FR,IRRITABILITY,5
FR,JAUNDICE CHOLESTATIC,5
FR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,5
FR,MEDICATION ERROR,5
FR,MENINGORRHAGIA,5
FR,MICROCYTIC ANAEMIA,5
FR,MUCOSAL INFLAMMATION,5
FR,MYELODYSPLASTIC SYNDROME,5
FR,NERVOUS SYSTEM DISORDER,5
FR,NEUROPATHY PERIPHERAL,5
FR,OSTEOPOROSIS,5
FR,PACKED RED BLOOD CELL TRANSFUSION,5
FR,PANCREATITIS NECROTISING,5
FR,PERICARDIAL EFFUSION,5
FR,PERITONEAL DIALYSIS COMPLICATION,5
FR,PHLEBITIS,5
FR,PLASMA CELL MYELOMA,5
FR,PROTHROMBIN TIME SHORTENED,5
FR,PULMONARY MASS,5
FR,PYELONEPHRITIS ACUTE,5
FR,RASH PAPULAR,5
FR,SALIVARY HYPERSECRETION,5
FR,SKIN LESION,5
FR,SQUAMOUS CELL CARCINOMA,5
FR,SUBDURAL HAEMORRHAGE,5
FR,THERAPY CESSATION,5
FR,THROMBOCYTOSIS,5
FR,TONGUE OEDEMA,5
FR,TRANSFUSION,5
FR,VISUAL ACUITY REDUCED,5
FR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
FR,AGEUSIA,4
FR,ANGINA UNSTABLE,4
FR,ANKLE FRACTURE,4
FR,APLASIA,4
FR,ASPHYXIA,4
FR,BLOOD LACTIC ACID INCREASED,4
FR,CARDIAC FAILURE CHRONIC,4
FR,CARDIO-RESPIRATORY DISTRESS,4
FR,CARDIOPULMONARY FAILURE,4
FR,CHOLELITHIASIS,4
FR,CHOLESTATIC LIVER INJURY,4
FR,CLOSTRIDIUM DIFFICILE COLITIS,4
FR,CORONARY ARTERY RESTENOSIS,4
FR,DERMO-HYPODERMITIS,4
FR,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,4
FR,DISSEMINATED INTRAVASCULAR COAGULATION,4
FR,DIVERTICULUM,4
FR,DYSGEUSIA,4
FR,ERYTHEMA MULTIFORME,4
FR,ERYTHRODERMIC PSORIASIS,4
FR,EXFOLIATIVE RASH,4
FR,FAECES DISCOLOURED,4
FR,FEELING DRUNK,4
FR,FEELING HOT,4
FR,FLUID RETENTION,4
FR,FLUSHING,4
FR,GASTRIC HAEMORRHAGE,4
FR,GASTRIC ULCER HAEMORRHAGE,4
FR,GINGIVAL BLEEDING,4
FR,GLYCOSYLATED HAEMOGLOBIN INCREASED,4
FR,HAEMATOCHEZIA,4
FR,HAEMOLYSIS,4
FR,HEPATIC CIRRHOSIS,4
FR,HIATUS HERNIA,4
FR,HYPERCALCAEMIA,4
FR,INCORRECT DRUG ADMINISTRATION DURATION,4
FR,INTESTINAL ISCHAEMIA,4
FR,INTESTINAL OBSTRUCTION,4
FR,ISCHAEMIC CARDIOMYOPATHY,4
FR,JOINT DISLOCATION,4
FR,LICHENOID KERATOSIS,4
FR,LIVER DISORDER,4
FR,LIVER INJURY,4
FR,LOCALISED OEDEMA,4
FR,LUMBAR SPINAL STENOSIS,4
FR,MACROGLOSSIA,4
FR,MENTAL DISORDER,4
FR,MIOSIS,4
FR,MOBILITY DECREASED,4
FR,MOUTH ULCERATION,4
FR,MYOCARDITIS,4
FR,NEPHROPATHY,4
FR,NEURALGIA,4
FR,NEUROMYELITIS OPTICA,4
FR,ORAL CANDIDIASIS,4
FR,OSTEONECROSIS OF JAW,4
FR,PERICARDIAL HAEMORRHAGE,4
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
FR,PRODUCT USE IN UNAPPROVED INDICATION,4
FR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,4
FR,PROSTATIC SPECIFIC ANTIGEN INCREASED,4
FR,PULMONARY TUBERCULOSIS,4
FR,RASH PRURITIC,4
FR,RASH PUSTULAR,4
FR,RENAL DISORDER,4
FR,RESPIRATORY ARREST,4
FR,RETINAL HAEMORRHAGE,4
FR,SINOATRIAL BLOCK,4
FR,SKIN DISORDER,4
FR,SKIN HAEMORRHAGE,4
FR,SLEEP DISORDER,4
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,4
FR,TENDONITIS,4
FR,TENSION,4
FR,THROMBECTOMY,4
FR,TOOTH ABSCESS,4
FR,TORSADE DE POINTES,4
FR,UROSEPSIS,4
FR,VASCULITIS,4
FR,VENTRICULAR TACHYCARDIA,4
FR,VITAMIN B12 DEFICIENCY,4
FR,WHEEZING,4
FR,ACUTE HEPATIC FAILURE,3
FR,ADENOCARCINOMA PANCREAS,3
FR,ADRENAL INSUFFICIENCY,3
FR,ADRENAL MASS,3
FR,AMNESIA,3
FR,ANAPHYLACTIC REACTION,3
FR,ANGIODYSPLASIA,3
FR,APNOEA,3
FR,APPENDICITIS,3
FR,ARTERIAL DISORDER,3
FR,ASCITES,3
FR,ASPIRATION,3
FR,ATAXIA,3
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,3
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,3
FR,BLOOD URINE PRESENT,3
FR,BRADYPNOEA,3
FR,BRAIN HERNIATION,3
FR,BRONCHIAL CARCINOMA,3
FR,BRONCHOPNEUMONIA,3
FR,CANDIDA INFECTION,3
FR,CARDIOMEGALY,3
FR,CAROTID ARTERY STENOSIS,3
FR,CAROTID ARTERY THROMBOSIS,3
FR,CEREBRAL ATROPHY,3
FR,CEREBRAL ISCHAEMIA,3
FR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
FR,COLORECTAL ADENOCARCINOMA,3
FR,CONTUSION,3
FR,CORONARY ARTERY OCCLUSION,3
FR,CUTANEOUS VASCULITIS,3
FR,CYTOMEGALOVIRUS INFECTION,3
FR,DELUSION,3
FR,DERMATITIS,3
FR,DIALYSIS,3
FR,DRUG ADMINISTRATION ERROR,3
FR,DRUG DOSE OMISSION,3
FR,DYSSTASIA,3
FR,DYSURIA,3
FR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
FR,EMPHYSEMA,3
FR,EXTRA DOSE ADMINISTERED,3
FR,EYELID OEDEMA,3
FR,FACIAL BONES FRACTURE,3
FR,FASCIITIS,3
FR,FOOT FRACTURE,3
FR,FUNGAL INFECTION,3
FR,GASTROINTESTINAL ANGIODYSPLASIA,3
FR,GASTROINTESTINAL PAIN,3
FR,GENERAL PHYSICAL CONDITION ABNORMAL,3
FR,GUILLAIN-BARRE SYNDROME,3
FR,HAEMORRHAGE INTRACRANIAL,3
FR,HAEMOTHORAX,3
FR,HEART RATE INCREASED,3
FR,HEPARIN-INDUCED THROMBOCYTOPENIA,3
FR,HEPATIC ENCEPHALOPATHY,3
FR,HIGH DENSITY LIPOPROTEIN DECREASED,3
FR,HYPERCHOLESTEROLAEMIA,3
FR,HYPERTONIA,3
FR,HYPERTRIGLYCERIDAEMIA,3
FR,HYPOALBUMINAEMIA,3
FR,HYPOTHYROIDISM,3
FR,HYPOVENTILATION,3
FR,IMPAIRED HEALING,3
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
FR,INFARCTION,3
FR,INFUSION RELATED REACTION,3
FR,INTRA-ABDOMINAL HAEMATOMA,3
FR,INTRACRANIAL HAEMATOMA,3
FR,IRON DEFICIENCY,3
FR,LACRIMATION INCREASED,3
FR,LARGE INTESTINE PERFORATION,3
FR,LARYNGEAL HAEMATOMA,3
FR,LARYNGOSPASM,3
FR,LEFT VENTRICULAR DYSFUNCTION,3
FR,LEUKOCYTOCLASTIC VASCULITIS,3
FR,LEUKOENCEPHALOPATHY,3
FR,LIP OEDEMA,3
FR,MALIGNANT MELANOMA,3
FR,MOVEMENT DISORDER,3
FR,MUSCLE ATROPHY,3
FR,MUSCLE RIGIDITY,3
FR,NECROSIS,3
FR,NEUTROPHIL COUNT DECREASED,3
FR,NIGHTMARE,3
FR,OPTIC ISCHAEMIC NEUROPATHY,3
FR,ORAL FUNGAL INFECTION,3
FR,ORAL PAIN,3
FR,OSTEOARTHRITIS,3
FR,PALLOR,3
FR,PERIPHERAL ARTERY THROMBOSIS,3
FR,PERITONITIS,3
FR,PHARYNGITIS,3
FR,PHOTOPHOBIA,3
FR,PNEUMOPERITONEUM,3
FR,PNEUMOTHORAX,3
FR,POLYURIA,3
FR,PRESCRIBED UNDERDOSE,3
FR,PRODUCT QUALITY ISSUE,3
FR,PRODUCT SUBSTITUTION ISSUE,3
FR,PRODUCTIVE COUGH,3
FR,PROSTATITIS,3
FR,PULMONARY HYPERTENSION,3
FR,QUADRIPARESIS,3
FR,RECTOSIGMOID CANCER,3
FR,RENAL ARTERY STENOSIS,3
FR,RENAL CANCER,3
FR,RENAL COLIC,3
FR,RHEUMATOID ARTHRITIS,3
FR,RHINORRHOEA,3
FR,RIB FRACTURE,3
FR,SINUS TACHYCARDIA,3
FR,SKIN DISCOLOURATION,3
FR,SPEECH DISORDER,3
FR,SPINAL COMPRESSION FRACTURE,3
FR,SPLENOMEGALY,3
FR,STAPHYLOCOCCAL SEPSIS,3
FR,STOMATITIS,3
FR,SUBCUTANEOUS HAEMATOMA,3
FR,SUICIDAL IDEATION,3
FR,SURGERY,3
FR,TETANY,3
FR,THROMBOCYTOPENIC PURPURA,3
FR,THROMBOTIC THROMBOCYTOPENIC PURPURA,3
FR,TONGUE DISCOLOURATION,3
FR,TONIC CONVULSION,3
FR,TRANSITIONAL CELL CARCINOMA,3
FR,TRAUMATIC HAEMATOMA,3
FR,TREATMENT FAILURE,3
FR,TROPONIN INCREASED,3
FR,TUMOUR LYSIS SYNDROME,3
FR,TYPE 1 DIABETES MELLITUS,3
FR,TYPE 2 DIABETES MELLITUS,3
FR,ULCER,3
FR,UPPER GASTROINTESTINAL HAEMORRHAGE,3
FR,URINARY BLADDER POLYP,3
FR,VENOUS THROMBOSIS,3
FR,VESSEL PUNCTURE SITE HAEMATOMA,3
FR,WHITE BLOOD CELL COUNT DECREASED,3
FR,WOUND HAEMORRHAGE,3
FR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
FR,ABSCESS LIMB,2
FR,ACCIDENT AT WORK,2
FR,ACTINIC KERATOSIS,2
FR,ACTION TREMOR,2
FR,ACUTE ABDOMEN,2
FR,ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,2
FR,ADENOCARCINOMA GASTRIC,2
FR,ADENOMA BENIGN,2
FR,AGE-RELATED MACULAR DEGENERATION,2
FR,ALCOHOL POISONING,2
FR,ANGLE CLOSURE GLAUCOMA,2
FR,ANTICHOLINERGIC SYNDROME,2
FR,AORTIC ANEURYSM,2
FR,AORTIC VALVE INCOMPETENCE,2
FR,APHTHOUS STOMATITIS,2
FR,APHTHOUS ULCER,2
FR,APPARENT DEATH,2
FR,APRAXIA,2
FR,ARRHYTHMIA SUPRAVENTRICULAR,2
FR,ARTERIAL OCCLUSIVE DISEASE,2
FR,ARTERIAL STENOSIS,2
FR,ARTHRITIS,2
FR,ASPERGILLUS INFECTION,2
FR,ASTHMA,2
FR,ATELECTASIS,2
FR,ATRIAL FLUTTER,2
FR,ATRIOVENTRICULAR BLOCK COMPLETE,2
FR,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
FR,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,2
FR,AZOTAEMIA,2
FR,BACILLUS TEST POSITIVE,2
FR,BILIRUBIN CONJUGATED INCREASED,2
FR,BIOPSY,2
FR,BLINDNESS,2
FR,BLINDNESS UNILATERAL,2
FR,BLOOD BICARBONATE DECREASED,2
FR,BLOOD CREATINE INCREASED,2
FR,BLOOD GLUCOSE INCREASED,2
FR,BLOOD IMMUNOGLOBULIN E INCREASED,2
FR,BLOOD PH DECREASED,2
FR,BLOOD PHOSPHORUS DECREASED,2
FR,BLOOD PHOSPHORUS INCREASED,2
FR,BLOOD POTASSIUM INCREASED,2
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,2
FR,BLOOD UREA INCREASED,2
FR,BODY TEMPERATURE DECREASED,2
FR,BONE LESION,2
FR,BOWEN^S DISEASE,2
FR,BRADYARRHYTHMIA,2
FR,BRAIN DEATH,2
FR,BRAIN MASS,2
FR,BRAIN OEDEMA,2
FR,BRAIN STEM HAEMATOMA,2
FR,BREATH SOUNDS ABNORMAL,2
FR,BRONCHIAL DISORDER,2
FR,BRONCHIAL HAEMORRHAGE,2
FR,BRONCHIECTASIS,2
FR,BRONCHOPNEUMOPATHY,2
FR,CARDIAC FAILURE CONGESTIVE,2
FR,CARDIAC FIBRILLATION,2
FR,CARDIOVASCULAR DISORDER,2
FR,CAROTID ARTERY ANEURYSM,2
FR,CENTRAL NERVOUS SYSTEM LESION,2
FR,CEREBELLAR ATAXIA,2
FR,CEREBRAL VASOCONSTRICTION,2
FR,CHEILITIS,2
FR,CHEST WALL HAEMATOMA,2
FR,CHOLECYSTITIS ACUTE,2
FR,CHROMATURIA,2
FR,COELIAC ARTERY STENOSIS,2
FR,COLECTOMY,2
FR,COLON NEOPLASM,2
FR,CONDUCTION DISORDER,2
FR,CONGESTIVE CARDIOMYOPATHY,2
FR,CONTRAINDICATED DRUG ADMINISTERED,2
FR,CORONARY ANGIOPLASTY,2
FR,CREATININE RENAL CLEARANCE DECREASED,2
FR,CULTURE URINE POSITIVE,2
FR,CUSHING^S SYNDROME,2
FR,DECUBITUS ULCER,2
FR,DELIRIUM TREMENS,2
FR,DEMENTIA,2
FR,DERMATITIS ATOPIC,2
FR,DEVICE MALFUNCTION,2
FR,DEVICE OCCLUSION,2
FR,DEVICE RELATED INFECTION,2
FR,DIARRHOEA HAEMORRHAGIC,2
FR,DIFFUSE ALOPECIA,2
FR,DILATATION ATRIAL,2
FR,DISCOMFORT,2
FR,DISEASE COMPLICATION,2
FR,DIVERTICULITIS,2
FR,DIVERTICULUM INTESTINAL,2
FR,DRUG EFFECT DECREASED,2
FR,DRUG HYPERSENSITIVITY,2
FR,DRUG LEVEL ABOVE THERAPEUTIC,2
FR,DYSAESTHESIA,2
FR,DYSENTERY,2
FR,DYSGRAPHIA,2
FR,DYSHIDROTIC ECZEMA,2
FR,ELECTROCARDIOGRAM T WAVE INVERSION,2
FR,EMBOLIC STROKE,2
FR,EMOTIONAL DISORDER,2
FR,ENDOCARDITIS,2
FR,ENTEROCOCCAL INFECTION,2
FR,EPSTEIN-BARR VIRUS TEST POSITIVE,2
FR,ESCHERICHIA SEPSIS,2
FR,ESCHERICHIA URINARY TRACT INFECTION,2
FR,EXCORIATION,2
FR,EXTENSOR PLANTAR RESPONSE,2
FR,EYE DISORDER,2
FR,EYE HAEMORRHAGE,2
FR,EYE PRURITUS,2
FR,FACE INJURY,2
FR,FACTOR V INHIBITION,2
FR,FISTULA,2
FR,FOETAL EXPOSURE DURING PREGNANCY,2
FR,FOETAL GROWTH RESTRICTION,2
FR,GASTRITIS ATROPHIC,2
FR,GASTROINTESTINAL INFECTION,2
FR,GASTROINTESTINAL MOTILITY DISORDER,2
FR,GASTROINTESTINAL NECROSIS,2
FR,GENERALISED ERYTHEMA,2
FR,GINGIVAL PAIN,2
FR,GINGIVAL ULCERATION,2
FR,GLOMERULAR FILTRATION RATE DECREASED,2
FR,GLOSSODYNIA,2
FR,HAEMORRHAGIC DIATHESIS,2
FR,HAEMORRHOIDS,2
FR,HAEMOSIDEROSIS,2
FR,HEAD DISCOMFORT,2
FR,HEART RATE DECREASED,2
FR,HEMIANOPIA,2
FR,HEPATIC FIBROSIS,2
FR,HEPATIC FUNCTION ABNORMAL,2
FR,HEPATOMEGALY,2
FR,HISTIOCYTOSIS HAEMATOPHAGIC,2
FR,HYPERBILIRUBINAEMIA,2
FR,HYPERCAPNIA,2
FR,HYPERCREATININAEMIA,2
FR,HYPERLIPIDAEMIA,2
FR,HYPOCHLORAEMIA,2
FR,HYPOCHOLESTEROLAEMIA,2
FR,HYPOGLYCAEMIC SEIZURE,2
FR,HYPOPHOSPHATAEMIA,2
FR,HYPOPROTEINAEMIA,2
FR,HYPOTHROMBINAEMIA,2
FR,IMMUNE SYSTEM DISORDER,2
FR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
FR,INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS,2
FR,INTESTINAL HAEMATOMA,2
FR,INTESTINAL INFARCTION,2
FR,INTRAVENTRICULAR HAEMORRHAGE,2
FR,KETOSIS,2
FR,KIDNEY INFECTION,2
FR,KLEBSIELLA INFECTION,2
FR,LIBIDO DECREASED,2
FR,LICHEN PLANUS,2
FR,LIMB DISCOMFORT,2
FR,LIMB INJURY,2
FR,LIP SWELLING,2
FR,LOBAR PNEUMONIA,2
FR,LOW DENSITY LIPOPROTEIN INCREASED,2
FR,LUNG NEOPLASM MALIGNANT,2
FR,LYMPHANGIOSIS CARCINOMATOSA,2
FR,LYMPHOCYTOSIS,2
FR,MACULAR OEDEMA,2
FR,MACULOPATHY,2
FR,MAJOR DEPRESSION,2
FR,MALABSORPTION,2
FR,MANUFACTURING MATERIALS ISSUE,2
FR,MEDICAL DEVICE COMPLICATION,2
FR,MENINGIOMA,2
FR,MESENTERIC ARTERIAL OCCLUSION,2
FR,MESENTERIC ARTERY THROMBOSIS,2
FR,METASTASES TO BONE,2
FR,METASTASES TO LIVER,2
FR,METASTASES TO LUNG,2
FR,MICROCEPHALY,2
FR,MICTURITION DISORDER,2
FR,MIXED LIVER INJURY,2
FR,MOOD SWINGS,2
FR,MOUTH HAEMORRHAGE,2
FR,MUCOUS STOOLS,2
FR,MUSCLE CONTRACTIONS INVOLUNTARY,2
FR,MUSCLE SPASTICITY,2
FR,MUSCULOSKELETAL STIFFNESS,2
FR,MYDRIASIS,2
FR,MYOCARDIAL NECROSIS,2
FR,MYOSITIS,2
FR,NEURITIS,2
FR,NEUROLEPTIC MALIGNANT SYNDROME,2
FR,NEUROLOGICAL DECOMPENSATION,2
FR,NEUTROPHIL COUNT INCREASED,2
FR,NEUTROPHILIA,2
FR,NIGHT SWEATS,2
FR,NOCARDIOSIS,2
FR,ODYNOPHAGIA,2
FR,OESOPHAGEAL ADENOCARCINOMA,2
FR,OESOPHAGEAL CARCINOMA,2
FR,OESOPHAGEAL ULCER HAEMORRHAGE,2
FR,OESOPHAGEAL VARICES HAEMORRHAGE,2
FR,OLIGOHYDRAMNIOS,2
FR,OLIGURIA,2
FR,OPTIC NEUROPATHY,2
FR,OROPHARYNGEAL PAIN,2
FR,PANCREATIC ATROPHY,2
FR,PANCREATIC CYST,2
FR,PANCREATIC FAILURE,2
FR,PANCREATIC NEOPLASM,2
FR,PAPILLARY RENAL CELL CARCINOMA,2
FR,PARALYSIS,2
FR,PARKINSONISM,2
FR,PELVIC FRACTURE,2
FR,PEPTIC ULCER HAEMORRHAGE,2
FR,PERIARTHRITIS,2
FR,PERIPHERAL COLDNESS,2
FR,PERIPHERAL SENSORY NEUROPATHY,2
FR,PERIPHERAL VASCULAR DISORDER,2
FR,PERITONEAL HAEMORRHAGE,2
FR,PERSECUTORY DELUSION,2
FR,PLATELET COUNT INCREASED,2
FR,PLATELET TRANSFUSION,2
FR,PNEUMOBILIA,2
FR,PNEUMONIA BACTERIAL,2
FR,PNEUMONITIS,2
FR,POLLAKIURIA,2
FR,POST PROCEDURAL HAEMATOMA,2
FR,POTENTIATING DRUG INTERACTION,2
FR,PREMATURE RUPTURE OF MEMBRANES,2
FR,PROSTATE CANCER RECURRENT,2
FR,PROSTATIC ADENOMA,2
FR,PROTHROMBIN TIME RATIO DECREASED,2
FR,PRURIGO,2
FR,PSEUDOMONAL SEPSIS,2
FR,PULMONARY VENOUS THROMBOSIS,2
FR,PULSELESS ELECTRICAL ACTIVITY,2
FR,PUPILS UNEQUAL,2
FR,RASH MACULAR,2
FR,RAYNAUD^S PHENOMENON,2
FR,RECALL PHENOMENON,2
FR,RENAL NEOPLASM,2
FR,RENAL VEIN THROMBOSIS,2
FR,RESPIRATORY ACIDOSIS,2
FR,RESPIRATORY TRACT HAEMORRHAGE,2
FR,RETINAL ARTERY OCCLUSION,2
FR,RETINAL DETACHMENT,2
FR,RETINAL VEIN OCCLUSION,2
FR,RETINOPATHY,2
FR,RHEUMATIC DISORDER,2
FR,RHONCHI,2
FR,ROAD TRAFFIC ACCIDENT,2
FR,SEDATION,2
FR,SKIN FISSURES,2
FR,SKIN INFECTION,2
FR,SKIN OEDEMA,2
FR,SKULL FRACTURED BASE,2
FR,SOMNAMBULISM,2
FR,SPUTUM PURULENT,2
FR,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,2
FR,STREPTOCOCCAL BACTERAEMIA,2
FR,STRESS,2
FR,SUBARACHNOID HAEMATOMA,2
FR,SUBILEUS,2
FR,SYSTOLIC DYSFUNCTION,2
FR,TELANGIECTASIA,2
FR,THIRST,2
FR,THORACIC VERTEBRAL FRACTURE,2
FR,THROAT IRRITATION,2
FR,THROMBOTIC MICROANGIOPATHY,2
FR,TONGUE BITING,2
FR,TOOTH FRACTURE,2
FR,TOXIC EPIDERMAL NECROLYSIS,2
FR,TRACHEITIS,2
FR,TRANSIENT GLOBAL AMNESIA,2
FR,TRICUSPID VALVE INCOMPETENCE,2
FR,ULCERATIVE KERATITIS,2
FR,UPPER AIRWAY OBSTRUCTION,2
FR,URINARY INCONTINENCE,2
FR,URINARY TRACT INFECTION BACTERIAL,2
FR,URINE ABNORMALITY,2
FR,VASCULAR OCCLUSION,2
FR,VASCULITIS NECROTISING,2
FR,VASOPLEGIA SYNDROME,2
FR,VIITH NERVE PARALYSIS,2
FR,VISUAL IMPAIRMENT,2
FR,WITHDRAWAL SYNDROME,2
FR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
FR,ABDOMINAL BRUIT,1
FR,ABDOMINAL DISCOMFORT,1
FR,ABDOMINAL RIGIDITY,1
FR,ABDOMINAL SEPSIS,1
FR,ABNORMAL DREAMS,1
FR,ABNORMAL SENSATION IN EYE,1
FR,ABORTION INDUCED,1
FR,ABSCESS INTESTINAL,1
FR,ACCIDENTAL EXPOSURE TO PRODUCT,1
FR,ACETONAEMIA,1
FR,ACNE,1
FR,ACQUIRED HAEMOPHILIA,1
FR,ACTIVATED PARTIAL THROMBOPLASTIN TIME,1
FR,ACUTE LEUKAEMIA,1
FR,ACUTE MYELOID LEUKAEMIA,1
FR,ACUTE MYOCARDIAL INFARCTION,1
FR,ADENOCARCINOMA,1
FR,ADMINISTRATION SITE EROSION,1
FR,ADMINISTRATION SITE ERYTHEMA,1
FR,ADVERSE DRUG REACTION,1
FR,AEROMONAS INFECTION,1
FR,AKATHISIA,1
FR,AKINESIA,1
FR,ALANINE AMINOTRANSFERASE ABNORMAL,1
FR,ALCOHOL WITHDRAWAL SYNDROME,1
FR,ALCOHOLISM,1
FR,ALKALOSIS,1
FR,ALLERGIC GRANULOMATOUS ANGIITIS,1
FR,ALOPECIA,1
FR,ALVEOLITIS,1
FR,ALVEOLITIS ALLERGIC,1
FR,AMAUROSIS,1
FR,AMMONIA INCREASED,1
FR,AMYLOIDOSIS,1
FR,AMYOTROPHY,1
FR,ANAEMIA POSTOPERATIVE,1
FR,ANAL CANCER RECURRENT,1
FR,ANAL CANDIDIASIS,1
FR,ANAL INFECTION,1
FR,ANAPHYLACTOID REACTION,1
FR,ANEURYSM,1
FR,ANGER,1
GE,DEATH,10
DE,DYSPNOEA,76
DE,FALL,70
DE,GASTROINTESTINAL HAEMORRHAGE,61
DE,MYOCARDIAL INFARCTION,59
DE,HAEMORRHAGE,53
DE,DIZZINESS,51
DE,GENERAL PHYSICAL HEALTH DETERIORATION,47
DE,DIARRHOEA,44
DE,FATIGUE,43
DE,DEATH,42
DE,NAUSEA,42
DE,CARDIAC FAILURE,39
DE,HAEMOGLOBIN DECREASED,39
DE,ANAEMIA,37
DE,CEREBRAL HAEMORRHAGE,37
DE,CORONARY ARTERY DISEASE,36
DE,ASTHENIA,35
DE,HAEMATOMA,35
DE,ACUTE KIDNEY INJURY,34
DE,PNEUMONIA,34
DE,ACUTE MYOCARDIAL INFARCTION,33
DE,ATRIAL FIBRILLATION,33
DE,PRESCRIBED UNDERDOSE,32
DE,ANGINA PECTORIS,31
DE,CEREBROVASCULAR ACCIDENT,31
DE,SYNCOPE,31
DE,RASH,29
DE,EPISTAXIS,27
DE,HEADACHE,27
DE,HYPERTENSION,27
DE,MYALGIA,27
DE,VOMITING,27
DE,ABDOMINAL PAIN,25
DE,CONTRAINDICATED PRODUCT ADMINISTERED,25
DE,LOSS OF CONSCIOUSNESS,24
DE,PYREXIA,24
DE,THROMBOCYTOPENIA,24
DE,CEREBRAL INFARCTION,23
DE,RENAL FAILURE,23
DE,STENT PLACEMENT,23
DE,DRUG INEFFECTIVE,22
DE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,22
DE,ACUTE CORONARY SYNDROME,21
DE,APHASIA,21
DE,ARTHRALGIA,21
DE,BLOOD PRESSURE DECREASED,21
DE,DECREASED APPETITE,21
DE,MUSCULAR WEAKNESS,21
DE,CARDIAC ARREST,20
DE,DYSARTHRIA,20
DE,HYPOTENSION,20
DE,MELAENA,20
DE,RHABDOMYOLYSIS,20
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,20
DE,WEIGHT DECREASED,20
DE,CONFUSIONAL STATE,19
DE,GAIT DISTURBANCE,19
DE,HYPOKALAEMIA,19
DE,PAIN IN EXTREMITY,19
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,19
DE,RENAL FAILURE ACUTE,19
DE,SEPSIS,19
DE,THROMBOSIS,19
DE,CHEST PAIN,18
DE,CORONARY ARTERY STENOSIS,18
DE,HEMIPARESIS,18
DE,SUBDURAL HAEMATOMA,18
DE,OEDEMA PERIPHERAL,17
DE,URINARY TRACT INFECTION,17
DE,CHEST DISCOMFORT,16
DE,HAEMORRHAGIC DIATHESIS,16
DE,RESTLESSNESS,16
DE,CIRCULATORY COLLAPSE,15
DE,DRUG ADMINISTRATION ERROR,15
DE,DYSPNOEA EXERTIONAL,15
DE,HAEMATURIA,15
DE,HYPONATRAEMIA,15
DE,MALAISE,15
DE,PAIN,15
DE,PANCYTOPENIA,15
DE,PRURITUS,15
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,14
DE,COAGULOPATHY,14
DE,HYPOAESTHESIA,14
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,14
DE,INTRAVENTRICULAR HAEMORRHAGE,14
DE,RESUSCITATION,14
DE,TRANSAMINASES INCREASED,14
DE,ARRHYTHMIA,13
DE,BLOOD GLUCOSE INCREASED,13
DE,BRAIN OEDEMA,13
DE,DRUG-INDUCED LIVER INJURY,13
DE,GLOMERULAR FILTRATION RATE DECREASED,13
DE,HAEMORRHAGE INTRACRANIAL,13
DE,INSOMNIA,13
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,13
DE,PERITONITIS,13
DE,ABDOMINAL PAIN UPPER,12
DE,BLOOD CREATININE INCREASED,12
DE,DISTURBANCE IN ATTENTION,12
DE,LEFT VENTRICULAR HYPERTROPHY,12
DE,POST PROCEDURAL HAEMORRHAGE,12
DE,PULMONARY EMBOLISM,12
DE,SOMNOLENCE,12
DE,SUBARACHNOID HAEMORRHAGE,12
DE,VISUAL IMPAIRMENT,12
DE,ABORTION MISSED,11
DE,AORTIC VALVE STENOSIS,11
DE,ASPIRATION,11
DE,BENIGN PROSTATIC HYPERPLASIA,11
DE,FACIAL NERVE DISORDER,11
DE,INFECTION,11
DE,INTERSTITIAL LUNG DISEASE,11
DE,LACTIC ACIDOSIS,11
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,11
DE,METABOLIC ACIDOSIS,11
DE,MYOCLONUS,11
DE,OBSTRUCTIVE AIRWAYS DISORDER,11
DE,SPINAL SUBARACHNOID HAEMORRHAGE,11
DE,SWELLING FACE,11
DE,TACHYCARDIA,11
DE,TRANSIENT ISCHAEMIC ATTACK,11
DE,ABDOMINAL DISCOMFORT,10
DE,ACUTE HEPATIC FAILURE,10
DE,BACK PAIN,10
DE,BLOOD BILIRUBIN INCREASED,10
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,10
DE,C-REACTIVE PROTEIN INCREASED,10
DE,CARDIAC DISORDER,10
DE,COUGH,10
DE,DYSPHAGIA,10
DE,GASTRIC ULCER,10
DE,HEPATIC FAILURE,10
DE,HYPERSENSITIVITY,10
DE,JOINT SWELLING,10
DE,NEUTROPENIA,10
DE,PERIPHERAL ARTERY STENOSIS,10
DE,RECTAL PERFORATION,10
DE,RESPIRATORY FAILURE,10
DE,VASCULAR STENT THROMBOSIS,10
DE,ACTINIC KERATOSIS,9
DE,BLISTER,9
DE,BLOOD PRESSURE INCREASED,9
DE,COMPARTMENT SYNDROME,9
DE,CYSTITIS,9
DE,DEHYDRATION,9
DE,DELIRIUM,9
DE,DISORIENTATION,9
DE,DRUG INTOLERANCE,9
DE,EMBOLISM,9
DE,EXPOSURE DURING PREGNANCY,9
DE,GASTRITIS,9
DE,GROIN PAIN,9
DE,HAEMOPTYSIS,9
DE,HEPATIC CYST,9
DE,HYPERTENSIVE CRISIS,9
DE,INTRACARDIAC THROMBUS,9
DE,IRON DEFICIENCY ANAEMIA,9
DE,ISCHAEMIC STROKE,9
DE,LACERATION,9
DE,MOTOR DYSFUNCTION,9
DE,MUCOSAL INFLAMMATION,9
DE,OVERDOSE,9
DE,PERIPHERAL SWELLING,9
DE,PULMONARY HYPERTENSION,9
DE,SUBACUTE HEPATIC FAILURE,9
DE,URINARY RETENTION,9
DE,VENTRICULAR FIBRILLATION,9
DE,ANGINA UNSTABLE,8
DE,ANXIETY,8
DE,ARTERIOSCLEROSIS,8
DE,BLEEDING TIME PROLONGED,8
DE,CARDIOGENIC SHOCK,8
DE,EYE HAEMORRHAGE,8
DE,HEPATIC ENZYME INCREASED,8
DE,IMPAIRED HEALING,8
DE,JAUNDICE,8
DE,LEUKOPENIA,8
DE,PARAESTHESIA,8
DE,PLATELET COUNT DECREASED,8
DE,PLEURAL EFFUSION,8
DE,PRODUCT USE IN UNAPPROVED INDICATION,8
DE,SEPTIC SHOCK,8
DE,SKIN HAEMORRHAGE,8
DE,VERTIGO,8
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,7
DE,ARTERIAL OCCLUSIVE DISEASE,7
DE,ARTERIAL STENOSIS,7
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,7
DE,CARDIOVASCULAR DISORDER,7
DE,CAROTID ARTERY STENOSIS,7
DE,CHRONIC KIDNEY DISEASE,7
DE,COAGULATION TIME PROLONGED,7
DE,CONJUNCTIVAL HAEMORRHAGE,7
DE,CONSTIPATION,7
DE,CRANIOCEREBRAL INJURY,7
DE,DEPRESSED MOOD,7
DE,DIVERTICULITIS,7
DE,DRUG RESISTANCE,7
DE,DYSSOMNIA,7
DE,EPILEPSY,7
DE,ERYTHEMA,7
DE,GENERALISED ERYTHEMA,7
DE,HAEMATOCHEZIA,7
DE,HEART RATE INCREASED,7
DE,ILEUS PARALYTIC,7
DE,INCORRECT DOSE ADMINISTERED,7
DE,MUSCLE HAEMORRHAGE,7
DE,PANCREATITIS NECROTISING,7
DE,PERIORBITAL HAEMATOMA,7
DE,PROSTATIC ADENOMA,7
DE,PROTHROMBIN TIME PROLONGED,7
DE,PRURITUS GENERALISED,7
DE,RECTAL HAEMORRHAGE,7
DE,RENAL IMPAIRMENT,7
DE,SHOCK HAEMORRHAGIC,7
DE,SPEECH DISORDER,7
DE,SPINAL CORD HAEMORRHAGE,7
DE,TACHYARRHYTHMIA,7
DE,AORTA HYPOPLASIA,6
DE,APATHY,6
DE,ATRIAL SEPTAL DEFECT,6
DE,BALANCE DISORDER,6
DE,BLOOD GLUCOSE ABNORMAL,6
DE,BRONCHITIS,6
DE,CARDIAC FAILURE CONGESTIVE,6
DE,CAROTID ARTERIOSCLEROSIS,6
DE,CEREBRAL ISCHAEMIA,6
DE,CHILLS,6
DE,COARCTATION OF THE AORTA,6
DE,CONJUNCTIVITIS,6
DE,CORONARY ARTERY OCCLUSION,6
DE,CORONARY ARTERY THROMBOSIS,6
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,6
DE,DRUG DOSE OMISSION,6
DE,DYSPEPSIA,6
DE,ELECTROCARDIOGRAM QT PROLONGED,6
DE,FAECES DISCOLOURED,6
DE,HELICOBACTER GASTRITIS,6
DE,HEMIPLEGIA,6
DE,HEPATITIS CHOLESTATIC,6
DE,HERPES ZOSTER,6
DE,HYPERHIDROSIS,6
DE,HYPERTHYROIDISM,6
DE,INFLAMMATION,6
DE,INTERMITTENT CLAUDICATION,6
DE,INTERNATIONAL NORMALISED RATIO INCREASED,6
DE,LEUKOCYTOSIS,6
DE,MITRAL VALVE HYPOPLASIA,6
DE,MITRAL VALVE INCOMPETENCE,6
DE,MULTI-ORGAN FAILURE,6
DE,MUSCULOSKELETAL DISCOMFORT,6
DE,PNEUMONIA ASPIRATION,6
DE,SKIN CANCER,6
DE,SUBDURAL HAEMORRHAGE,6
DE,SWOLLEN TONGUE,6
DE,THROMBOSIS IN DEVICE,6
DE,THROMBOTIC THROMBOCYTOPENIC PURPURA,6
DE,TOXICITY TO VARIOUS AGENTS,6
DE,TREMOR,6
DE,TROPONIN INCREASED,6
DE,ABDOMINAL HERNIA,5
DE,ABNORMAL LOSS OF WEIGHT,5
DE,AFFECTIVE DISORDER,5
DE,ALANINE AMINOTRANSFERASE INCREASED,5
DE,ANAL PROLAPSE,5
DE,ANAL STENOSIS,5
DE,ATYPICAL PNEUMONIA,5
DE,BLOOD URINE PRESENT,5
DE,BURSITIS,5
DE,CARDIOVASCULAR INSUFFICIENCY,5
DE,CAROTID ARTERY OCCLUSION,5
DE,CELLULITIS,5
DE,CHROMATURIA,5
DE,COLITIS ULCERATIVE,5
DE,COLON CANCER,5
DE,COMA,5
DE,CONTUSION,5
DE,CORONARY ARTERIAL STENT INSERTION,5
DE,DEPRESSION,5
DE,DIVERTICULUM,5
DE,ESCHERICHIA URINARY TRACT INFECTION,5
DE,FEMORAL NECK FRACTURE,5
DE,GANGRENE,5
DE,GASTROENTERITIS,5
DE,GASTROINTESTINAL OEDEMA,5
DE,GASTROOESOPHAGEAL REFLUX DISEASE,5
DE,HYPERKALAEMIA,5
DE,INJECTION SITE PAIN,5
DE,INTESTINAL OBSTRUCTION,5
DE,MALABSORPTION,5
DE,MALLORY-WEISS SYNDROME,5
DE,MESENTERIC ARTERY THROMBOSIS,5
DE,METALLOSIS OF GLOBE,5
DE,MUSCLE ABSCESS,5
DE,MUSCLE SPASMS,5
DE,OEDEMA,5
DE,OSTEOMYELITIS,5
DE,OSTEONECROSIS,5
DE,PALPITATIONS,5
DE,RECTOCELE,5
DE,RESPIRATORY DISORDER,5
DE,RESPIRATORY DISTRESS,5
DE,STAPHYLOCOCCAL INFECTION,5
DE,STOMATITIS,5
DE,UROSEPSIS,5
DE,VISION BLURRED,5
DE,WOUND HAEMORRHAGE,5
DE,ABDOMINAL PAIN LOWER,4
DE,ALVEOLITIS ALLERGIC,4
DE,ANAL HAEMORRHAGE,4
DE,ANGIOEDEMA,4
DE,AORTIC VALVE DISEASE,4
DE,ARTHRITIS,4
DE,ASPARTATE AMINOTRANSFERASE INCREASED,4
DE,ATRIAL FLUTTER,4
DE,BLOOD GLUCOSE DECREASED,4
DE,BLOOD UREA INCREASED,4
DE,CARDIAC FAILURE CHRONIC,4
DE,CEREBRAL ARTERY OCCLUSION,4
DE,CHOLELITHIASIS,4
DE,COAGULATION FACTOR INCREASED,4
DE,CONCOMITANT DISEASE AGGRAVATED,4
DE,CONDITION AGGRAVATED,4
DE,CONJUNCTIVAL OEDEMA,4
DE,CONVULSION,4
DE,CREATININE RENAL CLEARANCE DECREASED,4
DE,DEPERSONALISATION,4
DE,DEREALISATION,4
DE,DIABETES MELLITUS,4
DE,DIABETES MELLITUS INADEQUATE CONTROL,4
DE,DIVERTICULAR PERFORATION,4
DE,DRUG EFFECT DECREASED,4
DE,DYSPHONIA,4
DE,DYSPNOEA AT REST,4
DE,ENCEPHALOPATHY,4
DE,EXOPHTHALMOS,4
DE,EYELID HAEMATOMA,4
DE,FINE MOTOR SKILL DYSFUNCTION,4
DE,FINGER DEFORMITY,4
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
DE,GASTRIC HAEMORRHAGE,4
DE,HAEMARTHROSIS,4
DE,HAEMATEMESIS,4
DE,HEPATIC CIRRHOSIS,4
DE,HYPOACUSIS,4
DE,HYPOTHYROIDISM,4
DE,LEFT VENTRICULAR DYSFUNCTION,4
DE,LIP SWELLING,4
DE,LYMPHOPENIA,4
DE,MOBILITY DECREASED,4
DE,MULTIPLE SCLEROSIS RELAPSE,4
DE,MUSCLE RUPTURE,4
DE,NO THERAPEUTIC RESPONSE,4
DE,ORTHOPNOEA,4
DE,PARESIS,4
DE,PNEUMONITIS,4
DE,POLYNEUROPATHY,4
DE,PRESYNCOPE,4
DE,PRODUCT SUBSTITUTION ISSUE,4
DE,PRODUCT USE ISSUE,4
DE,PULMONARY OEDEMA,4
DE,RASH PRURITIC,4
DE,RHEUMATOID ARTHRITIS,4
DE,ROAD TRAFFIC ACCIDENT,4
DE,SEIZURE,4
DE,SKIN ULCER,4
DE,SLEEP DISORDER,4
DE,SPINAL OSTEOARTHRITIS,4
DE,SPLENOMEGALY,4
DE,STRESS FRACTURE,4
DE,SUDDEN DEATH,4
DE,SURGERY,4
DE,THROAT TIGHTNESS,4
DE,TOOTH DISORDER,4
DE,TORSADE DE POINTES,4
DE,TOXIC EPIDERMAL NECROLYSIS,4
DE,TRICUSPID VALVE INCOMPETENCE,4
DE,TROPONIN T INCREASED,4
DE,URINARY BLADDER HAEMORRHAGE,4
DE,URINARY INCONTINENCE,4
DE,UROGENITAL HAEMORRHAGE,4
DE,URTICARIA,4
DE,VASCULAR STENT STENOSIS,4
DE,VENTRICULAR TACHYARRHYTHMIA,4
DE,VISUAL ACUITY REDUCED,4
DE,ABDOMINAL DISTENSION,3
DE,ALOPECIA,3
DE,ALTERED STATE OF CONSCIOUSNESS,3
DE,AORTIC STENOSIS,3
DE,ASTHMA,3
DE,ATRIAL THROMBOSIS,3
DE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,3
DE,BASAL GANGLIA HAEMORRHAGE,3
DE,BLOOD POTASSIUM INCREASED,3
DE,BLOOD PRESSURE ABNORMAL,3
DE,BRADYARRHYTHMIA,3
DE,BRAIN CONTUSION,3
DE,BREATH ODOUR,3
DE,CARDIAC FLUTTER,3
DE,CARDIAC TAMPONADE,3
DE,CARDIAC VENTRICULAR THROMBOSIS,3
DE,CATARACT,3
DE,CHOLECYSTITIS,3
DE,CHRONIC GASTRITIS,3
DE,CONGENITAL AORTIC VALVE STENOSIS,3
DE,DEMENTIA,3
DE,DIPLOPIA,3
DE,DRUG ERUPTION,3
DE,DRY MOUTH,3
DE,DYSAESTHESIA,3
DE,EAR HAEMORRHAGE,3
DE,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
DE,EPIDIDYMITIS,3
DE,EXTRASYSTOLES,3
DE,EYE IRRITATION,3
DE,EYE PAIN,3
DE,FACIAL PARALYSIS,3
DE,FEMUR FRACTURE,3
DE,FIBULA FRACTURE,3
DE,FLANK PAIN,3
DE,FLATULENCE,3
DE,FLUID OVERLOAD,3
DE,FOOT FRACTURE,3
DE,FRACTURE DELAYED UNION,3
DE,GASTRITIS EROSIVE,3
DE,GASTROINTESTINAL INFECTION,3
DE,GINGIVAL BLEEDING,3
DE,GINGIVAL SWELLING,3
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,3
DE,HAEMOGLOBIN INCREASED,3
DE,HEART VALVE REPLACEMENT,3
DE,HEMIANOPIA,3
DE,HEPARIN-INDUCED THROMBOCYTOPENIA,3
DE,HIATUS HERNIA,3
DE,HYPERBILIRUBINAEMIA,3
DE,HYPERGLYCAEMIA,3
DE,HYPERLIPIDAEMIA,3
DE,HYPERTENSIVE HEART DISEASE,3
DE,INCORRECT DRUG ADMINISTRATION DURATION,3
DE,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
DE,INFARCTION,3
DE,INFLAMMATORY MARKER INCREASED,3
DE,INGUINAL HERNIA,3
DE,INTERVERTEBRAL DISC PROTRUSION,3
DE,INTESTINAL HAEMORRHAGE,3
DE,KETOACIDOSIS,3
DE,LIVER FUNCTION TEST INCREASED,3
DE,LOW DENSITY LIPOPROTEIN INCREASED,3
DE,LUNG INFECTION,3
DE,LYMPHOCELE,3
DE,MAJOR DEPRESSION,3
DE,MEMORY IMPAIRMENT,3
DE,MENISCUS INJURY,3
DE,MONOCYTE COUNT INCREASED,3
DE,MOUTH HAEMORRHAGE,3
DE,MUCOSAL HAEMORRHAGE,3
DE,MUSCULOSKELETAL PAIN,3
DE,MYOPATHY,3
DE,NASOPHARYNGITIS,3
DE,OCULAR HYPERAEMIA,3
DE,OCULAR RETROBULBAR HAEMORRHAGE,3
DE,OSTEOCHONDROSIS,3
DE,OXYGEN SATURATION DECREASED,3
DE,PANIC ATTACK,3
DE,PEMPHIGOID,3
DE,PERFORMANCE STATUS DECREASED,3
DE,PERICARDIAL EFFUSION,3
DE,PERIPHERAL ARTERY OCCLUSION,3
DE,PERIPHERAL VASCULAR DISORDER,3
DE,PHIMOSIS,3
DE,PHOTOSENSITIVITY REACTION,3
DE,PLATELET COUNT INCREASED,3
DE,POST PROCEDURAL COMPLICATION,3
DE,POST PROCEDURAL HAEMATOMA,3
DE,PRECANCEROUS SKIN LESION,3
DE,PROCEDURAL HAEMORRHAGE,3
DE,PSYCHOMOTOR RETARDATION,3
DE,PULMONARY CONGESTION,3
DE,PULMONARY SEPSIS,3
DE,PULSE ABSENT,3
DE,RED BLOOD CELL COUNT DECREASED,3
DE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
DE,RENAL ARTERY STENOSIS,3
DE,SCIATICA,3
DE,SECOND PRIMARY MALIGNANCY,3
DE,SEROMA,3
DE,SPONTANEOUS HAEMATOMA,3
DE,STAPHYLOCOCCAL SEPSIS,3
DE,STENOSIS,3
DE,STRESS,3
DE,SUICIDAL IDEATION,3
DE,TONGUE HAEMORRHAGE,3
DE,TRAUMATIC INTRACRANIAL HAEMORRHAGE,3
DE,VASCULAR GRAFT OCCLUSION,3
DE,VASCULAR OCCLUSION,3
DE,VASCULAR PSEUDOANEURYSM,3
DE,VENTRICULAR EXTRASYSTOLES,3
DE,VITREOUS HAEMORRHAGE,3
DE,ABNORMAL FAECES,2
DE,ACUTE ABDOMEN,2
DE,ACUTE RESPIRATORY FAILURE,2
DE,ADVERSE EVENT,2
DE,AGGRESSION,2
DE,ALVEOLITIS,2
DE,AMNESTIC DISORDER,2
DE,ANAEMIA POSTOPERATIVE,2
DE,ANGIOPATHY,2
DE,AORTIC ARTERIOSCLEROSIS,2
DE,APHTHOUS ULCER,2
DE,APLASTIC ANAEMIA,2
DE,ARTERIAL HAEMORRHAGE,2
DE,ARTERIOSCLEROSIS CORONARY ARTERY,2
DE,ARTERY DISSECTION,2
DE,ARTHROPATHY,2
DE,ATRIOVENTRICULAR BLOCK,2
DE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
DE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,2
DE,BACTERAEMIA,2
DE,BALANOPOSTHITIS,2
DE,BLINDNESS,2
DE,BLOOD CALCIUM DECREASED,2
DE,BLOOD CHOLESTEROL INCREASED,2
DE,BLOOD CREATININE ABNORMAL,2
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,2
DE,BLOOD POTASSIUM DECREASED,2
DE,BLOOD SODIUM DECREASED,2
DE,BONE PAIN,2
DE,BRADYCARDIA,2
DE,BRAIN INJURY,2
DE,BRAIN NATRIURETIC PEPTIDE INCREASED,2
DE,BREATH SOUNDS ABNORMAL,2
DE,BRONCHIAL CARCINOMA,2
DE,BUNDLE BRANCH BLOCK LEFT,2
DE,BUNDLE BRANCH BLOCK RIGHT,2
DE,CACHEXIA,2
DE,CARCINOMA IN SITU OF SKIN,2
DE,CARDIAC FAILURE ACUTE,2
DE,CARDIOMYOPATHY,2
DE,CARDIOVERSION,2
DE,CENTRAL NERVOUS SYSTEM LESION,2
DE,CEREBRAL ARTERY STENOSIS,2
DE,CERVICOBRACHIAL SYNDROME,2
DE,CHOROIDAL HAEMORRHAGE,2
DE,CONGENITAL AORTIC STENOSIS,2
DE,CONGENITAL HEART VALVE DISORDER,2
DE,CORNEAL OEDEMA,2
DE,CORONARY ANGIOPLASTY,2
DE,CROHN^S DISEASE,2
DE,CYANOSIS,2
DE,CYST,2
DE,DEEP VEIN THROMBOSIS,2
DE,DEMENTIA ALZHEIMER^S TYPE,2
DE,DERMATITIS ALLERGIC,2
DE,DEVICE DISLOCATION,2
DE,DEVICE MALFUNCTION,2
DE,DEVICE OCCLUSION,2
DE,DEVICE RELATED INFECTION,2
DE,DIABETIC FOOT,2
DE,DIABETIC RETINOPATHY,2
DE,DIARRHOEA HAEMORRHAGIC,2
DE,DIASTOLIC DYSFUNCTION,2
DE,DIPLEGIA,2
DE,DISEASE PROGRESSION,2
DE,DISEASE SUSCEPTIBILITY,2
DE,DIVERTICULUM INTESTINAL HAEMORRHAGIC,2
DE,DRUG LEVEL BELOW THERAPEUTIC,2
DE,DRUG PRESCRIBING ERROR,2
DE,DRY THROAT,2
DE,DUODENAL ULCER,2
DE,DUODENAL ULCER HAEMORRHAGE,2
DE,DUODENITIS,2
DE,DYSPNOEA PAROXYSMAL NOCTURNAL,2
DE,DYSSTASIA,2
DE,ECZEMA,2
DE,EJECTION FRACTION DECREASED,2
DE,ELECTROLYTE IMBALANCE,2
DE,EMBOLIC CEREBRAL INFARCTION,2
DE,EMBOLIC STROKE,2
DE,ERYSIPELAS,2
DE,EYE SWELLING,2
DE,FACIAL PARESIS,2
DE,FAECALOMA,2
DE,FEBRILE INFECTION,2
DE,FLUID RETENTION,2
DE,FOETAL EXPOSURE DURING PREGNANCY,2
DE,GASTRIC MUCOSA ERYTHEMA,2
DE,GASTRIC VARICES,2
DE,GASTRITIS HAEMORRHAGIC,2
DE,GASTROINTESTINAL ULCER,2
DE,GENERALISED TONIC-CLONIC SEIZURE,2
DE,HAEMATOCRIT DECREASED,2
DE,HAEMORRHOIDS,2
DE,HAEMOTHORAX,2
DE,HALLUCINATION,2
DE,HEAD DISCOMFORT,2
DE,HEART VALVE INCOMPETENCE,2
DE,HEPATIC STEATOSIS,2
DE,HEPATITIS B VIRUS TEST POSITIVE,2
DE,HERNIA OBSTRUCTIVE,2
DE,HOT FLUSH,2
DE,HYDROCEPHALUS,2
DE,HYDROCHOLECYSTIS,2
DE,HYPERURICAEMIA,2
DE,HYPHAEMA,2
DE,HYPOGLYCAEMIA,2
DE,HYPOXIA,2
DE,ILEUS,2
DE,INDURATION,2
DE,INFECTION IN AN IMMUNOCOMPROMISED HOST,2
DE,INFLUENZA,2
DE,INTESTINAL POLYP,2
DE,INTESTINAL PROLAPSE,2
DE,INTRA-ABDOMINAL HAEMATOMA,2
DE,KERATOACANTHOMA,2
DE,KYPHOSIS,2
DE,LABORATORY TEST ABNORMAL,2
DE,LACRIMATION INCREASED,2
DE,LIP EROSION,2
DE,LIPASE INCREASED,2
DE,LUNG DISORDER,2
DE,LYMPHOEDEMA,2
DE,MALIGNANT NEOPLASM PROGRESSION,2
DE,MATERNAL EXPOSURE DURING PREGNANCY,2
DE,MEDICAL DEVICE COMPLICATION,2
DE,MEDICATION ERROR,2
DE,MENTAL DISORDER,2
DE,MENTAL IMPAIRMENT,2
DE,MESENTERIC ARTERIAL OCCLUSION,2
DE,MONOPARESIS,2
DE,MULTI-ORGAN DISORDER,2
DE,MULTIPLE DRUG THERAPY,2
DE,MULTIPLE SCLEROSIS,2
DE,MUSCLE ATROPHY,2
DE,MYDRIASIS,2
DE,MYELODYSPLASTIC SYNDROME,2
DE,MYOCARDIAL HAEMORRHAGE,2
DE,MYOCARDIAL ISCHAEMIA,2
DE,MYXOEDEMA COMA,2
DE,NASAL NEOPLASM,2
DE,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,2
DE,NEPHROPATHY,2
DE,NERVOUS SYSTEM DISORDER,2
DE,NERVOUSNESS,2
DE,NEUROPATHY PERIPHERAL,2
DE,NEUTROPHILIA,2
DE,NITRITE URINE PRESENT,2
DE,NON-CARDIAC CHEST PAIN,2
DE,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
DE,OESOPHAGEAL VARICES HAEMORRHAGE,2
DE,OESOPHAGITIS,2
DE,OPTIC ATROPHY,2
DE,ORAL CANDIDIASIS,2
DE,ORAL HERPES,2
DE,ORAL PAIN,2
DE,OSTEOARTHRITIS,2
DE,OSTEOPOROSIS,2
DE,PANCREATITIS,2
DE,PANCREATITIS ACUTE,2
DE,PANCREATITIS RELAPSING,2
DE,PELVIC PAIN,2
DE,PERIPHERAL ARTERY ANGIOPLASTY,2
DE,PERIPHERAL EMBOLISM,2
DE,PERIPHERAL VENOUS DISEASE,2
DE,PERITONEAL HERNIA,2
DE,PERITONITIS BACTERIAL,2
DE,PERSONALITY CHANGE,2
DE,PITUITARY TUMOUR BENIGN,2
DE,PLATELET DYSFUNCTION,2
DE,PLEURISY,2
DE,PNEUMONIA FUNGAL,2
DE,POLYPECTOMY,2
DE,PORTAL VEIN THROMBOSIS,2
DE,PRODUCTIVE COUGH,2
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
DE,PROSTATE CANCER,2
DE,PROTEINURIA,2
DE,PSORIASIS,2
DE,PSYCHOTIC DISORDER,2
DE,PULMONARY ALVEOLAR HAEMORRHAGE,2
DE,PULMONARY FIBROSIS,2
DE,QUADRIPARESIS,2
DE,RASH GENERALISED,2
DE,RECTAL CANCER,2
DE,RED CELL DISTRIBUTION WIDTH INCREASED,2
DE,RENAL CELL CARCINOMA,2
DE,RENAL CYST,2
DE,RENAL FAILURE CHRONIC,2
DE,RESPIRATORY DEPRESSION,2
DE,RETCHING,2
DE,RETINAL HAEMORRHAGE,2
DE,RHEUMATIC DISORDER,2
DE,RHEUMATOID NODULE,2
DE,RIB FRACTURE,2
DE,RIGHT VENTRICULAR FAILURE,2
DE,ROTATOR CUFF SYNDROME,2
DE,SHOCK,2
DE,SHUNT MALFUNCTION,2
DE,SKIN BURNING SENSATION,2
DE,SKIN NECROSIS,2
DE,SMALL CELL LUNG CANCER,2
DE,SPINAL DISORDER,2
DE,STATUS EPILEPTICUS,2
DE,STRABISMUS,2
DE,SUDDEN CARDIAC DEATH,2
DE,SUICIDE ATTEMPT,2
DE,SUPRAVENTRICULAR TACHYCARDIA,2
DE,SUTURE RUPTURE,2
DE,SWELLING,2
DE,SYNOVITIS,2
DE,TACHYPNOEA,2
DE,THERAPEUTIC RESPONSE DECREASED,2
DE,THORACIC VERTEBRAL FRACTURE,2
DE,THROMBOPHLEBITIS,2
DE,THROMBOTIC STROKE,2
DE,TRANSFUSION,2
DE,TRICUSPID VALVE DISEASE,2
DE,TYPE 2 DIABETES MELLITUS,2
DE,UNRESPONSIVE TO STIMULI,2
DE,URETERIC STENOSIS,2
DE,VASCULAR GRAFT,2
DE,VASCULAR OPERATION,2
DE,VASODILATATION,2
DE,VENTRICULAR SEPTAL DEFECT,2
DE,VENTRICULAR TACHYCARDIA,2
DE,VERTIGO POSITIONAL,2
DE,VON WILLEBRAND^S DISEASE,2
DE,WEIGHT INCREASED,2
DE,WHITE BLOOD CELL COUNT DECREASED,2
DE,WHITE BLOOD CELL COUNT INCREASED,2
DE,WOUND DEHISCENCE,2
DE,WOUND INFECTION PSEUDOMONAS,2
DE,ABDOMINAL MASS,1
DE,ABDOMINAL WALL HAEMATOMA,1
DE,ABNORMAL DREAMS,1
DE,ABNORMAL PRECORDIAL MOVEMENT,1
DE,ACCIDENT,1
DE,ACCIDENTAL EXPOSURE TO PRODUCT,1
DE,ACIDOSIS,1
DE,ACNE,1
DE,ACQUIRED DIAPHRAGMATIC EVENTRATION,1
DE,ACQUIRED HAEMOPHILIA,1
DE,ACQUIRED HAEMOPHILIA WITH ANTI FVIII_ XI_ OR XIII,1
DE,ACROCHORDON,1
DE,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
DE,ACUTE MYELOID LEUKAEMIA,1
DE,ACUTE PRERENAL FAILURE,1
DE,ADENOCARCINOMA OF COLON,1
DE,ADENOMA BENIGN,1
DE,ADRENAL INSUFFICIENCY,1
DE,AGEUSIA,1
DE,AGITATION,1
DE,AGRANULOCYTOSIS,1
DE,AKINESIA,1
DE,ALLERGIC OEDEMA,1
DE,ALPHA 1 FOETOPROTEIN INCREASED,1
DE,AMPUTATION,1
DE,AMYLASE INCREASED,1
DE,ANAEMIA MACROCYTIC,1
DE,ANAL FISSURE,1
DE,ANAL FISTULA,1
DE,ANAL INCONTINENCE,1
DE,ANAL INFLAMMATION,1
DE,ANAL PRURITUS,1
DE,ANAPHYLACTIC REACTION,1
DE,ANAPHYLACTIC SHOCK,1
DE,ANEURYSM,1
DE,ANGIOPLASTY,1
DE,ANORECTAL INFECTION,1
DE,ANURIA,1
DE,ANXIETY DISORDER,1
DE,AORTIC DISORDER,1
DE,AORTIC THROMBOSIS,1
DE,AORTIC VALVE CALCIFICATION,1
DE,AORTIC VALVE INCOMPETENCE,1
DE,AORTIC VALVE SCLEROSIS,1
DE,APALLIC SYNDROME,1
DE,APPENDICITIS,1
DE,APPLICATION SITE INFLAMMATION,1
DE,APRAXIA,1
DE,ARTERIAL RESTENOSIS,1
DE,ARTERIOSPASM CORONARY,1
DE,ARTHRITIS INFECTIVE,1
DE,ASCITES,1
DE,ATAXIA,1
DE,ATRIAL TACHYCARDIA,1
DE,AUTOIMMUNE PANCREATITIS,1
DE,AZOTAEMIA,1
DE,BASAL CELL CARCINOMA,1
DE,BASILAR ARTERY STENOSIS,1
DE,BENIGN NEOPLASM,1
DE,BIOPSY,1
DE,BITE,1
DE,BK VIRUS INFECTION,1
DE,BLADDER CATHETERISATION,1
DE,BLADDER DISORDER,1
DE,BLADDER NEOPLASM,1
DE,BLADDER TAMPONADE,1
DE,BLINDNESS CORTICAL,1
DE,BLOOD ALBUMIN ABNORMAL,1
DE,BLOOD BRAIN BARRIER DEFECT,1
DE,BLOOD CHOLESTEROL ABNORMAL,1
DE,BLOOD CHROMOGRANIN A INCREASED,1
DE,BLOOD COUNT ABNORMAL,1
DE,BLOOD CREATINE INCREASED,1
DE,BLOOD CREATININE,1
DE,BLOOD GLUCOSE FLUCTUATION,1
DE,BLOOD IRON DECREASED,1
DE,BLOOD IRON INCREASED,1
DE,BLOOD LACTIC ACID INCREASED,1
DE,BLOOD PRESSURE FLUCTUATION,1
DE,BLOOD PRESSURE SYSTOLIC INCREASED,1
DE,BLOOD TRIGLYCERIDES ABNORMAL,1
DE,BLOOD URIC ACID INCREASED,1
DE,BLOOD URINE,1
DE,BODY TEMPERATURE INCREASED,1
DE,BONE DISORDER,1
DE,BRAIN ABSCESS,1
DE,BRAIN NATRIURETIC PEPTIDE ABNORMAL,1
DE,BRAIN NEOPLASM BENIGN,1
DE,BRAIN STEM INFARCTION,1
DE,BREAST CANCER,1
DE,BREAST CANCER METASTATIC,1
DE,BREAST NEOPLASM,1
DE,BREAST PAIN,1
DE,BREAST SWELLING,1
DE,BRONCHIOLITIS,1
DE,BRONCHITIS BACTERIAL,1
DE,BRONCHOPNEUMONIA,1
DE,BURNING SENSATION,1
DE,C-REACTIVE PROTEIN DECREASED,1
DE,CAESAREAN SECTION,1
DE,CAMPYLOBACTER GASTROENTERITIS,1
DE,CARDIAC FUNCTION TEST ABNORMAL,1
DE,CARDIAC MURMUR,1
DE,CARDIAC OUTPUT DECREASED,1
DE,CARDIAC SEPTAL HYPERTROPHY,1
DE,CARDIAC VALVE REPLACEMENT COMPLICATION,1
DE,CARDIO-RESPIRATORY ARREST,1
DE,CARDIOMEGALY,1
DE,CARDIOPULMONARY FAILURE,1
DE,CAROTID ARTERY THROMBOSIS,1
DE,CARPAL TUNNEL SYNDROME,1
DE,CATARACT OPERATION,1
DE,CATHETER PLACEMENT,1
DE,CATHETER SITE EROSION,1
DE,CATHETER SITE HAEMORRHAGE,1
DE,CATHETERISATION CARDIAC,1
DE,CD4 LYMPHOCYTES DECREASED,1
DE,CELL-MEDIATED IMMUNE DEFICIENCY,1
DE,CENTRAL NERVOUS SYSTEM INFLAMMATION,1
DE,CENTRAL VENOUS CATHETERISATION,1
DE,CEREBRAL HAEMATOMA,1
DE,CEREBRAL MICROANGIOPATHY,1
DE,CEREBRAL THROMBOSIS,1
DE,CEREBROSPINAL FLUID CIRCULATION DISORDER,1
DE,CERVICITIS,1
DE,CHAPPED LIPS,1
DE,CHEILITIS,1
DE,CHOLANGIOLITIS,1
DE,CHOLECYSTITIS ACUTE,1
DE,CHOLESTASIS,1
DE,CHONDROCALCINOSIS,1
DE,CHONDROMALACIA,1
DE,CHORIORETINAL FOLDS,1
DE,CHRONIC ALLOGRAFT NEPHROPATHY,1
DE,CLAMPING OF BLOOD VESSEL,1
DE,CLAUSTROPHOBIA,1
DE,CLOSTRIDIUM BACTERAEMIA,1
DE,CLOSTRIDIUM COLITIS,1
DE,CLOSTRIDIUM TEST POSITIVE,1
DE,CLUSTER HEADACHE,1
DE,CNS VENTRICULITIS,1
DE,COCHLEA IMPLANT,1
DE,COELIAC ARTERY STENOSIS,1
DE,COLD SWEAT,1
DE,COLECTOMY,1
DE,COLITIS,1
DE,COLON NEOPLASM,1
DE,COMPLEX PARTIAL SEIZURES,1
DE,COMPLICATION ASSOCIATED WITH DEVICE,1
DE,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
DE,COMPUTERISED TOMOGRAM ABNORMAL,1
DE,CONCOMITANT DISEASE PROGRESSION,1
DE,CONDUCTION DISORDER,1
DE,CONGESTIVE CARDIOMYOPATHY,1
DE,CONJUNCTIVAL HYPERAEMIA,1
DE,CONTRAINDICATION TO MEDICAL TREATMENT,1
DE,CONTRAST MEDIA ALLERGY,1
DE,CONTRAST MEDIA REACTION,1
DE,COR PULMONALE,1
DE,COR PULMONALE CHRONIC,1
DE,CORNEAL DISORDER,1
DE,CORNEAL EROSION,1
DE,CORONARY ARTERY BYPASS,1
DE,CORONARY ARTERY DISSECTION,1
DE,CORONARY ARTERY EMBOLISM,1
DE,CORONARY ARTERY RESTENOSIS,1
DE,CORONARY NO-REFLOW PHENOMENON,1
DE,CRANIAL NERVE DISORDER,1
DE,CRITICAL ILLNESS POLYNEUROPATHY,1
DE,CRYOTHERAPY,1
DE,CSF CELL COUNT INCREASED,1
DE,CSF OLIGOCLONAL BAND PRESENT,1
DE,CYST RUPTURE,1
DE,CYSTITIS HAEMORRHAGIC,1
DE,CYTOMEGALOVIRUS TEST POSITIVE,1
DE,CYTOPENIA,1
DE,DAYDREAMING,1
DE,DECUBITUS ULCER,1
DE,DEGENERATIVE MITRAL VALVE DISEASE,1
DE,DELUSION,1
DE,DEPRESSION SUICIDAL,1
DE,DERMAL CYST,1
DE,DERMATITIS,1
DE,DEVICE INAPPROPRIATE SHOCK DELIVERY,1
DE,DEVICE ISSUE,1
DE,DEVICE LEAKAGE,1
DE,DEVICE PHYSICAL PROPERTY ISSUE,1
DE,DEVICE RELATED SEPSIS,1
DE,DEVICE RELATED THROMBOSIS,1
DE,DIABETES INSIPIDUS,1
DE,DIABETIC KETOACIDOSIS,1
DE,DIABETIC NEPHROPATHY,1
DE,DIABETIC NEUROPATHY,1
DE,DILATATION ATRIAL,1
DE,DISORDER OF GLOBE,1
DE,DIVERTICULITIS INTESTINAL HAEMORRHAGIC,1
DE,DIVERTICULUM INTESTINAL,1
DE,DRESSLER^S SYNDROME,1
DE,DRUG HYPERSENSITIVITY,1
DE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
DE,DRUG LEVEL DECREASED,1
DE,DRUG LEVEL INCREASED,1
DE,DRUG NAME CONFUSION,1
DE,DRUG WITHDRAWAL SYNDROME,1
DE,DRY AGE-RELATED MACULAR DEGENERATION,1
DE,DRY EYE,1
DE,DRY SKIN,1
DE,DUODENAL ULCER PERFORATION,1
DE,DUPUYTREN^S CONTRACTURE,1
DE,DYSURIA,1
DE,EAR DISCOMFORT,1
DE,EAR OPERATION,1
DE,EAR PAIN,1
DE,ECZEMA ASTEATOTIC,1
DE,ECZEMA INFECTED,1
DE,ECZEMA NUMMULAR,1
DE,ELECTROCARDIOGRAM ABNORMAL,1
DE,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
DE,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
DE,ELECTROCARDIOGRAM T WAVE INVERSION,1
DE,EMOTIONAL DISTRESS,1
DE,EMPHYSEMA,1
DE,EMPYEMA,1
DE,ENDOCARDITIS,1
DE,ENDOMETRIAL CANCER,1
DE,ENTERITIS,1
DE,ENTEROCOCCAL INFECTION,1
DE,ENTEROCUTANEOUS FISTULA,1
DE,ENTEROSTOMY,1
DE,EROSIVE DUODENITIS,1
DE,ERUCTATION,1
DE,ERYTHEMA NODOSUM,1
DE,ESCHERICHIA INFECTION,1
DE,ESCHERICHIA SEPSIS,1
DE,EXTENSOR PLANTAR RESPONSE,1
DE,EXTREMITY NECROSIS,1
DE,EYE INJURY,1
DE,EYE MOVEMENT DISORDER,1
DE,EYE PRURITUS,1
DE,EYELID OEDEMA,1
DE,FACE INJURY,1
DE,FACE OEDEMA,1
DE,FACIAL PAIN,1
DE,FAECAL CALPROTECTIN INCREASED,1
DE,FAECAL VOLUME INCREASED,1
DE,FAILURE TO ANASTOMOSE,1
DE,FEAR,1
DE,FEAR OF FALLING,1
DE,FEBRILE NEUTROPENIA,1
DE,FEELING ABNORMAL,1
DE,FEELING COLD,1
DE,FEMORAL HERNIA INCARCERATED,1
DE,FIBRIN D DIMER INCREASED,1
DE,FIBROMYALGIA,1
DE,FINE MOTOR DELAY,1
DE,FISTULA DISCHARGE,1
DE,FOLATE DEFICIENCY,1
DE,FOOT DEFORMITY,1
DE,FOREIGN BODY SENSATION IN EYES,1
DE,FRACTURE DISPLACEMENT,1
DE,FRUCTOSE INTOLERANCE,1
DE,FUNGAL INFECTION,1
DE,FUNGAL TEST POSITIVE,1
DE,GAIT INABILITY,1
DE,GASTRIC CYST,1
DE,GASTROENTERITIS CLOSTRIDIAL,1
GH,DEPRESSED LEVEL OF CONSCIOUSNESS,1
GH,HYPERTENSION,1
GH,HYPOGLYCAEMIA,1
GR,CONDITION AGGRAVATED,15
GR,DYSPNOEA,14
GR,ENDOTHELIAL DYSFUNCTION,13
GR,DRUG INEFFECTIVE,11
GR,SKIN ULCER,11
GR,PYREXIA,10
GR,HAEMATOCRIT DECREASED,9
GR,ABDOMINAL PAIN,7
GR,ASTHENIA,7
GR,CARDIAC ARREST,7
GR,OEDEMA PERIPHERAL,7
GR,ANGINA PECTORIS,6
GR,DEATH,6
GR,DERMATITIS EXFOLIATIVE,6
GR,HAEMATOCHEZIA,6
GR,MYALGIA,6
GR,MYOCARDIAL INFARCTION,6
GR,ANAEMIA,5
GR,COUGH,5
GR,DIZZINESS,5
GR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
GR,EPISTAXIS,5
GR,ISCHAEMIC STROKE,5
GR,MUSCULAR WEAKNESS,5
GR,PRURITUS,5
GR,RENAL FAILURE,5
GR,SUBDURAL HAEMATOMA,5
GR,BLOOD ALKALINE PHOSPHATASE INCREASED,4
GR,CEREBROVASCULAR ACCIDENT,4
GR,CHEST EXPANSION DECREASED,4
GR,DIABETES MELLITUS,4
GR,DRUG CROSS-REACTIVITY,4
GR,DYSPHAGIA,4
GR,FALL,4
GR,GASTRIC HAEMORRHAGE,4
GR,GASTROINTESTINAL HAEMORRHAGE,4
GR,HAEMORRHOIDS,4
GR,HEADACHE,4
GR,HEPATIC ENZYME INCREASED,4
GR,HYPERKALAEMIA,4
GR,HYPERSENSITIVITY,4
GR,HYPOTENSION,4
GR,MELAENA,4
GR,NEUTROPENIA,4
GR,PULMONARY ARTERIAL HYPERTENSION,4
GR,QUADRIPARESIS,4
GR,SPINAL EPIDURAL HAEMATOMA,4
GR,WEIGHT DECREASED,4
GR,ACUTE LEUKAEMIA,3
GR,ATRIAL FIBRILLATION,3
GR,BACK PAIN,3
GR,BALANCE DISORDER,3
GR,BLINDNESS,3
GR,CARDIAC FAILURE,3
GR,CONSTIPATION,3
GR,CONTUSION,3
GR,DECREASED APPETITE,3
GR,DRUG HYPERSENSITIVITY,3
GR,FATIGUE,3
GR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
GR,HAEMATOMA,3
GR,HYPOAESTHESIA,3
GR,MALAISE,3
GR,MUSCLE SPASMS,3
GR,PAIN IN EXTREMITY,3
GR,PNEUMONIA,3
GR,PRODUCT USE ISSUE,3
GR,PULMONARY OEDEMA,3
GR,RENAL FAILURE ACUTE,3
GR,RETINAL VEIN THROMBOSIS,3
GR,SUDDEN DEATH,3
GR,THROMBOCYTOPENIA,3
GR,THROMBOSIS,3
GR,VERTIGO,3
GR,VOMITING,3
GR,ACUTE KIDNEY INJURY,2
GR,ACUTE MYOCARDIAL INFARCTION,2
GR,AGITATION,2
GR,ALOPECIA,2
GR,AMNESIA,2
GR,BLADDER PAPILLOMA,2
GR,BLOOD CHOLESTEROL INCREASED,2
GR,BLOOD LACTIC ACID INCREASED,2
GR,CARDIAC TAMPONADE,2
GR,CARDIO-RESPIRATORY ARREST,2
GR,CIRCULATORY COLLAPSE,2
GR,COLITIS,2
GR,CONFUSIONAL STATE,2
GR,CORONARY ARTERIAL STENT INSERTION,2
GR,DIARRHOEA,2
GR,DIEULAFOY^S VASCULAR MALFORMATION,2
GR,DISCOMFORT,2
GR,DISORIENTATION,2
GR,DRESSLER^S SYNDROME,2
GR,DRUG DOSE OMISSION,2
GR,DYSGEUSIA,2
GR,DYSPNOEA EXERTIONAL,2
GR,ERECTILE DYSFUNCTION,2
GR,ERYTHEMA,2
GR,GASTROINTESTINAL EROSION,2
GR,GENERALISED ERYTHEMA,2
GR,GRAND MAL CONVULSION,2
GR,HAEMATEMESIS,2
GR,HAEMODYNAMIC INSTABILITY,2
GR,HYPERTENSION,2
GR,INFECTION,2
GR,JEJUNAL ULCER,2
GR,LARGE INTESTINE PERFORATION,2
GR,LARGE INTESTINE POLYP,2
GR,LIVER INJURY,2
GR,LOSS OF CONSCIOUSNESS,2
GR,LUNG NEOPLASM MALIGNANT,2
GR,METABOLIC ACIDOSIS,2
GR,MUCOSAL INFLAMMATION,2
GR,NAUSEA,2
GR,NECK PAIN,2
GR,NO ADVERSE EVENT,2
GR,OEDEMA,2
GR,OROPHARYNGEAL PAIN,2
GR,OVARIAN CYST,2
GR,PAIN,2
GR,PANCREATIC PSEUDOCYST,2
GR,PANCREATITIS,2
GR,PANCREATITIS ACUTE,2
GR,PNEUMONIA ASPIRATION,2
GR,PNEUMOTHORAX,2
GR,PRODUCT USE IN UNAPPROVED INDICATION,2
GR,PROSTATITIS,2
GR,PRURITUS GENERALISED,2
GR,PULMONARY EMBOLISM,2
GR,RASH,2
GR,RASH PRURITIC,2
GR,RED BLOOD CELL COUNT DECREASED,2
GR,RENAL IMPAIRMENT,2
GR,RENAL INJURY,2
GR,RESPIRATORY TRACT INFECTION,2
GR,SEPTIC SHOCK,2
GR,SHOCK HAEMORRHAGIC,2
GR,SYNCOPE,2
GR,TRANSAMINASES INCREASED,2
GR,TREATMENT NONCOMPLIANCE,2
GR,URINARY TRACT INFECTION,2
GR,VISION BLURRED,2
GR,VISUAL IMPAIRMENT,2
GR,ABDOMINAL PAIN UPPER,1
GR,ABSCESS LIMB,1
GR,ACCIDENTAL OVERDOSE,1
GR,ACNE,1
GR,AGEUSIA,1
GR,AGRANULOCYTOSIS,1
GR,ALANINE AMINOTRANSFERASE INCREASED,1
GR,AMYLASE INCREASED,1
GR,ANAPHYLACTIC REACTION,1
GR,ANAPHYLACTIC SHOCK,1
GR,ANGIOPLASTY,1
GR,ANXIETY,1
GR,AORTIC ANEURYSM RUPTURE,1
GR,APHTHOUS STOMATITIS,1
GR,ARRHYTHMIA,1
GR,ARTERIOSCLEROSIS,1
GR,ARTHRALGIA,1
GR,ASPARTATE AMINOTRANSFERASE INCREASED,1
GR,ASPIRATION,1
GR,AUTOIMMUNE MYOCARDITIS,1
GR,BASOPHIL COUNT INCREASED,1
GR,BLOOD ALBUMIN INCREASED,1
GR,BLOOD BILIRUBIN ABNORMAL,1
GR,BLOOD BILIRUBIN INCREASED,1
GR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
GR,BLOOD CREATININE INCREASED,1
GR,BLOOD GLUCOSE INCREASED,1
GR,BLOOD HOMOCYSTEINE INCREASED,1
GR,BLOOD POTASSIUM DECREASED,1
GR,BLOOD PRESSURE FLUCTUATION,1
GR,BLOOD PRESSURE INCREASED,1
GR,BLOOD SMEAR TEST ABNORMAL,1
GR,BLOOD TRIGLYCERIDES INCREASED,1
GR,BLOOD UREA INCREASED,1
GR,BLOOD URINE PRESENT,1
GR,BONE MARROW FAILURE,1
GR,BONE PAIN,1
GR,BRADYCARDIA,1
GR,BREAST CANCER,1
GR,BRONCHITIS,1
GR,BRONCHOSPASM,1
GR,BURNING SENSATION,1
GR,CANCER PAIN,1
GR,CARDIAC DISORDER,1
GR,CARDIAC FAILURE CHRONIC,1
GR,CARDIOGENIC SHOCK,1
GR,CAROTID ARTERIOSCLEROSIS,1
GR,CEREBRAL HAEMORRHAGE,1
GR,CHILLS,1
GR,CHOKING SENSATION,1
GR,CHOLESTASIS,1
GR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
GR,CLONIC CONVULSION,1
GR,COAGULOPATHY,1
GR,CONVULSION,1
GR,CROSS SENSITIVITY REACTION,1
GR,CYANOSIS,1
GR,DEAFNESS TRANSITORY,1
GR,DEEP VEIN THROMBOSIS,1
GR,DEFAECATION URGENCY,1
GR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
GR,DEPRESSED MOOD,1
GR,DERMATITIS ALLERGIC,1
GR,DEVICE INTERACTION,1
GR,DIABETIC KETOACIDOSIS,1
GR,DIPLOPIA,1
GR,DIVERTICULITIS,1
GR,DRUG INTOLERANCE,1
GR,DRUG PRESCRIBING ERROR,1
GR,DRY MOUTH,1
GR,DRY SKIN,1
GR,DYSARTHRIA,1
GR,DYSSTASIA,1
GR,EAR INFECTION,1
GR,EMBOLISM ARTERIAL,1
GR,ENTERITIS,1
GR,ENTEROCOLITIS,1
GR,EOSINOPHILIA,1
GR,ESCHERICHIA URINARY TRACT INFECTION,1
GR,EXFOLIATIVE RASH,1
GR,EYE PAIN,1
GR,FACE OEDEMA,1
GR,FAECES DISCOLOURED,1
GR,FAT TISSUE INCREASED,1
GR,FEAR,1
GR,FEBRILE NEUTROPENIA,1
GR,FEELING ABNORMAL,1
GR,FEMUR FRACTURE,1
GR,FLATULENCE,1
GR,FLUID OVERLOAD,1
GR,FLUID RETENTION,1
GR,GAIT DISTURBANCE,1
GR,GANGRENE,1
GR,GASTROENTERITIS,1
GR,GASTROINTESTINAL DISORDER,1
GR,GENERAL PHYSICAL HEALTH DETERIORATION,1
GR,HAEMANGIOMA,1
GR,HAEMATURIA,1
GR,HAEMOGLOBIN DECREASED,1
GR,HAEMOGLOBIN DISTRIBUTION WIDTH INCREASED,1
GR,HAEMOGLOBIN INCREASED,1
GR,HAEMOPTYSIS,1
GR,HAEMORRHAGE INTRACRANIAL,1
GR,HAEMORRHAGIC STROKE,1
GR,HAEMORRHOIDAL HAEMORRHAGE,1
GR,HAEMOTHORAX,1
GR,HEAD INJURY,1
GR,HEART RATE DECREASED,1
GR,HEART RATE INCREASED,1
GR,HEMIPLEGIA,1
GR,HEPATIC VEIN OCCLUSION,1
GR,HEPATOMEGALY,1
GR,HEPATOTOXICITY,1
GR,HERPES ZOSTER,1
GR,HIP FRACTURE,1
GR,HYDROCELE,1
GR,HYPERGLYCAEMIA,1
GR,HYPERHIDROSIS,1
GR,HYPERKERATOSIS,1
GR,HYPOCALCAEMIA,1
GR,HYPOGLYCAEMIA,1
GR,HYPOGLYCAEMIC COMA,1
GR,HYPOVOLAEMIA,1
GR,ILEUS,1
GR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
GR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
GR,INCORRECT DOSE ADMINISTERED,1
GR,INCORRECT DRUG ADMINISTRATION DURATION,1
GR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
GR,INJECTION SITE ERYTHEMA,1
GR,INSOMNIA,1
GR,INTENTIONAL PRODUCT MISUSE,1
GR,INTERNATIONAL NORMALISED RATIO INCREASED,1
GR,INTERVERTEBRAL DISC PROTRUSION,1
GR,INTESTINAL HAEMORRHAGE,1
GR,INTRA-ABDOMINAL FLUID COLLECTION,1
GR,JUGULAR VEIN DISTENSION,1
GR,KOUNIS SYNDROME,1
GR,LACRIMATION INCREASED,1
GR,LEUKOENCEPHALOPATHY,1
GR,LEUKOPENIA,1
GR,LIBIDO DECREASED,1
GR,LIP ULCERATION,1
GR,LIPASE INCREASED,1
GR,LIVER FUNCTION TEST ABNORMAL,1
GR,LUNG INFECTION,1
GR,LYMPHOCYTE COUNT DECREASED,1
GR,MASS,1
GR,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
GR,MEAN CELL HAEMOGLOBIN DECREASED,1
GR,MEAN CELL VOLUME DECREASED,1
GR,MEAN PLATELET VOLUME INCREASED,1
GR,MEMORY IMPAIRMENT,1
GR,MITRAL VALVE INCOMPETENCE,1
GR,MONOCYTE COUNT DECREASED,1
GR,MONONUCLEAR CELL COUNT ABNORMAL,1
GR,MOVEMENT DISORDER,1
GR,MUSCLE TONE DISORDER,1
GR,MUSCLE TWITCHING,1
GR,MUSCULOSKELETAL STIFFNESS,1
GR,MYELODYSPLASTIC SYNDROME,1
GR,MYOCARDIAL ISCHAEMIA,1
GR,NASAL DRYNESS,1
GR,NASAL OEDEMA,1
GR,NEPHROLITHIASIS,1
GR,NEURALGIA,1
GR,NEUROPATHY PERIPHERAL,1
GR,NO THERAPEUTIC RESPONSE,1
GR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
GR,OESOPHAGEAL DISORDER,1
GR,ORAL PRURITUS,1
GR,OSTEOLYSIS,1
GR,PALLOR,1
GR,PALPITATIONS,1
GR,PANCREATIC CARCINOMA,1
GR,PANCREATIC MASS,1
GR,PANCYTOPENIA,1
GR,PARALYSIS,1
GR,PEMPHIGOID,1
GR,PERICARDIAL EFFUSION,1
GR,PERICARDITIS,1
GR,PERIPHERAL SWELLING,1
GR,PERITONITIS,1
GR,PIGMENTATION DISORDER,1
GR,PLASMA CELL MYELOMA,1
GR,PLASMACYTOMA,1
GR,PLATELET COUNT INCREASED,1
GR,PLEURAL EFFUSION,1
GR,PLEURISY,1
GR,PNEUMONIA VIRAL,1
GR,POLLAKIURIA,1
GR,POST PROCEDURAL HAEMORRHAGE,1
GR,POST PROCEDURAL MYOCARDIAL INFARCTION,1
GR,PRESCRIBED OVERDOSE,1
GR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
GR,PSEUDOMONAS INFECTION,1
GR,PSORIASIS,1
GR,PULMONARY HAEMORRHAGE,1
GR,PULMONARY HYPERTENSION,1
GR,PUPILLARY REFLEX IMPAIRED,1
GR,RASH GENERALISED,1
GR,RASH PUSTULAR,1
GR,RED BLOOD CELL ANISOCYTES PRESENT,1
GR,RED BLOOD CELL ELLIPTOCYTES PRESENT,1
GR,RED BLOOD CELL HYPOCHROMIC MORPHOLOGY PRESENT,1
GR,RED CELL DISTRIBUTION WIDTH INCREASED,1
GR,RETINAL ARTERY THROMBOSIS,1
GR,RHEUMATOID FACTOR INCREASED,1
GR,ROAD TRAFFIC ACCIDENT,1
GR,SECOND PRIMARY MALIGNANCY,1
GR,SEPSIS,1
GR,SKIN CANCER,1
GR,SKIN EXFOLIATION,1
GR,SKIN LESION,1
GR,SKIN OEDEMA,1
GR,SPLENOMEGALY,1
GR,STOMATITIS,1
GR,STRESS,1
GR,SUDDEN CARDIAC DEATH,1
GR,SWOLLEN TONGUE,1
GR,TACHYCARDIA,1
GR,THROAT IRRITATION,1
GR,THROAT TIGHTNESS,1
GR,THROMBOPHLEBITIS,1
GR,THROMBOTIC STROKE,1
GR,TONGUE DISORDER,1
GR,TONGUE ULCERATION,1
GR,TOOTH ABSCESS,1
GR,TRANSIENT ISCHAEMIC ATTACK,1
GR,TREMOR,1
GR,ULTRAFILTRATION FAILURE,1
GR,UPPER RESPIRATORY TRACT INFECTION,1
GR,URINARY RETENTION,1
GR,URINE OUTPUT DECREASED,1
GR,URINE OUTPUT INCREASED,1
GR,URTICARIA,1
GR,UTERINE POLYP,1
GR,VASCULAR STENT THROMBOSIS,1
GR,VENA CAVA THROMBOSIS,1
GR,WHITE BLOOD CELL COUNT DECREASED,1
GR,WOUND,1
GR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
GT,MALAISE,2
GT,ABNORMAL BEHAVIOUR,1
GT,AGGRESSION,1
GT,ARTHRALGIA,1
GT,ATRIAL FIBRILLATION,1
GT,BONE DISORDER,1
GT,CARDIAC DISORDER,1
GT,CARDIAC FAILURE,1
GT,CEREBROVASCULAR ACCIDENT,1
GT,DEATH,1
GT,DEMENTIA ALZHEIMER^S TYPE,1
GT,DIABETES MELLITUS,1
GT,DISORIENTATION,1
GT,GASTROINTESTINAL DISORDER,1
GT,HAEMATURIA,1
GT,INFARCTION,1
GT,INTRAOCULAR HAEMATOMA,1
GT,LUNG DISORDER,1
GT,NERVOUS SYSTEM DISORDER,1
GT,OSTEOARTHRITIS,1
GT,PRESCRIBED UNDERDOSE,1
GT,PROCEDURAL HAEMORRHAGE,1
GT,PROSTATE CANCER,1
GT,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
GT,RENAL FAILURE,1
GT,SUDDEN DEATH,1
GT,URINARY TRACT INFECTION,1
GT,VISUAL ACUITY REDUCED,1
GT,VISUAL IMPAIRMENT,1
GT,WEIGHT DECREASED,1
GT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
HN,ASTHENIA,1
HN,CHEST PAIN,1
HN,DIZZINESS,1
HN,HYPOTENSION,1
HN,NAUSEA,1
HN,VOMITING,1
HK,RETROPERITONEAL HAEMATOMA,3
HK,ANAEMIA,2
HK,ABDOMINAL WALL HAEMATOMA,1
HK,CACHEXIA,1
HK,CARDIOVASCULAR DISORDER,1
HK,CHEST PAIN,1
HK,COAGULOPATHY,1
HK,DEATH,1
HK,DIABETES MELLITUS INADEQUATE CONTROL,1
HK,ECCHYMOSIS,1
HK,HAEMODYNAMIC INSTABILITY,1
HK,HAEMORRHAGE INTRACRANIAL,1
HK,ISCHAEMIC STROKE,1
HK,MALAISE,1
HK,MUSCULOSKELETAL DISCOMFORT,1
HK,OVARIAN NEOPLASM,1
HK,OVERDOSE,1
HK,RENAL IMPAIRMENT,1
HK,SLEEP APNOEA SYNDROME,1
HK,SOMNOLENCE,1
HK,VESSEL PUNCTURE SITE HAEMATOMA,1
HU,ANAEMIA,12
HU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,7
HU,ACUTE MYOCARDIAL INFARCTION,5
HU,CHEST PAIN,5
HU,DIZZINESS,5
HU,HAEMATURIA,5
HU,HAEMORRHAGIC ANAEMIA,5
HU,INTERNATIONAL NORMALISED RATIO INCREASED,5
HU,VENTRICULAR FIBRILLATION,5
HU,ASTHENIA,4
HU,ATRIAL FIBRILLATION,4
HU,BLOOD PRESSURE INCREASED,4
HU,CARDIAC FAILURE,4
HU,DIARRHOEA,4
HU,DISEASE PROGRESSION,4
HU,DRUG ADMINISTRATION ERROR,4
HU,DYSPNOEA,4
HU,FATIGUE,4
HU,GASTRITIS EROSIVE,4
HU,HAEMORRHOIDAL HAEMORRHAGE,4
HU,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
HU,CONCOMITANT DISEASE PROGRESSION,3
HU,GASTRIC HAEMORRHAGE,3
HU,HAEMATOMA,3
HU,HEPATIC ENZYME INCREASED,3
HU,HYPERHIDROSIS,3
HU,HYPOTENSION,3
HU,IRON DEFICIENCY ANAEMIA,3
HU,ISCHAEMIC STROKE,3
HU,MELAENA,3
HU,MUSCULAR WEAKNESS,3
HU,PRODUCT USE IN UNAPPROVED INDICATION,3
HU,URINARY RETENTION,3
HU,VISUAL IMPAIRMENT,3
HU,ANGINA PECTORIS,2
HU,APHASIA,2
HU,CANDIDA INFECTION,2
HU,CARDIAC ARREST,2
HU,CARDIOPULMONARY FAILURE,2
HU,CIRCULATORY COLLAPSE,2
HU,CONTRAINDICATED PRODUCT ADMINISTERED,2
HU,COUGH,2
HU,DEATH,2
HU,DEEP VEIN THROMBOSIS,2
HU,DEHYDRATION,2
HU,DIVERTICULITIS,2
HU,DRUG INEFFECTIVE,2
HU,DRUG PRESCRIBING ERROR,2
HU,DYSPHONIA,2
HU,FALL,2
HU,FEMUR FRACTURE,2
HU,GASTROINTESTINAL HAEMORRHAGE,2
HU,HAEMATEMESIS,2
HU,HAEMATOCHEZIA,2
HU,HAEMORRHAGE,2
HU,HEPATIC FAILURE,2
HU,HYPOXIA,2
HU,INFLAMMATORY MARKER INCREASED,2
HU,LOSS OF CONSCIOUSNESS,2
HU,LOWER GASTROINTESTINAL HAEMORRHAGE,2
HU,LUNG ADENOCARCINOMA,2
HU,MALAISE,2
HU,MICTURITION URGENCY,2
HU,MYOCARDIAL INFARCTION,2
HU,NAUSEA,2
HU,OEDEMA PERIPHERAL,2
HU,PARAPARESIS,2
HU,PNEUMONIA,2
HU,PSYCHOTIC DISORDER,2
HU,PYREXIA,2
HU,RENAL FAILURE,2
HU,RENAL IMPAIRMENT,2
HU,RESPIRATORY FAILURE,2
HU,SHOCK HAEMORRHAGIC,2
HU,STOMATITIS,2
HU,TRANSFUSION,2
HU,UROSEPSIS,2
HU,VASCULAR STENT THROMBOSIS,2
HU,ABDOMINAL DISTENSION,1
HU,ABDOMINAL PAIN LOWER,1
HU,ABDOMINAL PAIN UPPER,1
HU,ACCIDENT,1
HU,ACIDOSIS,1
HU,ACQUIRED HAEMOPHILIA WITH ANTI FVIII_ XI_ OR XIII,1
HU,ACUTE CORONARY SYNDROME,1
HU,ACUTE KIDNEY INJURY,1
HU,ACUTE MYELOID LEUKAEMIA,1
HU,ALOPECIA,1
HU,ANKLE FRACTURE,1
HU,ANURIA,1
HU,AORTIC STENOSIS,1
HU,AORTIC THROMBOSIS,1
HU,APNOEA,1
HU,ARTERIOGRAM CORONARY,1
HU,ARTERIOSCLEROSIS CORONARY ARTERY,1
HU,ARTHRALGIA,1
HU,ASCITES,1
HU,ASPIRATION,1
HU,AUTOIMMUNE DISORDER,1
HU,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
HU,AZOTAEMIA,1
HU,BACK PAIN,1
HU,BASAL GANGLIA HAEMORRHAGE,1
HU,BENIGN PROSTATIC HYPERPLASIA,1
HU,BLADDER CANCER,1
HU,BLEEDING TIME PROLONGED,1
HU,BLISTER,1
HU,BLOOD BILIRUBIN INCREASED,1
HU,BLOOD CREATININE INCREASED,1
HU,BLOOD TEST,1
HU,CARDIAC FAILURE ACUTE,1
HU,CARDIAC FAILURE CONGESTIVE,1
HU,CARDIAC TAMPONADE,1
HU,CARDIOVERSION,1
HU,CEREBRAL HAEMORRHAGE,1
HU,CEREBROVASCULAR ACCIDENT,1
HU,CEREBROVASCULAR DISORDER,1
HU,CEREBROVASCULAR INSUFFICIENCY,1
HU,CHRONIC KIDNEY DISEASE,1
HU,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
HU,CLOSTRIDIUM DIFFICILE COLITIS,1
HU,COMPLEX REGIONAL PAIN SYNDROME,1
HU,CONDITION AGGRAVATED,1
HU,CONTUSION,1
HU,COORDINATION ABNORMAL,1
HU,CRYPTOCOCCOSIS,1
HU,CYSTITIS,1
HU,CYSTITIS HAEMORRHAGIC,1
HU,DECREASED APPETITE,1
HU,DECUBITUS ULCER,1
HU,DEVICE DISLOCATION,1
HU,DIABETIC KETOACIDOSIS,1
HU,DIVERTICULUM INTESTINAL,1
HU,DRUG EFFECT INCOMPLETE,1
HU,DRUG RESISTANCE,1
HU,DRY SKIN,1
HU,DYSPHAGIA,1
HU,ENCEPHALOMALACIA,1
HU,ENTEROCOCCAL INFECTION,1
HU,EPISTAXIS,1
HU,ERYTHEMA,1
HU,EXTRAVASATION BLOOD,1
HU,FEMORAL ARTERY EMBOLISM,1
HU,GAIT DISTURBANCE,1
HU,GASTROINTESTINAL NECROSIS,1
HU,GLOMERULAR FILTRATION RATE DECREASED,1
HU,GLOSSITIS,1
HU,HAEMOGLOBIN DECREASED,1
HU,HEAD INJURY,1
HU,HEPATIC CIRRHOSIS,1
HU,HEPATOMEGALY,1
HU,HYPERNATRAEMIA,1
HU,HYPERTENSION,1
HU,HYPOTONIA,1
HU,HYPOVOLAEMIC SHOCK,1
HU,INFECTION,1
HU,INTESTINAL OBSTRUCTION,1
HU,KIDNEY ANGIOMYOLIPOMA,1
HU,KLEBSIELLA INFECTION,1
HU,LACUNAR STROKE,1
HU,LUNG NEOPLASM MALIGNANT,1
HU,MENTAL IMPAIRMENT,1
HU,MESENTERIC ARTERY THROMBOSIS,1
HU,METABOLIC ACIDOSIS,1
HU,METASTATIC MALIGNANT MELANOMA,1
HU,MOUTH HAEMORRHAGE,1
HU,MUCOSAL INFLAMMATION,1
HU,MUSCLE ABSCESS,1
HU,MUSCLE HAEMORRHAGE,1
HU,MUSCLE SPASMS,1
HU,MUSCULOSKELETAL PAIN,1
HU,MYALGIA,1
HU,MYELODYSPLASTIC SYNDROME,1
HU,MYOPATHY TOXIC,1
HU,NECK PAIN,1
HU,NEOPLASM,1
HU,NEURITIS,1
HU,NEUTROPENIA,1
HU,NON-CARDIAC CHEST PAIN,1
HU,OPTIC NEURITIS,1
HU,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
HU,PALPITATIONS,1
HU,PANCREATIC CARCINOMA,1
HU,PANCREATITIS,1
HU,PARKINSON^S DISEASE,1
HU,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
HU,PNEUMONIA ESCHERICHIA,1
HU,POST PROCEDURAL HAEMORRHAGE,1
HU,PRESCRIBED UNDERDOSE,1
HU,PRURITUS,1
HU,PRURITUS GENERALISED,1
HU,PULMONARY ARTERIAL HYPERTENSION,1
HU,PULMONARY EMBOLISM,1
HU,PULMONARY HYPERTENSION,1
HU,PULSE ABSENT,1
HU,PYELONEPHRITIS,1
HU,RASH MACULAR,1
HU,RENAL DISORDER,1
HU,RESPIRATORY DISTRESS,1
HU,RHEUMATOID ARTHRITIS,1
HU,RICHTER^S SYNDROME,1
HU,RIGHT VENTRICULAR FAILURE,1
HU,ROAD TRAFFIC ACCIDENT,1
HU,SEPTIC SHOCK,1
HU,SHOCK,1
HU,SINUS TACHYCARDIA,1
HU,SKIN HAEMORRHAGE,1
HU,SOMNOLENCE,1
HU,SPINAL COMPRESSION FRACTURE,1
HU,SPINAL CORD COMPRESSION,1
HU,STAPHYLOCOCCAL INFECTION,1
HU,STOMA SITE DISCHARGE,1
HU,STOMA SITE GRANULOMA,1
HU,SUBACUTE HEPATIC FAILURE,1
HU,SUBARACHNOID HAEMORRHAGE,1
HU,SUDDEN DEATH,1
HU,SURGERY,1
HU,SWOLLEN TONGUE,1
HU,SYNCOPE,1
HU,THROMBOCYTOPENIA,1
HU,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
HU,TOOTH AVULSION,1
HU,TRACHEOSTOMY,1
HU,TRANSIENT ISCHAEMIC ATTACK,1
HU,TRAUMATIC HAEMORRHAGE,1
HU,URTICARIA,1
HU,VAGINAL HAEMORRHAGE,1
HU,VASCULAR ENCEPHALOPATHY,1
HU,VERTIGO POSITIONAL,1
HU,VISION BLURRED,1
HU,WALKING AID USER,1
HU,WEIGHT DECREASED,1
HU,WEIGHT INCREASED,1
IS,JAUNDICE,3
IS,HEPATITIS ACUTE,2
IS,HEPATOTOXICITY,2
IS,ABDOMINAL PAIN,1
IS,CHILLS,1
IS,CHROMATURIA,1
IS,DRUG-INDUCED LIVER INJURY,1
IS,GENERAL PHYSICAL HEALTH DETERIORATION,1
IS,HYPERHIDROSIS,1
IS,MYALGIA,1
IN,CARDIAC ARREST,12
IN,OVERDOSE,11
IN,SHOCK,10
IN,CARDIOGENIC SHOCK,9
IN,METABOLIC ACIDOSIS,9
IN,BRADYCARDIA,8
IN,DRUG INEFFECTIVE,8
IN,DYSARTHRIA,8
IN,RENAL FAILURE ACUTE,8
IN,RESPIRATORY ALKALOSIS,8
IN,RHABDOMYOLYSIS,8
IN,ATAXIA,7
IN,CONFUSIONAL STATE,7
IN,HAEMOTHORAX,7
IN,THROMBOCYTOPENIA,7
IN,VOMITING,7
IN,BUNDLE BRANCH BLOCK RIGHT,6
IN,CEREBELLAR SYNDROME,6
IN,TORSADE DE POINTES,6
IN,ANURIA,5
IN,ELECTROCARDIOGRAM QT PROLONGED,5
IN,HAEMATOMA,5
IN,HAEMOGLOBIN DECREASED,5
IN,HALLUCINATION_ VISUAL,5
IN,HYPERSENSITIVITY VASCULITIS,5
IN,MELAENA,5
IN,NAUSEA,5
IN,PSORIASIS,5
IN,BLOOD PRESSURE DECREASED,4
IN,CHEST PAIN,4
IN,DYSPNOEA,4
IN,MULTI-ORGAN FAILURE,4
IN,PYREXIA,4
IN,THROMBOTIC THROMBOCYTOPENIC PURPURA,4
IN,TOXICITY TO VARIOUS AGENTS,4
IN,VASCULAR STENT THROMBOSIS,4
IN,ABDOMINAL DISCOMFORT,3
IN,ANAEMIA,3
IN,ANXIETY,3
IN,CHILLS,3
IN,DEATH,3
IN,DRUG ADMINISTRATION ERROR,3
IN,DRUG-INDUCED LIVER INJURY,3
IN,GAIT DISTURBANCE,3
IN,GASTRITIS EROSIVE,3
IN,HAEMORRHAGE INTRACRANIAL,3
IN,HAEMORRHAGIC INFARCTION,3
IN,HALLUCINATION,3
IN,HEPATIC ENCEPHALOPATHY,3
IN,HYPOTENSION,3
IN,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
IN,MYALGIA,3
IN,NODAL ARRHYTHMIA,3
IN,ORTHOSTATIC HYPOTENSION,3
IN,OXYGEN SATURATION DECREASED,3
IN,SPINAL EPIDURAL HAEMATOMA,3
IN,TACHYCARDIA,3
IN,THROMBOSIS,3
IN,VESSEL PUNCTURE SITE HAEMATOMA,3
IN,ABDOMINAL PAIN UPPER,2
IN,ABNORMAL BEHAVIOUR,2
IN,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
IN,ACUTE KIDNEY INJURY,2
IN,ACUTE MYOCARDIAL INFARCTION,2
IN,ANAPHYLACTIC REACTION,2
IN,ASTHENIA,2
IN,BACK PAIN,2
IN,BRAIN STEM STROKE,2
IN,CEREBRAL HAEMORRHAGE,2
IN,CHROMATURIA,2
IN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
IN,COAGULOPATHY,2
IN,COUGH,2
IN,DECREASED APPETITE,2
IN,DRUG PRESCRIBING ERROR,2
IN,DYSPHAGIA,2
IN,ECCHYMOSIS,2
IN,HAEMATEMESIS,2
IN,HAEMATURIA,2
IN,HAEMORRHAGE,2
IN,HEART RATE DECREASED,2
IN,HEART RATE INCREASED,2
IN,HYPERSENSITIVITY,2
IN,HYPOAESTHESIA,2
IN,HYPOKALAEMIA,2
IN,INTENTIONAL OVERDOSE,2
IN,ISCHAEMIC STROKE,2
IN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
IN,NODAL RHYTHM,2
IN,ORTHOPNOEA,2
IN,PAIN IN EXTREMITY,2
IN,PALLOR,2
IN,PERIPHERAL COLDNESS,2
IN,POSTURE ABNORMAL,2
IN,PREMATURE DELIVERY,2
IN,PUSTULAR PSORIASIS,2
IN,TACHYPNOEA,2
IN,THROMBOSIS IN DEVICE,2
IN,URINE OUTPUT DECREASED,2
IN,VENTRICULAR FIBRILLATION,2
IN,VENTRICULAR TACHYCARDIA,2
IN,WEIGHT DECREASED,2
IN,ABDOMINAL PAIN,1
IN,ABDOMINAL TENDERNESS,1
IN,ABDOMINAL WALL HAEMATOMA,1
IN,ACUTE CORONARY SYNDROME,1
IN,ADVERSE EVENT,1
IN,ALANINE AMINOTRANSFERASE INCREASED,1
IN,ALOPECIA,1
IN,ANEURYSM RECANALISATION,1
IN,ANGINA UNSTABLE,1
IN,AORTIC OCCLUSION,1
IN,AREFLEXIA,1
IN,ARTERIOSCLEROSIS,1
IN,ASPARTATE AMINOTRANSFERASE INCREASED,1
IN,BLADDER CANCER,1
IN,BLINDNESS TRANSIENT,1
IN,BLISTER,1
IN,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IN,BLOOD CALCIUM DECREASED,1
IN,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IN,BLOOD CREATININE INCREASED,1
IN,BLOOD PHOSPHORUS INCREASED,1
IN,BLOOD UREA INCREASED,1
IN,BLOOD URIC ACID INCREASED,1
IN,BRAIN STEM HAEMORRHAGE,1
IN,BREAST CANCER,1
IN,BREATH SOUNDS ABSENT,1
IN,CARDIAC FAILURE,1
IN,CARDIO-RESPIRATORY ARREST,1
IN,CARDIOMEGALY,1
IN,CEREBRAL INFARCTION,1
IN,CEREBROVASCULAR ACCIDENT,1
IN,CONCOMITANT DISEASE AGGRAVATED,1
IN,CONCOMITANT DISEASE PROGRESSION,1
IN,CONDITION AGGRAVATED,1
IN,CONTRAINDICATED PRODUCT ADMINISTERED,1
IN,DECUBITUS ULCER,1
IN,DEEP VEIN THROMBOSIS,1
IN,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IN,DIABETIC AMYOTROPHY,1
IN,DIZZINESS,1
IN,DYSMETRIA,1
IN,ELECTROCARDIOGRAM P WAVE ABNORMAL,1
IN,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
IN,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
IN,ELECTROLYTE IMBALANCE,1
IN,EMBOLIC STROKE,1
IN,EPISTAXIS,1
IN,EXPOSURE DURING PREGNANCY,1
IN,EXTRAPYRAMIDAL DISORDER,1
IN,FACE OEDEMA,1
IN,FEELING HOT,1
IN,FOETAL EXPOSURE DURING PREGNANCY,1
IN,GASTRIC HAEMORRHAGE,1
IN,GASTRIC ULCER,1
IN,GASTROENTERITIS,1
IN,GASTROOESOPHAGEAL REFLUX DISEASE,1
IN,GENERAL PHYSICAL HEALTH DETERIORATION,1
IN,HAEMODIALYSIS,1
IN,HAEMOLYSIS,1
IN,HAEMORRHAGIC CEREBRAL INFARCTION,1
IN,HEADACHE,1
IN,HEPATITIS FULMINANT,1
IN,HYPERKALAEMIA,1
IN,HYPERURICAEMIA,1
IN,HYPOKINESIA,1
IN,HYPONATRAEMIA,1
IN,HYPOREFLEXIA,1
IN,HYPOTONIA,1
IN,HYPOXIA,1
IN,ILIAC ARTERY OCCLUSION,1
IN,ILLUSION,1
IN,INFECTION,1
IN,INSULIN AUTOIMMUNE SYNDROME,1
IN,INTESTINAL PERFORATION,1
IN,IRRITABILITY,1
IN,JAUNDICE,1
IN,LARGE INTESTINAL HAEMORRHAGE,1
IN,LEFT VENTRICULAR FAILURE,1
IN,LEUKOCYTOCLASTIC VASCULITIS,1
IN,LIP SWELLING,1
IN,LOCAL SWELLING,1
IN,LOSS OF CONSCIOUSNESS,1
IN,LOW BIRTH WEIGHT BABY,1
IN,MALAISE,1
IN,MATERNAL EXPOSURE DURING PREGNANCY,1
IN,MEDICATION ERROR,1
IN,MOUTH HAEMORRHAGE,1
IN,MUCOCUTANEOUS HAEMORRHAGE,1
IN,MUSCLE HAEMORRHAGE,1
IN,MUSCULAR WEAKNESS,1
IN,MYOGLOBIN URINE PRESENT,1
IN,NEPHROLITHIASIS,1
IN,NEUROTOXICITY,1
IN,OEDEMA PERIPHERAL,1
IN,OESOPHAGEAL COMPRESSION,1
IN,OESOPHAGEAL RUPTURE,1
IN,ORAL PAIN,1
IN,PAIN,1
IN,PANCYTOPENIA,1
IN,PARAPLEGIA,1
IN,PARATYPHOID FEVER,1
IN,PERIPHERAL SWELLING,1
IN,PLATELET COUNT DECREASED,1
IN,PLATELET DYSFUNCTION,1
IN,PLEURAL EFFUSION,1
IN,PNEUMONIA,1
IN,PORTAL VEIN EMBOLISATION,1
IN,POST PROCEDURAL HAEMATOMA,1
IN,PREMATURE BABY,1
IN,PROCEDURAL HAEMORRHAGE,1
IN,PROTHROMBIN TIME PROLONGED,1
IN,PRURITUS GENERALISED,1
IN,PULMONARY EMBOLISM,1
IN,PULMONARY HYPERTENSION,1
IN,PUNCTURE SITE HAEMORRHAGE,1
IN,PURPURA,1
IN,RENAL FAILURE CHRONIC,1
IN,RESPIRATORY FAILURE,1
IN,RESPIRATORY RATE INCREASED,1
IN,RESTLESSNESS,1
IN,RETCHING,1
IN,RETINAL HAEMORRHAGE,1
IN,RHONCHI,1
IN,SEIZURE,1
IN,SENSORY DISTURBANCE,1
IN,SENSORY LOSS,1
IN,SKIN EROSION,1
IN,SKIN PLAQUE,1
IN,SMALL INTESTINAL HAEMORRHAGE,1
IN,SPINAL CORD COMPRESSION,1
IN,SPINAL CORD INJURY CERVICAL,1
IN,STEVENS-JOHNSON SYNDROME,1
IN,STRABISMUS,1
IN,SUBDURAL HAEMATOMA,1
IN,SUBDURAL HAEMORRHAGE,1
IN,SUSPECTED COUNTERFEIT PRODUCT,1
IN,SWELLING FACE,1
IN,THERAPEUTIC RESPONSE DECREASED,1
IN,THINKING ABNORMAL,1
IN,TUBERCULOSIS,1
IN,ULCER,1
IN,UPPER GASTROINTESTINAL HAEMORRHAGE,1
IN,URINARY INCONTINENCE,1
IN,URINARY RETENTION,1
IN,URINARY TRACT INFECTION,1
IN,UROSEPSIS,1
IN,VAGINAL HAEMORRHAGE,1
IN,VASOSPASM,1
IN,VOLVULUS,1
IN,WHEEZING,1
IN,WHITE BLOOD CELL COUNT DECREASED,1
ID,DRUG RESISTANCE,5
ID,DEATH,3
ID,ACUTE CORONARY SYNDROME,2
ID,ACUTE MYOCARDIAL INFARCTION,2
ID,CHEST PAIN,2
ID,HAEMATURIA,2
ID,MYOCARDIAL INFARCTION,2
ID,ACUTE RESPIRATORY FAILURE,1
ID,ANAEMIA,1
ID,ASPIRATION,1
ID,BLOOD PRESSURE DECREASED,1
ID,CARDIAC ARREST,1
ID,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
ID,CORONARY ARTERY DISEASE,1
ID,CORONARY ARTERY RESTENOSIS,1
ID,DEFAECATION URGENCY,1
ID,DYSPNOEA,1
ID,EJECTION FRACTION DECREASED,1
ID,HEADACHE,1
ID,HYPOTENSION,1
ID,INFARCTION,1
ID,INTENTIONAL DRUG MISUSE,1
ID,INTRACRANIAL HAEMATOMA,1
ID,ISCHAEMIC STROKE,1
ID,LOSS OF CONSCIOUSNESS,1
ID,MALIGNANT NEOPLASM PROGRESSION,1
ID,MUSCLE STRAIN,1
ID,NAUSEA,1
ID,PERIPHERAL COLDNESS,1
ID,PLATELET AGGREGATION INHIBITION,1
ID,PYREXIA,1
ID,SOMNOLENCE,1
ID,SYNCOPE,1
ID,THROMBOSIS,1
ID,THROMBOSIS IN DEVICE,1
ID,URINARY TRACT INFECTION,1
ID,VASCULAR STENT THROMBOSIS,1
ID,VENTRICULAR TACHYCARDIA,1
IR,VASCULAR PSEUDOANEURYSM,8
IR,CARDIOGENIC SHOCK,4
IR,PARADOXICAL EMBOLISM,3
IR,DRUG INEFFECTIVE,2
IR,HEMIPLEGIA,2
IR,MYOCARDIAL INFARCTION,2
IR,AGITATION,1
IR,CARDIAC ARREST,1
IR,CEREBROVASCULAR ACCIDENT,1
IR,CHEST PAIN,1
IR,DYSPNOEA,1
IR,EYE IRRITATION,1
IR,HAEMATEMESIS,1
IR,HAEMOGLOBIN DECREASED,1
IR,HEPATITIS ACUTE,1
IR,HYPOTENSION,1
IR,ISCHAEMIA,1
IR,ISCHAEMIC STROKE,1
IR,JAUNDICE,1
IR,JAUNDICE CHOLESTATIC,1
IR,LARYNGOSPASM,1
IR,LIVER FUNCTION TEST ABNORMAL,1
IR,MASS,1
IR,MELAENA,1
IR,OCULAR HYPERAEMIA,1
IR,PAIN IN EXTREMITY,1
IR,PALPITATIONS,1
IR,PERICARDIAL EFFUSION,1
IR,PRURITUS,1
IR,PULMONARY ARTERIAL HYPERTENSION,1
IR,SKIN MASS,1
IR,SUBCUTANEOUS HAEMATOMA,1
IR,THERAPEUTIC PRODUCT INEFFECTIVE,1
IR,THROMBOSIS,1
IR,URTICARIA,1
IR,VASCULAR PSEUDOANEURYSM THROMBOSIS,1
IQ,HEADACHE,4
IQ,THALAMUS HAEMORRHAGE,4
IQ,DEATH,2
IQ,DEPRESSED LEVEL OF CONSCIOUSNESS,2
IQ,DYSPHAGIA,2
IQ,EXTENSOR PLANTAR RESPONSE,2
IQ,HEMIPARESIS,2
IQ,LOSS OF CONSCIOUSNESS,2
IQ,QUADRIPLEGIA,2
IQ,APHASIA,1
IQ,CIRCULATORY COLLAPSE,1
IQ,DIZZINESS,1
IQ,DRUG INEFFECTIVE,1
IQ,GASTROINTESTINAL DISORDER,1
IQ,HYPERREFLEXIA,1
IQ,HYPOREFLEXIA,1
IQ,LEFT VENTRICULAR HYPERTROPHY,1
IQ,QUADRIPARESIS,1
IQ,SUSPECTED COUNTERFEIT PRODUCT,1
IQ,VOMITING,1
IE,DEATH,14
IE,FALL,8
IE,NAUSEA,8
IE,HEADACHE,6
IE,MALAISE,6
IE,ABDOMINAL PAIN,5
IE,DYSPNOEA,5
IE,PAIN,5
IE,VOMITING,5
IE,ABDOMINAL DISCOMFORT,4
IE,DIARRHOEA,4
IE,LOWER RESPIRATORY TRACT INFECTION,4
IE,OROPHARYNGEAL PAIN,4
IE,PRODUCT USE ISSUE,4
IE,RESPIRATORY TRACT INFECTION,4
IE,URINARY TRACT INFECTION,4
IE,ANAEMIA,3
IE,BLOOD GLUCOSE INCREASED,3
IE,BLOOD PRESSURE ABNORMAL,3
IE,CONSTIPATION,3
IE,DIABETES MELLITUS INADEQUATE CONTROL,3
IE,DYSURIA,3
IE,HAEMOGLOBIN ABNORMAL,3
IE,HYPERTENSION,3
IE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,3
IE,INSOMNIA,3
IE,MUSCULAR WEAKNESS,3
IE,MYOCARDIAL ISCHAEMIA,3
IE,PAIN IN EXTREMITY,3
IE,PNEUMONIA,3
IE,POLLAKIURIA,3
IE,PRURITUS GENERALISED,3
IE,ANAPHYLACTIC REACTION,2
IE,ARTHRALGIA,2
IE,ARTHRITIS,2
IE,ASTHENIA,2
IE,BLOOD PRESSURE DECREASED,2
IE,BODY TEMPERATURE INCREASED,2
IE,CARDIAC DISORDER,2
IE,CARDIAC FAILURE,2
IE,CELLULITIS,2
IE,CEREBRAL HAEMORRHAGE,2
IE,CHEST PAIN,2
IE,CONFUSIONAL STATE,2
IE,CONTUSION,2
IE,CONVULSION,2
IE,DEHYDRATION,2
IE,DISEASE PROGRESSION,2
IE,DIZZINESS,2
IE,DRUG DOSE OMISSION,2
IE,ERYTHEMA,2
IE,FAECALOMA,2
IE,FATIGUE,2
IE,GANGRENE,2
IE,HAEMORRHAGE,2
IE,HEART RATE INCREASED,2
IE,JAUNDICE,2
IE,LETHARGY,2
IE,LIP SWELLING,2
IE,MUSCLE ATROPHY,2
IE,MUSCLE SPASMS,2
IE,MUSCULOSKELETAL PAIN,2
IE,MYOPATHY,2
IE,PRODUCTIVE COUGH,2
IE,PYREXIA,2
IE,RASH,2
IE,RASH PRURITIC,2
IE,RHABDOMYOLYSIS,2
IE,SWELLING,2
IE,SWELLING FACE,2
IE,SYNCOPE,2
IE,TYPE 2 DIABETES MELLITUS,2
IE,UNRESPONSIVE TO STIMULI,2
IE,ABDOMINAL PAIN UPPER,1
IE,ACCELERATED HYPERTENSION,1
IE,ACUTE KIDNEY INJURY,1
IE,ACUTE MYOCARDIAL INFARCTION,1
IE,ADHESION,1
IE,ADVERSE EVENT,1
IE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
IE,ANXIETY,1
IE,ARRHYTHMIA,1
IE,ASCITES,1
IE,ATRIAL FIBRILLATION,1
IE,AUTOIMMUNE DISORDER,1
IE,BACK INJURY,1
IE,BACK PAIN,1
IE,BLADDER MASS,1
IE,BLISTER,1
IE,BLOOD BILIRUBIN INCREASED,1
IE,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IE,CEREBRAL DISORDER,1
IE,CEREBRAL INFARCTION,1
IE,CEREBRAL ISCHAEMIA,1
IE,CEREBROVASCULAR ACCIDENT,1
IE,CHOKING SENSATION,1
IE,CHOLECYSTITIS ACUTE,1
IE,CHROMATURIA,1
IE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IE,CHYLOTHORAX,1
IE,CIRCULATORY COLLAPSE,1
IE,CLUMSINESS,1
IE,COLD SWEAT,1
IE,COLORECTAL CANCER,1
IE,CONCOMITANT DISEASE PROGRESSION,1
IE,CONDITION AGGRAVATED,1
IE,COUGH,1
IE,CYANOSIS,1
IE,DECREASED APPETITE,1
IE,DIABETES MELLITUS,1
IE,DIVERTICULUM,1
IE,DRUG ERUPTION,1
IE,DRUG HYPERSENSITIVITY,1
IE,DRUG INTOLERANCE,1
IE,DRUG LEVEL INCREASED,1
IE,DRUG RESISTANCE,1
IE,DYSKINESIA,1
IE,ELECTROCARDIOGRAM QT PROLONGED,1
IE,EMBOLIC STROKE,1
IE,ENTEROCOCCAL INFECTION,1
IE,EXFOLIATIVE RASH,1
IE,EXTRAVASATION,1
IE,EYE INFECTION,1
IE,EYE PAIN,1
IE,FEMORAL NECK FRACTURE,1
IE,FLATULENCE,1
IE,FLUSHING,1
IE,GAIT DISTURBANCE,1
IE,GASTROINTESTINAL TUBE INSERTION,1
IE,GROIN PAIN,1
IE,HALLUCINATION_ VISUAL,1
IE,HEPATIC ENZYME INCREASED,1
IE,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IE,INCORRECT DOSE ADMINISTERED,1
IE,INFECTION,1
IE,INFLUENZA LIKE ILLNESS,1
IE,INTENTIONAL PRODUCT MISUSE,1
IE,INVESTIGATION,1
IE,KETOACIDOSIS,1
IE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IE,LACRIMATION INCREASED,1
IE,LIMB INJURY,1
IE,LOCALISED INFECTION,1
IE,LOSS OF CONSCIOUSNESS,1
IE,LUNG INFECTION,1
IE,LYMPHOCYTOSIS,1
IE,MENORRHAGIA,1
IE,MENTAL DISORDER,1
IE,MENTAL IMPAIRMENT,1
IE,MICTURITION URGENCY,1
IE,MOBILITY DECREASED,1
IE,MONOPARESIS,1
IE,MOTOR DYSFUNCTION,1
IE,MULTI-ORGAN FAILURE,1
IE,MUSCULOSKELETAL DISCOMFORT,1
IE,MUSCULOSKELETAL STIFFNESS,1
IE,MYALGIA,1
IE,MYOCARDIAL INFARCTION,1
IE,NEUROLOGICAL DECOMPENSATION,1
IE,NEUROPATHY PERIPHERAL,1
IE,NEUTROPENIA,1
IE,OCULAR HYPERAEMIA,1
IE,OESOPHAGEAL CANCER METASTATIC,1
IE,OESOPHAGEAL CARCINOMA,1
IE,ON AND OFF PHENOMENON,1
IE,OROPHARYNGEAL DISCOMFORT,1
IE,OSTEITIS,1
IE,OSTEOARTHRITIS,1
IE,OXYGEN SATURATION DECREASED,1
IE,PATIENT-DEVICE INCOMPATIBILITY,1
IE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
IE,PERIPHERAL ARTERY BYPASS,1
IE,PERIPHERAL SWELLING,1
IE,PLATELET COUNT DECREASED,1
IE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
IE,PSYCHOTIC DISORDER,1
IE,PULMONARY OEDEMA,1
IE,PULMONARY VALVE INCOMPETENCE,1
IE,RENAL FAILURE ACUTE,1
IE,RESPIRATORY ARREST,1
IE,SCIATICA,1
IE,SEIZURE LIKE PHENOMENA,1
IE,SINUS TACHYCARDIA,1
IE,SINUSITIS,1
IE,SKIN DISCOLOURATION,1
IE,SKIN EXFOLIATION,1
IE,SKIN INFECTION,1
IE,SKIN ULCER,1
IE,SUBDURAL HAEMATOMA,1
IE,TACHYCARDIA,1
IE,THERAPEUTIC RESPONSE DECREASED,1
IE,THERAPY CESSATION,1
IE,THROMBOCYTOPENIA,1
IE,THROMBOSIS IN DEVICE,1
IE,TOOTH ABSCESS,1
IE,TRANSIENT ISCHAEMIC ATTACK,1
IE,UNEVALUABLE EVENT,1
IE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
IE,URINARY INCONTINENCE,1
IE,VASCULAR STENT THROMBOSIS,1
IL,ASTHENIA,12
IL,RENAL FAILURE,11
IL,DIARRHOEA,10
IL,DYSPNOEA,9
IL,CHEST PAIN,8
IL,HAEMOGLOBIN DECREASED,8
IL,ANAEMIA,7
IL,PNEUMONIA,7
IL,ACUTE MYOCARDIAL INFARCTION,6
IL,PYREXIA,6
IL,DEATH,5
IL,DIZZINESS,5
IL,GASTROINTESTINAL HAEMORRHAGE,5
IL,HAEMATOMA,5
IL,HAEMORRHAGE INTRACRANIAL,5
IL,HYPOGLYCAEMIA,5
IL,NAUSEA,5
IL,OSTEOPOROTIC FRACTURE,5
IL,PANCYTOPENIA,5
IL,ACUTE KIDNEY INJURY,4
IL,CARDIAC DISORDER,4
IL,CARDIAC FAILURE CONGESTIVE,4
IL,COGNITIVE DISORDER,4
IL,FALL,4
IL,FOOD INTERACTION,4
IL,MYOCARDIAL INFARCTION,4
IL,NEPHROPATHY TOXIC,4
IL,PALPITATIONS,4
IL,PROCEDURAL HAEMORRHAGE,4
IL,TOXICITY TO VARIOUS AGENTS,4
IL,ABDOMINAL PAIN,3
IL,BALANCE DISORDER,3
IL,BLOOD CREATININE INCREASED,3
IL,CEREBRAL HAEMORRHAGE,3
IL,CEREBROVASCULAR ACCIDENT,3
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
IL,DRUG INEFFECTIVE,3
IL,FEELING ABNORMAL,3
IL,HAEMOPTYSIS,3
IL,HAEMORRHAGE,3
IL,HEMIPARESIS,3
IL,HYPERTENSION,3
IL,INTRACARDIAC THROMBUS,3
IL,URINARY TRACT INFECTION,3
IL,VENTRICULAR TACHYCARDIA,3
IL,ANGINA PECTORIS,2
IL,APHASIA,2
IL,BACK PAIN,2
IL,BLOOD PRESSURE INCREASED,2
IL,BRADYCARDIA,2
IL,CARDIAC TAMPONADE,2
IL,CONFUSIONAL STATE,2
IL,COUGH,2
IL,DECREASED APPETITE,2
IL,DEEP VEIN THROMBOSIS,2
IL,EPISTAXIS,2
IL,ERYTHEMA,2
IL,ESCHERICHIA BACTERAEMIA,2
IL,FATIGUE,2
IL,GASTROENTERITIS,2
IL,GENERAL PHYSICAL HEALTH DETERIORATION,2
IL,HAEMATEMESIS,2
IL,HEAD INJURY,2
IL,HEADACHE,2
IL,HERBAL INTERACTION,2
IL,INFECTION,2
IL,INSOMNIA,2
IL,INTRA-ABDOMINAL HAEMATOMA,2
IL,INVASIVE DUCTAL BREAST CARCINOMA,2
IL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
IL,LOSS OF CONSCIOUSNESS,2
IL,MEMORY IMPAIRMENT,2
IL,MUCOSAL INFLAMMATION,2
IL,MUSCULOSKELETAL PAIN,2
IL,MYALGIA,2
IL,PAIN,2
IL,PAIN IN EXTREMITY,2
IL,PNEUMONIA ASPIRATION,2
IL,PULMONARY CONGESTION,2
IL,PULMONARY OEDEMA,2
IL,RASH,2
IL,RECTAL HAEMORRHAGE,2
IL,SPEECH DISORDER,2
IL,SUBDURAL HAEMATOMA,2
IL,SUBDURAL HAEMORRHAGE,2
IL,SYNCOPE,2
IL,THROMBOCYTOPENIA,2
IL,TRANSIENT ISCHAEMIC ATTACK,2
IL,ABDOMINAL DISTENSION,1
IL,ACUTE CORONARY SYNDROME,1
IL,ACUTE LYMPHOCYTIC LEUKAEMIA,1
IL,ACUTE RESPIRATORY FAILURE,1
IL,ADRENAL INSUFFICIENCY,1
IL,AKINESIA,1
IL,ANEURYSM,1
IL,ANGINA UNSTABLE,1
IL,ANXIETY,1
IL,ARTHRALGIA,1
IL,ASPARTATE AMINOTRANSFERASE INCREASED,1
IL,ASPIRATION PLEURAL CAVITY,1
IL,ATRIAL FIBRILLATION,1
IL,ATRIAL FLUTTER,1
IL,ATRIOVENTRICULAR BLOCK COMPLETE,1
IL,AURICULAR HAEMATOMA,1
IL,BACK INJURY,1
IL,BACTERAEMIA,1
IL,BACTERIAL SEPSIS,1
IL,BLISTER,1
IL,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IL,BLOOD GLUCOSE INCREASED,1
IL,BLOOD IRON DECREASED,1
IL,BLOOD LACTIC ACID INCREASED,1
IL,BLOOD PRESSURE FLUCTUATION,1
IL,BLOOD PRESSURE SYSTOLIC INCREASED,1
IL,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IL,BLOOD TRIGLYCERIDES INCREASED,1
IL,BLOOD UREA INCREASED,1
IL,BREAST MASS,1
IL,BRONCHITIS,1
IL,BUNDLE BRANCH BLOCK RIGHT,1
IL,CARDIAC FAILURE,1
IL,CARDIAC FAILURE ACUTE,1
IL,CARDIAC FAILURE CHRONIC,1
IL,CARDIAC FIBRILLATION,1
IL,CAROTID ARTERIOSCLEROSIS,1
IL,CATARACT,1
IL,CATHETERISATION CARDIAC,1
IL,CEREBRAL ATROPHY,1
IL,CHILLS,1
IL,CHOLANGITIS,1
IL,CHOLECYSTITIS ACUTE,1
IL,CHRONIC KIDNEY DISEASE,1
IL,CONDITION AGGRAVATED,1
IL,CONJUNCTIVITIS,1
IL,CONSTIPATION,1
IL,CONVULSION,1
IL,CORONARY ARTERY DISEASE,1
IL,CORONARY ARTERY OCCLUSION,1
IL,CORONARY ARTERY RESTENOSIS,1
IL,DECUBITUS ULCER,1
IL,DEHYDRATION,1
IL,DEPRESSION,1
IL,DERMATITIS HERPETIFORMIS,1
IL,DIABETES MELLITUS INADEQUATE CONTROL,1
IL,DIASTOLIC DYSFUNCTION,1
IL,DISEASE PROGRESSION,1
IL,DRUG ADMINISTRATION ERROR,1
IL,DRY SKIN,1
IL,DUODENAL ULCER,1
IL,DYSGEUSIA,1
IL,EAR INFECTION,1
IL,EJECTION FRACTION DECREASED,1
IL,ELECTROCARDIOGRAM QT PROLONGED,1
IL,EMPHYSEMA,1
IL,ENDOMETRIAL CANCER METASTATIC,1
IL,ESSENTIAL HYPERTENSION,1
IL,EYE HAEMORRHAGE,1
IL,GASTRITIS EROSIVE,1
IL,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
IL,GRANULOMATOSIS WITH POLYANGIITIS,1
IL,GRIP STRENGTH DECREASED,1
IL,HAEMATURIA,1
IL,HAEMORRHAGIC STROKE,1
IL,HEMIPLEGIA,1
IL,HEPATIC ENZYME INCREASED,1
IL,HEPATIC FUNCTION ABNORMAL,1
IL,HYPERCALCAEMIA,1
IL,HYPERHIDROSIS,1
IL,HYPERKERATOSIS,1
IL,HYPERMETABOLISM,1
IL,HYPERNATRAEMIA,1
IL,HYPERSENSITIVITY VASCULITIS,1
IL,HYPOAESTHESIA,1
IL,HYPOPNOEA,1
IL,HYPOTENSION,1
IL,ILLUSION,1
IL,IMPAIRED DRIVING ABILITY,1
IL,INAPPROPRIATE AFFECT,1
IL,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
IL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IL,INFLUENZA,1
IL,INFUSION RELATED REACTION,1
IL,INTENTIONAL DRUG MISUSE,1
IL,INTENTIONAL PRODUCT USE ISSUE,1
IL,INTERVERTEBRAL DISC PROTRUSION,1
IL,INTRAVENTRICULAR HAEMORRHAGE,1
IL,JAUNDICE,1
IL,KAPOSI^S SARCOMA,1
IL,KERATITIS,1
IL,KETOACIDOSIS,1
IL,LEFT VENTRICULAR DYSFUNCTION,1
IL,LEFT VENTRICULAR FAILURE,1
IL,LEUKOCYTOSIS,1
IL,LIMB INJURY,1
IL,LIP SWELLING,1
IL,LIVER INJURY,1
IL,MALIGNANT NEOPLASM PROGRESSION,1
IL,MECHANICAL VENTILATION,1
IL,MELAENA,1
IL,METABOLIC ACIDOSIS,1
IL,METABOLIC CARDIOMYOPATHY,1
IL,MOOD SWINGS,1
IL,MOUTH HAEMORRHAGE,1
IL,MULTI-ORGAN FAILURE,1
IL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IL,MUSCLE CONTRACTURE,1
IL,MYOCARDIAL ISCHAEMIA,1
IL,MYOPATHY,1
IL,NODULE,1
IL,NUTRITIONAL CONDITION ABNORMAL,1
IL,OEDEMA,1
IL,OPTIC NEUROPATHY,1
IL,OROPHARYNGEAL PAIN,1
IL,PANCREATIC CARCINOMA,1
IL,PANCREATITIS,1
IL,PARAESTHESIA,1
IL,PARALYSIS,1
IL,PARONYCHIA,1
IL,PAROSMIA,1
IL,PATHOLOGICAL FRACTURE,1
IL,PHOTOSENSITIVITY REACTION,1
IL,PLASMA CELL MYELOMA,1
IL,PLEURAL EFFUSION,1
IL,PNEUMONIA LEGIONELLA,1
IL,POST PROCEDURAL HAEMORRHAGE,1
IL,PROCTITIS,1
IL,PRODUCT QUALITY ISSUE,1
IL,PRODUCT STORAGE ERROR,1
IL,PRODUCT SUBSTITUTION ISSUE,1
IL,PROSTATE CANCER,1
IL,PROTEIN TOTAL DECREASED,1
IL,PROTEINURIA,1
IL,PRURITUS,1
IL,PSEUDOMONAL SEPSIS,1
IL,PSYCHOTIC DISORDER,1
IL,PULMONARY EMBOLISM,1
IL,PULMONARY FIBROSIS,1
IL,PULMONARY HYPERTENSION,1
IL,RENAL FAILURE ACUTE,1
IL,RENAL TUBULAR DISORDER,1
IL,RHABDOMYOLYSIS,1
IL,SEIZURE,1
IL,SEPSIS,1
IL,SHOCK,1
IL,SINUS TACHYCARDIA,1
IL,SKIN HYPERPIGMENTATION,1
IL,STOMATITIS,1
IL,SUBARACHNOID HAEMORRHAGE,1
IL,SURGERY,1
IL,SWELLING FACE,1
IL,THROMBOSIS,1
IL,TRANSCATHETER AORTIC VALVE IMPLANTATION,1
IL,TROPONIN INCREASED,1
IL,ULCER,1
IL,URINE KETONE BODY PRESENT,1
IL,UROSEPSIS,1
IL,VASCULAR DEVICE INFECTION,1
IL,VASCULAR STENT THROMBOSIS,1
IL,VENTRICULAR FIBRILLATION,1
IL,VERTEBROBASILAR INSUFFICIENCY,1
IL,VISION BLURRED,1
IL,VOMITING,1
IL,WEIGHT DECREASED,1
IL,WEIGHT INCREASED,1
IL,YELLOW SKIN,1
IT,ANAEMIA,210
IT,HYPOGLYCAEMIA,146
IT,ASTHENIA,125
IT,SYNCOPE,100
IT,SOPOR,93
IT,MELAENA,89
IT,HAEMATURIA,80
IT,RECTAL HAEMORRHAGE,74
IT,DYSPNOEA,73
IT,CONFUSIONAL STATE,71
IT,PRESYNCOPE,66
IT,HEADACHE,65
IT,VERTIGO,60
IT,VOMITING,60
IT,HYPOTENSION,59
IT,ABDOMINAL PAIN UPPER,53
IT,CEREBRAL HAEMORRHAGE,50
IT,PRURITUS,50
IT,ABDOMINAL PAIN,49
IT,EPISTAXIS,49
IT,NAUSEA,49
IT,LOSS OF CONSCIOUSNESS,47
IT,DIARRHOEA,46
IT,GASTROINTESTINAL HAEMORRHAGE,44
IT,ERYTHEMA,41
IT,INTERNATIONAL NORMALISED RATIO INCREASED,40
IT,MALAISE,39
IT,HYPERHIDROSIS,38
IT,HAEMATOMA,37
IT,DRUG INEFFECTIVE,35
IT,HEAD INJURY,33
IT,RASH,33
IT,APHASIA,31
IT,HYPOKALAEMIA,31
IT,IRON DEFICIENCY ANAEMIA,29
IT,CHEST PAIN,28
IT,DYSARTHRIA,28
IT,LIP OEDEMA,28
IT,CARDIAC FAILURE,27
IT,DRUG ABUSE,27
IT,SOMNOLENCE,27
IT,THROMBOCYTOPENIA,27
IT,HAEMOPTYSIS,26
IT,HAEMATEMESIS,25
IT,URTICARIA,25
IT,MEDICATION ERROR,24
IT,HAEMORRHAGE INTRACRANIAL,23
IT,SUBDURAL HAEMATOMA,23
IT,TRANSIENT ISCHAEMIC ATTACK,23
IT,DYSURIA,22
IT,FALL,22
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,22
IT,ATRIAL FIBRILLATION,21
IT,HYPOMAGNESAEMIA,21
IT,HYPONATRAEMIA,21
IT,METABOLIC ACIDOSIS,21
IT,TONGUE OEDEMA,21
IT,DYSPEPSIA,20
IT,GAIT DISTURBANCE,20
IT,HYPOCALCAEMIA,20
IT,PNEUMONIA,20
IT,PURPURA,20
IT,RHABDOMYOLYSIS,20
IT,ACUTE KIDNEY INJURY,19
IT,ACUTE MYOCARDIAL INFARCTION,19
IT,DIZZINESS,19
IT,EMBOLIC STROKE,19
IT,HYPOGLYCAEMIC COMA,19
IT,NEUTROPENIA,19
IT,OEDEMA PERIPHERAL,19
IT,OVERDOSE,19
IT,BRADYCARDIA,18
IT,HAEMORRHAGE,18
IT,HEPATITIS ACUTE,18
IT,HERPES ZOSTER,18
IT,HYPERKALAEMIA,18
IT,DISORIENTATION,17
IT,HYPERTENSION,17
IT,ARRHYTHMIA,16
IT,ELECTROCARDIOGRAM QT PROLONGED,16
IT,MYOCARDIAL INFARCTION,16
IT,PYREXIA,16
IT,TACHYCARDIA,16
IT,BLOOD CREATININE INCREASED,15
IT,CARDIAC ARREST,15
IT,HAEMOGLOBIN DECREASED,15
IT,LARYNGOSPASM,15
IT,PRURITUS GENERALISED,15
IT,VISION BLURRED,15
IT,ALTERED STATE OF CONSCIOUSNESS,14
IT,ANGINA PECTORIS,14
IT,ATRIAL FLUTTER,14
IT,BRADYKINESIA,14
IT,BRADYPHRENIA,14
IT,CARDIAC VENTRICULAR THROMBOSIS,14
IT,DROP ATTACKS,14
IT,MICROCYTIC ANAEMIA,14
IT,PARAESTHESIA,14
IT,RENAL IMPAIRMENT,14
IT,THERAPEUTIC RESPONSE DECREASED,14
IT,URINARY RETENTION,14
IT,CEREBRAL ISCHAEMIA,13
IT,GASTRIC ULCER,13
IT,GASTRITIS EROSIVE,13
IT,HAEMATOCHEZIA,13
IT,HYPERTENSIVE CRISIS,13
IT,HYPOPARATHYROIDISM,13
IT,ORTHOSTATIC HYPOTENSION,13
IT,RENAL FAILURE,13
IT,AGITATION,12
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,12
IT,COLD SWEAT,12
IT,HALLUCINATION_ VISUAL,12
IT,INTESTINAL HAEMORRHAGE,12
IT,LEUKOPENIA,12
IT,PALLOR,12
IT,PANCYTOPENIA,12
IT,RESPIRATORY FAILURE,12
IT,STRANGURY,12
IT,TOXICITY TO VARIOUS AGENTS,12
IT,ATRIAL THROMBOSIS,11
IT,DECREASED APPETITE,11
IT,HYPERSENSITIVITY,11
IT,ISCHAEMIC STROKE,11
IT,PRODUCT SUBSTITUTION ISSUE,11
IT,SEIZURE,11
IT,SHOCK HAEMORRHAGIC,11
IT,CARDIAC ABLATION,10
IT,CEREBROVASCULAR ACCIDENT,10
IT,CONJUNCTIVAL HAEMORRHAGE,10
IT,COUGH,10
IT,DEATH,10
IT,DEHYDRATION,10
IT,HYPOCOAGULABLE STATE,10
IT,HYPONATRAEMIC SYNDROME,10
IT,LIP SWELLING,10
IT,PAIN,10
IT,PAIN IN EXTREMITY,10
IT,SHOCK,10
IT,SPONTANEOUS HAEMATOMA,10
IT,TROPONIN I INCREASED,10
IT,ANGIOEDEMA,9
IT,ARTERIAL STENOSIS,9
IT,ARTHRALGIA,9
IT,BLADDER SPHINCTER ATONY,9
IT,CEREBELLAR ISCHAEMIA,9
IT,DRUG HYPERSENSITIVITY,9
IT,DRUG-INDUCED LIVER INJURY,9
IT,EPILEPSY,9
IT,EYE SWELLING,9
IT,GASTRIC HAEMORRHAGE,9
IT,GINGIVAL BLEEDING,9
IT,LOCALISED OEDEMA,9
IT,MYALGIA,9
IT,OEDEMA,9
IT,PSYCHOMOTOR RETARDATION,9
IT,TACHYARRHYTHMIA,9
IT,TRANSAMINASES INCREASED,9
IT,ATRIOVENTRICULAR BLOCK COMPLETE,8
IT,DRUG ADMINISTRATION ERROR,8
IT,DRY MOUTH,8
IT,DUODENAL ULCER,8
IT,FEELING HOT,8
IT,FLUSHING,8
IT,GASTRITIS,8
IT,HAEMORRHAGIC ANAEMIA,8
IT,HYPOTHERMIA,8
IT,LARYNGEAL OEDEMA,8
IT,MYOPATHY,8
IT,PARAESTHESIA ORAL,8
IT,PERIPHERAL ISCHAEMIA,8
IT,THROMBOSIS IN DEVICE,8
IT,TOXIC SKIN ERUPTION,8
IT,VISUAL IMPAIRMENT,8
IT,WEIGHT DECREASED,8
IT,ACUTE CORONARY SYNDROME,7
IT,AORTIC THROMBOSIS,7
IT,BALANCE DISORDER,7
IT,BLOOD PRESSURE INCREASED,7
IT,CELLULITIS,7
IT,COLITIS ULCERATIVE,7
IT,COMA,7
IT,CONJUNCTIVITIS,7
IT,CONTRAINDICATED PRODUCT ADMINISTERED,7
IT,DIABETES MELLITUS,7
IT,DRUG RESISTANCE,7
IT,DYSPHAGIA,7
IT,HEMIPLEGIA,7
IT,HEPATIC FAILURE,7
IT,HYPERGLYCAEMIA,7
IT,HYPORESPONSIVE TO STIMULI,7
IT,INFLAMMATION,7
IT,INTRAVENTRICULAR HAEMORRHAGE,7
IT,MYOCARDIAL NECROSIS MARKER INCREASED,7
IT,PLEURAL EFFUSION,7
IT,PRODUCT USE ISSUE,7
IT,PROTEINURIA,7
IT,RASH GENERALISED,7
IT,REACTION TO DRUG EXCIPIENTS,7
IT,RENAL FAILURE ACUTE,7
IT,SKIN EXFOLIATION,7
IT,THROMBOTIC THROMBOCYTOPENIC PURPURA,7
IT,TRANSFUSION,7
IT,TREMOR,7
IT,ANGINA UNSTABLE,6
IT,ASPARTATE AMINOTRANSFERASE INCREASED,6
IT,BLOOD GLUCOSE INCREASED,6
IT,CEREBELLAR SYNDROME,6
IT,CHEST DISCOMFORT,6
IT,CHILLS,6
IT,CHOKING SENSATION,6
IT,DISCOMFORT,6
IT,EROSIVE DUODENITIS,6
IT,EROSIVE OESOPHAGITIS,6
IT,HYPERPYREXIA,6
IT,HYPOVOLAEMIC SHOCK,6
IT,INCORRECT DOSE ADMINISTERED,6
IT,INJURY,6
IT,ISCHAEMIC CARDIOMYOPATHY,6
IT,LACTIC ACIDOSIS,6
IT,LICHENOID KERATOSIS,6
IT,MACULOPATHY,6
IT,METABOLIC ALKALOSIS,6
IT,METABOLIC DISORDER,6
IT,NEUTROPHILIA,6
IT,PSYCHOMOTOR HYPERACTIVITY,6
IT,RASH MACULO-PAPULAR,6
IT,RASH PAPULAR,6
IT,RETCHING,6
IT,STEVENS-JOHNSON SYNDROME,6
IT,SUBARACHNOID HAEMORRHAGE,6
IT,SUBCUTANEOUS HAEMATOMA,6
IT,VENTRICULAR TACHYCARDIA,6
IT,AGRANULOCYTOSIS,5
IT,ALANINE AMINOTRANSFERASE INCREASED,5
IT,ARTERIAL RESTENOSIS,5
IT,ASCITES,5
IT,C-REACTIVE PROTEIN INCREASED,5
IT,CARDIAC FAILURE ACUTE,5
IT,CHRONIC KIDNEY DISEASE,5
IT,CONDITION AGGRAVATED,5
IT,DUODENAL ULCER HAEMORRHAGE,5
IT,DYSENTERY,5
IT,DYSSTASIA,5
IT,FLATULENCE,5
IT,GENERAL PHYSICAL HEALTH DETERIORATION,5
IT,GENERALISED ERYTHEMA,5
IT,HYPOAESTHESIA,5
IT,INTENTIONAL PRODUCT MISUSE,5
IT,INTESTINAL ISCHAEMIA,5
IT,JAUNDICE,5
IT,MIGRAINE,5
IT,OESOPHAGITIS,5
IT,OESOPHAGITIS HAEMORRHAGIC,5
IT,PARINAUD SYNDROME,5
IT,PELVIC FRACTURE,5
IT,PETECHIAE,5
IT,TOXIC EPIDERMAL NECROLYSIS,5
IT,ABDOMINAL DISTENSION,4
IT,ABDOMINAL TENDERNESS,4
IT,AGGRESSION,4
IT,ANAL SPHINCTER ATONY,4
IT,ANXIETY,4
IT,ATAXIA,4
IT,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,4
IT,BLOOD MAGNESIUM DECREASED,4
IT,BONE MARROW FAILURE,4
IT,BRADYARRHYTHMIA,4
IT,BRONCHOSPASM,4
IT,BURNING SENSATION,4
IT,CARDIAC DISORDER,4
IT,CEREBELLAR HAEMORRHAGE,4
IT,COGNITIVE DISORDER,4
IT,CONFABULATION,4
IT,CORONARY ARTERY BYPASS,4
IT,CORONARY ARTERY STENOSIS,4
IT,DEEP VEIN THROMBOSIS,4
IT,DERMATITIS ALLERGIC,4
IT,DYSAESTHESIA,4
IT,DYSPNOEA AT REST,4
IT,DYSPNOEA EXERTIONAL,4
IT,DYSTONIA,4
IT,ERECTILE DYSFUNCTION,4
IT,FACIAL BONES FRACTURE,4
IT,FAECES DISCOLOURED,4
IT,FLUID RETENTION,4
IT,HAEMOLYTIC ANAEMIA,4
IT,HAEMORRHAGE URINARY TRACT,4
IT,HEART RATE INCREASED,4
IT,HEAT STROKE,4
IT,HEPATIC ENZYME INCREASED,4
IT,HYPERBILIRUBINAEMIA,4
IT,HYPERTRANSAMINASAEMIA,4
IT,HYPERTROPHY OF TONGUE PAPILLAE,4
IT,ILIAC VEIN OCCLUSION,4
IT,INFLUENZA,4
IT,INSOMNIA,4
IT,INTERSTITIAL LUNG DISEASE,4
IT,INTRACARDIAC THROMBUS,4
IT,KOUNIS SYNDROME,4
IT,MEMORY IMPAIRMENT,4
IT,MENTAL STATUS CHANGES,4
IT,MIOSIS,4
IT,MOVEMENT DISORDER,4
IT,MYOCARDIAL ISCHAEMIA,4
IT,OESOPHAGEAL ULCER,4
IT,OROPHARYNGEAL PAIN,4
IT,OSTEONECROSIS,4
IT,OSTEONECROSIS OF JAW,4
IT,PHOTOPSIA,4
IT,QUADRIPARESIS,4
IT,RENAL ISCHAEMIA,4
IT,RENAL TUBULAR DISORDER,4
IT,RETINAL HAEMORRHAGE,4
IT,SELF INJURIOUS BEHAVIOUR,4
IT,SEPSIS,4
IT,SWOLLEN TONGUE,4
IT,THERAPY NON-RESPONDER,4
IT,THROAT TIGHTNESS,4
IT,THROMBOSIS,4
IT,TREATMENT NONCOMPLIANCE,4
IT,URETERIC OBSTRUCTION,4
IT,VASCULITIS CEREBRAL,4
IT,VISCERAL ARTERIAL ISCHAEMIA,4
IT,VISUAL ACUITY REDUCED,4
IT,ACUTE RESPIRATORY FAILURE,3
IT,AMAUROSIS,3
IT,ANAPHYLACTIC SHOCK,3
IT,ANURIA,3
IT,ARTERIOSCLEROSIS CORONARY ARTERY,3
IT,AZOTAEMIA,3
IT,BACK PAIN,3
IT,BLOOD BILIRUBIN INCREASED,3
IT,BLOOD POTASSIUM INCREASED,3
IT,BLOOD PRESSURE FLUCTUATION,3
IT,BLOOD UREA INCREASED,3
IT,CEPHALHAEMATOMA,3
IT,CONSCIOUSNESS FLUCTUATING,3
IT,CONSTIPATION,3
IT,CORONARY ARTERY RESTENOSIS,3
IT,CRYING,3
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,3
IT,DEPRESSION,3
IT,DERMATITIS,3
IT,DIPLOPIA,3
IT,DISEASE RECURRENCE,3
IT,DIVERTICULUM,3
IT,DRUG PRESCRIBING ERROR,3
IT,EMBOLISM,3
IT,ERUCTATION,3
IT,EYELID OEDEMA,3
IT,FACE OEDEMA,3
IT,FAECALOMA,3
IT,FATIGUE,3
IT,GASTRIC ULCER HAEMORRHAGE,3
IT,GASTRITIS HAEMORRHAGIC,3
IT,GENERALISED TONIC-CLONIC SEIZURE,3
IT,HAEMORRHAGIC EROSIVE GASTRITIS,3
IT,HAEMORRHAGIC STROKE,3
IT,HAEMORRHOIDAL HAEMORRHAGE,3
IT,HALLUCINATION,3
IT,HEPATIC FUNCTION ABNORMAL,3
IT,HEPATIC ISCHAEMIA,3
IT,HEPATOTOXICITY,3
IT,HYPERCHLORHYDRIA,3
IT,HYPERINSULINAEMIC HYPOGLYCAEMIA,3
IT,HYPERLACTACIDAEMIA,3
IT,HYPOGLYCAEMIC UNCONSCIOUSNESS,3
IT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
IT,INTENTIONAL OVERDOSE,3
IT,ISCHAEMIA,3
IT,LEUKOCYTOSIS,3
IT,LIVER FUNCTION TEST ABNORMAL,3
IT,LOWER GASTROINTESTINAL HAEMORRHAGE,3
IT,MITRAL VALVE INCOMPETENCE,3
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
IT,MUSCLE SPASMS,3
IT,MUSCULAR WEAKNESS,3
IT,NEUROPATHY PERIPHERAL,3
IT,NODAL ARRHYTHMIA,3
IT,NORMOCHROMIC NORMOCYTIC ANAEMIA,3
IT,PALPITATIONS,3
IT,PANCREATITIS ACUTE,3
IT,PARALYSIS,3
IT,PARAPARESIS,3
IT,PARESIS,3
IT,PERICARDIAL EFFUSION,3
IT,PERIORBITAL HAEMATOMA,3
IT,PLATELET COUNT DECREASED,3
IT,PLEURISY,3
IT,POLLAKIURIA,3
IT,POTENTIATING DRUG INTERACTION,3
IT,RASH ERYTHEMATOUS,3
IT,RASH PRURITIC,3
IT,RECTAL CANCER,3
IT,RESPIRATORY DISORDER,3
IT,RETINAL ARTERY OCCLUSION,3
IT,SINUS BRADYCARDIA,3
IT,SKIN DISCOLOURATION,3
IT,SLOW RESPONSE TO STIMULI,3
IT,SUDDEN DEATH,3
IT,TRAUMATIC HAEMATOMA,3
IT,TRICUSPID VALVE INCOMPETENCE,3
IT,TROPONIN INCREASED,3
IT,URINARY TRACT INFECTION,3
IT,VASCULAR STENT RESTENOSIS,3
IT,VISUAL FIELD DEFECT,3
IT,VITAMIN D DECREASED,3
IT,ABDOMINAL WALL HAEMATOMA,2
IT,ACCIDENTAL OVERDOSE,2
IT,ACIDOSIS,2
IT,ACTIVITIES OF DAILY LIVING IMPAIRED,2
IT,ACUTE PULMONARY OEDEMA,2
IT,AMNESIA,2
IT,AMYLASE INCREASED,2
IT,AORTIC ANEURYSM,2
IT,APRAXIA,2
IT,ARTERIAL THROMBOSIS,2
IT,ASTRINGENT THERAPY,2
IT,ATONIC SEIZURES,2
IT,ATRIOVENTRICULAR BLOCK,2
IT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
IT,BLEEDING TIME PROLONGED,2
IT,BLISTER,2
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,2
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,2
IT,BLOOD PRESSURE DECREASED,2
IT,BLOOD SODIUM INCREASED,2
IT,CANDIDA INFECTION,2
IT,CAROTID ARTERY STENOSIS,2
IT,CEREBRAL THROMBOSIS,2
IT,CHOLELITHIASIS,2
IT,CHOLINERGIC SYNDROME,2
IT,CONVULSION,2
IT,CORONARY ARTERY OCCLUSION,2
IT,CORONARY OSTIAL STENOSIS,2
IT,CYTOMEGALOVIRUS INFECTION,2
IT,DEPRESSED MOOD,2
IT,DIABETES MELLITUS INADEQUATE CONTROL,2
IT,DIABETIC COMA,2
IT,DIARRHOEA HAEMORRHAGIC,2
IT,DISSEMINATED INTRAVASCULAR COAGULATION,2
IT,DISTURBANCE IN ATTENTION,2
IT,DIZZINESS POSTURAL,2
IT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
IT,DUODENITIS,2
IT,DYSGEUSIA,2
IT,DYSKINESIA,2
IT,DYSPHONIA,2
IT,ECCHYMOSIS,2
IT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
IT,ELECTROLYTE IMBALANCE,2
IT,ERYTHEMA MULTIFORME,2
IT,EXPOSURE DURING PREGNANCY,2
IT,FAECAL INCONTINENCE,2
IT,FASTING,2
IT,FEMUR FRACTURE,2
IT,FUNGAL INFECTION,2
IT,GASTROINTESTINAL DISORDER,2
IT,GENERALISED OEDEMA,2
IT,HAEMORRHOIDS,2
IT,HEART RATE DECREASED,2
IT,HEMIANOPIA,2
IT,HEPATITIS,2
IT,HEPATITIS CHOLESTATIC,2
IT,HEPATOCELLULAR CARCINOMA,2
IT,HYPERAEMIA,2
IT,HYPERCHOLESTEROLAEMIA,2
IT,HYPERCOAGULATION,2
IT,HYPOKINESIA,2
IT,INCORRECT DOSAGE ADMINISTERED,2
IT,INFECTION,2
IT,INFUSION RELATED REACTION,2
IT,INTENTIONAL SELF-INJURY,2
IT,INTRA-ABDOMINAL HAEMATOMA,2
IT,LEFT VENTRICULAR DYSFUNCTION,2
IT,LIP DISORDER,2
IT,LIPASE INCREASED,2
IT,LIVER INJURY,2
IT,LUNG DISORDER,2
IT,MOTOR DYSFUNCTION,2
IT,MUSCLE HAEMORRHAGE,2
IT,MYOCLONUS,2
IT,NEOPLASM PROGRESSION,2
IT,NODAL RHYTHM,2
IT,NON-HODGKIN^S LYMPHOMA,2
IT,OLIGURIA,2
IT,OSTEOPOROSIS,2
IT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
IT,PANCREATITIS,2
IT,PAPULE,2
IT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
IT,PERIPHERAL ARTERY STENOSIS,2
IT,PERITONITIS,2
IT,PNEUMONITIS,2
IT,POST INFLAMMATORY PIGMENTATION CHANGE,2
IT,POST PROCEDURAL HAEMORRHAGE,2
IT,PRODUCT MEASURED POTENCY ISSUE,2
IT,PRODUCT USE IN UNAPPROVED INDICATION,2
IT,PSEUDOMONAL SEPSIS,2
IT,PULMONARY EMBOLISM,2
IT,PULMONARY OEDEMA,2
IT,QUADRIPLEGIA,2
IT,RECTAL TENESMUS,2
IT,RECURRENT CANCER,2
IT,RENAL FAILURE CHRONIC,2
IT,RENAL INJURY,2
IT,SALIVARY HYPERSECRETION,2
IT,SENSE OF OPPRESSION,2
IT,SEPTIC SHOCK,2
IT,SKIN BURNING SENSATION,2
IT,SKIN LESION,2
IT,SKIN ULCER HAEMORRHAGE,2
IT,SLOW SPEECH,2
IT,SUBDURAL HAEMORRHAGE,2
IT,SWELLING,2
IT,THERAPEUTIC RESPONSE CHANGED,2
IT,URETHRAL INJURY,2
IT,URINARY INCONTINENCE,2
IT,URINE ABNORMALITY,2
IT,UTERINE HYPOTONUS,2
IT,VASCULAR ENCEPHALOPATHY,2
IT,VASCULAR OPERATION,2
IT,VASCULAR PSEUDOANEURYSM,2
IT,VENTRICULAR FIBRILLATION,2
IT,ABDOMINAL DISCOMFORT,1
IT,ABDOMINAL HERNIA,1
IT,ABDOMINAL HERNIA OBSTRUCTIVE,1
IT,ABDOMINAL WALL MASS,1
IT,ABNORMAL BEHAVIOUR,1
IT,ABSCESS,1
IT,ABSCESS INTESTINAL,1
IT,ACCIDENTAL EXPOSURE TO PRODUCT,1
IT,ACQUIRED HAEMOPHILIA,1
IT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
IT,ACUTE HEPATIC FAILURE,1
IT,ADENOCARCINOMA,1
IT,ADENOMA BENIGN,1
IT,ADRENAL DISORDER,1
IT,ADRENAL INSUFFICIENCY,1
IT,ADVERSE EVENT,1
IT,ALLERGIC OEDEMA,1
IT,ALVEOLITIS,1
IT,ANAPHYLACTIC REACTION,1
IT,ANAPHYLACTOID REACTION,1
IT,ANGIOPATHY,1
IT,ANORECTAL SWELLING,1
IT,AORTIC CALCIFICATION,1
IT,AORTIC VALVE INCOMPETENCE,1
IT,APATHY,1
IT,APLASTIC ANAEMIA,1
IT,APPENDICITIS,1
IT,AREFLEXIA,1
IT,ARTERIAL DISORDER,1
IT,ARTERIOSPASM CORONARY,1
IT,ARTHRITIS,1
IT,ATELECTASIS,1
IT,AURA,1
IT,AUTOIMMUNE THROMBOCYTOPENIA,1
IT,BACTERAEMIA,1
IT,BACTEROIDES INFECTION,1
IT,BILIRUBIN CONJUGATED INCREASED,1
IT,BLINDNESS,1
IT,BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED,1
IT,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
IT,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
IT,BLOOD LACTIC ACID INCREASED,1
IT,BLOOD PH DECREASED,1
IT,BLOOD POTASSIUM DECREASED,1
IT,BLOOD PRESSURE ABNORMAL,1
IT,BLOOD TEST ABNORMAL,1
IT,BLOOD TRIGLYCERIDES INCREASED,1
IT,BLOOD URIC ACID INCREASED,1
IT,BLOODY DISCHARGE,1
IT,BODY TEMPERATURE INCREASED,1
IT,BONE DISORDER,1
IT,BONE LESION,1
IT,BONE PAIN,1
IT,BRAIN NATRIURETIC PEPTIDE INCREASED,1
IT,BREAST CANCER RECURRENT,1
IT,BREAST SWELLING,1
IT,BRONCHIAL WALL THICKENING,1
IT,BRONCHIOLITIS,1
IT,BRONCHOSTENOSIS,1
IT,BULLOUS LUNG DISEASE,1
IT,BUNDLE BRANCH BLOCK LEFT,1
IT,CACHEXIA,1
IT,CAESAREAN SECTION,1
IT,CANDIDA SEPSIS,1
IT,CARDIAC FAILURE CONGESTIVE,1
IT,CARDIAC FIBRILLATION,1
IT,CARDIAC TAMPONADE,1
IT,CARDIO-RESPIRATORY ARREST,1
IT,CARDIOMEGALY,1
IT,CARDIOMYOPATHY,1
IT,CARDIOVASCULAR DISORDER,1
IT,CAROTID ARTERIOSCLEROSIS,1
IT,CAROTID ARTERY THROMBOSIS,1
IT,CARPAL TUNNEL SYNDROME,1
IT,CATARACT,1
IT,CENTRAL NERVOUS SYSTEM INFECTION,1
IT,CENTRAL NERVOUS SYSTEM LESION,1
IT,CEREBRAL ARTERY EMBOLISM,1
IT,CEREBRAL ARTERY OCCLUSION,1
IT,CEREBRAL ARTERY STENOSIS,1
IT,CEREBRAL ATROPHY,1
IT,CEREBRAL HAEMATOMA,1
IT,CEREBRAL INFARCTION,1
IT,CEREBROSPINAL FLUID LEAKAGE,1
IT,CEREBROVASCULAR DISORDER,1
IT,CHOLECYSTITIS ACUTE,1
IT,CHROMATURIA,1
IT,CHRONIC MYELOID LEUKAEMIA,1
IT,CLOSTRIDIUM DIFFICILE INFECTION,1
IT,COAGULOPATHY,1
IT,COLON ADENOMA,1
IT,COMA HEPATIC,1
IT,CONJUNCTIVAL HYPERAEMIA,1
IT,CONTRAST MEDIA REACTION,1
IT,CONTUSION,1
IT,CORONARY ANGIOPLASTY,1
IT,CORONARY ARTERY DISEASE,1
IT,CORTISOL DECREASED,1
IT,CRANIOCEREBRAL INJURY,1
IT,CYST,1
IT,CYTOMEGALOVIRUS COLITIS,1
IT,CYTOMEGALOVIRUS VIRAEMIA,1
IT,DELIRIUM,1
IT,DELUSION,1
IT,DERMATITIS BULLOUS,1
IT,DERMATITIS EXFOLIATIVE,1
IT,DERMATITIS EXFOLIATIVE GENERALISED,1
IT,DEVICE ISSUE,1
IT,DEVICE OCCLUSION,1
IT,DIABETES INSIPIDUS,1
IT,DIABETIC GASTROPARESIS,1
IT,DIABETIC ULCER,1
IT,DIEULAFOY^S VASCULAR MALFORMATION,1
IT,DISCOLOURED VOMIT,1
IT,DISEASE PROGRESSION,1
IT,DISSOCIATION,1
IT,DIVERTICULAR PERFORATION,1
IT,DIVERTICULUM INTESTINAL,1
IT,DRUG EFFECT INCOMPLETE,1
IT,DRUG INTOLERANCE,1
IT,DRUG LEVEL BELOW THERAPEUTIC,1
IT,DRUG LEVEL INCREASED,1
IT,DRY SKIN,1
IT,EFFUSION,1
IT,EJECTION FRACTION DECREASED,1
IT,ELECTROCARDIOGRAM ABNORMAL,1
IT,ENCEPHALOPATHY,1
IT,ENTHESOPATHY,1
IT,ENZYME LEVEL INCREASED,1
IT,EPIDERMOLYSIS,1
IT,EPIDIDYMITIS,1
IT,EPIGASTRIC DISCOMFORT,1
IT,EPIGLOTTIC OEDEMA,1
IT,ERYTHEMA MIGRANS,1
IT,ERYTHROPOIESIS ABNORMAL,1
IT,ESCHAR,1
IT,ESCHERICHIA SEPSIS,1
IT,ESSENTIAL HYPERTENSION,1
IT,EXOPHTHALMOS,1
IT,EXTRA DOSE ADMINISTERED,1
IT,EXTRADURAL HAEMATOMA,1
IT,EXTRAPYRAMIDAL DISORDER,1
IT,EXTREMITY NECROSIS,1
IT,EYE HAEMORRHAGE,1
IT,EYE OEDEMA,1
IT,EYE PRURITUS,1
IT,EYELID HAEMATOMA,1
IT,FACE INJURY,1
IT,FEBRILE BONE MARROW APLASIA,1
IT,FEBRILE NEUTROPENIA,1
IT,FEELING COLD,1
IT,FIBRIN D DIMER INCREASED,1
IT,FISTULA,1
IT,FLANK PAIN,1
IT,FRACTURE,1
IT,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
IT,GANGRENE,1
IT,GASTRIC DISORDER,1
IT,GASTRIC PERFORATION,1
IT,GASTRITIS ATROPHIC,1
IT,GASTROENTERITIS,1
IT,GASTROINTESTINAL TRACT ADENOMA,1
IT,GASTROOESOPHAGEAL REFLUX DISEASE,1
IT,GENERAL PHYSICAL CONDITION ABNORMAL,1
IT,GINGIVAL SWELLING,1
IT,GLOSSITIS,1
IT,GRAVITATIONAL OEDEMA,1
IT,GROSS MOTOR DELAY,1
IT,HAEMATOCRIT,1
IT,HAEMOBILIA,1
IT,HAEMOGLOBIN,1
IT,HAEMOLYSIS,1
IT,HALLUCINATION_ AUDITORY,1
IT,HELICOBACTER GASTRITIS,1
IT,HEMIANOPIA HOMONYMOUS,1
IT,HEMIPARESIS,1
IT,HENOCH-SCHONLEIN PURPURA,1
IT,HEPATIC ENCEPHALOPATHY,1
IT,HEPATIC LESION,1
IT,HEPATIC NECROSIS,1
IT,HEPATOMEGALY,1
IT,HERNIA,1
IT,HIATUS HERNIA,1
IT,HICCUPS,1
IT,HIGH DENSITY LIPOPROTEIN INCREASED,1
IT,HISTOLOGY ABNORMAL,1
IT,HOT FLUSH,1
IT,HYPERAMMONAEMIC ENCEPHALOPATHY,1
IT,HYPERCALCAEMIA,1
IT,HYPERCREATINAEMIA,1
IT,HYPERCREATININAEMIA,1
IT,HYPERLIPASAEMIA,1
IT,HYPERREFLEXIA,1
IT,HYPERTENSIVE CARDIOMYOPATHY,1
IT,HYPERTONIA,1
IT,HYPOCHROMIC ANAEMIA,1
IT,HYPOPHOSPHATAEMIA,1
IT,HYPOREFLEXIA,1
IT,HYPOSIDERAEMIA,1
IT,HYPOTHYROIDISM,1
IT,HYPOTONIC URINARY BLADDER,1
IT,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
IT,IATROGENIC INJURY,1
IT,IDIOPATHIC PULMONARY FIBROSIS,1
IT,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
IT,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
IT,INCREASED VISCOSITY OF BRONCHIAL SECRETION,1
IT,INFARCTION,1
IT,INFECTED SKIN ULCER,1
IT,INJECTION SITE HAEMATOMA,1
IT,INJECTION SITE RASH,1
IT,INTERMITTENT CLAUDICATION,1
IT,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
IT,INTESTINAL INFARCTION,1
IT,INTESTINAL OBSTRUCTION,1
IT,INTRACRANIAL PRESSURE INCREASED,1
IT,INTRAVASCULAR HAEMOLYSIS,1
IT,IRRITABLE BOWEL SYNDROME,1
IT,JOINT CONTRACTURE,1
IT,JOINT INJURY,1
IT,JOINT SWELLING,1
IT,KERATOPATHY,1
IT,KETOSIS,1
IT,LABORATORY TEST ABNORMAL,1
IT,LACTOSE INTOLERANCE,1
IT,LACUNAR STROKE,1
IT,LARGE INTESTINAL ULCER HAEMORRHAGE,1
IT,LARYNGEAL CANCER,1
IT,LEFT ATRIAL HYPERTROPHY,1
IT,LEFT VENTRICULAR FAILURE,1
IT,LEFT VENTRICULAR HYPERTROPHY,1
IT,LID MARGIN DISCHARGE,1
IT,LIMB DISCOMFORT,1
IT,LIVER DISORDER,1
IT,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
IT,LOW DENSITY LIPOPROTEIN ABNORMAL,1
IT,LUNG CONSOLIDATION,1
IT,LUNG NEOPLASM MALIGNANT,1
IT,LYMPHANGIOSIS CARCINOMATOSA,1
IT,MACROGLOSSIA,1
IT,MALIGNANT HYPERTENSION,1
IT,MALIGNANT NEOPLASM PROGRESSION,1
IT,MALLORY-WEISS SYNDROME,1
IT,MATERNAL EXPOSURE DURING PREGNANCY,1
IT,MEDICAL DEVICE SITE PLAQUE,1
IT,MENINGITIS,1
IT,MENORRHAGIA,1
IT,METASTASES TO BONE,1
IT,METASTASES TO MUSCLE,1
IT,MICROALBUMINURIA,1
IT,MICTURITION URGENCY,1
IT,MOOD ALTERED,1
IT,MUCOSAL DRYNESS,1
IT,MULTIPLE INJURIES,1
IT,MUSCLE INJURY,1
IT,MUSCLE RUPTURE,1
IT,MUSCLE TIGHTNESS,1
IT,MUSCULOSKELETAL INJURY,1
IT,MUSCULOSKELETAL STIFFNESS,1
IT,MYASTHENIA GRAVIS,1
IT,MYELODYSPLASTIC SYNDROME,1
IT,MYOGLOBIN BLOOD INCREASED,1
IT,NAIL DISORDER,1
IT,NECK PAIN,1
IT,NERVOUS SYSTEM DISORDER,1
IT,NEUROLEPTIC MALIGNANT SYNDROME,1
IT,NEUROTOXICITY,1
IT,NIGHT SWEATS,1
IT,NO THERAPEUTIC RESPONSE,1
IT,NOCTURIA,1
IT,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
IT,OCULAR DISCOMFORT,1
IT,OCULAR HYPERAEMIA,1
IT,OEDEMA MUCOSAL,1
IT,OESOPHAGEAL DYSPLASIA,1
IT,OESOPHAGEAL POLYP,1
IT,ORAL DYSAESTHESIA,1
IT,OXYGEN SATURATION ABNORMAL,1
IT,PANCREATIC CARCINOMA,1
IT,PARKINSONISM,1
IT,PAROSMIA,1
IT,PELVIC PAIN,1
IT,PEMPHIGOID,1
IT,PEPTIC ULCER,1
IT,PERCUTANEOUS CORONARY INTERVENTION,1
IT,PERIODONTITIS,1
IT,PERIPHERAL ARTERY ANEURYSM,1
IT,PERIPHERAL ARTERY THROMBOSIS,1
IT,PERIPHERAL SWELLING,1
IT,PHARYNGEAL OEDEMA,1
IT,PHOTOPHOBIA,1
IT,PLATELET AGGREGATION INHIBITION,1
IT,PLATELET DISORDER,1
IT,PLEURAL FIBROSIS,1
IT,POISONING,1
IT,POLYCYTHAEMIA,1
IT,POLYP,1
IT,PORTAL HYPERTENSIVE GASTROPATHY,1
IT,POSTURAL TREMOR,1
IT,PREGNANCY,1
IT,PRERENAL FAILURE,1
IT,PRESCRIBED OVERDOSE,1
IT,PROCEDURAL HAEMORRHAGE,1
IT,PROSTATOMEGALY,1
IT,PROTHROMBIN TIME SHORTENED,1
IT,PROTRUSION TONGUE,1
IT,PSEUDOMONAS INFECTION,1
IT,PSORIASIS,1
IT,PULMONARY HYPERTENSION,1
IT,PULMONARY MASS,1
IT,PUPILS UNEQUAL,1
IT,PYELOCALIECTASIS,1
IT,RALES,1
IT,RASH MACULAR,1
IT,REBOUND EFFECT,1
IT,RED BLOOD CELL COUNT ABNORMAL,1
IT,RED BLOOD CELL COUNT DECREASED,1
IT,RENAL ABSCESS,1
IT,RENAL ARTERY STENOSIS,1
IT,RENAL CANCER,1
IT,RESPIRATORY ACIDOSIS,1
IT,RESPIRATORY DISTRESS,1
IT,RESPIRATORY FATIGUE,1
IT,RETINAL VEIN OCCLUSION,1
IT,RHINITIS,1
IT,RIB FRACTURE,1
IT,SCROTAL CYST,1
IT,SCROTAL SWELLING,1
IT,SENSORY DISTURBANCE,1
IT,SENSORY LOSS,1
IT,SKIN DISORDER,1
IT,SKIN HYPERPIGMENTATION,1
IT,SKIN REACTION,1
IT,SKIN ULCER,1
IT,SKIN WARM,1
IT,SLUGGISHNESS,1
IT,SMALL CELL LUNG CANCER,1
IT,SOFT TISSUE INFECTION,1
IT,SOLAR URTICARIA,1
IT,SOMATOFORM DISORDER GASTROINTESTINAL,1
IT,SPEECH DISORDER,1
IT,SPINAL COMPRESSION FRACTURE,1
IT,SPINAL EPIDURAL HAEMATOMA,1
IT,SPINOCEREBELLAR ATAXIA,1
IT,SPLENOMEGALY,1
IT,STAPHYLOCOCCAL BACTERAEMIA,1
IT,STAPHYLOCOCCAL INFECTION,1
IT,STENT PLACEMENT,1
IT,STERNAL FRACTURE,1
IT,STOMATITIS,1
IT,STRESS,1
IT,STRESS CARDIOMYOPATHY,1
IT,STROKE IN EVOLUTION,1
IT,SUBILEUS,1
IT,SUFFOCATION FEELING,1
IT,SWELLING FACE,1
IT,TENDONITIS,1
IT,THERAPY PARTIAL RESPONDER,1
IT,THROMBOCYTOSIS,1
IT,TONGUE HAEMORRHAGE,1
IT,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
IT,TREATMENT FAILURE,1
IT,TYPE IIA HYPERLIPIDAEMIA,1
IT,ULCER,1
IT,UNEVALUABLE EVENT,1
IT,UNRESPONSIVE TO STIMULI,1
IT,URINARY FISTULA,1
IT,UROSEPSIS,1
IT,VASCULAR INSUFFICIENCY,1
IT,VASCULITIC RASH,1
IT,VENTRICULAR DYSFUNCTION,1
IT,VENTRICULAR EXTRASYSTOLES,1
IT,VENTRICULAR FAILURE,1
IT,VENTRICULAR HYPOKINESIA,1
IT,VERTIGO POSITIONAL,1
IT,VESICAL FISTULA,1
IT,VESICOURETERIC REFLUX,1
IT,VESSEL PUNCTURE SITE HAEMATOMA,1
IT,VITAMIN D DEFICIENCY,1
IT,WEIGHT INCREASED,1
IT,WOUND,1
IT,WOUND HAEMORRHAGE,1
IT,WOUND INFECTION STAPHYLOCOCCAL,1
IT,WRONG DRUG ADMINISTERED,1
JM,CARDIAC FAILURE,1
JP,CEREBRAL INFARCTION,165
JP,INTERSTITIAL LUNG DISEASE,116
JP,ANAEMIA,107
JP,PYREXIA,98
JP,PNEUMONIA,96
JP,CARDIAC FAILURE,84
JP,DECREASED APPETITE,84
JP,HEPATIC FUNCTION ABNORMAL,81
JP,NEUTROPENIA,75
JP,RENAL IMPAIRMENT,72
JP,ANGINA PECTORIS,69
JP,DIARRHOEA,67
JP,PLATELET COUNT DECREASED,66
JP,FALL,64
JP,MALAISE,59
JP,CEREBRAL HAEMORRHAGE,58
JP,FEBRILE NEUTROPENIA,57
JP,DRUG INEFFECTIVE,51
JP,RHABDOMYOLYSIS,51
JP,ALTERED STATE OF CONSCIOUSNESS,50
JP,DEHYDRATION,50
JP,LEUKOPENIA,50
JP,NAUSEA,50
JP,MYOCARDIAL INFARCTION,49
JP,DIZZINESS,47
JP,LOSS OF CONSCIOUSNESS,47
JP,VOMITING,47
JP,CONDITION AGGRAVATED,46
JP,RASH,45
JP,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,44
JP,BLOOD PRESSURE DECREASED,43
JP,DEATH,43
JP,DYSPNOEA,42
JP,GASTROINTESTINAL HAEMORRHAGE,39
JP,HYPOGLYCAEMIA,39
JP,ACUTE MYOCARDIAL INFARCTION,38
JP,ATRIAL FIBRILLATION,37
JP,DISSEMINATED INTRAVASCULAR COAGULATION,37
JP,HAEMORRHAGE,36
JP,HAEMOGLOBIN DECREASED,35
JP,HYPONATRAEMIA,34
JP,PRURITUS,33
JP,VASCULAR STENT THROMBOSIS,33
JP,CARDIAC FAILURE CONGESTIVE,32
JP,ELECTROCARDIOGRAM QT PROLONGED,32
JP,LIVER DISORDER,32
JP,SEPSIS,32
JP,HAEMATURIA,31
JP,WHITE BLOOD CELL COUNT DECREASED,31
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,30
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,30
JP,DRUG ERUPTION,30
JP,BLOOD CREATININE INCREASED,26
JP,BRADYCARDIA,26
JP,CONSTIPATION,26
JP,MELAENA,26
JP,ASPARTATE AMINOTRANSFERASE INCREASED,25
JP,CHEST PAIN,25
JP,HAEMATEMESIS,25
JP,HYPERTENSION,25
JP,AGRANULOCYTOSIS,24
JP,ALANINE AMINOTRANSFERASE INCREASED,24
JP,C-REACTIVE PROTEIN INCREASED,24
JP,DRUG-INDUCED LIVER INJURY,24
JP,PLEURAL EFFUSION,24
JP,RENAL FAILURE,24
JP,RESPIRATORY FAILURE,24
JP,SHOCK HAEMORRHAGIC,24
JP,URINARY RETENTION,24
JP,BLOOD PRESSURE INCREASED,23
JP,CARDIO-RESPIRATORY ARREST,23
JP,COUGH,23
JP,SUBDURAL HAEMATOMA,23
JP,ANGINA UNSTABLE,22
JP,HYPERKALAEMIA,22
JP,OEDEMA,22
JP,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,22
JP,PNEUMONIA ASPIRATION,22
JP,SHOCK,22
JP,SUBARACHNOID HAEMORRHAGE,22
JP,THROMBOCYTOPENIA,22
JP,ACUTE KIDNEY INJURY,21
JP,BLOOD UREA INCREASED,21
JP,CORONARY ARTERY STENOSIS,21
JP,DRUG ADMINISTRATION ERROR,21
JP,HAEMATOMA,21
JP,INSULIN AUTOIMMUNE SYNDROME,21
JP,NEUTROPHIL COUNT DECREASED,21
JP,DIABETES MELLITUS,20
JP,EOSINOPHIL COUNT INCREASED,20
JP,HEADACHE,20
JP,LUNG NEOPLASM MALIGNANT,20
JP,ERYTHEMA,19
JP,CHEST DISCOMFORT,18
JP,DELIRIUM,18
JP,EMBOLIC STROKE,18
JP,HAEMOPTYSIS,18
JP,HAEMORRHAGE SUBCUTANEOUS,18
JP,MALIGNANT NEOPLASM PROGRESSION,18
JP,URINARY TRACT INFECTION,18
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,17
JP,CARDIAC FAILURE ACUTE,17
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,17
JP,PAIN IN EXTREMITY,17
JP,BLOOD BILIRUBIN INCREASED,16
JP,COLITIS MICROSCOPIC,16
JP,EOSINOPHILIA,16
JP,GASTRIC ULCER,16
JP,HYPERNATRAEMIA,16
JP,OEDEMA PERIPHERAL,16
JP,ABDOMINAL PAIN UPPER,15
JP,CORONARY ARTERY RESTENOSIS,15
JP,FEMUR FRACTURE,15
JP,HEMIPLEGIA,15
JP,PALPITATIONS,15
JP,VENTRICULAR FIBRILLATION,15
JP,ASTHENIA,14
JP,CARDIAC ARREST,14
JP,COLON CANCER,14
JP,GENERALISED OEDEMA,14
JP,PANCYTOPENIA,14
JP,TRANSIENT ISCHAEMIC ATTACK,14
JP,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,13
JP,BLOOD GLUCOSE INCREASED,13
JP,CHOLECYSTITIS ACUTE,13
JP,CHOLELITHIASIS,13
JP,DEMENTIA,13
JP,FATIGUE,13
JP,GASTRIC ULCER HAEMORRHAGE,13
JP,HYPERGLYCAEMIA,13
JP,HYPOAESTHESIA,13
JP,RENAL DISORDER,13
JP,SEIZURE,13
JP,VASCULAR PSEUDOANEURYSM,13
JP,VENTRICULAR TACHYCARDIA,13
JP,ANAPHYLACTIC SHOCK,12
JP,ARRHYTHMIA,12
JP,CONTRAINDICATED PRODUCT ADMINISTERED,12
JP,DERMATITIS EXFOLIATIVE,12
JP,EPISTAXIS,12
JP,GAIT DISTURBANCE,12
JP,HYPOKALAEMIA,12
JP,ILEUS,12
JP,JAUNDICE,12
JP,MOUTH HAEMORRHAGE,12
JP,MUSCULAR WEAKNESS,12
JP,PEMPHIGOID,12
JP,SOMNOLENCE,12
JP,ASCITES,11
JP,CARDIAC FAILURE CHRONIC,11
JP,DRUG RESISTANCE,11
JP,ECZEMA,11
JP,ERYTHEMA MULTIFORME,11
JP,GASTROINTESTINAL DISORDER,11
JP,GASTROOESOPHAGEAL REFLUX DISEASE,11
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,11
JP,INTERMITTENT CLAUDICATION,11
JP,MYOCARDIAL ISCHAEMIA,11
JP,PERITONITIS,11
JP,SEPTIC SHOCK,11
JP,SYNCOPE,11
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,11
JP,WHITE BLOOD CELL COUNT INCREASED,11
JP,BACK PAIN,10
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,10
JP,CHOLECYSTITIS,10
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,10
JP,HYPOCALCAEMIA,10
JP,INTERNATIONAL NORMALISED RATIO INCREASED,10
JP,INTESTINAL OBSTRUCTION,10
JP,PROCEDURAL HAEMORRHAGE,10
JP,PROSTATE CANCER,10
JP,PURPURA,10
JP,STOMATITIS,10
JP,SURGERY,10
JP,THIRST,10
JP,THROMBOTIC THROMBOCYTOPENIC PURPURA,10
JP,ABDOMINAL PAIN,9
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,9
JP,ACUTE RESPIRATORY FAILURE,9
JP,APHASIA,9
JP,ATRIOVENTRICULAR BLOCK COMPLETE,9
JP,BRAIN CONTUSION,9
JP,CARDIOGENIC SHOCK,9
JP,CAROTID ARTERY STENOSIS,9
JP,DERMATITIS ACNEIFORM,9
JP,DISEASE PROGRESSION,9
JP,DYSARTHRIA,9
JP,DYSPHAGIA,9
JP,DYSPNOEA EXERTIONAL,9
JP,FEMORAL NECK FRACTURE,9
JP,GASTRIC CANCER,9
JP,HYPOKINESIA,9
JP,HYPOTENSION,9
JP,MULTI-ORGAN FAILURE,9
JP,MUSCLE HAEMORRHAGE,9
JP,MYALGIA,9
JP,NASOPHARYNGITIS,9
JP,OSTEOMYELITIS,9
JP,OVERDOSE,9
JP,PANCREATIC CARCINOMA,9
JP,RENAL FAILURE CHRONIC,9
JP,ROAD TRAFFIC ACCIDENT,9
JP,SMALL INTESTINAL HAEMORRHAGE,9
JP,SUICIDE ATTEMPT,9
JP,TACHYCARDIA,9
JP,THROMBOSIS,9
JP,THROMBOTIC CEREBRAL INFARCTION,9
JP,TOXIC EPIDERMAL NECROLYSIS,9
JP,TREMOR,9
JP,URTICARIA,9
JP,ACUTE CORONARY SYNDROME,8
JP,AORTIC ANEURYSM,8
JP,ASTHMA,8
JP,BRAIN NATRIURETIC PEPTIDE INCREASED,8
JP,BRONCHITIS,8
JP,CARDIAC TAMPONADE,8
JP,CELLULITIS,8
JP,CONTUSION,8
JP,DRUG EFFECT INCOMPLETE,8
JP,DRUG HYPERSENSITIVITY,8
JP,DYSLALIA,8
JP,EOSINOPHILIC PNEUMONIA,8
JP,FAT EMBOLISM,8
JP,FEELING ABNORMAL,8
JP,FRACTURE,8
JP,HAEMATOCHEZIA,8
JP,HAEMOTHORAX,8
JP,HEPATIC ENZYME INCREASED,8
JP,HEPATIC FAILURE,8
JP,HYPOXIA,8
JP,LACUNAR INFARCTION,8
JP,LARGE INTESTINE POLYP,8
JP,LYMPHADENOPATHY,8
JP,MALNUTRITION,8
JP,METABOLIC ACIDOSIS,8
JP,NEPHROTIC SYNDROME,8
JP,ORGANISING PNEUMONIA,8
JP,PAIN,8
JP,PARALYSIS,8
JP,PNEUMONIA BACTERIAL,8
JP,POST PROCEDURAL HAEMORRHAGE,8
JP,PROTEIN-LOSING GASTROENTEROPATHY,8
JP,PULMONARY ALVEOLAR HAEMORRHAGE,8
JP,STEVENS-JOHNSON SYNDROME,8
JP,THROMBOTIC MICROANGIOPATHY,8
JP,TUBULOINTERSTITIAL NEPHRITIS,8
JP,UPPER AIRWAY OBSTRUCTION,8
JP,WEIGHT DECREASED,8
JP,ABDOMINAL DISTENSION,7
JP,ARTHRALGIA,7
JP,BRAIN HERNIATION,7
JP,BRAIN STEM HAEMORRHAGE,7
JP,CARDIOMEGALY,7
JP,CEREBROVASCULAR ACCIDENT,7
JP,CHILLS,7
JP,CHRONIC KIDNEY DISEASE,7
JP,CONVULSION,7
JP,CORONARY ARTERY OCCLUSION,7
JP,DYSKINESIA,7
JP,ENCEPHALOPATHY,7
JP,EROSIVE OESOPHAGITIS,7
JP,GASTROINTESTINAL PERFORATION,7
JP,HAEMOLYTIC ANAEMIA,7
JP,HOSPITALISATION,7
JP,HYPOGLYCAEMIC COMA,7
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
JP,INSOMNIA,7
JP,ISCHAEMIC STROKE,7
JP,LOWER GASTROINTESTINAL HAEMORRHAGE,7
JP,LUNG INFECTION,7
JP,MALLORY-WEISS SYNDROME,7
JP,MYELODYSPLASTIC SYNDROME,7
JP,NEOPLASM MALIGNANT,7
JP,OESOPHAGEAL INTRAMURAL HAEMATOMA,7
JP,OLIGURIA,7
JP,OSTEONECROSIS OF JAW,7
JP,PARKINSON^S DISEASE,7
JP,PERCUTANEOUS CORONARY INTERVENTION,7
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,7
JP,POLLAKIURIA,7
JP,PRODUCT USE ISSUE,7
JP,PROTEINURIA,7
JP,RASH GENERALISED,7
JP,RED BLOOD CELL COUNT DECREASED,7
JP,SUDDEN DEATH,7
JP,UPPER RESPIRATORY TRACT INFLAMMATION,7
JP,ABDOMINAL PAIN LOWER,6
JP,ABNORMAL BEHAVIOUR,6
JP,ACUTE MYELOID LEUKAEMIA,6
JP,ANGIOPLASTY,6
JP,AORTIC VALVE STENOSIS,6
JP,BLADDER CANCER,6
JP,BLOOD URINE PRESENT,6
JP,BONE MARROW FAILURE,6
JP,CHROMATURIA,6
JP,COGNITIVE DISORDER,6
JP,COMA,6
JP,CORONARY ARTERY DISEASE,6
JP,DIPLOPIA,6
JP,FAECES DISCOLOURED,6
JP,GENERAL PHYSICAL HEALTH DETERIORATION,6
JP,GRANULOCYTOPENIA,6
JP,HAEMATOCRIT DECREASED,6
JP,HAEMOBILIA,6
JP,HAEMORRHAGE INTRACRANIAL,6
JP,HAEMORRHAGIC CEREBRAL INFARCTION,6
JP,HAEMORRHAGIC DIATHESIS,6
JP,HEPATITIS FULMINANT,6
JP,HERPES ZOSTER,6
JP,HYDROCEPHALUS,6
JP,HYPERURICAEMIA,6
JP,HYPOALBUMINAEMIA,6
JP,ILEAL ULCER,6
JP,ILEUS PARALYTIC,6
JP,INFECTION,6
JP,INFLAMMATION,6
JP,ISCHAEMIC CARDIOMYOPATHY,6
JP,LACTIC ACIDOSIS,6
JP,LUNG DISORDER,6
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,6
JP,NO ADVERSE EVENT,6
JP,OROPHARYNGEAL PAIN,6
JP,PROTHROMBIN TIME PROLONGED,6
JP,PRURITUS GENERALISED,6
JP,PULMONARY OEDEMA,6
JP,RENAL FAILURE ACUTE,6
JP,RESPIRATORY ARREST,6
JP,RETROPERITONEAL HAEMATOMA,6
JP,SPINAL COMPRESSION FRACTURE,6
JP,THALAMUS HAEMORRHAGE,6
JP,THROMBOSIS IN DEVICE,6
JP,TRANSFUSION,6
JP,VASCULAR STENT RESTENOSIS,6
JP,VENTRICULAR EXTRASYSTOLES,6
JP,ABDOMINAL DISCOMFORT,5
JP,ABDOMINAL TENDERNESS,5
JP,ANAPHYLACTIC REACTION,5
JP,APLASIA PURE RED CELL,5
JP,APPENDICITIS,5
JP,ARTERIOSPASM CORONARY,5
JP,ATRIOVENTRICULAR BLOCK,5
JP,BLADDER TAMPONADE,5
JP,BLOOD PRESSURE SYSTOLIC INCREASED,5
JP,BLOOD TRIGLYCERIDES INCREASED,5
JP,BREAST CANCER,5
JP,CARDIAC DISORDER,5
JP,CARDIAC PACEMAKER INSERTION,5
JP,CATARACT,5
JP,CEREBELLAR INFARCTION,5
JP,CEREBRAL ARTERY EMBOLISM,5
JP,CIRCULATORY COLLAPSE,5
JP,COLITIS ISCHAEMIC,5
JP,CONTRAST ENCEPHALOPATHY,5
JP,CORONARY ARTERIAL STENT INSERTION,5
JP,DEPRESSION,5
JP,DEVICE OCCLUSION,5
JP,DEVICE RELATED INFECTION,5
JP,DRY SKIN,5
JP,DUODENAL ULCER HAEMORRHAGE,5
JP,ENTEROCOLITIS,5
JP,EPILEPSY,5
JP,FEEDING DISORDER,5
JP,GASTRIC HAEMORRHAGE,5
JP,GASTROENTERITIS,5
JP,GENERALISED ERYTHEMA,5
JP,HAEMOGLOBIN INCREASED,5
JP,HEART RATE INCREASED,5
JP,HEMIPARESIS,5
JP,HEPARIN-INDUCED THROMBOCYTOPENIA,5
JP,HYPERHIDROSIS,5
JP,HYPOPHAGIA,5
JP,INTENTIONAL DRUG MISUSE,5
JP,INTENTIONAL OVERDOSE,5
JP,INTENTIONAL PRODUCT MISUSE,5
JP,INTESTINAL ISCHAEMIA,5
JP,IRON DEFICIENCY ANAEMIA,5
JP,LIVER FUNCTION TEST ABNORMAL,5
JP,MATERNAL EXPOSURE DURING PREGNANCY,5
JP,MUSCLE SPASMS,5
JP,MYASTHENIA GRAVIS,5
JP,OCULAR HYPERAEMIA,5
JP,OXYGEN SATURATION DECREASED,5
JP,PERICARDIAL EFFUSION,5
JP,PERIODONTITIS,5
JP,PHARYNGEAL OEDEMA,5
JP,PHARYNGITIS,5
JP,PNEUMOTHORAX,5
JP,PRERENAL FAILURE,5
JP,PULMONARY CONGESTION,5
JP,RESPIRATORY TRACT HAEMORRHAGE,5
JP,RESTLESSNESS,5
JP,RHEUMATOID ARTHRITIS,5
JP,RIB FRACTURE,5
JP,SKIN DISCOLOURATION,5
JP,SKIN DISORDER,5
JP,SKIN EXFOLIATION,5
JP,SKIN ULCER,5
JP,SMALL INTESTINE ULCER,5
JP,SUBCUTANEOUS HAEMATOMA,5
JP,SUPRAVENTRICULAR TACHYCARDIA,5
JP,SWELLING,5
JP,TOXIC SKIN ERUPTION,5
JP,URINARY BLADDER HAEMORRHAGE,5
JP,URINARY INCONTINENCE,5
JP,URINE OUTPUT DECREASED,5
JP,VENTRICULAR HYPOKINESIA,5
JP,VITREOUS HAEMORRHAGE,5
JP,WEIGHT INCREASED,5
JP,AGGRESSION,4
JP,AGITATION,4
JP,ANTI-INSULIN ANTIBODY INCREASED,4
JP,ANXIETY,4
JP,AORTIC ANEURYSM RUPTURE,4
JP,ASPIRATION,4
JP,ATAXIA,4
JP,BENIGN PROSTATIC HYPERPLASIA,4
JP,BILIRUBIN CONJUGATED INCREASED,4
JP,BLEEDING TIME PROLONGED,4
JP,BLOOD ALBUMIN DECREASED,4
JP,BLOOD GLUCOSE DECREASED,4
JP,BLOOD POTASSIUM INCREASED,4
JP,BLOOD SODIUM DECREASED,4
JP,BODY TEMPERATURE DECREASED,4
JP,CANCER PAIN,4
JP,CEREBELLAR HAEMORRHAGE,4
JP,CHEST X-RAY ABNORMAL,4
JP,CHOLANGITIS,4
JP,CHRONIC GASTRITIS,4
JP,COLD SWEAT,4
JP,COLITIS,4
JP,COMPUTERISED TOMOGRAM ABNORMAL,4
JP,DEEP VEIN THROMBOSIS,4
JP,DISORIENTATION,4
JP,DRUG DOSE OMISSION,4
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
JP,DYSSTASIA,4
JP,EATING DISORDER,4
JP,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,4
JP,EPIGASTRIC DISCOMFORT,4
JP,FACTOR V INHIBITION,4
JP,FEELING COLD,4
JP,FIBRIN D DIMER INCREASED,4
JP,GASTRIC POLYPS,4
JP,HAEMATOCOELE,4
JP,HAEMODYNAMIC INSTABILITY,4
JP,HEART RATE DECREASED,4
JP,HEPATIC CANCER,4
JP,HEPATITIS ACUTE,4
JP,HISTIOCYTOSIS HAEMATOPHAGIC,4
JP,HYPERBILIRUBINAEMIA,4
JP,HYPERPARATHYROIDISM SECONDARY,4
JP,IDIOPATHIC PULMONARY FIBROSIS,4
JP,INSULIN C-PEPTIDE INCREASED,4
JP,INTRAVENTRICULAR HAEMORRHAGE,4
JP,LARGE INTESTINAL ULCER,4
JP,LYMPHOCYTE COUNT DECREASED,4
JP,MALABSORPTION FROM APPLICATION SITE,4
JP,MEDIASTINAL HAEMATOMA,4
JP,MENTAL DISORDER,4
JP,MUCOSAL EROSION,4
JP,MUSCULOSKELETAL STIFFNESS,4
JP,MYOCARDIAL RUPTURE,4
JP,NEPHROLITHIASIS,4
JP,NERVOUS SYSTEM DISORDER,4
JP,NON-SMALL CELL LUNG CANCER,4
JP,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,4
JP,NYSTAGMUS,4
JP,OCULAR ICTERUS,4
JP,OROPHARYNGEAL SWELLING,4
JP,ORTHOSTATIC HYPOTENSION,4
JP,PERIPHERAL ARTERY RESTENOSIS,4
JP,PERIPHERAL COLDNESS,4
JP,PERIPHERAL SWELLING,4
JP,PITUITARY HAEMORRHAGE,4
JP,PLATELET COUNT INCREASED,4
JP,POLYP,4
JP,PSYCHIATRIC SYMPTOM,4
JP,PULMONARY HAEMORRHAGE,4
JP,PULMONARY HYPERTENSION,4
JP,PUNCTURE SITE HAEMORRHAGE,4
JP,PUTAMEN HAEMORRHAGE,4
JP,PYELONEPHRITIS ACUTE,4
JP,RENAL CANCER,4
JP,SEROTONIN SYNDROME,4
JP,STENT PLACEMENT,4
JP,STRESS CARDIOMYOPATHY,4
JP,TINNITUS,4
JP,UPPER RESPIRATORY TRACT INFECTION,4
JP,WERNICKE^S ENCEPHALOPATHY,4
JP,WHEEZING,4
JP,ABDOMINAL WALL HAEMATOMA,3
JP,ABDOMINAL WALL HAEMORRHAGE,3
JP,ADRENAL INSUFFICIENCY,3
JP,ALOPECIA,3
JP,AMNESIA,3
JP,AMYLASE INCREASED,3
JP,ANURIA,3
JP,APHAGIA,3
JP,APLASTIC ANAEMIA,3
JP,APPLICATION SITE ERYTHEMA,3
JP,ARTERIAL INJURY,3
JP,ARTERIAL THROMBOSIS,3
JP,ARTERIOSCLEROSIS,3
JP,ARTHRITIS,3
JP,ATELECTASIS,3
JP,BACTERIAL INFECTION,3
JP,BALANCE DISORDER,3
JP,BASOPHIL COUNT INCREASED,3
JP,BILE DUCT CANCER,3
JP,BLISTER,3
JP,BLOOD IMMUNOGLOBULIN E INCREASED,3
JP,BLOOD PHOSPHORUS DECREASED,3
JP,BLOOD POTASSIUM DECREASED,3
JP,BLOOD PRESSURE DIASTOLIC DECREASED,3
JP,BRAIN STEM INFARCTION,3
JP,BUNDLE BRANCH BLOCK RIGHT,3
JP,CACHEXIA,3
JP,CARDIAC ABLATION,3
JP,CEREBRAL ARTERY STENOSIS,3
JP,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
JP,COAGULOPATHY,3
JP,CORONARY ARTERY THROMBOSIS,3
JP,CYSTITIS,3
JP,CYTOMEGALOVIRUS INFECTION,3
JP,DEMENTIA ALZHEIMER^S TYPE,3
JP,DEMENTIA WITH LEWY BODIES,3
JP,DIABETES MELLITUS INADEQUATE CONTROL,3
JP,DIABETIC GANGRENE,3
JP,DILATATION VENTRICULAR,3
JP,DIVERTICULITIS,3
JP,DIVERTICULUM INTESTINAL,3
JP,DIVERTICULUM INTESTINAL HAEMORRHAGIC,3
JP,DRUG PRESCRIBING ERROR,3
JP,DUODENAL ULCER,3
JP,DYSPHONIA,3
JP,DYSURIA,3
JP,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
JP,EXPOSURE DURING PREGNANCY,3
JP,EXTRAPYRAMIDAL DISORDER,3
JP,EXTRAVASATION,3
JP,FACE OEDEMA,3
JP,FAECES SOFT,3
JP,GALLBLADDER DISORDER,3
JP,GALLBLADDER PERFORATION,3
JP,GASTRITIS,3
JP,GASTRITIS EROSIVE,3
JP,GASTROINTESTINAL ENDOSCOPIC THERAPY,3
JP,GASTROINTESTINAL EROSION,3
JP,GASTROINTESTINAL POLYP HAEMORRHAGE,3
JP,GINGIVAL BLEEDING,3
JP,GLOMERULAR FILTRATION RATE DECREASED,3
JP,GRANULOCYTE COUNT DECREASED,3
JP,HAEMODIALYSIS,3
JP,HAEMORRHAGIC CYST,3
JP,HAEMORRHAGIC INFARCTION,3
JP,HAEMORRHOIDS,3
JP,HALLUCINATION,3
JP,HEAD INJURY,3
JP,HEPATIC HAEMORRHAGE,3
JP,HEPATITIS,3
JP,HEPATOCELLULAR CARCINOMA,3
JP,HEPATOMEGALY,3
JP,HEPATOTOXICITY,3
JP,HYPERSENSITIVITY,3
JP,HYPOGLYCAEMIC ENCEPHALOPATHY,3
JP,HYPOMAGNESAEMIA,3
JP,INTERNAL HAEMORRHAGE,3
JP,INTESTINAL HAEMORRHAGE,3
JP,INTRA-ABDOMINAL HAEMORRHAGE,3
JP,INTRACRANIAL ANEURYSM,3
JP,IRRITABILITY,3
JP,LARGE INTESTINAL HAEMORRHAGE,3
JP,LARGE INTESTINE PERFORATION,3
JP,LARYNGEAL OEDEMA,3
JP,LOCAL SWELLING,3
JP,LUMBAR SPINAL STENOSIS,3
JP,MARASMUS,3
JP,MEMORY IMPAIRMENT,3
JP,METASTASES TO LUNG,3
JP,METASTASES TO TRACHEA,3
JP,MIOSIS,3
JP,MONOCYTE COUNT INCREASED,3
JP,MOVEMENT DISORDER,3
JP,NEPHROGENIC ANAEMIA,3
JP,NEUROLEPTIC MALIGNANT SYNDROME,3
JP,NEUTROPHIL COUNT INCREASED,3
JP,OBSTRUCTIVE AIRWAYS DISORDER,3
JP,OCCULT BLOOD POSITIVE,3
JP,OESOPHAGEAL HAEMORRHAGE,3
JP,OESOPHAGEAL ULCER,3
JP,OESOPHAGITIS,3
JP,OSTEOSYNTHESIS,3
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
JP,PARINAUD SYNDROME,3
JP,PEPTIC ULCER,3
JP,PERICARDIAL HAEMORRHAGE,3
JP,PERIPHERAL ARTERY OCCLUSION,3
JP,PERIPHERAL ARTERY STENOSIS,3
JP,PLASMA CELL MYELOMA,3
JP,PNEUMONIA INFLUENZAL,3
JP,PNEUMONITIS,3
JP,PORTAL VEIN THROMBOSIS,3
JP,POTENTIATING DRUG INTERACTION,3
JP,PREMATURE BABY,3
JP,PRODUCT USE IN UNAPPROVED INDICATION,3
JP,PROSTATITIS,3
JP,PROTEIN TOTAL DECREASED,3
JP,PULMONARY RADIATION INJURY,3
JP,PULMONARY TUBERCULOSIS,3
JP,PYELONEPHRITIS,3
JP,QUADRIPLEGIA,3
JP,RECTAL CANCER,3
JP,RECTAL ULCER HAEMORRHAGE,3
JP,RENAL TUBULAR DISORDER,3
JP,RENAL TUBULAR NECROSIS,3
JP,RESPIRATORY DISORDER,3
JP,RETICULOCYTE COUNT INCREASED,3
JP,RETINAL ARTERY OCCLUSION,3
JP,RETINAL DETACHMENT,3
JP,SCLERITIS,3
JP,SERONEGATIVE ARTHRITIS,3
JP,SINUS NODE DYSFUNCTION,3
JP,SINUS RHYTHM,3
JP,SINUS TACHYCARDIA,3
JP,SKIN EROSION,3
JP,SKIN NECROSIS,3
JP,SMALL INTESTINE CARCINOMA,3
JP,STAPHYLOCOCCAL INFECTION,3
JP,SUDDEN HEARING LOSS,3
JP,THERAPEUTIC RESPONSE DECREASED,3
JP,TORSADE DE POINTES,3
JP,TROPONIN T INCREASED,3
JP,VASCULAR INJURY,3
JP,VASCULAR PSEUDOANEURYSM RUPTURED,3
JP,VASCULAR STENT OCCLUSION,3
JP,VASCULAR STENT STENOSIS,3
JP,WOUND HAEMORRHAGE,3
JP,ACCIDENTAL OVERDOSE,2
JP,ACIDOSIS,2
JP,ACQUIRED HAEMOPHILIA,2
JP,ACTIVITIES OF DAILY LIVING IMPAIRED,2
JP,ACUTE PROMYELOCYTIC LEUKAEMIA,2
JP,ACUTE PULMONARY OEDEMA,2
JP,ANAEMIA MACROCYTIC,2
JP,ANASTOMOTIC HAEMORRHAGE,2
JP,ANGER,2
JP,APATHY,2
JP,APPLICATION SITE DERMATITIS,2
JP,APPLICATION SITE PRURITUS,2
JP,AREFLEXIA,2
JP,ARTERIAL OCCLUSIVE DISEASE,2
JP,ARTERIAL RESTENOSIS,2
JP,ARTERIOSCLEROSIS CORONARY ARTERY,2
JP,ARTERIOVENOUS FISTULA,2
JP,ARTHRITIS BACTERIAL,2
JP,ASPHYXIA,2
JP,ATRIAL FLUTTER,2
JP,ATRIAL THROMBOSIS,2
JP,AZOTAEMIA,2
JP,BACTERAEMIA,2
JP,BACTERIAL SEPSIS,2
JP,BACTERIAL TEST POSITIVE,2
JP,BILE DUCT OBSTRUCTION,2
JP,BILIRUBINURIA,2
JP,BLADDER NEOPLASM SURGERY,2
JP,BLOOD CHLORIDE DECREASED,2
JP,BLOOD CHLORIDE INCREASED,2
JP,BLOOD CHOLESTEROL DECREASED,2
JP,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
JP,BLOOD PRESSURE FLUCTUATION,2
JP,BLOOD PRESSURE SYSTOLIC DECREASED,2
JP,BLOOD URIC ACID INCREASED,2
JP,BLUE TOE SYNDROME,2
JP,BONE DENSITY DECREASED,2
JP,BRADYKINESIA,2
JP,BRAIN NEOPLASM,2
JP,BRAIN OEDEMA,2
JP,BREAST PAIN,2
JP,BREATH SOUNDS ABNORMAL,2
JP,BRONCHIAL OBSTRUCTION,2
JP,BURNING SENSATION,2
JP,CAESAREAN SECTION,2
JP,CALCULUS URINARY,2
JP,CARDIAC DEATH,2
JP,CARDIAC HYPERTROPHY,2
JP,CARDIAC MURMUR,2
JP,CARDIAC VENTRICULAR THROMBOSIS,2
JP,CAROTID ARTERY OCCLUSION,2
JP,CAROTID ARTERY STENT INSERTION,2
JP,CATHETERISATION CARDIAC,2
JP,CEREBELLAR ATAXIA,2
JP,CEREBRAL HAEMATOMA,2
JP,CEREBRAL HYPERPERFUSION SYNDROME,2
JP,CHOKING,2
JP,CHOLANGIOCARCINOMA,2
JP,CHOLANGITIS ACUTE,2
JP,CHOLECYSTECTOMY,2
JP,CHOLECYSTITIS INFECTIVE,2
JP,CLOSTRIDIUM DIFFICILE INFECTION,2
JP,COLLAGEN DISORDER,2
JP,COLON CANCER STAGE IV,2
JP,COMPLEMENT FACTOR C3 DECREASED,2
JP,COMPLEMENT FACTOR DECREASED,2
JP,CONCOMITANT DISEASE AGGRAVATED,2
JP,CORONARY ARTERY BYPASS,2
JP,CUSHINGOID,2
JP,CUTANEOUS SYMPTOM,2
JP,CYTOMEGALOVIRUS ENTEROCOLITIS,2
JP,CYTOPENIA,2
JP,DECUBITUS ULCER,2
JP,DELUSION,2
JP,DIABETES INSIPIDUS,2
JP,DIABETIC KETOACIDOSIS,2
JP,DISEASE RECURRENCE,2
JP,DISINHIBITION,2
JP,DISTURBANCE IN ATTENTION,2
JP,DIVERTICULAR PERFORATION,2
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
JP,DRY MOUTH,2
JP,DYSGEUSIA,2
JP,DYSLIPIDAEMIA,2
JP,DYSPEPSIA,2
JP,EJECTION FRACTION DECREASED,2
JP,EMBOLIC CEREBRAL INFARCTION,2
JP,EMOTIONAL DISORDER,2
JP,EMPHYSEMATOUS CYSTITIS,2
JP,EPIGLOTTITIS,2
JP,EYE MOVEMENT DISORDER,2
JP,EYELID OEDEMA,2
JP,EYELID PTOSIS,2
JP,FACIAL BONES FRACTURE,2
JP,FAECALOMA,2
JP,FLUID OVERLOAD,2
JP,FLUID RETENTION,2
JP,FOETAL EXPOSURE DURING PREGNANCY,2
JP,FULMINANT TYPE 1 DIABETES MELLITUS,2
JP,GALLBLADDER CANCER,2
JP,GALLBLADDER ENLARGEMENT,2
JP,GASTRIC ANTRAL VASCULAR ECTASIA,2
JP,GASTRIC MUCOSAL LESION,2
JP,GASTRIC PERFORATION,2
JP,GASTRODUODENAL ULCER,2
JP,GASTROENTERITIS NOROVIRUS,2
JP,GASTROINTESTINAL ULCER HAEMORRHAGE,2
JP,GENITAL HAEMORRHAGE,2
JP,GLASSY EYES,2
JP,GLOMERULONEPHRITIS,2
JP,GLOMERULONEPHRITIS MEMBRANOUS,2
JP,GLOSSODYNIA,2
JP,HAEMATOCRIT INCREASED,2
JP,HAEMOLYTIC URAEMIC SYNDROME,2
JP,HAEMORRHAGIC ANAEMIA,2
JP,HAEMORRHAGIC ASCITES,2
JP,HAEMORRHAGIC HEPATIC CYST,2
JP,HAEMORRHAGIC STROKE,2
JP,HAEMORRHOIDAL HAEMORRHAGE,2
JP,HALLUCINATION_ AUDITORY,2
JP,HAPTOGLOBIN DECREASED,2
JP,HEPATIC CIRRHOSIS,2
JP,HEPATIC CYST INFECTION,2
JP,HEPATOCELLULAR INJURY,2
JP,HERPES ZOSTER OTICUS,2
JP,HIATUS HERNIA,2
JP,HICCUPS,2
JP,HUNGER,2
JP,HYPEREOSINOPHILIC SYNDROME,2
JP,HYPERFERRITINAEMIA,2
JP,HYPERTHERMIA,2
JP,HYPOACUSIS,2
JP,HYPOAESTHESIA ORAL,2
JP,HYPOGLYCAEMIC UNCONSCIOUSNESS,2
JP,HYPOPHOSPHATAEMIA,2
JP,HYPOPITUITARISM,2
JP,HYPOREFLEXIA,2
JP,HYPOTHYROIDISM,2
JP,HYPOVOLAEMIC SHOCK,2
JP,INCONTINENCE,2
JP,INCORRECT DOSE ADMINISTERED,2
JP,INCORRECT DRUG ADMINISTRATION DURATION,2
JP,INFECTIVE SPONDYLITIS,2
JP,INFLUENZA,2
JP,INGUINAL HERNIA,2
JP,INJURY,2
JP,INTERNATIONAL NORMALISED RATIO DECREASED,2
JP,INTERVERTEBRAL DISC PROTRUSION,2
JP,INTRACARDIAC THROMBUS,2
JP,INTRAOCULAR PRESSURE INCREASED,2
JP,INTRAVASCULAR HAEMOLYSIS,2
JP,JAUNDICE CHOLESTATIC,2
JP,JAW FRACTURE,2
JP,LACERATION,2
JP,LEFT VENTRICULAR DYSFUNCTION,2
JP,LIPIDS ABNORMAL,2
JP,LIVEDO RETICULARIS,2
JP,LIVER INJURY,2
JP,LOGORRHOEA,2
JP,LOW BIRTH WEIGHT BABY,2
JP,LOW DENSITY LIPOPROTEIN DECREASED,2
JP,LOW DENSITY LIPOPROTEIN INCREASED,2
JP,LUNG INFILTRATION,2
JP,LUNG NEOPLASM,2
JP,LYMPHANGIOSIS CARCINOMATOSA,2
JP,LYMPHOCYTE PERCENTAGE INCREASED,2
JP,LYMPHOMA,2
JP,MENINGITIS BACTERIAL,2
JP,METASTASES TO PERITONEUM,2
JP,MOANING,2
JP,MOBILITY DECREASED,2
JP,MONOPLEGIA,2
JP,MOTOR DYSFUNCTION,2
JP,MUCOSAL HAEMORRHAGE,2
JP,MYDRIASIS,2
JP,NECK PAIN,2
JP,NECROSIS,2
JP,NERVOUSNESS,2
JP,NEUROLOGICAL DECOMPENSATION,2
JP,NEUROPATHY PERIPHERAL,2
JP,NEUROPSYCHIATRIC SYMPTOMS,2
JP,NOCTURIA,2
JP,OESOPHAGEAL CANDIDIASIS,2
JP,ORAL CANDIDIASIS,2
JP,ORAL HERPES,2
JP,ORTHOPNOEA,2
JP,OSTEOARTHRITIS,2
JP,OSTEONECROSIS,2
JP,OTORRHOEA,2
JP,OVARIAN NEOPLASM,2
JP,PALLOR,2
JP,PANCREATIC CARCINOMA METASTATIC,2
JP,PARKINSONISM,2
JP,PARONYCHIA,2
JP,PATELLA FRACTURE,2
JP,PERIPHERAL ARTERY THROMBOSIS,2
JP,PERIPHERAL ISCHAEMIA,2
JP,PETECHIAE,2
JP,PHOTOSENSITIVITY REACTION,2
JP,PIGMENTATION DISORDER,2
JP,PLEURISY,2
JP,PNEUMATOSIS INTESTINALIS,2
JP,POLYARTERITIS NODOSA,2
JP,POLYMYALGIA RHEUMATICA,2
JP,POLYURIA,2
JP,POSTOPERATIVE WOUND INFECTION,2
JP,PREMATURE DELIVERY,2
JP,PRESCRIBED OVERDOSE,2
JP,PRESYNCOPE,2
JP,PRINZMETAL ANGINA,2
JP,PROCEDURAL HYPOTENSION,2
JP,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
JP,PROTEIN URINE PRESENT,2
JP,PRURIGO,2
JP,PSEUDOMEMBRANOUS COLITIS,2
JP,PULMONARY ARTERY DILATATION,2
JP,PULMONARY EMBOLISM,2
JP,PULSE ABNORMAL,2
JP,PUNCTURE SITE SWELLING,2
JP,PUPILS UNEQUAL,2
JP,PYOMYOSITIS,2
JP,RADIATION PNEUMONITIS,2
JP,RECTAL PERFORATION,2
JP,RECTAL ULCER,2
JP,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
JP,REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA,2
JP,RENAL ARTERY STENOSIS,2
JP,RESPIRATION ABNORMAL,2
JP,RETINAL HAEMORRHAGE,2
JP,RETROPERITONEAL HAEMORRHAGE,2
JP,SERUM FERRITIN INCREASED,2
JP,SHUNT THROMBOSIS,2
JP,SKIN CANCER,2
JP,SKIN INFECTION,2
JP,SMALL INTESTINAL PERFORATION,2
JP,SMALL INTESTINAL STENOSIS,2
JP,SPEECH DISORDER,2
JP,SPINAL COLUMN STENOSIS,2
JP,SPINAL OSTEOARTHRITIS,2
JP,SPINAL SUBDURAL HAEMATOMA,2
JP,SPUTUM RETENTION,2
JP,SQUAMOUS CELL CARCINOMA OF LUNG,2
JP,STATUS EPILEPTICUS,2
JP,STREPTOCOCCAL INFECTION,2
JP,STRESS,2
JP,SUBDURAL HAEMORRHAGE,2
JP,SUBDURAL HYGROMA,2
JP,SUPRAVENTRICULAR EXTRASYSTOLES,2
JP,SWELLING FACE,2
JP,SWOLLEN TONGUE,2
JP,SYNOVIAL CYST,2
JP,SYSTEMIC CANDIDA,2
JP,THERAPEUTIC RESPONSE UNEXPECTED,2
JP,THORACIC VERTEBRAL FRACTURE,2
JP,THROMBOCYTOPENIC PURPURA,2
JP,TONGUE HAEMORRHAGE,2
JP,TOXIC ENCEPHALOPATHY,2
JP,TOXICITY TO VARIOUS AGENTS,2
JP,TRACHEOSTOMY,2
JP,TRANSPLANT REJECTION,2
JP,TRAUMATIC HAEMORRHAGE,2
JP,TRAUMATIC INTRACRANIAL HAEMORRHAGE,2
JP,TUMOUR COMPRESSION,2
JP,TUMOUR HAEMORRHAGE,2
JP,TUMOUR LYSIS SYNDROME,2
JP,TUMOUR MARKER INCREASED,2
JP,ULCER HAEMORRHAGE,2
JP,VARICELLA ZOSTER PNEUMONIA,2
JP,VASCULAR OCCLUSION,2
JP,VENTRICLE RUPTURE,2
JP,VERTIGO,2
JP,VESSEL PUNCTURE SITE HAEMATOMA,2
JP,VISUAL ACUITY REDUCED,2
JP,VISUAL FIELD DEFECT,2
JP,VITAMIN B1 DECREASED,2
JP,WHITE MATTER LESION,2
JP,WOUND ABSCESS,2
JP,WOUND DEHISCENCE,2
JP,WRIST FRACTURE,2
JP,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
JP,ABASIA,1
JP,ABDOMINAL ADHESIONS,1
JP,ABNORMAL WEIGHT GAIN,1
JP,ABULIA,1
JP,ACCIDENT,1
JP,ACCIDENTAL EXPOSURE TO PRODUCT,1
JP,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
JP,ACUTE HEPATIC FAILURE,1
JP,ACUTE LYMPHOCYTIC LEUKAEMIA,1
JP,ACUTE PRERENAL FAILURE,1
JP,ACUTE SINUSITIS,1
JP,ADAMTS13 ACTIVITY DECREASED,1
JP,ADENOCARCINOMA GASTRIC,1
JP,ADENOMA BENIGN,1
JP,ADRENAL ADENOMA,1
JP,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
JP,ADRENOMEGALY,1
JP,ADVERSE DRUG REACTION,1
JP,ADVERSE EVENT,1
JP,AFFECT LABILITY,1
JP,AKINESIA,1
JP,ALANINE AMINOTRANSFERASE ABNORMAL,1
JP,ALBUMIN URINE PRESENT,1
JP,ALCOHOLIC LIVER DISEASE,1
JP,ALCOHOLIC PANCREATITIS,1
JP,ALOPECIA TOTALIS,1
JP,AMMONIA INCREASED,1
JP,AMYLOIDOSIS,1
JP,ANAEMIA OF MALIGNANT DISEASE,1
JP,ANAL FISSURE,1
JP,ANAL ULCER HAEMORRHAGE,1
JP,ANAPHYLACTOID REACTION,1
JP,ANAPHYLACTOID SHOCK,1
JP,ANASTOMOTIC STENOSIS,1
JP,ANEURYSM,1
JP,ANEURYSM REPAIR,1
JP,ANEURYSM RUPTURED,1
JP,ANGIOEDEMA,1
JP,ANGIOPATHY,1
JP,ANGULAR CHEILITIS,1
JP,ANOMALOUS ARRANGEMENT OF PANCREATICOBILIARY DUCT,1
JP,ANORECTAL DISORDER,1
JP,ANOREXIA NERVOSA,1
JP,ANTI-THYROID ANTIBODY POSITIVE,1
JP,ANTICHOLINERGIC SYNDROME,1
JP,ANTINUCLEAR ANTIBODY,1
JP,ANTINUCLEAR ANTIBODY INCREASED,1
JP,ANTIPHOSPHOLIPID SYNDROME,1
JP,ANTITHROMBIN III INCREASED,1
JP,AORTIC DISSECTION,1
JP,AORTIC RUPTURE,1
JP,AORTIC VALVE INCOMPETENCE,1
JP,APPENDICITIS PERFORATED,1
JP,APPENDIX CANCER,1
JP,APPLICATION SITE ECZEMA,1
JP,ARTERIAL HAEMORRHAGE,1
JP,ARTERIAL REPAIR,1
JP,ARTERIOGRAM CORONARY,1
JP,ARTERIOVENOUS GRAFT ANEURYSM,1
JP,ARTHROPATHY,1
JP,ARTHROPOD STING,1
JP,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
JP,ASTERIXIS,1
JP,ATHEROEMBOLISM,1
JP,ATRIAL SEPTAL DEFECT,1
JP,ATRIAL TACHYCARDIA,1
JP,ATYPICAL FEMUR FRACTURE,1
JP,ATYPICAL FRACTURE,1
JP,ATYPICAL MYCOBACTERIAL INFECTION,1
JP,AUTOIMMUNE COLITIS,1
JP,AUTOIMMUNE PANCREATITIS,1
JP,BACK INJURY,1
JP,BACTERIAL TRANSLOCATION,1
JP,BACTERIURIA,1
JP,BASAL GANGLIA HAEMORRHAGE,1
JP,BASAL GANGLIA INFARCTION,1
JP,BASILAR ARTERY OCCLUSION,1
JP,BASILAR ARTERY STENOSIS,1
JP,BEHCET^S SYNDROME,1
JP,BENIGN NEOPLASM,1
JO,DIARRHOEA,2
JO,ARTHRALGIA,1
JO,BLOOD GLUCOSE DECREASED,1
JO,CHEST DISCOMFORT,1
JO,CHEST PAIN,1
JO,CHOLECYSTITIS,1
JO,CONTUSION,1
JO,DEATH,1
JO,DECREASED APPETITE,1
JO,DEHYDRATION,1
JO,DYSPNOEA,1
JO,ERYTHEMA,1
JO,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
JO,HAEMORRHAGIC STROKE,1
JO,HELICOBACTER GASTRITIS,1
JO,HYPERSENSITIVITY,1
JO,HYPOVOLAEMIA,1
JO,IMMUNOSUPPRESSION,1
JO,JAUNDICE,1
JO,LEGIONELLA INFECTION,1
JO,MYOCARDIAL INFARCTION,1
JO,PAIN,1
JO,PNEUMONIA LEGIONELLA,1
JO,SEPSIS,1
KZ,DRUG INEFFECTIVE,5
KZ,VASCULAR STENT THROMBOSIS,5
KZ,MYOCARDIAL INFARCTION,2
KZ,ANAEMIA,1
KZ,ASTHENIA,1
KZ,BLOOD CREATININE INCREASED,1
KZ,CARDIAC ARREST,1
KZ,CARDIOGENIC SHOCK,1
KZ,CHEST PAIN,1
KZ,CHRONIC KIDNEY DISEASE,1
KZ,COLD SWEAT,1
KZ,CORONARY ARTERY OCCLUSION,1
KZ,ELECTROCARDIOGRAM ABNORMAL,1
KZ,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
KZ,GLOMERULONEPHRITIS CHRONIC,1
KZ,HAEMOGLOBIN DECREASED,1
KZ,HEART RATE INCREASED,1
KZ,HYPERTENSION,1
KZ,PULMONARY OEDEMA,1
KZ,RENAL CYST,1
KZ,VENTRICULAR FIBRILLATION,1
KE,ISCHAEMIC STROKE,1
KE,PANCREATITIS ACUTE,1
KP,BLOOD PRESSURE DECREASED,2
KP,HEART RATE INCREASED,2
KP,HYPOVOLAEMIC SHOCK,2
KP,PUNCTURE SITE HAEMORRHAGE,2
KP,SCROTAL SWELLING,2
KP,ACQUIRED HAEMOPHILIA,1
KP,BACK PAIN,1
KP,CHEST DISCOMFORT,1
KP,CORONARY ARTERY OCCLUSION,1
KP,CYANOSIS,1
KP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
KP,EXTRADURAL HAEMATOMA,1
KP,PERIPHERAL ARTERY OCCLUSION,1
KP,VASCULAR STENT THROMBOSIS,1
KR,DYSPNOEA,12
KR,RENAL IMPAIRMENT,10
KR,CHEST PAIN,9
KR,GASTROINTESTINAL HAEMORRHAGE,9
KR,PNEUMONIA,9
KR,PULMONARY ALVEOLAR HAEMORRHAGE,9
KR,DIARRHOEA,8
KR,ARTERIAL RUPTURE,7
KR,CARDIOGENIC SHOCK,7
KR,EXTRADURAL HAEMATOMA,7
KR,PYREXIA,7
KR,SEPTIC SHOCK,7
KR,CARDIAC DEATH,6
KR,DRUG INEFFECTIVE,6
KR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,6
KR,PLEURAL EFFUSION,6
KR,RHABDOMYOLYSIS,6
KR,ACUTE RESPIRATORY FAILURE,5
KR,ANAEMIA,5
KR,CEREBRAL HYPERPERFUSION SYNDROME,5
KR,DEATH,5
KR,GASTRIC ULCER,5
KR,HYPOKALAEMIA,5
KR,INTERSTITIAL LUNG DISEASE,5
KR,PALPITATIONS,5
KR,RETROPERITONEAL HAEMATOMA,5
KR,VENTRICULAR FIBRILLATION,5
KR,ACUTE MYOCARDIAL INFARCTION,4
KR,ADVERSE EVENT,4
KR,ASTHENIA,4
KR,BLOOD CREATININE INCREASED,4
KR,CEREBRAL INFARCTION,4
KR,CYANOSIS,4
KR,DRUG RESISTANCE,4
KR,FEAR OF DEATH,4
KR,GASTRIC HAEMORRHAGE,4
KR,HAEMOPTYSIS,4
KR,HYPOAESTHESIA,4
KR,HYPOVOLAEMIC SHOCK,4
KR,INSOMNIA,4
KR,MUSCULAR WEAKNESS,4
KR,PERICARDIAL HAEMORRHAGE,4
KR,PULMONARY OEDEMA,4
KR,STATUS EPILEPTICUS,4
KR,VASCULAR STENT THROMBOSIS,4
KR,ACUTE KIDNEY INJURY,3
KR,BLOOD PRESSURE INCREASED,3
KR,CARDIAC ARREST,3
KR,CEREBRAL HAEMORRHAGE,3
KR,CHOLECYSTITIS ACUTE,3
KR,COAGULOPATHY,3
KR,CORONARY REVASCULARISATION,3
KR,COUGH,3
KR,DIZZINESS,3
KR,DRUG ADMINISTRATION ERROR,3
KR,GASTROINTESTINAL CANDIDIASIS,3
KR,HAEMATOCHEZIA,3
KR,HAEMORRHAGE,3
KR,HYPERREFLEXIA,3
KR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
KR,NAUSEA,3
KR,PAIN IN EXTREMITY,3
KR,RESPIRATORY FAILURE,3
KR,SHOCK,3
KR,STUPOR,3
KR,VOMITING,3
KR,ABDOMINAL PAIN UPPER,2
KR,ANGINA PECTORIS,2
KR,ANGIODYSPLASIA,2
KR,ARTERIAL HAEMORRHAGE,2
KR,ARTERIOSCLEROSIS CORONARY ARTERY,2
KR,BLOOD PRESSURE DECREASED,2
KR,BRONCHOPULMONARY ASPERGILLOSIS,2
KR,CONTUSION,2
KR,CORONARY ARTERY STENOSIS,2
KR,DECREASED APPETITE,2
KR,DEHYDRATION,2
KR,DYSPNOEA EXERTIONAL,2
KR,EMBOLISM,2
KR,EPISTAXIS,2
KR,FEBRILE NEUTROPENIA,2
KR,GASTRIC PERFORATION,2
KR,GASTRITIS EROSIVE,2
KR,HAEMATOMA,2
KR,HAEMOBILIA,2
KR,HAEMOGLOBIN DECREASED,2
KR,HAEMOTHORAX,2
KR,HYPERGLYCAEMIA,2
KR,HYPERHIDROSIS,2
KR,HYPOTENSION,2
KR,HYPOXIA,2
KR,INFLUENZA,2
KR,LARGE INTESTINE POLYP,2
KR,MEDIASTINAL HAEMATOMA,2
KR,MELAENA,2
KR,MOTOR DYSFUNCTION,2
KR,MUSCLE HAEMORRHAGE,2
KR,MYOCARDIAL INFARCTION,2
KR,NEUTROPENIA,2
KR,OXYGEN SATURATION DECREASED,2
KR,PARAPLEGIA,2
KR,PULMONARY CONGESTION,2
KR,SCROTAL SWELLING,2
KR,SHOCK HAEMORRHAGIC,2
KR,SKIN LESION,2
KR,STERNAL FRACTURE,2
KR,THROMBOCYTOPENIA,2
KR,THROMBOSIS,2
KR,TRANSFUSION,2
KR,VASOGENIC CEREBRAL OEDEMA,2
KR,WEIGHT DECREASED,2
KR,ABDOMINAL DISTENSION,1
KR,ABDOMINAL TENDERNESS,1
KR,ACQUIRED HAEMOPHILIA,1
KR,ANAL ABSCESS,1
KR,ANGINA UNSTABLE,1
KR,ANGIOKERATOMA,1
KR,APNOEA,1
KR,ARTERIOGRAM CORONARY,1
KR,ARTERIOSCLEROSIS,1
KR,ARTERIOVENOUS FISTULA SITE INFECTION,1
KR,ASPIRATION,1
KR,AUTOIMMUNE HEPATITIS,1
KR,AZOTAEMIA,1
KR,BACK PAIN,1
KR,BENIGN GASTRIC NEOPLASM,1
KR,BENIGN PROSTATIC HYPERPLASIA,1
KR,BENIGN SMALL INTESTINAL NEOPLASM,1
KR,BETA 2 MICROGLOBULIN INCREASED,1
KR,BILE DUCT CANCER,1
KR,BILE DUCT STONE,1
KR,BLOOD BICARBONATE DECREASED,1
KR,BLOOD CALCIUM DECREASED,1
KR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
KR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
KR,BLOOD PH DECREASED,1
KR,BLOOD POTASSIUM DECREASED,1
KR,BLOOD UREA INCREASED,1
KR,BRADYCARDIA,1
KR,BRAIN INJURY,1
KR,CARDIAC FAILURE,1
KR,CARDIAC FAILURE CONGESTIVE,1
KR,CARDIOMEGALY,1
KR,CEREBRAL VASOCONSTRICTION,1
KR,CEREBROSPINAL FLUID LEAKAGE,1
KR,CEREBROVASCULAR ACCIDENT,1
KR,CHOLECYSTITIS,1
KR,CHOLELITHIASIS,1
KR,COLITIS ISCHAEMIC,1
KR,CONSTIPATION,1
KR,CONTRAINDICATED PRODUCT ADMINISTERED,1
KR,CORONARY ARTERIAL STENT INSERTION,1
KR,CORONARY ARTERY OCCLUSION,1
KR,DEPRESSION,1
KR,DERMATITIS,1
KR,DIABETES MELLITUS,1
KR,DRUG EFFECT INCOMPLETE,1
KR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
KR,DRUG-INDUCED LIVER INJURY,1
KR,ECCHYMOSIS,1
KR,ELECTROENCEPHALOGRAM ABNORMAL,1
KR,ELECTROMYOGRAM ABNORMAL,1
KR,EMBOLIC CEREBRAL INFARCTION,1
KR,EPIGASTRIC DISCOMFORT,1
KR,EPILEPSY,1
KR,EXTENSOR PLANTAR RESPONSE,1
KR,FAECES SOFT,1
KR,FATIGUE,1
KR,FEELING ABNORMAL,1
KR,FEELING COLD,1
KR,GASTRIC ADENOMA,1
KR,GASTRIC CANCER,1
KR,GASTRIC MUCOSAL LESION,1
KR,GASTRIC POLYPS,1
KR,GASTROINTESTINAL ANGIODYSPLASIA,1
KR,GASTROINTESTINAL POLYP HAEMORRHAGE,1
KR,GASTROOESOPHAGEAL REFLUX DISEASE,1
KR,GENERAL PHYSICAL HEALTH DETERIORATION,1
KR,GENERALISED TONIC-CLONIC SEIZURE,1
KR,GINGIVAL BLEEDING,1
KR,HAEMODYNAMIC INSTABILITY,1
KR,HAEMOGLOBINURIA,1
KR,HAEMORRHAGE INTRACRANIAL,1
KR,HAEMORRHAGE SUBCUTANEOUS,1
KR,HAEMORRHAGIC ANAEMIA,1
KR,HAEMORRHAGIC TRANSFORMATION STROKE,1
KR,HEADACHE,1
KR,HEMIPLEGIA,1
KR,HICCUPS,1
KR,HYPERKALAEMIA,1
KR,HYPERSENSITIVITY,1
KR,HYPOACUSIS,1
KR,HYPONATRAEMIA,1
KR,HYPOREFLEXIA,1
KR,HYPOVOLAEMIA,1
KR,ILEAL PERFORATION,1
KR,INFECTIOUS COLITIS,1
KR,INFLAMMATION,1
KR,INJECTION SITE HAEMATOMA,1
KR,INTERVERTEBRAL DISC DISORDER,1
KR,INTRACRANIAL ANEURYSM,1
KR,LEUKOCYTOSIS,1
KR,LOCALISED OEDEMA,1
KR,LOWER LIMB FRACTURE,1
KR,LUMBAR SPINAL STENOSIS,1
KR,LUNG INFILTRATION,1
KR,LUNG NEOPLASM MALIGNANT,1
KR,LYMPHOEDEMA,1
KR,MALNUTRITION,1
KR,MENINGITIS,1
KR,MENTAL IMPAIRMENT,1
KR,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,1
KR,MOUTH HAEMORRHAGE,1
KR,MURPHY^S SIGN POSITIVE,1
KR,MUSCULOSKELETAL PAIN,1
KR,MYELODYSPLASTIC SYNDROME,1
KR,MYELOPATHY,1
KR,MYOPATHY,1
KR,NASAL DISCOMFORT,1
KR,OBSTRUCTIVE AIRWAYS DISORDER,1
KR,OPEN FRACTURE,1
KR,ORAL PAIN,1
KR,ORGAN FAILURE,1
KR,ORGANISING PNEUMONIA,1
KR,OSTEOMYELITIS,1
KR,OVERDOSE,1
KR,PAIN,1
KR,PALLOR,1
KR,PARALYSIS,1
KR,PERICARDITIS,1
KR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
KR,PERIPHERAL ARTERY OCCLUSION,1
KR,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
KR,PERITONITIS,1
KR,PHARYNGEAL INFLAMMATION,1
KR,PLASMA CELL MYELOMA,1
KR,PLATELET COUNT DECREASED,1
KR,PO2 DECREASED,1
KR,POLYPECTOMY,1
KR,POST PROCEDURAL OEDEMA,1
KR,PROCEDURAL HAEMORRHAGE,1
KR,PROCTALGIA,1
KR,PRODUCT USE IN UNAPPROVED INDICATION,1
KR,PRODUCT USE ISSUE,1
KR,PROTEINURIA,1
KR,PRURITUS,1
KR,PULSE ABSENT,1
KR,PUNCTURE SITE HAEMORRHAGE,1
KR,PURPURA,1
KR,PYELONEPHRITIS ACUTE,1
KR,RECTAL ULCER,1
KR,RENAL FAILURE ACUTE,1
KR,RESPIRATORY RATE INCREASED,1
KR,RHINORRHOEA,1
KR,RHONCHI,1
KR,ROAD TRAFFIC ACCIDENT,1
KR,RUPTURED CEREBRAL ANEURYSM,1
KR,SCOLIOSIS,1
KR,SEIZURE,1
KR,SEPSIS,1
KR,SKIN DISCOLOURATION,1
KR,SMALL INTESTINAL HAEMORRHAGE,1
KR,SMALL INTESTINE POLYP,1
KR,SOMNOLENCE,1
KR,SPINAL EPIDURAL HAEMATOMA,1
KR,SPINAL SUBARACHNOID HAEMORRHAGE,1
KR,SPONDYLOLISTHESIS,1
KR,SPONTANEOUS HAEMORRHAGE,1
KR,SPUTUM ABNORMAL,1
KR,STAPHYLOCOCCAL INFECTION,1
KR,STAPHYLOCOCCUS TEST,1
KR,SUBARACHNOID HAEMORRHAGE,1
KR,SUBDURAL HAEMORRHAGE,1
KR,SWELLING,1
KR,SYNCOPE,1
KR,THECAL SAC COMPRESSION,1
KR,THERAPEUTIC EMBOLISATION,1
KR,THERAPEUTIC RESPONSE DECREASED,1
KR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
KR,TINNITUS,1
KR,TRACHEAL HAEMORRHAGE,1
KR,URINE PROTEIN/CREATININE RATIO INCREASED,1
KR,VASCULAR STENT STENOSIS,1
KR,VENTRICULAR DYSFUNCTION,1
KR,VENTRICULAR TACHYCARDIA,1
KR,VITAMIN D DEFICIENCY,1
KR,VITH NERVE PARALYSIS,1
KR,WALKING AID USER,1
KR,WEIGHT INCREASED,1
KR,WHITE BLOOD CELL COUNT ABNORMAL,1
KR,WHITE BLOOD CELL COUNT DECREASED,1
KW,CEREBRAL HAEMORRHAGE,4
KW,COMA,4
KW,HYPOVENTILATION,2
KW,ANGINA UNSTABLE,1
KW,ASTHENIA,1
KW,DEATH,1
KW,DRUG INEFFECTIVE,1
KW,DYSURIA,1
KW,FATIGUE,1
KW,GASTROENTERITIS ESCHERICHIA COLI,1
KW,HAEMORRHAGIC STROKE,1
KW,PNEUMONIA,1
KW,PROSTATIC DISORDER,1
KW,PROSTATIC PAIN,1
LB,DYSPNOEA,9
LB,HYPERGLYCAEMIA,8
LB,CHEST PAIN,7
LB,FATIGUE,7
LB,MYOCARDIAL INFARCTION,7
LB,CEREBROVASCULAR ACCIDENT,4
LB,BLOOD CREATININE INCREASED,3
LB,CARDIAC OPERATION,3
LB,CHEST DISCOMFORT,3
LB,HYPERTENSION,3
LB,NAUSEA,3
LB,RENAL FAILURE,3
LB,VISION BLURRED,3
LB,ANXIETY,2
LB,CORONARY ARTERY DISEASE,2
LB,COUGH,2
LB,DIARRHOEA,2
LB,DYSPHAGIA,2
LB,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
LB,HEADACHE,2
LB,HYPERHIDROSIS,2
LB,INFLUENZA,2
LB,ISCHAEMIC STROKE,2
LB,LOSS OF CONSCIOUSNESS,2
LB,LUNG INFECTION,2
LB,PANCREATITIS,2
LB,SEPSIS,2
LB,SPEECH DISORDER,2
LB,VERTIGO,2
LB,VOMITING,2
LB,ABDOMINAL DISTENSION,1
LB,ABDOMINAL PAIN UPPER,1
LB,ABDOMINAL WALL HAEMORRHAGE,1
LB,ACUTE CORONARY SYNDROME,1
LB,ACUTE PULMONARY OEDEMA,1
LB,ANAEMIA,1
LB,APHONIA,1
LB,ARTERIAL STENOSIS,1
LB,ARTERIAL THERAPEUTIC PROCEDURE,1
LB,ARTERIOGRAM CORONARY,1
LB,ASTHENIA,1
LB,ATRIAL FIBRILLATION,1
LB,AZOTAEMIA,1
LB,BACK PAIN,1
LB,BALANCE DISORDER,1
LB,BLOOD ALBUMIN DECREASED,1
LB,BLOOD GLUCOSE INCREASED,1
LB,BLOOD PRESSURE FLUCTUATION,1
LB,BLOOD PRESSURE ORTHOSTATIC ABNORMAL,1
LB,CALCIFICATION OF MUSCLE,1
LB,CARDIAC DISORDER,1
LB,CAROTID ARTERY STENOSIS,1
LB,CAROTID ARTERY THROMBOSIS,1
LB,CATARACT,1
LB,CATHETER SITE THROMBOSIS,1
LB,CEREBRAL ARTERY EMBOLISM,1
LB,CEREBRAL ISCHAEMIA,1
LB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
LB,CONFUSIONAL STATE,1
LB,CONJUNCTIVAL HAEMORRHAGE,1
LB,CONTUSION,1
LB,CORONARY ARTERY STENOSIS,1
LB,CYANOSIS,1
LB,DEATH,1
LB,DECREASED APPETITE,1
LB,DEEP VEIN THROMBOSIS,1
LB,DEHYDRATION,1
LB,DEPRESSION,1
LB,DRUG INEFFECTIVE,1
LB,DRY MOUTH,1
LB,DRY SKIN,1
LB,DYSPHONIA,1
LB,EJECTION FRACTION DECREASED,1
LB,EMBOLISM,1
LB,EPISTAXIS,1
LB,GAIT DISTURBANCE,1
LB,GAIT INABILITY,1
LB,GASTRIC DISORDER,1
LB,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
LB,HAEMATEMESIS,1
LB,HEPARIN-INDUCED THROMBOCYTOPENIA,1
LB,HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE,1
LB,HERNIA,1
LB,HYPERKALAEMIA,1
LB,HYPOGLYCAEMIA,1
LB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
LB,INTERMITTENT CLAUDICATION,1
LB,INTERVERTEBRAL DISC PROTRUSION,1
LB,IRRITABILITY,1
LB,LARYNGEAL CANCER METASTATIC,1
LB,LOWER LIMB FRACTURE,1
LB,MOBILITY DECREASED,1
LB,MOTOR DYSFUNCTION,1
LB,MULTIPLE SCLEROSIS,1
LB,MUSCLE SPASMS,1
LB,MUSCULOSKELETAL CHEST PAIN,1
LB,MUSCULOSKELETAL DISORDER,1
LB,MUSCULOSKELETAL PAIN,1
LB,NECK PAIN,1
LB,NEPHRECTOMY,1
LB,NIGHT SWEATS,1
LB,NIGHTMARE,1
LB,ORGAN FAILURE,1
LB,PAIN,1
LB,PAIN IN EXTREMITY,1
LB,PARAESTHESIA,1
LB,PEPTIC ULCER,1
LB,PERIPHERAL SWELLING,1
LB,PLASMA CELL LEUKAEMIA,1
LB,PLASMACYTOMA,1
LB,PLEURAL EFFUSION,1
LB,PRESCRIBED UNDERDOSE,1
LB,PROCEDURAL PAIN,1
LB,PULMONARY EMBOLISM,1
LB,PULMONARY OEDEMA,1
LB,RASH,1
LB,RENAL DISORDER,1
LB,RENAL IMPAIRMENT,1
LB,SOMNOLENCE,1
LB,SUICIDAL BEHAVIOUR,1
LB,SYNCOPE,1
LB,TACHYCARDIA,1
LB,TENDONITIS,1
LB,THROMBOSIS IN DEVICE,1
LB,URINE OUTPUT DECREASED,1
LB,VASCULAR CALCIFICATION,1
LB,VASCULAR STENT RESTENOSIS,1
LB,VASCULAR STENT THROMBOSIS,1
LB,VENOUS STENOSIS,1
LB,VISUAL ACUITY REDUCED,1
LB,VITAMIN D DEFICIENCY,1
LB,WEIGHT DECREASED,1
LB,WOUND,1
LY,CHEST PAIN,1
LY,COUGH,1
LY,DEATH,1
LY,DYSPNOEA,1
LY,SUDDEN DEATH,1
LT,ACUTE MYOCARDIAL INFARCTION,1
LT,CARDIAC ARREST,1
LT,CARDIAC VALVE REPLACEMENT COMPLICATION,1
LT,CARDIOGENIC SHOCK,1
LT,EXPIRED PRODUCT ADMINISTERED,1
LT,GENERAL PHYSICAL HEALTH DETERIORATION,1
LT,MYOCARDIAL INFARCTION,1
LT,PEPTIC ULCER PERFORATION,1
LT,PULMONARY OEDEMA,1
LU,PULMONARY VALVE STENOSIS,2
LU,VENTRICULAR SEPTAL DEFECT,2
LU,ABASIA,1
LU,CARDIAC FAILURE CONGESTIVE,1
LU,ENDOMETRIAL CANCER,1
LU,FOETAL EXPOSURE DURING PREGNANCY,1
LU,MALAISE,1
LU,OSTEONECROSIS OF JAW,1
LU,PROSTATE CANCER,1
LU,RENAL FAILURE,1
LU,SOMNOLENCE,1
MK,FATIGUE,3
MK,PAIN IN EXTREMITY,2
MK,ABDOMINAL PAIN UPPER,1
MK,ASTHENIA,1
MK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
MK,BLOOD PRESSURE INCREASED,1
MK,DYSPNOEA,1
MK,DYSPNOEA EXERTIONAL,1
MK,MYOCARDIAL INFARCTION,1
MK,NAUSEA,1
MK,OEDEMA PERIPHERAL,1
MK,PAIN IN JAW,1
MK,PALPITATIONS,1
MK,PARAESTHESIA,1
MK,PERIPHERAL SWELLING,1
MY,ANAEMIA,3
MY,CHEST PAIN,3
MY,FOETAL EXPOSURE DURING PREGNANCY,3
MY,GASTROINTESTINAL HAEMORRHAGE,3
MY,LOW BIRTH WEIGHT BABY,3
MY,MYOCARDIAL INFARCTION,3
MY,PNEUMONIA,3
MY,PREMATURE BABY,3
MY,AGEUSIA,2
MY,CARDIAC FAILURE,2
MY,CEREBROVASCULAR ACCIDENT,2
MY,HAEMATEMESIS,2
MY,HAEMORRHAGE INTRACRANIAL,2
MY,HYPOGLYCAEMIA,2
MY,HYPOTENSION,2
MY,MELAENA,2
MY,QUALITY OF LIFE DECREASED,2
MY,URINARY TRACT INFECTION,2
MY,WEIGHT DECREASED,2
MY,ABDOMINAL PAIN UPPER,1
MY,ACUTE CORONARY SYNDROME,1
MY,ACUTE KIDNEY INJURY,1
MY,ACUTE MYOCARDIAL INFARCTION,1
MY,ACUTE PULMONARY OEDEMA,1
MY,AFFECT LABILITY,1
MY,ANGIOEDEMA,1
MY,ARTERIAL THROMBOSIS,1
MY,BLOOD ALKALINE PHOSPHATASE INCREASED,1
MY,BLOOD BILIRUBIN INCREASED,1
MY,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MY,CARDIAC ARREST,1
MY,CELLULITIS,1
MY,CHILLS,1
MY,CHRONIC KIDNEY DISEASE,1
MY,CONSTIPATION,1
MY,CORONARY ARTERY OCCLUSION,1
MY,DEATH,1
MY,DECREASED APPETITE,1
MY,DEHYDRATION,1
MY,DEVICE RELATED INFECTION,1
MY,DIABETES MELLITUS INADEQUATE CONTROL,1
MY,DIZZINESS,1
MY,DYSPHAGIA,1
MY,END STAGE RENAL DISEASE,1
MY,FACE OEDEMA,1
MY,FEMUR FRACTURE,1
MY,FLUID OVERLOAD,1
MY,GASTROENTERITIS,1
MY,GENERALISED OEDEMA,1
MY,GLOMERULAR FILTRATION RATE DECREASED,1
MY,HAEMATOMA,1
MY,HAEMODIALYSIS,1
MY,HYDRONEPHROSIS,1
MY,HYPERHIDROSIS,1
MY,HYPONATRAEMIA,1
MY,HYPORESPONSIVE TO STIMULI,1
MY,ILEUS PARALYTIC,1
MY,INFECTION,1
MY,INTERNATIONAL NORMALISED RATIO INCREASED,1
MY,INTERVERTEBRAL DISCITIS,1
MY,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
MY,LIPASE INCREASED,1
MY,LIVER ABSCESS,1
MY,MEDICATION RESIDUE PRESENT,1
MY,MEMORY IMPAIRMENT,1
MY,MYALGIA,1
MY,MYOCARDIAL ISCHAEMIA,1
MY,NAUSEA,1
MY,NEPHROGENIC ANAEMIA,1
MY,OBSTRUCTION GASTRIC,1
MY,ORBITAL OEDEMA,1
MY,ORCHITIS,1
MY,PANCREATIC ABSCESS,1
MY,PANCREATITIS ACUTE,1
MY,PERIPHERAL VASCULAR DISORDER,1
MY,PRODUCT QUALITY ISSUE,1
MY,PRURITUS,1
MY,PYREXIA,1
MY,REFUSAL OF TREATMENT BY PATIENT,1
MY,RENAL HAEMATOMA,1
MY,RHEUMATOID ARTHRITIS,1
MY,SEPTIC SHOCK,1
MY,SOMNOLENCE,1
MY,STAPHYLOCOCCAL INFECTION,1
MY,STEVENS-JOHNSON SYNDROME,1
MY,SURGERY,1
MY,THROMBOCYTOPENIA,1
MY,THROMBOPHLEBITIS,1
MY,TOOTHACHE,1
MY,TUBERCULOSIS,1
MY,UPPER GASTROINTESTINAL HAEMORRHAGE,1
MY,VASCULAR STENT STENOSIS,1
MY,VISION BLURRED,1
MY,VOMITING,1
MY,WEIGHT INCREASED,1
MT,DEEP VEIN THROMBOSIS,1
MT,EMBOLISM,1
MT,PULMONARY EMBOLISM,1
MT,RESPIRATORY FAILURE,1
MU,ACUTE KIDNEY INJURY,2
MX,FALL,15
MX,HYPERTENSION,12
MX,CEREBROVASCULAR ACCIDENT,11
MX,MALAISE,11
MX,CEREBRAL INFARCTION,10
MX,DIZZINESS,10
MX,FATIGUE,10
MX,ASTHENIA,9
MX,MYOCARDIAL INFARCTION,9
MX,BLOOD PRESSURE INCREASED,8
MX,HEADACHE,8
MX,PNEUMONIA,8
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,8
MX,DEMENTIA ALZHEIMER^S TYPE,7
MX,ARTERIAL OCCLUSIVE DISEASE,6
MX,ARTHRALGIA,6
MX,COUGH,6
MX,EMBOLISM,6
MX,INFARCTION,6
MX,PAIN IN EXTREMITY,6
MX,PRODUCT USE ISSUE,6
MX,ANXIETY,5
MX,ARRHYTHMIA,5
MX,BLINDNESS,5
MX,CARDIAC FAILURE,5
MX,DEATH,5
MX,DRUG PRESCRIBING ERROR,5
MX,MEMORY IMPAIRMENT,5
MX,PYREXIA,5
MX,URINARY TRACT INFECTION,5
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
MX,ABASIA,4
MX,BLOOD CHOLESTEROL INCREASED,4
MX,BLOOD PRESSURE DECREASED,4
MX,DRUG INTOLERANCE,4
MX,FEELING ABNORMAL,4
MX,GAIT DISTURBANCE,4
MX,GASTRITIS,4
MX,HYPERGLYCAEMIA,4
MX,HYPOTENSION,4
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
MX,INFLUENZA,4
MX,PEMPHIGUS,4
MX,SKIN DISCOLOURATION,4
MX,SPEECH DISORDER,4
MX,SPINAL DISORDER,4
MX,SYNCOPE,4
MX,WEIGHT DECREASED,4
MX,ABDOMINAL PAIN,3
MX,ABDOMINAL PAIN UPPER,3
MX,ACUTE MYOCARDIAL INFARCTION,3
MX,AMNESIA,3
MX,ANAEMIA,3
MX,ANGER,3
MX,BLOOD GLUCOSE INCREASED,3
MX,BRADYCARDIA,3
MX,BRAIN HYPOXIA,3
MX,BURNING SENSATION,3
MX,CAROTID ARTERY DISEASE,3
MX,CATARACT,3
MX,CONVULSION,3
MX,DECREASED APPETITE,3
MX,DEHYDRATION,3
MX,DEPRESSION,3
MX,DIARRHOEA,3
MX,DYSPEPSIA,3
MX,DYSPNOEA,3
MX,GASTROINTESTINAL HAEMORRHAGE,3
MX,GENERAL PHYSICAL HEALTH DETERIORATION,3
MX,HAEMOGLOBIN DECREASED,3
MX,LIMB DISCOMFORT,3
MX,LOWER LIMB FRACTURE,3
MX,MELAENA,3
MX,MOVEMENT DISORDER,3
MX,PERIPHERAL SWELLING,3
MX,PRODUCT USE IN UNAPPROVED INDICATION,3
MX,SPINAL PAIN,3
MX,THROAT IRRITATION,3
MX,VOMITING,3
MX,ABDOMINAL DISCOMFORT,2
MX,ACUTE PULMONARY OEDEMA,2
MX,AGGRESSION,2
MX,AGITATION,2
MX,AMAUROSIS,2
MX,ANGINA PECTORIS,2
MX,AZOTAEMIA,2
MX,BLOOD CREATININE INCREASED,2
MX,BLOOD POTASSIUM INCREASED,2
MX,BLOOD PRESSURE FLUCTUATION,2
MX,BLOOD SODIUM DECREASED,2
MX,CARDIAC DISORDER,2
MX,CEREBRAL ARTERY EMBOLISM,2
MX,CHEST PAIN,2
MX,CHIKUNGUNYA VIRUS INFECTION,2
MX,COGNITIVE DISORDER,2
MX,COMA,2
MX,CONSTIPATION,2
MX,CORONARY ARTERY BYPASS,2
MX,CYANOSIS,2
MX,DEAFNESS,2
MX,DIABETES MELLITUS,2
MX,DIVERTICULITIS,2
MX,DRUG INEFFECTIVE,2
MX,DRY SKIN,2
MX,DUODENAL ULCER,2
MX,DYSPHONIA,2
MX,DYSURIA,2
MX,ERECTILE DYSFUNCTION,2
MX,ERYTHEMA,2
MX,FEELING HOT,2
MX,FLUID RETENTION,2
MX,GASTRIC ULCER,2
MX,GLAUCOMA,2
MX,HAEMATURIA,2
MX,HEAD DISCOMFORT,2
MX,HOSPITALISATION,2
MX,HYPOACUSIS,2
MX,HYPOAESTHESIA,2
MX,HYPOGLYCAEMIA,2
MX,INGUINAL HERNIA,2
MX,INSOMNIA,2
MX,INTERVERTEBRAL DISC PROTRUSION,2
MX,JOINT INJURY,2
MX,MOBILITY DECREASED,2
MX,MULTI-ORGAN FAILURE,2
MX,MUSCLE SPASMS,2
MX,MUSCULOSKELETAL PAIN,2
MX,OEDEMA PERIPHERAL,2
MX,ORAL DISCOMFORT,2
MX,OVERDOSE,2
MX,PAIN,2
MX,POLLAKIURIA,2
MX,PRODUCTIVE COUGH,2
MX,PROSTATE CANCER,2
MX,RASH,2
MX,RECTAL HAEMORRHAGE,2
MX,RENAL PAIN,2
MX,RESPIRATORY FAILURE,2
MX,SENILE DEMENTIA,2
MX,SEPSIS,2
MX,SEPTIC SHOCK,2
MX,SOMNOLENCE,2
MX,SPINAL FRACTURE,2
MX,SURGERY,2
MX,SWELLING FACE,2
MX,SYSTEMIC LUPUS ERYTHEMATOSUS,2
MX,TINNITUS,2
MX,TRANSIENT ISCHAEMIC ATTACK,2
MX,TREMOR,2
MX,UPPER RESPIRATORY TRACT INFECTION,2
MX,URINARY RETENTION,2
MX,URINE ANALYSIS ABNORMAL,2
MX,VARICOSE ULCERATION,2
MX,ABDOMINAL DISTENSION,1
MX,ABDOMINAL PAIN LOWER,1
MX,ACCIDENT,1
MX,ACID BASE BALANCE ABNORMAL,1
MX,ACUTE KIDNEY INJURY,1
MX,ACUTE RESPIRATORY DISTRESS SYNDROME,1
MX,ACUTE RESPIRATORY FAILURE,1
MX,AGEUSIA,1
MX,ALOPECIA,1
MX,ALTERED STATE OF CONSCIOUSNESS,1
MX,AMAUROSIS FUGAX,1
MX,AMOEBIC DYSENTERY,1
MX,ANGINA UNSTABLE,1
MX,ANIMAL BITE,1
MX,ANTEROGRADE AMNESIA,1
MX,ANURIA,1
MX,AORTIC ANEURYSM,1
MX,APHAGIA,1
MX,APHASIA,1
MX,APPLICATION SITE BURN,1
MX,APPLICATION SITE ERYTHEMA,1
MX,APPLICATION SITE EXFOLIATION,1
MX,APPLICATION SITE INJURY,1
MX,APPLICATION SITE IRRITATION,1
MX,APPLICATION SITE LACERATION,1
MX,APPLICATION SITE PAIN,1
MX,APPLICATION SITE PRURITUS,1
MX,APPLICATION SITE SCAR,1
MX,ARTERIAL REPAIR,1
MX,ARTERIAL THROMBOSIS,1
MX,ARTERIOSCLEROSIS,1
MX,ARTHRITIS REACTIVE,1
MX,ASTERIXIS,1
MX,ATRIAL FIBRILLATION,1
MX,ATRIAL PRESSURE INCREASED,1
MX,ATROPHY,1
MX,BACTERIAL INFECTION,1
MX,BALANCE DISORDER,1
MX,BEDRIDDEN,1
MX,BENIGN BREAST NEOPLASM,1
MX,BENIGN NEOPLASM,1
MX,BLOOD DISORDER,1
MX,BLOOD ELECTROLYTES ABNORMAL,1
MX,BLOOD GLUCOSE DECREASED,1
MX,BLOOD POTASSIUM ABNORMAL,1
MX,BLOOD POTASSIUM DECREASED,1
MX,BLOOD PRESSURE DIASTOLIC DECREASED,1
MX,BLOOD PRESSURE SYSTOLIC INCREASED,1
MX,BLOOD SODIUM ABNORMAL,1
MX,BLOOD TRIGLYCERIDES INCREASED,1
MX,BLOOD URIC ACID INCREASED,1
MX,BODY TEMPERATURE INCREASED,1
MX,BONE DECALCIFICATION,1
MX,BONE PAIN,1
MX,BRADYPNOEA,1
MX,BREAST CANCER,1
MX,CARDIAC ARREST,1
MX,CARDIAC FAILURE CHRONIC,1
MX,CARDIO-RESPIRATORY ARREST,1
MX,CARDIOGENIC SHOCK,1
MX,CARDIOMEGALY,1
MX,CAROTID ARTERY OCCLUSION,1
MX,CARTILAGE INJURY,1
MX,CATARACT OPERATION,1
MX,CEREBRAL ISCHAEMIA,1
MX,CEREBROVASCULAR DISORDER,1
MX,CHEST DISCOMFORT,1
MX,CHOLELITHIASIS,1
MX,CHRONIC KIDNEY DISEASE,1
MX,COLON CANCER,1
MX,CONCOMITANT DISEASE PROGRESSION,1
MX,CONDITION AGGRAVATED,1
MX,CONFUSIONAL STATE,1
MX,CONJUNCTIVITIS,1
MX,CORONARY ARTERY OCCLUSION,1
MX,CORONARY ARTERY THROMBOSIS,1
MX,CRYING,1
MX,CYST,1
MX,CYSTITIS ESCHERICHIA,1
MX,DEAFNESS UNILATERAL,1
MX,DEEP VEIN THROMBOSIS,1
MX,DELIRIUM,1
MX,DEPRESSED MOOD,1
MX,DEVICE OCCLUSION,1
MX,DIABETIC COMA,1
MX,DIABETIC FOOT,1
MX,DIPLEGIA,1
MX,DISABILITY,1
MX,DISCOMFORT,1
MX,DISEASE SUSCEPTIBILITY,1
MX,DISORIENTATION,1
MX,DISSEMINATED INTRAVASCULAR COAGULATION,1
MX,DISTURBANCE IN ATTENTION,1
MX,DIVERTICULITIS INTESTINAL HAEMORRHAGIC,1
MX,DIVERTICULUM,1
MX,DROOLING,1
MX,DRUG ADMINISTRATION ERROR,1
MX,DRUG DISPENSING ERROR,1
MX,DRUG HYPERSENSITIVITY,1
MX,DRY THROAT,1
MX,DYSKINESIA,1
MX,DYSLALIA,1
MX,DYSPHAGIA,1
MX,DYSPNOEA EXERTIONAL,1
MX,DYSSTASIA,1
MX,EATING DISORDER,1
MX,ELECTROLYTE IMBALANCE,1
MX,EPILEPSY,1
MX,ESCHERICHIA TEST POSITIVE,1
MX,ESSENTIAL TREMOR,1
MX,FEAR OF FALLING,1
MX,FEEDING DISORDER,1
MX,FEELING DRUNK,1
MX,FLUID INTAKE REDUCED,1
MX,GAIT INABILITY,1
MX,GASTRIC DISORDER,1
MX,GASTRIC HAEMORRHAGE,1
MX,GASTRIC ULCER HAEMORRHAGE,1
MX,GASTROINTESTINAL DISORDER,1
MX,GASTROOESOPHAGEAL REFLUX DISEASE,1
MX,GENERALISED OEDEMA,1
MX,GRIMACING,1
MX,HAEMATEMESIS,1
MX,HAEMATOMA,1
MX,HAEMOPTYSIS,1
MX,HAEMORRHAGE,1
MX,HALLUCINATION,1
MX,HEAD INJURY,1
MX,HEARING IMPAIRED,1
MX,HEART RATE DECREASED,1
MX,HEMIPARESIS,1
MX,HEPATIC FAILURE,1
MX,HERNIA,1
MX,HIATUS HERNIA,1
MX,HIP FRACTURE,1
MX,HIP SURGERY,1
MX,HYDROCEPHALUS,1
MX,HYPERCHOLESTEROLAEMIA,1
MX,HYPERHIDROSIS,1
MX,HYPERSENSITIVITY,1
MX,HYPERTENSIVE CRISIS,1
MX,HYPERTHYROIDISM,1
MX,HYPERVENTILATION,1
MX,HYPOCHLORAEMIA,1
MX,HYPONATRAEMIA,1
MX,HYPOPHAGIA,1
MX,HYPOTHYROIDISM,1
MX,IMMOBILE,1
MX,INCORRECT DOSE ADMINISTERED,1
MX,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
MX,INCREASED APPETITE,1
MX,INFECTION,1
MX,INFLAMMATION,1
MX,INJURY,1
MX,INTENTIONAL OVERDOSE,1
MX,INTERNAL HAEMORRHAGE,1
MX,INTERNATIONAL NORMALISED RATIO INCREASED,1
MX,INTESTINAL DILATATION,1
MX,INTESTINAL HAEMORRHAGE,1
MX,INTESTINAL OBSTRUCTION,1
MX,IRREGULAR BREATHING,1
MX,IRRITABILITY,1
MX,JOINT SWELLING,1
MX,KNEE OPERATION,1
MX,LACERATION,1
MX,LIGAMENT RUPTURE,1
MX,LIGAMENT SPRAIN,1
MX,LIMB INJURY,1
MX,LIP DRY,1
MX,LIVER FUNCTION TEST ABNORMAL,1
MX,LOCALISED OEDEMA,1
MX,LOWER GASTROINTESTINAL HAEMORRHAGE,1
MX,LUNG INFECTION,1
MX,MACULE,1
MX,MALNUTRITION,1
MX,MENTAL IMPAIRMENT,1
MX,METABOLIC ACIDOSIS,1
MX,METASTASES TO STOMACH,1
MX,MONOPLEGIA,1
MX,MOTOR DYSFUNCTION,1
MX,MUSCLE CONTRACTURE,1
MX,MUSCLE INJURY,1
MX,MUSCULAR WEAKNESS,1
MX,MYALGIA,1
MX,MYOPATHY,1
MX,NEPHRECTOMY,1
MX,NEURALGIA,1
MX,NEUROLOGICAL SYMPTOM,1
MX,NEUROPATHY PERIPHERAL,1
MX,NOCTURIA,1
MX,OESOPHAGITIS,1
MX,OLIGURIA,1
MX,OPTIC NERVE INJURY,1
MX,ORAL DISORDER,1
MX,OSTEOARTHRITIS,1
MX,OSTEOPOROSIS,1
MX,OVERWEIGHT,1
MX,OXYGEN CONSUMPTION DECREASED,1
MX,OXYGEN SATURATION DECREASED,1
MX,PALPITATIONS,1
MX,PANCREATITIS,1
MX,PARAESTHESIA,1
MX,PARKINSON^S DISEASE,1
MX,PELVIC VENOUS THROMBOSIS,1
MX,PENILE BURNING SENSATION,1
MX,PERIPHERAL VASCULAR DISORDER,1
MX,PERITONITIS,1
MX,PERSONALITY CHANGE,1
MX,PHARYNGEAL OEDEMA,1
MX,PLATELET AGGREGATION,1
MX,PLATELET COUNT DECREASED,1
MX,PNEUMONIA PNEUMOCOCCAL,1
MX,POLYARTHRITIS,1
MX,POLYURIA,1
MX,POST PROCEDURAL INFECTION,1
MX,POSTOPERATIVE WOUND INFECTION,1
MX,PRESCRIBED UNDERDOSE,1
MX,PROCEDURAL HAEMORRHAGE,1
MX,PROCEDURAL PAIN,1
MX,PROSOPAGNOSIA,1
MX,PROTEIN C INCREASED,1
MX,PROTEINURIA,1
MX,PRURITUS,1
MX,PSEUDOACHALASIA,1
MX,PSORIATIC ARTHROPATHY,1
MX,PSYCHOMOTOR HYPERACTIVITY,1
MX,PULMONARY EMBOLISM,1
MX,PULMONARY OEDEMA,1
MX,RALES,1
MX,RASH PRURITIC,1
MX,RENAL DISORDER,1
MX,RENAL FAILURE,1
MX,RENAL IMPAIRMENT,1
MX,RESTLESSNESS,1
MX,RHABDOMYOLYSIS,1
MX,RHINORRHOEA,1
MX,RIB FRACTURE,1
MX,ROAD TRAFFIC ACCIDENT,1
MX,SENSE OF OPPRESSION,1
MX,SILENT MYOCARDIAL INFARCTION,1
MX,SINUS ARRHYTHMIA,1
MX,SKIN EXFOLIATION,1
MX,SKIN INJURY,1
MX,SKIN LESION,1
MX,SKIN ULCER,1
MX,SLEEP DISORDER,1
MX,SNEEZING,1
MX,SOFT TISSUE INFECTION,1
MX,SPINAL CORD INFECTION,1
MX,SPUTUM RETENTION,1
MX,SQUAMOUS CELL CARCINOMA OF SKIN,1
MX,STENOSIS,1
MX,STRESS,1
MX,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
MX,TACHYCARDIA,1
MX,TENDON RUPTURE,1
MX,THERAPEUTIC RESPONSE DECREASED,1
MX,THIRST,1
MX,THYROID ADENOMA,1
MX,THYROID DISORDER,1
MX,TOE AMPUTATION,1
MX,TOXIC EPIDERMAL NECROLYSIS,1
MX,TREATMENT NONCOMPLIANCE,1
MX,ULCER,1
MX,UPPER GASTROINTESTINAL HAEMORRHAGE,1
MX,URETHRAL OBSTRUCTION,1
MX,URINARY INCONTINENCE,1
MX,URINE OUTPUT DECREASED,1
MX,URTICARIA,1
MX,UTERINE DISORDER,1
MX,VASCULAR FRAGILITY,1
MX,VASCULITIS,1
MX,VENOUS THROMBOSIS LIMB,1
MX,VENTRICULAR FIBRILLATION,1
MX,VENTRICULAR TACHYCARDIA,1
MX,VISION BLURRED,1
MX,VISUAL ACUITY REDUCED,1
MX,VISUAL IMPAIRMENT,1
MX,WEIGHT INCREASED,1
MX,WHEEZING,1
MX,WHITE MATTER LESION,1
MX,WOUND DEHISCENCE,1
ME,HEPATOTOXICITY,3
ME,JAUNDICE,2
ME,LIVER INJURY,2
ME,PRURITUS GENERALISED,2
ME,RASH,2
ME,ACUTE HEPATIC FAILURE,1
ME,ACUTE KIDNEY INJURY,1
ME,ALANINE AMINOTRANSFERASE INCREASED,1
ME,ASPARTATE AMINOTRANSFERASE INCREASED,1
ME,BILIRUBIN CONJUGATED INCREASED,1
ME,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ME,BLOOD BILIRUBIN INCREASED,1
ME,BLOOD DISORDER,1
ME,BODY TEMPERATURE INCREASED,1
ME,CONFUSIONAL STATE,1
ME,DIARRHOEA,1
ME,DISORIENTATION,1
ME,DRUG-INDUCED LIVER INJURY,1
ME,ELECTROLYTE IMBALANCE,1
ME,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ME,HEPATIC LESION,1
ME,MOUTH ULCERATION,1
ME,POTENTIATING DRUG INTERACTION,1
ME,VOMITING,1
MA,PULMONARY ALVEOLAR HAEMORRHAGE,4
MA,DRUG ADMINISTRATION ERROR,2
MA,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
MA,ACUTE RESPIRATORY DISTRESS SYNDROME,1
MA,ALTERED STATE OF CONSCIOUSNESS,1
MA,ANAEMIA,1
MA,APHASIA,1
MA,ATRIAL FIBRILLATION,1
MA,BRAIN STEM STROKE,1
MA,BRONCHOSPASM,1
MA,C-REACTIVE PROTEIN INCREASED,1
MA,CARDIAC FAILURE,1
MA,CEREBRAL HAEMORRHAGE,1
MA,CEREBROVASCULAR ACCIDENT,1
MA,CYST,1
MA,DRUG-INDUCED LIVER INJURY,1
MA,DYSPNOEA,1
MA,HAEMATOMA,1
MA,HAEMOPTYSIS,1
MA,HAEMORRHAGIC INFARCTION,1
MA,HAEMORRHAGIC STROKE,1
MA,HEART RATE DECREASED,1
MA,HEMIPLEGIA,1
MA,ISCHAEMIC STROKE,1
MA,LEUKOCYTOSIS,1
MA,PYREXIA,1
MA,RENAL FAILURE,1
MA,TRICUSPID VALVE INCOMPETENCE,1
MA,WHITE BLOOD CELL COUNT INCREASED,1
NP,ACCIDENTAL OVERDOSE,1
NP,DIZZINESS,1
NP,HYPOTENSION,1
NP,MYASTHENIA GRAVIS,1
NP,PRESYNCOPE,1
NL,DEATH,21
NL,MYOCARDIAL INFARCTION,16
NL,DYSPNOEA,14
NL,HEADACHE,13
NL,TRANSIENT ISCHAEMIC ATTACK,13
NL,VOMITING,11
NL,CEREBROVASCULAR ACCIDENT,10
NL,MALAISE,10
NL,NAUSEA,10
NL,FATIGUE,9
NL,HAEMORRHAGE,9
NL,PNEUMONIA,9
NL,CARDIAC FAILURE,8
NL,DIZZINESS,8
NL,RENAL IMPAIRMENT,8
NL,VISION BLURRED,8
NL,CARDIAC DISORDER,7
NL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,7
NL,PARAESTHESIA,7
NL,CHEST PAIN,6
NL,CONFUSIONAL STATE,6
NL,CORONARY ARTERY STENOSIS,6
NL,DISTURBANCE IN ATTENTION,6
NL,FALL,6
NL,HYPERTENSION,6
NL,LOSS OF CONSCIOUSNESS,6
NL,MYALGIA,6
NL,PROSTATE CANCER METASTATIC,6
NL,PULMONARY EMBOLISM,6
NL,RENAL FAILURE,6
NL,ACUTE CORONARY SYNDROME,5
NL,ANAEMIA,5
NL,GASTROINTESTINAL HAEMORRHAGE,5
NL,HAEMOGLOBIN DECREASED,5
NL,HALLUCINATION,5
NL,HEMIPLEGIA,5
NL,MUSCLE SPASMS,5
NL,PAIN,5
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,5
NL,SHOCK,5
NL,TERMINAL STATE,5
NL,ACUTE MYOCARDIAL INFARCTION,4
NL,ANGIOEDEMA,4
NL,ARTERIAL HAEMORRHAGE,4
NL,ARTHRALGIA,4
NL,CEREBRAL INFARCTION,4
NL,CHEST DISCOMFORT,4
NL,DIARRHOEA,4
NL,GAIT DISTURBANCE,4
NL,HOT FLUSH,4
NL,HYPERVENTILATION,4
NL,HYPOAESTHESIA,4
NL,HYPOCALCAEMIA,4
NL,HYPOMAGNESAEMIA,4
NL,INTERMITTENT CLAUDICATION,4
NL,MUSCLE RUPTURE,4
NL,OEDEMA,4
NL,PYREXIA,4
NL,RECTAL HAEMORRHAGE,4
NL,THROMBOSIS IN DEVICE,4
NL,URTICARIA,4
NL,ABASIA,3
NL,ABDOMINAL DISCOMFORT,3
NL,ANGINA PECTORIS,3
NL,ARRHYTHMIA,3
NL,ASTHENIA,3
NL,BACK PAIN,3
NL,BALANCE DISORDER,3
NL,CEREBRAL HAEMORRHAGE,3
NL,CEREBROSPINAL FLUID LEAKAGE,3
NL,DELIRIUM,3
NL,DYSPHAGIA,3
NL,EOSINOPHILIA,3
NL,GENERAL PHYSICAL HEALTH DETERIORATION,3
NL,HYPOKALAEMIA,3
NL,INJECTION SITE INDURATION,3
NL,LUNG DISORDER,3
NL,MULTI-ORGAN FAILURE,3
NL,PALPITATIONS,3
NL,PROSTATE CANCER,3
NL,RESPIRATORY FAILURE,3
NL,STENT PLACEMENT,3
NL,SWOLLEN TONGUE,3
NL,THROMBOCYTOPENIA,3
NL,TREMOR,3
NL,WEIGHT DECREASED,3
NL,ABDOMINAL PAIN UPPER,2
NL,ABDOMINAL WALL HAEMATOMA,2
NL,ACUTE HEPATIC FAILURE,2
NL,ADVERSE DRUG REACTION,2
NL,ADVERSE EVENT,2
NL,AGEUSIA,2
NL,ANAPHYLACTIC SHOCK,2
NL,ANGIOPLASTY,2
NL,AORTIC ANEURYSM RUPTURE,2
NL,APHASIA,2
NL,ATRIAL FLUTTER,2
NL,BRADYCARDIA,2
NL,CARDIAC ARREST,2
NL,CARDIAC OPERATION,2
NL,CAROTID ARTERY STENOSIS,2
NL,CHOLECYSTITIS,2
NL,CHOLELITHIASIS,2
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
NL,COMPLETED SUICIDE,2
NL,CONSTIPATION,2
NL,CONTRAINDICATED PRODUCT ADMINISTERED,2
NL,CONTUSION,2
NL,CORONARY ARTERY DISEASE,2
NL,COUGH,2
NL,CYSTITIS,2
NL,DECREASED APPETITE,2
NL,DEHYDRATION,2
NL,DEMENTIA,2
NL,DUODENITIS,2
NL,DYSARTHRIA,2
NL,HAEMATURIA,2
NL,HAEMOTHORAX,2
NL,HOSPITALISATION,2
NL,HYPOTENSION,2
NL,INFARCTION,2
NL,INJECTION SITE REACTION,2
NL,ISCHAEMIC STROKE,2
NL,MELAENA,2
NL,MEMORY IMPAIRMENT,2
NL,METASTASES TO CENTRAL NERVOUS SYSTEM,2
NL,MUSCULAR WEAKNESS,2
NL,NEOPLASM MALIGNANT,2
NL,NEPHROTIC SYNDROME,2
NL,OXYGEN SATURATION DECREASED,2
NL,PAIN IN EXTREMITY,2
NL,PAIN IN JAW,2
NL,PLEURAL EFFUSION,2
NL,PNEUMOTHORAX,2
NL,PRODUCT USE IN UNAPPROVED INDICATION,2
NL,PROTEINURIA,2
NL,PRURITUS,2
NL,PULMONARY ALVEOLAR HAEMORRHAGE,2
NL,PULMONARY OEDEMA,2
NL,REBOUND EFFECT,2
NL,RETINAL INFARCTION,2
NL,RIB FRACTURE,2
NL,SECRETION DISCHARGE,2
NL,SEPSIS,2
NL,SQUAMOUS CELL CARCINOMA OF THE TONGUE,2
NL,SUBDURAL HAEMATOMA,2
NL,SUICIDAL IDEATION,2
NL,SYNCOPE,2
NL,THERAPEUTIC RESPONSE DECREASED,2
NL,TINNITUS,2
NL,TRANSFUSION,2
NL,TRISMUS,2
NL,URINARY RETENTION,2
NL,UROSEPSIS,2
NL,VASCULAR PSEUDOANEURYSM,2
NL,VASCULAR STENT RESTENOSIS,2
NL,VIRAL INFECTION,2
NL,VISUAL ACUITY REDUCED,2
NL,VISUAL IMPAIRMENT,2
NL,WEIGHT INCREASED,2
NL,ABDOMINAL DISTENSION,1
NL,ABDOMINAL PAIN,1
NL,ABDOMINAL WALL HAEMORRHAGE,1
NL,ACUTE KIDNEY INJURY,1
NL,ACUTE MYELOID LEUKAEMIA,1
NL,ADRENAL NEOPLASM,1
NL,AGE-RELATED MACULAR DEGENERATION,1
NL,AGRANULOCYTOSIS,1
NL,ALANINE AMINOTRANSFERASE INCREASED,1
NL,AMAUROSIS FUGAX,1
NL,AMNESIA,1
NL,ANGINA UNSTABLE,1
NL,AORTIC STENOSIS,1
NL,APNOEA,1
NL,ARTERECTOMY,1
NL,ARTERIOSCLEROSIS CORONARY ARTERY,1
NL,ARTHROPATHY,1
NL,ASCITES,1
NL,ATRIAL FIBRILLATION,1
NL,ATRIAL TACHYCARDIA,1
NL,BEDRIDDEN,1
NL,BILE DUCT OBSTRUCTION,1
NL,BLADDER CANCER,1
NL,BLEEDING VARICOSE VEIN,1
NL,BLINDNESS UNILATERAL,1
NL,BLOOD CREATININE INCREASED,1
NL,BLOOD PRESSURE DECREASED,1
NL,BLOOD PRESSURE FLUCTUATION,1
NL,BLOOD PRESSURE INCREASED,1
NL,BLOOD TEST ABNORMAL,1
NL,BODY TEMPERATURE INCREASED,1
NL,BONE PAIN,1
NL,BRAIN STEM INFARCTION,1
NL,BREAST CANCER,1
NL,BREAST CANCER METASTATIC,1
NL,BRONCHOSPASM,1
NL,BULBAR PALSY,1
NL,CANDIDA SEPSIS,1
NL,CARDIAC ASTHMA,1
NL,CARDIAC DEATH,1
NL,CARDIAC TAMPONADE,1
NL,CARDIOGENIC SHOCK,1
NL,CARDIOMYOPATHY,1
NL,CATARACT,1
NL,CELLULITIS,1
NL,CHOLANGITIS,1
NL,CHRONIC KIDNEY DISEASE,1
NL,CIRCULATORY COLLAPSE,1
NL,CLUMSINESS,1
NL,COGNITIVE DISORDER,1
NL,COLITIS,1
NL,COLON ADENOMA,1
NL,CONDITION AGGRAVATED,1
NL,CORONARY ARTERY OCCLUSION,1
NL,CRITICAL ILLNESS POLYNEUROPATHY,1
NL,CYSTITIS NONINFECTIVE,1
NL,CYSTITIS RADIATION,1
NL,DEAFNESS,1
NL,DEMENTIA ALZHEIMER^S TYPE,1
NL,DEPRESSED MOOD,1
NL,DEPRESSION,1
NL,DIABETES MELLITUS INADEQUATE CONTROL,1
NL,DIABETIC NEUROPATHY,1
NL,DIAPHRAGMATIC HERNIA,1
NL,DIPLOPIA,1
NL,DRUG ADMINISTRATION ERROR,1
NL,DRUG HYPERSENSITIVITY,1
NL,DRUG INEFFECTIVE,1
NL,DRUG INTOLERANCE,1
NL,DRUG LEVEL INCREASED,1
NL,DYSPNOEA EXERTIONAL,1
NL,EJECTION FRACTION ABNORMAL,1
NL,EMOTIONAL DISORDER,1
NL,ENCEPHALITIS VIRAL,1
NL,ENDODONTIC PROCEDURE,1
NL,ERYSIPELAS,1
NL,ESCHERICHIA SEPSIS,1
NL,EXPOSURE VIA INHALATION,1
NL,EYE PAIN,1
NL,FAECES DISCOLOURED,1
NL,FEAR,1
NL,FEELING COLD,1
NL,FOETAL GROWTH RESTRICTION,1
NL,FREQUENT BOWEL MOVEMENTS,1
NL,GASTROENTERITIS,1
NL,GASTROINTESTINAL ANGIODYSPLASIA,1
NL,GASTROINTESTINAL DISORDER,1
NL,GASTROINTESTINAL INJURY,1
NL,GASTROINTESTINAL SOUNDS ABNORMAL,1
NL,GASTROOESOPHAGEAL REFLUX DISEASE,1
NL,GLOSSODYNIA,1
NL,GROIN INFECTION,1
NL,HAEMATEMESIS,1
NL,HAEMATOMA,1
NL,HAEMATOSPERMIA,1
NL,HAEMODYNAMIC INSTABILITY,1
NL,HAEMORRHAGIC STROKE,1
NL,HAIR GROWTH ABNORMAL,1
NL,HEART RATE INCREASED,1
NL,HEART RATE IRREGULAR,1
NL,HEART VALVE INCOMPETENCE,1
NL,HEPATIC FAILURE,1
NL,HEPATIC NECROSIS,1
NL,HEPATOBILIARY DISEASE,1
NL,HIP FRACTURE,1
NL,HIP SURGERY,1
NL,HYPERHIDROSIS,1
NL,HYPERSENSITIVITY,1
NL,HYPERSENSITIVITY VASCULITIS,1
NL,HYPONATRAEMIA,1
NL,HYPOVOLAEMIC SHOCK,1
NL,HYPOXIA,1
NL,ILEUS,1
NL,IMPAIRED HEALING,1
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
NL,INCORRECT DOSE ADMINISTERED,1
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NL,INCREASED UPPER AIRWAY SECRETION,1
NL,INFECTION,1
NL,INFLUENZA,1
NL,INFLUENZA LIKE ILLNESS,1
NL,INFREQUENT BOWEL MOVEMENTS,1
NL,INJECTION SITE ERYTHEMA,1
NL,INJECTION SITE HAEMATOMA,1
NL,INJECTION SITE PAIN,1
NL,INJECTION SITE SWELLING,1
NL,INSOMNIA,1
NL,INTENTIONAL PRODUCT MISUSE,1
NL,INTERNATIONAL NORMALISED RATIO INCREASED,1
NL,INTERSTITIAL LUNG DISEASE,1
NL,INTESTINAL ISCHAEMIA,1
NL,INTESTINAL POLYP,1
NL,INTRAOCULAR LENS IMPLANT,1
NL,ISCHAEMIA,1
NL,ISCHAEMIC CEREBRAL INFARCTION,1
NL,JAUNDICE,1
NL,KNEE ARTHROPLASTY,1
NL,LABORATORY TEST ABNORMAL,1
NL,LARGE INTESTINE POLYP,1
NL,LASER THERAPY,1
NL,LEG AMPUTATION,1
NL,LETHARGY,1
NL,LIP SWELLING,1
NL,LIVER ABSCESS,1
NL,LIVER DISORDER,1
NL,LONG QT SYNDROME,1
NL,LOWER LIMB FRACTURE,1
NL,LUNG INFILTRATION,1
NL,LUNG NEOPLASM MALIGNANT,1
NL,MALIGNANT NEOPLASM PROGRESSION,1
NL,MATERNAL EXPOSURE DURING PREGNANCY,1
NL,METASTASIS,1
NL,METASTATIC CARCINOMA OF THE BLADDER,1
NL,METASTATIC RENAL CELL CARCINOMA,1
NL,MICROCYTIC ANAEMIA,1
NL,MOOD SWINGS,1
NL,MOTOR DYSFUNCTION,1
NL,MUSCULOSKELETAL PAIN,1
NL,MYELODYSPLASTIC SYNDROME,1
NL,NECK PAIN,1
NL,NON-ALCOHOLIC STEATOHEPATITIS,1
NL,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
NL,OCULAR RETROBULBAR HAEMORRHAGE,1
NL,OESOPHAGEAL CARCINOMA,1
NL,OESOPHAGEAL OBSTRUCTION,1
NL,OESOPHAGITIS,1
NL,ONCOLOGIC COMPLICATION,1
NL,OROMANDIBULAR DYSTONIA,1
NL,OROPHARYNGEAL PAIN,1
NL,OSTEOPOROSIS,1
NL,PANCREATIC CARCINOMA,1
NL,PANCREATIC MASS,1
NL,PANCREATITIS,1
NL,PANCREATITIS NECROTISING,1
NL,PARAESTHESIA ORAL,1
NL,PARKINSON^S DISEASE,1
NL,PELVIC PAIN,1
NL,PEMPHIGOID,1
NL,PERCUTANEOUS CORONARY INTERVENTION,1
NL,PERICARDIAL EFFUSION,1
NL,PERICARDIAL HAEMORRHAGE,1
NL,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
NL,PERIPHERAL SWELLING,1
NL,PERIPHERAL VASCULAR DISORDER,1
NL,PERITONEAL DISORDER,1
NL,PERITONEAL HAEMORRHAGE,1
NL,PERITONITIS,1
NL,PETIT MAL EPILEPSY,1
NL,PLACENTAL INSUFFICIENCY,1
NL,PLATELET AGGREGATION INCREASED,1
NL,PNEUMONIA ASPIRATION,1
NL,POOR QUALITY SLEEP,1
NL,PRESCRIBED OVERDOSE,1
NL,PRESCRIBED UNDERDOSE,1
NL,PRESYNCOPE,1
NL,PROCEDURAL COMPLICATION,1
NL,PROCTITIS ULCERATIVE,1
NL,PRODUCT CONTAMINATION MICROBIAL,1
NL,PRODUCT SUBSTITUTION ISSUE,1
NL,PRODUCT TASTE ABNORMAL,1
NL,PRODUCT USE ISSUE,1
NL,PULMONARY ARTERIAL HYPERTENSION,1
NL,PULMONARY FIBROSIS,1
NL,PULMONARY SEPSIS,1
NL,PYELONEPHRITIS,1
NL,PYONEPHROSIS,1
NL,RASH,1
NL,REHABILITATION THERAPY,1
NL,RENAL DISORDER,1
NL,RESPIRATORY DEPRESSION,1
NL,RESPIRATORY TRACT INFECTION,1
NL,RHABDOMYOLYSIS,1
NL,RHINORRHOEA,1
NL,ROTATOR CUFF SYNDROME,1
NL,SEIZURE,1
NL,SENSE OF OPPRESSION,1
NL,SINUS TACHYCARDIA,1
NL,SNORING,1
NL,SOMNOLENCE,1
NL,SPEECH DISORDER,1
NL,SPINAL FRACTURE,1
NL,SPONTANEOUS HAEMATOMA,1
NL,SUBARACHNOID HAEMORRHAGE,1
NL,SUPRAVENTRICULAR TACHYCARDIA,1
NL,SURGERY,1
NL,TACHYPNOEA,1
NL,TENSION HEADACHE,1
NL,THROMBOTIC MICROANGIOPATHY,1
NL,TONGUE DISORDER,1
NL,TOOTH EXTRACTION,1
NL,TOOTHACHE,1
NL,TRANSPLANT,1
NL,TREATMENT FAILURE,1
NL,UNDERDOSE,1
NL,UNRESPONSIVE TO STIMULI,1
NL,URINARY TRACT INFECTION,1
NL,VENTILATION PERFUSION MISMATCH,1
NL,VENTRICULAR EXTRASYSTOLES,1
NL,VENTRICULAR TACHYCARDIA,1
NL,VERTEBRAL ARTERY OCCLUSION,1
NL,VITAMIN D DEFICIENCY,1
NL,WAIST CIRCUMFERENCE INCREASED,1
NL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NZ,ACUTE MYOCARDIAL INFARCTION,6
NZ,DYSPNOEA,6
NZ,MYOCARDIAL INFARCTION,4
NZ,BACK PAIN,3
NZ,CARDIAC ARREST,3
NZ,DEATH,3
NZ,NEUTROPENIA,3
NZ,SUBDURAL HAEMORRHAGE,3
NZ,URTICARIA,3
NZ,ANAEMIA,2
NZ,ANXIETY,2
NZ,CEREBELLAR HAEMORRHAGE,2
NZ,CHEST PAIN,2
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
NZ,CONTUSION,2
NZ,COUGH,2
NZ,DIZZINESS,2
NZ,DRUG INEFFECTIVE,2
NZ,FALL,2
NZ,HAEMATEMESIS,2
NZ,HAEMATOMA,2
NZ,HAEMATURIA,2
NZ,HAEMOGLOBIN DECREASED,2
NZ,HEADACHE,2
NZ,INSOMNIA,2
NZ,PRURITUS,2
NZ,PYREXIA,2
NZ,RASH,2
NZ,RENAL FAILURE ACUTE,2
NZ,RESPIRATORY FAILURE,2
NZ,STENT PLACEMENT,2
NZ,SWELLING,2
NZ,VERTIGO,2
NZ,ABDOMINAL PAIN,1
NZ,ABDOMINAL PAIN UPPER,1
NZ,ABDOMINAL TENDERNESS,1
NZ,ACUTE RESPIRATORY DISTRESS SYNDROME,1
NZ,ANGIOEDEMA,1
NZ,AORTIC DISSECTION,1
NZ,APLASTIC ANAEMIA,1
NZ,ARTHRALGIA,1
NZ,ATRIAL FIBRILLATION,1
NZ,ATRIAL FLUTTER,1
NZ,BALANCE DISORDER,1
NZ,BASILAR ARTERY STENOSIS,1
NZ,BLISTER,1
NZ,BLOOD PRESSURE DECREASED,1
NZ,BLOOD SODIUM DECREASED,1
NZ,C-REACTIVE PROTEIN ABNORMAL,1
NZ,CARDIAC ANEURYSM,1
NZ,CARDIAC FAILURE,1
NZ,CARDIAC FAILURE CONGESTIVE,1
NZ,CARDIOMEGALY,1
NZ,CAROTID ARTERY STENOSIS,1
NZ,CELLULITIS,1
NZ,CEREBRAL HAEMORRHAGE,1
NZ,CEREBRAL INFARCTION,1
NZ,CEREBROVASCULAR ACCIDENT,1
NZ,CHILLS,1
NZ,COMPLETED SUICIDE,1
NZ,CONSTIPATION,1
NZ,CORONARY ARTERIAL STENT INSERTION,1
NZ,CORONARY ARTERY DISEASE,1
NZ,DEHYDRATION,1
NZ,DELIRIUM,1
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NZ,DEPRESSION,1
NZ,DIARRHOEA,1
NZ,DRUG ADMINISTRATION ERROR,1
NZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
NZ,DRY MOUTH,1
NZ,DYSGEUSIA,1
NZ,DYSPHAGIA,1
NZ,ECZEMA,1
NZ,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
NZ,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
NZ,EPISTAXIS,1
NZ,ERYTHEMA,1
NZ,FEBRILE NEUTROPENIA,1
NZ,FLUSHING,1
NZ,GASTRIC DISORDER,1
NZ,GASTRITIS,1
NZ,GASTROINTESTINAL ANGIODYSPLASIA,1
NZ,GOUT,1
NZ,HAEMODYNAMIC INSTABILITY,1
NZ,HAEMORRHAGE,1
NZ,HAEMORRHAGE INTRACRANIAL,1
NZ,HAEMORRHAGE URINARY TRACT,1
NZ,HAEMORRHAGIC STROKE,1
NZ,HIP FRACTURE,1
NZ,HYPERHIDROSIS,1
NZ,HYPOKALAEMIA,1
NZ,HYPOTENSION,1
NZ,INTERNAL HAEMORRHAGE,1
NZ,INTERSTITIAL LUNG DISEASE,1
NZ,INVASIVE DUCTAL BREAST CARCINOMA,1
NZ,ISCHAEMIA,1
NZ,ISCHAEMIC STROKE,1
NZ,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
NZ,LACTIC ACIDOSIS,1
NZ,LARYNGEAL OEDEMA,1
NZ,LOWER RESPIRATORY TRACT INFECTION,1
NZ,LUNG INFILTRATION,1
NZ,MEDICATION ERROR,1
NZ,MELAENA,1
NZ,MUSCLE HAEMORRHAGE,1
NZ,MUSCULOSKELETAL PAIN,1
NZ,MUSCULOSKELETAL STIFFNESS,1
NZ,MYALGIA,1
NZ,MYOCARDIAL ISCHAEMIA,1
NZ,MYOCARDITIS,1
NZ,NAUSEA,1
NZ,NECK PAIN,1
NZ,NEUTROPHIL COUNT DECREASED,1
NZ,ORTHOSTATIC HYPOTENSION,1
NZ,OSTEOARTHRITIS,1
NZ,PAIN,1
NZ,PALPITATIONS,1
NZ,PERIORBITAL OEDEMA,1
NZ,PERIPHERAL CIRCULATORY FAILURE,1
NZ,PHARYNGITIS,1
NZ,PNEUMONIA,1
NZ,PNEUMONITIS,1
NZ,PRODUCT USE IN UNAPPROVED INDICATION,1
NZ,PRODUCTIVE COUGH,1
NZ,PSEUDOMONAS INFECTION,1
NZ,PULMONARY OEDEMA,1
NZ,RASH ERYTHEMATOUS,1
NZ,RASH MACULAR,1
NZ,RECTAL HAEMORRHAGE,1
NZ,RED BLOOD CELL COUNT ABNORMAL,1
NZ,RESPIRATORY ARREST,1
NZ,RETINAL HAEMORRHAGE,1
NZ,RETROPERITONEAL HAEMATOMA,1
NZ,RHINITIS,1
NZ,SEIZURE,1
NZ,SENSORY LOSS,1
NZ,SEPSIS,1
NZ,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,1
NZ,STRIDOR,1
NZ,SUICIDAL IDEATION,1
NZ,SYNCOPE,1
NZ,TACHYCARDIA,1
NZ,THERAPY CESSATION,1
NZ,THROMBOCYTOPENIA,1
NZ,THROMBOSIS IN DEVICE,1
NZ,TRANSIENT ISCHAEMIC ATTACK,1
NZ,TROPONIN INCREASED,1
NZ,UPPER GASTROINTESTINAL HAEMORRHAGE,1
NZ,URINARY RETENTION,1
NZ,VENTRICULAR FIBRILLATION,1
NZ,VENTRICULAR TACHYCARDIA,1
NZ,VOMITING,1
NZ,WHITE BLOOD CELL COUNT INCREASED,1
NO,CEREBRAL HAEMORRHAGE,13
NO,DYSPNOEA,11
NO,PAIN IN EXTREMITY,10
NO,FATIGUE,9
NO,BLOOD CREATININE INCREASED,8
NO,GENERAL PHYSICAL HEALTH DETERIORATION,8
NO,HEADACHE,8
NO,INTERSTITIAL LUNG DISEASE,7
NO,PAIN,7
NO,COLD SWEAT,6
NO,DIZZINESS,6
NO,ECZEMA,6
NO,MYALGIA,6
NO,RASH PRURITIC,6
NO,AMNESIA,5
NO,ASTHENIA,5
NO,BLOOD PRESSURE DECREASED,5
NO,MYOCARDIAL INFARCTION,5
NO,MYOGLOBIN BLOOD INCREASED,5
NO,OSTEITIS,5
NO,OSTEONECROSIS OF JAW,5
NO,PNEUMONIA,5
NO,ACUTE MYOCARDIAL INFARCTION,4
NO,DEATH,4
NO,DIARRHOEA,4
NO,IMPAIRED QUALITY OF LIFE,4
NO,NAUSEA,4
NO,PLEURAL EFFUSION,4
NO,PYREXIA,4
NO,SKIN DISORDER,4
NO,TREMOR,4
NO,ABDOMINAL PAIN UPPER,3
NO,CARDIAC FAILURE,3
NO,CEREBROVASCULAR ACCIDENT,3
NO,CHEST PAIN,3
NO,CONFUSIONAL STATE,3
NO,DISSEMINATED INTRAVASCULAR COAGULATION,3
NO,DRUG INEFFECTIVE,3
NO,EOSINOPHILIA,3
NO,HAEMATOMA,3
NO,HYPOKINESIA,3
NO,INFLUENZA LIKE ILLNESS,3
NO,LYME DISEASE,3
NO,MALAISE,3
NO,MUSCLE ATROPHY,3
NO,MYOCLONUS,3
NO,NECK PAIN,3
NO,NEUROPATHY PERIPHERAL,3
NO,PARAESTHESIA,3
NO,PSORIASIS,3
NO,PULMONARY HAEMORRHAGE,3
NO,SEPSIS,3
NO,SOMNOLENCE,3
NO,SUBDURAL HAEMATOMA,3
NO,SYNCOPE,3
NO,VOMITING,3
NO,ABDOMINAL PAIN,2
NO,ALANINE AMINOTRANSFERASE INCREASED,2
NO,ARTERIOSCLEROSIS,2
NO,BLINDNESS,2
NO,CEREBRAL INFARCTION,2
NO,CONSTIPATION,2
NO,CONTRAINDICATED PRODUCT ADMINISTERED,2
NO,DEPRESSION,2
NO,DISORIENTATION,2
NO,DUODENITIS,2
NO,DYSCHEZIA,2
NO,EMBOLISM,2
NO,EMBOLISM ARTERIAL,2
NO,ERECTILE DYSFUNCTION,2
NO,FALL,2
NO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
NO,GASTRITIS,2
NO,HAEMOGLOBIN DECREASED,2
NO,HAEMORRHAGE SUBCUTANEOUS,2
NO,HEMIPARESIS,2
NO,HYPOAESTHESIA,2
NO,INFECTION,2
NO,LOSS OF CONSCIOUSNESS,2
NO,MEMORY IMPAIRMENT,2
NO,MOUTH ULCERATION,2
NO,MUSCLE CONTRACTIONS INVOLUNTARY,2
NO,MUSCULOSKELETAL STIFFNESS,2
NO,ORGAN FAILURE,2
NO,OROPHARYNGEAL PAIN,2
NO,PERIPHERAL ISCHAEMIA,2
NO,PETECHIAE,2
NO,PLATELET COUNT INCREASED,2
NO,POST PROCEDURAL HAEMORRHAGE,2
NO,PULMONARY EMBOLISM,2
NO,RASH,2
NO,RECTAL HAEMORRHAGE,2
NO,SPEECH DISORDER,2
NO,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
NO,TESTICULAR MASS,2
NO,THROMBOTIC CEREBRAL INFARCTION,2
NO,TRANSIENT ISCHAEMIC ATTACK,2
NO,URINARY INCONTINENCE,2
NO,URINE OUTPUT INCREASED,2
NO,VISUAL FIELD DEFECT,2
NO,ABDOMINAL DISTENSION,1
NO,ABDOMINAL PAIN LOWER,1
NO,ABDOMINAL WALL HAEMATOMA,1
NO,ACTINIC KERATOSIS,1
NO,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NO,ACUTE KIDNEY INJURY,1
NO,ACUTE TONSILLITIS,1
NO,AGEUSIA,1
NO,ANGINA PECTORIS,1
NO,ANGINA UNSTABLE,1
NO,ANKLE FRACTURE,1
NO,AORTIC ANEURYSM,1
NO,APHASIA,1
NO,ARTHRALGIA,1
NO,ARTHROPATHY,1
NO,ARTHROPOD BITE,1
NO,ASCITES,1
NO,ATRIAL FIBRILLATION,1
NO,BLADDER CANCER,1
NO,BONE PAIN,1
NO,BURNING SENSATION,1
NO,C-REACTIVE PROTEIN INCREASED,1
NO,CANCER SURGERY,1
NO,CEREBELLAR HAEMORRHAGE,1
NO,CEREBRAL HAEMATOMA,1
NO,CHANGE OF BOWEL HABIT,1
NO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NO,COMA SCALE ABNORMAL,1
NO,CONDITION AGGRAVATED,1
NO,CONJUNCTIVAL HAEMORRHAGE,1
NO,CONTUSION,1
NO,CONVULSION,1
NO,DECREASED APPETITE,1
NO,DEEP VEIN THROMBOSIS,1
NO,DERMATITIS,1
NO,DERMATITIS ALLERGIC,1
NO,DIABETIC KETOACIDOSIS,1
NO,DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,1
NO,DRUG HYPERSENSITIVITY,1
NO,DYSARTHRIA,1
NO,DYSPHAGIA,1
NO,EMPHYSEMA,1
NO,EPILEPSY,1
NO,EYE PAIN,1
NO,FLANK PAIN,1
NO,FLUSHING,1
NO,GAIT DISTURBANCE,1
NO,GASTRITIS HAEMORRHAGIC,1
NO,GASTROENTERITIS,1
NO,GASTROINTESTINAL HAEMORRHAGE,1
NO,GASTROOESOPHAGEAL REFLUX DISEASE,1
NO,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
NO,HAEMATOCHEZIA,1
NO,HAEMODYNAMIC INSTABILITY,1
NO,HAEMOPTYSIS,1
NO,HAEMORRHAGE,1
NO,HAEMORRHAGE URINARY TRACT,1
NO,HAEMORRHAGIC CEREBRAL INFARCTION,1
NO,HAEMORRHAGIC STROKE,1
NO,HAEMORRHOIDS,1
NO,HEAD INJURY,1
NO,HEART RATE INCREASED,1
NO,HEMIANOPIA HOMONYMOUS,1
NO,HEPATIC CANCER METASTATIC,1
NO,HEPATIC FAILURE,1
NO,HYPERAEMIA,1
NO,HYPERSOMNIA,1
NO,HYPERTENSION,1
NO,HYPOTENSION,1
NO,HYPOTONIA,1
NO,IGA NEPHROPATHY,1
NO,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
NO,INCREASED TENDENCY TO BRUISE,1
NO,INFUSION RELATED REACTION,1
NO,ISCHAEMIA,1
NO,ISCHAEMIC CARDIOMYOPATHY,1
NO,JOB DISSATISFACTION,1
NO,LAPAROSCOPIC SURGERY,1
NO,LIGAMENT INJURY,1
NO,LIMB CRUSHING INJURY,1
NO,LIP SWELLING,1
NO,LIVER DISORDER,1
NO,LYMPHADENOPATHY,1
NO,METASTASES TO LUNG,1
NO,METASTASES TO LYMPH NODES,1
NO,MUCOUS MEMBRANE DISORDER,1
NO,MUSCLE TWITCHING,1
NO,MUSCULAR WEAKNESS,1
NO,MYELODYSPLASTIC SYNDROME,1
NO,NEOADJUVANT THERAPY,1
NO,OEDEMA,1
NO,OEDEMA PERIPHERAL,1
NO,OSTEOARTHRITIS,1
NO,PAIN IN JAW,1
NO,PERCUTANEOUS CORONARY INTERVENTION,1
NO,PERICARDIAL EFFUSION,1
NO,PERIPHERAL EMBOLISM,1
NO,PHARYNGEAL ERYTHEMA,1
NO,PHARYNGITIS,1
NO,PNEUMONIA BACTERIAL,1
NO,POLLAKIURIA,1
NO,POLYARTHRITIS,1
NO,POLYMYALGIA RHEUMATICA,1
NO,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
NO,PRURITUS,1
NO,PULMONARY OEDEMA,1
NO,RASH MACULAR,1
NO,RECTAL CANCER,1
NO,RECTAL CANCER METASTATIC,1
NO,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
NO,RHEUMATOID ARTHRITIS,1
NO,SEROTONIN SYNDROME,1
NO,SHOCK HAEMORRHAGIC,1
NO,SKIN DISCOLOURATION,1
NO,SKIN EXFOLIATION,1
NO,SKIN HAEMORRHAGE,1
NO,SPONDYLITIS,1
NO,SURGERY,1
NO,SWELLING,1
NO,THROMBOSIS,1
NO,TYPE III IMMUNE COMPLEX MEDIATED REACTION,1
NO,UPPER RESPIRATORY TRACT INFECTION,1
NO,URINARY RETENTION,1
NO,URINARY TRACT DISORDER,1
NO,UROSEPSIS,1
NO,UTERINE PAIN,1
NO,UTERINE POLYP,1
NO,VAGINAL HAEMORRHAGE,1
NO,VISION BLURRED,1
NO,VITAMIN D DEFICIENCY,1
NO,WEIGHT DECREASED,1
OM,FOETAL GROWTH RESTRICTION,2
OM,PREMATURE DELIVERY,2
OM,DRUG INEFFECTIVE,1
OM,EXPOSURE DURING PREGNANCY,1
OM,FOETAL EXPOSURE DURING PREGNANCY,1
OM,HAEMATURIA,1
OM,ISCHAEMIC STROKE,1
OM,LEFT VENTRICULAR DYSFUNCTION,1
OM,LIVE BIRTH,1
OM,MATERNAL EXPOSURE DURING PREGNANCY,1
OM,MYOCARDIAL INFARCTION,1
OM,NO THERAPEUTIC RESPONSE,1
OM,PREMATURE BABY,1
PK,DEATH,8
PK,CHEST PAIN,6
PK,DYSPNOEA,3
PK,PERIPHERAL ISCHAEMIA,3
PK,SHOCK,3
PK,TOXIC EPIDERMAL NECROLYSIS,3
PK,ACUTE KIDNEY INJURY,2
PK,ANGIOPLASTY,2
PK,BLOOD GLUCOSE ABNORMAL,2
PK,CHEST DISCOMFORT,2
PK,DIARRHOEA,2
PK,LOSS OF CONSCIOUSNESS,2
PK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
PK,ODYNOPHAGIA,2
PK,VOMITING,2
PK,ABDOMINAL PAIN,1
PK,ABSCESS,1
PK,ANGINA PECTORIS,1
PK,ARTERIOVENOUS FISTULA SITE HAEMORRHAGE,1
PK,BLOOD GLUCOSE DECREASED,1
PK,BURNING SENSATION,1
PK,CARDIAC ARREST,1
PK,CARDIAC TAMPONADE,1
PK,CORONARY ARTERY DISEASE,1
PK,COUGH,1
PK,DEHYDRATION,1
PK,DIABETIC NEPHROPATHY,1
PK,DISORIENTATION,1
PK,DIZZINESS,1
PK,DRUG INEFFECTIVE,1
PK,HEADACHE,1
PK,HYPERHIDROSIS,1
PK,HYPERTENSION,1
PK,HYPOAESTHESIA,1
PK,HYPOTENSION,1
PK,MEMORY IMPAIRMENT,1
PK,MYOCARDIAL INFARCTION,1
PK,PAIN IN EXTREMITY,1
PK,PAIN IN JAW,1
PK,PARAESTHESIA,1
PK,PERICARDIAL HAEMORRHAGE,1
PK,PNEUMONIA,1
PK,PRODUCT USE IN UNAPPROVED INDICATION,1
PK,RASH ERYTHEMATOUS,1
PK,RASH GENERALISED,1
PK,RASH PRURITIC,1
PK,RENAL IMPAIRMENT,1
PK,RESTLESSNESS,1
PK,ROAD TRAFFIC ACCIDENT,1
PK,SEIZURE,1
PK,SKIN DISCOLOURATION,1
PK,SKIN EXFOLIATION,1
PK,SKULL FRACTURE,1
PK,VEIN DISORDER,1
PW,ANGINA UNSTABLE,1
PS,ABDOMINAL PAIN UPPER,1
PS,BLOOD PARATHYROID HORMONE INCREASED,1
PS,ELECTROLYTE IMBALANCE,1
PS,NAUSEA,1
PS,TREMOR,1
PS,VOMITING,1
PA,ANURIA,1
PA,BALANCE DISORDER,1
PA,BLOOD PRESSURE INCREASED,1
PA,CEREBROVASCULAR ACCIDENT,1
PA,DISORIENTATION,1
PA,MYOCARDIAL INFARCTION,1
PA,SALIVARY HYPERSECRETION,1
PA,SEIZURE,1
PE,DEATH,2
PE,DUCTUS ARTERIOSUS STENOSIS FOETAL,2
PE,VASCULAR STENT THROMBOSIS,2
PE,ARTERIOSCLEROSIS,1
PE,ARTERIOSPASM CORONARY,1
PE,CEREBRAL PALSY,1
PE,CEREBROVASCULAR ACCIDENT,1
PE,DIZZINESS,1
PE,FOOT AMPUTATION,1
PE,GAIT DISTURBANCE,1
PE,INFECTED SKIN ULCER,1
PE,MACULAR HOLE,1
PE,MALAISE,1
PE,MYOSITIS,1
PE,NAUSEA,1
PE,PNEUMONIA,1
PE,SEPSIS,1
PE,SEPTIC SHOCK,1
PE,STAPHYLOCOCCAL INFECTION,1
PE,SUDDEN DEATH,1
PE,VOMITING,1
PH,DYSPNOEA,7
PH,CEREBROVASCULAR ACCIDENT,4
PH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
PH,LOSS OF CONSCIOUSNESS,4
PH,PNEUMONIA,4
PH,ACUTE MYOCARDIAL INFARCTION,3
PH,ARRHYTHMIA,3
PH,ASTHENIA,3
PH,BLOOD CREATININE INCREASED,3
PH,CARDIAC FAILURE,3
PH,CARDIAC FAILURE CONGESTIVE,3
PH,CHEST PAIN,3
PH,DEATH,3
PH,DECREASED APPETITE,3
PH,DIZZINESS,3
PH,FATIGUE,3
PH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
PH,PLEURAL EFFUSION,3
PH,PULMONARY CONGESTION,3
PH,ACUTE RESPIRATORY FAILURE,2
PH,ALANINE AMINOTRANSFERASE INCREASED,2
PH,ANGINA UNSTABLE,2
PH,CARDIAC ARREST,2
PH,CARDIO-RESPIRATORY ARREST,2
PH,CARDIOGENIC SHOCK,2
PH,CARDIOMEGALY,2
PH,CONCOMITANT DISEASE PROGRESSION,2
PH,FALL,2
PH,HYPOTENSION,2
PH,MUSCULAR WEAKNESS,2
PH,MYOCARDIAL ISCHAEMIA,2
PH,PEPTIC ULCER HAEMORRHAGE,2
PH,PERITONITIS,2
PH,POLYURIA,2
PH,PULMONARY OEDEMA,2
PH,PYREXIA,2
PH,SEPSIS,2
PH,SEPTIC SHOCK,2
PH,SUDDEN DEATH,2
PH,ABDOMINAL PAIN UPPER,1
PH,ACUTE HEPATIC FAILURE,1
PH,ACUTE MYELOID LEUKAEMIA,1
PH,ALPHA 1 FOETOPROTEIN INCREASED,1
PH,ASTHMA,1
PH,ATAXIA,1
PH,ATELECTASIS,1
PH,BLISTER,1
PH,BLOOD CHOLESTEROL INCREASED,1
PH,BLOOD CREATINE PHOSPHOKINASE MM INCREASED,1
PH,BLOOD GLUCOSE ABNORMAL,1
PH,BLOOD PRESSURE DECREASED,1
PH,BLOOD PRESSURE FLUCTUATION,1
PH,BRONCHITIS,1
PH,CEREBELLAR HAEMORRHAGE,1
PH,CEREBRAL HAEMORRHAGE,1
PH,CHOLECYSTITIS,1
PH,CHOLELITHIASIS,1
PH,CORONARY ARTERY DISEASE,1
PH,COUGH,1
PH,DEFECT CONDUCTION INTRAVENTRICULAR,1
PH,DEHYDRATION,1
PH,DIABETIC COMPLICATION,1
PH,DIABETIC NEUROPATHY,1
PH,DRUG INEFFECTIVE,1
PH,DYSPNOEA AT REST,1
PH,DYSPNOEA PAROXYSMAL NOCTURNAL,1
PH,ELECTROLYTE IMBALANCE,1
PH,FIBROSIS,1
PH,FLUID INTAKE REDUCED,1
PH,FLUID OVERLOAD,1
PH,GASTRIC HAEMORRHAGE,1
PH,GASTRITIS,1
PH,GASTROENTERITIS,1
PH,GOUTY ARTHRITIS,1
PH,HAEMATOCHEZIA,1
PH,HAEMORRHAGIC STROKE,1
PH,HAEMOTHORAX,1
PH,HEADACHE,1
PH,HEPATIC ENZYME INCREASED,1
PH,HEPATOCELLULAR CARCINOMA,1
PH,HYDROCEPHALUS,1
PH,HYPERSENSITIVITY,1
PH,HYPERTENSIVE NEPHROPATHY,1
PH,HYPERURICAEMIA,1
PH,HYPOALBUMINAEMIA,1
PH,HYPOGLYCAEMIA,1
PH,HYPOKALAEMIA,1
PH,HYPONATRAEMIA,1
PH,HYPOPHAGIA,1
PH,IMPAIRED HEALING,1
PH,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
PH,INFLUENZA,1
PH,INTERMITTENT CLAUDICATION,1
PH,INTERNATIONAL NORMALISED RATIO INCREASED,1
PH,LEFT ATRIAL DILATATION,1
PH,LEFT VENTRICULAR HYPERTROPHY,1
PH,LUNG ADENOCARCINOMA,1
PH,MITRAL VALVE STENOSIS,1
PH,MYOCARDIAL INFARCTION,1
PH,NASOPHARYNGITIS,1
PH,NEPHROSCLEROSIS,1
PH,OEDEMA,1
PH,OEDEMA PERIPHERAL,1
PH,ORTHOPNOEA,1
PH,ORTHOSTATIC HYPOTENSION,1
PH,PALLOR,1
PH,PALPITATIONS,1
PH,PERITONEAL DIALYSIS COMPLICATION,1
PH,PNEUMONIA ASPIRATION,1
PH,PNEUMOTHORAX,1
PH,PRODUCT USE ISSUE,1
PH,PROTHROMBIN TIME PROLONGED,1
PH,PULMONARY SEPSIS,1
PH,PYELONEPHRITIS ACUTE,1
PH,RENAL FAILURE CHRONIC,1
PH,RHABDOMYOLYSIS,1
PH,RHEUMATIC HEART DISEASE,1
PH,RHINITIS,1
PH,SINUS TACHYCARDIA,1
PH,SOMNOLENCE,1
PH,SPINAL DISORDER,1
PH,STUPOR,1
PH,SUBDURAL HAEMATOMA,1
PH,THROMBOSIS IN DEVICE,1
PH,TRANSIENT ISCHAEMIC ATTACK,1
PH,ULCER,1
PH,UNDERDOSE,1
PH,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PH,UTERINE ATROPHY,1
PH,VENTRICULAR EXTRASYSTOLES,1
PH,WEIGHT DECREASED,1
PL,MYOCARDIAL INFARCTION,15
PL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,13
PL,ANAEMIA,10
PL,ATRIAL FIBRILLATION,10
PL,CARDIAC FAILURE,10
PL,CORONARY ARTERY DISEASE,10
PL,DRUG INEFFECTIVE,10
PL,CHEST PAIN,9
PL,COUGH,9
PL,PNEUMONIA,9
PL,ACUTE MYOCARDIAL INFARCTION,8
PL,ANGINA PECTORIS,8
PL,MYALGIA,8
PL,VASCULAR PSEUDOANEURYSM,8
PL,VASCULAR STENT THROMBOSIS,8
PL,HAEMORRHAGE INTRACRANIAL,7
PL,MUSCLE SPASMS,7
PL,DRUG INTOLERANCE,6
PL,GASTROINTESTINAL HAEMORRHAGE,6
PL,LABILE HYPERTENSION,6
PL,TINNITUS,6
PL,ASTHENIA,5
PL,CONFUSIONAL STATE,5
PL,DRUG ADMINISTRATION ERROR,5
PL,DRUG RESISTANCE,5
PL,HYPOTENSION,5
PL,SYNCOPE,5
PL,UPPER GASTROINTESTINAL HAEMORRHAGE,5
PL,CARDIAC ARREST,4
PL,DEATH,4
PL,DYSPNOEA,4
PL,HAEMATOCHEZIA,4
PL,HAEMOGLOBIN DECREASED,4
PL,PERIPHERAL SWELLING,4
PL,THROMBOCYTOPENIA,4
PL,VISUAL IMPAIRMENT,4
PL,CARDIAC FAILURE CHRONIC,3
PL,CHEST DISCOMFORT,3
PL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
PL,COMA,3
PL,FEELING ABNORMAL,3
PL,GASTRITIS HAEMORRHAGIC,3
PL,GENERAL PHYSICAL HEALTH DETERIORATION,3
PL,HAEMATEMESIS,3
PL,HAEMORRHAGIC STROKE,3
PL,MELAENA,3
PL,NAUSEA,3
PL,OEDEMA PERIPHERAL,3
PL,OSTEONECROSIS OF JAW,3
PL,PULMONARY OEDEMA,3
PL,THROMBOSIS IN DEVICE,3
PL,ABDOMINAL PAIN,2
PL,ACUTE CORONARY SYNDROME,2
PL,AGRANULOCYTOSIS,2
PL,ANXIETY,2
PL,ARTERIOSCLEROSIS,2
PL,ATRIAL THROMBOSIS,2
PL,BLOOD PRESSURE INCREASED,2
PL,BONE PAIN,2
PL,CARDIOGENIC SHOCK,2
PL,CEREBRAL HAEMATOMA,2
PL,CEREBRAL HAEMORRHAGE,2
PL,CONTRAINDICATED PRODUCT ADMINISTERED,2
PL,DRY MOUTH,2
PL,DRY SKIN,2
PL,EPISTAXIS,2
PL,GASTROINTESTINAL OBSTRUCTION,2
PL,HAEMATOMA,2
PL,HAEMORRHAGE,2
PL,HAEMORRHAGIC DISORDER,2
PL,HEART RATE DECREASED,2
PL,HYPERTENSION,2
PL,HYPOTONIA,2
PL,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
PL,INFLUENZA LIKE ILLNESS,2
PL,ISCHAEMIC STROKE,2
PL,LOSS OF CONSCIOUSNESS,2
PL,LOW DENSITY LIPOPROTEIN INCREASED,2
PL,MALAISE,2
PL,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
PL,PETECHIAE,2
PL,PLATELET AGGREGATION INCREASED,2
PL,PULMONARY HYPERTENSION,2
PL,RASH ERYTHEMATOUS,2
PL,RENAL FAILURE,2
PL,RENAL IMPAIRMENT,2
PL,RESPIRATORY FAILURE,2
PL,SINUS NODE DYSFUNCTION,2
PL,SINUS TACHYCARDIA,2
PL,SKIN EROSION,2
PL,SLEEP DISORDER,2
PL,SYSTOLIC DYSFUNCTION,2
PL,THERAPY CESSATION,2
PL,TONSILLITIS,2
PL,VENTRICULAR FIBRILLATION,2
PL,ABDOMINAL PAIN UPPER,1
PL,ACCESSORY SPLEEN,1
PL,ACCIDENTAL OVERDOSE,1
PL,ACUTE RESPIRATORY FAILURE,1
PL,ADAMS-STOKES SYNDROME,1
PL,ADENOCARCINOMA OF COLON,1
PL,ALANINE AMINOTRANSFERASE INCREASED,1
PL,ALOPECIA,1
PL,ANAL STENOSIS,1
PL,ANGINA UNSTABLE,1
PL,ARTERIAL HAEMORRHAGE,1
PL,ARTERIAL STENOSIS,1
PL,ASPARTATE AMINOTRANSFERASE INCREASED,1
PL,BACK PAIN,1
PL,BASAL CELL CARCINOMA,1
PL,BLADDER DILATATION,1
PL,BLEEDING TIME PROLONGED,1
PL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PL,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
PL,BLOOD PRESSURE ABNORMAL,1
PL,BLOOD PRESSURE DECREASED,1
PL,BLOOD PRESSURE SYSTOLIC INCREASED,1
PL,BLOOD TRIGLYCERIDES INCREASED,1
PL,BODY TEMPERATURE INCREASED,1
PL,BRAIN STEM HAEMORRHAGE,1
PL,BRONCHIECTASIS,1
PL,BUNDLE BRANCH BLOCK RIGHT,1
PL,CARDIAC DEATH,1
PL,CARDIAC FAILURE ACUTE,1
PL,CARDIAC FAILURE CONGESTIVE,1
PL,CARDIAC TAMPONADE,1
PL,CARDIOMYOPATHY,1
PL,CARDIOVASCULAR DISORDER,1
PL,CAROTID ARTERY OCCLUSION,1
PL,CHILLS,1
PL,CHOLECYSTITIS,1
PL,CHOLELITHIASIS,1
PL,CIRCULATORY COLLAPSE,1
PL,CONJUNCTIVAL HAEMORRHAGE,1
PL,CONTRAST MEDIA REACTION,1
PL,CONTUSION,1
PL,CORONARY ARTERY OCCLUSION,1
PL,CORONARY ARTERY STENOSIS,1
PL,CORONARY ARTERY THROMBOSIS,1
PL,CYTOPENIA,1
PL,DEHYDRATION,1
PL,DIARRHOEA,1
PL,DILATATION VENTRICULAR,1
PL,DISEASE PROGRESSION,1
PL,DIVERTICULUM INTESTINAL,1
PL,DYSARTHRIA,1
PL,DYSKINESIA,1
PL,DYSLIPIDAEMIA,1
PL,DYSPEPSIA,1
PL,DYSPHONIA,1
PL,ECCHYMOSIS,1
PL,ECHOCARDIOGRAM ABNORMAL,1
PL,EJECTION FRACTION DECREASED,1
PL,EMBOLISM VENOUS,1
PL,ENZYME LEVEL INCREASED,1
PL,ERYTHEMA,1
PL,EXERCISE TOLERANCE DECREASED,1
PL,FALL,1
PL,FATIGUE,1
PL,FEMORAL ARTERY OCCLUSION,1
PL,FRACTURE,1
PL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
PL,GASTRITIS,1
PL,GASTROOESOPHAGEAL REFLUX DISEASE,1
PL,GINGIVAL BLEEDING,1
PL,GLIOMA,1
PL,HAEMOPTYSIS,1
PL,HAEMORRHAGE URINARY TRACT,1
PL,HAEMORRHAGIC DIATHESIS,1
PL,HAEMORRHAGIC TRANSFORMATION STROKE,1
PL,HEAD BANGING,1
PL,HEADACHE,1
PL,HEART RATE INCREASED,1
PL,HEART VALVE INCOMPETENCE,1
PL,HELICOBACTER INFECTION,1
PL,HEMIANOPIA,1
PL,HEPATIC LESION,1
PL,HEPATIC STEATOSIS,1
PL,HEPATOMEGALY,1
PL,HIATUS HERNIA,1
PL,HYPERCOAGULATION,1
PL,HYPERKALAEMIA,1
PL,HYPOVOLAEMIC SHOCK,1
PL,ILLOGICAL THINKING,1
PL,INCONTINENCE,1
PL,INTRAVENTRICULAR HAEMORRHAGE,1
PL,IRON DEFICIENCY,1
PL,LABILE BLOOD PRESSURE,1
PL,LEUKOPENIA,1
PL,LIVER DISORDER,1
PL,LOWER LIMB FRACTURE,1
PL,MEAN PLATELET VOLUME DECREASED,1
PL,METAMORPHOPSIA,1
PL,MITRAL VALVE CALCIFICATION,1
PL,MITRAL VALVE INCOMPETENCE,1
PL,MITRAL VALVE SCLEROSIS,1
PL,MUCOSAL HAEMORRHAGE,1
PL,MUSCULAR WEAKNESS,1
PL,MUSCULOSKELETAL PAIN,1
PL,MYOCARDIAL ISCHAEMIA,1
PL,NECK PAIN,1
PL,NEPHROPATHY,1
PL,NEUROLOGICAL SYMPTOM,1
PL,NEUTROPENIA,1
PL,NON-CARDIAC CHEST PAIN,1
PL,NON-CARDIOGENIC PULMONARY OEDEMA,1
PL,ORTHOSTATIC HYPOTENSION,1
PL,OSTEOMYELITIS CHRONIC,1
PL,OSTEONECROSIS,1
PL,OTITIS MEDIA CHRONIC,1
PL,PALATAL DISORDER,1
PL,PALPITATIONS,1
PL,PARAESTHESIA ORAL,1
PL,PEMPHIGOID,1
PL,PERIPHERAL ISCHAEMIA,1
PL,PHYSICAL DISABILITY,1
PL,PLEURAL MESOTHELIOMA MALIGNANT,1
PL,POST PROCEDURAL HAEMORRHAGE,1
PL,POST THROMBOTIC SYNDROME,1
PL,POSTPERICARDIOTOMY SYNDROME,1
PL,PRESCRIBED OVERDOSE,1
PL,PRODUCTIVE COUGH,1
PL,PROSOPAGNOSIA,1
PL,PRURITUS GENERALISED,1
PL,PURPURA,1
PL,RASH GENERALISED,1
PL,RASH PRURITIC,1
PL,RHABDOMYOLYSIS,1
PL,RHEUMATOID ARTHRITIS,1
PL,SCAR,1
PL,SEIZURE,1
PL,SKIN DISCOLOURATION,1
PL,SKIN HYPERTROPHY,1
PL,SMALL INTESTINAL HAEMORRHAGE,1
PL,STAPHYLOCOCCAL SEPSIS,1
PL,STREPTOCOCCAL INFECTION,1
PL,SWEATING FEVER,1
PL,THROMBOSIS,1
PL,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
PL,TONGUE HAEMATOMA,1
PL,TRANSAMINASES INCREASED,1
PL,TRICUSPID VALVE INCOMPETENCE,1
PL,TROPONIN I INCREASED,1
PL,TROPONIN T INCREASED,1
PL,UPPER RESPIRATORY TRACT INFECTION,1
PL,URINARY BLADDER HAEMORRHAGE,1
PL,URTICARIA,1
PL,VAGINAL HAEMORRHAGE,1
PL,VASCULAR STENT OCCLUSION,1
PL,VASCULITIS NECROTISING,1
PL,VENOUS HAEMORRHAGE,1
PL,VENTRICULAR EXTRASYSTOLES,1
PL,VERTIGO,1
PL,VESSEL PUNCTURE SITE HAEMATOMA,1
PL,VISION BLURRED,1
PL,VISUAL ACUITY REDUCED,1
PL,VOMITING,1
PL,WHEEZING,1
PL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
PT,ACUTE KIDNEY INJURY,6
PT,DYSPNOEA,6
PT,ACUTE MYOCARDIAL INFARCTION,5
PT,HYPERTENSION,5
PT,HYPOTENSION,5
PT,LACTIC ACIDOSIS,5
PT,METABOLIC DISORDER,5
PT,NAUSEA,5
PT,PLEURAL EFFUSION,5
PT,RENAL IMPAIRMENT,5
PT,ANAEMIA,4
PT,CHEST PAIN,4
PT,CONTRAINDICATED PRODUCT ADMINISTERED,4
PT,DEATH,4
PT,RETROPERITONEAL HAEMORRHAGE,4
PT,ABDOMINAL DISTENSION,3
PT,ARRHYTHMIA,3
PT,COMA,3
PT,DECREASED APPETITE,3
PT,DIARRHOEA,3
PT,DRUG ADMINISTRATION ERROR,3
PT,DRUG INEFFECTIVE,3
PT,EOSINOPHILIA,3
PT,HAEMATURIA,3
PT,HAEMOGLOBIN DECREASED,3
PT,HALLUCINATION,3
PT,HYPERCHLORAEMIA,3
PT,HYPERNATRAEMIA,3
PT,HYPERTHYROIDISM,3
PT,LOSS OF CONSCIOUSNESS,3
PT,MYOCARDIAL INFARCTION,3
PT,OVERDOSE,3
PT,PNEUMONIA,3
PT,PRURITUS,3
PT,RESPIRATORY DEPRESSION,3
PT,THROMBOCYTOPENIA,3
PT,TOXIC SKIN ERUPTION,3
PT,TREMOR,3
PT,VOMITING,3
PT,ABDOMINAL PAIN,2
PT,ALTERED STATE OF CONSCIOUSNESS,2
PT,ARTHRALGIA,2
PT,BRADYCARDIA,2
PT,BRONCHOSPASM,2
PT,CARDIAC FAILURE,2
PT,COLITIS MICROSCOPIC,2
PT,CONDITION AGGRAVATED,2
PT,DIVERTICULUM INTESTINAL HAEMORRHAGIC,2
PT,DRUG HYPERSENSITIVITY,2
PT,DRUG SCREEN FALSE POSITIVE,2
PT,DYSPHONIA,2
PT,ECCHYMOSIS,2
PT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
PT,ERYTHEMA,2
PT,FEELING ABNORMAL,2
PT,FLATULENCE,2
PT,GAIT DISTURBANCE,2
PT,GENERAL PHYSICAL HEALTH DETERIORATION,2
PT,GINGIVAL BLEEDING,2
PT,HAEMATOCHEZIA,2
PT,HAEMODYNAMIC INSTABILITY,2
PT,HAEMORRHAGE,2
PT,HAEMORRHAGIC STROKE,2
PT,HYPERTONIA,2
PT,HYPOKALAEMIA,2
PT,HYPONATRAEMIA,2
PT,ISCHAEMIC STROKE,2
PT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
PT,OCULAR TOXICITY,2
PT,OROPHARYNGEAL PAIN,2
PT,PAIN,2
PT,PARKINSONISM,2
PT,PRODUCT QUALITY ISSUE,2
PT,PROTEINURIA,2
PT,PULMONARY ALVEOLAR HAEMORRHAGE,2
PT,RASH MACULO-PAPULAR,2
PT,SEIZURE,2
PT,TUBULOINTERSTITIAL NEPHRITIS,2
PT,UPPER GASTROINTESTINAL HAEMORRHAGE,2
PT,ABDOMINAL PAIN UPPER,1
PT,ACUTE PULMONARY OEDEMA,1
PT,AGGRESSION,1
PT,AGITATION,1
PT,ANAL FISSURE,1
PT,ANGIOEDEMA,1
PT,ANTINUCLEAR ANTIBODY POSITIVE,1
PT,ANXIETY,1
PT,ARTHRITIS,1
PT,ASTHENIA,1
PT,ATRIAL FIBRILLATION,1
PT,BLISTER,1
PT,BLOOD CREATININE INCREASED,1
PT,BLOOD GLUCOSE INCREASED,1
PT,BLOOD PRESSURE INCREASED,1
PT,BLOOD UREA INCREASED,1
PT,BODY TEMPERATURE INCREASED,1
PT,BONE PAIN,1
PT,BRADYARRHYTHMIA,1
PT,BREAST MASS,1
PT,BREAST NEOPLASM,1
PT,BUNDLE BRANCH BLOCK RIGHT,1
PT,BURN OF INTERNAL ORGANS,1
PT,CARDIAC ARREST,1
PT,CARDIAC DISORDER,1
PT,CARDIAC FAILURE ACUTE,1
PT,CARDIAC TAMPONADE,1
PT,CARDIO-RESPIRATORY ARREST,1
PT,CEREBRAL HAEMORRHAGE,1
PT,CEREBRAL ISCHAEMIA,1
PT,CEREBROVASCULAR ACCIDENT,1
PT,CHRONIC GASTRITIS,1
PT,CHRONIC KIDNEY DISEASE,1
PT,CONJUNCTIVITIS,1
PT,CONSTIPATION,1
PT,CONTUSION,1
PT,CORNEAL DEGENERATION,1
PT,CORONARY ARTERY THROMBOSIS,1
PT,COUGH,1
PT,CYANOSIS,1
PT,CYSTITIS ESCHERICHIA,1
PT,DEHYDRATION,1
PT,DELIRIUM,1
PT,DERMATITIS,1
PT,DERMATITIS BULLOUS,1
PT,DEVICE EMBOLISATION,1
PT,DEVICE RELATED THROMBOSIS,1
PT,DIABETES MELLITUS INADEQUATE CONTROL,1
PT,DIABETIC KETOACIDOSIS,1
PT,DISORIENTATION,1
PT,DIVERTICULUM OESOPHAGEAL,1
PT,DOUBLE STRANDED DNA ANTIBODY POSITIVE,1
PT,DRUG DOSE OMISSION,1
PT,DYSPEPSIA,1
PT,DYSPHAGIA,1
PT,ELECTROCARDIOGRAM ABNORMAL,1
PT,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
PT,ELECTROCARDIOGRAM T WAVE INVERSION,1
PT,EPISTAXIS,1
PT,ESCHERICHIA SEPSIS,1
PT,EYE PAIN,1
PT,FALL,1
PT,GASTROOESOPHAGEAL REFLUX DISEASE,1
PT,GENERALISED ERYTHEMA,1
PT,HAEMANGIOMA,1
PT,HAEMATEMESIS,1
PT,HAEMATOMA,1
PT,HAEMOPTYSIS,1
PT,HAEMORRHOIDAL HAEMORRHAGE,1
PT,HEAD INJURY,1
PT,HEADACHE,1
PT,HEMIPARESIS,1
PT,HYPERHIDROSIS,1
PT,HYPERKALAEMIA,1
PT,HYPERSENSITIVITY VASCULITIS,1
PT,HYPOAESTHESIA ORAL,1
PT,HYPOCOAGULABLE STATE,1
PT,HYPOGLYCAEMIA,1
PT,HYPOKINESIA,1
PT,HYPOVOLAEMIC SHOCK,1
PT,IMPAIRED SELF-CARE,1
PT,IMPULSIVE BEHAVIOUR,1
PT,INFECTION,1
PT,INSOMNIA,1
PT,ISCHAEMIA,1
PT,JOINT SWELLING,1
PT,LACTOSE INTOLERANCE,1
PT,LARYNGEAL OEDEMA,1
PT,LEFT VENTRICULAR HYPERTROPHY,1
PT,LEUKOCYTOSIS,1
PT,LEUKOCYTURIA,1
PT,LUPUS-LIKE SYNDROME,1
PT,MALAISE,1
PT,MATERNAL EXPOSURE DURING PREGNANCY,1
PT,METABOLIC ACIDOSIS,1
PT,MULTI-ORGAN FAILURE,1
PT,MUSCLE ATROPHY,1
PT,MUSCLE TWITCHING,1
PT,MUSCULOSKELETAL PAIN,1
PT,MYALGIA,1
PT,NASOPHARYNGITIS,1
PT,NEPHRITIS ALLERGIC,1
PT,NEPHROANGIOSCLEROSIS,1
PT,NERVOUS SYSTEM DISORDER,1
PT,NERVOUSNESS,1
PT,NEUTROPENIA,1
PT,NIGHTMARE,1
PT,NODULE,1
PT,ORAL MUCOSA EROSION,1
PT,ORTHOSTATIC HYPOTENSION,1
PT,OSTEOARTHROPATHY,1
PT,PALLOR,1
PT,PARTIAL SEIZURES,1
PT,PERICARDIAL EFFUSION,1
PT,PERICARDITIS,1
PT,PERIPHERAL ARTERY STENOSIS,1
PT,PERIPHERAL ISCHAEMIA,1
PT,PHLEBITIS,1
PT,PLEURISY,1
PT,PNEUMONIA BACTERIAL,1
PT,POLYNEUROPATHY,1
PT,PRODUCT USE ISSUE,1
PT,PRODUCTIVE COUGH,1
PT,PRURITUS GENITAL,1
PT,PSORIATIC ARTHROPATHY,1
PT,PULMONARY CONGESTION,1
PT,PULMONARY EMBOLISM,1
PT,RASH,1
PT,RASH ERYTHEMATOUS,1
PT,RASH MORBILLIFORM,1
PT,RENAL ARTERY THROMBOSIS,1
PT,RESPIRATORY DISORDER,1
PT,RESPIRATORY DISTRESS,1
PT,RESPIRATORY FAILURE,1
PT,RESPIRATORY TRACT INFECTION,1
PT,RHINORRHOEA,1
PT,ROSACEA,1
PT,SALMONELLOSIS,1
PT,SENSORY LOSS,1
PT,SEPSIS,1
PT,SHOCK HAEMORRHAGIC,1
PT,SINUS BRADYCARDIA,1
PT,SKIN LESION,1
PT,SKIN TOXICITY,1
PT,SKIN ULCER,1
PT,SMALL INTESTINAL HAEMORRHAGE,1
PT,SPINAL PAIN,1
PT,STOMATITIS,1
PT,STRIDOR,1
PT,SWELLING,1
PT,SYNCOPE,1
PT,TACHYARRHYTHMIA,1
PT,TACHYCARDIA,1
PT,TELANGIECTASIA,1
PT,TENDON CALCIFICATION,1
PT,THERAPY NON-RESPONDER,1
PT,TINNITUS,1
PT,TOXICITY TO VARIOUS AGENTS,1
PT,TREATMENT FAILURE,1
PT,TROPONIN INCREASED,1
PT,TYPE IV HYPERSENSITIVITY REACTION,1
PT,ULCER,1
PT,URINARY INCONTINENCE,1
PT,URINE OUTPUT DECREASED,1
PT,UTERINE HAEMORRHAGE,1
PT,VASCULAR GRAFT OCCLUSION,1
PT,VASCULAR STENT THROMBOSIS,1
PT,WHEEZING,1
PR,NASOPHARYNGITIS,13
PR,INJECTION SITE PAIN,11
PR,PAIN,9
PR,DIZZINESS,7
PR,NAUSEA,7
PR,PSORIASIS,7
PR,ABDOMINAL PAIN,5
PR,DRUG INEFFECTIVE,5
PR,FALL,5
PR,FATIGUE,5
PR,PAIN IN EXTREMITY,5
PR,ABDOMINAL DISCOMFORT,4
PR,ARTHRALGIA,4
PR,CELLULITIS,4
PR,COUGH,4
PR,DIARRHOEA,4
PR,HEADACHE,4
PR,HYPERTENSION,4
PR,PERIPHERAL SWELLING,4
PR,VENOUS OCCLUSION,4
PR,VOMITING,4
PR,WEIGHT DECREASED,4
PR,ABDOMINAL PAIN UPPER,3
PR,ASTHENIA,3
PR,BRONCHITIS,3
PR,CHEST PAIN,3
PR,DECREASED APPETITE,3
PR,HAEMOGLOBIN DECREASED,3
PR,HEART RATE DECREASED,3
PR,INFLUENZA,3
PR,MALAISE,3
PR,PHARYNGITIS,3
PR,PULMONARY OEDEMA,3
PR,PYREXIA,3
PR,TRANSIENT ISCHAEMIC ATTACK,3
PR,ARTHRITIS,2
PR,ASPHYXIA,2
PR,BACK PAIN,2
PR,BLINDNESS,2
PR,BLOOD GLUCOSE INCREASED,2
PR,CARDIAC DISORDER,2
PR,CATARACT,2
PR,CEREBROVASCULAR ACCIDENT,2
PR,CHIKUNGUNYA VIRUS INFECTION,2
PR,DEPRESSION,2
PR,DERMATITIS ALLERGIC,2
PR,DIABETES MELLITUS,2
PR,DRUG HYPERSENSITIVITY,2
PR,DYSPHONIA,2
PR,DYSPNOEA,2
PR,GAIT DISTURBANCE,2
PR,GASTROINTESTINAL DISORDER,2
PR,GASTROINTESTINAL INFLAMMATION,2
PR,HYPOAESTHESIA,2
PR,HYPOTENSION,2
PR,INCORRECT DOSE ADMINISTERED,2
PR,INFLAMMATION,2
PR,INJECTION SITE ERYTHEMA,2
PR,INJECTION SITE INFLAMMATION,2
PR,INJECTION SITE WARMTH,2
PR,INTERVERTEBRAL DISC PROTRUSION,2
PR,JOINT SWELLING,2
PR,LOSS OF CONSCIOUSNESS,2
PR,MUSCULOSKELETAL STIFFNESS,2
PR,MYALGIA,2
PR,MYOCARDIAL INFARCTION,2
PR,NECK PAIN,2
PR,PALLOR,2
PR,PRODUCTIVE COUGH,2
PR,PRURITUS,2
PR,PRURITUS GENERALISED,2
PR,RECTAL HAEMORRHAGE,2
PR,RESPIRATORY TRACT CONGESTION,2
PR,RHEUMATOID FACTOR INCREASED,2
PR,SYNCOPE,2
PR,THROMBOPHLEBITIS,2
PR,URINARY TRACT INFECTION,2
PR,ABDOMINAL ADHESIONS,1
PR,AGITATION,1
PR,AMNESIA,1
PR,ANAEMIA,1
PR,ANAPHYLACTIC REACTION,1
PR,ANGIOPATHY,1
PR,ANGIOPLASTY,1
PR,ANKLE FRACTURE,1
PR,ARRHYTHMIA,1
PR,ARTERIAL OCCLUSIVE DISEASE,1
PR,ARTERIAL STENOSIS,1
PR,ASTHMA,1
PR,ATRIAL FIBRILLATION,1
PR,AXILLARY PAIN,1
PR,BACTERIAL INFECTION,1
PR,BEDRIDDEN,1
PR,BLISTER,1
PR,BLOOD CHOLESTEROL ABNORMAL,1
PR,BLOOD CHOLESTEROL INCREASED,1
PR,BLOOD POTASSIUM INCREASED,1
PR,BLOOD PRESSURE ABNORMAL,1
PR,BONE PAIN,1
PR,BRONCHOSPASM,1
PR,BURNING SENSATION,1
PR,CAPILLARY DISORDER,1
PR,CAPILLARY FRAGILITY,1
PR,CAROTID ARTERY DISEASE,1
PR,CAROTID ARTERY OCCLUSION,1
PR,CEREBRAL INFARCTION,1
PR,CEREBRAL THROMBOSIS,1
PR,CHEMICAL BURN OF SKIN,1
PR,CHILLS,1
PR,CHOLECYSTITIS,1
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
PR,CONJUNCTIVAL HAEMORRHAGE,1
PR,CONSTIPATION,1
PR,CONTUSION,1
PR,COORDINATION ABNORMAL,1
PR,CORONARY ARTERY DISEASE,1
PR,DEATH,1
PR,DEPRESSED MOOD,1
PR,DERMATITIS PSORIASIFORM,1
PR,DERMATOSIS,1
PR,DIABETES MELLITUS INADEQUATE CONTROL,1
PR,DISCOMFORT,1
PR,DISEASE COMPLICATION,1
PR,DIVERTICULUM,1
PR,DRUG PRESCRIBING ERROR,1
PR,DRUG RESISTANCE,1
PR,DRY SKIN,1
PR,DYSGEUSIA,1
PR,DYSPEPSIA,1
PR,ELEPHANTIASIS,1
PR,EMPHYSEMA,1
PR,ERYTHEMA,1
PR,EYE OPERATION,1
PR,FLUID RETENTION,1
PR,FREQUENT BOWEL MOVEMENTS,1
PR,GALLBLADDER DISORDER,1
PR,GALLBLADDER PERFORATION,1
PR,GASTRIC CANCER,1
PR,GASTRIC INFECTION,1
PR,GASTROINTESTINAL HAEMORRHAGE,1
PR,GENITAL DISCOMFORT,1
PR,GINGIVAL INFECTION,1
PR,HAEMATEMESIS,1
PR,HAEMATOCHEZIA,1
PR,HAEMATOMA,1
PR,HAEMOGLOBIN ABNORMAL,1
PR,HAEMORRHAGE,1
PR,HAEMORRHAGE INTRACRANIAL,1
PR,HAEMORRHAGIC STROKE,1
PR,HAEMORRHOIDS,1
PR,HEART RATE INCREASED,1
PR,HEPATIC ENZYME INCREASED,1
PR,HERNIA,1
PR,HERPES ZOSTER,1
PR,HIP FRACTURE,1
PR,HYPERCHOLESTEROLAEMIA,1
PR,HYPERSENSITIVITY,1
PR,HYPOPHAGIA,1
PR,HYPOTHYROIDISM,1
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PR,INCISION SITE INFECTION,1
PR,INCREASED UPPER AIRWAY SECRETION,1
PR,INFARCTION,1
PR,INFLAMMATORY MARKER INCREASED,1
PR,INGROWING NAIL,1
PR,INJECTION SITE HAEMATOMA,1
PR,INJECTION SITE HAEMORRHAGE,1
PR,INJECTION SITE RASH,1
PR,INTENTIONAL PRODUCT MISUSE,1
PR,INTRACRANIAL ANEURYSM,1
PR,INTRAOCULAR PRESSURE INCREASED,1
PR,JOINT INJURY,1
PR,LACERATION,1
PR,LUNG DISORDER,1
PR,MASS,1
PR,MEDICAL DEVICE SITE PUSTULE,1
PR,MELAENA,1
PR,MOBILITY DECREASED,1
PR,MOVEMENT DISORDER,1
PR,MUSCLE SPASMS,1
PR,MUSCULAR WEAKNESS,1
PR,MUSCULOSKELETAL DISORDER,1
PR,MUSCULOSKELETAL PAIN,1
PR,NAIL BED INFLAMMATION,1
PR,NASAL CONGESTION,1
PR,NEOPLASM PROGRESSION,1
PR,NEUROPATHY PERIPHERAL,1
PR,OEDEMA PERIPHERAL,1
PR,OESOPHAGEAL PAIN,1
PR,OESOPHAGEAL ULCER,1
PR,ORAL SURGERY,1
PR,OROPHARYNGEAL DISCOMFORT,1
PR,OSTEOARTHRITIS,1
PR,OXYGEN SATURATION DECREASED,1
PR,PARAESTHESIA,1
PR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
PR,PERIPHERAL ARTERY OCCLUSION,1
PR,PHLEBITIS,1
PR,PLATELET COUNT DECREASED,1
PR,PNEUMONIA,1
PR,POST PROCEDURAL HAEMORRHAGE,1
PR,PRODUCT PREPARATION ERROR,1
PR,PRODUCT USE IN UNAPPROVED INDICATION,1
PR,PULMONARY HYPERTENSION,1
PR,PULMONARY PAIN,1
PR,RASH,1
PR,RASH GENERALISED,1
PR,RASH MACULAR,1
PR,RENAL DISORDER,1
PR,RENAL IMPAIRMENT,1
PR,RESPIRATORY ARREST,1
PR,RESPIRATORY FAILURE,1
PR,RHEUMATOID ARTHRITIS,1
PR,ROTATOR CUFF SYNDROME,1
PR,SEIZURE,1
PR,SINUSITIS,1
PR,SKIN DISORDER,1
PR,SKIN EXFOLIATION,1
PR,SKIN ULCER,1
PR,STOMA SITE CELLULITIS,1
PR,STOMA SITE HAEMORRHAGE,1
PR,STRESS,1
PR,SUFFOCATION FEELING,1
PR,SWELLING FACE,1
PR,SYNOVIAL CYST,1
PR,TACHYCARDIA,1
PR,THYROID DISORDER,1
PR,TINEA PEDIS,1
PR,TRACHEAL OBSTRUCTION,1
PR,TYPE 2 DIABETES MELLITUS,1
PR,UNEVALUABLE EVENT,1
PR,URTICARIA,1
PR,VERTIGO POSITIONAL,1
PR,VISUAL IMPAIRMENT,1
PR,WHITE BLOOD CELL COUNT INCREASED,1
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
QA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,3
QA,DRUG INEFFECTIVE,2
QA,SEROTONIN SYNDROME,2
QA,ABDOMINAL WALL HAEMATOMA,1
QA,DRUG ADMINISTRATION ERROR,1
QA,GASTROINTESTINAL HAEMORRHAGE,1
QA,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
QA,MYOCARDIAL INFARCTION,1
QA,SUPRAVENTRICULAR TACHYCARDIA,1
QA,THROMBOSIS IN DEVICE,1
RO,DRUG INEFFECTIVE,18
RO,ACUTE MYOCARDIAL INFARCTION,12
RO,VASCULAR STENT THROMBOSIS,9
RO,ISCHAEMIC STROKE,8
RO,ANGINA PECTORIS,7
RO,APHASIA,7
RO,HEMIPLEGIA,7
RO,TREATMENT NONCOMPLIANCE,7
RO,HAEMOGLOBIN DECREASED,6
RO,PRODUCT USE IN UNAPPROVED INDICATION,6
RO,VOMITING,6
RO,CORONARY ARTERY DISEASE,5
RO,HAEMATOCRIT DECREASED,5
RO,VITAMIN B12 DECREASED,5
RO,CARDIAC FAILURE,4
RO,CARDIAC FAILURE CHRONIC,4
RO,DRUG INTOLERANCE,4
RO,DRUG RESISTANCE,4
RO,INTENTIONAL DOSE OMISSION,4
RO,OEDEMA PERIPHERAL,4
RO,RHEUMATOID ARTHRITIS,4
RO,TRANSIENT ISCHAEMIC ATTACK,4
RO,CARDIO-RESPIRATORY ARREST,3
RO,DIARRHOEA,3
RO,HYPERTENSION,3
RO,INTENTIONAL PRODUCT MISUSE,3
RO,IRON DEFICIENCY,3
RO,MITRAL VALVE INCOMPETENCE,3
RO,MYOCARDIAL INFARCTION,3
RO,SYNCOPE,3
RO,ANAEMIA,2
RO,ANAPHYLACTIC SHOCK,2
RO,ARTERIOSCLEROSIS,2
RO,CARDIAC ANEURYSM,2
RO,CARDIAC DEATH,2
RO,CHEST PAIN,2
RO,CONDITION AGGRAVATED,2
RO,DECREASED APPETITE,2
RO,DIZZINESS,2
RO,DYSPNOEA,2
RO,HEADACHE,2
RO,HEPATOCELLULAR INJURY,2
RO,HYPOAESTHESIA,2
RO,MENINGIOMA,2
RO,NAUSEA,2
RO,PAIN IN EXTREMITY,2
RO,PANCREATITIS,2
RO,PNEUMONIA,2
RO,PSYCHOTIC DISORDER,2
RO,RECTAL HAEMORRHAGE,2
RO,THROMBOSIS,2
RO,THROMBOSIS IN DEVICE,2
RO,VASCULAR STENT OCCLUSION,2
RO,WEIGHT DECREASED,2
RO,ABDOMINAL PAIN,1
RO,ABDOMINAL PAIN UPPER,1
RO,ABULIA,1
RO,ACUTE RESPIRATORY DISTRESS SYNDROME,1
RO,ACUTE RESPIRATORY FAILURE,1
RO,ADRENAL MASS,1
RO,AMYLOIDOSIS,1
RO,ANAL POLYP,1
RO,ANEURYSM,1
RO,AORTIC ARTERIOSCLEROSIS,1
RO,AORTIC VALVE CALCIFICATION,1
RO,AORTIC VALVE INCOMPETENCE,1
RO,AORTIC VALVE SCLEROSIS,1
RO,ARTHRALGIA,1
RO,ASCITES,1
RO,ASPHYXIA,1
RO,ASTHENIA,1
RO,ATRIAL FIBRILLATION,1
RO,ATROPHIC THYROIDITIS,1
RO,BALANCE DISORDER,1
RO,BLINDNESS UNILATERAL,1
RO,BLOOD CHOLESTEROL INCREASED,1
RO,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
RO,BLOOD GLUCOSE INCREASED,1
RO,BLOOD POTASSIUM INCREASED,1
RO,BLOOD TRIGLYCERIDES INCREASED,1
RO,BLOOD UREA INCREASED,1
RO,BODY TEMPERATURE DECREASED,1
RO,BRAIN OEDEMA,1
RO,BRAIN STEM STROKE,1
RO,CACHEXIA,1
RO,CARDIAC FAILURE ACUTE,1
RO,CARDIAC FAILURE CONGESTIVE,1
RO,CARDIAC VALVE DISEASE,1
RO,CARDIAC VENTRICULAR THROMBOSIS,1
RO,CEREBRAL ATROPHY,1
RO,CEREBRAL HAEMATOMA,1
RO,CEREBROVASCULAR ACCIDENT,1
RO,CHOLECYSTITIS,1
RO,CHOLECYSTITIS ACUTE,1
RO,CHOLESTASIS,1
RO,COGNITIVE DISORDER,1
RO,CONFUSIONAL STATE,1
RO,CORONARY ARTERIAL STENT INSERTION,1
RO,CORONARY ARTERY THROMBOSIS,1
RO,CYANOSIS,1
RO,DEATH,1
RO,DEEP VEIN THROMBOSIS,1
RO,DELIRIUM,1
RO,DELUSION,1
RO,DEPRESSION,1
RO,DIABETES MELLITUS INADEQUATE CONTROL,1
RO,DIVERTICULUM INTESTINAL,1
RO,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
RO,DRUG-INDUCED LIVER INJURY,1
RO,DRY SKIN,1
RO,DYSPEPSIA,1
RO,DYSPHONIA,1
RO,DYSPNOEA PAROXYSMAL NOCTURNAL,1
RO,EAR DISCOMFORT,1
RO,EJECTION FRACTION DECREASED,1
RO,ENTEROCOLITIS HAEMORRHAGIC,1
RO,ERYSIPELAS,1
RO,ERYTHEMA,1
RO,FALL,1
RO,FATIGUE,1
RO,FINGER DEFORMITY,1
RO,FOOT DEFORMITY,1
RO,GANGRENE,1
RO,GASTRIC ULCER,1
RO,GASTROINTESTINAL HAEMORRHAGE,1
RO,GENERALISED OEDEMA,1
RO,HALLUCINATION_ VISUAL,1
RO,HEART RATE DECREASED,1
RO,HEMIANAESTHESIA,1
RO,HEMIPARESIS,1
RO,HEPATOMEGALY,1
RO,HERPES ZOSTER,1
RO,HIP FRACTURE,1
RO,HYPERGLYCAEMIA,1
RO,HYPERHIDROSIS,1
RO,HYPERTENSIVE CRISIS,1
RO,HYPERTONIA,1
RO,HYPOKALAEMIA,1
RO,HYPONATRAEMIA,1
RO,HYPOPROTEINAEMIA,1
RO,HYPOTENSION,1
RO,HYPOTHYROIDISM,1
RO,ILEUS PARALYTIC,1
RO,INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION,1
RO,INFECTED SKIN ULCER,1
RO,INFECTIVE MYOSITIS,1
RO,INFLAMMATION,1
RO,INFLUENZA,1
RO,INGUINAL HERNIA,1
RO,INGUINAL HERNIA STRANGULATED,1
RO,INHIBITORY DRUG INTERACTION,1
RO,INSOMNIA,1
RO,INTESTINAL OBSTRUCTION,1
RO,INTRACARDIAC THROMBUS,1
RO,ISCHAEMIC CARDIOMYOPATHY,1
RO,JAUNDICE,1
RO,LACUNAR STROKE,1
RO,LEFT VENTRICULAR FAILURE,1
RO,LEUKOCYTOSIS,1
RO,MALIGNANT ANORECTAL NEOPLASM,1
RO,MEDICATION ERROR,1
RO,MUSCULAR WEAKNESS,1
RO,MYOCARDIAL BRIDGING,1
RO,MYOCARDIAL ISCHAEMIA,1
RO,NASOPHARYNGITIS,1
RO,NEOPLASM PROGRESSION,1
RO,NEUTROPENIA,1
RO,ORTHOPNOEA,1
RO,PAIN,1
RO,PALMOMENTAL REFLEX,1
RO,PALPITATIONS,1
RO,PANCREATITIS ACUTE,1
RO,PARANOIA,1
RO,PARESIS,1
RO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
RO,PLEURISY,1
RO,PNEUMONIA PSEUDOMONAL,1
RO,PRURITUS,1
RO,PSYCHOMOTOR HYPERACTIVITY,1
RO,PULMONARY ARTERY THROMBOSIS,1
RO,PULMONARY EMBOLISM,1
RO,RHONCHI,1
RO,SCROTAL SWELLING,1
RO,SHOCK HAEMORRHAGIC,1
RO,SKIN DISCOLOURATION,1
RO,SKIN FISSURES,1
RO,SKIN HYPERTROPHY,1
RO,SKIN ULCER,1
RO,SMALL INTESTINAL HAEMORRHAGE,1
RO,SOMNOLENCE,1
RO,SPINAL PAIN,1
RO,STOMATITIS,1
RO,SYSTOLIC DYSFUNCTION,1
RO,THERAPEUTIC RESPONSE DECREASED,1
RO,TREMOR,1
RO,TRICUSPID VALVE INCOMPETENCE,1
RO,TYPE 1 DIABETES MELLITUS,1
RO,URINARY TRACT INFECTION,1
RO,VARICOSE VEIN,1
RO,VENTRICULAR DYSKINESIA,1
RO,VENTRICULAR HYPOKINESIA,1
RO,VENTRICULAR TACHYCARDIA,1
RU,CHEST PAIN,28
RU,DEATH,20
RU,MYOCARDIAL INFARCTION,14
RU,MYOCARDIAL RUPTURE,13
RU,ANGINA PECTORIS,12
RU,CONTUSION,12
RU,DRUG INEFFECTIVE,11
RU,DYSPNOEA,11
RU,ANGINA UNSTABLE,10
RU,ASTHENIA,10
RU,THROMBOSIS IN DEVICE,10
RU,VASCULAR STENT THROMBOSIS,10
RU,CORONARY ARTERY RESTENOSIS,9
RU,GASTRITIS EROSIVE,9
RU,EPISTAXIS,8
RU,ATRIAL FIBRILLATION,7
RU,CARDIAC FAILURE,7
RU,CORONARY ARTERY STENOSIS,7
RU,CORONARY ARTERY THROMBOSIS,7
RU,VASCULAR PSEUDOANEURYSM,7
RU,HYPERTENSION,6
RU,THROMBOSIS,6
RU,ABDOMINAL PAIN UPPER,5
RU,BLOOD PRESSURE DECREASED,5
RU,BLOOD PRESSURE INCREASED,5
RU,CEREBROVASCULAR ACCIDENT,5
RU,CHEST DISCOMFORT,5
RU,GENERAL PHYSICAL HEALTH DETERIORATION,5
RU,HYPERHIDROSIS,5
RU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,5
RU,COUGH,4
RU,DIZZINESS,4
RU,GINGIVAL BLEEDING,4
RU,HAEMOGLOBIN DECREASED,4
RU,PERICARDIAL HAEMORRHAGE,4
RU,PRODUCT QUALITY ISSUE,4
RU,PRURITUS,4
RU,ACUTE CORONARY SYNDROME,3
RU,ARRHYTHMIA,3
RU,ARTERIAL RESTENOSIS,3
RU,ASPHYXIA,3
RU,BRADYCARDIA,3
RU,CARDIAC DISORDER,3
RU,CARDIOGENIC SHOCK,3
RU,DYSPEPSIA,3
RU,GASTROINTESTINAL HAEMORRHAGE,3
RU,HAEMATURIA,3
RU,HYPOAESTHESIA,3
RU,LUNG NEOPLASM MALIGNANT,3
RU,NAUSEA,3
RU,OVERDOSE,3
RU,PAIN,3
RU,PALPITATIONS,3
RU,PRODUCT COUNTERFEIT,3
RU,PYREXIA,3
RU,SUSPECTED COUNTERFEIT PRODUCT,3
RU,TYPE 2 DIABETES MELLITUS,3
RU,ABDOMINAL ABSCESS,2
RU,ACUTE MYOCARDIAL INFARCTION,2
RU,AORTIC ARTERIOSCLEROSIS,2
RU,ARTERIOSCLEROSIS CORONARY ARTERY,2
RU,ATRIOVENTRICULAR BLOCK,2
RU,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
RU,BLOOD GLUCOSE INCREASED,2
RU,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
RU,BLOOD URINE PRESENT,2
RU,BRACHIOCEPHALIC ARTERY OCCLUSION,2
RU,BRONCHIAL HAEMORRHAGE,2
RU,CHOLECYSTECTOMY,2
RU,CHOLECYSTITIS,2
RU,CIRCULATORY COLLAPSE,2
RU,CONTRAINDICATED PRODUCT ADMINISTERED,2
RU,CORONARY ARTERY OCCLUSION,2
RU,DIABETES MELLITUS,2
RU,DIARRHOEA,2
RU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
RU,EROSIVE DUODENITIS,2
RU,ERYTHEMA,2
RU,HAEMATOMA,2
RU,HAEMOPTYSIS,2
RU,HAEMORRHAGIC STROKE,2
RU,HEADACHE,2
RU,HEART RATE INCREASED,2
RU,HYPERSENSITIVITY,2
RU,INTENTIONAL DRUG MISUSE,2
RU,ISCHAEMIC STROKE,2
RU,MELAENA,2
RU,MYOCARDIAL FIBROSIS,2
RU,NERVOUSNESS,2
RU,OSTEOCHONDROSIS,2
RU,PAIN IN EXTREMITY,2
RU,PANCREATITIS CHRONIC,2
RU,PERIPHERAL ARTERY THROMBOSIS,2
RU,PNEUMONIA,2
RU,PRODUCT USE IN UNAPPROVED INDICATION,2
RU,PRODUCT USE ISSUE,2
RU,PRODUCTIVE COUGH,2
RU,RECTAL POLYP,2
RU,TACHYARRHYTHMIA,2
RU,TACHYCARDIA,2
RU,TRANSIENT ISCHAEMIC ATTACK,2
RU,ULCER HAEMORRHAGE,2
RU,UNEVALUABLE EVENT,2
RU,URTICARIA,2
RU,VASCULAR STENT OCCLUSION,2
RU,VOMITING,2
RU,ABDOMINAL PAIN,1
RU,ABDOMINAL PAIN LOWER,1
RU,ACTIVITIES OF DAILY LIVING IMPAIRED,1
RU,ACUTE LYMPHOCYTIC LEUKAEMIA,1
RU,ADAMS-STOKES SYNDROME,1
RU,ADRENAL INSUFFICIENCY,1
RU,ALOPECIA,1
RU,ANAEMIA,1
RU,ANAPHYLACTIC SHOCK,1
RU,ANOREXIA NERVOSA,1
RU,ANXIETY,1
RU,AORTIC ANEURYSM,1
RU,AORTIC STENOSIS,1
RU,AORTIC THROMBOSIS,1
RU,APATHY,1
RU,APHASIA,1
RU,APNOEA,1
RU,APPETITE DISORDER,1
RU,APRAXIA,1
RU,ARTERIAL STENOSIS,1
RU,ARTHRALGIA,1
RU,ASCITES,1
RU,ATRIAL FLUTTER,1
RU,ATRIAL SEPTAL DEFECT,1
RU,ATRIAL THROMBOSIS,1
RU,ATRIOVENTRICULAR BLOCK COMPLETE,1
RU,ATYPICAL PNEUMONIA,1
RU,BACK PAIN,1
RU,BACTERIAL INFECTION,1
RU,BLINDNESS,1
RU,BLOOD CALCIUM INCREASED,1
RU,BLOOD CHOLESTEROL INCREASED,1
RU,BLOOD CREATININE INCREASED,1
RU,BLOOD PRESSURE FLUCTUATION,1
RU,BODY TEMPERATURE INCREASED,1
RU,BRAIN HERNIATION,1
RU,BRAIN OEDEMA,1
RU,BRAIN STEM INFARCTION,1
RU,BRONCHITIS,1
RU,BRONCHITIS CHRONIC,1
RU,BRONCHOALVEOLAR LAVAGE ABNORMAL,1
RU,BURNING SENSATION,1
RU,CARDIAC ARREST,1
RU,CARDIAC DISCOMFORT,1
RU,CARDIAC FAILURE ACUTE,1
RU,CARDIAC FAILURE CONGESTIVE,1
RU,CARDIAC PACEMAKER INSERTION,1
RU,CARDIOMYOPATHY,1
RU,CARDIOVASCULAR DISORDER,1
RU,CEREBRAL ARTERIOSCLEROSIS,1
RU,CEREBRAL INFARCTION,1
RU,CEREBROVASCULAR DISORDER,1
RU,CHEST X-RAY ABNORMAL,1
RU,CHOKING,1
RU,CHOLECYSTITIS CHRONIC,1
RU,CHRONIC GASTRITIS,1
RU,CHRONIC HEPATITIS,1
RU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
RU,COCCYDYNIA,1
RU,COLON GANGRENE,1
RU,COMA,1
RU,COMPLICATION ASSOCIATED WITH DEVICE,1
RU,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
RU,CONDITION AGGRAVATED,1
RU,CONFUSIONAL STATE,1
RU,CONGENITAL PNEUMONIA,1
RU,CORONARY ARTERIAL STENT INSERTION,1
RU,CORONARY ARTERY BYPASS,1
RU,CORONARY ARTERY DISEASE,1
RU,CREATININE RENAL CLEARANCE DECREASED,1
RU,CYANOSIS,1
RU,DEEP VEIN THROMBOSIS,1
RU,DEMYELINATING POLYNEUROPATHY,1
RU,DEPRESSION,1
RU,DERMATITIS,1
RU,DEVICE OCCLUSION,1
RU,DIABETIC METABOLIC DECOMPENSATION,1
RU,DISEASE PROGRESSION,1
RU,DISTURBANCE IN ATTENTION,1
RU,DRUG DEPENDENCE,1
RU,DRUG DOSE OMISSION,1
RU,DRUG PRESCRIBING ERROR,1
RU,DUODENAL ULCER,1
RU,DYSLIPIDAEMIA,1
RU,DYSPNOEA EXERTIONAL,1
RU,ECCHYMOSIS,1
RU,ECZEMA,1
RU,ELECTROCARDIOGRAM QT PROLONGED,1
RU,EROSIVE OESOPHAGITIS,1
RU,ERYSIPELAS,1
RU,EXPOSURE DURING PREGNANCY,1
RU,EYE HAEMORRHAGE,1
RU,FAECES DISCOLOURED,1
RU,FATIGUE,1
RU,FLUSHING,1
RU,GASTRIC HAEMORRHAGE,1
RU,GASTRIC POLYPS,1
RU,GASTRIC ULCER,1
RU,GASTRITIS,1
RU,GASTROOESOPHAGEAL REFLUX DISEASE,1
RU,GINGIVAL OEDEMA,1
RU,GLAUCOMA,1
RU,GLOMERULAR FILTRATION RATE DECREASED,1
RU,HAEMATOCHEZIA,1
RU,HAEMODYNAMIC INSTABILITY,1
RU,HAEMORRHAGE,1
RU,HAEMORRHAGE INTRACRANIAL,1
RU,HAEMORRHAGE SUBCUTANEOUS,1
RU,HAEMORRHAGIC ANAEMIA,1
RU,HAEMORRHOIDAL HAEMORRHAGE,1
RU,HALLUCINATION,1
RU,HEART DISEASE CONGENITAL,1
RU,HEMIPARESIS,1
RU,HEMIPLEGIA,1
RU,HEPATIC FUNCTION ABNORMAL,1
RU,HEPATIC NEOPLASM,1
RU,HEPATIC STEATOSIS,1
RU,HERPES DERMATITIS,1
RU,HERPES VIRUS INFECTION,1
RU,HIATUS HERNIA,1
RU,HYDROCEPHALUS,1
RU,HYPERBILIRUBINAEMIA NEONATAL,1
RU,HYPERCHOLESTEROLAEMIA,1
RU,HYPERHOMOCYSTEINAEMIA,1
RU,HYPERTENSIVE CRISIS,1
RU,HYPERTENSIVE HEART DISEASE,1
RU,HYPERTROPHIC CARDIOMYOPATHY,1
RU,HYPOACUSIS,1
RU,HYPOTENSION,1
RU,HYPOTHYROIDISM,1
RU,IMPAIRED HEALING,1
RU,IMPAIRED SELF-CARE,1
RU,INCORRECT DRUG ADMINISTRATION DURATION,1
RU,INFARCTION,1
RU,INTENTIONAL OVERDOSE,1
RU,INTERVERTEBRAL DISC PROTRUSION,1
RU,JOINT NEOPLASM,1
RU,LEUKODYSTROPHY,1
RU,LIP NEOPLASM,1
RU,LOSS OF CONSCIOUSNESS,1
RU,LOW DENSITY LIPOPROTEIN INCREASED,1
RU,LUNG INFILTRATION,1
RU,MALAISE,1
RU,MALLORY-WEISS SYNDROME,1
RU,MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
RU,MESENTERIC ARTERY THROMBOSIS,1
RU,METRORRHAGIA,1
RU,MUSCLE SPASMS,1
RU,NASOPHARYNGITIS,1
RU,NEONATAL ASPHYXIA,1
RU,NEPHROLITHIASIS,1
RU,NEPHROPATHY TOXIC,1
RU,NERVE CONDUCTION STUDIES ABNORMAL,1
RU,NERVOUS SYSTEM DISORDER,1
RU,NEUROLOGIC NEGLECT SYNDROME,1
RU,OESOPHAGITIS,1
RU,OXYGEN SATURATION DECREASED,1
RU,PARAESTHESIA,1
RU,PAROXYSMAL ARRHYTHMIA,1
RU,PEPTIC ULCER,1
RU,PERCUTANEOUS CORONARY INTERVENTION,1
RU,PERIPHERAL COLDNESS,1
RU,PERIPHERAL SWELLING,1
RU,PHARYNGEAL ERYTHEMA,1
RU,PLATELET AGGREGATION INCREASED,1
RU,POST PROCEDURAL HAEMORRHAGE,1
RU,PRE-EXISTING CONDITION IMPROVED,1
RU,PREMATURE BABY,1
RU,PREMATURE DELIVERY,1
RU,PROCEDURAL COMPLICATION,1
RU,PRODUCT SOLUBILITY ABNORMAL,1
RU,PSYCHOMOTOR HYPERACTIVITY,1
RU,PULMONARY ARTERIAL HYPERTENSION,1
RU,PULMONARY EMBOLISM,1
RU,PURPURA,1
RU,RALES,1
RU,RASH,1
RU,RENAL FAILURE,1
RU,RENAL PAIN,1
RU,RENAL SURGERY,1
RU,RESPIRATORY ARREST,1
RU,RESPIRATORY DISORDER,1
RU,RESPIRATORY FAILURE,1
RU,RESPIRATORY TRACT INFECTION,1
RU,RESPIRATORY TRACT INFECTION VIRAL,1
RU,RETINAL DEGENERATION,1
RU,RETINAL VASCULAR THROMBOSIS,1
RU,RETINOPATHY,1
RU,RHINITIS,1
RU,RHINORRHOEA,1
RU,SCIATICA,1
RU,SCROTAL SWELLING,1
RU,SENSORY DISTURBANCE,1
RU,SEPSIS,1
RU,SHOCK HAEMORRHAGIC,1
RU,SKIN NECROSIS,1
RU,SPINAL CORD NEOPLASM,1
RU,SPINAL OSTEOARTHRITIS,1
RU,SPUTUM ABNORMAL,1
RU,STENT PLACEMENT,1
RU,STRESS,1
RU,THERAPEUTIC RESPONSE DECREASED,1
RU,THERAPEUTIC RESPONSE UNEXPECTED,1
RU,THERAPY CESSATION,1
RU,TINNITUS,1
RU,TOOTH LOSS,1
RU,TYPE I HYPERSENSITIVITY,1
RU,UNRESPONSIVE TO STIMULI,1
RU,VAGINAL HAEMATOMA,1
RU,VAGINAL HAEMORRHAGE,1
RU,VASCULAR STENT STENOSIS,1
RU,VASCULITIS,1
RU,VENTRICULAR EXTRASYSTOLES,1
RU,VERTIGO,1
RU,VISUAL ACUITY REDUCED,1
RU,VISUAL IMPAIRMENT,1
RU,WALKING DISTANCE TEST ABNORMAL,1
RU,WHEEZING,1
RU,WITHDRAWAL SYNDROME,1
SA,ANAEMIA,2
SA,CARDIAC FAILURE CONGESTIVE,2
SA,CORONARY REVASCULARISATION,2
SA,DYSPNOEA,2
SA,FATIGUE,2
SA,JAUNDICE,2
SA,RENAL IMPAIRMENT,2
SA,BLOOD GLUCOSE DECREASED,1
SA,BLOOD PRESSURE SYSTOLIC DECREASED,1
SA,CARDIAC DISORDER,1
SA,CHEST PAIN,1
SA,DEATH,1
SA,DEPRESSED LEVEL OF CONSCIOUSNESS,1
SA,DISORIENTATION,1
SA,DRUG INEFFECTIVE,1
SA,ENCEPHALOPATHY,1
SA,HYPERKALAEMIA,1
SA,ISCHAEMIC CEREBRAL INFARCTION,1
SA,MEDIASTINAL HAEMORRHAGE,1
SA,OEDEMA,1
SA,OXYGEN SATURATION DECREASED,1
SA,PRURITUS GENERALISED,1
SA,RENAL FAILURE,1
SA,SPINAL OSTEOARTHRITIS,1
RS,APHASIA,4
RS,HAEMATEMESIS,4
RS,ABDOMINAL WALL HAEMATOMA,3
RS,DISORIENTATION,3
RS,GASTROINTESTINAL HAEMORRHAGE,3
RS,HAEMOGLOBIN DECREASED,3
RS,HAEMORRHAGE INTRACRANIAL,3
RS,HEMIPLEGIA,3
RS,INTRAVENTRICULAR HAEMORRHAGE,3
RS,MUSCULAR WEAKNESS,3
RS,MYOCARDIAL INFARCTION,3
RS,ARTERIAL HAEMORRHAGE,2
RS,CARDIAC FAILURE,2
RS,CEREBRAL HAEMORRHAGE,2
RS,MELAENA,2
RS,PYREXIA,2
RS,ABDOMINAL MASS,1
RS,ABDOMINAL PAIN,1
RS,ACUTE MYOCARDIAL INFARCTION,1
RS,ANAEMIA,1
RS,ANGINA PECTORIS,1
RS,ARRHYTHMIA,1
RS,ARTERIAL INJURY,1
RS,BLOOD CREATININE INCREASED,1
RS,BLOOD DISORDER,1
RS,BLOOD PRESSURE DECREASED,1
RS,CARDIOGENIC SHOCK,1
RS,COMA,1
RS,CORONARY ARTERY THROMBOSIS,1
RS,CYANOSIS,1
RS,DELIRIUM,1
RS,DRUG INEFFECTIVE,1
RS,DRUG WITHDRAWAL SYNDROME,1
RS,DUODENAL ULCER,1
RS,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
RS,ELECTROCARDIOGRAM T WAVE INVERSION,1
RS,ERYTHEMA MULTIFORME,1
RS,FAECES DISCOLOURED,1
RS,GASTRIC ULCER,1
RS,GASTRITIS EROSIVE,1
RS,GLOMERULAR FILTRATION RATE DECREASED,1
RS,HAEMODYNAMIC INSTABILITY,1
RS,HAEMORRHAGE,1
RS,HEPATIC HAEMORRHAGE,1
RS,IMMUNE THROMBOCYTOPENIC PURPURA,1
RS,INTESTINAL ISCHAEMIA,1
RS,ISCHAEMIC STROKE,1
RS,LEFT VENTRICULAR HYPERTROPHY,1
RS,MALAISE,1
RS,METABOLIC ACIDOSIS,1
RS,NEPHROPATHY TOXIC,1
RS,NEUTROPENIA,1
RS,PARESIS,1
RS,PRURITUS,1
RS,RASH,1
RS,RENAL DISORDER,1
RS,RENAL FAILURE CHRONIC,1
RS,THROMBOSIS IN DEVICE,1
RS,VASCULAR STENT THROMBOSIS,1
RS,WITHDRAWAL SYNDROME,1
SG,ACUTE MYOCARDIAL INFARCTION,4
SG,SPINAL EPIDURAL HAEMATOMA,4
SG,CONSTIPATION,3
SG,UPPER RESPIRATORY TRACT INFECTION,3
SG,VASCULAR STENT THROMBOSIS,3
SG,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
SG,ANAEMIA,2
SG,CARDIAC FAILURE CONGESTIVE,2
SG,DIZZINESS,2
SG,EYE SWELLING,2
SG,GASTROINTESTINAL ULCER HAEMORRHAGE,2
SG,HAEMATEMESIS,2
SG,HAEMORRHAGE,2
SG,HAEMORRHAGE INTRACRANIAL,2
SG,HIATUS HERNIA,2
SG,ISCHAEMIC STROKE,2
SG,MALLORY-WEISS SYNDROME,2
SG,MYOCARDIAL INFARCTION,2
SG,MYOCARDIAL ISCHAEMIA,2
SG,ACUTE KIDNEY INJURY,1
SG,ACUTE STRESS DISORDER,1
SG,ANGINA PECTORIS,1
SG,ANGINA UNSTABLE,1
SG,ANGIOEDEMA,1
SG,ASTHENIA,1
SG,BACK PAIN,1
SG,BLEEDING TIME PROLONGED,1
SG,BRAIN CONTUSION,1
SG,CARDIAC ARREST,1
SG,CARDIAC DISORDER,1
SG,CAROTID ARTERIAL EMBOLUS,1
SG,CAROTID ARTERY OCCLUSION,1
SG,CEREBRAL INFARCTION,1
SG,CORONARY ARTERY DISEASE,1
SG,DEATH,1
SG,DERMATITIS EXFOLIATIVE,1
SG,DERMATITIS EXFOLIATIVE GENERALISED,1
SG,DRUG INEFFECTIVE,1
SG,DRUG INTOLERANCE,1
SG,DYSHIDROTIC ECZEMA,1
SG,DYSPEPSIA,1
SG,DYSPNOEA,1
SG,ECCHYMOSIS,1
SG,ECZEMA ASTEATOTIC,1
SG,EMBOLIC CEREBRAL INFARCTION,1
SG,FAECES DISCOLOURED,1
SG,FALL,1
SG,GASTRIC ULCER,1
SG,GASTROINTESTINAL HAEMORRHAGE,1
SG,GENERAL PHYSICAL HEALTH DETERIORATION,1
SG,GENERALISED OEDEMA,1
SG,HAEMODYNAMIC INSTABILITY,1
SG,HAEMOGLOBIN DECREASED,1
SG,HAEMOPTYSIS,1
SG,HERPES ZOSTER MENINGOMYELITIS,1
SG,HYPOAESTHESIA,1
SG,HYPONATRAEMIA,1
SG,HYPOTENSION,1
SG,INTENTIONAL PRODUCT MISUSE,1
SG,LACERATION,1
SG,LIP SWELLING,1
SG,MALAISE,1
SG,MENTAL STATUS CHANGES,1
SG,MUSCULAR WEAKNESS,1
SG,NERVE COMPRESSION,1
SG,ORAL PAIN,1
SG,ORTHOSTATIC HYPOTENSION,1
SG,OSTEOARTHRITIS,1
SG,PANCREATIC CARCINOMA,1
SG,PANCREATITIS,1
SG,PANCREATITIS ACUTE,1
SG,PERIORBITAL OEDEMA,1
SG,PRURITUS,1
SG,PULMONARY OEDEMA,1
SG,RASH,1
SG,RASH MACULO-PAPULAR,1
SG,RENAL FAILURE,1
SG,SEPSIS,1
SG,SKULL FRACTURED BASE,1
SG,SPINAL CORD COMPRESSION,1
SG,SUPRAVENTRICULAR TACHYCARDIA,1
SG,THROMBOCYTOPENIA,1
SG,THROMBOSIS IN DEVICE,1
SG,UPPER GASTROINTESTINAL HAEMORRHAGE,1
SG,URINARY RETENTION,1
SG,VENTRICULAR FIBRILLATION,1
SG,VENTRICULAR TACHYCARDIA,1
SK,KIDNEY RUPTURE,11
SK,RETROPERITONEAL HAEMORRHAGE,11
SK,DYSPNOEA,5
SK,ACUTE KIDNEY INJURY,3
SK,ANAEMIA,3
SK,HAEMOGLOBIN DECREASED,3
SK,HYPOTENSION,3
SK,LACTIC ACIDOSIS,3
SK,PAIN,3
SK,RHABDOMYOLYSIS,3
SK,VASCULAR STENT THROMBOSIS,3
SK,ACUTE MYOCARDIAL INFARCTION,2
SK,ASTHENIA,2
SK,COMA,2
SK,DIVERTICULUM INTESTINAL,2
SK,HAEMATOMA,2
SK,MYOCARDIAL INFARCTION,2
SK,NODAL RHYTHM,2
SK,RASH,2
SK,SHOCK HAEMORRHAGIC,2
SK,SOMNOLENCE,2
SK,TOXIC SKIN ERUPTION,2
SK,TRANSIENT ISCHAEMIC ATTACK,2
SK,VOMITING,2
SK,ABDOMINAL WALL HAEMATOMA,1
SK,ANAEMIA MACROCYTIC,1
SK,ANGINA PECTORIS,1
SK,ANGIOEDEMA,1
SK,APNOEA,1
SK,ATRIAL FIBRILLATION,1
SK,ATRIAL THROMBOSIS,1
SK,BACK PAIN,1
SK,BACTERIAL TEST POSITIVE,1
SK,BLADDER TAMPONADE,1
SK,BLOOD CREATININE INCREASED,1
SK,BRONCHITIS,1
SK,CARDIOGENIC SHOCK,1
SK,CARDIOPULMONARY FAILURE,1
SK,CARDIOTOXICITY,1
SK,CHEST PAIN,1
SK,CHRONIC GASTRITIS,1
SK,CHRONIC KIDNEY DISEASE,1
SK,CONDITION AGGRAVATED,1
SK,CORONARY ARTERY STENOSIS,1
SK,CYSTITIS,1
SK,DECREASED APPETITE,1
SK,DEHYDRATION,1
SK,DEPRESSION,1
SK,DERMATOMYOSITIS,1
SK,DRUG ADMINISTRATION ERROR,1
SK,DRUG DISPENSING ERROR,1
SK,DRUG INEFFECTIVE,1
SK,DRUG RESISTANCE,1
SK,DUODENITIS,1
SK,ENDOPHTHALMITIS,1
SK,EYE OEDEMA,1
SK,EYELID OEDEMA,1
SK,FALL,1
SK,FATIGUE,1
SK,FOLATE DEFICIENCY,1
SK,GAIT INABILITY,1
SK,GASTROINTESTINAL ANGIODYSPLASIA,1
SK,GASTROINTESTINAL HAEMORRHAGE,1
SK,GENERAL PHYSICAL HEALTH DETERIORATION,1
SK,GOUT,1
SK,HAEMARTHROSIS,1
SK,HAEMORRHAGE,1
SK,HYPERKALAEMIA,1
SK,HYPERSENSITIVITY,1
SK,HYPERTENSION,1
SK,HYPOPHAGIA,1
SK,HYPOTHYROIDISM,1
SK,INTESTINAL HAEMORRHAGE,1
SK,ISCHAEMIC STROKE,1
SK,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
SK,LOWER RESPIRATORY TRACT INFECTION,1
SK,MACULAR PIGMENTATION,1
SK,MELAENA,1
SK,METABOLIC ACIDOSIS,1
SK,MITRAL VALVE INCOMPETENCE,1
SK,MYALGIA,1
SK,MYOPATHY,1
SK,NAUSEA,1
SK,NEUTROPENIA,1
SK,PARAPLEGIA,1
SK,PIGMENTATION DISORDER,1
SK,PLEURAL EFFUSION,1
SK,PRODUCT USE ISSUE,1
SK,PURPURA,1
SK,QUADRIPLEGIA,1
SK,RENAL IMPAIRMENT,1
SK,RESPIRATORY FAILURE,1
SK,SINUS BRADYCARDIA,1
SK,SKIN LESION,1
SK,SKIN NECROSIS,1
SK,SPINAL CORD COMPRESSION,1
SK,SPINAL CORD HAEMATOMA,1
SK,SUBDURAL HAEMATOMA,1
SK,SUBDURAL HAEMORRHAGE,1
SK,SUDDEN CARDIAC DEATH,1
SK,SYNOVIAL CYST,1
SK,THROMBOCYTOPENIA,1
SK,THROMBOSIS IN DEVICE,1
SK,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
SK,URINARY BLADDER RUPTURE,1
SK,URINARY INCONTINENCE,1
SK,VENOUS THROMBOSIS,1
SK,VERTIGO,1
SK,VITREOUS HAEMORRHAGE,1
SI,PULMONARY HAEMATOMA,9
SI,DRUG ADMINISTRATION ERROR,6
SI,HAEMATURIA,6
SI,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,6
SI,RESPIRATORY FAILURE,5
SI,ASTHENIA,4
SI,BRADYCARDIA,4
SI,DYSPNOEA,4
SI,NORMOCYTIC ANAEMIA,4
SI,OCCULT BLOOD POSITIVE,4
SI,SERUM FERRITIN DECREASED,4
SI,ACUTE MYOCARDIAL INFARCTION,3
SI,ANGINA UNSTABLE,3
SI,BLOOD IRON DECREASED,3
SI,CHEST PAIN,3
SI,CORONARY ARTERY DISEASE,3
SI,GINGIVAL ABSCESS,3
SI,HAEMOGLOBIN DECREASED,3
SI,MEDICAL DEVICE SITE HAEMORRHAGE,3
SI,SYNCOPE,3
SI,VENTRICULAR ASYSTOLE,3
SI,ADHESION,2
SI,ANURIA,2
SI,CHOLECYSTITIS ACUTE,2
SI,CORONARY ARTERY RESTENOSIS,2
SI,GALLBLADDER EMPYEMA,2
SI,HAEMATOMA INFECTION,2
SI,HAEMORRHAGE SUBCUTANEOUS,2
SI,INFECTION,2
SI,LUNG INFECTION,2
SI,MYOCARDIAL INFARCTION,2
SI,PERITONITIS,2
SI,PROSTATOMEGALY,2
SI,SEPSIS,2
SI,URINARY RETENTION,2
SI,ABDOMINAL PAIN,1
SI,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
SI,ACUTE RESPIRATORY DISTRESS SYNDROME,1
SI,AGRANULOCYTOSIS,1
SI,ALTERED STATE OF CONSCIOUSNESS,1
SI,ANGINA PECTORIS,1
SI,ANGIOEDEMA,1
SI,AORTIC ANEURYSM,1
SI,ASPHYXIA,1
SI,ASPIRATION,1
SI,BLADDER CANCER RECURRENT,1
SI,BLOOD CREATININE INCREASED,1
SI,BLOOD GLUCOSE FLUCTUATION,1
SI,BLOOD PARATHYROID HORMONE INCREASED,1
SI,C-REACTIVE PROTEIN INCREASED,1
SI,CARDIAC ARREST,1
SI,CATHETER SITE INFECTION,1
SI,CHEST X-RAY ABNORMAL,1
SI,CHRONIC GASTRITIS,1
SI,COLORECTAL CANCER,1
SI,COMPUTERISED TOMOGRAM ABNORMAL,1
SI,CORONARY ARTERY STENOSIS,1
SI,DEATH,1
SI,DIABETIC NEPHROPATHY,1
SI,FLATULENCE,1
SI,HOSPITALISATION,1
SI,HYPERKALAEMIA,1
SI,HYPOKALAEMIA,1
SI,HYPOTENSION,1
SI,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
SI,MUSCULOSKELETAL CHEST PAIN,1
SI,PAIN IN EXTREMITY,1
SI,PALPITATIONS,1
SI,PYREXIA,1
SI,RENAL FAILURE,1
SI,STAPHYLOCOCCAL SEPSIS,1
SI,STATUS EPILEPTICUS,1
SI,TACHYCARDIA,1
SI,TINNITUS,1
SI,URTICARIA,1
SI,VERTIGO,1
ZA,MALAISE,3
ZA,ACUTE MYOCARDIAL INFARCTION,2
ZA,ANAEMIA,2
ZA,CARDIAC FAILURE,2
ZA,DEATH,2
ZA,DYSPNOEA,2
ZA,MUSCULAR WEAKNESS,2
ZA,MYOCARDIAL INFARCTION,2
ZA,PYREXIA,2
ZA,RASH,2
ZA,STENT PLACEMENT,2
ZA,SYNCOPE,2
ZA,A VERY LOCAL CANCER_ BECAME RED AND MOVED ALONG THE SURFACE OF THE SKIN,1
ZA,ANGINA UNSTABLE,1
ZA,ARTERIAL OCCLUSIVE DISEASE,1
ZA,ARTHRALGIA,1
ZA,ASTHENIA,1
ZA,ATYPICAL PNEUMONIA,1
ZA,BLOOD GLUCOSE INCREASED,1
ZA,BLOOD PRESSURE DECREASED,1
ZA,BRADYCARDIA,1
ZA,C-REACTIVE PROTEIN INCREASED,1
ZA,CEREBROVASCULAR ACCIDENT,1
ZA,CHEST DISCOMFORT,1
ZA,CONFUSIONAL STATE,1
ZA,CONTUSION,1
ZA,CORONARY ARTERIAL STENT INSERTION,1
ZA,CORONARY ARTERY DISEASE,1
ZA,CORONARY ARTERY OCCLUSION,1
ZA,COUGH,1
ZA,CSF PRESSURE INCREASED,1
ZA,DISORIENTATION,1
ZA,DRUG ADMINISTRATION ERROR,1
ZA,DRUG DISPENSING ERROR,1
ZA,DRUG INEFFECTIVE,1
ZA,FATIGUE,1
ZA,FEELING ABNORMAL,1
ZA,FOOT AMPUTATION,1
ZA,GASTROINTESTINAL HAEMORRHAGE,1
ZA,HAEMORRHAGE,1
ZA,HEPATIC FAILURE,1
ZA,HEPATITIS,1
ZA,HOSPITALISATION,1
ZA,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
ZA,INFLAMMATION,1
ZA,INSOMNIA,1
ZA,JAUNDICE,1
ZA,JAUNDICE HEPATOCELLULAR,1
ZA,KOUNIS SYNDROME,1
ZA,LOSS OF CONSCIOUSNESS,1
ZA,MUSCLE TWITCHING,1
ZA,OESOPHAGITIS,1
ZA,OPTIC ISCHAEMIC NEUROPATHY,1
ZA,OPTIC NEURITIS,1
ZA,PAIN IN EXTREMITY,1
ZA,PAPILLOEDEMA,1
ZA,PITUITARY TUMOUR,1
ZA,PLEURAL EFFUSION,1
ZA,PROSTATOMEGALY,1
ZA,PULMONARY OEDEMA,1
ZA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
ZA,RENAL FAILURE,1
ZA,RENAL IMPAIRMENT,1
ZA,SEPSIS,1
ZA,VENTRICULAR TACHYCARDIA,1
ZA,VISUAL ACUITY REDUCED,1
ZA,VITREOUS FLOATERS,1
ZA,WEIGHT DECREASED,1
ZA,WRONG DRUG ADMINISTERED,1
ES,DRUG INEFFECTIVE,34
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,20
ES,VASCULAR STENT THROMBOSIS,20
ES,ANAEMIA,17
ES,DYSPNOEA,16
ES,CHEST PAIN,15
ES,RENAL FAILURE ACUTE,15
ES,ACUTE MYOCARDIAL INFARCTION,14
ES,SYNCOPE,14
ES,DIARRHOEA,13
ES,ACUTE KIDNEY INJURY,12
ES,ANGINA PECTORIS,12
ES,ASTHENIA,12
ES,HAEMORRHAGE INTRACRANIAL,12
ES,HYPERTENSION,12
ES,CEREBRAL HAEMORRHAGE,11
ES,DRUG RESISTANCE,11
ES,DIZZINESS,10
ES,HAEMATURIA,10
ES,HYPOTENSION,10
ES,APHASIA,9
ES,CONDITION AGGRAVATED,9
ES,EPISTAXIS,9
ES,HAEMATOMA,9
ES,HEMIPARESIS,9
ES,ATRIOVENTRICULAR BLOCK COMPLETE,8
ES,FALL,8
ES,HEPATITIS CHOLESTATIC,8
ES,LOWER GASTROINTESTINAL HAEMORRHAGE,8
ES,NEUTROPENIA,8
ES,PLEURAL EFFUSION,8
ES,VENTRICULAR FIBRILLATION,8
ES,ACUTE CORONARY SYNDROME,7
ES,ATRIAL FIBRILLATION,7
ES,DYSPHAGIA,7
ES,FATIGUE,7
ES,HYPOGLYCAEMIA,7
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,7
ES,ISCHAEMIC STROKE,7
ES,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,7
ES,PNEUMONIA,7
ES,PYREXIA,7
ES,THROMBOSIS IN DEVICE,7
ES,ABDOMINAL PAIN,6
ES,CHOLELITHIASIS,6
ES,DECREASED APPETITE,6
ES,DYSARTHRIA,6
ES,GASTROINTESTINAL HAEMORRHAGE,6
ES,HAEMATEMESIS,6
ES,HEADACHE,6
ES,HYPERGLYCAEMIA,6
ES,HYPOCOAGULABLE STATE,6
ES,HYPONATRAEMIA,6
ES,MYOCARDIAL INFARCTION,6
ES,OEDEMA PERIPHERAL,6
ES,THROMBOCYTOPENIA,6
ES,WEIGHT DECREASED,6
ES,ABDOMINAL DISTENSION,5
ES,BRADYCARDIA,5
ES,CARDIAC ARREST,5
ES,CARDIAC FAILURE CONGESTIVE,5
ES,CONFUSIONAL STATE,5
ES,DISORIENTATION,5
ES,ENCEPHALOPATHY,5
ES,GAIT DISTURBANCE,5
ES,GASTRIC ULCER,5
ES,HALLUCINATION_ VISUAL,5
ES,HYPERKALAEMIA,5
ES,MEDICATION ERROR,5
ES,NAUSEA,5
ES,PAIN,5
ES,RENAL FAILURE,5
ES,SUBDURAL HAEMATOMA,5
ES,TOXICITY TO VARIOUS AGENTS,5
ES,AGITATION,4
ES,AGRANULOCYTOSIS,4
ES,CARDIAC DISORDER,4
ES,CARDIAC FAILURE,4
ES,CEREBROVASCULAR ACCIDENT,4
ES,CHOROIDAL HAEMORRHAGE,4
ES,COUGH,4
ES,DEATH,4
ES,DRUG EFFECT INCOMPLETE,4
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
ES,DYSPEPSIA,4
ES,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,4
ES,EMBOLISM,4
ES,EXTRASYSTOLES,4
ES,HAEMOPTYSIS,4
ES,HAEMOTHORAX,4
ES,HEPATITIS,4
ES,INSOMNIA,4
ES,IRON DEFICIENCY ANAEMIA,4
ES,LACUNAR STROKE,4
ES,LOSS OF CONSCIOUSNESS,4
ES,METABOLIC ACIDOSIS,4
ES,PARAESTHESIA,4
ES,PRURITUS GENERALISED,4
ES,RHABDOMYOLYSIS,4
ES,SEIZURE,4
ES,SEPSIS,4
ES,SEPTIC SHOCK,4
ES,SPRUE-LIKE ENTEROPATHY,4
ES,SUBARACHNOID HAEMORRHAGE,4
ES,TORSADE DE POINTES,4
ES,VENTRICULAR TACHYCARDIA,4
ES,VOMITING,4
ES,ACUTE PULMONARY OEDEMA,3
ES,ADENOCARCINOMA OF COLON,3
ES,ADRENAL INSUFFICIENCY,3
ES,ATAXIA,3
ES,ATRIAL THROMBOSIS,3
ES,BACK PAIN,3
ES,CARDIAC FAILURE ACUTE,3
ES,CARDIAC TAMPONADE,3
ES,CEREBRAL HAEMATOMA,3
ES,CHOLECYSTITIS,3
ES,CHRONIC KIDNEY DISEASE,3
ES,COLITIS,3
ES,CORONARY ARTERY DISEASE,3
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,3
ES,DEPRESSION,3
ES,DISCOMFORT,3
ES,DRUG ADMINISTRATION ERROR,3
ES,DUODENAL ULCER HAEMORRHAGE,3
ES,FEBRILE NEUTROPENIA,3
ES,GASTRODUODENAL HAEMORRHAGE,3
ES,HAEMORRHAGE,3
ES,HYPOAESTHESIA,3
ES,INCORRECT DOSE ADMINISTERED,3
ES,INTRAVENTRICULAR HAEMORRHAGE,3
ES,NEPHROLITHIASIS,3
ES,PERIPHERAL ISCHAEMIA,3
ES,PULMONARY EMBOLISM,3
ES,PULMONARY HAEMORRHAGE,3
ES,RESPIRATORY FAILURE,3
ES,RESPIRATORY TRACT INFECTION,3
ES,RETROPERITONEAL HAEMATOMA,3
ES,SINUS BRADYCARDIA,3
ES,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,3
ES,TACHYCARDIA,3
ES,THROMBOSIS,3
ES,WEIGHT INCREASED,3
ES,ACUTE RESPIRATORY FAILURE,2
ES,AGGRESSION,2
ES,AMPUTATION,2
ES,ANGINA UNSTABLE,2
ES,ANGIOEDEMA,2
ES,ANGIOPATHY,2
ES,ANXIETY,2
ES,ARRHYTHMIA,2
ES,ARTERIOSCLEROSIS,2
ES,ARTHRALGIA,2
ES,ASCITES,2
ES,ASPARTATE AMINOTRANSFERASE INCREASED,2
ES,AUTOIMMUNE COLITIS,2
ES,BALANCE DISORDER,2
ES,BLOOD CREATININE INCREASED,2
ES,BLOOD GLUCOSE INCREASED,2
ES,BLOOD TRIGLYCERIDES INCREASED,2
ES,CARDIAC PACEMAKER INSERTION,2
ES,CARDIOGENIC SHOCK,2
ES,CEREBRAL INFARCTION,2
ES,CHOLESTASIS,2
ES,CONCOMITANT DISEASE PROGRESSION,2
ES,CONDUCT DISORDER,2
ES,CONSTIPATION,2
ES,CONTRAINDICATED PRODUCT ADMINISTERED,2
ES,CORONARY ARTERY OCCLUSION,2
ES,CRANIOCEREBRAL INJURY,2
ES,DEAFNESS,2
ES,DEHYDRATION,2
ES,DIABETES MELLITUS INADEQUATE CONTROL,2
ES,DISEASE RECURRENCE,2
ES,DRUG HYPERSENSITIVITY,2
ES,DUODENITIS,2
ES,DYSLIPIDAEMIA,2
ES,EJECTION FRACTION DECREASED,2
ES,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,2
ES,FEELING ABNORMAL,2
ES,FISTULA DISCHARGE,2
ES,FOLLICULITIS,2
ES,GASTRIC DISORDER,2
ES,GASTRIC POLYPS,2
ES,HAEMATOCRIT DECREASED,2
ES,HAEMODYNAMIC INSTABILITY,2
ES,HALLUCINATION,2
ES,HEMIPLEGIA,2
ES,HERPES ZOSTER,2
ES,HYPERHIDROSIS,2
ES,HYPERSENSITIVITY,2
ES,HYPERTHYROIDISM,2
ES,HYPOVOLAEMIC SHOCK,2
ES,INFLUENZA,2
ES,INTERNAL HAEMORRHAGE,2
ES,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,2
ES,LACUNAR INFARCTION,2
ES,LEFT ATRIAL DILATATION,2
ES,LUNG INFILTRATION,2
ES,MALAISE,2
ES,MALLORY-WEISS SYNDROME,2
ES,MICROANGIOPATHY,2
ES,MITRAL VALVE INCOMPETENCE,2
ES,MOBILITY DECREASED,2
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
ES,MUSCULOSKELETAL PAIN,2
ES,NECK PAIN,2
ES,NEOPLASM,2
ES,NERVOUSNESS,2
ES,NEUROTOXICITY,2
ES,NODAL ARRHYTHMIA,2
ES,OCULAR ICTERUS,2
ES,OVERDOSE,2
ES,PALPITATIONS,2
ES,PARESIS,2
ES,PARKINSONISM,2
ES,PEMPHIGOID,2
ES,PERICARDIAL HAEMORRHAGE,2
ES,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
ES,PHOTOPSIA,2
ES,PITUITARY HAEMORRHAGE,2
ES,PNEUMONIA ASPIRATION,2
ES,PNEUMONITIS,2
ES,POLYURIA,2
ES,PSYCHOMOTOR HYPERACTIVITY,2
ES,RASH,2
ES,RENAL CYST,2
ES,RETINAL DETACHMENT,2
ES,SOMNOLENCE,2
ES,SPEECH DISORDER,2
ES,SUBDURAL HAEMORRHAGE,2
ES,SUDDEN DEATH,2
ES,SUICIDAL IDEATION,2
ES,SUPRAVENTRICULAR EXTRASYSTOLES,2
ES,SWOLLEN TONGUE,2
ES,THYROIDITIS,2
ES,TRANSIENT ISCHAEMIC ATTACK,2
ES,TREMOR,2
ES,TRICUSPID VALVE INCOMPETENCE,2
ES,TYPE 2 DIABETES MELLITUS,2
ES,URINARY HESITATION,2
ES,URINARY TRACT INFECTION,2
ES,VENTRICULAR EXTRASYSTOLES,2
ES,VENTRICULAR HYPERTROPHY,2
ES,VENTRICULAR HYPOKINESIA,2
ES,ABDOMINAL WALL HAEMATOMA,1
ES,ABNORMAL BEHAVIOUR,1
ES,ABSCESS,1
ES,ABSCESS JAW,1
ES,ACCIDENTAL OVERDOSE,1
ES,ACUTE MONOCYTIC LEUKAEMIA,1
ES,ACUTE MYELOID LEUKAEMIA,1
ES,ADRENAL HAEMORRHAGE,1
ES,ADRENAL MASS,1
ES,ALANINE AMINOTRANSFERASE INCREASED,1
ES,ALTERED STATE OF CONSCIOUSNESS,1
ES,AMNESIA,1
ES,AMYLOID RELATED IMAGING ABNORMALITIES,1
ES,ANAL FISTULA,1
ES,ANAPHYLACTIC REACTION,1
ES,ANEURYSM,1
ES,ANGLE CLOSURE GLAUCOMA,1
ES,AORTIC ANEURYSM,1
ES,ARTHROPATHY,1
ES,ASPIRATION BRONCHIAL,1
ES,ASTHMA,1
ES,ATRIOVENTRICULAR BLOCK,1
ES,AUTOIMMUNE THROMBOCYTOPENIA,1
ES,BACTERAEMIA,1
ES,BASAL GANGLIA HAEMORRHAGE,1
ES,BASILAR ARTERY STENOSIS,1
ES,BILIARY COLIC,1
ES,BILIARY FISTULA,1
ES,BILIRUBIN CONJUGATED INCREASED,1
ES,BIOPSY LIVER ABNORMAL,1
ES,BLADDER DYSFUNCTION,1
ES,BLINDNESS,1
ES,BLINDNESS UNILATERAL,1
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ES,BLOOD BILIRUBIN INCREASED,1
ES,BLOOD CALCIUM INCREASED,1
ES,BLOOD CHOLESTEROL ABNORMAL,1
ES,BLOOD CHOLESTEROL INCREASED,1
ES,BLOOD DISORDER,1
ES,BLOOD GLUCOSE DECREASED,1
ES,BLOOD PRESSURE ABNORMAL,1
ES,BLOOD PRESSURE INCREASED,1
ES,BONE MARROW FAILURE,1
ES,BRADYPHRENIA,1
ES,BRAIN STEM STROKE,1
ES,BRONCHIECTASIS,1
ES,BUNDLE BRANCH BLOCK LEFT,1
ES,CACHEXIA,1
ES,CALCIUM DEFICIENCY,1
ES,CAMPYLOBACTER GASTROENTERITIS,1
ES,CARDIAC ANEURYSM,1
ES,CARDIAC FUNCTION TEST ABNORMAL,1
ES,CARDIAC MURMUR,1
ES,CARDIO-RESPIRATORY ARREST,1
ES,CARDIOMEGALY,1
ES,CAROTID ARTERY OCCLUSION,1
ES,CAROTID ARTERY STENOSIS,1
ES,CAROTID ARTERY THROMBOSIS,1
ES,CATARACT,1
ES,CATARACT OPERATION,1
ES,CATHETER SITE HAEMORRHAGE,1
ES,CEREBRAL AMYLOID ANGIOPATHY,1
ES,CEREBRAL ARTERIOSCLEROSIS,1
ES,CEREBRAL MICROHAEMORRHAGE,1
ES,CEREBROVASCULAR DISORDER,1
ES,CHOLANGITIS,1
ES,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
ES,CIRCULATORY COLLAPSE,1
ES,COAGULOPATHY,1
ES,COGNITIVE DISORDER,1
ES,COLD SWEAT,1
ES,COLITIS ISCHAEMIC,1
ES,COLITIS ULCERATIVE,1
ES,COLON OPERATION,1
ES,COLOSTOMY,1
ES,COMPLICATION OF DEVICE INSERTION,1
ES,CONJUNCTIVAL HAEMORRHAGE,1
ES,CONTRAINDICATED DRUG ADMINISTERED,1
ES,CORONARY ARTERY ANEURYSM,1
ES,CORONARY ARTERY INSUFFICIENCY,1
ES,CORONARY ARTERY RESTENOSIS,1
ES,CORONARY ARTERY STENOSIS,1
ES,CORONARY REVASCULARISATION,1
ES,CRYOGLOBULINAEMIA,1
ES,CYSTATIN C INCREASED,1
ES,CYSTITIS,1
ES,CYTOMEGALOVIRUS INFECTION,1
ES,DEEP VEIN THROMBOSIS,1
ES,DELIRIUM,1
ES,DEPRESSED MOOD,1
ES,DERMATITIS EXFOLIATIVE,1
ES,DEVICE OCCLUSION,1
ES,DIABETIC EYE DISEASE,1
ES,DIABETIC KETOACIDOSIS,1
ES,DIVERTICULUM,1
ES,DRUG DOSE TITRATION NOT PERFORMED,1
ES,DRUG EFFECT DECREASED,1
ES,DRUG ERUPTION,1
ES,DRUG-INDUCED LIVER INJURY,1
ES,DRY MOUTH,1
ES,DYSURIA,1
ES,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
ES,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
ES,ELECTROCARDIOGRAM T WAVE INVERSION,1
ES,ENTEROCUTANEOUS FISTULA,1
ES,EPILEPSY,1
ES,ERYSIPELAS,1
ES,ERYTHEMA INFECTIOSUM,1
ES,ERYTHEMA MULTIFORME,1
ES,EXTENSOR PLANTAR RESPONSE,1
ES,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),1
ES,EYE HAEMORRHAGE,1
ES,FACE INJURY,1
ES,FACE OEDEMA,1
ES,FIXED ERUPTION,1
ES,FLOPPY IRIS SYNDROME,1
ES,FLUID OVERLOAD,1
ES,FLUID RETENTION,1
ES,FREQUENT BOWEL MOVEMENTS,1
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ES,GASTRIC HAEMORRHAGE,1
ES,GASTRIC ULCER HAEMORRHAGE,1
ES,GASTRITIS EROSIVE,1
ES,GASTROENTERITIS,1
ES,GASTROINTESTINAL ULCER HAEMORRHAGE,1
ES,GENERALISED ERYTHEMA,1
ES,GENERALISED TONIC-CLONIC SEIZURE,1
ES,GENITAL CANDIDIASIS,1
ES,GLOSSODYNIA,1
ES,HAEMATOCHEZIA,1
ES,HAEMOGLOBIN DECREASED,1
ES,HAEMORRHAGE CORONARY ARTERY,1
ES,HAEMORRHAGIC ANAEMIA,1
ES,HAEMORRHAGIC EROSIVE GASTRITIS,1
ES,HAEMORRHAGIC STROKE,1
ES,HAEMORRHOIDAL HAEMORRHAGE,1
ES,HEART RATE DECREASED,1
ES,HEMIANOPIA HOMONYMOUS,1
ES,HEPATIC CONGESTION,1
ES,HEPATIC ENCEPHALOPATHY,1
ES,HEPATIC FAILURE,1
ES,HEPATIC FUNCTION ABNORMAL,1
ES,HEPATIC STEATOSIS,1
ES,HEPATITIS ACUTE,1
ES,HEPATITIS TOXIC,1
ES,HYPERBILIRUBINAEMIA,1
ES,HYPERTENSIVE CRISIS,1
ES,HYPERTENSIVE EMERGENCY,1
ES,HYPOALBUMINAEMIA,1
ES,HYPOKALAEMIA,1
ES,HYPOPHAGIA,1
ES,HYPOTONIA,1
ES,HYPOTRICHOSIS,1
ES,HYPOXIA,1
ES,IMMUNE THROMBOCYTOPENIC PURPURA,1
ES,IMPAIRED HEALING,1
ES,IMPLANT SITE PAIN,1
ES,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
ES,INCORRECT DRUG ADMINISTRATION RATE,1
ES,INCORRECT PRODUCT STORAGE,1
ES,INCREASED TENDENCY TO BRUISE,1
ES,INFLAMMATION,1
ES,INJECTION SITE MASS,1
ES,INJECTION SITE PAIN,1
ES,INJURY,1
ES,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
ES,INTERVERTEBRAL DISC DISORDER,1
ES,INTERVERTEBRAL DISCITIS,1
ES,INTESTINAL HAEMORRHAGE,1
ES,INTESTINAL POLYP,1
ES,INTRA-ABDOMINAL HAEMANGIOMA,1
ES,INTRA-ABDOMINAL HAEMATOMA,1
ES,INTRACARDIAC THROMBUS,1
ES,ISCHAEMIC CARDIOMYOPATHY,1
ES,ISCHAEMIC CEREBRAL INFARCTION,1
ES,JAUNDICE,1
ES,KLEBSIELLA BACTERAEMIA,1
ES,LABORATORY TEST ABNORMAL,1
ES,LACTIC ACIDOSIS,1
ES,LARGE INTESTINAL ULCER,1
ES,LARGE INTESTINE POLYP,1
ES,LATERAL MEDULLARY SYNDROME,1
ES,LEUKOCYTOSIS,1
ES,LIMB INJURY,1
ES,LIP SWELLING,1
ES,LIVER ABSCESS,1
ES,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
ES,LUNG DISORDER,1
ES,LUNG NEOPLASM,1
ES,LUPUS-LIKE SYNDROME,1
ES,LYMPHOPENIA,1
ES,MACULAR OEDEMA,1
ES,MALIGNANT MELANOMA,1
ES,MALIGNANT NEOPLASM PROGRESSION,1
ES,MECHANICAL URTICARIA,1
ES,MELAENA,1
ES,MENINGITIS PNEUMOCOCCAL,1
ES,MENORRHAGIA,1
ES,METASTASES TO LIVER,1
ES,METASTATIC CARCINOMA OF THE BLADDER,1
ES,MICROVASCULAR CORONARY ARTERY DISEASE,1
ES,MIXED LIVER INJURY,1
ES,MONOPARESIS,1
ES,MOUTH HAEMORRHAGE,1
ES,MUCOSAL HAEMORRHAGE,1
ES,MUSCLE RUPTURE,1
ES,MUSCULAR WEAKNESS,1
ES,MUSCULOSKELETAL CHEST PAIN,1
ES,MYASTHENIA GRAVIS,1
ES,MYASTHENIA GRAVIS CRISIS,1
ES,MYELODYSPLASTIC SYNDROME,1
ES,MYOCARDIAL ISCHAEMIA,1
ES,MYOCARDITIS,1
ES,MYOCLONIC EPILEPSY,1
ES,MYOCLONUS,1
ES,NEPHROPATHY TOXIC,1
ES,NERVOUS SYSTEM DISORDER,1
ES,NEUROLOGICAL DECOMPENSATION,1
ES,NIGHTMARE,1
ES,NO ADVERSE EVENT,1
ES,NO THERAPEUTIC RESPONSE,1
ES,NON-CARDIAC CHEST PAIN,1
ES,NUCHAL RIGIDITY,1
ES,OEDEMA,1
ES,OESOPHAGEAL MUCOSAL TEAR,1
ES,OESOPHAGEAL RUPTURE,1
ES,OESOPHAGEAL ULCER HAEMORRHAGE,1
ES,OLIGURIA,1
ES,OROPHARYNGEAL PAIN,1
ES,PAIN IN EXTREMITY,1
ES,PANCREATIC CARCINOMA METASTATIC,1
ES,PANCREATIC NEOPLASM,1
ES,PANCREATITIS ACUTE,1
ES,PANCYTOPENIA,1
ES,PARALYSIS,1
ES,PENETRATING ATHEROSCLEROTIC ULCER,1
ES,PERCUTANEOUS CORONARY INTERVENTION,1
ES,PERFORATION,1
ES,PERIPHERAL PARALYSIS,1
ES,PERIPHERAL SENSORY NEUROPATHY,1
ES,PERITONITIS,1
ES,PERIVASCULAR DERMATITIS,1
ES,PETECHIAE,1
ES,PHAEOCHROMOCYTOMA,1
ES,PLATELET FUNCTION TEST ABNORMAL,1
ES,PNEUMONIA HERPES VIRAL,1
ES,PNEUMONIA PNEUMOCOCCAL,1
ES,POLYMYOSITIS,1
ES,POST PROCEDURAL COMPLICATION,1
ES,POST PROCEDURAL DISCOMFORT,1
ES,POST PROCEDURAL HAEMORRHAGE,1
ES,POST-ANOXIC MYOCLONUS,1
ES,POSTOPERATIVE WOUND INFECTION,1
ES,PRESCRIBED UNDERDOSE,1
ES,PRODUCTIVE COUGH,1
ES,PSEUDOMONAS TEST POSITIVE,1
ES,PSORIASIS,1
ES,PULMONARY ALVEOLAR HAEMORRHAGE,1
ES,PULMONARY FIBROSIS,1
ES,PULMONARY FUNCTION TEST DECREASED,1
ES,PULMONARY MASS,1
ES,PULSE ABSENT,1
ES,PURPURA,1
ES,QUALITY OF LIFE DECREASED,1
ES,RAPID CORRECTION OF HYPONATRAEMIA,1
ES,RASH ERYTHEMATOUS,1
ES,RASH PAPULAR,1
ES,RASH PRURITIC,1
ES,RECTAL HAEMORRHAGE,1
ES,RECTAL ULCER,1
ES,RED BLOOD CELL COUNT DECREASED,1
ES,RENAL COLIC,1
ES,RENAL IMPAIRMENT,1
ES,RESPIRATORY DISORDER,1
ES,RETINAL HAEMORRHAGE,1
ES,RHEUMATOID ARTHRITIS,1
ES,SENSE OF OPPRESSION,1
ES,SHOCK HAEMORRHAGIC,1
ES,SINUS RHYTHM,1
ES,SKELETAL INJURY,1
ES,SKIN HAEMORRHAGE,1
ES,SKIN ULCER,1
ES,SKULL FRACTURE,1
ES,SNEEZING,1
ES,SPINAL COMPRESSION FRACTURE,1
ES,SPINAL OSTEOARTHRITIS,1
ES,SPONTANEOUS HAEMATOMA,1
ES,STEATOHEPATITIS,1
ES,STOMATITIS,1
ES,SUICIDE ATTEMPT,1
ES,SUPERINFECTION,1
ES,SUPRAVENTRICULAR TACHYCARDIA,1
ES,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
ES,SYSTEMIC LUPUS ERYTHEMATOSUS,1
ES,SYSTOLIC HYPERTENSION,1
ES,THERAPEUTIC PRODUCT INEFFECTIVE,1
ES,THERAPEUTIC RESPONSE DECREASED,1
ES,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
ES,THYROID DISORDER,1
ES,TIBIA FRACTURE,1
ES,TONGUE OEDEMA,1
ES,TOOTH LOSS,1
ES,TREATMENT FAILURE,1
ES,TREATMENT NONCOMPLIANCE,1
ES,URINARY BLADDER ATROPHY,1
ES,URINARY TRACT INFECTION ENTEROCOCCAL,1
ES,URTICARIA,1
ES,VARICES OESOPHAGEAL,1
ES,VASCULAR GRAFT,1
ES,VENTRICULAR ASYSTOLE,1
ES,VESSEL PUNCTURE SITE HAEMORRHAGE,1
ES,VISUAL IMPAIRMENT,1
ES,VITREOUS HAEMORRHAGE,1
ES,WITHDRAWAL SYNDROME,1
ES,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
LK,RESPIRATORY FAILURE,2
LK,UPPER GASTROINTESTINAL HAEMORRHAGE,2
LK,ACUTE KIDNEY INJURY,1
LK,ACUTE MYOCARDIAL INFARCTION,1
LK,CARDIAC ARREST,1
LK,CARDIO-RESPIRATORY ARREST,1
LK,COMA,1
LK,CONTRAST MEDIA REACTION,1
LK,DRUG ADMINISTRATION ERROR,1
LK,GASTRIC ULCER,1
LK,GASTROINTESTINAL HAEMORRHAGE,1
LK,HEPATIC CIRRHOSIS,1
LK,HEPATIC FAILURE,1
LK,HYPOTENSION,1
LK,INFECTION,1
LK,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
LK,LEFT VENTRICULAR FAILURE,1
LK,PELVIC VENOUS THROMBOSIS,1
LK,PNEUMONIA,1
SD,DEATH,2
SE,CEREBRAL HAEMORRHAGE,13
SE,DYSPNOEA,9
SE,PRURITUS,9
SE,DIZZINESS,8
SE,MYOCARDIAL INFARCTION,8
SE,HYPERSENSITIVITY,7
SE,CONFUSIONAL STATE,6
SE,FATIGUE,6
SE,ANAEMIA,5
SE,COUGH,5
SE,DEATH,5
SE,DIARRHOEA,5
SE,FALL,5
SE,HAEMORRHAGE,5
SE,HEADACHE,5
SE,PLATELET AGGREGATION INCREASED,5
SE,ALOPECIA AREATA,4
SE,BACK PAIN,4
SE,CARDIAC DISORDER,4
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,4
SE,DISTURBANCE IN ATTENTION,4
SE,GASTROINTESTINAL HAEMORRHAGE,4
SE,MUSCLE SPASMS,4
SE,ABDOMINAL DISCOMFORT,3
SE,ABDOMINAL PAIN,3
SE,ARTHRALGIA,3
SE,CHEST PAIN,3
SE,DYSARTHRIA,3
SE,DYSPHAGIA,3
SE,EPISTAXIS,3
SE,ERYTHEMA,3
SE,EYE HAEMORRHAGE,3
SE,HAEMATURIA,3
SE,LIP SWELLING,3
SE,MASTOCYTIC ENTEROCOLITIS,3
SE,MOUTH SWELLING,3
SE,MYALGIA,3
SE,NEUTROPENIA,3
SE,OESOPHAGEAL CANDIDIASIS,3
SE,PAIN IN EXTREMITY,3
SE,PERIPHERAL SWELLING,3
SE,PRODUCT SUBSTITUTION ISSUE,3
SE,PYREXIA,3
SE,RASH PRURITIC,3
SE,RENAL FAILURE ACUTE,3
SE,STEVENS-JOHNSON SYNDROME,3
SE,TRANSIENT ISCHAEMIC ATTACK,3
SE,VOMITING,3
SE,ANXIETY,2
SE,ARRHYTHMIA,2
SE,ATRIAL FIBRILLATION,2
SE,CEREBROVASCULAR ACCIDENT,2
SE,CONSTIPATION,2
SE,CONTUSION,2
SE,DEHYDRATION,2
SE,DISORIENTATION,2
SE,DRUG INEFFECTIVE,2
SE,DRY MOUTH,2
SE,DUODENAL ULCER,2
SE,HAEMOGLOBIN DECREASED,2
SE,HALLUCINATION,2
SE,HALLUCINATION_ VISUAL,2
SE,HYPOAESTHESIA,2
SE,INTERSTITIAL LUNG DISEASE,2
SE,ISCHAEMIC STROKE,2
SE,MUSCULAR WEAKNESS,2
SE,NAUSEA,2
SE,PAIN,2
SE,PARANOIA,2
SE,PHARYNGEAL OEDEMA,2
SE,PRODUCT QUALITY ISSUE,2
SE,PULMONARY EMBOLISM,2
SE,RASH,2
SE,SOMNOLENCE,2
SE,SUBDURAL HAEMATOMA,2
SE,THROMBOSIS IN DEVICE,2
SE,TOXICITY TO VARIOUS AGENTS,2
SE,URINARY INCONTINENCE,2
SE,VASCULAR STENOSIS,2
SE,VISUAL IMPAIRMENT,2
SE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
SE,ABDOMINAL DISTENSION,1
SE,ABDOMINAL PAIN UPPER,1
SE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
SE,ADVERSE DRUG REACTION,1
SE,AGGRESSION,1
SE,AGITATION,1
SE,AMNESIA,1
SE,ANGINA PECTORIS,1
SE,ANGINA UNSTABLE,1
SE,ANGIOEDEMA,1
SE,ANURIA,1
SE,APATHY,1
SE,ASCITES,1
SE,ASTHENIA,1
SE,BASAL GANGLIA INFARCTION,1
SE,BLOOD BLISTER,1
SE,BLOOD CREATININE INCREASED,1
SE,BLOOD PRESSURE DECREASED,1
SE,BLOOD PRESSURE INCREASED,1
SE,BURNING SENSATION,1
SE,CARDIAC ARREST,1
SE,CARDIAC FAILURE,1
SE,CARDIAC FAILURE CONGESTIVE,1
SE,CENTRAL NERVOUS SYSTEM LESION,1
SE,CHEST DISCOMFORT,1
SE,CHEST INJURY,1
SE,CHOLESTASIS,1
SE,CIRCULATORY COLLAPSE,1
SE,COLITIS,1
SE,COLITIS ULCERATIVE,1
SE,CONTRAINDICATED PRODUCT ADMINISTERED,1
SE,DECREASED APPETITE,1
SE,DEEP VEIN THROMBOSIS,1
SE,DEMYELINATING POLYNEUROPATHY,1
SE,DENTAL CARIES,1
SE,DEPRESSED MOOD,1
SE,DIARRHOEA HAEMORRHAGIC,1
SE,DIATHERMY,1
SE,DRUG ADMINISTRATION ERROR,1
SE,DYSPHONIA,1
SE,DYSURIA,1
SE,EAR SWELLING,1
SE,EMOTIONAL DISTRESS,1
SE,ENDOCARDITIS,1
SE,ERYTHEMA MULTIFORME,1
SE,EYE SWELLING,1
SE,FAECAL INCONTINENCE,1
SE,FEBRILE NEUTROPENIA,1
SE,FOOT OPERATION,1
SE,GAIT DISTURBANCE,1
SE,GASTRIC ULCER,1
SE,HAEMATOMA,1
SE,HAEMORRHAGIC ANAEMIA,1
SE,HAEMORRHAGIC DIATHESIS,1
SE,HEAD INJURY,1
SE,HEART RATE INCREASED,1
SE,HEMIPARESIS,1
SE,HEPATIC CIRRHOSIS,1
SE,HEPATIC FUNCTION ABNORMAL,1
SE,HYPERGLYCAEMIA,1
SE,HYPERHIDROSIS,1
SE,HYPERKERATOSIS,1
SE,HYPERTENSION,1
SE,HYPOGLYCAEMIA,1
SE,HYPONATRAEMIA,1
SE,HYPOTENSION,1
SE,INCORRECT DOSE ADMINISTERED,1
SE,INFARCTION,1
SE,INFECTION,1
SE,INGUINAL HERNIA,1
SE,INSOMNIA,1
SE,INTERVERTEBRAL DISC COMPRESSION,1
SE,ISCHAEMIA,1
SE,JOINT SWELLING,1
SE,KETOACIDOSIS,1
SE,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
SE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
SE,LEUKOPENIA,1
SE,LIP SQUAMOUS CELL CARCINOMA,1
SE,MALAISE,1
SE,MALIGNANT HYPERTENSION,1
SE,MELAENA,1
SE,MEMORY IMPAIRMENT,1
SE,MUCOUS STOOLS,1
SE,MUSCLE HAEMORRHAGE,1
SE,MUSCLE TWITCHING,1
SE,NECK PAIN,1
SE,NEPHROLITHIASIS,1
SE,NEPHROTIC SYNDROME,1
SE,NOCTURIA,1
SE,ORAL DISCOMFORT,1
SE,ORAL MUCOSAL BLISTERING,1
SE,ORAL PRURITUS,1
SE,ORTHOSTATIC INTOLERANCE,1
SE,PALPITATIONS,1
SE,PARAESTHESIA,1
SE,PERICARDIAL EFFUSION,1
SE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
SE,PERSONALITY CHANGE,1
SE,PNEUMONIA,1
SE,POISONING,1
SE,POLYMYALGIA RHEUMATICA,1
SE,PORTAL HYPERTENSION,1
SE,PORTAL VEIN THROMBOSIS,1
SE,POST PROCEDURAL INFECTION,1
SE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
SE,PULMONARY HAEMORRHAGE,1
SE,QUALITY OF LIFE DECREASED,1
SE,RECTAL ADENOMA,1
SE,RECTAL HAEMORRHAGE,1
SE,RENAL FAILURE,1
SE,RESPIRATORY FAILURE,1
SE,RHABDOMYOLYSIS,1
SE,RIGHT VENTRICULAR FAILURE,1
SE,SENSORY DISTURBANCE,1
SE,SEPTIC EMBOLUS,1
SE,SKIN CANCER,1
SE,SKIN DISCOLOURATION,1
SE,SKIN ULCER,1
SE,SMALL FIBRE NEUROPATHY,1
SE,SPINAL SUBDURAL HAEMATOMA,1
SE,SPONDYLITIS,1
SE,STAPHYLOCOCCAL SEPSIS,1
SE,STOMATITIS,1
SE,SUBDURAL HAEMORRHAGE,1
SE,SUDDEN CARDIAC DEATH,1
SE,SWELLING FACE,1
SE,SYNCOPE,1
SE,TACHYCARDIA,1
SE,TEETH BRITTLE,1
SE,TENDON RUPTURE,1
SE,THERAPY CESSATION,1
SE,THROMBOTIC MICROANGIOPATHY,1
SE,TINNITUS,1
SE,TOOTH DISORDER,1
SE,TOOTH LOSS,1
SE,TREMOR,1
SE,TUBULOINTERSTITIAL NEPHRITIS,1
SE,UNRESPONSIVE TO STIMULI,1
SE,URINARY RETENTION,1
SE,URINE ABNORMALITY,1
SE,UROSEPSIS,1
SE,VASCULAR OPERATION,1
SE,VASCULAR PSEUDOANEURYSM,1
SE,VERTIGO,1
SE,VISUAL ACUITY REDUCED,1
SE,VITAMIN D DEFICIENCY,1
SE,VITREOUS DETACHMENT,1
SE,VITREOUS HAEMORRHAGE,1
SE,WEIGHT DECREASED,1
SE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
CH,ANAEMIA,30
CH,GASTROINTESTINAL HAEMORRHAGE,28
CH,MELAENA,24
CH,SYNCOPE,23
CH,HAEMATURIA,19
CH,HAEMORRHAGIC ANAEMIA,19
CH,ACUTE KIDNEY INJURY,17
CH,ASTHENIA,16
CH,FALL,15
CH,BRADYCARDIA,14
CH,HYPOTENSION,11
CH,CEREBRAL HAEMORRHAGE,10
CH,PNEUMONIA,10
CH,POTENTIATING DRUG INTERACTION,10
CH,SUBARACHNOID HAEMORRHAGE,10
CH,BLADDER TAMPONADE,9
CH,HYPOGLYCAEMIA,9
CH,RASH,9
CH,SUBDURAL HAEMATOMA,9
CH,ACUTE MYOCARDIAL INFARCTION,8
CH,CARDIAC FAILURE,8
CH,DYSPNOEA,8
CH,ELECTROCARDIOGRAM QT PROLONGED,8
CH,GASTRIC ULCER,8
CH,HAEMATOMA,8
CH,HAEMOPTYSIS,8
CH,HYPOKALAEMIA,8
CH,HYPONATRAEMIA,8
CH,RENAL FAILURE ACUTE,8
CH,DIARRHOEA,7
CH,EOSINOPHILIA,7
CH,EPISTAXIS,7
CH,HEADACHE,7
CH,HYPERKALAEMIA,7
CH,INTERNATIONAL NORMALISED RATIO INCREASED,7
CH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,7
CH,NAUSEA,7
CH,THROMBOSIS,7
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,7
CH,VOMITING,7
CH,ANGINA PECTORIS,6
CH,CRANIOCEREBRAL INJURY,6
CH,FATIGUE,6
CH,GENERAL PHYSICAL HEALTH DETERIORATION,6
CH,HAEMATEMESIS,6
CH,HAEMOGLOBIN DECREASED,6
CH,HEPATOCELLULAR INJURY,6
CH,HYPOCALCAEMIA,6
CH,ORTHOSTATIC HYPOTENSION,6
CH,PYREXIA,6
CH,WEIGHT DECREASED,6
CH,ALTERED STATE OF CONSCIOUSNESS,5
CH,BLOOD PRESSURE DECREASED,5
CH,CARDIAC ARREST,5
CH,CARDIOGENIC SHOCK,5
CH,CEREBROVASCULAR ACCIDENT,5
CH,CONDITION AGGRAVATED,5
CH,CONFUSIONAL STATE,5
CH,CONTRAINDICATED PRODUCT ADMINISTERED,5
CH,DIZZINESS,5
CH,DUODENAL ULCER,5
CH,HEMIPARESIS,5
CH,HYPERTENSION,5
CH,LEUKOPENIA,5
CH,LOSS OF CONSCIOUSNESS,5
CH,RENAL FAILURE CHRONIC,5
CH,SOMNOLENCE,5
CH,THROMBOCYTOPENIA,5
CH,TOXICITY TO VARIOUS AGENTS,5
CH,TRAUMATIC HAEMATOMA,5
CH,ATRIAL FIBRILLATION,4
CH,ATRIOVENTRICULAR BLOCK COMPLETE,4
CH,CONTRAINDICATED DRUG ADMINISTERED,4
CH,DEHYDRATION,4
CH,DRUG ADMINISTRATION ERROR,4
CH,ENDOTRACHEAL INTUBATION,4
CH,HYPERGLYCAEMIA,4
CH,HYPERTHYROIDISM,4
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,4
CH,INFLAMMATION,4
CH,INHIBITORY DRUG INTERACTION,4
CH,INTERSTITIAL LUNG DISEASE,4
CH,LOWER GASTROINTESTINAL HAEMORRHAGE,4
CH,MYALGIA,4
CH,MYOCARDIAL INFARCTION,4
CH,OEDEMA PERIPHERAL,4
CH,RENAL FAILURE,4
CH,SEIZURE,4
CH,ACCIDENTAL EXPOSURE TO PRODUCT,3
CH,AGGRESSION,3
CH,AGRANULOCYTOSIS,3
CH,APPLICATION SITE HAEMORRHAGE,3
CH,ARRHYTHMIA,3
CH,ARTHRALGIA,3
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
CH,C-REACTIVE PROTEIN INCREASED,3
CH,CHEST PAIN,3
CH,CHOLESTATIC LIVER INJURY,3
CH,DECREASED APPETITE,3
CH,DEPRESSION,3
CH,DISTURBANCE IN ATTENTION,3
CH,DRUG PRESCRIBING ERROR,3
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
CH,ERYTHEMA,3
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
CH,HAEMORRHAGIC STROKE,3
CH,HEPATIC ENZYME INCREASED,3
CH,HYPERHIDROSIS,3
CH,HYPOMAGNESAEMIA,3
CH,LARGE INTESTINE POLYP,3
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,3
CH,PRESYNCOPE,3
CH,PRURITUS,3
CH,PSYCHOMOTOR HYPERACTIVITY,3
CH,RHABDOMYOLYSIS,3
CH,SHOCK HAEMORRHAGIC,3
CH,SLEEP DISORDER,3
CH,SUBARACHNOID HAEMATOMA,3
CH,TRANSIENT ISCHAEMIC ATTACK,3
CH,WEIGHT INCREASED,3
CH,ABDOMINAL DISCOMFORT,2
CH,ABDOMINAL PAIN,2
CH,ABDOMINAL PAIN UPPER,2
CH,ACCIDENTAL OVERDOSE,2
CH,ACUTE CORONARY SYNDROME,2
CH,AGITATION,2
CH,ANEURYSM,2
CH,ANURIA,2
CH,ANXIETY,2
CH,ATRIAL FLUTTER,2
CH,BLOOD CREATINE PHOSPHOKINASE,2
CH,BLOOD GLUCOSE INCREASED,2
CH,BLOOD PRESSURE INCREASED,2
CH,BONE DENSITY DECREASED,2
CH,CARDIAC PACEMAKER INSERTION,2
CH,CATHETER SITE HAEMATOMA,2
CH,COGWHEEL RIGIDITY,2
CH,COMPLETED SUICIDE,2
CH,CORONARY ARTERY STENOSIS,2
CH,CREATININE RENAL CLEARANCE DECREASED,2
CH,DEATH,2
CH,DIVERTICULUM INTESTINAL HAEMORRHAGIC,2
CH,DRUG ABUSE,2
CH,DRUG ERUPTION,2
CH,DRUG INEFFECTIVE,2
CH,DRUG LEVEL ABOVE THERAPEUTIC,2
CH,DRUG LEVEL INCREASED,2
CH,DRUG RESISTANCE,2
CH,EJECTION FRACTION DECREASED,2
CH,ELECTROLYTE IMBALANCE,2
CH,EYE SWELLING,2
CH,FEBRILE NEUTROPENIA,2
CH,HAEMATOCHEZIA,2
CH,HAEMODYNAMIC INSTABILITY,2
CH,HAEMOLYTIC ANAEMIA,2
CH,HAEMORRHAGE,2
CH,HEPATIC FIBROSIS,2
CH,HEPATITIS,2
CH,HYPERNATRAEMIA,2
CH,HYPOAESTHESIA,2
CH,HYPOTHYROIDISM,2
CH,INSOMNIA,2
CH,INTENTIONAL PRODUCT MISUSE,2
CH,LACTIC ACIDOSIS,2
CH,LIP SWELLING,2
CH,MANIA,2
CH,METABOLIC ACIDOSIS,2
CH,MUSCULAR WEAKNESS,2
CH,MYOPATHY,2
CH,NEUTROPENIA,2
CH,ORAL MUCOSA EROSION,2
CH,ORGANISING PNEUMONIA,2
CH,OSTEOARTHRITIS,2
CH,OVERDOSE,2
CH,PAIN,2
CH,PALPITATIONS,2
CH,PANCREATITIS,2
CH,PETECHIAE,2
CH,PNEUMONITIS,2
CH,POLYNEUROPATHY,2
CH,PROTHROMBIN TIME PROLONGED,2
CH,PSYCHOMOTOR RETARDATION,2
CH,PULMONARY MASS,2
CH,PULMONARY OEDEMA,2
CH,RASH GENERALISED,2
CH,RASH MACULO-PAPULAR,2
CH,REBOUND EFFECT,2
CH,RESPIRATORY DISTRESS,2
CH,RESPIRATORY FAILURE,2
CH,SEPTIC SHOCK,2
CH,SKIN EROSION,2
CH,SPEECH DISORDER,2
CH,SPONTANEOUS HAEMATOMA,2
CH,SUPRAVENTRICULAR TACHYCARDIA,2
CH,TACHYARRHYTHMIA,2
CH,TACHYCARDIA,2
CH,TINNITUS,2
CH,TORSADE DE POINTES,2
CH,TOXIC SKIN ERUPTION,2
CH,TRACHEOSTOMY,2
CH,TRANSAMINASES INCREASED,2
CH,TREMOR,2
CH,TUBULOINTERSTITIAL NEPHRITIS,2
CH,VASCULAR STENT OCCLUSION,2
CH,VASCULAR STENT THROMBOSIS,2
CH,WOUND,2
CH,ABASIA,1
CH,ABNORMAL DREAMS,1
CH,ACIDOSIS,1
CH,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
CH,ACUTE RESPIRATORY FAILURE,1
CH,AMMONIA INCREASED,1
CH,ANAEMIA MACROCYTIC,1
CH,ANAPHYLACTOID REACTION,1
CH,ANGINA UNSTABLE,1
CH,ANGIOEDEMA,1
CH,ANKLE FRACTURE,1
CH,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
CH,AORTIC VALVE SCLEROSIS,1
CH,ARRHYTHMIA SUPRAVENTRICULAR,1
CH,ARTHRITIS,1
CH,ATRIAL TACHYCARDIA,1
CH,ATRIOVENTRICULAR BLOCK,1
CH,BACTERIAL INFECTION,1
CH,BALANCE DISORDER,1
CH,BASE EXCESS INCREASED,1
CH,BLADDER CANCER,1
CH,BLINDNESS,1
CH,BLOOD CREATININE INCREASED,1
CH,BLOOD GLUCOSE ABNORMAL,1
CH,BLOOD PHOSPHORUS DECREASED,1
CH,BLOOD POTASSIUM INCREASED,1
CH,BLOOD PRESSURE ABNORMAL,1
CH,BLOOD UREA INCREASED,1
CH,BONE PAIN,1
CH,BRADYARRHYTHMIA,1
CH,BRAIN NATRIURETIC PEPTIDE INCREASED,1
CH,BRONCHIAL CARCINOMA,1
CH,BRONCHOSCOPY ABNORMAL,1
CH,BUNDLE BRANCH BLOCK RIGHT,1
CH,CACHEXIA,1
CH,CARCINOID TUMOUR,1
CH,CARDIAC DEATH,1
CH,CARDIAC VALVE REPLACEMENT COMPLICATION,1
CH,CARDIAC VENTRICULAR THROMBOSIS,1
CH,CARDIOVASCULAR DISORDER,1
CH,CEREBELLAR ATAXIA,1
CH,CEREBRAL ISCHAEMIA,1
CH,CHILLS,1
CH,CHOLESTASIS,1
CH,CHONDROCALCINOSIS PYROPHOSPHATE,1
CH,CHRONIC KIDNEY DISEASE,1
CH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CH,CLOSTRIDIUM COLITIS,1
CH,COGNITIVE DISORDER,1
CH,COLITIS,1
CH,COLITIS ULCERATIVE,1
CH,COMPUTERISED TOMOGRAM THORAX NORMAL,1
CH,COORDINATION ABNORMAL,1
CH,CORNEAL DEGENERATION,1
CH,CORNEAL DYSTROPHY,1
CH,CORNEAL OPACITY,1
CH,CORONARY ARTERY DISEASE,1
CH,COUGH,1
CH,CSF PROTEIN INCREASED,1
CH,DEAFNESS,1
CH,DEEP VEIN THROMBOSIS,1
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CH,DEPRESSED MOOD,1
CH,DERMATITIS BULLOUS,1
CH,DEVICE OCCLUSION,1
CH,DILATATION ATRIAL,1
CH,DIPLOPIA,1
CH,DISORIENTATION,1
CH,DIVERTICULITIS,1
CH,DIVERTICULUM INTESTINAL,1
CH,DRUG DOSE OMISSION,1
CH,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CH,DRUG-INDUCED LIVER INJURY,1
CH,DYSPHAGIA,1
CH,DYSPNOEA AT REST,1
CH,ECZEMA,1
CH,ELECTROCARDIOGRAM T WAVE INVERSION,1
CH,EMBOLISM,1
CH,ENCEPHALOPATHY,1
CH,EOSINOPHILIC PNEUMONIA,1
CH,EPILEPSY,1
CH,EXTRAPYRAMIDAL DISORDER,1
CH,FAECES DISCOLOURED,1
CH,FANCONI SYNDROME,1
CH,FANCONI SYNDROME ACQUIRED,1
CH,FAT EMBOLISM,1
CH,FEMORAL ARTERY EMBOLISM,1
CH,FEMUR FRACTURE,1
CH,FIXED DRUG ERUPTION,1
CH,FLANK PAIN,1
CH,FOOD ALLERGY,1
CH,GAIT INABILITY,1
CH,GALLBLADDER DISORDER,1
CH,GANGRENE,1
CH,GASTRIC HAEMORRHAGE,1
CH,GASTRITIS EROSIVE,1
CH,GASTROENTERITIS,1
CH,GASTROOESOPHAGEAL REFLUX DISEASE,1
CH,GENERALISED OEDEMA,1
CH,GENERALISED TONIC-CLONIC SEIZURE,1
CH,GINGIVITIS,1
CH,HAEMANGIOMA,1
CH,HAEMORRHOIDS,1
CH,HALLUCINATION,1
CH,HEAD DISCOMFORT,1
CH,HEAD INJURY,1
CH,HEPARIN-INDUCED THROMBOCYTOPENIA,1
CH,HISTIOCYTOSIS HAEMATOPHAGIC,1
CH,HYPERREFLEXIA,1
CH,HYPERSENSITIVITY VASCULITIS,1
CH,HYPERTENSIVE CRISIS,1
CH,HYPERVOLAEMIA,1
CH,HYPHAEMA,1
CH,HYPOCHROMIC ANAEMIA,1
CH,HYPOGLYCAEMIC COMA,1
CH,HYPOKINESIA,1
CH,HYPOPHOSPHATAEMIA,1
CH,HYPOTHERMIA,1
CH,HYPOTONIA,1
CH,IMMOBILE,1
CH,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
CH,IMPAIRED HEALING,1
CH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CH,INFECTION,1
CH,INFLAMMATORY MARKER INCREASED,1
CH,INFLUENZA LIKE ILLNESS,1
CH,INJURY,1
CH,INTENTION TREMOR,1
CH,INTENTIONAL OVERDOSE,1
CH,INTESTINAL ULCER,1
CH,INTRAVENTRICULAR HAEMORRHAGE,1
CH,ISCHAEMIC CARDIOMYOPATHY,1
CH,ISCHAEMIC STROKE,1
CH,JAUNDICE,1
CH,LEG AMPUTATION,1
CH,LEUKOCYTOSIS,1
CH,LIBIDO DISORDER,1
CH,LIPODYSTROPHY ACQUIRED,1
CH,LIVEDO RETICULARIS,1
CH,LIVER INJURY,1
CH,LIVER SCAN ABNORMAL,1
CH,LUMBAR VERTEBRAL FRACTURE,1
CH,LUNG CONSOLIDATION,1
CH,LUNG DISORDER,1
CH,MALAISE,1
CH,MALIGNANT NEOPLASM PROGRESSION,1
CH,MEMORY IMPAIRMENT,1
CH,MENINGISM,1
CH,MENORRHAGIA,1
CH,MENTAL IMPAIRMENT,1
CH,MOUTH INJURY,1
CH,MUSCLE RUPTURE,1
CH,MUSCLE SPASTICITY,1
CH,MYOCARDIAL ISCHAEMIA,1
CH,MYOSITIS,1
CH,MYXOEDEMA COMA,1
CH,NASOPHARYNGEAL CANCER,1
CH,NIGHT SWEATS,1
CH,NIGHTMARE,1
CH,NYSTAGMUS,1
CH,OCCULT BLOOD POSITIVE,1
CH,OEDEMA,1
CH,OSTEONECROSIS,1
CH,OSTEONECROSIS OF JAW,1
CH,OSTEOPOROSIS,1
CH,OXYGEN SATURATION DECREASED,1
CH,PACHYMENINGITIS,1
CH,PAIN IN EXTREMITY,1
CH,PALLOR,1
CH,PANCREATITIS NECROTISING,1
CH,PEMPHIGOID,1
CH,PERIORBITAL HAEMATOMA,1
CH,PERIPHERAL ISCHAEMIA,1
CH,PERITONITIS,1
CH,PERSECUTORY DELUSION,1
CH,PHOTOPHOBIA,1
CH,PIGMENTATION DISORDER,1
CH,PLEURAL EFFUSION,1
CH,POLYARTHRITIS,1
CH,POLYCYTHAEMIA,1
CH,POLYP,1
CH,PRESCRIBED OVERDOSE,1
CH,PROCTALGIA,1
CH,PRODUCT USE ISSUE,1
CH,PROSTATE CANCER METASTATIC,1
CH,PSORIASIS,1
CH,PSYCHOMOTOR SKILLS IMPAIRED,1
CH,PUBIS FRACTURE,1
CH,PULMONARY TUBERCULOSIS,1
CH,RASH PRURITIC,1
CH,RECTAL HAEMORRHAGE,1
CH,RED MAN SYNDROME,1
CH,RENAL IMPAIRMENT,1
CH,RENAL TUBULAR DISORDER,1
CH,RENAL TUBULAR DYSFUNCTION,1
CH,RESPIRATORY TRACT INFECTION,1
CH,RETROPERITONEAL HAEMATOMA,1
CH,RETROPERITONEAL LYMPHADENOPATHY,1
CH,SEPSIS,1
CH,SERUM FERRITIN INCREASED,1
CH,SICK SINUS SYNDROME,1
CH,SPLENOMEGALY,1
CH,SPONDYLOLISTHESIS,1
CH,STAPHYLOCOCCAL SEPSIS,1
CH,SUPERINFECTION BACTERIAL,1
CH,SUPRAVENTRICULAR EXTRASYSTOLES,1
CH,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
CH,TACHYPNOEA,1
CH,TENSION,1
CH,THORACIC VERTEBRAL FRACTURE,1
CH,TOE AMPUTATION,1
CH,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
CH,TRI-IODOTHYRONINE FREE DECREASED,1
CH,UNDERDOSE,1
CH,URINARY RETENTION,1
CH,UROSEPSIS,1
CH,UVEITIS,1
CH,VASCULITIS,1
CH,VERTIGO,1
CH,VISION BLURRED,1
CH,VISUAL IMPAIRMENT,1
CH,VITAMIN B12 DEFICIENCY,1
CH,VITREOUS DETACHMENT,1
CH,VITREOUS FLOATERS,1
CH,VITREOUS HAEMORRHAGE,1
CH,WOUND INFECTION,1
TW,DYSPNOEA,23
TW,PYREXIA,18
TW,CARDIAC FAILURE CONGESTIVE,17
TW,COUGH,13
TW,CHEST DISCOMFORT,12
TW,ACUTE PULMONARY OEDEMA,10
TW,DIZZINESS,10
TW,DEATH,9
TW,PNEUMONIA,8
TW,ABDOMINAL DISCOMFORT,7
TW,ASTHENIA,7
TW,CORONARY ARTERY DISEASE,7
TW,URINARY TRACT INFECTION,7
TW,ACUTE MYOCARDIAL INFARCTION,5
TW,CARDIAC ARREST,5
TW,CARDIAC FAILURE,5
TW,CHEST PAIN,5
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
TW,FATIGUE,5
TW,HAEMATURIA,5
TW,HYPERTRIGLYCERIDAEMIA,5
TW,HYPOTENSION,5
TW,PULMONARY OEDEMA,5
TW,SOMNOLENCE,5
TW,ABDOMINAL PAIN,4
TW,ARTERIOSCLEROSIS CORONARY ARTERY,4
TW,DECREASED APPETITE,4
TW,FALL,4
TW,LOSS OF CONSCIOUSNESS,4
TW,MALAISE,4
TW,MUSCLE HAEMORRHAGE,4
TW,NEUTROPENIA,4
TW,RHINORRHOEA,4
TW,VASCULAR CALCIFICATION,4
TW,VASCULAR STENT THROMBOSIS,4
TW,VISION BLURRED,4
TW,ALTERED STATE OF CONSCIOUSNESS,3
TW,ANAEMIA,3
TW,ANGINA PECTORIS,3
TW,ANGINA UNSTABLE,3
TW,APNOEA,3
TW,BACK PAIN,3
TW,CONTUSION,3
TW,DIARRHOEA,3
TW,DYSARTHRIA,3
TW,GASTROINTESTINAL HAEMORRHAGE,3
TW,HAEMOGLOBIN DECREASED,3
TW,HAEMOTHORAX,3
TW,NAUSEA,3
TW,PAIN IN EXTREMITY,3
TW,PALPITATIONS,3
TW,PANCYTOPENIA,3
TW,PLEURAL EFFUSION,3
TW,SEPSIS,3
TW,VENTRICULAR TACHYCARDIA,3
TW,VOMITING,3
TW,WHITE BLOOD CELL COUNT DECREASED,3
TW,ABDOMINAL COMPARTMENT SYNDROME,2
TW,ABDOMINAL DISTENSION,2
TW,ABDOMINAL PAIN LOWER,2
TW,ABDOMINAL PAIN UPPER,2
TW,ALANINE AMINOTRANSFERASE INCREASED,2
TW,ARTERIAL RESTENOSIS,2
TW,ATRIAL FIBRILLATION,2
TW,BLOOD CREATININE INCREASED,2
TW,BONE PAIN,2
TW,BRADYCARDIA,2
TW,CELLULITIS,2
TW,CEREBROVASCULAR ACCIDENT,2
TW,CHOLELITHIASIS,2
TW,CONJUNCTIVAL PALLOR,2
TW,CORONARY ARTERY RESTENOSIS,2
TW,CORONARY ARTERY STENOSIS,2
TW,DISEASE PROGRESSION,2
TW,DRUG ADMINISTRATION ERROR,2
TW,DUODENAL ULCER HAEMORRHAGE,2
TW,EYE MOVEMENT DISORDER,2
TW,GASTRIC ULCER,2
TW,HAEMORRHAGE,2
TW,HEMIPARESIS,2
TW,HEPARIN RESISTANCE,2
TW,HEPATITIS ACUTE,2
TW,HEPATOTOXICITY,2
TW,HYPERHIDROSIS,2
TW,HYPERTENSION,2
TW,HYPOAESTHESIA,2
TW,HYPONATRAEMIA,2
TW,HYPOVOLAEMIC SHOCK,2
TW,ISCHAEMIC STROKE,2
TW,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
TW,MELAENA,2
TW,MENTAL STATUS CHANGES,2
TW,MUSCULAR WEAKNESS,2
TW,PERICARDIAL HAEMORRHAGE,2
TW,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
TW,PLATELET COUNT DECREASED,2
TW,PNEUMONIA BACTERIAL,2
TW,PRODUCTIVE COUGH,2
TW,RENAL FAILURE CHRONIC,2
TW,RETROPERITONEAL HAEMATOMA,2
TW,SEIZURE,2
TW,SUDDEN DEATH,2
TW,TACHYCARDIA,2
TW,TACHYPNOEA,2
TW,TORSADE DE POINTES,2
TW,UROSEPSIS,2
TW,WEIGHT INCREASED,2
TW,ABASIA,1
TW,ACUTE ABDOMEN,1
TW,ACUTE CORONARY SYNDROME,1
TW,ACUTE KIDNEY INJURY,1
TW,ACUTE RESPIRATORY DISTRESS SYNDROME,1
TW,ACUTE RESPIRATORY FAILURE,1
TW,ANAPHYLACTIC SHOCK,1
TW,ANGIOPLASTY,1
TW,ANTITHROMBIN III DEFICIENCY,1
TW,AORTIC VALVE INCOMPETENCE,1
TW,AORTIC VALVE SCLEROSIS,1
TW,APHTHOUS STOMATITIS,1
TW,ARTHROPATHY,1
TW,ASCITES,1
TW,ASPARTATE AMINOTRANSFERASE INCREASED,1
TW,BASAL GANGLION DEGENERATION,1
TW,BILE DUCT OBSTRUCTION,1
TW,BILE DUCT STONE,1
TW,BLOOD ALKALINE PHOSPHATASE INCREASED,1
TW,BLOOD GLUCOSE ABNORMAL,1
TW,BLOOD GLUCOSE INCREASED,1
TW,BLOOD POTASSIUM INCREASED,1
TW,BLOOD PRESSURE DECREASED,1
TW,BLOOD PRESSURE DIASTOLIC DECREASED,1
TW,BLOOD UREA INCREASED,1
TW,BRONCHOSPASM,1
TW,CALCULUS BLADDER,1
TW,CARDIOGENIC SHOCK,1
TW,CARDIOMEGALY,1
TW,CAROTID ARTERY OCCLUSION,1
TW,CATHETERISATION CARDIAC,1
TW,CEREBRAL INFARCTION,1
TW,CHOLANGIOCARCINOMA,1
TW,CHOLECYSTITIS,1
TW,CHOLECYSTITIS ACUTE,1
TW,CHRONIC KIDNEY DISEASE,1
TW,COLD SWEAT,1
TW,CONDITION AGGRAVATED,1
TW,CONSTIPATION,1
TW,CORONARY ARTERIAL STENT INSERTION,1
TW,CORONARY ARTERY OCCLUSION,1
TW,CORONARY ARTERY THROMBOSIS,1
TW,CYP2C19 POLYMORPHISM,1
TW,DEVICE DISLOCATION,1
TW,DIABETES MELLITUS,1
TW,DIASTOLIC DYSFUNCTION,1
TW,DIPLOPIA,1
TW,DISSEMINATED TUBERCULOSIS,1
TW,DIVERTICULAR PERFORATION,1
TW,DIZZINESS POSTURAL,1
TW,DRUG INEFFECTIVE,1
TW,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TW,DRUG RESISTANCE,1
TW,DRUG-INDUCED LIVER INJURY,1
TW,DRY MOUTH,1
TW,DYSPHAGIA,1
TW,DYSPNOEA EXERTIONAL,1
TW,ECCHYMOSIS,1
TW,EJECTION FRACTION DECREASED,1
TW,ELECTROCARDIOGRAM QT PROLONGED,1
TW,END STAGE RENAL DISEASE,1
TW,EXERCISE TOLERANCE DECREASED,1
TW,EXOPHTHALMOS,1
TW,EYE HAEMORRHAGE,1
TW,FACIAL PARALYSIS,1
TW,FAECES DISCOLOURED,1
TW,FEMORAL NECK FRACTURE,1
TW,FLATULENCE,1
TW,FOOT FRACTURE,1
TW,FULL BLOOD COUNT ABNORMAL,1
TW,GALLBLADDER DISORDER,1
TW,GASTRIC CANCER,1
TW,GASTRIC ULCER HAEMORRHAGE,1
TW,GASTRITIS,1
TW,GASTROENTERITIS,1
TW,GASTROENTERITIS RADIATION,1
TW,GASTROINTESTINAL ULCER,1
TW,GASTROOESOPHAGEAL REFLUX DISEASE,1
TW,GAZE PALSY,1
TW,HAEMATEMESIS,1
TW,HAEMATURIA TRAUMATIC,1
TW,HAEMORRHAGIC ANAEMIA,1
TW,HAEMORRHAGIC TRANSFORMATION STROKE,1
TW,HEADACHE,1
TW,HEART RATE DECREASED,1
TW,HELICOBACTER INFECTION,1
TW,HEMIANOPIA,1
TW,HEMIPLEGIA,1
TW,HEPATIC ENZYME INCREASED,1
TW,HEPATIC STEATOSIS,1
TW,HIP ARTHROPLASTY,1
TW,HIP FRACTURE,1
TW,HYPERCHOLESTEROLAEMIA,1
TW,HYPERGLYCAEMIA,1
TW,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,1
TW,HYPOREFLEXIA,1
TW,HYPOTHYROIDISM,1
TW,HYPOVENTILATION,1
TW,HYPOXIA,1
TW,INFECTION,1
TW,INFECTIOUS COLITIS,1
TW,INFLUENZA,1
TW,INSOMNIA,1
TW,INTERNAL HAEMORRHAGE,1
TW,INTERVERTEBRAL DISC DEGENERATION,1
TW,INTESTINAL ISCHAEMIA,1
TW,INTRACARDIAC THROMBUS,1
TW,JAUNDICE,1
TW,JAUNDICE CHOLESTATIC,1
TW,LATENT SYPHILIS,1
TW,LEFT ATRIAL DILATATION,1
TW,LEFT VENTRICULAR DILATATION,1
TW,LEFT VENTRICULAR DYSFUNCTION,1
TW,LEFT VENTRICULAR HYPERTROPHY,1
TW,LOCALISED INFECTION,1
TW,LUNG CANCER METASTATIC,1
TW,LUNG NEOPLASM MALIGNANT,1
TW,MITRAL VALVE CALCIFICATION,1
TW,MITRAL VALVE INCOMPETENCE,1
TW,MULTI-ORGAN FAILURE,1
TW,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
TW,MYALGIA,1
TW,MYOCARDIAL INFARCTION,1
TW,MYOCARDIAL ISCHAEMIA,1
TW,NASOPHARYNGITIS,1
TW,NEOPLASM RECURRENCE,1
TW,NEPHROPATHY,1
TW,NERVE COMPRESSION,1
TW,NEUROLOGIC NEGLECT SYNDROME,1
TW,NEUROPATHY PERIPHERAL,1
TW,NEUTROPHIL COUNT DECREASED,1
TW,NODAL ARRHYTHMIA,1
TW,ORTHOPNOEA,1
TW,OSTEOARTHRITIS,1
TW,OSTEOMYELITIS,1
TW,PAIN,1
TW,PANCREATIC CARCINOMA,1
TW,PARALYSIS,1
TW,PARKINSONISM,1
TW,PERCUTANEOUS CORONARY INTERVENTION,1
TW,PERICARDIAL DRAINAGE,1
TW,PERICARDIAL EFFUSION,1
TW,PERIODONTITIS,1
TW,PERIPHERAL ARTERY OCCLUSION,1
TW,PERITONITIS,1
TW,PERITONITIS BACTERIAL,1
TW,PHARYNGITIS,1
TW,POOR QUALITY SLEEP,1
TW,POST PROCEDURAL COMPLICATION,1
TW,PRESYNCOPE,1
TW,PROSTATE CANCER,1
TW,PROSTATITIS,1
TW,PRURITUS,1
TW,PSEUDOMONAS INFECTION,1
TW,PULMONARY CONGESTION,1
TW,PULMONARY HYPERTENSION,1
TW,RALES,1
TW,RANULA,1
TW,RENAL DISORDER,1
TW,RENAL FAILURE ACUTE,1
TW,RENAL IMPAIRMENT,1
TW,RESPIRATORY ACIDOSIS,1
TW,RESPIRATORY DISTRESS,1
TW,RESPIRATORY FAILURE,1
TW,RHABDOMYOLYSIS,1
TW,RIB FRACTURE,1
TW,SCOLIOSIS,1
TW,SEPTIC SHOCK,1
TW,SICK SINUS SYNDROME,1
TW,SINUS TACHYCARDIA,1
TW,SKIN ABRASION,1
TW,SKIN HAEMORRHAGE,1
TW,SKIN ULCER,1
TW,SOMNAMBULISM,1
TW,SPINAL OSTEOARTHRITIS,1
TW,SPONDYLOLISTHESIS,1
TW,STAPHYLOCOCCAL BACTERAEMIA,1
TW,STENT PLACEMENT,1
TW,SUDDEN CARDIAC DEATH,1
TW,SWELLING FACE,1
TW,THROMBOCYTOPENIA,1
TW,THROMBOLYSIS,1
TW,TINEA CRURIS,1
TW,TONIC CONVULSION,1
TW,TRANSIENT ISCHAEMIC ATTACK,1
TW,TRICUSPID VALVE INCOMPETENCE,1
TW,TROPONIN T INCREASED,1
TW,TUBERCULIN TEST POSITIVE,1
TW,ULCER,1
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TW,UPPER RESPIRATORY TRACT INFECTION,1
TW,URINARY RETENTION,1
TW,URINE OUTPUT DECREASED,1
TW,VASCULAR GRAFT COMPLICATION,1
TW,VASCULAR GRAFT OCCLUSION,1
TW,VASCULAR PSEUDOANEURYSM,1
TW,VASCULAR STENT OCCLUSION,1
TW,VASCULAR STENT RESTENOSIS,1
TW,VENTRICULAR DYSFUNCTION,1
TW,VENTRICULAR FIBRILLATION,1
TW,VERTIGO,1
TW,WOUND COMPLICATION,1
TH,ATRIAL FIBRILLATION,2
TH,HEPATIC FUNCTION ABNORMAL,2
TH,SEPSIS,2
TH,SEPTIC SHOCK,2
TH,ACUTE KIDNEY INJURY,1
TH,ACUTE PULMONARY OEDEMA,1
TH,ALTERED STATE OF CONSCIOUSNESS,1
TH,ANGINA UNSTABLE,1
TH,BLOOD CHOLESTEROL INCREASED,1
TH,BRAIN DEATH,1
TH,CARDIAC ARREST,1
TH,CARDIAC FAILURE CONGESTIVE,1
TH,CHEST PAIN,1
TH,CHOLECYSTITIS,1
TH,CONDITION AGGRAVATED,1
TH,DRUG INEFFECTIVE,1
TH,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
TH,DUODENAL ULCER HAEMORRHAGE,1
TH,DYSPNOEA,1
TH,EPISTAXIS,1
TH,GANGRENE,1
TH,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
TH,HAEMATURIA,1
TH,HAEMORRHAGE INTRACRANIAL,1
TH,HAEMORRHAGIC TRANSFORMATION STROKE,1
TH,HEPATIC FAILURE,1
TH,HYPERAESTHESIA,1
TH,INTERNATIONAL NORMALISED RATIO INCREASED,1
TH,ISCHAEMIA,1
TH,MONONEUROPATHY MULTIPLEX,1
TH,MULTI-ORGAN FAILURE,1
TH,OESOPHAGITIS HAEMORRHAGIC,1
TH,PANCREATITIS ACUTE,1
TH,POLYARTERITIS NODOSA,1
TH,RESPIRATORY FAILURE,1
TH,THERAPEUTIC RESPONSE INCREASED,1
TH,URINARY TRACT INFECTION,1
TT,ANGINA PECTORIS,1
TT,BLOOD GLUCOSE DECREASED,1
TT,BLOOD GLUCOSE INCREASED,1
TT,CATARACT,1
TT,CHEST DISCOMFORT,1
TT,DRUG DOSE OMISSION,1
TT,DYSPNOEA,1
TT,HILAR LYMPHADENOPATHY,1
TT,LYMPHADENOPATHY MEDIASTINAL,1
TT,MYOCARDIAL INFARCTION,1
TT,NAUSEA,1
TT,WEIGHT DECREASED,1
TN,CARDIAC ARREST,38
TN,CHEST PAIN,16
TN,CARDIOGENIC SHOCK,14
TN,CARDIAC FAILURE,11
TN,DEATH,11
TN,MYOCARDIAL INFARCTION,9
TN,ACUTE MYOCARDIAL INFARCTION,8
TN,ACUTE PULMONARY OEDEMA,7
TN,GENERAL PHYSICAL HEALTH DETERIORATION,7
TN,VASCULAR STENT THROMBOSIS,7
TN,DYSPNOEA,6
TN,KOUNIS SYNDROME,6
TN,CONDITION AGGRAVATED,4
TN,LUNG NEOPLASM MALIGNANT,4
TN,THROMBOSIS IN DEVICE,4
TN,ANAPHYLACTIC SHOCK,3
TN,ISCHAEMIC STROKE,3
TN,RESPIRATORY DISORDER,3
TN,SUDDEN DEATH,3
TN,BACK PAIN,2
TN,CARDIO-RESPIRATORY ARREST,2
TN,COMA,2
TN,CORONARY ARTERY STENOSIS,2
TN,DECREASED APPETITE,2
TN,DRUG INEFFECTIVE,2
TN,FATIGUE,2
TN,HYPOTENSION,2
TN,LUNG INFECTION,2
TN,MALAISE,2
TN,PAIN IN EXTREMITY,2
TN,RENAL FAILURE,2
TN,RENAL FAILURE CHRONIC,2
TN,ROAD TRAFFIC ACCIDENT,2
TN,SEPTIC SHOCK,2
TN,ABDOMINAL PAIN,1
TN,ANGINA PECTORIS,1
TN,AORTIC DISSECTION,1
TN,AORTIC VALVE INCOMPETENCE,1
TN,ASTHENIA,1
TN,ATRIAL FIBRILLATION,1
TN,BREAST CANCER,1
TN,CEREBROVASCULAR ACCIDENT,1
TN,CHOLESTASIS,1
TN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
TN,COLON CANCER,1
TN,CORONARY ARTERY BYPASS,1
TN,DECUBITUS ULCER,1
TN,DEPRESSED LEVEL OF CONSCIOUSNESS,1
TN,DEPRESSION,1
TN,DEVICE OCCLUSION,1
TN,DIABETIC GANGRENE,1
TN,DIALYSIS RELATED COMPLICATION,1
TN,DIZZINESS,1
TN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TN,DRUG RESISTANCE,1
TN,DYSLIPIDAEMIA,1
TN,EMBOLIC STROKE,1
TN,EMPHYSEMA,1
TN,ERYSIPELAS,1
TN,FACE OEDEMA,1
TN,FAILURE TO THRIVE,1
TN,FLUSHING,1
TN,GALLBLADDER PERFORATION,1
TN,GANGRENE,1
TN,GASTROINTESTINAL CARCINOMA,1
TN,GASTROINTESTINAL DISORDER,1
TN,GASTROINTESTINAL HAEMORRHAGE,1
TN,GASTROINTESTINAL NECROSIS,1
TN,HAEMORRHAGIC STROKE,1
TN,HEMIPLEGIA,1
TN,HEPATIC NEOPLASM,1
TN,HYPERGLYCAEMIA,1
TN,HYPERTENSION,1
TN,INTENTIONAL PRODUCT MISUSE,1
TN,INTESTINAL OBSTRUCTION,1
TN,LEFT VENTRICULAR FAILURE,1
TN,METASTATIC GASTRIC CANCER,1
TN,METASTATIC NEOPLASM,1
TN,MIXED LIVER INJURY,1
TN,MULTI-ORGAN FAILURE,1
TN,MYOCARDIAL ISCHAEMIA,1
TN,OEDEMA PERIPHERAL,1
TN,PAIN,1
TN,PANCREATIC CARCINOMA,1
TN,PANCREATITIS ACUTE,1
TN,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
TN,PNEUMONIA ASPIRATION,1
TN,POST PROCEDURAL HAEMORRHAGE,1
TN,PROSTATE CANCER,1
TN,PRURITUS,1
TN,PULMONARY OEDEMA,1
TN,PYREXIA,1
TN,RENAL CANCER,1
TN,RESPIRATORY DISTRESS,1
TN,RESPIRATORY FAILURE,1
TN,SHOCK,1
TN,SKIN WARM,1
TN,SUFFOCATION FEELING,1
TN,SWELLING,1
TN,SYNCOPE,1
TN,TACHYCARDIA,1
TN,THROMBOCYTOPENIA,1
TN,TROPONIN I INCREASED,1
TN,URTICARIA,1
TN,VASCULAR STENT STENOSIS,1
TN,VENTRICULAR FIBRILLATION,1
TN,VOMITING,1
TR,DYSPNOEA,12
TR,THROMBOSIS IN DEVICE,10
TR,VASCULAR STENT THROMBOSIS,9
TR,ACUTE CORONARY SYNDROME,8
TR,ANAEMIA,8
TR,DRUG RESISTANCE,7
TR,FAT EMBOLISM,7
TR,CARDIAC FAILURE,6
TR,DIARRHOEA,6
TR,DRUG INEFFECTIVE,6
TR,HAEMATOSPERMIA,6
TR,ATELECTASIS,5
TR,CARDIAC TAMPONADE,5
TR,CEREBROVASCULAR ACCIDENT,5
TR,DYSARTHRIA,5
TR,HAEMATOMA,5
TR,HAEMATURIA,5
TR,HYPONATRAEMIA,5
TR,NAUSEA,5
TR,RESPIRATORY ALKALOSIS,5
TR,THROMBOSIS,5
TR,TRACHEAL OBSTRUCTION,5
TR,CAROTID ARTERY THROMBOSIS,4
TR,CHEST PAIN,4
TR,CHONDROCALCINOSIS PYROPHOSPHATE,4
TR,DEATH,4
TR,DEHYDRATION,4
TR,DRUG ADMINISTRATION ERROR,4
TR,HAEMORRHAGE,4
TR,HEMIPLEGIA,4
TR,INTERNATIONAL NORMALISED RATIO INCREASED,4
TR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,4
TR,MUCOSAL HAEMORRHAGE,4
TR,MYOCARDIAL INFARCTION,4
TR,PANCYTOPENIA,4
TR,RESPIRATORY FAILURE,4
TR,RETROPERITONEAL HAEMATOMA,4
TR,STOMATITIS,4
TR,THROMBOCYTOPENIA,4
TR,ACUTE KIDNEY INJURY,3
TR,ACUTE MYOCARDIAL INFARCTION,3
TR,ALCOHOL INTERACTION,3
TR,ARRHYTHMIA,3
TR,ASTHENIA,3
TR,BLOOD CREATININE INCREASED,3
TR,BLUE TOE SYNDROME,3
TR,CEREBRAL ISCHAEMIA,3
TR,CORONARY ARTERY OCCLUSION,3
TR,CORONARY ARTERY THROMBOSIS,3
TR,GASTRIC HAEMORRHAGE,3
TR,HAEMOGLOBIN DECREASED,3
TR,HAEMORRHAGE INTRACRANIAL,3
TR,HYPOTENSION,3
TR,JOINT SWELLING,3
TR,NEPHROPATHY,3
TR,PULMONARY ALVEOLAR HAEMORRHAGE,3
TR,PULMONARY EMBOLISM,3
TR,PYREXIA,3
TR,RENAL FAILURE ACUTE,3
TR,RENAL IMPAIRMENT,3
TR,SPINAL EPIDURAL HAEMATOMA,3
TR,SYNCOPE,3
TR,TACHYPNOEA,3
TR,VOMITING,3
TR,ABDOMINAL PAIN,2
TR,ABDOMINAL WALL HAEMATOMA,2
TR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
TR,AKATHISIA,2
TR,ANGIOEDEMA,2
TR,ARTHRALGIA,2
TR,ARTHRITIS,2
TR,ASTHMA,2
TR,ATRIAL FIBRILLATION,2
TR,BACK PAIN,2
TR,BACTERIAL SEPSIS,2
TR,C-REACTIVE PROTEIN INCREASED,2
TR,CARDIAC PACEMAKER INSERTION,2
TR,CEREBRAL INFARCTION,2
TR,CEREBROVASCULAR DISORDER,2
TR,CIRCULATORY COLLAPSE,2
TR,COMPUTERISED TOMOGRAM ABNORMAL,2
TR,CONTRAST ENCEPHALOPATHY,2
TR,CORONARY ARTERY STENOSIS,2
TR,COUGH,2
TR,DIASTOLIC DYSFUNCTION,2
TR,DIZZINESS,2
TR,DYSGEUSIA,2
TR,DYSPHAGIA,2
TR,EJECTION FRACTION DECREASED,2
TR,EMBOLISM,2
TR,EPILEPSY,2
TR,FATIGUE,2
TR,HAEMOPTYSIS,2
TR,HALLUCINATION,2
TR,HERPES ZOSTER,2
TR,HYPERHIDROSIS,2
TR,HYPERSENSITIVITY,2
TR,INTRA-ABDOMINAL HAEMORRHAGE,2
TR,LOCAL SWELLING,2
TR,MONOPARESIS,2
TR,MUSCULAR WEAKNESS,2
TR,ORAL CANDIDIASIS,2
TR,ORTHOPNOEA,2
TR,PERICARDIAL EFFUSION,2
TR,PLEURAL EFFUSION,2
TR,RENAL ARTERY OCCLUSION,2
TR,RENAL INJURY,2
TR,TACHYCARDIA,2
TR,TRANSPLANT FAILURE,2
TR,URINARY TRACT INFECTION,2
TR,ABDOMINAL DISTENSION,1
TR,ABDOMINAL MASS,1
TR,ACCIDENT,1
TR,ACUTE INTERSTITIAL PNEUMONITIS,1
TR,ACUTE MOTOR AXONAL NEUROPATHY,1
TR,ACUTE PROMYELOCYTIC LEUKAEMIA,1
TR,AGEUSIA,1
TR,AGITATION,1
TR,ALOPECIA,1
TR,ANGINA PECTORIS,1
TR,AORTIC ANEURYSM,1
TR,APHASIA,1
TR,APHTHOUS STOMATITIS,1
TR,ARTERIOSCLEROSIS,1
TR,ARTERY DISSECTION,1
TR,ARTHROPATHY,1
TR,ATRIOVENTRICULAR BLOCK COMPLETE,1
TR,BLADDER NEOPLASM,1
TR,BLISTER,1
TR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
TR,BLOOD GLUCOSE INCREASED,1
TR,BLOOD PRESSURE DECREASED,1
TR,BLOOD PRESSURE INCREASED,1
TR,BLOOD TEST ABNORMAL,1
TR,BLOOD UREA INCREASED,1
TR,BONE MARROW EOSINOPHILIC LEUKOCYTE COUNT INCREASED,1
TR,BONE MARROW FAILURE,1
TR,BRADYCARDIA,1
TR,BRONCHITIS,1
TR,CARBON MONOXIDE POISONING,1
TR,CARDIAC DISORDER,1
TR,CARDIOGENIC SHOCK,1
TR,CARDIOTOXICITY,1
TR,CAROTID ARTERY OCCLUSION,1
TR,CATHETER SITE BRUISE,1
TR,CEREBRAL DISORDER,1
TR,CEREBRAL MICROHAEMORRHAGE,1
TR,CHEST DISCOMFORT,1
TR,CHEST X-RAY ABNORMAL,1
TR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
TR,COMPLETED SUICIDE,1
TR,CONDITION AGGRAVATED,1
TR,CONSTIPATION,1
TR,CONTUSION,1
TR,CORONARY ARTERIAL STENT INSERTION,1
TR,CORONARY ARTERY DISEASE,1
TR,CORONARY ARTERY RESTENOSIS,1
TR,CORONARY BYPASS STENOSIS,1
TR,CYANOSIS,1
TR,DELIRIUM,1
TR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
TR,DERMATOMYOSITIS,1
TR,DEVICE OCCLUSION,1
TR,DIABETES MELLITUS,1
TR,DILATATION VENTRICULAR,1
TR,DIPLOPIA,1
TR,DYSKINESIA,1
TR,DYSURIA,1
TR,EAR SWELLING,1
TR,ECHOCARDIOGRAM ABNORMAL,1
TR,ELECTROCARDIOGRAM ABNORMAL,1
TR,ELECTROCARDIOGRAM T WAVE INVERSION,1
TR,EMBOLISM ARTERIAL,1
TR,EMBOLISM VENOUS,1
TR,ENCEPHALOPATHY,1
TR,EOSINOPHIL COUNT INCREASED,1
TR,EOSINOPHILIA,1
TR,EPIGASTRIC DISCOMFORT,1
TR,EPISTAXIS,1
TR,ERYTHEMA,1
TR,FALL,1
TR,FEAR OF DEATH,1
TR,FEBRILE NEUTROPENIA,1
TR,FLUID RETENTION,1
TR,GAIT DISTURBANCE,1
TR,GANGRENE,1
TR,GASTROINTESTINAL DISORDER,1
TR,GENERAL PHYSICAL HEALTH DETERIORATION,1
TR,GRAFT COMPLICATION,1
TR,GYNAECOMASTIA,1
TR,HAEMODIALYSIS,1
TR,HAEMOLYTIC ANAEMIA,1
TR,HAEMORRHAGIC DIATHESIS,1
TR,HAEMOTHORAX,1
TR,HALLUCINATION_ VISUAL,1
TR,HEADACHE,1
TR,HEARING IMPAIRED,1
TR,HEPARIN-INDUCED THROMBOCYTOPENIA,1
TR,HEPATIC ENZYME INCREASED,1
TR,HEPATITIS TOXIC,1
TR,HEPATOTOXICITY,1
TR,HOSPITALISATION,1
TR,HYPERGLYCAEMIA,1
TR,HYPERTENSION,1
TR,HYPOAESTHESIA,1
TR,HYPOALBUMINAEMIA,1
TR,HYPOKINESIA,1
TR,HYPOMAGNESAEMIA,1
TR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
TR,INCORRECT DOSE ADMINISTERED,1
TR,INFECTION,1
TR,INJECTION SITE MASS,1
TR,INJECTION SITE NECROSIS,1
TR,INJECTION SITE PAIN,1
TR,INTERVENTRICULAR SEPTUM RUPTURE,1
TR,INTRACRANIAL HAEMATOMA,1
TR,JOINT EFFUSION,1
TR,KOUNIS SYNDROME,1
TR,LARYNGOSCOPY ABNORMAL,1
TR,LEUKOPENIA,1
TR,LOSS OF CONSCIOUSNESS,1
TR,LOW CARDIAC OUTPUT SYNDROME,1
TR,LUNG INFECTION,1
TR,LUNG INFILTRATION,1
TR,LYMPHOCYTE COUNT DECREASED,1
TR,LYMPHOCYTE PERCENTAGE DECREASED,1
TR,LYMPHOMA,1
TR,MALIGNANT NEOPLASM PROGRESSION,1
TR,MANTLE CELL LYMPHOMA,1
TR,MEAN CELL VOLUME INCREASED,1
TR,MEAN PLATELET VOLUME DECREASED,1
TR,MEDIASTINAL DISORDER,1
TR,METABOLIC ENCEPHALOPATHY,1
TR,MONOPLEGIA,1
TR,MOTOR DYSFUNCTION,1
TR,MOUTH ULCERATION,1
TR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
TR,MUSCLE CONTRACTIONS INVOLUNTARY,1
TR,MUSCLE RIGIDITY,1
TR,MUSCLE SPASMS,1
TR,MUSCULOSKELETAL STIFFNESS,1
TR,MYOPATHY,1
TR,NEAR DROWNING,1
TR,NERVOUS SYSTEM DISORDER,1
TR,NEUTROPHIL COUNT INCREASED,1
TR,NEUTROPHIL PERCENTAGE INCREASED,1
TR,NON-CARDIAC CHEST PAIN,1
TR,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
TR,OEDEMA,1
TR,OSTEONECROSIS,1
TR,OXYGEN SATURATION DECREASED,1
TR,PAIN,1
TR,PAIN IN EXTREMITY,1
TR,PALPITATIONS,1
TR,PANCREATIC FISTULA,1
TR,PANCREATITIS ACUTE,1
TR,PARAPLEGIA,1
TR,PARESIS,1
TR,PERIPHERAL SWELLING,1
TR,PLATELET DISTRIBUTION WIDTH INCREASED,1
TR,PNEUMONIA,1
TR,PO2 DECREASED,1
TR,PROTHROMBIN TIME PROLONGED,1
TR,PRURITUS,1
TR,PULMONARY ARTERIAL PRESSURE INCREASED,1
TR,PULMONARY HAEMORRHAGE,1
TR,PULMONARY MASS,1
TR,PULMONARY TOXICITY,1
TR,RASH PRURITIC,1
TR,RECTAL HAEMORRHAGE,1
TR,RED CELL DISTRIBUTION WIDTH INCREASED,1
TR,RENAL DISORDER,1
TR,RENAL FAILURE,1
TR,RENAL HAEMORRHAGE,1
TR,RESPIRATORY ARREST,1
TR,RESPIRATORY DISORDER,1
TR,RESPIRATORY DISTRESS,1
TR,RESPIRATORY TRACT HAEMORRHAGE,1
TR,RETINOPATHY HYPERTENSIVE,1
TR,RHABDOMYOLYSIS,1
TR,RIB FRACTURE,1
TR,SENSORY DISTURBANCE,1
TR,SEPSIS,1
TR,SKIN HAEMORRHAGE,1
TR,SKIN TOXICITY,1
TR,SLEEP DISORDER,1
TR,SOMNOLENCE,1
TR,SPINAL CORD COMPRESSION,1
TR,SPONTANEOUS HAEMATOMA,1
TR,SPONTANEOUS HAEMORRHAGE,1
TR,SUBARACHNOID HAEMORRHAGE,1
TR,SUICIDAL IDEATION,1
TR,SWOLLEN TONGUE,1
TR,SYNOVITIS,1
TR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
TR,TENSION,1
TR,THERAPEUTIC RESPONSE DECREASED,1
TR,THYROID HAEMORRHAGE,1
TR,THYROID NEOPLASM,1
TR,TONGUE OEDEMA,1
TR,TONGUE SPASM,1
TR,TRACHEAL HAEMORRHAGE,1
TR,TRAUMATIC RENAL INJURY,1
TR,TREATMENT NONCOMPLIANCE,1
TR,TRICUSPID VALVE INCOMPETENCE,1
TR,TROPONIN I INCREASED,1
TR,ULTRAFILTRATION FAILURE,1
TR,URTICARIA,1
TR,VASOSPASM,1
TR,VEIN DISORDER,1
TR,VENTRICULAR ARRHYTHMIA,1
TR,VENTRICULAR FIBRILLATION,1
TR,VERTIGO,1
TR,VISUAL IMPAIRMENT,1
TR,VOCAL CORD DISORDER,1
TR,WHEEZING,1
TR,WHITE BLOOD CELL COUNT INCREASED,1
UA,DYSPNOEA,3
UA,ACUTE MYOCARDIAL INFARCTION,2
UA,ASTHENIA,2
UA,DRUG INEFFECTIVE,2
UA,HAEMATOMA,2
UA,MUSCULAR WEAKNESS,2
UA,THROMBOSIS IN DEVICE,2
UA,VASCULAR STENT THROMBOSIS,2
UA,ANAL HAEMORRHAGE,1
UA,ANAL POLYP,1
UA,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
UA,BRADYCARDIA,1
UA,CATHETER SITE HAEMORRHAGE,1
UA,CHEST PAIN,1
UA,CIRCULATORY COLLAPSE,1
UA,CONVULSION,1
UA,CORONARY ARTERY RESTENOSIS,1
UA,CORONARY ARTERY THROMBOSIS,1
UA,DIZZINESS,1
UA,DYSPHAGIA,1
UA,ELECTROCARDIOGRAM QT PROLONGED,1
UA,ERYTHEMA,1
UA,FALL,1
UA,GASTROINTESTINAL HAEMORRHAGE,1
UA,HAEMORRHAGIC STROKE,1
UA,HEART RATE IRREGULAR,1
UA,HYPERSENSITIVITY,1
UA,HYPOKALAEMIA,1
UA,INTENTIONAL PRODUCT MISUSE,1
UA,MEDICATION ERROR,1
UA,MOBILITY DECREASED,1
UA,MYASTHENIC SYNDROME,1
UA,MYOCARDIAL INFARCTION,1
UA,PANCREATITIS CHRONIC,1
UA,PRESYNCOPE,1
UA,PRURITUS,1
UA,PURPURA,1
UA,SINUS BRADYCARDIA,1
UA,SWELLING,1
UA,SYNCOPE,1
UA,THERAPY CESSATION,1
UA,TRANSAMINASES INCREASED,1
UA,VENTRICULAR ARRHYTHMIA,1
UA,VENTRICULAR EXTRASYSTOLES,1
UA,VENTRICULAR TACHYCARDIA,1
AE,CHEST PAIN,2
AE,FOETAL EXPOSURE DURING PREGNANCY,2
AE,HEADACHE,2
AE,HEPATITIS CHOLESTATIC,2
AE,LOW BIRTH WEIGHT BABY,2
AE,MATERNAL EXPOSURE DURING PREGNANCY,2
AE,PREMATURE BABY,2
AE,BRAIN COMPRESSION,1
AE,BRAIN MIDLINE SHIFT,1
AE,BRAIN OEDEMA,1
AE,CARDIAC ARREST,1
AE,CHOLESTASIS,1
AE,CONFUSIONAL STATE,1
AE,COUGH,1
AE,DIARRHOEA,1
AE,DYSARTHRIA,1
AE,GASTROINTESTINAL STROMAL TUMOUR,1
AE,HAEMORRHAGE,1
AE,HAEMORRHAGE INTRACRANIAL,1
AE,HEMIPARESIS,1
AE,HYPERTENSION,1
AE,HYPONATRAEMIA,1
AE,INTESTINAL OBSTRUCTION,1
AE,MALIGNANT NEOPLASM PROGRESSION,1
AE,PAIN IN EXTREMITY,1
AE,PNEUMONIA,1
AE,PNEUMOTHORAX,1
AE,PRE-ECLAMPSIA,1
AE,PREMATURE DELIVERY,1
AE,PRURITUS,1
AE,PYREXIA,1
AE,SEPSIS,1
AE,TUMOUR NECROSIS,1
AE,URINE OUTPUT DECREASED,1
AE,VOMITING,1
GB,DYSPNOEA,317
GB,FATIGUE,284
GB,DIZZINESS,265
GB,MALAISE,260
GB,ACUTE KIDNEY INJURY,238
GB,CONFUSIONAL STATE,220
GB,MYALGIA,172
GB,HYPONATRAEMIA,167
GB,NAUSEA,165
GB,DIARRHOEA,162
GB,VOMITING,158
GB,FALL,156
GB,GASTROINTESTINAL HAEMORRHAGE,153
GB,HEADACHE,148
GB,HYPOTENSION,134
GB,PAIN IN EXTREMITY,131
GB,CHEST PAIN,127
GB,CONTUSION,123
GB,ARTHRALGIA,121
GB,PRURITUS,115
GB,ABDOMINAL PAIN,113
GB,COUGH,113
GB,CEREBROVASCULAR ACCIDENT,111
GB,PAIN,110
GB,BRADYCARDIA,108
GB,HAEMATEMESIS,107
GB,LOWER RESPIRATORY TRACT INFECTION,105
GB,MELAENA,103
GB,MUSCLE SPASMS,103
GB,RASH,99
GB,SYNCOPE,98
GB,CIRCULATORY COLLAPSE,97
GB,LETHARGY,94
GB,BALANCE DISORDER,90
GB,CARDIAC ARREST,86
GB,SEPSIS,86
GB,ATRIAL FIBRILLATION,85
GB,LOSS OF CONSCIOUSNESS,82
GB,TREMOR,81
GB,HAEMOGLOBIN DECREASED,80
GB,INSOMNIA,80
GB,ANAEMIA,79
GB,DYSPHAGIA,78
GB,ABDOMINAL PAIN UPPER,77
GB,HALLUCINATION,76
GB,BACK PAIN,75
GB,ASTHENIA,74
GB,PERIPHERAL SWELLING,74
GB,MUSCULAR WEAKNESS,73
GB,PYREXIA,73
GB,RECTAL HAEMORRHAGE,73
GB,LIVER FUNCTION TEST ABNORMAL,72
GB,TRANSIENT ISCHAEMIC ATTACK,69
GB,GASTRITIS,65
GB,CONSTIPATION,64
GB,DECREASED APPETITE,64
GB,DEPRESSION,64
GB,PARAESTHESIA,64
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,64
GB,DEATH,62
GB,EPISTAXIS,62
GB,HYPERHIDROSIS,62
GB,LIP SWELLING,62
GB,RENAL FAILURE ACUTE,62
GB,HAEMORRHAGE,61
GB,WHEEZING,61
GB,ANXIETY,59
GB,DRUG INEFFECTIVE,59
GB,PALPITATIONS,59
GB,NIGHTMARE,58
GB,SOMNOLENCE,58
GB,ERYTHEMA,56
GB,HYPERKALAEMIA,56
GB,HYPERTENSION,56
GB,MYOCARDIAL INFARCTION,56
GB,SEIZURE,56
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,55
GB,DRY MOUTH,55
GB,URINARY TRACT INFECTION,55
GB,CHEST DISCOMFORT,54
GB,DYSPEPSIA,54
GB,HAEMATURIA,54
GB,RENAL IMPAIRMENT,54
GB,TOXICITY TO VARIOUS AGENTS,54
GB,FAECES DISCOLOURED,53
GB,SWOLLEN TONGUE,53
GB,AGITATION,52
GB,SWELLING FACE,51
GB,FEELING ABNORMAL,50
GB,AMNESIA,49
GB,UNRESPONSIVE TO STIMULI,49
GB,CONDITION AGGRAVATED,48
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,48
GB,ORTHOSTATIC HYPOTENSION,48
GB,PNEUMONIA,48
GB,VISION BLURRED,48
GB,TACHYCARDIA,46
GB,DEPRESSED MOOD,45
GB,HAEMORRHAGE INTRACRANIAL,44
GB,SUICIDAL IDEATION,44
GB,GENERAL PHYSICAL HEALTH DETERIORATION,43
GB,INTENTIONAL OVERDOSE,43
GB,ANGINA PECTORIS,42
GB,DEHYDRATION,41
GB,FEELING HOT,41
GB,HYPOKALAEMIA,41
GB,MOUTH ULCERATION,41
GB,NEUTROPENIA,41
GB,DRUG PRESCRIBING ERROR,39
GB,HYPERSENSITIVITY,39
GB,OEDEMA PERIPHERAL,39
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,38
GB,ANGIOEDEMA,36
GB,CEREBRAL HAEMORRHAGE,36
GB,DYSARTHRIA,36
GB,AGGRESSION,35
GB,CARDIAC FAILURE,35
GB,ISCHAEMIC STROKE,35
GB,OESOPHAGITIS,35
GB,MUSCLE TWITCHING,34
GB,MUSCULOSKELETAL PAIN,34
GB,ABDOMINAL DISTENSION,33
GB,BLOOD GLUCOSE INCREASED,33
GB,ELECTROCARDIOGRAM QT PROLONGED,33
GB,HYPOMAGNESAEMIA,33
GB,PANCYTOPENIA,33
GB,RENAL FAILURE,33
GB,ABNORMAL WEIGHT GAIN,32
GB,ALANINE AMINOTRANSFERASE INCREASED,32
GB,NEUROPATHY PERIPHERAL,32
GB,RASH GENERALISED,32
GB,RASH PRURITIC,32
GB,SKIN EXFOLIATION,32
GB,ACUTE MYOCARDIAL INFARCTION,31
GB,CLOSTRIDIUM DIFFICILE INFECTION,31
GB,CONVULSION,31
GB,DIABETES MELLITUS INADEQUATE CONTROL,31
GB,HAEMATOMA,31
GB,HIATUS HERNIA,31
GB,SLEEP DISORDER,31
GB,THIRST,31
GB,VERTIGO,31
GB,BLOOD PRESSURE DECREASED,30
GB,CONTRAINDICATED PRODUCT ADMINISTERED,30
GB,DIPLOPIA,30
GB,MEMORY IMPAIRMENT,30
GB,ORAL PAIN,30
GB,POLLAKIURIA,29
GB,SUICIDE ATTEMPT,29
GB,SWELLING,29
GB,VISUAL IMPAIRMENT,29
GB,ACUTE CORONARY SYNDROME,28
GB,GAIT DISTURBANCE,28
GB,NECK PAIN,28
GB,HYPOPHAGIA,27
GB,JAUNDICE,27
GB,MOBILITY DECREASED,27
GB,OXYGEN SATURATION DECREASED,27
GB,ANAPHYLACTIC REACTION,26
GB,BURNING SENSATION,26
GB,HYPOGLYCAEMIA,26
GB,RHABDOMYOLYSIS,26
GB,DYSKINESIA,25
GB,HYPOAESTHESIA,25
GB,WHITE BLOOD CELL COUNT INCREASED,25
GB,HEMIPARESIS,24
GB,INFECTION,24
GB,CHILLS,23
GB,DISORIENTATION,23
GB,DRY SKIN,23
GB,FACIAL PARALYSIS,23
GB,PRODUCT SUBSTITUTION ISSUE,23
GB,RESTLESSNESS,23
GB,URTICARIA,23
GB,ALOPECIA,22
GB,APHASIA,22
GB,BLISTER,22
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,22
GB,DRUG INTOLERANCE,22
GB,DYSGEUSIA,22
GB,GYNAECOMASTIA,22
GB,HEART RATE DECREASED,22
GB,MEDICATION ERROR,22
GB,MYOCARDIAL ISCHAEMIA,22
GB,OEDEMA,22
GB,PHARYNGEAL OEDEMA,22
GB,SUBDURAL HAEMORRHAGE,22
GB,URINARY RETENTION,22
GB,ABNORMAL LOSS OF WEIGHT,21
GB,GASTRIC ULCER,21
GB,INTESTINAL ISCHAEMIA,21
GB,PALLOR,21
GB,THROMBOCYTOPENIA,21
GB,TINNITUS,21
GB,WEIGHT DECREASED,21
GB,BLOOD CREATININE INCREASED,20
GB,DUODENITIS,20
GB,EOSINOPHILIA,20
GB,GASTRIC HAEMORRHAGE,20
GB,OVERDOSE,20
GB,RASH ERYTHEMATOUS,20
GB,URINARY INCONTINENCE,20
GB,DIABETES MELLITUS,19
GB,DISTURBANCE IN ATTENTION,19
GB,HEAD INJURY,19
GB,RESPIRATORY FAILURE,19
GB,SKIN ABRASION,19
GB,SKIN LESION,19
GB,TROPONIN INCREASED,19
GB,WITHDRAWAL SYNDROME,19
GB,CELLULITIS,18
GB,COMA SCALE ABNORMAL,18
GB,HAEMOPTYSIS,18
GB,HALLUCINATION_ VISUAL,18
GB,PRURITUS GENERALISED,18
GB,AGEUSIA,17
GB,C-REACTIVE PROTEIN INCREASED,17
GB,CEREBRAL INFARCTION,17
GB,COGNITIVE DISORDER,17
GB,CONTRAINDICATED DRUG ADMINISTERED,17
GB,DRUG HYPERSENSITIVITY,17
GB,DRY EYE,17
GB,EYE SWELLING,17
GB,FASCIITIS,17
GB,GASTROOESOPHAGEAL REFLUX DISEASE,17
GB,INTERSTITIAL LUNG DISEASE,17
GB,MENTAL IMPAIRMENT,17
GB,PLATELET COUNT DECREASED,17
GB,PRODUCT USE ISSUE,17
GB,PULSELESS ELECTRICAL ACTIVITY,17
GB,SKIN OEDEMA,17
GB,SPEECH DISORDER,17
GB,UROSEPSIS,17
GB,ACQUIRED HAEMOPHILIA,16
GB,ADDISON^S DISEASE,16
GB,ASTHMA,16
GB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,16
GB,ATYPICAL FEMUR FRACTURE,16
GB,CATARACT,16
GB,DERMATITIS EXFOLIATIVE,16
GB,EMOTIONAL DISTRESS,16
GB,HYPOCALCAEMIA,16
GB,OSTEOPOROSIS,16
GB,PARANOIA,16
GB,SPINAL CORD COMPRESSION,16
GB,TOOTHACHE,16
GB,ADVERSE EVENT,15
GB,ERECTILE DYSFUNCTION,15
GB,EXTRADURAL HAEMATOMA,15
GB,MENTAL DISORDER,15
GB,MIGRAINE WITH AURA,15
GB,MUCOUS MEMBRANE DISORDER,15
GB,NEUTROPHIL COUNT DECREASED,15
GB,PAIN OF SKIN,15
GB,PHOTOPSIA,15
GB,SEROTONIN SYNDROME,15
GB,SKIN FISSURES,15
GB,SKIN ULCER,15
GB,SPUTUM DISCOLOURED,15
GB,VIITH NERVE PARALYSIS,15
GB,WHITE BLOOD CELL COUNT DECREASED,15
GB,ABDOMINAL DISCOMFORT,14
GB,AFFECT LABILITY,14
GB,ARRHYTHMIA,14
GB,ARTERIOSPASM CORONARY,14
GB,DELIRIUM,14
GB,DERMATITIS BULLOUS,14
GB,DIABETIC KETOACIDOSIS,14
GB,DRUG DOSE OMISSION,14
GB,FLATULENCE,14
GB,INTERNATIONAL NORMALISED RATIO INCREASED,14
GB,IRRITABILITY,14
GB,MUSCLE HAEMORRHAGE,14
GB,NODULE,14
GB,SENSORY DISTURBANCE,14
GB,SKIN DISCOLOURATION,14
GB,THROAT IRRITATION,14
GB,ABNORMAL DREAMS,13
GB,AGRANULOCYTOSIS,13
GB,ARTHROPATHY,13
GB,COMPARTMENT SYNDROME,13
GB,DISCOMFORT,13
GB,EPILEPSY,13
GB,EYE PAIN,13
GB,FAECAL INCONTINENCE,13
GB,FEELING DRUNK,13
GB,HYPOXIA,13
GB,LUNG INFECTION,13
GB,MOOD SWINGS,13
GB,MOUTH SWELLING,13
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,13
GB,MUSCULOSKELETAL CHEST PAIN,13
GB,NIGHT SWEATS,13
GB,PNEUMOTHORAX,13
GB,RASH MACULAR,13
GB,SALIVARY HYPERSECRETION,13
GB,TENDONITIS,13
GB,THROMBOSIS,13
GB,VOMITING PROJECTILE,13
GB,ABNORMAL BEHAVIOUR,12
GB,ACCIDENTAL OVERDOSE,12
GB,ATRIAL FLUTTER,12
GB,ATRIOVENTRICULAR BLOCK,12
GB,ATRIOVENTRICULAR BLOCK COMPLETE,12
GB,BLINDNESS CORTICAL,12
GB,CARDIAC DISORDER,12
GB,CHANGE OF BOWEL HABIT,12
GB,COLD SWEAT,12
GB,DEEP VEIN THROMBOSIS,12
GB,DERMATITIS ALLERGIC,12
GB,DYSSTASIA,12
GB,EYELID OEDEMA,12
GB,FEEDING DISORDER,12
GB,GLOSSODYNIA,12
GB,HEART RATE INCREASED,12
GB,HERPES ZOSTER,12
GB,HYPERCHOLESTEROLAEMIA,12
GB,LOSS OF CONTROL OF LEGS,12
GB,PERITONITIS,12
GB,PLEURAL EFFUSION,12
GB,PRODUCTIVE COUGH,12
GB,PSORIASIS,12
GB,PULMONARY FIBROSIS,12
GB,RALES,12
GB,RETROPERITONEAL HAEMATOMA,12
GB,SECRETION DISCHARGE,12
GB,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,12
GB,THINKING ABNORMAL,12
GB,TREATMENT NONCOMPLIANCE,12
GB,ACUTE LEFT VENTRICULAR FAILURE,11
GB,BEDRIDDEN,11
GB,BLOOD UREA INCREASED,11
GB,BLOOD URINE PRESENT,11
GB,BRADYPHRENIA,11
GB,BRAIN INJURY,11
GB,CHROMATURIA,11
GB,CHRONIC KIDNEY DISEASE,11
GB,CONTRAINDICATION TO MEDICAL TREATMENT,11
GB,DECREASED ACTIVITY,11
GB,DIVERTICULITIS,11
GB,DRUG ADMINISTRATION ERROR,11
GB,DRUG DISPENSING ERROR,11
GB,DYSPNOEA AT REST,11
GB,EXCORIATION,11
GB,EYELID PTOSIS,11
GB,HAEMORRHAGIC DIATHESIS,11
GB,HYDROCEPHALUS,11
GB,INTESTINAL PERFORATION,11
GB,JOINT SWELLING,11
GB,LARGE INTESTINAL ULCER,11
GB,LARGE INTESTINE POLYP,11
GB,LIMB DISCOMFORT,11
GB,NASAL DRYNESS,11
GB,NEUTROPHIL COUNT INCREASED,11
GB,NYSTAGMUS,11
GB,OBSTRUCTIVE AIRWAYS DISORDER,11
GB,OCULAR MYASTHENIA,11
GB,PAIN IN JAW,11
GB,RASH MACULO-PAPULAR,11
GB,RAYNAUD^S PHENOMENON,11
GB,SENSORY LOSS,11
GB,SOCIAL AVOIDANT BEHAVIOUR,11
GB,SUBARACHNOID HAEMORRHAGE,11
GB,TEARFULNESS,11
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,10
GB,CARDIAC FAILURE CONGESTIVE,10
GB,CARDIOACTIVE DRUG LEVEL INCREASED,10
GB,CEREBRAL ISCHAEMIA,10
GB,CHOLESTASIS,10
GB,COAGULATION TIME PROLONGED,10
GB,CONVULSIVE THRESHOLD LOWERED,10
GB,DIZZINESS POSTURAL,10
GB,FLUSHING,10
GB,GROIN PAIN,10
GB,HAEMODYNAMIC INSTABILITY,10
GB,HYPERGLYCAEMIA,10
GB,INCORRECT DRUG ADMINISTRATION DURATION,10
GB,INFECTED SKIN ULCER,10
GB,INHIBITORY DRUG INTERACTION,10
GB,IRON DEFICIENCY ANAEMIA,10
GB,LEFT VENTRICULAR DYSFUNCTION,10
GB,LIP ULCERATION,10
GB,LIVER DISORDER,10
GB,MUSCLE FATIGUE,10
GB,MYOPATHY,10
GB,MYOSITIS,10
GB,NEPHROLITHIASIS,10
GB,NEUTROPENIC SEPSIS,10
GB,OROPHARYNGEAL PAIN,10
GB,PANCREATITIS NECROTISING,10
GB,PURPURA,10
GB,RASH PUSTULAR,10
GB,RESPIRATORY ARREST,10
GB,SEDATION,10
GB,SENSITIVITY OF TEETH,10
GB,WEIGHT INCREASED,10
GB,ABSCESS,9
GB,ACANTHOSIS,9
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,9
GB,BARRETT^S OESOPHAGUS,9
GB,BRAIN HERNIATION,9
GB,BUNDLE BRANCH BLOCK LEFT,9
GB,CARPAL TUNNEL SYNDROME,9
GB,CHOLELITHIASIS,9
GB,COLITIS,9
GB,CORONARY ARTERY THROMBOSIS,9
GB,EXTRAVASATION BLOOD,9
GB,FLUID INTAKE REDUCED,9
GB,GUILLAIN-BARRE SYNDROME,9
GB,HANGOVER,9
GB,HEPATIC CIRRHOSIS,9
GB,INCREASED TENDENCY TO BRUISE,9
GB,LIVER INJURY,9
GB,LOCAL SWELLING,9
GB,LOWER GASTROINTESTINAL HAEMORRHAGE,9
GB,MASTICATION DISORDER,9
GB,MICROCYTIC ANAEMIA,9
GB,NEUTROPHILIC DERMATOSIS,9
GB,PHOTOSENSITIVITY REACTION,9
GB,PRESCRIBED OVERDOSE,9
GB,PRESYNCOPE,9
GB,PROCEDURAL HAEMORRHAGE,9
GB,PULMONARY EMBOLISM,9
GB,PULMONARY OEDEMA,9
GB,RENAL TUBULAR NECROSIS,9
GB,SCHIZOPHRENIA,9
GB,STRESS FRACTURE,9
GB,SUBDURAL HAEMATOMA,9
GB,TENDERNESS,9
GB,THROMBOSIS IN DEVICE,9
GB,TOTAL LUNG CAPACITY DECREASED,9
GB,TRIGGER FINGER,9
GB,TUMOUR LYSIS SYNDROME,9
GB,UPPER RESPIRATORY TRACT INFECTION,9
GB,VARICOSE VEIN,9
GB,VISUAL ACUITY REDUCED,9
GB,ACIDOSIS,8
GB,ASCITES,8
GB,BLEEDING TIME PROLONGED,8
GB,CARDIOPULMONARY FAILURE,8
GB,DELUSION,8
GB,DEMENTIA,8
GB,DISSOCIATION,8
GB,DRUG-INDUCED LIVER INJURY,8
GB,DUODENAL ULCER HAEMORRHAGE,8
GB,EYE DISORDER,8
GB,FACE OEDEMA,8
GB,FEELING COLD,8
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,8
GB,GASTROINTESTINAL NECROSIS,8
GB,HAIR COLOUR CHANGES,8
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,8
GB,INFLAMMATORY BOWEL DISEASE,8
GB,INFLUENZA LIKE ILLNESS,8
GB,IRRITABLE BOWEL SYNDROME,8
GB,ISCHAEMIA,8
GB,KIDNEY INFECTION,8
GB,LIBIDO INCREASED,8
GB,OCCULT BLOOD POSITIVE,8
GB,OESOPHAGEAL ULCER,8
GB,PANIC ATTACK,8
GB,PERIPHERAL ISCHAEMIA,8
GB,POLYDIPSIA,8
GB,RESPIRATORY DISORDER,8
GB,SEXUAL DYSFUNCTION,8
GB,SLUGGISHNESS,8
GB,SPLENIC RUPTURE,8
GB,TRACHEO-OESOPHAGEAL FISTULA,8
GB,TRANSFUSION,8
GB,TREATMENT FAILURE,8
GB,URINE OUTPUT DECREASED,8
GB,WOUND HAEMORRHAGE,8
GB,ALPHA 1 FOETOPROTEIN INCREASED,7
GB,BLINDNESS,7
GB,BLOOD BILIRUBIN ABNORMAL,7
GB,BLOOD POTASSIUM DECREASED,7
GB,BRONCHOSPASM,7
GB,COAGULOPATHY,7
GB,CONCOMITANT DISEASE PROGRESSION,7
GB,DECUBITUS ULCER,7
GB,DRUG LEVEL INCREASED,7
GB,DYSPNOEA EXERTIONAL,7
GB,ECZEMA,7
GB,ENDOCARDITIS,7
GB,EXFOLIATIVE RASH,7
GB,EYE ALLERGY,7
GB,EYELID PAIN,7
GB,GASTRIC ULCER HAEMORRHAGE,7
GB,GINGIVAL BLEEDING,7
GB,HAEMARTHROSIS,7
GB,HAEMORRHAGIC TRANSFORMATION STROKE,7
GB,HAEMOTHORAX,7
GB,HEAD DISCOMFORT,7
GB,HEPATORENAL SYNDROME,7
GB,HYDRONEPHROSIS,7
GB,HYPERCALCAEMIA,7
GB,HYPERCHLORHYDRIA,7
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,7
GB,INFLAMMATORY MARKER INCREASED,7
GB,INFLUENZA,7
GB,LIVEDO RETICULARIS,7
GB,LUPUS-LIKE SYNDROME,7
GB,MASS,7
GB,MAST CELL DEGRANULATION PRESENT,7
GB,METHAEMOGLOBINAEMIA,7
GB,MIOSIS,7
GB,NAIL DISCOLOURATION,7
GB,NIPPLE PAIN,7
GB,NON-CARDIAC CHEST PAIN,7
GB,PNEUMOPERITONEUM,7
GB,POST PROCEDURAL HAEMORRHAGE,7
GB,QUALITY OF LIFE DECREASED,7
GB,RECTAL PERFORATION,7
GB,RENAL CANCER,7
GB,RENAL FAILURE CHRONIC,7
GB,RHINORRHOEA,7
GB,SKIN DISORDER,7
GB,SKIN INFECTION,7
GB,SMALL INTESTINAL HAEMORRHAGE,7
GB,SPINAL PAIN,7
GB,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,7
GB,TEMPOROMANDIBULAR JOINT SYNDROME,7
GB,TENDON RUPTURE,7
GB,TENOSYNOVITIS,7
GB,THERAPEUTIC RESPONSE UNEXPECTED,7
GB,TONGUE BITING,7
GB,TOXIC EPIDERMAL NECROLYSIS,7
GB,TYPE 2 DIABETES MELLITUS,7
GB,UNDERWEIGHT,7
GB,VERTIGO POSITIONAL,7
GB,VOLVULUS,7
GB,ABASIA,6
GB,ACUTE HEPATIC FAILURE,6
GB,ALTERED STATE OF CONSCIOUSNESS,6
GB,ANTICONVULSANT DRUG LEVEL INCREASED,6
GB,APLASIA PURE RED CELL,6
GB,ARTERIAL HAEMORRHAGE,6
GB,ARTERIAL THROMBOSIS,6
GB,BILIARY SEPSIS,6
GB,BLAST CELLS PRESENT,6
GB,BODY TEMPERATURE INCREASED,6
GB,CARDIAC FLUTTER,6
GB,CEREBELLAR ATAXIA,6
GB,CEREBELLAR HAEMORRHAGE,6
GB,CHILLBLAINS,6
GB,CHOLECYSTITIS ACUTE,6
GB,COGWHEEL RIGIDITY,6
GB,DIVERTICULUM,6
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,6
GB,DUODENAL ULCER,6
GB,DYSCHROMATOPSIA,6
GB,DYSURIA,6
GB,EATING DISORDER,6
GB,ECCHYMOSIS,6
GB,EJACULATION DELAYED,6
GB,ELECTROLYTE IMBALANCE,6
GB,EXTRAPYRAMIDAL DISORDER,6
GB,EYELID RETRACTION,6
GB,FACIAL PAIN,6
GB,FEAR,6
GB,GASTRIC MUCOSAL LESION,6
GB,GENERALISED TONIC-CLONIC SEIZURE,6
GB,GLAUCOMA,6
GB,HAEMOBILIA,6
GB,HEMIPLEGIA,6
GB,HEPATIC FAILURE,6
GB,HERNIA,6
GB,HOT FLUSH,6
GB,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,6
GB,HYPERSENSITIVITY VASCULITIS,6
GB,HYPOGAMMAGLOBULINAEMIA,6
GB,HYPOTHERMIA,6
GB,INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION,6
GB,JAUNDICE CHOLESTATIC,6
GB,JOINT CREPITATION,6
GB,LACTIC ACIDOSIS,6
GB,LUNG DISORDER,6
GB,METASTASES TO LYMPH NODES,6
GB,MULTI-ORGAN FAILURE,6
GB,MUSCLE RUPTURE,6
GB,MUSCLE TIGHTNESS,6
GB,MYOCLONUS,6
GB,NERVOUSNESS,6
GB,NEURALGIA,6
GB,NOCTURIA,6
GB,NOSOCOMIAL INFECTION,6
GB,OSTEOARTHRITIS,6
GB,PARKINSONIAN REST TREMOR,6
GB,PARKINSONISM,6
GB,PARTIAL SEIZURES,6
GB,PELVIC PAIN,6
GB,PEMPHIGOID,6
GB,PENILE ULCERATION,6
GB,PENIS DISORDER,6
GB,PNEUMONIA ASPIRATION,6
GB,POST PROCEDURAL HAEMATOMA,6
GB,PYELONEPHRITIS,6
GB,RHEUMATOID ARTHRITIS,6
GB,SCAB,6
GB,STEVENS-JOHNSON SYNDROME,6
GB,TETANY,6
GB,TONGUE DISCOLOURATION,6
GB,TORSADE DE POINTES,6
GB,VITILIGO,6
GB,WOUND SECRETION,6
GB,ABDOMINAL PAIN LOWER,5
GB,ACUTE PULMONARY OEDEMA,5
GB,ADRENAL HAEMORRHAGE,5
GB,AGITATED DEPRESSION,5
GB,ANGINA UNSTABLE,5
GB,ARTHRITIS,5
GB,BASAL CELL CARCINOMA,5
GB,BLOOD DISORDER,5
GB,BONE PAIN,5
GB,BREAST CANCER,5
GB,CARDIO-RESPIRATORY ARREST,5
GB,CHOLANGITIS,5
GB,CORONARY ARTERY OCCLUSION,5
GB,DAYDREAMING,5
GB,DEAFNESS,5
GB,DEPRESSIVE SYMPTOM,5
GB,DISEASE PROGRESSION,5
GB,DIZZINESS EXERTIONAL,5
GB,DUODENAL PERFORATION,5
GB,EAR INFECTION,5
GB,ESCHERICHIA URINARY TRACT INFECTION,5
GB,FAECES SOFT,5
GB,FEMORAL NECK FRACTURE,5
GB,GASTRIC ANTRAL VASCULAR ECTASIA,5
GB,GASTROINTESTINAL DISORDER,5
GB,GLOMERULAR FILTRATION RATE ABNORMAL,5
GB,HAEMORRHAGE URINARY TRACT,5
GB,HALLUCINATIONS_ MIXED,5
GB,HEPARIN-INDUCED THROMBOCYTOPENIA,5
GB,HEPATIC FUNCTION ABNORMAL,5
GB,HEPATIC NECROSIS,5
GB,HEPATITIS CHOLESTATIC,5
GB,HYPERSOMNIA,5
GB,HYPORESPONSIVE TO STIMULI,5
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
GB,INCREASED BRONCHIAL SECRETION,5
GB,INJECTION SITE ERYTHEMA,5
GB,METABOLIC ACIDOSIS,5
GB,METASTASES TO LUNG,5
GB,MUSCLE ATROPHY,5
GB,MUSCLE RIGIDITY,5
GB,NEUROLOGICAL SYMPTOM,5
GB,OCULAR HYPERAEMIA,5
GB,OESOPHAGEAL CARCINOMA,5
GB,PANCREATITIS ACUTE,5
GB,PAPULE,5
GB,PERIARTHRITIS,5
GB,PERINEAL PAIN,5
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,5
GB,PRINZMETAL ANGINA,5
GB,PRODUCT QUALITY ISSUE,5
GB,PULMONARY HAEMATOMA,5
GB,RECTOCELE,5
GB,RESPIRATION ABNORMAL,5
GB,RESPIRATORY TRACT INFECTION,5
GB,RETROPERITONEAL HAEMORRHAGE,5
GB,SKIN HAEMORRHAGE,5
GB,SPINAL COLUMN STENOSIS,5
GB,SPINAL CORD HAEMORRHAGE,5
GB,SQUAMOUS CELL CARCINOMA,5
GB,SUPERFICIAL VEIN PROMINENCE,5
GB,SYSTEMIC LUPUS ERYTHEMATOSUS,5
GB,TONGUE ULCERATION,5
GB,TRANSCATHETER AORTIC VALVE IMPLANTATION,5
GB,VAGINAL HAEMORRHAGE,5
GB,VASCULAR INJURY,5
GB,VASCULAR PAIN,5
GB,VASCULITIC RASH,5
GB,VASODILATATION,5
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
GB,ABDOMINAL RIGIDITY,4
GB,ABDOMINAL TENDERNESS,4
GB,ABDOMINAL WALL HAEMATOMA,4
GB,AIRWAY COMPLICATION OF ANAESTHESIA,4
GB,ANGER,4
GB,ANGIOPATHY,4
GB,AUTOIMMUNE HEPATITIS,4
GB,BINOCULAR EYE MOVEMENT DISORDER,4
GB,BLOOD BILIRUBIN INCREASED,4
GB,BLOOD PHOSPHORUS DECREASED,4
GB,BRAIN MIDLINE SHIFT,4
GB,CANDIDA INFECTION,4
GB,CAPILLARY FRAGILITY TEST,4
GB,CARDIOGENIC SHOCK,4
GB,CENTRAL NERVOUS SYSTEM LESION,4
GB,CEREBROVASCULAR DISORDER,4
GB,CHOKING,4
GB,COLON CANCER STAGE III,4
GB,CONJUNCTIVAL HAEMORRHAGE,4
GB,CORNEAL DISORDER,4
GB,CORONARY ARTERY DISEASE,4
GB,CRYING,4
GB,DIARRHOEA HAEMORRHAGIC,4
GB,DRUG DEPENDENCE,4
GB,DRUG ERUPTION,4
GB,ECHOCARDIOGRAM ABNORMAL,4
GB,EJECTION FRACTION DECREASED,4
GB,ENCEPHALOPATHY,4
GB,END STAGE RENAL DISEASE,4
GB,FISTULA,4
GB,FOOD INTERACTION,4
GB,FOREIGN BODY,4
GB,FREQUENT BOWEL MOVEMENTS,4
GB,GASTROINTESTINAL ULCER,4
GB,GLOMERULAR FILTRATION RATE DECREASED,4
GB,HAEMORRHAGIC STROKE,4
GB,HYPERTHYROIDISM,4
GB,HYPOVOLAEMIC SHOCK,4
GB,INCORRECT DOSE ADMINISTERED,4
GB,INFREQUENT BOWEL MOVEMENTS,4
GB,LEFT VENTRICULAR HYPERTROPHY,4
GB,LOCALISED OEDEMA,4
GB,MOVEMENT DISORDER,4
GB,MUCOSAL INFLAMMATION,4
GB,MUCOSAL ULCERATION,4
GB,MUSCLE SPASTICITY,4
GB,MYASTHENIA GRAVIS,4
GB,ORAL MUCOSAL BLISTERING,4
GB,ORBITAL OEDEMA,4
GB,ORTHOPNOEA,4
GB,OSTEONECROSIS OF EXTERNAL AUDITORY CANAL,4
GB,PANCREATITIS,4
GB,PERIPHERAL COLDNESS,4
GB,PLATELET DYSFUNCTION,4
GB,PNEUMONITIS,4
GB,PORTAL VENOUS GAS,4
GB,POSTOPERATIVE WOUND INFECTION,4
GB,PROCEDURAL HYPOTENSION,4
GB,PRODUCT SHAPE ISSUE,4
GB,PRODUCT USE IN UNAPPROVED INDICATION,4
GB,PUNCTATE KERATITIS,4
GB,QUADRIPLEGIA,4
GB,RENAL PAIN,4
GB,RESPIRATORY RATE INCREASED,4
GB,RESPIRATORY TRACT INFECTION VIRAL,4
GB,SEPTIC SHOCK,4
GB,SKIN EROSION,4
GB,SUPRAVENTRICULAR EXTRASYSTOLES,4
GB,SYNOVIAL CYST,4
GB,TACHYPNOEA,4
GB,THIRST DECREASED,4
GB,ULCERATIVE KERATITIS,4
GB,URETHRAL HAEMORRHAGE,4
GB,ABDOMINAL SEPSIS,3
GB,ACTINIC KERATOSIS,3
GB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,3
GB,ALCOHOL ABUSE,3
GB,AMAUROSIS FUGAX,3
GB,ANAL HAEMORRHAGE,3
GB,APHTHOUS ULCER,3
GB,ASPARTATE AMINOTRANSFERASE INCREASED,3
GB,AZOTAEMIA,3
GB,BLOOD CHOLESTEROL ABNORMAL,3
GB,BLOOD CREATININE ABNORMAL,3
GB,BLOOD POTASSIUM INCREASED,3
GB,BLOOD PRESSURE INCREASED,3
GB,BRAIN STEM STROKE,3
GB,BRONCHITIS,3
GB,CAROTID ARTERY OCCLUSION,3
GB,CAROTID ARTERY STENOSIS,3
GB,CENTRAL NERVOUS SYSTEM LYMPHOMA,3
GB,COLITIS ULCERATIVE,3
GB,CONTRAINDICATED DRUG PRESCRIBED,3
GB,CROHN^S DISEASE,3
GB,CUTANEOUS VASCULITIS,3
GB,DERMATITIS PSORIASIFORM,3
GB,DRUG TITRATION ERROR,3
GB,DUODENAL ULCER PERFORATION,3
GB,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
GB,EMOTIONAL DISORDER,3
GB,EOSINOPHIL COUNT NORMAL,3
GB,EYE HAEMORRHAGE,3
GB,EYE IRRITATION,3
GB,FANCONI SYNDROME,3
GB,FEBRILE NEUTROPENIA,3
GB,FEELING OF DESPAIR,3
GB,FEELINGS OF WORTHLESSNESS,3
GB,FEMUR FRACTURE,3
GB,FOREIGN BODY SENSATION IN EYES,3
GB,GASTRIC PH INCREASED,3
GB,GASTROENTERITIS,3
GB,GASTROINTESTINAL ULCER HAEMORRHAGE,3
GB,HAEMATOCRIT DECREASED,3
GB,HIP FRACTURE,3
GB,HYPERPHAGIA,3
GB,IMMOBILE,3
GB,IMPAIRED DRIVING ABILITY,3
GB,INCORRECT DOSE ADMINISTERED BY DEVICE,3
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
GB,INFARCTION,3
GB,INFLAMMATION,3
GB,INJECTION SITE PAIN,3
GB,INTENTIONAL PRODUCT MISUSE,3
GB,INTERNATIONAL NORMALISED RATIO DECREASED,3
GB,INTERNATIONAL NORMALISED RATIO FLUCTUATION,3
GB,INTRACARDIAC THROMBUS,3
GB,LEUKAEMIA,3
GB,LEUKOCYTOSIS,3
GB,LIGAMENT PAIN,3
GB,LIP PAIN,3
GB,LUNG NEOPLASM MALIGNANT,3
GB,MALIGNANT NEOPLASM PROGRESSION,3
GB,MUSCLE DISORDER,3
GB,MUSCULOSKELETAL DISCOMFORT,3
GB,NASAL DISCOMFORT,3
GB,NASOPHARYNGITIS,3
GB,NECROSIS,3
GB,NEGATIVE THOUGHTS,3
GB,NERVE INJURY,3
GB,OESOPHAGITIS HAEMORRHAGIC,3
GB,OSTEITIS,3
GB,PANCREATIC CARCINOMA,3
GB,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,3
GB,PERSONALITY CHANGE,3
GB,PLEURITIC PAIN,3
GB,POSTICTAL STATE,3
GB,POTENTIATING DRUG INTERACTION,3
GB,PROSTATOMEGALY,3
GB,PSYCHIATRIC SYMPTOM,3
GB,PULMONARY HAEMORRHAGE,3
GB,PUPIL FIXED,3
GB,PYODERMA GANGRENOSUM,3
GB,RASH PAPULAR,3
GB,RASH PAPULOSQUAMOUS,3
GB,RED BLOOD CELL COUNT DECREASED,3
GB,RENAL TUBULAR ACIDOSIS,3
GB,RETINAL ARTERY OCCLUSION,3
GB,RHINALGIA,3
GB,SINUSITIS,3
GB,SKIN ATROPHY,3
GB,SKIN NECROSIS,3
GB,SKIN ODOUR ABNORMAL,3
GB,SKIN REACTION,3
GB,SKIN WOUND,3
GB,SLEEP APNOEA SYNDROME,3
GB,SUDDEN DEATH,3
GB,SUPRAVENTRICULAR TACHYCARDIA,3
GB,SWEAT GLAND TUMOUR,3
GB,THYROTOXIC CRISIS,3
GB,TONGUE BLISTERING,3
GB,TONGUE DISCOMFORT,3
GB,TONIC CONVULSION,3
GB,TUBULOINTERSTITIAL NEPHRITIS,3
GB,URINARY BLADDER HAEMORRHAGE,3
GB,VASCULAR STENT THROMBOSIS,3
GB,VENTRICULAR FIBRILLATION,3
GB,VENTRICULAR TACHYCARDIA,3
GB,VITREOUS FLOATERS,3
GB,WALKING AID USER,3
GB,WOUND COMPLICATION,3
GB,ACCIDENT,2
GB,ACUTE LEUKAEMIA,2
GB,ADRENAL INSUFFICIENCY,2
GB,ANAPHYLACTIC SHOCK,2
GB,ANEURYSM RUPTURED,2
GB,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,2
GB,AORTIC ANEURYSM,2
GB,AORTIC STENOSIS,2
GB,APPLICATION SITE RASH,2
GB,ATAXIA,2
GB,ATRIAL THROMBOSIS,2
GB,AUDITORY DISORDER,2
GB,AURA,2
GB,BASAL GANGLIA INFARCTION,2
GB,BIPOLAR DISORDER,2
GB,BLADDER DISCOMFORT,2
GB,BLADDER IRRITATION,2
GB,BLINDNESS TRANSIENT,2
GB,BLINDNESS UNILATERAL,2
GB,BLOOD CHOLESTEROL INCREASED,2
GB,BLOOD GLUCOSE ABNORMAL,2
GB,BLOOD MAGNESIUM DECREASED,2
GB,BLOOD SODIUM DECREASED,2
GB,BODY TEMPERATURE FLUCTUATION,2
GB,BONE MARROW MYELOGRAM ABNORMAL,2
GB,BREAST HAEMATOMA,2
GB,BREAST SWELLING,2
GB,BRONCHIAL CARCINOMA,2
GB,BRONCHIECTASIS,2
GB,BUNDLE BRANCH BLOCK RIGHT,2
GB,BURSITIS,2
GB,CARDIOMYOPATHY,2
GB,CARDIOVASCULAR DISORDER,2
GB,CEREBELLAR INFARCTION,2
GB,CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE,2
GB,CHAPPED LIPS,2
GB,CHOLANGIOCARCINOMA,2
GB,CHROMATOPSIA,2
GB,CILIARY ZONULAR DEHISCENCE,2
GB,CLUSTER HEADACHE,2
GB,COMA,2
GB,COORDINATION ABNORMAL,2
GB,CORNEAL ABRASION,2
GB,CORNEAL DYSTROPHY,2
GB,CORNEAL THINNING,2
GB,CORONARY ARTERY RESTENOSIS,2
GB,CUTANEOUS LUPUS ERYTHEMATOSUS,2
GB,CYSTITIS,2
GB,DEFAECATION URGENCY,2
GB,DIABETIC FOOT INFECTION,2
GB,DILATATION VENTRICULAR,2
GB,DIVERTICULAR PERFORATION,2
GB,DRUG EFFECT INCOMPLETE,2
GB,DYSPHONIA,2
GB,ECTROPION,2
GB,EOSINOPHIL COUNT INCREASED,2
GB,ESCHERICHIA BACTERAEMIA,2
GB,EXOSTOSIS,2
GB,FACIAL PARESIS,2
GB,FAECALOMA,2
GB,FEMORAL ARTERY ANEURYSM,2
GB,FLUID OVERLOAD,2
GB,GASTRIC DISORDER,2
GB,GASTRITIS HAEMORRHAGIC,2
GB,GASTROINTESTINAL PAIN,2
GB,GASTROINTESTINAL STOMA COMPLICATION,2
GB,GASTROINTESTINAL TUBE INSERTION,2
GB,GINGIVAL PAIN,2
GB,GOUT,2
GB,GRIP STRENGTH DECREASED,2
GB,HAIR DISORDER,2
GB,HALO VISION,2
GB,HEART RATE IRREGULAR,2
GB,HEPATIC ENZYME INCREASED,2
GB,HEPATOTOXICITY,2
GB,HODGKIN^S DISEASE,2
GB,HOSPITALISATION,2
GB,HYPERNATRAEMIA,2
GB,HYPERREFLEXIA,2
GB,HYPERTONIA,2
GB,HYPOKINESIA,2
GB,HYPOPHOSPHATAEMIA,2
GB,HYPOPNOEA,2
GB,IIIRD NERVE PARALYSIS,2
GB,IMMUNE THROMBOCYTOPENIC PURPURA,2
GB,IMMUNOSUPPRESSION,2
GB,IMPETIGO,2
GB,IMPULSIVE BEHAVIOUR,2
GB,INCONTINENCE,2
GB,INFUSION RELATED REACTION,2
GB,INJECTION SITE SWELLING,2
GB,INTESTINAL HAEMORRHAGE,2
GB,INTESTINAL INFARCTION,2
GB,INTESTINAL OBSTRUCTION,2
GB,JOB DISSATISFACTION,2
GB,JOINT STIFFNESS,2
GB,LEFT VENTRICULAR FAILURE,2
GB,LEUKOPENIA,2
GB,LIP BLISTER,2
GB,LUNG INFILTRATION,2
GB,MACULAR HOLE,2
GB,MALNUTRITION,2
GB,METAMORPHOPSIA,2
GB,METASTASES TO BONE,2
GB,METASTASES TO CENTRAL NERVOUS SYSTEM,2
GB,METASTASES TO LIVER,2
GB,MICTURITION URGENCY,2
GB,MIDDLE INSOMNIA,2
GB,MIGRAINE,2
GB,MITRAL VALVE INCOMPETENCE,2
GB,MUSCULOSKELETAL STIFFNESS,2
GB,NASAL CONGESTION,2
GB,NEOPLASM MALIGNANT,2
GB,NERVOUS SYSTEM DISORDER,2
GB,NODAL ARRHYTHMIA,2
GB,NODAL RHYTHM,2
GB,NONINFECTIVE GINGIVITIS,2
GB,OEDEMA MOUTH,2
GB,ONYCHOCLASIS,2
GB,ORAL CANDIDIASIS,2
GB,ORAL HERPES,2
GB,ORGANISING PNEUMONIA,2
GB,OSTEONECROSIS OF JAW,2
GB,OSTEOPENIA,2
GB,PANIC DISORDER,2
GB,PANIC REACTION,2
GB,PERIPHERAL VASCULAR DISORDER,2
GB,PETECHIAE,2
GB,PHOTOPHOBIA,2
GB,PO2 DECREASED,2
GB,POLYARTHRITIS,2
GB,POLYCYTHAEMIA,2
GB,POOR QUALITY SLEEP,2
GB,POST HERPETIC NEURALGIA,2
GB,POSTICTAL PARALYSIS,2
GB,PROTHROMBIN TIME PROLONGED,2
GB,PSORIATIC ARTHROPATHY,2
GB,PULMONARY ARTERIAL HYPERTENSION,2
GB,PUPILLARY REFLEX IMPAIRED,2
GB,RASH VESICULAR,2
GB,RENAL CYST,2
GB,RESUSCITATION,2
GB,RETCHING,2
US,GASTROINTESTINAL HAEMORRHAGE,4642
US,MYOCARDIAL INFARCTION,3543
US,CEREBROVASCULAR ACCIDENT,1988
US,DYSPNOEA,1986
US,DRUG INEFFECTIVE,1873
US,FATIGUE,1807
US,DIARRHOEA,1563
US,NAUSEA,1546
US,DIZZINESS,1438
US,CARDIAC FAILURE CONGESTIVE,1428
US,ASTHENIA,1313
US,PAIN,1274
US,HAEMORRHAGE,1237
US,FALL,1216
US,DEATH,1201
US,HEADACHE,1155
US,CORONARY ARTERY DISEASE,1148
US,CHEST PAIN,1023
US,ACUTE MYOCARDIAL INFARCTION,1021
US,MALAISE,966
US,MULTIPLE INJURIES,961
US,WEIGHT DECREASED,960
US,DRUG DOSE OMISSION,932
US,PNEUMONIA,916
US,PAIN IN EXTREMITY,904
US,ANAEMIA,889
US,CEREBRAL HAEMORRHAGE,868
US,ULCER HAEMORRHAGE,831
US,EPISTAXIS,808
US,VOMITING,789
US,ARTHRALGIA,741
US,BACK PAIN,716
US,COUGH,703
US,RASH,694
US,CONTUSION,690
US,HYPERTENSION,667
US,CONSTIPATION,663
US,HYPOTENSION,637
US,PRURITUS,633
US,GAIT DISTURBANCE,629
US,INSOMNIA,607
US,FEELING ABNORMAL,578
US,RECTAL HAEMORRHAGE,569
US,MUSCLE SPASMS,563
US,BLOOD GLUCOSE INCREASED,562
US,CORONARY ARTERIAL STENT INSERTION,561
US,DECREASED APPETITE,558
US,CARDIAC DISORDER,532
US,ABDOMINAL PAIN UPPER,528
US,ACUTE KIDNEY INJURY,528
US,ATRIAL FIBRILLATION,491
US,MYALGIA,480
US,PERIPHERAL SWELLING,470
US,URINARY TRACT INFECTION,461
US,ABDOMINAL DISCOMFORT,447
US,PRODUCT USE ISSUE,445
US,DRUG HYPERSENSITIVITY,444
US,ANXIETY,441
US,UPPER GASTROINTESTINAL HAEMORRHAGE,439
US,TRANSIENT ISCHAEMIC ATTACK,436
US,WEIGHT INCREASED,435
US,PRODUCT QUALITY ISSUE,426
US,DEPRESSION,422
US,MEMORY IMPAIRMENT,422
US,DEHYDRATION,417
US,CONFUSIONAL STATE,416
US,HAEMOGLOBIN DECREASED,406
US,BLOOD PRESSURE INCREASED,404
US,ABDOMINAL PAIN,391
US,CONDITION AGGRAVATED,382
US,HYPOAESTHESIA,377
US,MUSCULAR WEAKNESS,373
US,PYREXIA,371
US,TREMOR,354
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,353
US,ANGINA PECTORIS,350
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,350
US,SOMNOLENCE,349
US,INJECTION SITE PAIN,345
US,CORONARY ARTERY OCCLUSION,341
US,GASTROOESOPHAGEAL REFLUX DISEASE,337
US,BALANCE DISORDER,331
US,HAEMATURIA,329
US,INCORRECT DOSE ADMINISTERED,325
US,RENAL FAILURE,325
US,THROMBOSIS,325
US,DYSPEPSIA,323
US,INJURY,320
US,NASOPHARYNGITIS,313
US,VISION BLURRED,312
US,INJECTION SITE BRUISING,307
US,SYNCOPE,307
US,OEDEMA PERIPHERAL,299
US,PARAESTHESIA,294
US,AMNESIA,293
US,CHEST DISCOMFORT,290
US,INTENTIONAL PRODUCT MISUSE,289
US,LOSS OF CONSCIOUSNESS,282
US,DYSPHAGIA,281
US,INTERNAL HAEMORRHAGE,277
US,HAEMATOCHEZIA,273
US,HYPERHIDROSIS,271
US,FLUSHING,270
US,VISUAL IMPAIRMENT,268
US,HYPERSENSITIVITY,265
US,DIABETES MELLITUS,264
US,BRONCHITIS,259
US,ARTHRITIS,258
US,NEUROPATHY PERIPHERAL,258
US,STENT PLACEMENT,251
US,FLUID RETENTION,249
US,SEPSIS,247
US,ALOPECIA,242
US,ANGINA UNSTABLE,237
US,ERYTHEMA,236
US,MUSCULOSKELETAL PAIN,236
US,INFLUENZA,235
US,DRUG ADMINISTRATION ERROR,233
US,JOINT SWELLING,233
US,CARDIAC ARREST,232
US,THROMBOTIC THROMBOCYTOPENIC PURPURA,230
US,DYSGEUSIA,228
US,CATARACT,223
US,ABDOMINAL DISTENSION,219
US,HAEMORRHAGIC ANAEMIA,216
US,OROPHARYNGEAL PAIN,216
US,SINUSITIS,216
US,HAEMATOMA,215
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,215
US,HAEMOPTYSIS,214
US,PLATELET COUNT DECREASED,214
US,RESPIRATORY FAILURE,212
US,CORONARY ARTERY BYPASS,210
US,HEART RATE INCREASED,208
US,DRY MOUTH,204
US,CHILLS,203
US,BLOOD PRESSURE DECREASED,202
US,URTICARIA,202
US,PALPITATIONS,199
US,BURNING SENSATION,198
US,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,198
US,OEDEMA,197
US,HAEMORRHAGE INTRACRANIAL,196
US,PLEURAL EFFUSION,193
US,SWELLING,190
US,DYSPHONIA,188
US,RHINORRHOEA,185
US,BLOOD CHOLESTEROL INCREASED,184
US,FLATULENCE,182
US,SEIZURE,178
US,BLOOD GLUCOSE DECREASED,177
US,COAGULOPATHY,177
US,LOWER GASTROINTESTINAL HAEMORRHAGE,176
US,CELLULITIS,175
US,INFECTION,174
US,INJECTION SITE HAEMORRHAGE,173
US,THERAPY CESSATION,169
US,SKIN DISCOLOURATION,168
US,TYPE 2 DIABETES MELLITUS,168
US,HOSPITALISATION,167
US,DEEP VEIN THROMBOSIS,166
US,NASAL CONGESTION,166
US,OSTEOARTHRITIS,166
US,THROMBOCYTOPENIA,166
US,ADVERSE EVENT,164
US,CARDIAC FAILURE,162
US,SPEECH DISORDER,161
US,OSTEOPOROSIS,157
US,UNDERDOSE,157
US,GASTROINTESTINAL DISORDER,156
US,PULMONARY EMBOLISM,156
US,RENAL IMPAIRMENT,156
US,DYSPNOEA EXERTIONAL,155
US,PRODUCT USE IN UNAPPROVED INDICATION,154
US,VISUAL ACUITY REDUCED,153
US,WHITE BLOOD CELL COUNT DECREASED,153
US,NECK PAIN,152
US,PULMONARY OEDEMA,152
US,HAEMORRHAGIC STROKE,149
US,ARTERIAL OCCLUSIVE DISEASE,148
US,ARTERIOSCLEROSIS,148
US,ARRHYTHMIA,147
US,INFLUENZA LIKE ILLNESS,147
US,OVERDOSE,147
US,PSORIASIS,147
US,THERAPEUTIC RESPONSE UNEXPECTED,147
US,UNEVALUABLE EVENT,147
US,DRY SKIN,146
US,SUBDURAL HAEMATOMA,146
US,HAEMATEMESIS,145
US,RENAL DISORDER,144
US,BLOOD CREATININE INCREASED,143
US,BONE PAIN,143
US,FAECES DISCOLOURED,143
US,RENAL FAILURE ACUTE,143
US,INCORRECT DRUG ADMINISTRATION DURATION,142
US,LETHARGY,142
US,HALLUCINATION,141
US,ASTHMA,140
US,DRUG EFFECT INCOMPLETE,140
US,BLISTER,139
US,DYSURIA,139
US,STRESS,139
US,DISEASE PROGRESSION,138
US,HOT FLUSH,138
US,ABASIA,137
US,MUSCULOSKELETAL STIFFNESS,137
US,HIP FRACTURE,136
US,POLLAKIURIA,135
US,PRODUCTIVE COUGH,135
US,SLEEP DISORDER,134
US,ARTHROPATHY,133
US,MOBILITY DECREASED,131
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,131
US,HEAD INJURY,130
US,MELAENA,130
US,ACUTE CORONARY SYNDROME,128
US,HYPOGLYCAEMIA,128
US,VERTIGO,128
US,NEPHROLITHIASIS,127
US,GASTRITIS,125
US,RHEUMATOID ARTHRITIS,124
US,UPPER RESPIRATORY TRACT INFECTION,124
US,HERPES ZOSTER,122
US,ISCHAEMIC STROKE,122
US,ARTERIOSCLEROSIS CORONARY ARTERY,121
US,LOCAL SWELLING,121
US,PANCREATITIS,121
US,GASTRIC ULCER,120
US,STOMATITIS,120
US,WHEEZING,120
US,BLOOD URINE PRESENT,118
US,INJECTION SITE ERYTHEMA,118
US,NERVOUSNESS,118
US,EMOTIONAL DISTRESS,117
US,GASTRIC DISORDER,117
US,GOUT,116
US,PAIN IN JAW,115
US,LUNG DISORDER,114
US,SKIN EXFOLIATION,114
US,DRUG INTOLERANCE,111
US,HIATUS HERNIA,111
US,MYOCARDIAL ISCHAEMIA,111
US,ADVERSE DRUG REACTION,110
US,THROAT IRRITATION,109
US,CHRONIC KIDNEY DISEASE,108
US,HEART RATE DECREASED,108
US,HYPERLIPIDAEMIA,108
US,BLINDNESS,107
US,HYPOACUSIS,107
US,INTENTIONAL PRODUCT USE ISSUE,107
US,CARDIOVASCULAR DISORDER,106
US,DYSARTHRIA,106
US,GENERAL PHYSICAL HEALTH DETERIORATION,106
US,INCREASED TENDENCY TO BRUISE,106
US,BLOOD POTASSIUM INCREASED,104
US,PHYSICAL DISABILITY,104
US,HEMIPARESIS,103
US,MIGRAINE,103
US,BLOOD POTASSIUM DECREASED,102
US,OXYGEN SATURATION DECREASED,102
US,CARDIO-RESPIRATORY ARREST,101
US,DIVERTICULITIS,101
US,DRUG EFFECT DECREASED,101
US,LIMB DISCOMFORT,101
US,APHASIA,100
US,CEREBRAL INFARCTION,99
US,INTERVERTEBRAL DISC PROTRUSION,99
US,FEELING HOT,98
US,INTERNATIONAL NORMALISED RATIO INCREASED,98
US,URINARY INCONTINENCE,98
US,BONE DISORDER,97
US,CYSTITIS,97
US,GASTRIC HAEMORRHAGE,97
US,MALIGNANT NEOPLASM PROGRESSION,97
US,ACUTE RESPIRATORY FAILURE,96
US,HAEMORRHAGIC ARTERIOVENOUS MALFORMATION,96
US,MENTAL STATUS CHANGES,96
US,HYPOXIA,94
US,IMPAIRED HEALING,94
US,RIB FRACTURE,94
US,STAPHYLOCOCCAL INFECTION,93
US,HAEMORRHOIDS,92
US,HYPOTHYROIDISM,92
US,ORAL PAIN,92
US,BODY HEIGHT DECREASED,91
US,CHOLELITHIASIS,91
US,LACERATION,91
US,SURGERY,91
US,CHROMATURIA,90
US,DEMENTIA,90
US,DRUG PRESCRIBING ERROR,90
US,EYE PAIN,90
US,FULL BLOOD COUNT DECREASED,90
US,HEPATIC ENZYME INCREASED,90
US,LUNG NEOPLASM MALIGNANT,90
US,AGITATION,89
US,DYSSTASIA,89
US,MEDICATION ERROR,89
US,TINNITUS,89
US,DEVICE MALFUNCTION,88
US,HYPOKALAEMIA,88
US,SKIN ULCER,88
US,SWELLING FACE,88
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,87
US,HYPERKALAEMIA,87
US,PRESYNCOPE,87
US,RASH PRURITIC,87
US,ACTIVITIES OF DAILY LIVING IMPAIRED,86
US,IRON DEFICIENCY ANAEMIA,86
US,BRADYCARDIA,85
US,GINGIVAL BLEEDING,85
US,ANHEDONIA,84
US,PERIPHERAL VASCULAR DISORDER,84
US,RED BLOOD CELL COUNT DECREASED,84
US,TREATMENT NONCOMPLIANCE,84
US,VAGINAL HAEMORRHAGE,84
US,DISORIENTATION,83
US,GASTRIC ULCER HAEMORRHAGE,83
US,HYPERSOMNIA,83
US,NEUTROPENIA,83
US,SLEEP APNOEA SYNDROME,83
US,TACHYCARDIA,83
US,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,82
US,PULMONARY MASS,82
US,COMPLETED SUICIDE,81
US,HEART RATE IRREGULAR,81
US,LIMB INJURY,81
US,NEOPLASM MALIGNANT,81
US,OSTEOMYELITIS,81
US,SUBARACHNOID HAEMORRHAGE,81
US,DISCOMFORT,80
US,INTENTIONAL DRUG MISUSE,80
US,LOCALISED INFECTION,80
US,ROAD TRAFFIC ACCIDENT,80
US,EYE HAEMORRHAGE,79
US,IRRITABILITY,79
US,BLOOD PRESSURE ABNORMAL,78
US,FLUID OVERLOAD,78
US,ISCHAEMIC CARDIOMYOPATHY,78
US,PRODUCT SUBSTITUTION ISSUE,78
US,UPPER LIMB FRACTURE,78
US,WHITE BLOOD CELL COUNT INCREASED,78
US,DRUG DISPENSING ERROR,77
US,PULMONARY HYPERTENSION,77
US,RASH GENERALISED,77
US,CAROTID ARTERY OCCLUSION,76
US,DIVERTICULUM,76
US,DRY EYE,76
US,MULTIPLE SCLEROSIS RELAPSE,76
US,HYPONATRAEMIA,75
US,PRURITUS GENERALISED,75
US,WOUND,75
US,EXPIRED PRODUCT ADMINISTERED,74
US,EYE SWELLING,74
US,HAEMORRHOIDAL HAEMORRHAGE,74
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,74
US,THERAPEUTIC RESPONSE DECREASED,73
US,TOXICITY TO VARIOUS AGENTS,73
US,CARDIOMYOPATHY,72
US,INJECTION SITE MASS,72
US,MUSCULOSKELETAL CHEST PAIN,72
US,RASH MACULAR,72
US,CONTRAINDICATED PRODUCT ADMINISTERED,71
US,DIVERTICULUM INTESTINAL HAEMORRHAGIC,71
US,HAEMATOCRIT DECREASED,71
US,INTERVERTEBRAL DISC DEGENERATION,71
US,NO ADVERSE EVENT,71
US,PLASMA CELL MYELOMA,71
US,ATELECTASIS,70
US,COGNITIVE DISORDER,70
US,DISTURBANCE IN ATTENTION,70
US,DYSKINESIA,70
US,ECCHYMOSIS,70
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,70
US,JOINT INJURY,70
US,SEPTIC SHOCK,70
US,URINARY RETENTION,70
US,VASCULAR GRAFT,70
US,AGEUSIA,69
US,PERICARDIAL EFFUSION,69
US,POST PROCEDURAL HAEMORRHAGE,69
US,RETCHING,69
US,BACK DISORDER,68
US,BLOOD TRIGLYCERIDES INCREASED,68
US,GLAUCOMA,68
US,SPINAL OSTEOARTHRITIS,68
US,THROMBOSIS IN DEVICE,68
US,EYE DISORDER,67
US,ULCER,67
US,NEURALGIA,66
US,OSTEONECROSIS OF JAW,66
US,PANIC ATTACK,66
US,SKIN CANCER,66
US,ASPARTATE AMINOTRANSFERASE INCREASED,65
US,HYPOPHAGIA,65
US,SINUS DISORDER,65
US,ANKLE FRACTURE,64
US,BLOOD COUNT ABNORMAL,64
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,64
US,LARGE INTESTINE POLYP,64
US,VENTRICULAR TACHYCARDIA,64
US,GALLBLADDER DISORDER,63
US,PANCYTOPENIA,63
US,SUICIDAL IDEATION,63
US,CAROTID ARTERY STENOSIS,62
US,DEFORMITY,62
US,LACRIMATION INCREASED,62
US,SPINAL FRACTURE,62
US,WRIST FRACTURE,62
US,ALANINE AMINOTRANSFERASE INCREASED,61
US,CORONARY ARTERY STENOSIS,61
US,DEPRESSED MOOD,61
US,ECONOMIC PROBLEM,61
US,HYPERGLYCAEMIA,61
US,SWOLLEN TONGUE,61
US,VIRAL INFECTION,61
US,ABNORMAL BEHAVIOUR,60
US,FOOT FRACTURE,60
US,LYMPHADENOPATHY,60
US,MALABSORPTION,60
US,MENTAL IMPAIRMENT,60
US,PHARYNGEAL OEDEMA,60
US,CONVULSION,59
US,FEELING COLD,59
US,LEUKOCYTOSIS,59
US,FUNGAL INFECTION,58
US,LOWER LIMB FRACTURE,58
US,MUSCULOSKELETAL DISCOMFORT,58
US,MUSCULOSKELETAL DISORDER,58
US,RESPIRATORY DISORDER,58
US,TOOTHACHE,58
US,UNRESPONSIVE TO STIMULI,58
US,CHOKING,57
US,CLOSTRIDIUM DIFFICILE INFECTION,57
US,EATING DISORDER,57
US,EYE IRRITATION,57
US,GLOSSODYNIA,57
US,KIDNEY INFECTION,57
US,ORTHOSTATIC HYPOTENSION,57
US,ROTATOR CUFF SYNDROME,57
US,VITAMIN D DEFICIENCY,57
US,CANDIDA INFECTION,56
US,DEVICE ISSUE,56
US,NERVE INJURY,56
US,RASH ERYTHEMATOUS,56
US,SCIATICA,56
US,SKIN DISORDER,56
US,BLOOD PRESSURE FLUCTUATION,55
US,CATHETERISATION CARDIAC,55
US,ERUCTATION,55
US,INTESTINAL OBSTRUCTION,55
US,MASS,55
US,NIGHT SWEATS,55
US,TOOTH DISORDER,55
US,ABNORMAL DREAMS,54
US,BLOOD GLUCOSE ABNORMAL,54
US,COLITIS,54
US,ERECTILE DYSFUNCTION,54
US,INJECTION SITE SWELLING,54
US,LIVER DISORDER,54
US,LIVER FUNCTION TEST ABNORMAL,54
US,MACULAR DEGENERATION,54
US,MITRAL VALVE INCOMPETENCE,54
US,NIGHTMARE,54
US,OSTEOPENIA,54
US,RESPIRATORY DISTRESS,54
US,SHOCK HAEMORRHAGIC,54
US,SKIN HAEMORRHAGE,54
US,FEMUR FRACTURE,53
US,MENTAL DISORDER,53
US,MOUTH HAEMORRHAGE,53
US,MOVEMENT DISORDER,53
US,PULMONARY ARTERIAL HYPERTENSION,53
US,AORTIC ANEURYSM,52
US,CROHN^S DISEASE,52
US,CRYING,52
US,DIPLOPIA,52
US,EMPHYSEMA,52
US,FEAR,52
US,HERNIA,52
US,CARDIAC OPERATION,51
US,DEAFNESS,51
US,DIABETIC NEUROPATHY,51
US,INJECTION SITE PRURITUS,51
US,NERVOUS SYSTEM DISORDER,51
US,RESPIRATORY TRACT CONGESTION,51
US,SKIN BURNING SENSATION,51
US,CARDIOMEGALY,50
US,DRUG WITHDRAWAL SYNDROME,50
US,HEMIPLEGIA,50
US,ILL-DEFINED DISORDER,50
US,MULTIPLE FRACTURES,50
US,PNEUMONIA ASPIRATION,50
US,PROSTATE CANCER,50
US,RESTLESS LEGS SYNDROME,50
US,SPINAL COLUMN STENOSIS,50
US,TRANSFUSION,50
US,AGGRESSION,49
US,ANGIOEDEMA,49
US,BLOOD SODIUM DECREASED,49
US,CARDIAC PACEMAKER INSERTION,49
US,NOCTURIA,49
US,PANCREATITIS ACUTE,49
US,TENSION,49
US,WRONG DRUG ADMINISTERED,49
US,BLINDNESS UNILATERAL,48
US,CARPAL TUNNEL SYNDROME,48
US,DISABILITY,48
US,JOINT STIFFNESS,48
US,LABORATORY TEST ABNORMAL,48
US,METASTASES TO LIVER,48
US,MULTIPLE SCLEROSIS,48
US,PRODUCT ADHESION ISSUE,48
US,BLOOD GLUCOSE FLUCTUATION,47
US,BLOOD UREA INCREASED,47
US,DEVICE OCCLUSION,47
US,LIP SWELLING,47
US,LOSS OF EMPLOYMENT,47
US,ORAL DISCOMFORT,47
US,PARKINSON^S DISEASE,47
US,PRESCRIBED UNDERDOSE,47
US,PSYCHOLOGICAL TRAUMA,47
US,VASCULAR STENT THROMBOSIS,47
US,APPLICATION SITE ERYTHEMA,46
US,APPLICATION SITE PAIN,46
US,EAR PAIN,46
US,IRRITABLE BOWEL SYNDROME,46
US,PLATELET COUNT INCREASED,46
US,PULMONARY FIBROSIS,46
US,SKIN LESION,46
US,ABNORMAL LOSS OF WEIGHT,45
US,ANEURYSM,45
US,BLOOD DISORDER,45
US,FIBROMYALGIA,45
US,PRE-EXISTING CONDITION IMPROVED,45
US,ATRIOVENTRICULAR BLOCK,44
US,BLOOD IRON DECREASED,44
US,DELIRIUM,44
US,FREQUENT BOWEL MOVEMENTS,44
US,HYPOKINESIA,44
US,URINE OUTPUT DECREASED,44
US,WITHDRAWAL SYNDROME,44
US,CARDIOGENIC SHOCK,43
US,DIZZINESS POSTURAL,43
US,INFLAMMATION,43
US,INJECTION SITE REACTION,43
US,RHABDOMYOLYSIS,43
US,WOUND HAEMORRHAGE,43
US,COMA,42
US,IMPAIRED WORK ABILITY,42
US,ISCHAEMIA,42
US,MALNUTRITION,42
US,POOR PERIPHERAL CIRCULATION,42
US,PSORIATIC ARTHROPATHY,42
US,RENAL FAILURE CHRONIC,42
US,SOCIAL PROBLEM,42
US,SPLENOMEGALY,42
US,VASCULAR OCCLUSION,42
US,VASCULAR PSEUDOANEURYSM,42
US,ACNE,41
US,BLOOD CALCIUM INCREASED,41
US,ESSENTIAL HYPERTENSION,41
US,GLOMERULAR FILTRATION RATE DECREASED,41
US,LOW DENSITY LIPOPROTEIN INCREASED,41
US,OBESITY,41
US,OCULAR HYPERAEMIA,41
US,POLYP,41
US,TOOTH FRACTURE,41
US,APPLICATION SITE PRURITUS,40
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,40
US,EJECTION FRACTION DECREASED,40
US,FEEDING DISORDER,40
US,PALLOR,40
US,PULMONARY ALVEOLAR HAEMORRHAGE,40
US,PULMONARY HAEMORRHAGE,40
US,SINUS BRADYCARDIA,40
US,SNEEZING,40
US,TOOTH LOSS,40
US,WOUND COMPLICATION,40
US,ATRIAL FLUTTER,39
US,DENTAL CARIES,39
US,DIABETES MELLITUS INADEQUATE CONTROL,39
US,HYPERCHOLESTEROLAEMIA,39
US,LUNG INFECTION,39
US,LUNG INFILTRATION,39
US,PETECHIAE,39
US,SINUS CONGESTION,39
US,SKIN IRRITATION,39
US,TENDERNESS,39
US,THINKING ABNORMAL,39
US,TOOTH INFECTION,39
US,BACK INJURY,38
US,BREAST CANCER,38
US,ENCEPHALOPATHY,38
US,FEBRILE NEUTROPENIA,38
US,HEPATIC STEATOSIS,38
US,INCONTINENCE,38
US,INCORRECT PRODUCT STORAGE,38
US,MULTI-ORGAN FAILURE,38
US,RESTLESSNESS,38
US,RETROPERITONEAL HAEMORRHAGE,38
US,SCAR,38
US,TRICUSPID VALVE INCOMPETENCE,38
US,TROPONIN INCREASED,38
US,BLOOD MAGNESIUM DECREASED,37
US,DIABETIC KETOACIDOSIS,37
US,EAR INFECTION,37
US,FLANK PAIN,37
US,INTRACRANIAL ANEURYSM,37
US,MUSCLE ATROPHY,37
US,RETINAL HAEMORRHAGE,37
US,UPPER-AIRWAY COUGH SYNDROME,37
US,VENTRICULAR FIBRILLATION,37
US,ANAPHYLACTIC REACTION,36
US,ANGIOPATHY,36
US,CHOLECYSTITIS,36
US,EXTRA DOSE ADMINISTERED,36
US,GANGRENE,36
US,HYPOVOLAEMIC SHOCK,36
US,INJECTION SITE DISCOLOURATION,36
US,MICTURITION URGENCY,36
US,NEOPLASM PROGRESSION,36
US,PANCREATIC CARCINOMA,36
US,PARALYSIS,36
US,POOR QUALITY SLEEP,36
US,THYROID DISORDER,36
US,BASAL CELL CARCINOMA,35
US,COLON CANCER,35
US,FOOT DEFORMITY,35
US,GASTROENTERITIS VIRAL,35
US,HAEMORRHAGIC DIATHESIS,35
US,INJECTION SITE NODULE,35
US,METASTASES TO BONE,35
US,PRODUCT TASTE ABNORMAL,35
US,PULMONARY CONGESTION,35
US,SPINAL COMPRESSION FRACTURE,35
US,ABDOMINAL PAIN LOWER,34
US,BLOOD BLISTER,34
US,BLOOD CHOLESTEROL ABNORMAL,34
US,BRAIN INJURY,34
US,COLD SWEAT,34
US,DEVICE USE ERROR,34
US,EXOSTOSIS,34
US,PNEUMOTHORAX,34
US,SCRATCH,34
US,SPINAL DISORDER,34
US,BOWEL MOVEMENT IRREGULARITY,33
US,DIALYSIS,33
US,DYSLIPIDAEMIA,33
US,EYE PRURITUS,33
US,GASTRITIS EROSIVE,33
US,NODULE,33
US,OESOPHAGITIS,33
US,PERICARDIAL HAEMORRHAGE,33
US,PROCEDURAL PAIN,33
US,PRODUCT PHYSICAL ISSUE,33
US,SCAB,33
US,VENTRICULAR EXTRASYSTOLES,33
US,WOUND INFECTION,33
US,ACCIDENTAL EXPOSURE TO PRODUCT,32
US,CARDIAC MURMUR,32
US,CARDIAC VALVE DISEASE,32
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,32
US,DUODENAL ULCER,32
US,DUODENAL ULCER HAEMORRHAGE,32
US,HYPOAESTHESIA ORAL,32
US,MUSCLE DISORDER,32
US,PRESCRIBED OVERDOSE,32
US,PRODUCT ODOUR ABNORMAL,32
US,RENAL CYST,32
US,SMALL INTESTINAL OBSTRUCTION,32
US,VITAMIN D DECREASED,32
US,ANGER,31
US,AORTIC STENOSIS,31
US,BARRETT^S OESOPHAGUS,31
US,BLOOD TEST ABNORMAL,31
US,BLOOD TESTOSTERONE DECREASED,31
US,CAROTID ARTERY DISEASE,31
US,CHOLECYSTECTOMY,31
US,COORDINATION ABNORMAL,31
US,EMOTIONAL DISORDER,31
US,FEELING JITTERY,31
US,GASTROINTESTINAL ULCER,31
US,IMPAIRED GASTRIC EMPTYING,31
US,JOINT RANGE OF MOTION DECREASED,31
US,MEDICATION RESIDUE PRESENT,31
US,MUSCLE STRAIN,31
US,MUSCLE TIGHTNESS,31
US,NEPHROGENIC SYSTEMIC FIBROSIS,31
US,PERIPHERAL ARTERY OCCLUSION,31
US,PERIPHERAL COLDNESS,31
US,PERIPHERAL ISCHAEMIA,31
US,POST PROCEDURAL COMPLICATION,31
US,RETROPERITONEAL HAEMATOMA,31
US,VISUAL FIELD DEFECT,31
US,ABSCESS,30
US,BLADDER DISORDER,30
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,30
US,CLOSTRIDIUM DIFFICILE COLITIS,30
US,COLITIS ISCHAEMIC,30
US,COLITIS ULCERATIVE,30
US,DECUBITUS ULCER,30
US,FACIAL PARALYSIS,30
US,GROIN PAIN,30
US,HEAD DISCOMFORT,30
US,IMPAIRED DRIVING ABILITY,30
US,JOINT EFFUSION,30
US,MOOD SWINGS,30
US,RENAL CANCER,30
US,RESPIRATORY ARREST,30
US,SMALL INTESTINAL HAEMORRHAGE,30
US,ANGIOPLASTY,29
US,BENIGN PROSTATIC HYPERPLASIA,29
US,BURSITIS,29
US,CONCUSSION,29
US,DEVICE DISLOCATION,29
US,DRY THROAT,29
US,GASTRITIS HAEMORRHAGIC,29
US,HEARING IMPAIRED,29
US,INTENTIONAL OVERDOSE,29
US,INTERSTITIAL LUNG DISEASE,29
US,JAUNDICE,29
US,LEFT VENTRICULAR DYSFUNCTION,29
US,MOOD ALTERED,29
US,POST PROCEDURAL HAEMATOMA,29
US,PRODUCT SOLUBILITY ABNORMAL,29
US,TOE AMPUTATION,29
US,APHONIA,28
US,ASCITES,28
US,BLOOD BILIRUBIN INCREASED,28
US,BLOOD PRESSURE INADEQUATELY CONTROLLED,28
US,DEVICE RELATED INFECTION,28
US,DRUG-INDUCED LIVER INJURY,28
US,HAEMORRHAGE SUBCUTANEOUS,28
US,HEPATIC CIRRHOSIS,28
US,MUSCLE TWITCHING,28
US,SECRETION DISCHARGE,28
US,SUPRAVENTRICULAR TACHYCARDIA,28
US,THROAT TIGHTNESS,28
US,BACTERAEMIA,27
US,BLADDER CANCER,27
US,DIVERTICULUM INTESTINAL,27
US,ECZEMA,27
US,HAND FRACTURE,27
US,HYPERAESTHESIA,27
US,HYPOMAGNESAEMIA,27
US,LIGAMENT SPRAIN,27
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,27
US,MIDDLE INSOMNIA,27
US,OESOPHAGEAL DISORDER,27
US,RASH PAPULAR,27
US,SENSORY LOSS,27
US,TENDONITIS,27
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,27
US,VITREOUS FLOATERS,27
US,WEIGHT FLUCTUATION,27
US,BONE DENSITY DECREASED,26
US,CORONARY ARTERY RESTENOSIS,26
US,DECREASED ACTIVITY,26
US,DUODENITIS,26
US,HEPATIC FAILURE,26
US,HYPERCALCAEMIA,26
US,INCREASED APPETITE,26
US,JOINT DISLOCATION,26
US,LEUKOPENIA,26
US,LYMPHOMA,26
US,METABOLIC ACIDOSIS,26
US,PANCREATIC CARCINOMA METASTATIC,26
US,PULSELESS ELECTRICAL ACTIVITY,26
US,RENAL INJURY,26
US,WALKING AID USER,26
US,BLOOD ALKALINE PHOSPHATASE INCREASED,25
US,CYST,25
US,END STAGE RENAL DISEASE,25
US,GASTROINTESTINAL PAIN,25
US,HIP ARTHROPLASTY,25
US,INTERMITTENT CLAUDICATION,25
US,INTESTINAL HAEMORRHAGE,25
US,KNEE ARTHROPLASTY,25
US,LEFT VENTRICULAR HYPERTROPHY,25
US,LEG AMPUTATION,25
US,MENISCUS INJURY,25
US,NERVE COMPRESSION,25
US,NON-CARDIAC CHEST PAIN,25
US,ORAL CANDIDIASIS,25
US,ORAL MUCOSAL BLISTERING,25
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,25
US,PELVIC FRACTURE,25
US,PIGMENTATION DISORDER,25
US,RENAL PAIN,25
US,SENSORY DISTURBANCE,25
US,SYSTEMIC LUPUS ERYTHEMATOSUS,25
US,ABDOMINAL WALL HAEMATOMA,24
US,ACCIDENTAL OVERDOSE,24
US,ARTERIAL DISORDER,24
US,DERMATITIS,24
US,ELECTROCARDIOGRAM QT PROLONGED,24
US,GAIT INABILITY,24
US,LACUNAR INFARCTION,24
US,LARYNGITIS,24
US,MOUTH ULCERATION,24
US,ORAL HERPES,24
US,OSTEOSCLEROSIS,24
US,PERONEAL NERVE PALSY,24
US,RENAL HAEMORRHAGE,24
US,SPINAL PAIN,24
US,SQUAMOUS CELL CARCINOMA OF SKIN,24
US,THERAPY NON-RESPONDER,24
US,TONGUE DISORDER,24
US,TREATMENT FAILURE,24
US,AORTIC ARTERIOSCLEROSIS,23
US,APHAGIA,23
US,ATAXIA,23
US,CARDIAC FLUTTER,23
US,COMPARTMENT SYNDROME,23
US,DEVICE FAILURE,23
US,EMBOLIC STROKE,23
US,GENERALISED OEDEMA,23
US,IMPLANTABLE DEFIBRILLATOR INSERTION,23
US,INJECTION SITE EXTRAVASATION,23
US,LARGE INTESTINAL HAEMORRHAGE,23
US,METASTASES TO LUNG,23
US,NEOPLASM,23
US,PAIN OF SKIN,23
US,POSTOPERATIVE WOUND INFECTION,23
US,PROCEDURAL COMPLICATION,23
US,RESPIRATORY TRACT INFECTION,23
US,SEASONAL ALLERGY,23
US,TENDON RUPTURE,23
US,APPLICATION SITE RASH,22
US,BLOOD CALCIUM DECREASED,22
US,CEREBROVASCULAR DISORDER,22
US,DELUSION,22
US,ELECTROLYTE IMBALANCE,22
US,FIBULA FRACTURE,22
US,FRACTURE,22
US,GASTROENTERITIS,22
US,GINGIVAL PAIN,22
US,HAEMARTHROSIS,22
US,HAEMORRHAGIC TRANSFORMATION STROKE,22
US,HYPOVOLAEMIA,22
US,INJURY ASSOCIATED WITH DEVICE,22
US,INTRAVENTRICULAR HAEMORRHAGE,22
US,LUMBAR SPINAL STENOSIS,22
US,MALIGNANT MELANOMA,22
US,MENORRHAGIA,22
US,METABOLIC ENCEPHALOPATHY,22
US,MUSCLE SPASTICITY,22
US,OESOPHAGEAL HAEMORRHAGE,22
US,OSTEOLYSIS,22
US,PEPTIC ULCER,22
US,QUALITY OF LIFE DECREASED,22
US,SCOLIOSIS,22
US,SLUGGISHNESS,22
US,SUBDURAL HAEMORRHAGE,22
US,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,22
US,THIRST,22
US,TOOTH ABSCESS,22
US,URINE ODOUR ABNORMAL,22
US,ACCIDENT,21
US,AORTIC VALVE INCOMPETENCE,21
US,BACTERIAL INFECTION,21
US,BONE MARROW FAILURE,21
US,EXTRADURAL HAEMATOMA,21
US,FAECAL INCONTINENCE,21
US,GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC,21
US,INTENTIONAL UNDERDOSE,21
US,LIVER FUNCTION TEST INCREASED,21
US,MULTIPLE ALLERGIES,21
US,NEPHROPATHY,21
US,NEUTROPHIL COUNT DECREASED,21
US,NONSPECIFIC REACTION,21
US,PNEUMONITIS,21
US,PRODUCT LABEL ISSUE,21
US,PROTEINURIA,21
US,TUBULOINTERSTITIAL NEPHRITIS,21
US,UROSEPSIS,21
US,VARICOSE VEIN,21
US,ABDOMINAL TENDERNESS,20
US,ADVERSE REACTION,20
US,ARTERIOSPASM CORONARY,20
US,BEDRIDDEN,20
US,BLEEDING TIME PROLONGED,20
US,BRONCHOSPASM,20
US,COMPRESSION FRACTURE,20
US,DEPRESSED LEVEL OF CONSCIOUSNESS,20
US,EAR HAEMORRHAGE,20
US,ELECTROCARDIOGRAM ABNORMAL,20
US,EXPOSED BONE IN JAW,20
US,FOREIGN BODY,20
US,HAEMORRHAGE URINARY TRACT,20
US,HAIR COLOUR CHANGES,20
US,HALLUCINATION_ VISUAL,20
US,INCOHERENT,20
US,INTRAOCULAR PRESSURE INCREASED,20
US,LOOSE TOOTH,20
US,LYMPHOEDEMA,20
US,MUCOSAL INFLAMMATION,20
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,20
US,MYOCLONUS,20
US,POOR QUALITY DRUG ADMINISTERED,20
US,PROCEDURAL HAEMORRHAGE,20
US,PROSTATOMEGALY,20
US,RHINITIS ALLERGIC,20
US,SPUTUM DISCOLOURED,20
US,SQUAMOUS CELL CARCINOMA,20
US,SUDDEN CARDIAC DEATH,20
US,TEMPERATURE INTOLERANCE,20
US,ANAL INCONTINENCE,19
US,APPARENT DEATH,19
US,ARTHROPOD BITE,19
US,BASAL GANGLIA HAEMORRHAGE,19
US,BONE LESION,19
US,BONE LOSS,19
US,CARDIAC FAILURE ACUTE,19
US,CERVICAL VERTEBRAL FRACTURE,19
US,CORONARY ANGIOPLASTY,19
US,EXERCISE TOLERANCE DECREASED,19
US,EXTRASYSTOLES,19
US,FACIAL PAIN,19
US,GASTROINTESTINAL INFECTION,19
US,IMMUNE SYSTEM DISORDER,19
US,INCREASED UPPER AIRWAY SECRETION,19
US,INJECTION SITE RASH,19
US,MALLORY-WEISS SYNDROME,19
US,MUSCLE HAEMORRHAGE,19
US,ORAL DISORDER,19
US,PERITONITIS,19
US,PHARYNGITIS,19
US,POLYURIA,19
US,PURULENT DISCHARGE,19
US,SINUS TACHYCARDIA,19
US,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,19
US,TIBIA FRACTURE,19
US,ABDOMINAL HERNIA,18
US,AORTIC DISORDER,18
US,AORTIC VALVE REPLACEMENT,18
US,CATARACT OPERATION,18
US,DECREASED INTEREST,18
US,DIABETIC RETINOPATHY,18
US,DIEULAFOY^S VASCULAR MALFORMATION,18
US,DISSEMINATED INTRAVASCULAR COAGULATION,18
US,EAR DISCOMFORT,18
US,EYE INFECTION,18
US,FORMICATION,18
US,GASTROINTESTINAL MOTILITY DISORDER,18
US,HAEMOTHORAX,18
US,HEART VALVE INCOMPETENCE,18
US,HEPATITIS,18
US,HYPERKERATOSIS,18
US,HYPERTENSIVE HEART DISEASE,18
US,INITIAL INSOMNIA,18
US,MYOCARDIAL NECROSIS MARKER INCREASED,18
US,PROTEIN TOTAL DECREASED,18
US,RENAL CELL CARCINOMA,18
US,RENAL FUNCTION TEST ABNORMAL,18
US,SALIVARY HYPERSECRETION,18
US,SECOND PRIMARY MALIGNANCY,18
US,SKIN ABRASION,18
US,ABNORMAL FAECES,17
US,APPLICATION SITE DISCOLOURATION,17
US,APPLICATION SITE HAEMORRHAGE,17
US,ARTERIAL HAEMORRHAGE,17
US,BLINDNESS TRANSIENT,17
US,BODY TEMPERATURE INCREASED,17
US,BRAIN NATRIURETIC PEPTIDE INCREASED,17
US,BRONCHITIS CHRONIC,17
US,CARDIAC FAILURE CHRONIC,17
US,CARDIAC TAMPONADE,17
US,CHOLECYSTITIS ACUTE,17
US,COELIAC DISEASE,17
US,CONJUNCTIVAL HAEMORRHAGE,17
US,DEAFNESS UNILATERAL,17
US,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,17
US,DRUG RESISTANCE,17
US,DYSGRAPHIA,17
US,EPIGASTRIC DISCOMFORT,17
US,EYE DISCHARGE,17
US,FACIAL BONES FRACTURE,17
US,FUNCTIONAL GASTROINTESTINAL DISORDER,17
US,GLUCOSE TOLERANCE IMPAIRED,17
US,GYNAECOMASTIA,17
US,HUMERUS FRACTURE,17
US,HYPOCALCAEMIA,17
US,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,17
US,IMMUNE THROMBOCYTOPENIC PURPURA,17
US,LACTIC ACIDOSIS,17
US,LIBIDO DECREASED,17
US,LUMBAR VERTEBRAL FRACTURE,17
US,MOTOR DYSFUNCTION,17
US,MYOPATHY,17
US,NO THERAPEUTIC RESPONSE,17
US,OESOPHAGEAL ULCER,17
US,ONYCHOCLASIS,17
US,PARANASAL SINUS HYPERSECRETION,17
US,PAROSMIA,17
US,PROCTALGIA,17
UY,CONSTIPATION,1
UY,DEHYDRATION,1
UY,FALL,1
UY,GENERAL PHYSICAL HEALTH DETERIORATION,1
UY,GLUCOCORTICOID DEFICIENCY,1
UY,HAEMATURIA,1
UY,HEAD INJURY,1
UY,HYPONATRAEMIA,1
UY,LACERATION,1
UY,LOCALISED INFECTION,1
UY,MOBILITY DECREASED,1
UY,ORTHOSTATIC HYPOTENSION,1
UY,PRESYNCOPE,1
UY,URINARY RETENTION,1
UY,URINARY TRACT INFECTION,1
UY,VOMITING,1
VE,DEATH,16
VE,CEREBROVASCULAR ACCIDENT,9
VE,MYOCARDIAL INFARCTION,9
VE,RESPIRATORY ARREST,6
VE,CARDIO-RESPIRATORY ARREST,5
VE,DRUG INEFFECTIVE,4
VE,DYSPNOEA,4
VE,FALL,4
VE,FATIGUE,4
VE,HYPERTENSION,4
VE,LUNG DISORDER,4
VE,CARDIAC ARREST,3
VE,CARDIAC DISORDER,3
VE,HIP FRACTURE,3
VE,PAIN IN EXTREMITY,3
VE,ABDOMINAL PAIN,2
VE,AORTIC ANEURYSM,2
VE,ARRHYTHMIA,2
VE,ARTHRALGIA,2
VE,BLOOD CREATININE INCREASED,2
VE,BLOOD UREA INCREASED,2
VE,CARDIAC FAILURE,2
VE,CHEST PAIN,2
VE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
VE,CONFUSIONAL STATE,2
VE,CORONARY ARTERY OCCLUSION,2
VE,GAIT DISTURBANCE,2
VE,GASTROINTESTINAL HAEMORRHAGE,2
VE,HAEMOGLOBIN DECREASED,2
VE,HEADACHE,2
VE,HYPOTENSION,2
VE,INFLUENZA,2
VE,MALAISE,2
VE,MUSCLE SPASMS,2
VE,OSTEOARTHRITIS,2
VE,PNEUMONIA,2
VE,PRODUCT USE ISSUE,2
VE,PULMONARY OEDEMA,2
VE,RESPIRATORY DISORDER,2
VE,RETINAL HAEMORRHAGE,2
VE,TACHYCARDIA,2
VE,TENSION,2
VE,VOMITING,2
VE,ABASIA,1
VE,ABDOMINAL DISTENSION,1
VE,ACQUIRED MACROGLOSSIA,1
VE,AMOEBIC DYSENTERY,1
VE,ANAL HAEMORRHAGE,1
VE,ANGINA PECTORIS,1
VE,ANXIETY,1
VE,APPENDICITIS,1
VE,ARTERIAL OCCLUSIVE DISEASE,1
VE,ASTHMA,1
VE,BLADDER CANCER,1
VE,BLINDNESS,1
VE,BLINDNESS UNILATERAL,1
VE,BLOOD CALCIUM DECREASED,1
VE,BLOOD CHOLESTEROL INCREASED,1
VE,BLOOD GLUCOSE INCREASED,1
VE,BLOOD PRESSURE DECREASED,1
VE,BLOOD TRIGLYCERIDES INCREASED,1
VE,BONE CYST,1
VE,BONE DISORDER,1
VE,BONE FORMATION INCREASED,1
VE,BRAIN HYPOXIA,1
VE,BREAST CANCER,1
VE,BRONCHITIS,1
VE,BRONCHOSPASM,1
VE,CARDIAC FAILURE CONGESTIVE,1
VE,CARDIOGENIC SHOCK,1
VE,CARDIOMEGALY,1
VE,CAROTID ARTERY OCCLUSION,1
VE,CATHETERISATION CARDIAC,1
VE,CELLULITIS,1
VE,CEREBRAL ISCHAEMIA,1
VE,CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE,1
VE,CHOLELITHIASIS,1
VE,CHRONIC SINUSITIS,1
VE,CLEAR CELL RENAL CELL CARCINOMA,1
VE,CONTUSION,1
VE,CONVULSION,1
VE,COORDINATION ABNORMAL,1
VE,CORONARY ARTERY DISEASE,1
VE,COUGH,1
VE,DEAFNESS,1
VE,DEPRESSED MOOD,1
VE,DIABETES MELLITUS,1
VE,DIARRHOEA,1
VE,DISCOMFORT,1
VE,DISEASE PROGRESSION,1
VE,DISORIENTATION,1
VE,DIVERTICULITIS,1
VE,DRUG LEVEL DECREASED,1
VE,DYSLIPIDAEMIA,1
VE,DYSPEPSIA,1
VE,DYSPNOEA EXERTIONAL,1
VE,DYSPNOEA PAROXYSMAL NOCTURNAL,1
VE,ECCHYMOSIS,1
VE,ENCEPHALOPATHY,1
VE,ENDOCARDITIS BACTERIAL,1
VE,EXERCISE TOLERANCE DECREASED,1
VE,EYE DISORDER,1
VE,FEELING HOT,1
VE,FEMUR FRACTURE,1
VE,FOOT DEFORMITY,1
VE,FRACTURE,1
VE,GASTRIC DISORDER,1
VE,GASTRITIS,1
VE,GASTROINTESTINAL INFECTION,1
VE,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
VE,GENERAL PHYSICAL HEALTH DETERIORATION,1
VE,HAEMORRHAGE,1
VE,HEMIPLEGIA,1
VE,HYPERAESTHESIA,1
VE,HYPERLIPIDAEMIA,1
VE,HYPERTENSIVE CARDIOMYOPATHY,1
VE,HYPERTENSIVE HEART DISEASE,1
VE,HYPOKINESIA,1
VE,HYPONATRAEMIA,1
VE,IMPAIRED WORK ABILITY,1
VE,INFARCTION,1
VE,INGUINAL HERNIA,1
VE,INTERVERTEBRAL DISC PROTRUSION,1
VE,INTRACRANIAL ANEURYSM,1
VE,IRRITABLE BOWEL SYNDROME,1
VE,ISCHAEMIC STROKE,1
VE,JOINT DISLOCATION,1
VE,KIDNEY INFECTION,1
VE,LARGE INTESTINE BENIGN NEOPLASM,1
VE,LIMB DISCOMFORT,1
VE,LIMB INJURY,1
VE,LUNG INFECTION,1
VE,MEMORY IMPAIRMENT,1
VE,METASTASES TO LIVER,1
VE,METASTASES TO LUNG,1
VE,MYOCARDIAL ISCHAEMIA,1
VE,NAUSEA,1
VE,NEOPLASM,1
VE,NEPHROLITHIASIS,1
VE,OBESITY,1
VE,OSTEOPOROSIS,1
VE,PAIN,1
VE,PARKINSON^S DISEASE,1
VE,PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA,1
VE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
VE,PLEURAL EFFUSION,1
VE,POLLAKIURIA,1
VE,POLYURIA,1
VE,POST PROCEDURAL COMPLICATION,1
VE,PRODUCTIVE COUGH,1
VE,PROSTATIC DISORDER,1
VE,PULMONARY FIBROSIS,1
VE,PYELOCALIECTASIS,1
VE,PYELONEPHRITIS,1
VE,RASH GENERALISED,1
VE,RASH PAPULAR,1
VE,RENAL DISORDER,1
VE,RENAL FAILURE,1
VE,RESPIRATORY FAILURE,1
VE,RESPIRATORY TRACT ULCERATION,1
VE,RETINAL INFARCTION,1
VE,SEIZURE,1
VE,SPEECH DISORDER,1
VE,SPINAL DEFORMITY,1
VE,SPINAL PAIN,1
VE,SPONDYLITIS,1
VE,SWELLING,1
VE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
VE,TERMINAL STATE,1
VE,THIRST,1
VE,THROMBOSIS,1
VE,THYROID NEOPLASM,1
VE,TOOTHACHE,1
VE,TREMOR,1
VE,TYPE 2 DIABETES MELLITUS,1
VE,URINARY TRACT INFECTION,1
VE,VASCULAR OCCLUSION,1
VE,VENTRICULAR HYPOKINESIA,1
VE,VISUAL IMPAIRMENT,1
VN,ACUTE CORONARY SYNDROME,1
VN,ANAEMIA,1
VN,CARDIAC FAILURE,1
VN,CEREBROVASCULAR ACCIDENT,1
VN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
VN,DEATH,1
VN,ELECTROLYTE IMBALANCE,1
VN,GASTROINTESTINAL HAEMORRHAGE,1
VN,GOUT,1
VN,HAEMORRHAGE INTRACRANIAL,1
VN,HEPATIC ENZYME INCREASED,1
VN,IMPAIRED HEALING,1
VN,INFECTION,1
VN,MALNUTRITION,1
VN,PNEUMONIA,1
VN,RESPIRATORY FAILURE,1
VN,SEPSIS,1
VN,VESTIBULAR ATAXIA,1
VN,VESTIBULAR DISORDER,1
VI,CORONARY ARTERIAL STENT INSERTION,1
VI,HEREDITARY ANGIOEDEMA,1
VI,MYOCARDIAL INFARCTION,1
